{
  "Status Epilepticus": {
    "id": "status-epilepticus",
    "title": "Status Epilepticus",
    "version": "1.4",
    "icd10": [
      "** G40.901 (Epilepsy",
      "unspecified",
      "not intractable",
      "with status epilepticus)",
      "G41.0 (Grand mal status epilepticus)",
      "G41.1 (Petit mal status epilepticus)",
      "G41.2 (Complex partial status epilepticus)",
      "G41.8 (Other status epilepticus)",
      "G41.9 (Status epilepticus",
      "unspecified)"
    ],
    "scope": "** Management of convulsive status epilepticus (CSE) and non-convulsive status epilepticus (NCSE) in adults. Covers staged treatment protocol from emergent benzodiazepines through refractory and super-refractory phases. Includes diagnostic workup to identify underlying etiology and specific protocols for NORSE/FIRES. Excludes pediatric status epilepticus, neonatal seizures, and psychogenic non-epileptic status.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "Point-of-care glucose",
            "rationale": "Hypoglycemia is immediately reversible cause",
            "target": ">70 mg/dL",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "CBC with differential",
            "rationale": "Infection screen, baseline before ASMs",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "CMP (BMP + LFTs)",
            "rationale": "Electrolyte abnormalities, renal/hepatic function for ASM dosing",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Magnesium",
            "rationale": "Hypomagnesemia lowers seizure threshold",
            "target": ">1.8 mg/dL",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Calcium (ionized if available)",
            "rationale": "Hypocalcemia can cause seizures",
            "target": "Ionized 4.5-5.3 mg/dL",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Phosphorus",
            "rationale": "Hypophosphatemia lowers seizure threshold",
            "target": ">2.5 mg/dL",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Blood gas (ABG or VBG)",
            "rationale": "Acidosis, oxygenation, ventilation status",
            "target": "pH >7.2; correct severe acidosis",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Lactate",
            "rationale": "Elevated in prolonged seizure; marker of severity",
            "target": "Will be elevated; trending useful",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Urine drug screen",
            "rationale": "Illicit drugs, withdrawal states",
            "target": "Identify triggers",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Blood alcohol level",
            "rationale": "Alcohol withdrawal common cause",
            "target": "Correlate with history",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "ASM levels (if on therapy)",
            "rationale": "Subtherapeutic levels as precipitant",
            "target": "Therapeutic range",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Pregnancy test (women of childbearing age)",
            "rationale": "Eclampsia; affects ASM choice",
            "target": "Document status",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Extended Workup": [
          {
            "item": "Ammonia",
            "rationale": "Hepatic encephalopathy, valproate toxicity, urea cycle disorders",
            "target": "<35 μmol/L",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "TSH",
            "rationale": "Thyroid storm/myxedema",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Troponin",
            "rationale": "Cardiac stress from prolonged seizure",
            "target": "May be elevated",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "CPK/CK",
            "rationale": "Rhabdomyolysis from prolonged convulsions",
            "target": "Elevated; monitor trend",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Cortisol (random)",
            "rationale": "Adrenal insufficiency",
            "target": "Normal stress response",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Serum osmolality",
            "rationale": "Hypo/hyperosmolar states",
            "target": "280-295 mOsm/kg",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Procalcitonin",
            "rationale": "CNS infection if suspected",
            "target": "<0.5 ng/mL",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Coagulation panel (PT/INR, PTT)",
            "rationale": "Pre-LP, hemorrhage risk",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Type and screen",
            "rationale": "Anticipate possible surgical intervention",
            "target": "Available",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Urinalysis",
            "rationale": "UTI as precipitant (especially elderly)",
            "target": "Negative",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "URGENT"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Autoimmune encephalitis panel (serum)",
            "rationale": "Anti-NMDAR, LGI1, CASPR2 in NORSE",
            "target": "Negative",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Paraneoplastic panel (serum)",
            "rationale": "Subacute onset, smoking history, weight loss",
            "target": "Negative",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "HIV",
            "rationale": "HIV-associated CNS disease",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "RPR/VDRL",
            "rationale": "Neurosyphilis",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Ceruloplasmin, serum copper",
            "rationale": "Wilson disease (young patients)",
            "target": "Normal",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "Porphyrins (urine/serum)",
            "rationale": "Acute intermittent porphyria",
            "target": "Normal",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "Mitochondrial DNA testing",
            "rationale": "MELAS, other mitochondrial disorders",
            "target": "Normal",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "Pyridoxine trial (empiric)",
            "rationale": "Pyridoxine-dependent seizures (rare, usually pediatric)",
            "target": "Response to treatment",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "URGENT"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "Opening pressure",
            "rationale": "Elevated ICP",
            "target": "10-20 cm H2O",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Cell count (tubes 1 and 4)",
            "rationale": "Infection, inflammation",
            "target": "WBC <5; RBC 0",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Protein",
            "rationale": "Elevated in infection, inflammation",
            "target": "15-45 mg/dL",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Glucose with serum glucose",
            "rationale": "Low in bacterial/fungal meningitis",
            "target": ">60% serum",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Gram stain and culture",
            "rationale": "Bacterial meningitis",
            "target": "No organisms",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "BioFire FilmArray ME Panel",
            "rationale": "Rapid pathogen identification",
            "target": "Negative",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "HSV-1/2 PCR",
            "rationale": "HSV encephalitis",
            "target": "Negative",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Autoimmune encephalitis panel (CSF)",
            "rationale": "NORSE, limbic encephalitis",
            "target": "Negative",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Cytology",
            "rationale": "Carcinomatous meningitis",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Oligoclonal bands",
            "rationale": "Demyelinating disease",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "CT head without contrast",
            "timing": "Immediately after stabilization",
            "target": "Mass, hemorrhage, stroke, herniation, hydrocephalus",
            "contraindications": "None in emergency",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Continuous EEG (cEEG) monitoring",
            "timing": "As soon as available; mandatory in RSE/SRSE",
            "target": "Seizure burden, treatment response, NCSE detection",
            "contraindications": "None significant",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Chest X-ray",
            "timing": "Aspiration risk, ETT placement confirmation",
            "target": "Aspiration, ETT position",
            "contraindications": "None",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Extended": [
          {
            "item": "MRI brain with and without contrast",
            "timing": "When stable; within 24-48h",
            "target": "Encephalitis, stroke, tumor, cortical injury from SE",
            "contraindications": "Hemodynamic instability, pacemaker",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "CT angiography head/neck",
            "timing": "If stroke suspected",
            "target": "Large vessel occlusion, dissection",
            "contraindications": "Contrast allergy, renal insufficiency",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "MRA/MRV brain",
            "timing": "If vascular etiology suspected",
            "target": "Venous thrombosis, vascular malformation",
            "contraindications": "Hemodynamic instability, pacemaker",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "CT chest/abdomen/pelvis",
            "timing": "If paraneoplastic suspected",
            "target": "Occult malignancy",
            "contraindications": "Contrast allergy",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Echocardiogram",
            "timing": "If embolic stroke suspected, endocarditis",
            "target": "Vegetation, thrombus",
            "contraindications": "None",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "PET-CT (whole body)",
            "timing": "Occult malignancy workup",
            "target": "Tumor identification",
            "contraindications": "Hemodynamic instability",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "Brain biopsy",
            "timing": "Refractory cases, suspected encephalitis",
            "target": "Histopathologic diagnosis",
            "contraindications": "Coagulopathy, critical location",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          }
        ]
      },
      "Treatment": {
        "Stabilization (Time 0)": [
          {
            "item": "Airway positioning/management",
            "route": "—",
            "indication": "Airway protection",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Airway positioning/management N/A —"
                }
              ],
              "route": "—",
              "instructions": "Head-tilt chin-lift, oral airway, prepare for intubation",
              "orderSentence": "Airway positioning/management N/A —"
            },
            "contraindications": "None",
            "monitoring": "O2 sat, airway patency",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Supplemental oxygen",
            "route": "INH",
            "indication": "Oxygenation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "15 L/min NRB",
                  "orderSentence": "Supplemental oxygen 15 L/min NRB INH"
                }
              ],
              "route": "INH",
              "instructions": "Non-rebreather 15 L/min or bag-valve-mask; target O2 sat >94%",
              "orderSentence": "Supplemental oxygen 15 L/min NRB INH"
            },
            "contraindications": "None",
            "monitoring": "O2 sat >94%",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "IV access (two large-bore)",
            "route": "—",
            "indication": "Vascular access",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "IV access (two large-bore) N/A —"
                }
              ],
              "route": "—",
              "instructions": "18G or larger x2",
              "orderSentence": "IV access (two large-bore) N/A —"
            },
            "contraindications": "None",
            "monitoring": "IV patency",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Cardiac monitoring",
            "route": "—",
            "indication": "Rhythm monitoring",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Cardiac monitoring N/A —"
                }
              ],
              "route": "—",
              "instructions": "Continuous telemetry",
              "orderSentence": "Cardiac monitoring N/A —"
            },
            "contraindications": "None",
            "monitoring": "Rhythm, HR, BP",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Dextrose 50%",
            "route": "IV",
            "indication": "Hypoglycemia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mL",
                  "orderSentence": "Dextrose 50% 25 mL IV"
                },
                {
                  "text": "50 mL",
                  "orderSentence": "Dextrose 50% 50 mL IV"
                }
              ],
              "route": "IV",
              "instructions": "50 mL IV push (25g) if glucose <70 or unknown",
              "orderSentence": "Dextrose 50% 25 mL IV"
            },
            "contraindications": "Document hyperglycemia",
            "monitoring": "Glucose",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Thiamine",
            "route": "IV",
            "indication": "Wernicke prevention",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg",
                  "orderSentence": "Thiamine 100 mg IV"
                },
                {
                  "text": "500 mg",
                  "orderSentence": "Thiamine 500 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "100-500 mg IV BEFORE or WITH glucose",
              "orderSentence": "Thiamine 100 mg IV"
            },
            "contraindications": "None",
            "monitoring": "None",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Isotonic fluids",
            "route": "IV",
            "indication": "Volume resuscitation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "NS 1000 mL",
                  "orderSentence": "Isotonic fluids NS 1000 mL IV"
                },
                {
                  "text": "LR 1000 mL",
                  "orderSentence": "Isotonic fluids LR 1000 mL IV"
                }
              ],
              "route": "IV",
              "instructions": "NS or LR wide open initially",
              "orderSentence": "Isotonic fluids NS 1000 mL IV"
            },
            "contraindications": "Pulmonary edema",
            "monitoring": "BP, I/O",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Emergent/First-Line - Benzodiazepines (Time 0-5 min)": [
          {
            "item": "Lorazepam IV",
            "route": "IV",
            "indication": "Active seizure termination",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 mg",
                  "orderSentence": "Lorazepam IV 2 mg IV"
                },
                {
                  "text": "4 mg",
                  "orderSentence": "Lorazepam IV 4 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "0.1 mg/kg IV (max 4 mg/dose); may repeat x1 in 5 min if still seizing; total max 8 mg",
              "orderSentence": "Lorazepam IV 2 mg IV"
            },
            "contraindications": "Acute narrow-angle glaucoma",
            "monitoring": "RR, O2 sat, BP, sedation; airway equipment ready",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Midazolam IM",
            "route": "IM",
            "indication": "Active seizure (no IV access)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Midazolam IM 10 mg IM"
                }
              ],
              "route": "IM",
              "instructions": "10 mg IM (≥40 kg) or 0.2 mg/kg IM; faster than IV if no access",
              "orderSentence": "Midazolam IM 10 mg IM"
            },
            "contraindications": "Respiratory compromise",
            "monitoring": "RR, O2 sat; prepare IV access",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Midazolam IV",
            "route": "IV",
            "indication": "Active seizure termination",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Midazolam IV 5 mg IV"
                },
                {
                  "text": "10 mg",
                  "orderSentence": "Midazolam IV 10 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "0.2 mg/kg IV (max 10 mg); may repeat x1",
              "orderSentence": "Midazolam IV 5 mg IV"
            },
            "contraindications": "Acute narrow-angle glaucoma",
            "monitoring": "RR, O2 sat, BP",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Midazolam intranasal",
            "route": "IN",
            "indication": "Active seizure (no IV access)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Midazolam intranasal 10 mg IN"
                }
              ],
              "route": "IN",
              "instructions": "5 mg per nostril (10 mg total) if no IV/IM access",
              "orderSentence": "Midazolam intranasal 10 mg IN"
            },
            "contraindications": "Nasal obstruction",
            "monitoring": "RR, O2 sat",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Midazolam buccal",
            "route": "BUCCAL",
            "indication": "Active seizure (no IV access)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Midazolam buccal 10 mg BUCCAL"
                }
              ],
              "route": "BUCCAL",
              "instructions": "10 mg buccal (if available)",
              "orderSentence": "Midazolam buccal 10 mg BUCCAL"
            },
            "contraindications": "Oral trauma",
            "monitoring": "RR, O2 sat",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Diazepam IV",
            "route": "IV",
            "indication": "Active seizure termination",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Diazepam IV 5 mg IV"
                },
                {
                  "text": "10 mg",
                  "orderSentence": "Diazepam IV 10 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "0.15 mg/kg IV (max 10 mg); may repeat x1 in 5 min; short duration - requires follow-up ASM",
              "orderSentence": "Diazepam IV 5 mg IV"
            },
            "contraindications": "Acute narrow-angle glaucoma",
            "monitoring": "RR, O2 sat; short duration - requires follow-up ASM",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Diazepam rectal",
            "route": "PR",
            "indication": "Active seizure (no IV access)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Diazepam rectal 10 mg PR"
                },
                {
                  "text": "20 mg",
                  "orderSentence": "Diazepam rectal 20 mg PR"
                }
              ],
              "route": "PR",
              "instructions": "0.2-0.5 mg/kg PR (max 20 mg); use rectal gel formulation",
              "orderSentence": "Diazepam rectal 10 mg PR"
            },
            "contraindications": "Rectal pathology",
            "monitoring": "RR, O2 sat",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Urgent/Second-Line ASMs (Time 5-20 min)": [
          {
            "item": "Levetiracetam IV (ESETT dosing)",
            "route": "IV",
            "indication": "Second-line SE treatment",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4000 mg",
                  "orderSentence": "Levetiracetam IV (ESETT dosing) 4000 mg IV"
                },
                {
                  "text": "4500 mg",
                  "orderSentence": "Levetiracetam IV (ESETT dosing) 4500 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "60 mg/kg IV (max 4500 mg) over 10-15 min",
              "orderSentence": "Levetiracetam IV (ESETT dosing) 4000 mg IV"
            },
            "contraindications": "None absolute; reduce if CrCl <50",
            "monitoring": "Generally well tolerated; agitation",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Levetiracetam IV (conservative)",
            "route": "IV",
            "indication": "Second-line SE treatment",
            "dosing": {
              "doseOptions": [
                {
                  "text": "3000 mg",
                  "orderSentence": "Levetiracetam IV (conservative) 3000 mg IV"
                },
                {
                  "text": "4000 mg",
                  "orderSentence": "Levetiracetam IV (conservative) 4000 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "40 mg/kg IV (max 4500 mg) over 10-15 min",
              "orderSentence": "Levetiracetam IV (conservative) 3000 mg IV"
            },
            "contraindications": "None absolute; reduce if CrCl <50",
            "monitoring": "Generally well tolerated; agitation",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Fosphenytoin IV",
            "route": "IV",
            "indication": "Second-line SE treatment",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mg PE",
                  "orderSentence": "Fosphenytoin IV 1000 mg PE IV"
                },
                {
                  "text": "1500 mg PE",
                  "orderSentence": "Fosphenytoin IV 1500 mg PE IV"
                }
              ],
              "route": "IV",
              "instructions": "20 mg PE/kg IV at 150 mg PE/min; may give additional 5-10 mg PE/kg if needed",
              "orderSentence": "Fosphenytoin IV 1000 mg PE IV"
            },
            "contraindications": "2nd/3rd degree AV block, sinus bradycardia, allergy",
            "monitoring": "Continuous cardiac monitor, BP q5min during infusion",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Valproate IV",
            "route": "IV",
            "indication": "Second-line SE treatment",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2000 mg",
                  "orderSentence": "Valproate IV 2000 mg IV"
                },
                {
                  "text": "2500 mg",
                  "orderSentence": "Valproate IV 2500 mg IV"
                },
                {
                  "text": "3000 mg",
                  "orderSentence": "Valproate IV 3000 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "40 mg/kg IV (max 3000 mg) over 10 min",
              "orderSentence": "Valproate IV 2000 mg IV"
            },
            "contraindications": "Pregnancy, hepatic disease, mitochondrial disease, urea cycle disorders, pancreatitis",
            "monitoring": "Ammonia, LFTs; avoid in unknown pregnancy status",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Lacosamide IV",
            "route": "IV",
            "indication": "Second-line SE treatment",
            "dosing": {
              "doseOptions": [
                {
                  "text": "200 mg",
                  "orderSentence": "Lacosamide IV 200 mg IV"
                },
                {
                  "text": "300 mg",
                  "orderSentence": "Lacosamide IV 300 mg IV"
                },
                {
                  "text": "400 mg",
                  "orderSentence": "Lacosamide IV 400 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "400 mg IV over 15 min (can give 200 mg over 5 min if urgent)",
              "orderSentence": "Lacosamide IV 200 mg IV"
            },
            "contraindications": "PR >200 ms, 2nd/3rd degree AV block, severe hepatic impairment",
            "monitoring": "ECG for PR interval",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Brivaracetam IV",
            "route": "IV",
            "indication": "Second-line SE treatment",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg",
                  "orderSentence": "Brivaracetam IV 100 mg IV"
                },
                {
                  "text": "200 mg",
                  "orderSentence": "Brivaracetam IV 200 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "100-200 mg IV over 2-5 min; no titration needed",
              "orderSentence": "Brivaracetam IV 100 mg IV"
            },
            "contraindications": "Hepatic impairment (reduce dose)",
            "monitoring": "Faster onset than levetiracetam; fewer behavioral effects",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Phenytoin IV",
            "route": "IV",
            "indication": "Second-line SE treatment",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mg",
                  "orderSentence": "Phenytoin IV 1000 mg IV"
                },
                {
                  "text": "1500 mg",
                  "orderSentence": "Phenytoin IV 1500 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "20 mg/kg IV at max 50 mg/min (if fosphenytoin unavailable); MUST use large vein",
              "orderSentence": "Phenytoin IV 1000 mg IV"
            },
            "contraindications": "AV block, sinus bradycardia",
            "monitoring": "Cardiac monitor; tissue necrosis risk",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Phenobarbital IV",
            "route": "IV",
            "indication": "Second-line SE treatment",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mg",
                  "orderSentence": "Phenobarbital IV 1000 mg IV"
                },
                {
                  "text": "1500 mg",
                  "orderSentence": "Phenobarbital IV 1500 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "15-20 mg/kg IV at 50-100 mg/min; often requires intubation",
              "orderSentence": "Phenobarbital IV 1000 mg IV"
            },
            "contraindications": "Severe respiratory disease, porphyria",
            "monitoring": "Respiratory depression",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Refractory SE - Anesthetic Infusions (Time 20-60 min)": [
          {
            "item": "Midazolam infusion",
            "route": "IV",
            "indication": "Refractory SE anesthesia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.1 mg/kg/hr",
                  "orderSentence": "Midazolam infusion 0.1 mg/kg/hr IV"
                },
                {
                  "text": "0.5 mg/kg/hr",
                  "orderSentence": "Midazolam infusion 0.5 mg/kg/hr IV"
                },
                {
                  "text": "1 mg/kg/hr",
                  "orderSentence": "Midazolam infusion 1 mg/kg/hr IV"
                },
                {
                  "text": "2 mg/kg/hr",
                  "orderSentence": "Midazolam infusion 2 mg/kg/hr IV"
                }
              ],
              "route": "IV",
              "instructions": "Load 0.2 mg/kg bolus; start 0.1 mg/kg/hr, titrate by 0.1 mg/kg/hr q15min to seizure suppression; max 2 mg/kg/hr",
              "orderSentence": "Midazolam infusion 0.1 mg/kg/hr IV"
            },
            "contraindications": "Hemodynamic instability (relative)",
            "monitoring": "cEEG, BP (hypotension common), sedation scale",
            "ED": "URGENT",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Propofol infusion",
            "route": "IV",
            "indication": "Refractory SE anesthesia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mcg/kg/min",
                  "orderSentence": "Propofol infusion 20 mcg/kg/min IV"
                },
                {
                  "text": "50 mcg/kg/min",
                  "orderSentence": "Propofol infusion 50 mcg/kg/min IV"
                },
                {
                  "text": "100 mcg/kg/min",
                  "orderSentence": "Propofol infusion 100 mcg/kg/min IV"
                },
                {
                  "text": "200 mcg/kg/min",
                  "orderSentence": "Propofol infusion 200 mcg/kg/min IV"
                }
              ],
              "route": "IV",
              "instructions": "Load 1-2 mg/kg bolus (may repeat x1); start 20 mcg/kg/min, titrate by 10 mcg/kg/min q5min; max 200 mcg/kg/min",
              "orderSentence": "Propofol infusion 20 mcg/kg/min IV"
            },
            "contraindications": "Propofol infusion syndrome (limit to <48h at high dose), egg/soy allergy, pregnancy",
            "monitoring": "cEEG, triglycerides q24-48h, CPK, metabolic acidosis, BP",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Ketamine infusion",
            "route": "IV",
            "indication": "Refractory SE anesthesia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 mg/kg/hr",
                  "orderSentence": "Ketamine infusion 1 mg/kg/hr IV"
                },
                {
                  "text": "2 mg/kg/hr",
                  "orderSentence": "Ketamine infusion 2 mg/kg/hr IV"
                },
                {
                  "text": "3 mg/kg/hr",
                  "orderSentence": "Ketamine infusion 3 mg/kg/hr IV"
                },
                {
                  "text": "5 mg/kg/hr",
                  "orderSentence": "Ketamine infusion 5 mg/kg/hr IV"
                }
              ],
              "route": "IV",
              "instructions": "Load 1-2 mg/kg bolus; start 1 mg/kg/hr, titrate by 0.5 mg/kg/hr q15-30min; max 5 mg/kg/hr; consider EARLY use",
              "orderSentence": "Ketamine infusion 1 mg/kg/hr IV"
            },
            "contraindications": "Uncontrolled hypertension, elevated ICP (relative - may be neuroprotective)",
            "monitoring": "cEEG, BP (may increase), HR; less hypotension than other anesthetics",
            "ED": "URGENT",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Ketamine + Midazolam (combination)",
            "route": "IV",
            "indication": "Refractory SE anesthesia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Dual infusion",
                  "orderSentence": "Ketamine + Midazolam (combination) Dual infusion IV"
                }
              ],
              "route": "IV",
              "instructions": "Ketamine load 1 mg/kg + Midazolam load 0.2 mg/kg; Ketamine 1-5 mg/kg/hr + Midazolam 0.1-2 mg/kg/hr; titrate to burst suppression; 2024 data supports combination",
              "orderSentence": "Ketamine + Midazolam (combination) Dual infusion IV"
            },
            "contraindications": "Uncontrolled hypertension, elevated ICP (relative), hemodynamic instability (relative)",
            "monitoring": "cEEG, combination may reduce SE duration faster than midazolam alone",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Pentobarbital infusion",
            "route": "IV",
            "indication": "Super-refractory SE anesthesia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5 mg/kg/hr",
                  "orderSentence": "Pentobarbital infusion 0.5 mg/kg/hr IV"
                },
                {
                  "text": "1 mg/kg/hr",
                  "orderSentence": "Pentobarbital infusion 1 mg/kg/hr IV"
                },
                {
                  "text": "3 mg/kg/hr",
                  "orderSentence": "Pentobarbital infusion 3 mg/kg/hr IV"
                },
                {
                  "text": "5 mg/kg/hr",
                  "orderSentence": "Pentobarbital infusion 5 mg/kg/hr IV"
                }
              ],
              "route": "IV",
              "instructions": "Load 5-15 mg/kg at 50 mg/min; start 0.5-1 mg/kg/hr, titrate to burst suppression; max 5 mg/kg/hr; longest half-life",
              "orderSentence": "Pentobarbital infusion 0.5 mg/kg/hr IV"
            },
            "contraindications": "Severe cardiac dysfunction",
            "monitoring": "cEEG, BP (significant hypotension - need pressors), cardiac output",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Super-Refractory SE - Additional Agents": [
          {
            "item": "Add second anesthetic",
            "route": "IV",
            "indication": "Super-refractory SE",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per agent",
                  "orderSentence": "Add second anesthetic Per agent IV"
                }
              ],
              "route": "IV",
              "instructions": "Combine midazolam + propofol, or add ketamine to either",
              "orderSentence": "Add second anesthetic Per agent IV"
            },
            "contraindications": "Per agent",
            "monitoring": "cEEG, hemodynamics",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Topiramate (enteral)",
            "route": "NGT",
            "indication": "Super-refractory SE adjunct",
            "dosing": {
              "doseOptions": [
                {
                  "text": "200 mg BID",
                  "orderSentence": "Topiramate (enteral) 200 mg BID NGT"
                },
                {
                  "text": "300 mg BID",
                  "orderSentence": "Topiramate (enteral) 300 mg BID NGT"
                },
                {
                  "text": "400 mg BID",
                  "orderSentence": "Topiramate (enteral) 400 mg BID NGT"
                }
              ],
              "route": "NGT",
              "instructions": "Load 300-400 mg via NGT; then 200-400 mg BID; max 1600 mg/day",
              "orderSentence": "Topiramate (enteral) 200 mg BID NGT"
            },
            "contraindications": "Metabolic acidosis, kidney stones",
            "monitoring": "Bicarbonate, renal function",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Lacosamide (if not tried)",
            "route": "IV",
            "indication": "Super-refractory SE adjunct",
            "dosing": {
              "doseOptions": [
                {
                  "text": "200 mg BID",
                  "orderSentence": "Lacosamide (if not tried) 200 mg BID IV"
                },
                {
                  "text": "300 mg BID",
                  "orderSentence": "Lacosamide (if not tried) 300 mg BID IV"
                },
                {
                  "text": "400 mg BID",
                  "orderSentence": "Lacosamide (if not tried) 400 mg BID IV"
                }
              ],
              "route": "IV",
              "instructions": "400 mg IV load, then 200-400 mg BID",
              "orderSentence": "Lacosamide (if not tried) 200 mg BID IV"
            },
            "contraindications": "PR prolongation",
            "monitoring": "ECG",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Perampanel (enteral)",
            "route": "NGT",
            "indication": "Super-refractory SE adjunct",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4 mg daily",
                  "orderSentence": "Perampanel (enteral) 4 mg daily NGT"
                },
                {
                  "text": "8 mg daily",
                  "orderSentence": "Perampanel (enteral) 8 mg daily NGT"
                },
                {
                  "text": "12 mg daily",
                  "orderSentence": "Perampanel (enteral) 12 mg daily NGT"
                }
              ],
              "route": "NGT",
              "instructions": "4-8 mg via NGT daily; titrate to 12 mg daily",
              "orderSentence": "Perampanel (enteral) 4 mg daily NGT"
            },
            "contraindications": "None absolute",
            "monitoring": "Aggression, sedation",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Magnesium sulfate infusion",
            "route": "IV",
            "indication": "Super-refractory SE adjunct",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4 g load",
                  "orderSentence": "Magnesium sulfate infusion 4 g load IV"
                },
                {
                  "text": "1 g/hr infusion",
                  "orderSentence": "Magnesium sulfate infusion 1 g/hr infusion IV"
                },
                {
                  "text": "2 g/hr infusion",
                  "orderSentence": "Magnesium sulfate infusion 2 g/hr infusion IV"
                }
              ],
              "route": "IV",
              "instructions": "4-6 g IV over 20 min, then 1-2 g/hr infusion; target Mg 3.5-4 mg/dL",
              "orderSentence": "Magnesium sulfate infusion 4 g load IV"
            },
            "contraindications": "Renal failure (relative), myasthenia",
            "monitoring": "Mg levels, reflexes, respiratory status",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Pyridoxine (empiric trial)",
            "route": "IV",
            "indication": "Pyridoxine-dependent seizures",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg",
                  "orderSentence": "Pyridoxine (empiric trial) 100 mg IV"
                },
                {
                  "text": "500 mg",
                  "orderSentence": "Pyridoxine (empiric trial) 500 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "100-500 mg IV; may try single dose empirically",
              "orderSentence": "Pyridoxine (empiric trial) 100 mg IV"
            },
            "contraindications": "None",
            "monitoring": "Response to treatment",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Ketogenic diet",
            "route": "ENTERAL",
            "indication": "Super-refractory SE metabolic therapy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Ketogenic diet N/A ENTERAL"
                }
              ],
              "route": "ENTERAL",
              "instructions": "Initiate within 7 days per NORSE consensus; requires nutrition support",
              "orderSentence": "Ketogenic diet N/A ENTERAL"
            },
            "contraindications": "Pyruvate carboxylase deficiency, fatty acid oxidation disorders",
            "monitoring": "Ketones, glucose, lipids",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Hypothermia (32-35°C)",
            "route": "—",
            "indication": "Super-refractory SE neuroprotection",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Hypothermia (32-35°C) N/A —"
                }
              ],
              "route": "—",
              "instructions": "Targeted temperature management x 24-48h",
              "orderSentence": "Hypothermia (32-35°C) N/A —"
            },
            "contraindications": "Coagulopathy, severe infection",
            "monitoring": "Temperature, coagulation, infection",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "Electroconvulsive therapy",
            "route": "—",
            "indication": "Super-refractory SE rescue",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Electroconvulsive therapy N/A —"
                }
              ],
              "route": "—",
              "instructions": "If all else fails; requires anesthesia",
              "orderSentence": "Electroconvulsive therapy N/A —"
            },
            "contraindications": "Raised ICP, recent stroke",
            "monitoring": "Per ECT protocol",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "Epilepsy surgery (emergent)",
            "route": "—",
            "indication": "Lesional super-refractory SE",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Epilepsy surgery (emergent) N/A —"
                }
              ],
              "route": "—",
              "instructions": "Resection if focal lesion identified",
              "orderSentence": "Epilepsy surgery (emergent) N/A —"
            },
            "contraindications": "Eloquent cortex, multifocal",
            "monitoring": "Per surgical team",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "EXT"
          }
        ],
        "NORSE/FIRES Immunotherapy Protocol": [
          {
            "timing": "**Day 0-3**",
            "dosing": "See below"
          },
          {
            "timing": "**Day 3-7**",
            "dosing": "Add remaining first-line agents"
          },
          {
            "timing": "**Day 7**",
            "dosing": "Initiate with nutrition support"
          },
          {
            "timing": "**Day 7+**",
            "dosing": "If first-line inadequate"
          }
        ],
        "Symptomatic/Supportive ICU Care": [
          {
            "item": "Norepinephrine",
            "route": "IV",
            "indication": "Hypotension from anesthetics",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.1 mcg/kg/min",
                  "orderSentence": "Norepinephrine 0.1 mcg/kg/min IV"
                },
                {
                  "text": "0.2 mcg/kg/min",
                  "orderSentence": "Norepinephrine 0.2 mcg/kg/min IV"
                },
                {
                  "text": "0.5 mcg/kg/min",
                  "orderSentence": "Norepinephrine 0.5 mcg/kg/min IV"
                }
              ],
              "route": "IV",
              "instructions": "Start 0.1 mcg/kg/min; titrate to MAP ≥65",
              "orderSentence": "Norepinephrine 0.1 mcg/kg/min IV"
            },
            "contraindications": "Hypovolemia (correct first)",
            "monitoring": "Arterial line, MAP",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Vasopressin",
            "route": "IV",
            "indication": "Adjunct pressor",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.04 units/min",
                  "orderSentence": "Vasopressin 0.04 units/min IV"
                }
              ],
              "route": "IV",
              "instructions": "0.04 units/min fixed dose",
              "orderSentence": "Vasopressin 0.04 units/min IV"
            },
            "contraindications": "Cardiac ischemia",
            "monitoring": "MAP, cardiac status",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Fentanyl infusion",
            "route": "IV",
            "indication": "Analgesia/sedation adjunct",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mcg/hr",
                  "orderSentence": "Fentanyl infusion 25 mcg/hr IV"
                },
                {
                  "text": "50 mcg/hr",
                  "orderSentence": "Fentanyl infusion 50 mcg/hr IV"
                },
                {
                  "text": "100 mcg/hr",
                  "orderSentence": "Fentanyl infusion 100 mcg/hr IV"
                }
              ],
              "route": "IV",
              "instructions": "25-100 mcg/hr; titrate to comfort",
              "orderSentence": "Fentanyl infusion 25 mcg/hr IV"
            },
            "contraindications": "Hemodynamic instability",
            "monitoring": "Pain scale, respiratory status",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Propofol (sub-anesthetic)",
            "route": "IV",
            "indication": "Sedation during cEEG",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mcg/kg/min",
                  "orderSentence": "Propofol (sub-anesthetic) 10 mcg/kg/min IV"
                },
                {
                  "text": "25 mcg/kg/min",
                  "orderSentence": "Propofol (sub-anesthetic) 25 mcg/kg/min IV"
                },
                {
                  "text": "50 mcg/kg/min",
                  "orderSentence": "Propofol (sub-anesthetic) 50 mcg/kg/min IV"
                }
              ],
              "route": "IV",
              "instructions": "5-50 mcg/kg/min",
              "orderSentence": "Propofol (sub-anesthetic) 10 mcg/kg/min IV"
            },
            "contraindications": "Propofol infusion syndrome risk, egg/soy allergy, pregnancy",
            "monitoring": "Sedation scale",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Dexmedetomidine",
            "route": "IV",
            "indication": "Sedation, possible antiseizure",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.2 mcg/kg/hr",
                  "orderSentence": "Dexmedetomidine 0.2 mcg/kg/hr IV"
                },
                {
                  "text": "0.5 mcg/kg/hr",
                  "orderSentence": "Dexmedetomidine 0.5 mcg/kg/hr IV"
                },
                {
                  "text": "1 mcg/kg/hr",
                  "orderSentence": "Dexmedetomidine 1 mcg/kg/hr IV"
                },
                {
                  "text": "1.5 mcg/kg/hr",
                  "orderSentence": "Dexmedetomidine 1.5 mcg/kg/hr IV"
                }
              ],
              "route": "IV",
              "instructions": "0.2-1.5 mcg/kg/hr",
              "orderSentence": "Dexmedetomidine 0.2 mcg/kg/hr IV"
            },
            "contraindications": "Bradycardia, heart block",
            "monitoring": "HR, BP",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Pantoprazole",
            "route": "IV",
            "indication": "Stress ulcer prophylaxis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg",
                  "orderSentence": "Pantoprazole 40 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "40 mg IV daily",
              "orderSentence": "Pantoprazole 40 mg IV"
            },
            "contraindications": "None significant",
            "monitoring": "GI bleeding",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Enoxaparin",
            "route": "SC",
            "indication": "DVT prophylaxis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg",
                  "orderSentence": "Enoxaparin 40 mg SC"
                }
              ],
              "route": "SC",
              "instructions": "40 mg SC daily (start when stable)",
              "orderSentence": "Enoxaparin 40 mg SC"
            },
            "contraindications": "Active bleeding, recent LP",
            "monitoring": "Platelets, bleeding",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Insulin infusion",
            "route": "IV",
            "indication": "Stress hyperglycemia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per protocol",
                  "orderSentence": "Insulin infusion Per protocol IV"
                }
              ],
              "route": "IV",
              "instructions": "Per ICU protocol; target glucose 140-180 mg/dL",
              "orderSentence": "Insulin infusion Per protocol IV"
            },
            "contraindications": "Hypoglycemia",
            "monitoring": "Glucose q1-4h",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Bowel regimen",
            "route": "PO",
            "indication": "Constipation prophylaxis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Docusate 100 mg BID",
                  "orderSentence": "Bowel regimen Docusate 100 mg BID PO"
                },
                {
                  "text": "Senna 8.6 mg daily",
                  "orderSentence": "Bowel regimen Senna 8.6 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Docusate 100 mg BID + senna 8.6 mg daily; escalate to bisacodyl or lactulose PRN",
              "orderSentence": "Bowel regimen Docusate 100 mg BID PO"
            },
            "contraindications": "Bowel obstruction",
            "monitoring": "Bowel movements",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Skin care protocol",
            "route": "—",
            "indication": "Pressure injury prevention",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Skin care protocol N/A —"
                }
              ],
              "route": "—",
              "instructions": "Turn q2h, specialty mattress, moisture barrier, Braden scale assessment",
              "orderSentence": "Skin care protocol N/A —"
            },
            "contraindications": "None",
            "monitoring": "Skin integrity daily",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Eye care",
            "route": "TOPICAL",
            "indication": "Corneal protection",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Lubricating drops",
                  "orderSentence": "Eye care Lubricating drops TOPICAL"
                }
              ],
              "route": "TOPICAL",
              "instructions": "Lubricating drops q4h, eyelid taping if incomplete closure",
              "orderSentence": "Eye care Lubricating drops TOPICAL"
            },
            "contraindications": "None",
            "monitoring": "Corneal integrity",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "STAT"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurology/Epilepsy STAT consult",
            "indication": "All cases of SE",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Neurocritical care consult",
            "indication": "RSE/SRSE, need for anesthetic infusions",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "ICU admission",
            "indication": "All SE requiring second-line agents or ongoing seizures",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "—"
          },
          {
            "item": "EEG technologist/cEEG initiation",
            "indication": "Mandatory for RSE/SRSE; strongly recommended for all SE",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Infectious disease consult",
            "indication": "Suspected CNS infection",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Rheumatology/Neuroimmunology consult",
            "indication": "NORSE/FIRES, suspected autoimmune encephalitis",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Pharmacy consult",
            "indication": "Complex ASM dosing, drug interactions",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Nutrition/Dietitian consult",
            "indication": "Enteral feeding, ketogenic diet initiation (by Day 7 in NORSE)",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Palliative care consult",
            "indication": "SRSE with poor prognosis, goals of care discussion",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Social work consult",
            "indication": "Family support, discharge planning",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Epilepsy surgery evaluation",
            "indication": "Focal lesion on imaging, refractory to medical therapy",
            "ED": "—",
            "HOSP": "—",
            "OPD": "EXT",
            "ICU": "EXT"
          },
          {
            "item": "PT/OT/Speech evaluation",
            "indication": "Once stabilized; assess for deficits",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Epilepsy outpatient follow-up",
            "indication": "All SE survivors; ASM optimization, etiology workup",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Outpatient video-EEG monitoring",
            "indication": "Characterization of seizure type, presurgical evaluation",
            "ED": "—",
            "HOSP": "—",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Neuropsychology testing",
            "indication": "Cognitive assessment post-SE; baseline before surgery",
            "ED": "—",
            "HOSP": "—",
            "OPD": "ROUTINE",
            "ICU": "—"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Explain SE is a medical emergency requiring ICU care",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—"
          },
          {
            "item": "Discuss prognosis based on etiology and duration of SE",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—"
          },
          {
            "item": "Educate on importance of ASM adherence (if applicable)",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—"
          },
          {
            "item": "Seizure first aid education for family",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—"
          },
          {
            "item": "Rescue medication training (rectal diazepam, nasal midazolam)",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—"
          },
          {
            "item": "Driving restrictions (minimum 3-6 months seizure-free, varies by state)",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—"
          },
          {
            "item": "Medical alert bracelet recommendation",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—"
          },
          {
            "item": "Seizure action plan development",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—"
          },
          {
            "item": "Discuss goals of care if SRSE with poor prognosis",
            "ED": "—",
            "HOSP": "—",
            "OPD": "ROUTINE (ICU)"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Medication adherence counseling",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—"
          },
          {
            "item": "Avoid abrupt ASM discontinuation (common SE precipitant)",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—"
          },
          {
            "item": "Alcohol cessation",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—"
          },
          {
            "item": "Sleep hygiene (sleep deprivation lowers threshold)",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—"
          },
          {
            "item": "Avoid known seizure triggers",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—"
          },
          {
            "item": "Drug interaction review (OTC, supplements)",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—"
          },
          {
            "item": "Pregnancy planning counseling (women of childbearing potential)",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Psychogenic non-epileptic status",
        "features": "Preserved awareness, asynchronous movements, eye closure, pelvic thrusting, prolonged duration with minimal post-ictal period",
        "tests": "Video EEG, normal cEEG during event"
      },
      {
        "diagnosis": "Convulsive syncope",
        "features": "Brief (< 30 sec), occurs with LOC, myoclonic jerks possible",
        "tests": "History of prodrome, rapid recovery, normal EEG"
      },
      {
        "diagnosis": "Movement disorders (dystonia, chorea)",
        "features": "Non-rhythmic, preserved awareness, stereotyped pattern",
        "tests": "EEG normal during movements"
      },
      {
        "diagnosis": "Rigors (sepsis, transfusion reaction)",
        "features": "Associated with fever/chills, rhythmic shaking, preserves awareness",
        "tests": "Infectious workup, temperature, EEG normal"
      },
      {
        "diagnosis": "Decerebrate/decorticate posturing",
        "features": "Associated with structural brain injury, sustained posturing",
        "tests": "Imaging, cEEG"
      },
      {
        "diagnosis": "Drug-induced dyskinesia",
        "features": "Medication history, stereotyped movements",
        "tests": "Drug levels, history, EEG normal"
      },
      {
        "diagnosis": "Neuroleptic malignant syndrome",
        "features": "Rigidity, hyperthermia, AMS, autonomic instability",
        "tests": "CPK, medication history"
      },
      {
        "diagnosis": "Serotonin syndrome",
        "features": "Hyperreflexia, clonus, agitation, fever",
        "tests": "Medication history, clinical features"
      },
      {
        "diagnosis": "Tetanus",
        "features": "Sustained muscle contraction, trismus, opisthotonos",
        "tests": "History of wound, vaccination status"
      },
      {
        "diagnosis": "Strychnine poisoning",
        "features": "Opisthotonus with preserved consciousness",
        "tests": "Toxicology"
      }
    ],
    "evidence": [
      {
        "recommendation": "Benzodiazepines first-line for SE",
        "evidenceLevel": "Class I, Level A",
        "source": "[NCS Guidelines 2012](https://pubmed.ncbi.nlm.nih.gov/22528274/); [AES Guidelines 2016](https://pubmed.ncbi.nlm.nih.gov/26900382/)"
      },
      {
        "recommendation": "Lorazepam preferred IV benzodiazepine",
        "evidenceLevel": "Class I, Level A",
        "source": "[Alldredge et al. NEJM 2001](https://pubmed.ncbi.nlm.nih.gov/11547716/)"
      },
      {
        "recommendation": "IM midazolam non-inferior to IV lorazepam",
        "evidenceLevel": "Class I, Level A",
        "source": "[RAMPART Trial, Silbergleit et al. NEJM 2012](https://pubmed.ncbi.nlm.nih.gov/22335736/)"
      },
      {
        "recommendation": "Second-line agents (LEV, VPA, fPHT) equivalent efficacy",
        "evidenceLevel": "Class I, Level A",
        "source": "[ESETT Trial, Kapur et al. NEJM 2019;381:2103-2113](https://pubmed.ncbi.nlm.nih.gov/31774955/)"
      },
      {
        "recommendation": "Levetiracetam 60 mg/kg dosing",
        "evidenceLevel": "Class I, Level A",
        "source": "[ESETT Trial](https://pubmed.ncbi.nlm.nih.gov/31774955/) - higher than traditional 20-40 mg/kg"
      },
      {
        "recommendation": "Levetiracetam 40 mg/kg may be adequate",
        "evidenceLevel": "Class II, Level B",
        "source": "Meta-analysis, pharmacokinetic modeling 2023-2024"
      },
      {
        "recommendation": "cEEG monitoring in RSE",
        "evidenceLevel": "Class I, Level B",
        "source": "[NCS Guidelines 2012](https://pubmed.ncbi.nlm.nih.gov/22528274/)"
      },
      {
        "recommendation": "Burst suppression target for RSE",
        "evidenceLevel": "Class IIb, Level C",
        "source": "Expert consensus"
      },
      {
        "recommendation": "Ketamine in RSE/SRSE",
        "evidenceLevel": "Class IIb, Level B",
        "source": "Multiple case series; 2024 systematic reviews"
      },
      {
        "recommendation": "Earlier ketamine = better outcomes",
        "evidenceLevel": "Class II, Level B",
        "source": "2024 two-center study; systematic reviews"
      },
      {
        "recommendation": "Ketamine efficacy in RSE/SRSE",
        "evidenceLevel": "Class IIa, Level B",
        "source": "[Rosati A et al., CNS Drugs 2018;32(11):997-1009](https://pubmed.ncbi.nlm.nih.gov/30232735/)"
      },
      {
        "recommendation": "Ketamine ± midazolam superiority over midazolam alone",
        "evidenceLevel": "Class II, Level B",
        "source": "[Fletman et al., Clin Neurol Neurosurg 2024](https://pubmed.ncbi.nlm.nih.gov/39418930/); [Yan et al., J Neurol 2024](https://pubmed.ncbi.nlm.nih.gov/38782798/)"
      },
      {
        "recommendation": "NORSE first-line immunotherapy within 72h",
        "evidenceLevel": "Class IIa, Level C",
        "source": "[Wickström et al. Epilepsia 2022](https://pubmed.ncbi.nlm.nih.gov/35997591/)"
      },
      {
        "recommendation": "Ketogenic diet by Day 7 in NORSE",
        "evidenceLevel": "Class IIa, Level C",
        "source": "[International Consensus 2022](https://pubmed.ncbi.nlm.nih.gov/35951466/); FIRES case series"
      },
      {
        "recommendation": "Second-line immunotherapy by Day 7 if first-line fails",
        "evidenceLevel": "Class IIb, Level C",
        "source": "[International Consensus 2022](https://pubmed.ncbi.nlm.nih.gov/35997591/)"
      },
      {
        "recommendation": "Brivaracetam for SE",
        "evidenceLevel": "Class IIb, Level C",
        "source": "Emerging evidence; case series"
      }
    ],
    "monitoring": [
      {
        "item": "Continuous EEG",
        "frequency": "Continuous",
        "action": "Adjust ASMs/anesthetics",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Cardiac telemetry",
        "frequency": "Continuous",
        "action": "Treat arrhythmia; assess ASM effect",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Pulse oximetry",
        "frequency": "Continuous",
        "action": "Increase O2, assess airway",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Blood pressure",
        "frequency": "q5min during treatment, then q1h",
        "action": "Pressors or antihypertensives",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Neurologic exam",
        "frequency": "q1-2h when off sedation",
        "action": "Imaging, reassess etiology",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Glucose",
        "frequency": "q1-4h",
        "action": "Insulin or dextrose",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Electrolytes (Na, K, Mg, Ca, Phos)",
        "frequency": "q6-12h",
        "action": "Replete deficiencies",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "ABG/VBG",
        "frequency": "q4-6h (RSE), PRN",
        "action": "Adjust ventilator, treat acidosis",
        "ED": "STAT",
        "HOSP": "ROUTINE",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Lactate",
        "frequency": "q6-12h",
        "action": "Treat underlying cause",
        "ED": "STAT",
        "HOSP": "ROUTINE",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "ASM levels",
        "frequency": "24h after load, then PRN",
        "action": "Adjust dosing",
        "ED": "URGENT",
        "HOSP": "ROUTINE",
        "OPD": "—",
        "ICU": "URGENT"
      },
      {
        "item": "Ammonia",
        "frequency": "q24h if on valproate",
        "action": "Reduce/stop valproate",
        "ED": "URGENT",
        "HOSP": "ROUTINE",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "LFTs",
        "frequency": "q24-48h",
        "action": "Adjust hepatically-metabolized ASMs",
        "ED": "URGENT",
        "HOSP": "ROUTINE",
        "OPD": "—",
        "ICU": "ROUTINE"
      },
      {
        "item": "Renal function",
        "frequency": "q24h",
        "action": "Adjust renally-cleared ASMs",
        "ED": "URGENT",
        "HOSP": "ROUTINE",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "CPK",
        "frequency": "q12-24h if prolonged convulsions",
        "action": "Aggressive hydration, monitor renal",
        "ED": "—",
        "HOSP": "ROUTINE",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Triglycerides",
        "frequency": "q24-48h if on propofol",
        "action": "Reduce propofol dose",
        "ED": "—",
        "HOSP": "—",
        "OPD": "—",
        "ICU": "ROUTINE"
      },
      {
        "item": "Temperature",
        "frequency": "q4h",
        "action": "Infection workup; cooling if hyperthermic",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "ICP (if monitored)",
        "frequency": "Continuous",
        "action": "ICP management protocol",
        "ED": "—",
        "HOSP": "—",
        "OPD": "—",
        "ICU": "STAT"
      }
    ],
    "disposition": [
      {
        "disposition": "ICU admission (REQUIRED)",
        "criteria": "All SE requiring second-line ASMs; all RSE/SRSE; altered mental status; need for airway management; hemodynamic instability"
      },
      {
        "disposition": "Step-down/Telemetry",
        "criteria": "Seizures controlled x 24h, off anesthetics x 24h, stable neuro exam, no airway concerns"
      },
      {
        "disposition": "General floor",
        "criteria": "Seizures controlled, off continuous monitoring, stable on oral ASMs, resolved AMS"
      },
      {
        "disposition": "Discharge home",
        "criteria": "Seizures controlled, stable on oral ASM regimen, etiology identified and addressed, family educated, follow-up arranged"
      },
      {
        "disposition": "Transfer to higher level care",
        "criteria": "Need for services unavailable (cEEG, neurocritical care, epilepsy surgery evaluation)"
      },
      {
        "disposition": "Long-term care/Rehab",
        "criteria": "Persistent deficits after prolonged SE, need for ongoing rehabilitation"
      },
      {
        "disposition": "Palliative/Hospice",
        "criteria": "SRSE with irreversible brain injury, goals of care established"
      }
    ]
  },
  "New Onset Seizure": {
    "id": "new-onset-seizure",
    "title": "New Onset Seizure",
    "version": "1.2",
    "icd10": [
      "** R56.9 (Unspecified convulsions)",
      "G40.909 (Epilepsy",
      "unspecified",
      "not intractable",
      "without status epilepticus)"
    ],
    "scope": "** Initial evaluation and management of first-time unprovoked seizure or first presentation of seizure activity in adults. Covers immediate stabilization, diagnostic workup to identify etiology, acute treatment, and framework for anti-seizure medication (ASM) initiation. Excludes status epilepticus (see \"Status Epilepticus\" template), pediatric seizures, febrile seizures, and known epilepsy with breakthrough seizures.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "Point-of-care glucose",
            "rationale": "Hypoglycemia is immediately reversible cause",
            "target": ">70 mg/dL",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "CBC with differential",
            "rationale": "Infection screen, baseline before ASMs",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "CMP (BMP + LFTs)",
            "rationale": "Electrolyte abnormalities (Na, Ca, Mg, glucose), renal/hepatic function for ASM dosing",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Magnesium",
            "rationale": "Hypomagnesemia lowers seizure threshold",
            "target": ">1.8 mg/dL",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Calcium (ionized if available)",
            "rationale": "Hypocalcemia can cause seizures",
            "target": "Normal (ionized 4.5-5.3 mg/dL)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Urine drug screen",
            "rationale": "Illicit drugs (cocaine, amphetamines) and withdrawal states",
            "target": "Negative",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Blood alcohol level",
            "rationale": "Alcohol intoxication or withdrawal",
            "target": "Correlate with history",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Urinalysis",
            "rationale": "UTI can provoke seizures (especially elderly)",
            "target": "Negative",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Prolactin level",
            "rationale": "Elevated if drawn within 10-20 min of event; helps distinguish seizure from non-epileptic event",
            "target": "Elevated 2-3× baseline (if drawn <20 min)",
            "ED": "STAT",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Phosphorus",
            "rationale": "Hypophosphatemia lowers seizure threshold (especially alcohol withdrawal)",
            "target": ">2.5 mg/dL",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Lactate",
            "rationale": "Elevated post-ictal confirms recent seizure; metabolic acidosis screen",
            "target": "Mild elevation acceptable post-ictal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Extended Workup": [
          {
            "item": "TSH",
            "rationale": "Thyroid dysfunction can affect seizure threshold",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Ammonia",
            "rationale": "Hepatic encephalopathy, urea cycle disorders",
            "target": "Normal (<35 μmol/L)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Troponin",
            "rationale": "Cardiac ischemia as cause or consequence",
            "target": "Negative",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "ECG",
            "rationale": "Arrhythmia, prolonged QTc (some ASMs), Brugada",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Blood gas (ABG or VBG)",
            "rationale": "Acidosis, hypoxia",
            "target": "Normal or mild post-ictal acidosis",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Serum osmolality",
            "rationale": "Hypo/hyperosmolar states",
            "target": "280-295 mOsm/kg",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Pregnancy test (urine or serum β-hCG)",
            "rationale": "Eclampsia; affects imaging and ASM choice",
            "target": "Negative (or explains eclampsia if positive)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "B12 level",
            "rationale": "Deficiency associated with seizures",
            "target": "Normal (>300 pg/mL)",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Folate level",
            "rationale": "Deficiency can lower threshold; important for women of childbearing potential",
            "target": "Normal",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Serum/urine toxicology (expanded panel)",
            "rationale": "Synthetic drugs, medications not on standard screen",
            "target": "Negative",
            "ED": "URGENT",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "URGENT"
          },
          {
            "item": "Heavy metals (lead, mercury)",
            "rationale": "Occupational exposure, pica",
            "target": "Normal",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "Ceruloplasmin, serum copper",
            "rationale": "Wilson disease (young patients)",
            "target": "Normal",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "HIV",
            "rationale": "HIV-associated CNS disease",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "RPR/VDRL",
            "rationale": "Neurosyphilis",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Autoimmune encephalitis panel (serum)",
            "rationale": "Anti-NMDAR, LGI1, CASPR2, GABA-B if clinical suspicion",
            "target": "Negative",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "Paraneoplastic panel (serum)",
            "rationale": "Subacute onset, smoking, weight loss",
            "target": "Negative",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "Porphyrins (urine/serum)",
            "rationale": "Acute intermittent porphyria",
            "target": "Normal",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "Genetic epilepsy panel",
            "rationale": "Young onset, family history, refractory",
            "target": "Variable",
            "ED": "—",
            "HOSP": "—",
            "OPD": "EXT",
            "ICU": "—"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "Opening pressure",
            "rationale": "Elevated ICP, mass effect",
            "target": "10-20 cm H2O",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Cell count (tubes 1 and 4)",
            "rationale": "Infection, inflammation",
            "target": "WBC <5; RBC 0",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Protein",
            "rationale": "Elevated in infection, inflammation",
            "target": "15-45 mg/dL",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Glucose with serum glucose",
            "rationale": "Low in bacterial/fungal/TB meningitis",
            "target": ">60% serum",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Gram stain and culture",
            "rationale": "Bacterial meningitis",
            "target": "No organisms",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "BioFire FilmArray ME Panel",
            "rationale": "Rapid pathogen identification (14 pathogens)",
            "target": "Negative",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "HSV-1/2 PCR",
            "rationale": "HSV encephalitis (most common treatable cause)",
            "target": "Negative",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Autoimmune encephalitis panel (CSF)",
            "rationale": "If clinical suspicion for autoimmune etiology",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Cytology",
            "rationale": "Carcinomatous meningitis",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "VDRL (CSF)",
            "rationale": "Neurosyphilis",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Oligoclonal bands",
            "rationale": "If demyelinating disease suspected",
            "target": "Negative or matched with serum",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "CT head without contrast",
            "timing": "Immediate in ED",
            "target": "Mass, hemorrhage, stroke, calcification, hydrocephalus",
            "contraindications": "Pregnancy (relative - benefit usually outweighs risk)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "MRI brain with and without contrast (epilepsy protocol)*",
            "timing": "Within 24-48h if inpatient; within 2 weeks if outpatient",
            "target": "Tumor, mesial temporal sclerosis, cortical dysplasia, encephalitis, stroke, vascular malformation",
            "contraindications": "GFR <30, gadolinium allergy, pacemaker",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "EEG (routine)",
            "timing": "Within 24h if possible; ideally within 24-48h of seizure",
            "target": "Epileptiform discharges (spikes, sharp waves), focal slowing",
            "contraindications": "None significant",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          }
        ],
        "Extended": [
          {
            "item": "Continuous EEG (cEEG) monitoring",
            "timing": "If altered mental status persists, suspected non-convulsive status",
            "target": "Non-convulsive seizures, non-convulsive status epilepticus",
            "contraindications": "None significant",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Prolonged ambulatory EEG (24-72h)",
            "timing": "Outpatient if routine EEG non-diagnostic",
            "target": "Capture interictal or ictal activity",
            "contraindications": "None significant",
            "ED": "—",
            "HOSP": "—",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Video-EEG monitoring",
            "timing": "If diagnosis uncertain (vs. psychogenic)",
            "target": "Correlate clinical events with EEG",
            "contraindications": "None significant",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "MRA/MRV brain",
            "timing": "If vascular etiology suspected",
            "target": "AVM, aneurysm, venous thrombosis",
            "contraindications": "GFR <30, gadolinium allergy, pacemaker",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "CT angiography head",
            "timing": "If MRA unavailable and vascular cause suspected",
            "target": "Vascular malformation, aneurysm",
            "contraindications": "Contrast allergy, renal insufficiency",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Echocardiogram",
            "timing": "If embolic stroke suspected as cause",
            "target": "Thrombus, PFO, vegetation",
            "contraindications": "None significant",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Chest X-ray",
            "timing": "Aspiration risk post-ictal, lung cancer screening if paraneoplastic suspected",
            "target": "Clear lungs or mass",
            "contraindications": "None significant",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "URGENT"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "PET-CT brain (interictal FDG)",
            "timing": "Epilepsy surgery workup",
            "target": "Focal hypometabolism",
            "contraindications": "Pregnancy, uncontrolled diabetes",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "SPECT (ictal/interictal)",
            "timing": "Epilepsy surgery workup",
            "target": "Ictal hyperperfusion",
            "contraindications": "Requires seizure capture",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "MEG (magnetoencephalography)",
            "timing": "Epilepsy surgery workup",
            "target": "Localize epileptogenic focus",
            "contraindications": "Metallic implants",
            "ED": "—",
            "HOSP": "—",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "Neuropsychological testing",
            "timing": "Pre-surgical evaluation, cognitive concerns",
            "target": "Lateralizing deficits",
            "contraindications": "Patient cooperation",
            "ED": "—",
            "HOSP": "—",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "Wada test (intracarotid amobarbital)",
            "timing": "Pre-surgical language/memory lateralization",
            "target": "Language and memory dominance",
            "contraindications": "Contrast allergy, vascular anomaly",
            "ED": "—",
            "HOSP": "—",
            "OPD": "EXT",
            "ICU": "—"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "Lorazepam",
            "route": "IV/IM",
            "indication": "Active seizure termination",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 mg",
                  "orderSentence": "Lorazepam 2 mg IV"
                },
                {
                  "text": "4 mg",
                  "orderSentence": "Lorazepam 4 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "0.1 mg/kg IV (max 4 mg); may repeat once in 5 min if still seizing; max 8 mg total",
              "orderSentence": "Lorazepam 2 mg IV"
            },
            "contraindications": "Respiratory depression, severe hypotension",
            "monitoring": "RR, O2 sat, BP; have airway equipment ready",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Midazolam IM",
            "route": "IM",
            "indication": "Active seizure (no IV access)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Midazolam IM 10 mg IM"
                }
              ],
              "route": "IM",
              "instructions": "10 mg IM (if >40 kg) or 0.2 mg/kg IM; single dose; faster than IV if no access",
              "orderSentence": "Midazolam IM 10 mg IM"
            },
            "contraindications": "Respiratory depression",
            "monitoring": "RR, O2 sat; have airway equipment ready",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Midazolam intranasal",
            "route": "IN",
            "indication": "Active seizure (no IV access)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Midazolam intranasal 10 mg IN"
                }
              ],
              "route": "IN",
              "instructions": "5 mg per nostril (total 10 mg)",
              "orderSentence": "Midazolam intranasal 10 mg IN"
            },
            "contraindications": "Respiratory depression",
            "monitoring": "RR, O2 sat",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Dextrose 50%",
            "route": "IV",
            "indication": "Hypoglycemia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mL",
                  "orderSentence": "Dextrose 50% 25 mL IV"
                },
                {
                  "text": "50 mL",
                  "orderSentence": "Dextrose 50% 50 mL IV"
                }
              ],
              "route": "IV",
              "instructions": "25-50 mL IV (12.5-25g) if hypoglycemia confirmed or suspected",
              "orderSentence": "Dextrose 50% 25 mL IV"
            },
            "contraindications": "Hyperglycemia",
            "monitoring": "Glucose",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Thiamine",
            "route": "IV",
            "indication": "Wernicke prevention",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg",
                  "orderSentence": "Thiamine 100 mg IV"
                },
                {
                  "text": "500 mg",
                  "orderSentence": "Thiamine 500 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "100-500 mg IV BEFORE glucose if alcohol use suspected",
              "orderSentence": "Thiamine 100 mg IV"
            },
            "contraindications": "None significant",
            "monitoring": "None",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Supplemental oxygen",
            "route": "INH",
            "indication": "Hypoxia prevention",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2-4 L/min NC",
                  "orderSentence": "Supplemental oxygen 2-4 L/min NC INH"
                },
                {
                  "text": "15 L/min NRB",
                  "orderSentence": "Supplemental oxygen 15 L/min NRB INH"
                }
              ],
              "route": "INH",
              "instructions": "2-4 L NC or non-rebreather as needed; target O2 sat >94%",
              "orderSentence": "Supplemental oxygen 2-4 L/min NC INH"
            },
            "contraindications": "None",
            "monitoring": "O2 sat >94%",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "IV fluids (isotonic)",
            "route": "IV",
            "indication": "Volume resuscitation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "NS 500 mL",
                  "orderSentence": "IV fluids (isotonic) NS 500 mL IV"
                },
                {
                  "text": "NS 1000 mL",
                  "orderSentence": "IV fluids (isotonic) NS 1000 mL IV"
                },
                {
                  "text": "LR 1000 mL",
                  "orderSentence": "IV fluids (isotonic) LR 1000 mL IV"
                }
              ],
              "route": "IV",
              "instructions": "NS or LR bolus if hypotensive; maintenance if euvolemic",
              "orderSentence": "IV fluids (isotonic) NS 500 mL IV"
            },
            "contraindications": "Fluid overload, severe hyponatremia",
            "monitoring": "I/O, BP, Na",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Flumazenil (rescue only)",
            "route": "IV",
            "indication": "BZD reversal (severe respiratory depression)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.2 mg",
                  "orderSentence": "Flumazenil (rescue only) 0.2 mg IV"
                },
                {
                  "text": "0.4 mg",
                  "orderSentence": "Flumazenil (rescue only) 0.4 mg IV"
                },
                {
                  "text": "1 mg",
                  "orderSentence": "Flumazenil (rescue only) 1 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "0.2 mg IV over 30 sec; may repeat 0.2 mg q1min to max 1 mg; CAUTION: may precipitate seizures",
              "orderSentence": "Flumazenil (rescue only) 0.2 mg IV"
            },
            "contraindications": "Chronic benzodiazepine use; seizure history; tricyclic overdose",
            "monitoring": "RR, O2 sat; may lower seizure threshold; use only if severe respiratory depression unresponsive to supportive care",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Anti-Seizure Medications (ASMs) - Acute Loading": [
          {
            "item": "Levetiracetam IV",
            "route": "IV",
            "indication": "First-line acute loading",
            "dosing": {
              "doseOptions": [
                {
                  "text": "3000 mg",
                  "orderSentence": "Levetiracetam IV 3000 mg IV"
                },
                {
                  "text": "4000 mg",
                  "orderSentence": "Levetiracetam IV 4000 mg IV"
                },
                {
                  "text": "4500 mg",
                  "orderSentence": "Levetiracetam IV 4500 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "40-60 mg/kg IV (max 4500 mg) over 15 min",
              "orderSentence": "Levetiracetam IV 3000 mg IV"
            },
            "contraindications": "None significant; reduce dose if CrCl <50",
            "monitoring": "Somnolence, agitation (rare)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Levetiracetam PO",
            "route": "PO",
            "indication": "Acute loading if stable",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1500 mg",
                  "orderSentence": "Levetiracetam PO 1500 mg PO"
                },
                {
                  "text": "2000 mg",
                  "orderSentence": "Levetiracetam PO 2000 mg PO"
                },
                {
                  "text": "2500 mg",
                  "orderSentence": "Levetiracetam PO 2500 mg PO"
                },
                {
                  "text": "3000 mg",
                  "orderSentence": "Levetiracetam PO 3000 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Load 1500-3000 mg PO x1, then start maintenance",
              "orderSentence": "Levetiracetam PO 1500 mg PO"
            },
            "contraindications": "None significant; reduce dose if CrCl <50",
            "monitoring": "Somnolence, agitation (rare)",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "URGENT",
            "ICU": "—"
          },
          {
            "item": "Fosphenytoin IV",
            "route": "IV",
            "indication": "Alternative first-line",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mg PE",
                  "orderSentence": "Fosphenytoin IV 1000 mg PE IV"
                },
                {
                  "text": "1500 mg PE",
                  "orderSentence": "Fosphenytoin IV 1500 mg PE IV"
                }
              ],
              "route": "IV",
              "instructions": "20 mg PE/kg IV at 150 mg PE/min (max rate); may give additional 5-10 mg PE/kg if needed",
              "orderSentence": "Fosphenytoin IV 1000 mg PE IV"
            },
            "contraindications": "AV block, sinus bradycardia, pregnancy (relative)",
            "monitoring": "Continuous cardiac monitoring, BP; purple glove syndrome rare with fosphenytoin",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Phenytoin IV",
            "route": "IV",
            "indication": "If fosphenytoin unavailable",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mg",
                  "orderSentence": "Phenytoin IV 1000 mg IV"
                },
                {
                  "text": "1500 mg",
                  "orderSentence": "Phenytoin IV 1500 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "20 mg/kg IV at max 50 mg/min",
              "orderSentence": "Phenytoin IV 1000 mg IV"
            },
            "contraindications": "AV block, sinus bradycardia, pregnancy",
            "monitoring": "Cardiac monitor, BP; give via large vein (tissue necrosis risk)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Valproate IV",
            "route": "IV",
            "indication": "Alternative (broad-spectrum)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2000 mg",
                  "orderSentence": "Valproate IV 2000 mg IV"
                },
                {
                  "text": "2500 mg",
                  "orderSentence": "Valproate IV 2500 mg IV"
                },
                {
                  "text": "3000 mg",
                  "orderSentence": "Valproate IV 3000 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "40 mg/kg IV over 10 min (max 3000 mg)",
              "orderSentence": "Valproate IV 2000 mg IV"
            },
            "contraindications": "Pregnancy (teratogenic - neural tube defects), hepatic disease, mitochondrial disease, urea cycle disorders",
            "monitoring": "LFTs, ammonia, platelets; pancreatitis risk",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Lacosamide IV",
            "route": "IV",
            "indication": "Alternative first-line",
            "dosing": {
              "doseOptions": [
                {
                  "text": "200 mg",
                  "orderSentence": "Lacosamide IV 200 mg IV"
                },
                {
                  "text": "300 mg",
                  "orderSentence": "Lacosamide IV 300 mg IV"
                },
                {
                  "text": "400 mg",
                  "orderSentence": "Lacosamide IV 400 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "200-400 mg IV over 15-30 min (can give 200 mg over 5 min if urgent)",
              "orderSentence": "Lacosamide IV 200 mg IV"
            },
            "contraindications": "PR prolongation >200 ms, 2nd/3rd degree AV block",
            "monitoring": "ECG for PR interval; dizziness",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          }
        ],
        "Anti-Seizure Medications (ASMs) - Maintenance Therapy": [
          {
            "item": "Levetiracetam",
            "route": "PO",
            "indication": "First-line maintenance",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mg BID",
                  "orderSentence": "Levetiracetam 500 mg BID PO"
                },
                {
                  "text": "750 mg BID",
                  "orderSentence": "Levetiracetam 750 mg BID PO"
                },
                {
                  "text": "1000 mg BID",
                  "orderSentence": "Levetiracetam 1000 mg BID PO"
                },
                {
                  "text": "1500 mg BID",
                  "orderSentence": "Levetiracetam 1500 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 500 mg BID; may increase by 500 mg/dose weekly; max 3000 mg/day",
              "orderSentence": "Levetiracetam 500 mg BID PO"
            },
            "contraindications": "Renal impairment (adjust per CrCl)",
            "monitoring": "Behavioral changes (irritability, depression - \"Keppra rage\"); renal function",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Lamotrigine",
            "route": "PO",
            "indication": "First-line (especially women of childbearing potential)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg daily",
                  "orderSentence": "Lamotrigine 25 mg daily PO"
                },
                {
                  "text": "50 mg daily",
                  "orderSentence": "Lamotrigine 50 mg daily PO"
                },
                {
                  "text": "100 mg daily",
                  "orderSentence": "Lamotrigine 100 mg daily PO"
                },
                {
                  "text": "200 mg daily",
                  "orderSentence": "Lamotrigine 200 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg daily × 2 wk, then 50 mg daily × 2 wk, then 100 mg daily; target 200-400 mg/day; SLOW TITRATION REQUIRED",
              "orderSentence": "Lamotrigine 25 mg daily PO"
            },
            "contraindications": "Slow titration required (SJS/TEN risk)",
            "monitoring": "Rash (stop if any rash; SJS/TEN risk higher with fast titration or valproate co-therapy)",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Lacosamide",
            "route": "PO",
            "indication": "First-line alternative",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg BID",
                  "orderSentence": "Lacosamide 100 mg BID PO"
                },
                {
                  "text": "150 mg BID",
                  "orderSentence": "Lacosamide 150 mg BID PO"
                },
                {
                  "text": "200 mg BID",
                  "orderSentence": "Lacosamide 200 mg BID PO"
                },
                {
                  "text": "300 mg BID",
                  "orderSentence": "Lacosamide 300 mg BID PO"
                },
                {
                  "text": "400 mg BID",
                  "orderSentence": "Lacosamide 400 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 100 mg BID; increase by 100 mg/day weekly; target 200-400 mg BID; max 400 mg BID",
              "orderSentence": "Lacosamide 100 mg BID PO"
            },
            "contraindications": "PR prolongation, 2nd/3rd degree AV block, severe hepatic impairment",
            "monitoring": "ECG at baseline and dose changes; dizziness, diplopia",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Oxcarbazepine",
            "route": "PO",
            "indication": "Focal seizures",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg BID",
                  "orderSentence": "Oxcarbazepine 300 mg BID PO"
                },
                {
                  "text": "450 mg BID",
                  "orderSentence": "Oxcarbazepine 450 mg BID PO"
                },
                {
                  "text": "600 mg BID",
                  "orderSentence": "Oxcarbazepine 600 mg BID PO"
                },
                {
                  "text": "900 mg BID",
                  "orderSentence": "Oxcarbazepine 900 mg BID PO"
                },
                {
                  "text": "1200 mg BID",
                  "orderSentence": "Oxcarbazepine 1200 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 300 mg BID; increase by 300-600 mg/day weekly; target 1200-2400 mg/day divided",
              "orderSentence": "Oxcarbazepine 300 mg BID PO"
            },
            "contraindications": "Hypersensitivity to carbamazepine",
            "monitoring": "Sodium (hyponatremia in 2-3%); HLA-B*1502 screening in at-risk populations",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Carbamazepine",
            "route": "PO",
            "indication": "Focal seizures",
            "dosing": {
              "doseOptions": [
                {
                  "text": "200 mg BID",
                  "orderSentence": "Carbamazepine 200 mg BID PO"
                },
                {
                  "text": "300 mg BID",
                  "orderSentence": "Carbamazepine 300 mg BID PO"
                },
                {
                  "text": "400 mg BID",
                  "orderSentence": "Carbamazepine 400 mg BID PO"
                },
                {
                  "text": "500 mg BID",
                  "orderSentence": "Carbamazepine 500 mg BID PO"
                },
                {
                  "text": "600 mg BID",
                  "orderSentence": "Carbamazepine 600 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 200 mg BID; increase by 200 mg/day weekly; target 800-1200 mg/day; max 1600 mg/day",
              "orderSentence": "Carbamazepine 200 mg BID PO"
            },
            "contraindications": "AV block; bone marrow suppression; concurrent MAOIs",
            "monitoring": "CBC, LFTs, sodium at baseline and periodically; HLA-B*1502 screening",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Valproate/Divalproex",
            "route": "PO",
            "indication": "Generalized seizures",
            "dosing": {
              "doseOptions": [
                {
                  "text": "250 mg BID",
                  "orderSentence": "Valproate/Divalproex 250 mg BID PO"
                },
                {
                  "text": "500 mg BID",
                  "orderSentence": "Valproate/Divalproex 500 mg BID PO"
                },
                {
                  "text": "750 mg BID",
                  "orderSentence": "Valproate/Divalproex 750 mg BID PO"
                },
                {
                  "text": "1000 mg BID",
                  "orderSentence": "Valproate/Divalproex 1000 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10-15 mg/kg/day divided; increase by 5-10 mg/kg/week; target 1000-2000 mg/day; max 60 mg/kg/day",
              "orderSentence": "Valproate/Divalproex 250 mg BID PO"
            },
            "contraindications": "Pregnancy (teratogenic); hepatic disease; mitochondrial disease; pancreatitis history",
            "monitoring": "LFTs, ammonia, CBC, platelets at baseline, then q3-6mo; weight gain, hair loss, tremor",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Phenytoin",
            "route": "PO",
            "indication": "Focal or generalized",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg TID",
                  "orderSentence": "Phenytoin 100 mg TID PO"
                },
                {
                  "text": "200 mg BID",
                  "orderSentence": "Phenytoin 200 mg BID PO"
                },
                {
                  "text": "300 mg daily",
                  "orderSentence": "Phenytoin 300 mg daily PO"
                },
                {
                  "text": "400 mg daily",
                  "orderSentence": "Phenytoin 400 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "300-400 mg daily (extended release) or divided TID; adjust by level; target 10-20 μg/mL",
              "orderSentence": "Phenytoin 100 mg TID PO"
            },
            "contraindications": "Pregnancy (relative - fetal hydantoin syndrome); AV block",
            "monitoring": "Free phenytoin level (target 1-2 μg/mL); total level 10-20 μg/mL; CBC, LFTs; gingival hyperplasia, hirsutism",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Brivaracetam",
            "route": "PO",
            "indication": "Alternative to levetiracetam",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg BID",
                  "orderSentence": "Brivaracetam 50 mg BID PO"
                },
                {
                  "text": "75 mg BID",
                  "orderSentence": "Brivaracetam 75 mg BID PO"
                },
                {
                  "text": "100 mg BID",
                  "orderSentence": "Brivaracetam 100 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 50 mg BID; may increase to 100 mg BID; max 200 mg/day",
              "orderSentence": "Brivaracetam 50 mg BID PO"
            },
            "contraindications": "Hepatic impairment (reduce dose)",
            "monitoring": "Less behavioral side effects than levetiracetam; somnolence; Schedule C-V",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Zonisamide",
            "route": "PO",
            "indication": "Adjunctive or monotherapy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg daily",
                  "orderSentence": "Zonisamide 100 mg daily PO"
                },
                {
                  "text": "200 mg daily",
                  "orderSentence": "Zonisamide 200 mg daily PO"
                },
                {
                  "text": "300 mg daily",
                  "orderSentence": "Zonisamide 300 mg daily PO"
                },
                {
                  "text": "400 mg daily",
                  "orderSentence": "Zonisamide 400 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 100 mg daily; increase by 100 mg q2 weeks; target 300-400 mg daily; max 600 mg/day",
              "orderSentence": "Zonisamide 100 mg daily PO"
            },
            "contraindications": "Sulfonamide allergy; kidney stones",
            "monitoring": "Kidney stones (carbonic anhydrase inhibitor); oligohidrosis (pediatric); metabolic acidosis",
            "ED": "—",
            "HOSP": "—",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Topiramate",
            "route": "PO",
            "indication": "Adjunctive or monotherapy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg BID",
                  "orderSentence": "Topiramate 25 mg BID PO"
                },
                {
                  "text": "50 mg BID",
                  "orderSentence": "Topiramate 50 mg BID PO"
                },
                {
                  "text": "100 mg BID",
                  "orderSentence": "Topiramate 100 mg BID PO"
                },
                {
                  "text": "200 mg BID",
                  "orderSentence": "Topiramate 200 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg BID; increase by 50 mg/day weekly; target 200-400 mg/day divided; max 400 mg/day",
              "orderSentence": "Topiramate 25 mg BID PO"
            },
            "contraindications": "Kidney stones; metabolic acidosis; glaucoma",
            "monitoring": "Cognitive impairment (\"dopamax\"); paresthesias; kidney stones; weight loss",
            "ED": "—",
            "HOSP": "—",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Clobazam",
            "route": "PO",
            "indication": "Adjunctive therapy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg daily",
                  "orderSentence": "Clobazam 5 mg daily PO"
                },
                {
                  "text": "10 mg daily",
                  "orderSentence": "Clobazam 10 mg daily PO"
                },
                {
                  "text": "20 mg daily",
                  "orderSentence": "Clobazam 20 mg daily PO"
                },
                {
                  "text": "40 mg daily",
                  "orderSentence": "Clobazam 40 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5-10 mg daily; increase by 5-10 mg weekly; max 40 mg/day divided",
              "orderSentence": "Clobazam 5 mg daily PO"
            },
            "contraindications": "Severe hepatic impairment; sleep apnea (untreated)",
            "monitoring": "Sedation; tolerance may develop; CYP2C19 poor metabolizers need lower dose",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Perampanel",
            "route": "PO",
            "indication": "Adjunctive for focal or GTCS",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 mg qHS",
                  "orderSentence": "Perampanel 2 mg qHS PO"
                },
                {
                  "text": "4 mg qHS",
                  "orderSentence": "Perampanel 4 mg qHS PO"
                },
                {
                  "text": "6 mg qHS",
                  "orderSentence": "Perampanel 6 mg qHS PO"
                },
                {
                  "text": "8 mg qHS",
                  "orderSentence": "Perampanel 8 mg qHS PO"
                },
                {
                  "text": "10 mg qHS",
                  "orderSentence": "Perampanel 10 mg qHS PO"
                },
                {
                  "text": "12 mg qHS",
                  "orderSentence": "Perampanel 12 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 2 mg qHS; increase by 2 mg weekly; target 8-12 mg qHS; max 12 mg/day",
              "orderSentence": "Perampanel 2 mg qHS PO"
            },
            "contraindications": "None absolute",
            "monitoring": "Psychiatric effects (aggression, hostility); dizziness; take at bedtime; Schedule III",
            "ED": "—",
            "HOSP": "—",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Cenobamate",
            "route": "PO",
            "indication": "Adjunctive for focal",
            "dosing": {
              "doseOptions": [
                {
                  "text": "12.5 mg daily",
                  "orderSentence": "Cenobamate 12.5 mg daily PO"
                },
                {
                  "text": "25 mg daily",
                  "orderSentence": "Cenobamate 25 mg daily PO"
                },
                {
                  "text": "50 mg daily",
                  "orderSentence": "Cenobamate 50 mg daily PO"
                },
                {
                  "text": "100 mg daily",
                  "orderSentence": "Cenobamate 100 mg daily PO"
                },
                {
                  "text": "200 mg daily",
                  "orderSentence": "Cenobamate 200 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 12.5 mg daily × 2 wk; titrate slowly per package insert; target 200-400 mg daily; SLOW TITRATION REQUIRED",
              "orderSentence": "Cenobamate 12.5 mg daily PO"
            },
            "contraindications": "Familial short QT syndrome",
            "monitoring": "Very slow titration required (DRESS risk); QT shortening; titration pack available",
            "ED": "—",
            "HOSP": "—",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Phenobarbital",
            "route": "PO",
            "indication": "Refractory or resource-limited",
            "dosing": {
              "doseOptions": [
                {
                  "text": "60 mg daily",
                  "orderSentence": "Phenobarbital 60 mg daily PO"
                },
                {
                  "text": "90 mg daily",
                  "orderSentence": "Phenobarbital 90 mg daily PO"
                },
                {
                  "text": "120 mg daily",
                  "orderSentence": "Phenobarbital 120 mg daily PO"
                },
                {
                  "text": "180 mg daily",
                  "orderSentence": "Phenobarbital 180 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Maintenance 1-3 mg/kg/day (60-180 mg/day); target level 15-40 μg/mL",
              "orderSentence": "Phenobarbital 60 mg daily PO"
            },
            "contraindications": "Porphyria; severe respiratory disease",
            "monitoring": "Sedation; cognitive effects; drug interactions (CYP inducer); level monitoring",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          }
        ],
        "Symptomatic Treatments": [
          {
            "item": "Acetaminophen",
            "route": "PO/IV",
            "indication": "Post-ictal headache",
            "dosing": {
              "doseOptions": [
                {
                  "text": "650 mg",
                  "orderSentence": "Acetaminophen 650 mg PO"
                },
                {
                  "text": "1000 mg",
                  "orderSentence": "Acetaminophen 1000 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "650-1000 mg PO/IV q6h PRN; max 3000 mg/day (2000 mg if liver disease)",
              "orderSentence": "Acetaminophen 650 mg PO"
            },
            "contraindications": "Severe hepatic impairment",
            "monitoring": "LFTs if chronic use",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Ibuprofen",
            "route": "PO",
            "indication": "Post-ictal headache",
            "dosing": {
              "doseOptions": [
                {
                  "text": "400 mg",
                  "orderSentence": "Ibuprofen 400 mg PO"
                },
                {
                  "text": "600 mg",
                  "orderSentence": "Ibuprofen 600 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "400-600 mg PO q6-8h PRN; max 2400 mg/day",
              "orderSentence": "Ibuprofen 400 mg PO"
            },
            "contraindications": "Renal impairment; GI bleed; post-CABG",
            "monitoring": "Renal function if prolonged use",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Ondansetron",
            "route": "IV/PO",
            "indication": "Post-ictal nausea",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4 mg",
                  "orderSentence": "Ondansetron 4 mg IV"
                },
                {
                  "text": "8 mg",
                  "orderSentence": "Ondansetron 8 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "4-8 mg IV/PO q8h PRN",
              "orderSentence": "Ondansetron 4 mg IV"
            },
            "contraindications": "QT prolongation; severe hepatic impairment",
            "monitoring": "QTc if multiple doses",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Lorazepam",
            "route": "IV/PO",
            "indication": "Post-ictal agitation (if severe)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5 mg",
                  "orderSentence": "Lorazepam 0.5 mg IV"
                },
                {
                  "text": "1 mg",
                  "orderSentence": "Lorazepam 1 mg IV"
                },
                {
                  "text": "2 mg",
                  "orderSentence": "Lorazepam 2 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "0.5-2 mg IV/PO PRN; use with caution",
              "orderSentence": "Lorazepam 0.5 mg IV"
            },
            "contraindications": "Respiratory depression; altered mental status",
            "monitoring": "RR, sedation level; avoid if post-ictal confusion resolving",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Sertraline",
            "route": "PO",
            "indication": "Depression/anxiety (chronic)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg daily",
                  "orderSentence": "Sertraline 50 mg daily PO"
                },
                {
                  "text": "100 mg daily",
                  "orderSentence": "Sertraline 100 mg daily PO"
                },
                {
                  "text": "150 mg daily",
                  "orderSentence": "Sertraline 150 mg daily PO"
                },
                {
                  "text": "200 mg daily",
                  "orderSentence": "Sertraline 200 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 50 mg daily; increase by 25-50 mg q1-2 weeks; max 200 mg daily",
              "orderSentence": "Sertraline 50 mg daily PO"
            },
            "contraindications": "Concurrent MAOIs",
            "monitoring": "Suicidality monitoring weeks 1-4",
            "ED": "—",
            "HOSP": "—",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Escitalopram",
            "route": "PO",
            "indication": "Depression/anxiety (chronic)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg daily",
                  "orderSentence": "Escitalopram 10 mg daily PO"
                },
                {
                  "text": "20 mg daily",
                  "orderSentence": "Escitalopram 20 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10 mg daily; max 20 mg daily",
              "orderSentence": "Escitalopram 10 mg daily PO"
            },
            "contraindications": "Concurrent MAOIs; QT prolongation",
            "monitoring": "QTc if risk factors",
            "ED": "—",
            "HOSP": "—",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Melatonin",
            "route": "PO",
            "indication": "Sleep disturbance",
            "dosing": {
              "doseOptions": [
                {
                  "text": "3 mg qHS",
                  "orderSentence": "Melatonin 3 mg qHS PO"
                },
                {
                  "text": "5 mg qHS",
                  "orderSentence": "Melatonin 5 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "3-5 mg PO qHS; well tolerated; may help with ASM-related sleep disruption",
              "orderSentence": "Melatonin 3 mg qHS PO"
            },
            "contraindications": "None significant",
            "monitoring": "None routine",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Trazodone",
            "route": "PO",
            "indication": "Insomnia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Trazodone 25 mg qHS PO"
                },
                {
                  "text": "50 mg qHS",
                  "orderSentence": "Trazodone 50 mg qHS PO"
                },
                {
                  "text": "100 mg qHS",
                  "orderSentence": "Trazodone 100 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "25-100 mg PO qHS",
              "orderSentence": "Trazodone 25 mg qHS PO"
            },
            "contraindications": "Concurrent MAOIs",
            "monitoring": "Orthostatic hypotension; priapism (rare)",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          }
        ],
        "Second-line/Refractory": [
          {
            "item": "Add second ASM",
            "route": "PO",
            "indication": "Drug-resistant epilepsy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per agent",
                  "orderSentence": "Add second ASM Per agent PO"
                }
              ],
              "route": "PO",
              "instructions": "Choose complementary mechanism; see maintenance options",
              "orderSentence": "Add second ASM Per agent PO"
            },
            "contraindications": "Per specific agent",
            "monitoring": "Per specific agent",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Epilepsy surgery evaluation referral",
            "route": "—",
            "indication": "Drug-resistant epilepsy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Epilepsy surgery evaluation referral N/A —"
                }
              ],
              "route": "—",
              "instructions": "Refer if failed 2+ appropriately chosen ASMs",
              "orderSentence": "Epilepsy surgery evaluation referral N/A —"
            },
            "contraindications": "N/A",
            "monitoring": "N/A",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "Vagus nerve stimulator (VNS)",
            "route": "For drug-resistant epilepsy not surgical candidates",
            "indication": "N/A",
            "dosing": {
              "instructions": "Device checks",
              "orderSentence": "Vagus nerve stimulator (VNS) - For drug-resistant epilepsy not surgical candidates - see dosing"
            },
            "contraindications": "—",
            "monitoring": "—",
            "ED": "EXT",
            "HOSP": "—"
          },
          {
            "item": "Dietary therapy (ketogenic diet, modified Atkins)",
            "route": "For drug-resistant epilepsy",
            "indication": "Fatty acid oxidation disorders; pyruvate carboxylase deficiency",
            "dosing": {
              "instructions": "Metabolic panels; lipids; kidney function",
              "orderSentence": "Dietary therapy (ketogenic diet, modified Atkins) - For drug-resistant epilepsy - see dosing"
            },
            "contraindications": "—",
            "monitoring": "—",
            "ED": "EXT",
            "HOSP": "—"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurology consult",
            "indication": "All new onset seizures for evaluation and management",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Epilepsy specialist referral",
            "indication": "Diagnostic uncertainty, refractory seizures, surgical candidacy",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "EEG technologist/neurodiagnostics",
            "indication": "EEG scheduling; continuous EEG if indicated",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Neurosurgery consult",
            "indication": "Structural lesion requiring intervention (tumor, AVM, SDH)",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "EXT",
            "ICU": "URGENT"
          },
          {
            "item": "Medical toxicology consult",
            "indication": "Suspected drug/toxin-induced seizure",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Infectious disease consult",
            "indication": "CNS infection confirmed or suspected",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Oncology consult",
            "indication": "Brain tumor identified",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Psychiatry consult",
            "indication": "Depression, anxiety post-diagnosis; psychogenic non-epileptic spells suspected",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Social work consult",
            "indication": "Driving restrictions impact, employment concerns, insurance navigation",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Occupational therapy",
            "indication": "Work safety evaluation, activity modification",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Physical therapy",
            "indication": "If post-ictal weakness, falls, injury from seizure",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Neuropsychology referral",
            "indication": "Cognitive complaints, pre-surgical evaluation",
            "ED": "—",
            "HOSP": "—",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Women's health/OB-GYN",
            "indication": "Contraception counseling (ASM interactions), pregnancy planning",
            "ED": "—",
            "HOSP": "—",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Epilepsy monitoring unit (EMU) admission",
            "indication": "Characterize seizure type, video-EEG monitoring, pre-surgical evaluation",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "Driving evaluation/rehabilitation",
            "indication": "Return to driving assessment when eligible",
            "ED": "—",
            "HOSP": "—",
            "OPD": "EXT",
            "ICU": "—"
          }
        ],
        "Patient Instructions": [
          {
            "item": "**Return to ED immediately if:** recurrent seizure, prolonged seizure >5 minutes, head injury, persistent confusion, difficulty breathing, or status epilepticus",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Do NOT drive until cleared by neurology (driving restrictions per state guidelines; typically require seizure-free interval)",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Avoid operating heavy machinery, working at heights, or swimming alone",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Do not bathe alone; showers preferred over baths; keep bathroom door unlocked",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Inform employer if job involves safety-sensitive duties",
            "ED": "—",
            "HOSP": "✓",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Take ASM exactly as prescribed; do NOT stop abruptly (risk of breakthrough seizures or status epilepticus)",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Avoid common seizure triggers: sleep deprivation, alcohol, illicit drugs, missed medications",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Keep a seizure diary: date, time, duration, description, triggers, post-ictal symptoms",
            "ED": "—",
            "HOSP": "✓",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Wear medical identification (bracelet or necklace)",
            "ED": "—",
            "HOSP": "✓",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Educate family/coworkers on seizure first aid: stay with person, protect head, do NOT put anything in mouth, time the seizure, call 911 if >5 minutes",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Follow up with neurology within 1-2 weeks of discharge",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "—",
            "ICU": "—"
          },
          {
            "item": "Bring list of all medications (including OTC and supplements) to all appointments - many interact with ASMs",
            "ED": "—",
            "HOSP": "✓",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Women: discuss contraception with provider; some ASMs reduce efficacy of hormonal contraception",
            "ED": "—",
            "HOSP": "✓",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Report side effects (mood changes, rash, dizziness, cognitive issues) promptly; do NOT stop medication without calling",
            "ED": "—",
            "HOSP": "✓",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Avoid flashing/strobe lights if photosensitive seizures suspected",
            "ED": "—",
            "HOSP": "✓",
            "OPD": "✓",
            "ICU": "—"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Sleep hygiene: aim for 7-9 hours nightly; maintain regular sleep schedule",
            "ED": "—",
            "HOSP": "✓",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Avoid alcohol (lowers seizure threshold; interacts with ASMs)",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Avoid illicit drugs (especially stimulants: cocaine, amphetamines)",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Stress management techniques",
            "ED": "—",
            "HOSP": "—",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Regular moderate exercise (not extreme sleep deprivation from overtraining)",
            "ED": "—",
            "HOSP": "—",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Medication adherence: use pill organizers, phone alarms, refill reminders",
            "ED": "—",
            "HOSP": "✓",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Folic acid supplementation 1-4 mg daily for women of childbearing potential (especially if on enzyme-inducing ASMs)",
            "ED": "—",
            "HOSP": "✓",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Bone health: vitamin D 1000-2000 IU daily; calcium as needed (enzyme-inducing ASMs affect bone density)",
            "ED": "—",
            "HOSP": "—",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Avoid known personal triggers (flashing lights, certain foods, stress, if identified)",
            "ED": "—",
            "HOSP": "✓",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Home safety modifications: pad sharp furniture corners, avoid glass shower doors, use microwave instead of stovetop when alone",
            "ED": "—",
            "HOSP": "✓",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Seizure alert devices or apps for those living alone (optional)",
            "ED": "—",
            "HOSP": "—",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Smoking cessation (increases ASM metabolism; general health)",
            "ED": "—",
            "HOSP": "✓",
            "OPD": "✓",
            "ICU": "—"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Syncope (convulsive syncope)",
        "features": "Brief (<15 sec), triggered by standing/Valsalva/micturition, rapid recovery, no post-ictal confusion, possible prodrome (lightheaded, tunnel vision)",
        "tests": "ECG, orthostatic vitals, tilt table test, echocardiogram"
      },
      {
        "diagnosis": "Psychogenic non-epileptic spells (PNES)",
        "features": "Variable/atypical semiology, prolonged duration, preserved awareness with bilateral movements, eye closure, pelvic thrusting, no post-ictal confusion, psychiatric comorbidity",
        "tests": "Video-EEG capturing event; normal prolactin"
      },
      {
        "diagnosis": "Transient ischemic attack (TIA)",
        "features": "Negative symptoms (weakness, numbness), no LOC, no convulsive activity",
        "tests": "MRI DWI, vascular imaging"
      },
      {
        "diagnosis": "Migraine with aura",
        "features": "Gradual onset, spreading symptoms, headache follows, stereotyped",
        "tests": "Clinical history, normal EEG"
      },
      {
        "diagnosis": "Hypoglycemia",
        "features": "Diaphoresis, tremor, confusion, rapid glucose corrects symptoms",
        "tests": "Fingerstick glucose"
      },
      {
        "diagnosis": "Cardiac arrhythmia",
        "features": "Palpitations, sudden LOC without warning, rapid recovery",
        "tests": "ECG, Holter monitor, event recorder, EP study"
      },
      {
        "diagnosis": "Transient global amnesia",
        "features": "Isolated anterograde amnesia, repetitive questioning, no convulsive activity",
        "tests": "Clinical presentation (self-limited), MRI DWI (hippocampal)"
      },
      {
        "diagnosis": "Sleep disorders (parasomnias, cataplexy)",
        "features": "Occur from sleep, specific features (cataplexy with emotion)",
        "tests": "Sleep study, clinical history"
      },
      {
        "diagnosis": "Movement disorders (dystonia, tics)",
        "features": "Stereotyped, no LOC, suppressible (tics), may have sensory urge",
        "tests": "Clinical history, video"
      },
      {
        "diagnosis": "Drug intoxication/withdrawal",
        "features": "History of substance use, known withdrawal timeline",
        "tests": "Toxicology screen, history"
      },
      {
        "diagnosis": "Metabolic encephalopathy",
        "features": "Gradual onset, diffuse abnormality, asterixis, no discrete seizures",
        "tests": "Labs (ammonia, glucose, Na), EEG (diffuse slowing)"
      }
    ],
    "evidence": [
      {
        "recommendation": "ILAE 2017 seizure classification",
        "evidenceLevel": "Class I",
        "source": "Fisher RS et al. Epilepsia 2017"
      },
      {
        "recommendation": "ILAE 2014 practical definition of epilepsy",
        "evidenceLevel": "Class I",
        "source": "Fisher RS et al. Epilepsia 2014"
      },
      {
        "recommendation": "EEG within 24-48h increases yield",
        "evidenceLevel": "Class II, Level B",
        "source": "AAN Practice Parameter 2007"
      },
      {
        "recommendation": "MRI superior to CT for epilepsy evaluation",
        "evidenceLevel": "Class I, Level A",
        "source": "ILAE Commission Report 2019"
      },
      {
        "recommendation": "Levetiracetam non-inferior to phenytoin for acute seizure cessation",
        "evidenceLevel": "Class I, Level A",
        "source": "ESETT Trial, NEJM 2019"
      },
      {
        "recommendation": "Risk of recurrence after first unprovoked seizure ~40-50%",
        "evidenceLevel": "Class I",
        "source": "Hauser et al., NEJM 1998"
      },
      {
        "recommendation": "Starting ASM after first seizure reduces recurrence but not long-term remission",
        "evidenceLevel": "Class I, Level A",
        "source": "FIRST and MESS trials"
      },
      {
        "recommendation": "Lamotrigine and levetiracetam preferred in women of childbearing potential",
        "evidenceLevel": "Class II, Level B",
        "source": "AAN/AES Guidelines 2009, MONEAD Study"
      },
      {
        "recommendation": "Driving restrictions reduce accident risk",
        "evidenceLevel": "Class II, Level B",
        "source": "Multiple observational studies"
      },
      {
        "recommendation": "Prolactin elevation supports diagnosis of epileptic seizure (if drawn <20 min)",
        "evidenceLevel": "Class II, Level B",
        "source": "Chen et al., Neurology 2005"
      },
      {
        "recommendation": "Continuous EEG detects non-convulsive status in altered patients",
        "evidenceLevel": "Class II, Level B",
        "source": "Claassen et al., Neurology 2004"
      },
      {
        "recommendation": "Folate supplementation reduces teratogenicity risk",
        "evidenceLevel": "Class II, Level B",
        "source": "AAN Practice Parameter"
      }
    ],
    "monitoring": [
      {
        "item": "Neurologic exam (level of consciousness, focal deficits)",
        "frequency": "Q1-2h in ED; Q4h inpatient; each visit OPD",
        "action": "If prolonged post-ictal state: continuous EEG to rule out non-convulsive status",
        "ED": "✓",
        "HOSP": "✓",
        "OPD": "✓",
        "ICU": "✓"
      },
      {
        "item": "Vital signs",
        "frequency": "Continuous in ED/ICU; Q4h floor",
        "action": "Treat hyperthermia, hypotension, hypoxia",
        "ED": "✓",
        "HOSP": "✓",
        "OPD": "—",
        "ICU": "✓"
      },
      {
        "item": "Respiratory monitoring (post-benzodiazepine)",
        "frequency": "RR q15min × 1h post-administration; SpO2 continuous",
        "action": "Supplemental O2; airway management; consider flumazenil only if severe",
        "ED": "✓",
        "HOSP": "✓",
        "OPD": "—",
        "ICU": "✓"
      },
      {
        "item": "Glucose",
        "frequency": "On arrival; repeat if altered",
        "action": "Dextrose if low",
        "ED": "✓",
        "HOSP": "✓",
        "OPD": "—",
        "ICU": "✓"
      },
      {
        "item": "Electrolytes (Na, Ca, Mg)",
        "frequency": "On arrival; daily if abnormal",
        "action": "Correct deficiencies; identify cause",
        "ED": "✓",
        "HOSP": "✓",
        "OPD": "✓",
        "ICU": "✓"
      },
      {
        "item": "ASM level (phenytoin, valproate, phenobarbital, carbamazepine)",
        "frequency": "Trough level 5-7 days after initiation or dose change; PRN",
        "action": "Adjust dose; check free level for phenytoin",
        "ED": "—",
        "HOSP": "✓",
        "OPD": "✓",
        "ICU": "✓"
      },
      {
        "item": "LFTs",
        "frequency": "Baseline; q3-6 months on valproate, carbamazepine",
        "action": "Discontinue if hepatotoxicity; hold if transaminases >3× ULN",
        "ED": "—",
        "HOSP": "✓",
        "OPD": "✓",
        "ICU": "✓"
      },
      {
        "item": "CBC",
        "frequency": "Baseline; q3-6 months on carbamazepine, valproate",
        "action": "Discontinue if significant bone marrow suppression",
        "ED": "—",
        "HOSP": "✓",
        "OPD": "✓",
        "ICU": "✓"
      },
      {
        "item": "Sodium",
        "frequency": "Baseline; periodically on oxcarbazepine, carbamazepine",
        "action": "Reduce dose or switch if severe hyponatremia",
        "ED": "—",
        "HOSP": "✓",
        "OPD": "✓",
        "ICU": "✓"
      },
      {
        "item": "EEG",
        "frequency": "Within 24-48h of first seizure; repeat if diagnosis unclear",
        "action": "Adjust treatment if epileptiform activity or non-convulsive seizures",
        "ED": "✓",
        "HOSP": "✓",
        "OPD": "✓",
        "ICU": "✓"
      },
      {
        "item": "MRI brain",
        "frequency": "Within 2 weeks of first seizure; sooner if structural cause suspected",
        "action": "Address structural cause; refer to appropriate specialist",
        "ED": "—",
        "HOSP": "✓",
        "OPD": "✓",
        "ICU": "—"
      }
    ],
    "disposition": [
      {
        "disposition": "**Discharge home**",
        "criteria": "Single, self-limited seizure; returned to baseline; no dangerous etiology identified on initial workup; reliable adult supervision for 24h; ASM initiated or deferred with close follow-up; outpatient EEG and MRI arranged; understands return precautions and driving restriction"
      },
      {
        "disposition": "**Admit to floor (observation)**",
        "criteria": "Prolonged post-ictal period; multiple seizures; new structural lesion requiring monitoring; ASM loading requiring observation; social situation preventing safe discharge; need for inpatient EEG; new focal neurologic deficit"
      },
      {
        "disposition": "**Admit to ICU**",
        "criteria": "Status epilepticus (current or recent); recurrent seizures despite treatment; need for continuous EEG monitoring; airway compromise; hemodynamic instability; significant aspiration; large structural lesion with mass effect; CNS infection"
      },
      {
        "disposition": "**Transfer to higher level**",
        "criteria": "MRI unavailable; EEG unavailable; neurology not available for consultation; need for neurosurgical intervention unavailable at facility"
      }
    ]
  },
  "Multiple Sclerosis - New Diagnosis": {
    "id": "ms-new-diagnosis",
    "title": "Multiple Sclerosis - New Diagnosis",
    "version": "2.5",
    "icd10": [
      "** G35 (Multiple sclerosis)",
      "H46.9 (Optic neuritis",
      "if presenting symptom)",
      "G37.9 (Demyelinating disease of CNS",
      "unspecified)"
    ],
    "scope": "** Initial diagnostic workup and management of suspected or newly confirmed MS. Covers diagnostic criteria evaluation, mimics exclusion, acute symptom treatment, and DMT initiation framework. For established MS with acute relapse, use \"MS - Exacerbation\" template. For ongoing DMT management and monitoring, use \"MS - Maintenance\" template.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC with differential",
            "rationale": "Infection screen, baseline before steroids",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "CMP",
            "rationale": "Metabolic screen, renal function",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "TSH",
            "rationale": "Thyroid disease mimics MS",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Vitamin B12",
            "rationale": "B12 deficiency causes myelopathy",
            "target": "Normal (>300 pg/mL)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Folate",
            "rationale": "Folate deficiency causes myelopathy",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "ESR",
            "rationale": "Inflammatory/vasculitis screen",
            "target": "Normal (<20 mm/hr)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "CRP",
            "rationale": "Inflammatory marker",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Urinalysis",
            "rationale": "UTI as symptom trigger",
            "target": "Negative",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Blood glucose",
            "rationale": "Pre-steroid baseline",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "HbA1c",
            "rationale": "Glycemic status before steroids",
            "target": "<5.7%",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended Workup": [
          {
            "item": "Vitamin D (25-OH)",
            "rationale": "Low levels associated with MS risk/activity",
            "target": ">30 ng/mL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "ANA",
            "rationale": "Lupus/connective tissue disease screen",
            "target": "Negative or low titer",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Anti-dsDNA",
            "rationale": "If ANA positive, lupus evaluation",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "**Mayo CDS1 Panel** (AQP4-IgG + MOG-IgG by FACS)",
            "rationale": "Combined NMO/MOGAD screen; cell-based assay is gold standard",
            "target": "Both negative",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "HIV",
            "rationale": "HIV-associated myelopathy/encephalopathy",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "RPR/VDRL",
            "rationale": "Neurosyphilis mimics MS",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lyme serology",
            "rationale": "Endemic areas; neuroborreliosis",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "ACE level",
            "rationale": "Neurosarcoidosis",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Anti-SSA/SSB (Ro/La)",
            "rationale": "SjÃ¶gren syndrome",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "ANCA panel",
            "rationale": "CNS vasculitis",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Copper, ceruloplasmin",
            "rationale": "Wilson disease (young patients)",
            "target": "Normal",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Very long chain fatty acids",
            "rationale": "Adrenomyeloneuropathy",
            "target": "Normal",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Mitochondrial DNA studies",
            "rationale": "Leber hereditary optic neuropathy",
            "target": "Normal",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Genetic testing (HLA-DRB1)",
            "rationale": "Research/prognostic, not diagnostic",
            "target": "Variable",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "Opening pressure",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Rule out elevated ICP",
            "target": "10-20 cm H2O"
          },
          {
            "item": "Cell count (tubes 1 and 4)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Inflammation, rule out infection",
            "target": "WBC <50 (mild pleocytosis acceptable); RBC 0"
          },
          {
            "item": "Protein",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Elevated in inflammation",
            "target": "Normal to mildly elevated (<100 mg/dL)"
          },
          {
            "item": "Glucose with serum glucose",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Low in infection/carcinomatous",
            "target": "Normal (>60% serum)"
          },
          {
            "item": "Gram stain and culture",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Rule out infection",
            "target": "No organisms"
          },
          {
            "item": "Oligoclonal bands (CSF AND serum)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Intrathecal IgG synthesis",
            "target": "â‰¥2 CSF-specific bands (not in serum)"
          },
          {
            "item": "IgG index",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Intrathecal antibody synthesis",
            "target": ">0.7 = elevated"
          },
          {
            "item": "Myelin basic protein",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Active demyelination marker",
            "target": "May be elevated acutely"
          },
          {
            "item": "Cytology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Rule out malignancy",
            "target": "Negative"
          },
          {
            "item": "VDRL (CSF)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Neurosyphilis",
            "target": "Negative"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "MRI brain with and without contrast (MS protocol)*",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "timing": "Within 24-48h if acute; within 2 weeks if stable",
            "target": "Periventricular, juxtacortical, infratentorial, or cord lesions; gadolinium enhancement = active",
            "contraindications": "GFR <30, gadolinium allergy, pacemaker"
          },
          {
            "item": "MRI C-spine with and without contrast",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "timing": "With brain MRI",
            "target": "Cord lesions (short segment, peripheral, dorsal)",
            "contraindications": "GFR <30, gadolinium allergy, pacemaker"
          },
          {
            "item": "MRI T-spine with and without contrast",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "timing": "With brain/C-spine",
            "target": "Cord lesions",
            "contraindications": "GFR <30, gadolinium allergy, pacemaker"
          }
        ],
        "Extended": [
          {
            "item": "Visual evoked potentials (VEP)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "During workup",
            "target": "Prolonged P100 latency (subclinical optic nerve involvement)",
            "contraindications": "None significant"
          },
          {
            "item": "OCT (Optical coherence tomography)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Baseline",
            "target": "RNFL thinning (prior optic neuritis)",
            "contraindications": "None significant"
          },
          {
            "item": "MRI orbits with contrast",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If optic neuritis suspected",
            "target": "Optic nerve enhancement, swelling",
            "contraindications": "Gadolinium contraindications"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "CT chest",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "If sarcoidosis suspected",
            "target": "Hilar lymphadenopathy",
            "contraindications": "Contrast allergy"
          },
          {
            "item": "PET-CT",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "If CNS lymphoma or paraneoplastic suspected",
            "target": "FDG-avid lesions",
            "contraindications": "Pregnancy, uncontrolled diabetes"
          },
          {
            "item": "Conventional angiography",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "If CNS vasculitis suspected",
            "target": "Beading, stenosis",
            "contraindications": "Contrast allergy, renal failure"
          },
          {
            "item": "Brain biopsy",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "-",
            "timing": "Atypical cases, tumefactive lesions",
            "target": "Demyelination vs neoplasm vs other",
            "contraindications": "Coagulopathy, inaccessible location"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "Methylprednisolone IV",
            "route": "IV",
            "indication": "Acute MS relapse",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mg",
                  "orderSentence": "Methylprednisolone IV 1000 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "1000 mg IV daily × 3-5 days",
              "orderSentence": "Methylprednisolone IV 1000 mg IV"
            },
            "contraindications": "Active untreated infection, uncontrolled diabetes, psychosis history",
            "monitoring": "Glucose q6h (target <180), BP, mood, sleep, I/O",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Omeprazole",
            "route": "PO",
            "indication": "GI prophylaxis during steroids",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg",
                  "orderSentence": "Omeprazole 20 mg PO"
                },
                {
                  "text": "40 mg",
                  "orderSentence": "Omeprazole 40 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "20-40 mg daily during steroids",
              "orderSentence": "Omeprazole 20 mg PO"
            },
            "contraindications": "PPI allergy",
            "monitoring": "None routine",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Insulin sliding scale",
            "route": "SC",
            "indication": "Steroid-induced hyperglycemia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per protocol",
                  "orderSentence": "Insulin sliding scale Per protocol SC"
                }
              ],
              "route": "SC",
              "instructions": "Per protocol if glucose >180 mg/dL",
              "orderSentence": "Insulin sliding scale Per protocol SC"
            },
            "contraindications": "Hypoglycemia risk",
            "monitoring": "Glucose q6h",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Prednisone oral taper (optional)",
            "route": "PO",
            "indication": "Steroid taper post-IV",
            "dosing": {
              "doseOptions": [
                {
                  "text": "60 mg",
                  "orderSentence": "Prednisone oral taper (optional) 60 mg PO"
                },
                {
                  "text": "40 mg",
                  "orderSentence": "Prednisone oral taper (optional) 40 mg PO"
                },
                {
                  "text": "20 mg",
                  "orderSentence": "Prednisone oral taper (optional) 20 mg PO"
                },
                {
                  "text": "10 mg",
                  "orderSentence": "Prednisone oral taper (optional) 10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "60 mg daily × 7 days, then taper over 2 weeks",
              "orderSentence": "Prednisone oral taper (optional) 60 mg PO"
            },
            "contraindications": "Active untreated infection, uncontrolled diabetes, psychosis history",
            "monitoring": "Glucose, BP, mood",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Symptomatic Treatments - First-line": [
          {
            "item": "Baclofen",
            "route": "PO",
            "indication": "Spasticity",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg TID",
                  "orderSentence": "Baclofen 5 mg TID PO"
                },
                {
                  "text": "10 mg TID",
                  "orderSentence": "Baclofen 10 mg TID PO"
                },
                {
                  "text": "20 mg TID",
                  "orderSentence": "Baclofen 20 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg TID; increase by 5 mg/dose q3 days; max 80 mg/day divided",
              "orderSentence": "Baclofen 5 mg TID PO"
            },
            "contraindications": "Renal impairment (reduce dose)",
            "monitoring": "Sedation, weakness; do NOT stop abruptly (withdrawal risk)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Tizanidine",
            "route": "PO",
            "indication": "Spasticity",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 mg TID",
                  "orderSentence": "Tizanidine 2 mg TID PO"
                },
                {
                  "text": "4 mg TID",
                  "orderSentence": "Tizanidine 4 mg TID PO"
                },
                {
                  "text": "8 mg TID",
                  "orderSentence": "Tizanidine 8 mg TID PO"
                },
                {
                  "text": "12 mg TID",
                  "orderSentence": "Tizanidine 12 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 2 mg qHS or TID; increase by 2-4 mg q3-4 days; max 36 mg/day divided",
              "orderSentence": "Tizanidine 2 mg TID PO"
            },
            "contraindications": "Hepatic impairment; concurrent ciprofloxacin or fluvoxamine",
            "monitoring": "LFTs at baseline, 1, 3, 6 months; sedation; hypotension",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Gabapentin",
            "route": "PO",
            "indication": "Neuropathic pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg TID",
                  "orderSentence": "Gabapentin 300 mg TID PO"
                },
                {
                  "text": "600 mg TID",
                  "orderSentence": "Gabapentin 600 mg TID PO"
                },
                {
                  "text": "900 mg TID",
                  "orderSentence": "Gabapentin 900 mg TID PO"
                },
                {
                  "text": "1200 mg TID",
                  "orderSentence": "Gabapentin 1200 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 300 mg qHS; increase by 300 mg q1-3 days; target 900-1800 mg TID; max 3600 mg/day",
              "orderSentence": "Gabapentin 300 mg TID PO"
            },
            "contraindications": "Renal impairment (adjust dose per CrCl)",
            "monitoring": "Sedation, dizziness, peripheral edema",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Pregabalin",
            "route": "PO",
            "indication": "Neuropathic pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "75 mg BID",
                  "orderSentence": "Pregabalin 75 mg BID PO"
                },
                {
                  "text": "150 mg BID",
                  "orderSentence": "Pregabalin 150 mg BID PO"
                },
                {
                  "text": "225 mg BID",
                  "orderSentence": "Pregabalin 225 mg BID PO"
                },
                {
                  "text": "300 mg BID",
                  "orderSentence": "Pregabalin 300 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 75 mg BID; increase to 150 mg BID after 1 week; max 300 mg BID",
              "orderSentence": "Pregabalin 75 mg BID PO"
            },
            "contraindications": "Renal impairment (adjust dose per CrCl)",
            "monitoring": "Sedation, weight gain, peripheral edema",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Duloxetine",
            "route": "PO",
            "indication": "Neuropathic pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mg daily",
                  "orderSentence": "Duloxetine 30 mg daily PO"
                },
                {
                  "text": "60 mg daily",
                  "orderSentence": "Duloxetine 60 mg daily PO"
                },
                {
                  "text": "90 mg daily",
                  "orderSentence": "Duloxetine 90 mg daily PO"
                },
                {
                  "text": "120 mg daily",
                  "orderSentence": "Duloxetine 120 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 30 mg daily × 1 week; increase to 60 mg daily; max 120 mg/day",
              "orderSentence": "Duloxetine 30 mg daily PO"
            },
            "contraindications": "Hepatic impairment; concurrent MAOIs; uncontrolled narrow-angle glaucoma",
            "monitoring": "Nausea (usually transient), BP, discontinuation syndrome",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Amitriptyline",
            "route": "PO",
            "indication": "Neuropathic pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg qHS",
                  "orderSentence": "Amitriptyline 10 mg qHS PO"
                },
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Amitriptyline 25 mg qHS PO"
                },
                {
                  "text": "50 mg qHS",
                  "orderSentence": "Amitriptyline 50 mg qHS PO"
                },
                {
                  "text": "75 mg qHS",
                  "orderSentence": "Amitriptyline 75 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10-25 mg qHS; increase by 10-25 mg weekly; max 150 mg qHS",
              "orderSentence": "Amitriptyline 10 mg qHS PO"
            },
            "contraindications": "Cardiac conduction abnormality; recent MI; urinary retention; narrow-angle glaucoma",
            "monitoring": "Anticholinergic effects; ECG if dose >100 mg/day",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Carbamazepine",
            "route": "PO",
            "indication": "Trigeminal neuralgia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg BID",
                  "orderSentence": "Carbamazepine 100 mg BID PO"
                },
                {
                  "text": "200 mg BID",
                  "orderSentence": "Carbamazepine 200 mg BID PO"
                },
                {
                  "text": "300 mg BID",
                  "orderSentence": "Carbamazepine 300 mg BID PO"
                },
                {
                  "text": "400 mg BID",
                  "orderSentence": "Carbamazepine 400 mg BID PO"
                },
                {
                  "text": "600 mg BID",
                  "orderSentence": "Carbamazepine 600 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 100 mg BID; increase by 200 mg/day q3-7 days; max 1200 mg/day",
              "orderSentence": "Carbamazepine 100 mg BID PO"
            },
            "contraindications": "AV block; bone marrow suppression; concurrent MAOIs",
            "monitoring": "CBC, LFTs, sodium at baseline and periodically; HLA-B*1502 screening",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Oxcarbazepine",
            "route": "PO",
            "indication": "Trigeminal neuralgia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg BID",
                  "orderSentence": "Oxcarbazepine 300 mg BID PO"
                },
                {
                  "text": "450 mg BID",
                  "orderSentence": "Oxcarbazepine 450 mg BID PO"
                },
                {
                  "text": "600 mg BID",
                  "orderSentence": "Oxcarbazepine 600 mg BID PO"
                },
                {
                  "text": "900 mg BID",
                  "orderSentence": "Oxcarbazepine 900 mg BID PO"
                },
                {
                  "text": "1200 mg BID",
                  "orderSentence": "Oxcarbazepine 1200 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 300 mg BID; increase by 300 mg q3 days; max 1200 mg BID",
              "orderSentence": "Oxcarbazepine 300 mg BID PO"
            },
            "contraindications": "Hypersensitivity to carbamazepine",
            "monitoring": "Sodium (hyponatremia risk); HLA-B*1502 screening",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Oxybutynin IR",
            "route": "PO",
            "indication": "Bladder urgency",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg BID",
                  "orderSentence": "Oxybutynin IR 5 mg BID PO"
                },
                {
                  "text": "5 mg TID",
                  "orderSentence": "Oxybutynin IR 5 mg TID PO"
                },
                {
                  "text": "5 mg QID",
                  "orderSentence": "Oxybutynin IR 5 mg QID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg BID-TID; max 5 mg QID",
              "orderSentence": "Oxybutynin IR 5 mg BID PO"
            },
            "contraindications": "Urinary retention; uncontrolled narrow-angle glaucoma; GI obstruction",
            "monitoring": "Dry mouth, constipation, cognitive impairment (especially elderly)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Oxybutynin ER",
            "route": "PO",
            "indication": "Bladder urgency",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg daily",
                  "orderSentence": "Oxybutynin ER 5 mg daily PO"
                },
                {
                  "text": "10 mg daily",
                  "orderSentence": "Oxybutynin ER 10 mg daily PO"
                },
                {
                  "text": "15 mg daily",
                  "orderSentence": "Oxybutynin ER 15 mg daily PO"
                },
                {
                  "text": "20 mg daily",
                  "orderSentence": "Oxybutynin ER 20 mg daily PO"
                },
                {
                  "text": "30 mg daily",
                  "orderSentence": "Oxybutynin ER 30 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5-10 mg daily; max 30 mg daily",
              "orderSentence": "Oxybutynin ER 5 mg daily PO"
            },
            "contraindications": "Urinary retention; uncontrolled narrow-angle glaucoma; GI obstruction",
            "monitoring": "Dry mouth, constipation, cognitive impairment (fewer than IR)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Solifenacin",
            "route": "PO",
            "indication": "Bladder urgency",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg daily",
                  "orderSentence": "Solifenacin 5 mg daily PO"
                },
                {
                  "text": "10 mg daily",
                  "orderSentence": "Solifenacin 10 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg daily; may increase to 10 mg daily",
              "orderSentence": "Solifenacin 5 mg daily PO"
            },
            "contraindications": "Urinary retention; gastric retention; uncontrolled narrow-angle glaucoma; severe hepatic impairment",
            "monitoring": "Dry mouth, constipation; preferred if cognitive concerns",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Mirabegron",
            "route": "PO",
            "indication": "Bladder urgency",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg daily",
                  "orderSentence": "Mirabegron 25 mg daily PO"
                },
                {
                  "text": "50 mg daily",
                  "orderSentence": "Mirabegron 50 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg daily; may increase to 50 mg daily",
              "orderSentence": "Mirabegron 25 mg daily PO"
            },
            "contraindications": "Uncontrolled hypertension",
            "monitoring": "BP monitoring; fewer anticholinergic effects (beta-3 agonist)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Tamsulosin",
            "route": "PO",
            "indication": "Urinary retention",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.4 mg daily",
                  "orderSentence": "Tamsulosin 0.4 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "0.4 mg daily 30 min after same meal each day",
              "orderSentence": "Tamsulosin 0.4 mg daily PO"
            },
            "contraindications": "Severe sulfonamide allergy (use caution)",
            "monitoring": "Orthostatic hypotension; retrograde ejaculation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Bethanechol",
            "route": "PO",
            "indication": "Urinary retention",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg TID",
                  "orderSentence": "Bethanechol 10 mg TID PO"
                },
                {
                  "text": "25 mg TID",
                  "orderSentence": "Bethanechol 25 mg TID PO"
                },
                {
                  "text": "50 mg TID",
                  "orderSentence": "Bethanechol 50 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "10-50 mg TID-QID",
              "orderSentence": "Bethanechol 10 mg TID PO"
            },
            "contraindications": "Asthma; bradycardia; hypotension; GI/GU obstruction",
            "monitoring": "GI cramping, bronchospasm",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Desmopressin",
            "route": "PO/IN",
            "indication": "Nocturia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.1 mg qHS",
                  "orderSentence": "Desmopressin 0.1 mg qHS PO"
                },
                {
                  "text": "0.2 mg qHS",
                  "orderSentence": "Desmopressin 0.2 mg qHS PO"
                },
                {
                  "text": "0.4 mg qHS",
                  "orderSentence": "Desmopressin 0.4 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "0.1-0.4 mg qHS (oral) or 10-40 mcg intranasal",
              "orderSentence": "Desmopressin 0.1 mg qHS PO"
            },
            "contraindications": "Hyponatremia risk; age >65 (relative); CHF; polydipsia",
            "monitoring": "Sodium at baseline, 1 week, 1 month, then periodically; fluid restrict evening",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Amantadine",
            "route": "PO",
            "indication": "Fatigue",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg qAM",
                  "orderSentence": "Amantadine 100 mg qAM PO"
                },
                {
                  "text": "100 mg BID",
                  "orderSentence": "Amantadine 100 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "100 mg every morning; may add 100 mg early afternoon (before 2 PM); max 200 mg/day",
              "orderSentence": "Amantadine 100 mg qAM PO"
            },
            "contraindications": "Renal impairment (adjust dose); uncontrolled seizures",
            "monitoring": "Livedo reticularis; ankle edema; insomnia; hallucinations",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Modafinil",
            "route": "PO",
            "indication": "Fatigue",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg qAM",
                  "orderSentence": "Modafinil 100 mg qAM PO"
                },
                {
                  "text": "200 mg qAM",
                  "orderSentence": "Modafinil 200 mg qAM PO"
                },
                {
                  "text": "400 mg qAM",
                  "orderSentence": "Modafinil 400 mg qAM PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 100 mg every morning; may increase to 200 mg; max 400 mg/day; Schedule IV",
              "orderSentence": "Modafinil 100 mg qAM PO"
            },
            "contraindications": "Cardiac arrhythmia; LV hypertrophy; hepatic impairment",
            "monitoring": "BP, HR; may reduce efficacy of hormonal contraception",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Armodafinil",
            "route": "PO",
            "indication": "Fatigue",
            "dosing": {
              "doseOptions": [
                {
                  "text": "150 mg qAM",
                  "orderSentence": "Armodafinil 150 mg qAM PO"
                },
                {
                  "text": "250 mg qAM",
                  "orderSentence": "Armodafinil 250 mg qAM PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 150 mg every morning; max 250 mg daily; longer half-life; Schedule IV",
              "orderSentence": "Armodafinil 150 mg qAM PO"
            },
            "contraindications": "Cardiac arrhythmia; LV hypertrophy; hepatic impairment",
            "monitoring": "BP, HR; may reduce efficacy of hormonal contraception",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Methylphenidate",
            "route": "PO",
            "indication": "Fatigue",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg BID",
                  "orderSentence": "Methylphenidate 5 mg BID PO"
                },
                {
                  "text": "10 mg BID",
                  "orderSentence": "Methylphenidate 10 mg BID PO"
                },
                {
                  "text": "20 mg BID",
                  "orderSentence": "Methylphenidate 20 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg BID (morning and noon); max 60 mg/day; Schedule II",
              "orderSentence": "Methylphenidate 5 mg BID PO"
            },
            "contraindications": "Marked anxiety; glaucoma; tics/Tourette; concurrent MAOIs",
            "monitoring": "BP, HR, mood",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Dalfampridine",
            "route": "PO",
            "indication": "Walking impairment",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg q12h",
                  "orderSentence": "Dalfampridine 10 mg q12h PO"
                }
              ],
              "route": "PO",
              "instructions": "10 mg q12h (must be exactly 12 hours apart); do NOT exceed 20 mg/day",
              "orderSentence": "Dalfampridine 10 mg q12h PO"
            },
            "contraindications": "Seizure history; CrCl <50 mL/min",
            "monitoring": "Seizure risk (dose-dependent); UTI; insomnia",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sertraline",
            "route": "PO",
            "indication": "Depression",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg daily",
                  "orderSentence": "Sertraline 50 mg daily PO"
                },
                {
                  "text": "100 mg daily",
                  "orderSentence": "Sertraline 100 mg daily PO"
                },
                {
                  "text": "150 mg daily",
                  "orderSentence": "Sertraline 150 mg daily PO"
                },
                {
                  "text": "200 mg daily",
                  "orderSentence": "Sertraline 200 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 50 mg daily; increase by 25-50 mg q1-2 weeks; max 200 mg daily",
              "orderSentence": "Sertraline 50 mg daily PO"
            },
            "contraindications": "Concurrent MAOIs; pimozide",
            "monitoring": "Suicidality monitoring (especially weeks 1-4); serotonin syndrome",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Escitalopram",
            "route": "PO",
            "indication": "Depression",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg daily",
                  "orderSentence": "Escitalopram 10 mg daily PO"
                },
                {
                  "text": "20 mg daily",
                  "orderSentence": "Escitalopram 20 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10 mg daily; may increase to 20 mg after 1 week; max 20 mg daily",
              "orderSentence": "Escitalopram 10 mg daily PO"
            },
            "contraindications": "Concurrent MAOIs; pimozide; QT prolongation",
            "monitoring": "QTc if risk factors or dose >10 mg; suicidality monitoring",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Fluoxetine",
            "route": "PO",
            "indication": "Depression",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg daily",
                  "orderSentence": "Fluoxetine 20 mg daily PO"
                },
                {
                  "text": "40 mg daily",
                  "orderSentence": "Fluoxetine 40 mg daily PO"
                },
                {
                  "text": "60 mg daily",
                  "orderSentence": "Fluoxetine 60 mg daily PO"
                },
                {
                  "text": "80 mg daily",
                  "orderSentence": "Fluoxetine 80 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 20 mg daily; may increase after several weeks; max 80 mg daily",
              "orderSentence": "Fluoxetine 20 mg daily PO"
            },
            "contraindications": "Concurrent MAOIs; pimozide; thioridazine",
            "monitoring": "Long half-life (washout important); suicidality monitoring",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Bupropion SR/XL",
            "route": "PO",
            "indication": "Depression",
            "dosing": {
              "doseOptions": [
                {
                  "text": "150 mg daily",
                  "orderSentence": "Bupropion SR/XL 150 mg daily PO"
                },
                {
                  "text": "150 mg BID",
                  "orderSentence": "Bupropion SR/XL 150 mg BID PO"
                },
                {
                  "text": "300 mg XL daily",
                  "orderSentence": "Bupropion SR/XL 300 mg XL daily PO"
                },
                {
                  "text": "400 mg/day",
                  "orderSentence": "Bupropion SR/XL 400 mg/day PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 150 mg SR daily; increase to 150 mg SR BID after 3 days (or 300 mg XL daily); max 400 mg/day",
              "orderSentence": "Bupropion SR/XL 150 mg daily PO"
            },
            "contraindications": "Seizure disorder; eating disorders; abrupt alcohol/benzo withdrawal",
            "monitoring": "Seizure risk; insomnia; no sexual side effects",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Venlafaxine XR",
            "route": "PO",
            "indication": "Depression/pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "75 mg daily",
                  "orderSentence": "Venlafaxine XR 75 mg daily PO"
                },
                {
                  "text": "150 mg daily",
                  "orderSentence": "Venlafaxine XR 150 mg daily PO"
                },
                {
                  "text": "225 mg daily",
                  "orderSentence": "Venlafaxine XR 225 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 37.5-75 mg daily; increase by 75 mg q4 days; max 225 mg daily",
              "orderSentence": "Venlafaxine XR 75 mg daily PO"
            },
            "contraindications": "Uncontrolled hypertension; concurrent MAOIs",
            "monitoring": "BP monitoring; discontinuation syndrome (taper slowly)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Mirtazapine",
            "route": "PO",
            "indication": "Depression/insomnia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "15 mg qHS",
                  "orderSentence": "Mirtazapine 15 mg qHS PO"
                },
                {
                  "text": "30 mg qHS",
                  "orderSentence": "Mirtazapine 30 mg qHS PO"
                },
                {
                  "text": "45 mg qHS",
                  "orderSentence": "Mirtazapine 45 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 15 mg qHS; may increase by 15 mg q1-2 weeks; max 45 mg daily",
              "orderSentence": "Mirtazapine 15 mg qHS PO"
            },
            "contraindications": "Concurrent MAOIs",
            "monitoring": "Weight gain; sedation (lower at higher doses); agranulocytosis (rare)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Polyethylene glycol 3350",
            "route": "PO",
            "indication": "Constipation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "17 g daily",
                  "orderSentence": "Polyethylene glycol 3350 17 g daily PO"
                }
              ],
              "route": "PO",
              "instructions": "17 g (1 capful) in 8 oz liquid once daily; adjust to effect",
              "orderSentence": "Polyethylene glycol 3350 17 g daily PO"
            },
            "contraindications": "Bowel obstruction; ileus",
            "monitoring": "Electrolytes if prolonged use; may take 1-3 days for effect",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Docusate sodium",
            "route": "PO",
            "indication": "Constipation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg BID",
                  "orderSentence": "Docusate sodium 100 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "100 mg BID; max 500 mg/day",
              "orderSentence": "Docusate sodium 100 mg BID PO"
            },
            "contraindications": "Intestinal obstruction; concurrent mineral oil",
            "monitoring": "Minimal efficacy as monotherapy; best for stool softening",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Senna",
            "route": "PO",
            "indication": "Constipation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "8.6 mg qHS",
                  "orderSentence": "Senna 8.6 mg qHS PO"
                },
                {
                  "text": "17.2 mg qHS",
                  "orderSentence": "Senna 17.2 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "8.6-17.2 mg qHS; max 34.4 mg/day",
              "orderSentence": "Senna 8.6 mg qHS PO"
            },
            "contraindications": "Intestinal obstruction; acute abdominal pain",
            "monitoring": "Cramping; dependency with chronic daily use",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Bisacodyl",
            "route": "PO/PR",
            "indication": "Constipation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg qHS",
                  "orderSentence": "Bisacodyl 5 mg qHS PO"
                },
                {
                  "text": "10 mg qHS",
                  "orderSentence": "Bisacodyl 10 mg qHS PO"
                },
                {
                  "text": "10 mg PR",
                  "orderSentence": "Bisacodyl 10 mg PR PO"
                }
              ],
              "route": "PO",
              "instructions": "5-10 mg PO qHS or 10 mg PR PRN",
              "orderSentence": "Bisacodyl 5 mg qHS PO"
            },
            "contraindications": "Intestinal obstruction; acute abdominal pain",
            "monitoring": "Cramping; electrolyte disturbance with overuse",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lubiprostone",
            "route": "PO",
            "indication": "Constipation (refractory)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "24 mcg BID",
                  "orderSentence": "Lubiprostone 24 mcg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "24 mcg BID with food",
              "orderSentence": "Lubiprostone 24 mcg BID PO"
            },
            "contraindications": "Mechanical GI obstruction",
            "monitoring": "Nausea (common); dyspnea; diarrhea",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Propranolol",
            "route": "PO",
            "indication": "Tremor",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg BID",
                  "orderSentence": "Propranolol 20 mg BID PO"
                },
                {
                  "text": "40 mg BID",
                  "orderSentence": "Propranolol 40 mg BID PO"
                },
                {
                  "text": "60 mg BID",
                  "orderSentence": "Propranolol 60 mg BID PO"
                },
                {
                  "text": "80 mg BID",
                  "orderSentence": "Propranolol 80 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 20 mg BID; increase by 20-40 mg q3-7 days; max 320 mg/day divided",
              "orderSentence": "Propranolol 20 mg BID PO"
            },
            "contraindications": "Asthma/COPD; bradycardia <50; heart block; decompensated CHF",
            "monitoring": "HR, BP; fatigue; depression; bronchospasm",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Primidone",
            "route": "PO",
            "indication": "Tremor",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Primidone 25 mg qHS PO"
                },
                {
                  "text": "50 mg TID",
                  "orderSentence": "Primidone 50 mg TID PO"
                },
                {
                  "text": "125 mg TID",
                  "orderSentence": "Primidone 125 mg TID PO"
                },
                {
                  "text": "250 mg TID",
                  "orderSentence": "Primidone 250 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg qHS; increase by 25 mg weekly; usual 50-250 mg TID",
              "orderSentence": "Primidone 25 mg qHS PO"
            },
            "contraindications": "Porphyria; hypersensitivity to phenobarbital",
            "monitoring": "Severe sedation initially (start very low); ataxia; nausea",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Clonazepam",
            "route": "PO",
            "indication": "Tremor",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.25 mg BID",
                  "orderSentence": "Clonazepam 0.25 mg BID PO"
                },
                {
                  "text": "0.5 mg BID",
                  "orderSentence": "Clonazepam 0.5 mg BID PO"
                },
                {
                  "text": "1 mg BID",
                  "orderSentence": "Clonazepam 1 mg BID PO"
                },
                {
                  "text": "2 mg BID",
                  "orderSentence": "Clonazepam 2 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.25-0.5 mg BID; increase by 0.5 mg q3 days; max 6 mg/day",
              "orderSentence": "Clonazepam 0.25 mg BID PO"
            },
            "contraindications": "Severe hepatic impairment; myasthenia gravis; untreated narrow-angle glaucoma",
            "monitoring": "Sedation; dependence; falls risk; do NOT stop abruptly",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Topiramate",
            "route": "PO",
            "indication": "Tremor",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg daily",
                  "orderSentence": "Topiramate 25 mg daily PO"
                },
                {
                  "text": "50 mg BID",
                  "orderSentence": "Topiramate 50 mg BID PO"
                },
                {
                  "text": "100 mg BID",
                  "orderSentence": "Topiramate 100 mg BID PO"
                },
                {
                  "text": "200 mg BID",
                  "orderSentence": "Topiramate 200 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg daily; increase by 25 mg weekly; max 400 mg/day divided",
              "orderSentence": "Topiramate 25 mg daily PO"
            },
            "contraindications": "Metabolic acidosis; kidney stones",
            "monitoring": "Cognitive slowing (\"dopamax\"); paresthesias; kidney stones; weight loss",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Dextromethorphan-quinidine",
            "route": "PO",
            "indication": "Pseudobulbar affect",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20/10 mg daily",
                  "orderSentence": "Dextromethorphan-quinidine 20/10 mg daily PO"
                },
                {
                  "text": "20/10 mg q12h",
                  "orderSentence": "Dextromethorphan-quinidine 20/10 mg q12h PO"
                }
              ],
              "route": "PO",
              "instructions": "20/10 mg daily × 7 days, then 20/10 mg q12h",
              "orderSentence": "Dextromethorphan-quinidine 20/10 mg daily PO"
            },
            "contraindications": "QT prolongation; concurrent MAOIs; concurrent quinidine/quinine; CYP2D6 substrate drugs",
            "monitoring": "ECG at baseline; QTc monitoring; multiple drug interactions",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Second-line/Refractory (Acute Treatment)": [
          {
            "item": "Plasmapheresis (PLEX)",
            "route": "—",
            "indication": "Refractory acute relapse",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5-7 exchanges",
                  "orderSentence": "Plasmapheresis (PLEX) 5-7 exchanges —"
                }
              ],
              "route": "—",
              "instructions": "5-7 exchanges over 10-14 days",
              "orderSentence": "Plasmapheresis (PLEX) 5-7 exchanges —"
            },
            "contraindications": "Hemodynamic instability, sepsis, line contraindication",
            "monitoring": "BP, electrolytes, coags, fibrinogen, line infection",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT"
          },
          {
            "item": "IVIG",
            "route": "IV",
            "indication": "Refractory acute relapse",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.4 g/kg/day",
                  "orderSentence": "IVIG 0.4 g/kg/day IV"
                }
              ],
              "route": "IV",
              "instructions": "0.4 g/kg/day × 5 days (total 2 g/kg)",
              "orderSentence": "IVIG 0.4 g/kg/day IV"
            },
            "contraindications": "IgA deficiency, renal failure, thrombosis risk",
            "monitoring": "Renal function, headache, thrombosis",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT"
          },
          {
            "item": "Extended IV steroids",
            "route": "IV",
            "indication": "Refractory acute relapse",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mg",
                  "orderSentence": "Extended IV steroids 1000 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "Additional 2-5 days methylprednisolone (total 5-10 days)",
              "orderSentence": "Extended IV steroids 1000 mg IV"
            },
            "contraindications": "Active untreated infection, uncontrolled diabetes, psychosis history",
            "monitoring": "Glucose q6h, BP, mood, sleep",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE"
          },
          {
            "item": "ACTH gel (H.P. Acthar)",
            "route": "IM/SC",
            "indication": "Refractory acute relapse",
            "dosing": {
              "doseOptions": [
                {
                  "text": "80 units",
                  "orderSentence": "ACTH gel (H.P. Acthar) 80 units IM/SC"
                }
              ],
              "route": "IM/SC",
              "instructions": "80 units IM/SC daily × 2-3 weeks",
              "orderSentence": "ACTH gel (H.P. Acthar) 80 units IM/SC"
            },
            "contraindications": "Active untreated infection, uncontrolled diabetes, psychosis history",
            "monitoring": "Glucose, BP, electrolytes",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Disease-Modifying Therapies (DMT) - OPD ONLY": [
          {
            "item": "**INJECTABLE - MODERATE EFFICACY**"
          },
          {
            "item": "Interferon beta-1a (Avonex)",
            "route": "IM",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "30 mcg IM once weekly",
              "orderSentence": "Interferon beta-1a (Avonex) - IM - see dosing"
            },
            "pretreatment": "CBC, LFTs, TSH",
            "contraindications": "Depression (relative); decompensated liver disease",
            "monitoring": "CBC, LFTs q3-6mo; TSH annually; flu-like symptoms common (pretreat with NSAIDs/acetaminophen)"
          },
          {
            "item": "Interferon beta-1a (Rebif)",
            "route": "SC",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "22 or 44 mcg SC three times weekly (titrate over 4 weeks)",
              "orderSentence": "Interferon beta-1a (Rebif) - SC - see dosing"
            },
            "pretreatment": "CBC, LFTs, TSH",
            "contraindications": "Depression (relative); decompensated liver disease",
            "monitoring": "CBC, LFTs q3-6mo; TSH annually; injection site reactions"
          },
          {
            "item": "Interferon beta-1b (Betaseron/Extavia)",
            "route": "SC",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "250 mcg SC every other day (titrate over 6 weeks)",
              "orderSentence": "Interferon beta-1b (Betaseron/Extavia) - SC - see dosing"
            },
            "pretreatment": "CBC, LFTs, TSH",
            "contraindications": "Depression (relative); decompensated liver disease",
            "monitoring": "CBC, LFTs q3-6mo; TSH annually; flu-like symptoms common"
          },
          {
            "item": "Peginterferon beta-1a (Plegridy)",
            "route": "SC",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "125 mcg SC every 14 days (titrate over first 4 doses)",
              "orderSentence": "Peginterferon beta-1a (Plegridy) - SC - see dosing"
            },
            "pretreatment": "CBC, LFTs, TSH",
            "contraindications": "Depression (relative); decompensated liver disease",
            "monitoring": "CBC, LFTs q3-6mo; TSH annually; less frequent dosing"
          },
          {
            "item": "Glatiramer acetate (Copaxone) 20mg",
            "route": "SC",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "20 mg SC daily",
              "orderSentence": "Glatiramer acetate (Copaxone) 20mg - SC - see dosing"
            },
            "pretreatment": "None required",
            "contraindications": "Hypersensitivity",
            "monitoring": "Injection site reactions; post-injection systemic reaction (rare, self-limited)"
          },
          {
            "item": "Glatiramer acetate (Copaxone) 40mg",
            "route": "SC",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "40 mg SC three times weekly (â‰¥48 hours apart)",
              "orderSentence": "Glatiramer acetate (Copaxone) 40mg - SC - see dosing"
            },
            "pretreatment": "None required",
            "contraindications": "Hypersensitivity",
            "monitoring": "Same"
          },
          {
            "item": "Glatiramer acetate (Glatopa)",
            "route": "SC",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "20 mg SC daily or 40 mg SC three times weekly",
              "orderSentence": "Glatiramer acetate (Glatopa) - SC - see dosing"
            },
            "pretreatment": "None required",
            "contraindications": "Hypersensitivity",
            "monitoring": "Same (generic)"
          },
          {
            "item": "**ORAL - MODERATE EFFICACY**"
          },
          {
            "item": "Dimethyl fumarate (Tecfidera)",
            "route": "PO",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "120 mg BID Ã— 7 days, then 240 mg BID",
              "orderSentence": "Dimethyl fumarate (Tecfidera) - PO - see dosing"
            },
            "pretreatment": "CBC, LFTs",
            "contraindications": "Lymphopenia <500 (discontinue)",
            "monitoring": "CBC q6mo (lymphocytes); LFTs; GI side effects (take with food); flushing (aspirin 30 min prior)"
          },
          {
            "item": "Diroximel fumarate (Vumerity)",
            "route": "PO",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "231 mg BID Ã— 7 days, then 462 mg BID",
              "orderSentence": "Diroximel fumarate (Vumerity) - PO - see dosing"
            },
            "pretreatment": "CBC, LFTs",
            "contraindications": "Lymphopenia <500 (discontinue)",
            "monitoring": "CBC q6mo (lymphocytes); LFTs; less GI side effects than Tecfidera; flushing"
          },
          {
            "item": "Monomethyl fumarate (Bafiertam)",
            "route": "PO",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "95 mg BID Ã— 7 days, then 190 mg BID",
              "orderSentence": "Monomethyl fumarate (Bafiertam) - PO - see dosing"
            },
            "pretreatment": "CBC, LFTs",
            "contraindications": "Lymphopenia <500 (discontinue)",
            "monitoring": "CBC q6mo (lymphocytes); LFTs; GI side effects; flushing"
          },
          {
            "item": "Teriflunomide (Aubagio)",
            "route": "PO",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "7 or 14 mg once daily",
              "orderSentence": "Teriflunomide (Aubagio) - PO - see dosing"
            },
            "pretreatment": "CBC, LFTs, TB test, BP",
            "contraindications": "Pregnancy (Category X - teratogenic); severe hepatic impairment; concurrent leflunomide",
            "monitoring": "LFTs monthly Ã— 6 months, then periodically; BP; hair thinning; requires cholestyramine washout if pregnancy desired"
          },
          {
            "item": "**ORAL - HIGH EFFICACY (S1P MODULATORS)**"
          },
          {
            "item": "Fingolimod (Gilenya)",
            "route": "PO",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "0.5 mg once daily",
              "orderSentence": "Fingolimod (Gilenya) - PO - see dosing"
            },
            "pretreatment": "CBC, LFTs, ECG, ophthalmology exam (macular edema), VZV IgG (vaccinate if negative and wait 4 weeks)",
            "contraindications": "Bradycardia <55; 2nd/3rd degree AV block; sick sinus syndrome; QTc >500 ms; recent MI/stroke/TIA (within 6 months)",
            "monitoring": "First-dose observation 6 hours (HR, BP q1h, ECG at 6h); macular edema screen at 3-4 months; lymphocytes; LFTs"
          },
          {
            "item": "Siponimod (Mayzent)",
            "route": "PO",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "Titration pack days 1-5, then 2 mg daily (1 mg if CYP2C9 *1/*3 or *2/*3)",
              "orderSentence": "Siponimod (Mayzent) - PO - see dosing"
            },
            "pretreatment": "CBC, LFTs, ECG, ophthalmology exam, VZV IgG, CYP2C9 genotype",
            "contraindications": "Bradycardia <55; 2nd/3rd degree AV block; sick sinus syndrome; QTc >500 ms; recent MI/stroke/TIA; CYP2C9 *3/*3 genotype",
            "monitoring": "First-dose observation 6 hours; macular edema screen; lymphocytes; LFTs; genotype required"
          },
          {
            "item": "Ozanimod (Zeposia)",
            "route": "PO",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "0.23 mg daily Ã— 4 days, 0.46 mg daily Ã— 3 days, then 0.92 mg daily",
              "orderSentence": "Ozanimod (Zeposia) - PO - see dosing"
            },
            "pretreatment": "CBC, LFTs, ECG, ophthalmology exam, VZV IgG",
            "contraindications": "Bradycardia <55; 2nd/3rd degree AV block; sick sinus syndrome; QTc >500 ms; recent MI/stroke/TIA; concurrent MAOIs",
            "monitoring": "No first-dose observation required (slower titration); macular edema screen at 3-4 months; lymphocytes; LFTs"
          },
          {
            "item": "Ponesimod (Ponvory)",
            "route": "PO",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "14-day titration pack, then 20 mg daily",
              "orderSentence": "Ponesimod (Ponvory) - PO - see dosing"
            },
            "pretreatment": "CBC, LFTs, ECG, ophthalmology exam, VZV IgG",
            "contraindications": "Bradycardia <55; 2nd/3rd degree AV block; sick sinus syndrome; QTc >500 ms; recent MI/stroke/TIA",
            "monitoring": "No first-dose observation required; macular edema screen at 3-4 months; lymphocytes; LFTs"
          },
          {
            "item": "**ORAL - HIGH EFFICACY (OTHER)**"
          },
          {
            "item": "Cladribine (Mavenclad)",
            "route": "PO",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "Year 1: 1.75 mg/kg divided into 2 treatment weeks (week 1 and week 5); Year 2: repeat same dosing; no treatment years 3-4",
              "orderSentence": "Cladribine (Mavenclad) - PO - see dosing"
            },
            "pretreatment": "CBC, LFTs, HIV, Hepatitis B/C, TB, VZV IgG",
            "contraindications": "Active infection; HIV; active malignancy; pregnancy/breastfeeding; CrCl <30",
            "monitoring": "CBC at months 2 and 6 of each treatment year; lymphopenia expected and desired; screen for malignancy"
          },
          {
            "item": "**INFUSION - HIGH EFFICACY**"
          },
          {
            "item": "Natalizumab (Tysabri)",
            "route": "IV",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "300 mg IV every 4 weeks (or extended interval q6 weeks if stable and JCV negative)",
              "orderSentence": "Natalizumab (Tysabri) - IV - see dosing"
            },
            "pretreatment": "JCV antibody, CBC, LFTs",
            "contraindications": "JCV antibody positive with index >1.5 and prior immunosuppression (high PML risk); active infection",
            "monitoring": "JCV antibody q6mo; MRI for PML surveillance q6-12mo; infusion reactions; REMS program required"
          },
          {
            "item": "Ocrelizumab (Ocrevus)",
            "route": "IV",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "Initial: 300 mg IV Ã— 2 doses 14 days apart; Maintenance: 600 mg IV every 6 months",
              "orderSentence": "Ocrelizumab (Ocrevus) - IV - see dosing"
            },
            "pretreatment": "Hepatitis B serology, TB test, immunoglobulins",
            "contraindications": "Active Hepatitis B; active infection",
            "monitoring": "Immunoglobulins annually; infection monitoring; infusion reactions (premedicate with methylprednisolone, antihistamine, acetaminophen)"
          },
          {
            "item": "Ofatumumab (Kesimpta)",
            "route": "SC",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "Initial: 20 mg SC at weeks 0, 1, 2; Maintenance: 20 mg SC monthly starting week 4",
              "orderSentence": "Ofatumumab (Kesimpta) - SC - see dosing"
            },
            "pretreatment": "Hepatitis B serology, TB test, immunoglobulins",
            "contraindications": "Active Hepatitis B; active infection",
            "monitoring": "Immunoglobulins annually; infection monitoring; self-administered at home"
          },
          {
            "item": "Ublituximab (Briumvi)",
            "route": "IV",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "Initial: 150 mg IV day 1, 450 mg IV day 15; Maintenance: 450 mg IV every 24 weeks",
              "orderSentence": "Ublituximab (Briumvi) - IV - see dosing"
            },
            "pretreatment": "Hepatitis B serology, TB test, immunoglobulins",
            "contraindications": "Active Hepatitis B; active infection",
            "monitoring": "Immunoglobulins annually; infection monitoring; infusion reactions (premedicate); 1-hour infusion"
          },
          {
            "item": "Alemtuzumab (Lemtrada)",
            "route": "IV",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "Year 1: 12 mg IV daily Ã— 5 consecutive days; Year 2: 12 mg IV daily Ã— 3 consecutive days (12 months after year 1)",
              "orderSentence": "Alemtuzumab (Lemtrada) - IV - see dosing"
            },
            "pretreatment": "CBC, LFTs, TSH, creatinine, urinalysis, Hepatitis B/C, VZV IgG, TB, HPV screening",
            "contraindications": "Active infection; HIV; ongoing autoimmune disease other than MS",
            "monitoring": "CBC monthly Ã— 48 months; TSH q3mo Ã— 48 months; creatinine/urinalysis monthly Ã— 48 months; REMS program; secondary autoimmunity risk (thyroid, ITP, nephropathy)"
          },
          {
            "item": "**MODERATE EFFICACY - SPECIAL POPULATIONS**"
          },
          {
            "item": "Glatiramer acetate (Copaxone)",
            "route": "SC",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "20 mg daily or 40 mg TIW",
              "orderSentence": "Glatiramer acetate (Copaxone) - SC - see dosing"
            },
            "pretreatment": "None",
            "contraindications": "Hypersensitivity",
            "monitoring": "Preferred in pregnancy (no evidence of harm)"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "MS specialist/Neuroimmunology referral",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "indication": "All new MS diagnoses for DMT discussion"
          },
          {
            "item": "Neuro-ophthalmology referral",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Optic neuritis, visual symptoms, OCT baseline"
          },
          {
            "item": "Physical therapy consult for gait and balance",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE",
            "indication": "Gait dysfunction, lower extremity weakness, falls"
          },
          {
            "item": "Occupational therapy consult for ADL assessment",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Upper extremity dysfunction, ADL impairment, energy conservation"
          },
          {
            "item": "Speech therapy for swallow evaluation",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "indication": "Brainstem involvement, dysphagia, dysarthria"
          },
          {
            "item": "Speech therapy for cognitive rehabilitation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Cognitive complaints affecting function"
          },
          {
            "item": "Urology referral for bladder dysfunction",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Urgency, frequency, retention, recurrent UTI"
          },
          {
            "item": "Psychiatry/Psychology referral",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Depression, anxiety, adjustment to diagnosis"
          },
          {
            "item": "Social work consult",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Insurance navigation, disability questions, support resources"
          },
          {
            "item": "Rehabilitation medicine consult",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Significant functional impairment, comprehensive rehab needs"
          },
          {
            "item": "Infusion center coordination",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "PLEX scheduling; future DMT infusion planning"
          },
          {
            "item": "Ophthalmology referral (pre-DMT)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Baseline macular exam before S1P modulator initiation"
          },
          {
            "item": "Genetic counseling",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "indication": "If atypical features, family history concerns"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Return to ED if rapid vision loss, sudden weakness, difficulty breathing, or urinary retention",
            "ED": "âœ“",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Avoid driving until cleared by neurology",
            "ED": "âœ“",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Heat may temporarily worsen symptoms (Uhthoff phenomenon) - this is not a new attack",
            "ED": "âœ“",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Expect temporary steroid side effects: insomnia, mood changes, increased appetite, metallic taste",
            "ED": "âœ“",
            "HOSP": "âœ“",
            "OPD": "-"
          },
          {
            "item": "Keep symptom diary noting new or worsening symptoms",
            "ED": "-",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Do not stop steroids abruptly if on oral taper",
            "ED": "-",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Do not stop baclofen or tizanidine abruptly - risk of withdrawal/rebound spasticity",
            "ED": "-",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Monitor blood sugars if diabetic - steroids elevate glucose",
            "ED": "âœ“",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Avoid sick contacts while on high-dose steroids",
            "ED": "âœ“",
            "HOSP": "âœ“",
            "OPD": "-"
          },
          {
            "item": "Contact MS specialist before starting any new medications (drug interactions with DMTs)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "âœ“"
          },
          {
            "item": "Vaccinations should be completed before DMT initiation (especially live vaccines)",
            "ED": "-",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Pregnancy planning requires DMT discussion (some DMTs teratogenic, washout periods vary)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "âœ“"
          },
          {
            "item": "Report any signs of infection (fever, cough, dysuria) promptly",
            "ED": "-",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Post-void residual check if difficulty emptying bladder or recurrent UTIs",
            "ED": "-",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Smoking cessation (smoking accelerates MS progression and disability)",
            "ED": "âœ“",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Vitamin D supplementation 2000-5000 IU daily (target serum 25-OH vitamin D >40 ng/mL)",
            "ED": "-",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Regular aerobic exercise 150 min/week as tolerated (improves fatigue, mood, function)",
            "ED": "-",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Resistance training 2-3Ã—/week",
            "ED": "-",
            "HOSP": "-",
            "OPD": "âœ“"
          },
          {
            "item": "Stress management and adequate sleep (7-8 hours nightly)",
            "ED": "-",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Avoid excessive heat exposure (hot tubs, saunas, prolonged direct sun, exercising in heat)",
            "ED": "-",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Cooling vest for outdoor activities in warm weather",
            "ED": "-",
            "HOSP": "-",
            "OPD": "âœ“"
          },
          {
            "item": "Maintain healthy weight (obesity associated with worse outcomes)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "âœ“"
          },
          {
            "item": "Limit alcohol intake (can worsen balance, cognition, bladder symptoms)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "âœ“"
          },
          {
            "item": "Ensure vaccinations up to date before DMT initiation (live vaccines contraindicated on many DMTs)",
            "ED": "-",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Fall prevention: remove loose rugs, ensure adequate lighting, use assistive devices if needed",
            "ED": "-",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Energy conservation techniques for fatigue management (pacing, prioritization, positioning)",
            "ED": "-",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Neuromyelitis optica spectrum disorder (NMOSD)",
        "features": "Longitudinally extensive transverse myelitis (â‰¥3 segments), severe optic neuritis (often bilateral), area postrema syndrome (intractable nausea/vomiting), brain lesions in NMOSD-typical locations",
        "tests": "AQP4-IgG positive (Mayo CDS1 or NMOFS); MRI pattern different"
      },
      {
        "diagnosis": "MOG antibody disease (MOGAD)",
        "features": "Bilateral optic neuritis, ADEM-like presentation, longitudinally extensive myelitis, cortical encephalitis, better steroid response, more favorable prognosis",
        "tests": "MOG-IgG positive (Mayo CDS1 or MOGFS)"
      },
      {
        "diagnosis": "Acute disseminated encephalomyelitis (ADEM)",
        "features": "Monophasic (usually), encephalopathy, post-infectious, large poorly-defined lesions, pediatric predominance",
        "tests": "Clinical course, MRI pattern, MOG-IgG status"
      },
      {
        "diagnosis": "CNS vasculitis",
        "features": "Headache, encephalopathy, stroke-like episodes, multifocal infarcts",
        "tests": "Elevated ESR/CRP, angiography, brain/leptomeningeal biopsy"
      },
      {
        "diagnosis": "Neurosarcoidosis",
        "features": "Cranial neuropathies (especially VII), hypothalamic involvement, leptomeningeal enhancement, hilar adenopathy",
        "tests": "ACE level, chest CT, biopsy (non-caseating granulomas)"
      },
      {
        "diagnosis": "CNS lymphoma",
        "features": "Progressive course, deep gray matter/periventricular involvement, homogeneous enhancement, older/immunocompromised",
        "tests": "CSF cytology/flow, FDG-PET, biopsy"
      },
      {
        "diagnosis": "Susac syndrome",
        "features": "Encephalopathy, hearing loss, branch retinal artery occlusions, corpus callosum \"snowball\" lesions",
        "tests": "Audiogram, fluorescein angiography, MRI pattern"
      },
      {
        "diagnosis": "Neurosyphilis",
        "features": "Progressive cognitive decline, tabes dorsalis, Argyll Robertson pupils, positive serology",
        "tests": "RPR/VDRL, CSF VDRL, FTA-ABS"
      },
      {
        "diagnosis": "HIV-associated myelopathy/encephalopathy",
        "features": "Risk factors, vacuolar myelopathy, cognitive impairment",
        "tests": "HIV testing, CD4 count"
      },
      {
        "diagnosis": "B12 deficiency myelopathy",
        "features": "Subacute combined degeneration, dorsal column signs, peripheral neuropathy, macrocytic anemia",
        "tests": "B12, MMA, homocysteine"
      },
      {
        "diagnosis": "Migraine with white matter lesions",
        "features": "Headache history, non-specific white matter changes, no enhancement, no cord lesions",
        "tests": "Clinical history, MRI pattern"
      },
      {
        "diagnosis": "Small vessel ischemic disease",
        "features": "Older age, vascular risk factors, periventricular caps/halos, no enhancement, no cord lesions",
        "tests": "Risk factor profile, MRI pattern"
      }
    ],
    "evidence": [
      {
        "recommendation": "2017 McDonald Criteria for MS diagnosis",
        "evidenceLevel": "Class I",
        "source": "[Thompson AJ et al. Lancet Neurol 2018](https://pubmed.ncbi.nlm.nih.gov/29275977/)"
      },
      {
        "recommendation": "MRI brain/spine with contrast for diagnosis",
        "evidenceLevel": "Class I, Level A",
        "source": "[Wattjes MP et al. Lancet Neurol 2021 (MAGNIMS)](https://pubmed.ncbi.nlm.nih.gov/34139157/)"
      },
      {
        "recommendation": "CSF OCBs can substitute for dissemination in time",
        "evidenceLevel": "Class II, Level B",
        "source": "[Thompson AJ et al. Lancet Neurol 2018](https://pubmed.ncbi.nlm.nih.gov/29275977/)"
      },
      {
        "recommendation": "IV methylprednisolone 1g Ã— 3-5 days for acute attacks",
        "evidenceLevel": "Class I, Level A",
        "source": "[Filippini et al. Cochrane 2000](https://pubmed.ncbi.nlm.nih.gov/11034713/); Expert consensus"
      },
      {
        "recommendation": "PLEX for steroid-refractory attacks",
        "evidenceLevel": "Class II, Level B",
        "source": "[Faissner et al. J Neurol 2016](https://pubmed.ncbi.nlm.nih.gov/27039388/)"
      },
      {
        "recommendation": "Cell-based assay (FACS) for NMO/MOG antibodies",
        "evidenceLevel": "Class I, Level B",
        "source": "[Waters et al. 2014](https://pubmed.ncbi.nlm.nih.gov/27840658/); [Pittock et al.](https://pmc.ncbi.nlm.nih.gov/articles/PMC3286228/)"
      },
      {
        "recommendation": "Vitamin D supplementation",
        "evidenceLevel": "Class II, Level B",
        "source": "[SOLAR trial](https://pubmed.ncbi.nlm.nih.gov/31594857/); [CHOLINE trial](https://pubmed.ncbi.nlm.nih.gov/31454777/)"
      },
      {
        "recommendation": "Smoking cessation reduces progression",
        "evidenceLevel": "Class II, Level B",
        "source": "[Hedström et al. Brain 2013](https://pubmed.ncbi.nlm.nih.gov/23365092/)"
      },
      {
        "recommendation": "Early DMT initiation improves outcomes",
        "evidenceLevel": "Class I, Level A",
        "source": "[BENEFIT extension](https://pubmed.ncbi.nlm.nih.gov/26833940/); Multiple RCTs"
      },
      {
        "recommendation": "Dalfampridine for walking impairment",
        "evidenceLevel": "Class I, Level A",
        "source": "[Goodman et al. Lancet 2009](https://pubmed.ncbi.nlm.nih.gov/19249634/)"
      },
      {
        "recommendation": "Exercise improves fatigue and function",
        "evidenceLevel": "Class I, Level B",
        "source": "[Heine et al. Cochrane 2015](https://pubmed.ncbi.nlm.nih.gov/26358158/)"
      }
    ],
    "monitoring": [
      {
        "item": "Blood glucose",
        "ED": "✓",
        "HOSP": "✓",
        "OPD": "-",
        "ICU": "✓",
        "frequency": "Q6h during IV steroids",
        "action": "Insulin sliding scale; endocrine consult if persistent >250"
      },
      {
        "item": "Blood pressure",
        "ED": "✓",
        "HOSP": "✓",
        "OPD": "-",
        "ICU": "✓",
        "frequency": "Q shift during steroids",
        "action": "Antihypertensives PRN"
      },
      {
        "item": "Mood and sleep",
        "ED": "-",
        "HOSP": "✓",
        "OPD": "-",
        "ICU": "✓",
        "frequency": "Daily during steroids",
        "action": "Psychiatry consult; consider dose adjustment"
      },
      {
        "item": "Temperature",
        "ED": "✓",
        "HOSP": "✓",
        "OPD": "-",
        "ICU": "✓",
        "frequency": "Q shift",
        "action": "Infection workup if febrile"
      },
      {
        "item": "Neurologic exam",
        "ED": "✓",
        "HOSP": "✓",
        "OPD": "✓",
        "ICU": "✓",
        "frequency": "Daily (inpatient); each visit (OPD)",
        "action": "If worsening: re-image, consider PLEX"
      },
      {
        "item": "I/O and weight",
        "ED": "-",
        "HOSP": "✓",
        "OPD": "-",
        "ICU": "✓",
        "frequency": "Daily (inpatient)",
        "action": "Diuretics if fluid overload"
      },
      {
        "item": "Respiratory status",
        "ED": "-",
        "HOSP": "✓",
        "OPD": "-",
        "ICU": "✓",
        "frequency": "Q shift if cervical myelitis",
        "action": "ICU transfer if NIF >-20 (critical)"
      },
      {
        "item": "Post-void residual",
        "ED": "-",
        "HOSP": "✓",
        "OPD": "✓",
        "ICU": "-",
        "frequency": "If retention suspected",
        "action": "Intermittent catheterization if >200 mL; urology referral"
      },
      {
        "item": "MRI (follow-up) - early",
        "ED": "-",
        "HOSP": "-",
        "OPD": "✓",
        "ICU": "-",
        "frequency": "3 months after baseline",
        "action": "DMT escalation discussion if new activity"
      },
      {
        "item": "MRI (follow-up) - standard",
        "ED": "-",
        "HOSP": "-",
        "OPD": "✓",
        "ICU": "-",
        "frequency": "6 months after baseline, then annually",
        "action": "DMT escalation discussion if new activity"
      },
      {
        "item": "Vitamin D level",
        "ED": "-",
        "HOSP": "-",
        "OPD": "✓",
        "ICU": "-",
        "frequency": "Annually",
        "action": "Increase supplementation if low"
      },
      {
        "item": "JCV antibody (if on natalizumab)",
        "ED": "-",
        "HOSP": "-",
        "OPD": "✓",
        "ICU": "-",
        "frequency": "Every 6 months",
        "action": "If positive/rising: PML risk stratification, consider DMT switch"
      }
    ],
    "disposition": [
      {
        "disposition": "**Discharge home**",
        "criteria": "Mild symptoms; able to ambulate safely; reliable follow-up within 1-2 weeks; no IV steroids needed OR completing outpatient infusion; stable baseline function; understands return precautions"
      },
      {
        "disposition": "**Admit to floor**",
        "criteria": "Moderate-severe symptoms; needs IV steroids; functional decline requiring therapy; diagnostic uncertainty requiring expedited workup; unable to care for self at home"
      },
      {
        "disposition": "**Admit to ICU**",
        "criteria": "Severe myelitis with respiratory compromise (NIF >-30 declining toward -20); brainstem involvement with airway risk or autonomic instability; severe encephalopathy"
      },
      {
        "disposition": "**Transfer to higher level**",
        "criteria": "PLEX needed but unavailable; MS specialist not available for complex decision-making; MRI unavailable for urgent imaging"
      }
    ]
  },
  "Peripheral Neuropathy - New Diagnosis/Evaluation": {
    "id": "peripheral-neuropathy",
    "title": "Peripheral Neuropathy - New Diagnosis/Evaluation",
    "version": "2.2",
    "icd10": [
      "** G62.9 (Polyneuropathy",
      "unspecified)",
      "G60.9 (Hereditary and idiopathic neuropathy",
      "unspecified)",
      "G62.0 (Drug-induced polyneuropathy)",
      "G62.1 (Alcoholic polyneuropathy)",
      "G63 (Polyneuropathy in diseases classified elsewhere)",
      "E11.42 (Type 2 diabetes with diabetic polyneuropathy)",
      "E10.42 (Type 1 diabetes with diabetic polyneuropathy)",
      "G60.0 (Hereditary motor and sensory neuropathy - CMT)",
      "E85.1 (Neuropathic heredofamilial amyloidosis - hATTR)"
    ],
    "scope": "** Initial diagnostic workup and symptomatic management of suspected or newly diagnosed peripheral neuropathy. Covers etiologic evaluation, electrodiagnostic testing, pain management, and lifestyle modifications. For acute inflammatory neuropathies (GBS, CIDP), use dedicated templates. For diabetic neuropathy-specific management, this template applies but see also diabetes care protocols for glycemic optimization.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC with differential",
            "rationale": "Anemia (B12), infection, malignancy screen",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "CMP (BMP + LFTs)",
            "rationale": "Renal dysfunction (uremic neuropathy), hepatic disease, electrolytes",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Fasting glucose",
            "rationale": "Diabetes screening",
            "target": "<100 mg/dL",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "HbA1c",
            "rationale": "Diabetes/prediabetes (most common cause)",
            "target": "<5.7%",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Vitamin B12",
            "rationale": "B12 deficiency neuropathy",
            "target": ">300 pg/mL",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Methylmalonic acid (MMA)",
            "rationale": "If B12 borderline (200-400); more sensitive",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Folate",
            "rationale": "Folate deficiency",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "TSH",
            "rationale": "Hypothyroidism causes neuropathy",
            "target": "Normal (0.4-4.0 mIU/L)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "ESR",
            "rationale": "Inflammatory/vasculitic process",
            "target": "Normal (<20 mm/hr)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "CRP",
            "rationale": "Inflammatory marker",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          }
        ],
        "Extended Workup": [
          {
            "item": "Oral glucose tolerance test (2-hour)",
            "rationale": "Detects IGT missed by FBG/HbA1c; high yield in idiopathic neuropathy (34-62% have abnormal OGTT)",
            "target": "<140 mg/dL at 2h",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Serum protein electrophoresis (SPEP) with immunofixation",
            "rationale": "Monoclonal gammopathy (MGUS, myeloma)",
            "target": "No M-spike",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "24-hour urine protein electrophoresis (UPEP)",
            "rationale": "Light chain disease",
            "target": "No monoclonal protein",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Free light chains (kappa/lambda)",
            "rationale": "AL amyloidosis, light chain deposition",
            "target": "Normal ratio (0.26-1.65)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin B1 (thiamine)",
            "rationale": "Alcoholism, malnutrition, bariatric surgery",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin B6 (pyridoxine)",
            "rationale": "Deficiency OR toxicity (>200 mg/day) causes neuropathy",
            "target": "Normal (5-50 ng/mL)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin E",
            "rationale": "Malabsorption, cholestasis",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Copper",
            "rationale": "Copper deficiency (zinc excess, bariatric surgery)",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Zinc",
            "rationale": "Zinc excess suppresses copper",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "HIV antibody",
            "rationale": "HIV-associated distal sensory polyneuropathy",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Hepatitis B surface antigen/antibody",
            "rationale": "Hepatitis B-associated PAN, cryoglobulinemia",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Hepatitis C antibody",
            "rationale": "HCV-associated cryoglobulinemia, vasculitic neuropathy",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lyme serology (endemic areas)",
            "rationale": "Lyme neuroborreliosis",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "ANA",
            "rationale": "Connective tissue disease screen",
            "target": "Negative or low titer",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "RPR/VDRL",
            "rationale": "Syphilitic neuropathy",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rheumatoid factor",
            "rationale": "Rheumatoid vasculitis",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Anti-SSA/SSB (Ro/La)",
            "rationale": "SjÃƒÂ¶gren syndrome (small fiber)",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "ACE level",
            "rationale": "Sarcoidosis",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Anti-MAG antibody",
            "rationale": "IgM paraproteinemic neuropathy",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Anti-ganglioside antibodies (GM1, GD1a, GD1b, GQ1b)",
            "rationale": "If motor-predominant or acute onset (GBS variants)",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Paraneoplastic panel",
            "rationale": "Subacute sensory neuronopathy, weight loss, smoking",
            "target": "Negative (Anti-Hu, CV2)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Cryoglobulins",
            "rationale": "Hepatitis C, autoimmune, vasculitic neuropathy",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Anti-CASPR2, Anti-LGI1",
            "rationale": "Neuromyotonia, Morvan syndrome",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Fat pad or sural nerve biopsy",
            "rationale": "Amyloidosis, vasculitis, CIDP variants",
            "target": "No amyloid or vasculitis",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Genetic testing (CMT panel, TTR gene)",
            "rationale": "Hereditary neuropathy, familial amyloidosis",
            "target": "No pathogenic variant",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Skin punch biopsy for IENFD",
            "rationale": "Small fiber neuropathy confirmation",
            "target": ">8.8 fibers/mm (varies by site/age)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Heavy metal panel (lead, arsenic, thallium, mercury)",
            "rationale": "Occupational/environmental exposure",
            "target": "Normal",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "Opening pressure",
            "rationale": "Rule out elevated ICP",
            "target": "10-20 cm H2O",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Cell count (tubes 1 and 4)",
            "rationale": "Inflammation, infection",
            "target": "WBC <5, RBC 0",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Protein",
            "rationale": "Albuminocytologic dissociation in GBS/CIDP",
            "target": "Normal 15-45 mg/dL; elevated in GBS/CIDP",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Glucose with serum glucose",
            "rationale": "Infection, carcinomatous meningitis",
            "target": "Normal (>60% serum)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Gram stain and culture",
            "rationale": "Rule out infection",
            "target": "No organisms",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Cytology",
            "rationale": "Leptomeningeal carcinomatosis",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "VDRL (CSF)",
            "rationale": "Neurosyphilis",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lyme PCR/antibody index",
            "rationale": "Endemic areas",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "Nerve conduction studies (NCS) and EMG",
            "timing": "Optimal 3-4 weeks after symptom onset (allows Wallerian degeneration to manifest); can be done earlier if acute weakness suspected",
            "target": "Pattern determines axonal vs demyelinating, distribution, severity",
            "contraindications": "Pacemaker (relative); anticoagulation for needle EMG (relative)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended": [
          {
            "item": "MRI spine (cervical/lumbar) with and without contrast",
            "timing": "If radiculopathy, myelopathy, or polyradiculopathy suspected",
            "target": "Nerve root enhancement (radiculopathy), cord signal change",
            "contraindications": "GFR <30, pacemaker, gadolinium allergy",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "MRI lumbar plexus with contrast",
            "timing": "Lumbosacral plexopathy, asymmetric proximal weakness",
            "target": "Plexus enhancement, mass lesion",
            "contraindications": "GFR <30; pacemaker; gadolinium allergy",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "MRI brachial plexus with contrast",
            "timing": "Brachial plexopathy, Parsonage-Turner syndrome",
            "target": "Plexus enhancement, denervation changes",
            "contraindications": "GFR <30; pacemaker; gadolinium allergy",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Autonomic function testing (QSART, tilt table, HRV)",
            "timing": "Autonomic symptoms (orthostasis, anhidrosis, GI dysmotility)",
            "target": "Abnormal sudomotor or cardiovagal function",
            "contraindications": "None significant",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Quantitative sensory testing (QST)",
            "timing": "Small fiber neuropathy evaluation",
            "target": "Abnormal thermal thresholds",
            "contraindications": "None significant",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Chest X-ray",
            "timing": "Lung cancer (paraneoplastic), sarcoidosis",
            "target": "Normal",
            "contraindications": "Pregnancy (relative)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "CT chest/abdomen/pelvis",
            "timing": "Occult malignancy if paraneoplastic suspected",
            "target": "No mass",
            "contraindications": "Contrast allergy, renal impairment",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "PET-CT",
            "timing": "Occult malignancy, amyloidosis",
            "target": "No FDG-avid lesions",
            "contraindications": "Pregnancy, uncontrolled diabetes",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Nerve ultrasound",
            "timing": "CIDP (nerve enlargement), entrapment",
            "target": "Normal nerve caliber",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "MR neurography",
            "timing": "Focal nerve pathology, plexopathy",
            "target": "Normal nerve signal/caliber",
            "contraindications": "GFR <30; pacemaker; gadolinium allergy",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Sural nerve biopsy",
            "timing": "Vasculitic neuropathy, amyloidosis, CIDP",
            "target": "No vasculitis or amyloid deposits",
            "contraindications": "Coagulopathy",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "-"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "Thiamine (if alcoholic or malnourished)",
            "route": "IV",
            "indication": "Wernicke prevention, thiamine deficiency",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mg",
                  "orderSentence": "Thiamine (if alcoholic or malnourished) 500 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "500 mg IV TID x 3 days, then 250 mg IV daily x 3-5 days, then oral",
              "orderSentence": "Thiamine (if alcoholic or malnourished) 500 mg IV"
            },
            "contraindications": "None significant",
            "monitoring": "Anaphylaxis (rare)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Vitamin B12 (if deficient)",
            "route": "IM",
            "indication": "B12 deficiency neuropathy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mcg",
                  "orderSentence": "Vitamin B12 (if deficient) 1000 mcg IM"
                }
              ],
              "route": "IM",
              "instructions": "1000 mcg IM daily x 7 days, then weekly x 4 weeks, then monthly",
              "orderSentence": "Vitamin B12 (if deficient) 1000 mcg IM"
            },
            "contraindications": "Cobalt allergy",
            "monitoring": "Reticulocyte count at 1 week; B12 level at 1-2 months",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Glucose control optimization",
            "route": "IV/PO",
            "indication": "Diabetic neuropathy stabilization",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per protocol",
                  "orderSentence": "Glucose control optimization Per protocol IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "Per diabetes protocol; target HbA1c <7%",
              "orderSentence": "Glucose control optimization Per protocol IV/PO"
            },
            "contraindications": "Hypoglycemia risk",
            "monitoring": "Glucose monitoring",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          }
        ],
        "Symptomatic Treatments - Neuropathic Pain": [
          {
            "item": "Gabapentin",
            "route": "PO",
            "indication": "Neuropathic pain (first-line)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg qHS",
                  "orderSentence": "Gabapentin 300 mg qHS PO"
                },
                {
                  "text": "300 mg TID",
                  "orderSentence": "Gabapentin 300 mg TID PO"
                },
                {
                  "text": "600 mg TID",
                  "orderSentence": "Gabapentin 600 mg TID PO"
                },
                {
                  "text": "900 mg TID",
                  "orderSentence": "Gabapentin 900 mg TID PO"
                },
                {
                  "text": "1200 mg TID",
                  "orderSentence": "Gabapentin 1200 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 300 mg qHS; increase by 300 mg q1-3d; target 900-1800 mg TID; max 3600 mg/day",
              "orderSentence": "Gabapentin 300 mg qHS PO"
            },
            "contraindications": "Renal impairment (CrCl 30-59: max 1400 mg/day; CrCl 15-29: max 600 mg/day; CrCl <15: max 300 mg/day)",
            "monitoring": "Sedation, dizziness, peripheral edema; taper to discontinue",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Pregabalin",
            "route": "PO",
            "indication": "Neuropathic pain (first-line)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "75 mg BID",
                  "orderSentence": "Pregabalin 75 mg BID PO"
                },
                {
                  "text": "150 mg BID",
                  "orderSentence": "Pregabalin 150 mg BID PO"
                },
                {
                  "text": "225 mg BID",
                  "orderSentence": "Pregabalin 225 mg BID PO"
                },
                {
                  "text": "300 mg BID",
                  "orderSentence": "Pregabalin 300 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 75 mg BID; increase to 150 mg BID after 1 week; max 300 mg BID",
              "orderSentence": "Pregabalin 75 mg BID PO"
            },
            "contraindications": "Renal impairment (adjust per CrCl); Class V controlled",
            "monitoring": "Sedation, weight gain, peripheral edema",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Duloxetine",
            "route": "PO",
            "indication": "Neuropathic pain (first-line, diabetic)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mg daily",
                  "orderSentence": "Duloxetine 30 mg daily PO"
                },
                {
                  "text": "60 mg daily",
                  "orderSentence": "Duloxetine 60 mg daily PO"
                },
                {
                  "text": "90 mg daily",
                  "orderSentence": "Duloxetine 90 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 30 mg daily x 1 week; increase to 60 mg daily; max 120 mg/day",
              "orderSentence": "Duloxetine 30 mg daily PO"
            },
            "contraindications": "Hepatic impairment; CrCl <30; MAOIs; narrow-angle glaucoma",
            "monitoring": "Nausea, BP; discontinuation syndrome (taper 2+ weeks)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Venlafaxine XR",
            "route": "PO",
            "indication": "Neuropathic pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "75 mg daily",
                  "orderSentence": "Venlafaxine XR 75 mg daily PO"
                },
                {
                  "text": "150 mg daily",
                  "orderSentence": "Venlafaxine XR 150 mg daily PO"
                },
                {
                  "text": "225 mg daily",
                  "orderSentence": "Venlafaxine XR 225 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 37.5-75 mg daily; increase by 75 mg q4-7d; max 225 mg daily",
              "orderSentence": "Venlafaxine XR 75 mg daily PO"
            },
            "contraindications": "Uncontrolled HTN; concurrent MAOIs",
            "monitoring": "BP monitoring; discontinuation syndrome",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Amitriptyline",
            "route": "PO",
            "indication": "Neuropathic pain (second-line)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg qHS",
                  "orderSentence": "Amitriptyline 10 mg qHS PO"
                },
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Amitriptyline 25 mg qHS PO"
                },
                {
                  "text": "50 mg qHS",
                  "orderSentence": "Amitriptyline 50 mg qHS PO"
                },
                {
                  "text": "75 mg qHS",
                  "orderSentence": "Amitriptyline 75 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10-25 mg qHS; increase by 10-25 mg weekly; max 150 mg qHS",
              "orderSentence": "Amitriptyline 10 mg qHS PO"
            },
            "contraindications": "Cardiac conduction abnormality; recent MI; urinary retention; glaucoma; elderly",
            "monitoring": "ECG if dose >100 mg/day; anticholinergic effects",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Nortriptyline",
            "route": "PO",
            "indication": "Neuropathic pain (second-line)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg qHS",
                  "orderSentence": "Nortriptyline 10 mg qHS PO"
                },
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Nortriptyline 25 mg qHS PO"
                },
                {
                  "text": "50 mg qHS",
                  "orderSentence": "Nortriptyline 50 mg qHS PO"
                },
                {
                  "text": "75 mg qHS",
                  "orderSentence": "Nortriptyline 75 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10-25 mg qHS; increase by 10-25 mg weekly; max 150 mg qHS",
              "orderSentence": "Nortriptyline 10 mg qHS PO"
            },
            "contraindications": "Cardiac conduction abnormality; recent MI; urinary retention; glaucoma; elderly",
            "monitoring": "ECG if dose >100 mg/day; fewer anticholinergic effects than amitriptyline",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Desipramine",
            "route": "PO",
            "indication": "Neuropathic pain (second-line)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Desipramine 25 mg qHS PO"
                },
                {
                  "text": "50 mg qHS",
                  "orderSentence": "Desipramine 50 mg qHS PO"
                },
                {
                  "text": "75 mg qHS",
                  "orderSentence": "Desipramine 75 mg qHS PO"
                },
                {
                  "text": "100 mg qHS",
                  "orderSentence": "Desipramine 100 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg qHS; increase by 25 mg weekly; max 150 mg daily",
              "orderSentence": "Desipramine 25 mg qHS PO"
            },
            "contraindications": "Cardiac conduction abnormality; recent MI; urinary retention; glaucoma; elderly",
            "monitoring": "ECG if dose >100 mg/day; least anticholinergic of TCAs",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Carbamazepine",
            "route": "PO",
            "indication": "Trigeminal neuralgia, lancinating pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg BID",
                  "orderSentence": "Carbamazepine 100 mg BID PO"
                },
                {
                  "text": "200 mg BID",
                  "orderSentence": "Carbamazepine 200 mg BID PO"
                },
                {
                  "text": "300 mg BID",
                  "orderSentence": "Carbamazepine 300 mg BID PO"
                },
                {
                  "text": "400 mg BID",
                  "orderSentence": "Carbamazepine 400 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 100 mg BID; increase by 200 mg/day q3-7d; max 1200 mg/day",
              "orderSentence": "Carbamazepine 100 mg BID PO"
            },
            "contraindications": "AV block; bone marrow suppression; MAOIs",
            "monitoring": "CBC, LFTs, sodium; HLA-B*1502 screening in at-risk populations",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Oxcarbazepine",
            "route": "PO",
            "indication": "Trigeminal neuralgia, lancinating pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg BID",
                  "orderSentence": "Oxcarbazepine 300 mg BID PO"
                },
                {
                  "text": "600 mg BID",
                  "orderSentence": "Oxcarbazepine 600 mg BID PO"
                },
                {
                  "text": "900 mg BID",
                  "orderSentence": "Oxcarbazepine 900 mg BID PO"
                },
                {
                  "text": "1200 mg BID",
                  "orderSentence": "Oxcarbazepine 1200 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 300 mg BID; increase by 300 mg q3d; max 1200 mg BID",
              "orderSentence": "Oxcarbazepine 300 mg BID PO"
            },
            "contraindications": "Carbamazepine hypersensitivity",
            "monitoring": "Sodium (hyponatremia risk); HLA-B*1502 screening",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Capsaicin cream 0.075%",
            "route": "TOP",
            "indication": "Localized neuropathic pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Apply thin layer",
                  "orderSentence": "Capsaicin cream 0.075% Apply thin layer TOP"
                }
              ],
              "route": "TOP",
              "instructions": "Apply TID-QID to affected area; takes 2-4 weeks for effect",
              "orderSentence": "Capsaicin cream 0.075% Apply thin layer TOP"
            },
            "contraindications": "Open wounds; avoid eyes/mucous membranes",
            "monitoring": "Initial burning (decreases with use); wash hands after",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Capsaicin 8% patch (Qutenza)",
            "route": "TOP",
            "indication": "Localized neuropathic pain (refractory)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 patch",
                  "orderSentence": "Capsaicin 8% patch (Qutenza) 1 patch TOP"
                }
              ],
              "route": "TOP",
              "instructions": "Apply by healthcare provider for 30-60 min; may repeat q3 months",
              "orderSentence": "Capsaicin 8% patch (Qutenza) 1 patch TOP"
            },
            "contraindications": "Open wounds; avoid eyes/mucous membranes",
            "monitoring": "Must be applied in clinic; pretreat with topical lidocaine",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lidocaine 5% patch",
            "route": "TOP",
            "indication": "Localized neuropathic pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1-3 patches",
                  "orderSentence": "Lidocaine 5% patch 1-3 patches TOP"
                }
              ],
              "route": "TOP",
              "instructions": "Apply 1-3 patches to painful area for 12h on, 12h off",
              "orderSentence": "Lidocaine 5% patch 1-3 patches TOP"
            },
            "contraindications": "Severe hepatic impairment; broken skin",
            "monitoring": "Minimal systemic absorption; local irritation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Tramadol",
            "route": "PO",
            "indication": "Moderate neuropathic pain (adjunct)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg",
                  "orderSentence": "Tramadol 50 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 50 mg q6h PRN; may use ER 100 mg daily; max 400 mg/day",
              "orderSentence": "Tramadol 50 mg PO"
            },
            "contraindications": "Seizure disorder; MAOIs; SSRIs (serotonin syndrome)",
            "monitoring": "Serotonin syndrome; seizures; dependence (Schedule IV)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Tapentadol ER",
            "route": "PO",
            "indication": "Moderate-severe neuropathic pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg",
                  "orderSentence": "Tapentadol ER 50 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 50 mg BID; increase by 50 mg BID q3d; max 250 mg BID",
              "orderSentence": "Tapentadol ER 50 mg PO"
            },
            "contraindications": "Seizure disorder; MAOIs; SSRIs (serotonin syndrome)",
            "monitoring": "Serotonin syndrome; seizures; dependence (Schedule II)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Morphine ER",
            "route": "PO",
            "indication": "Severe refractory pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "15 mg",
                  "orderSentence": "Morphine ER 15 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 15 mg q12h; titrate q1-2d; no max (titrate to effect)",
              "orderSentence": "Morphine ER 15 mg PO"
            },
            "contraindications": "Respiratory depression; paralytic ileus; MAOIs",
            "monitoring": "Sedation, constipation, respiratory status; naloxone available",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Oxycodone ER",
            "route": "PO",
            "indication": "Severe refractory pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Oxycodone ER 10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10 mg q12h; titrate q1-2d",
              "orderSentence": "Oxycodone ER 10 mg PO"
            },
            "contraindications": "Respiratory depression; paralytic ileus; MAOIs",
            "monitoring": "Sedation, constipation, respiratory status; naloxone available (Schedule II)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Methadone",
            "route": "PO",
            "indication": "Severe refractory neuropathic pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2.5 mg",
                  "orderSentence": "Methadone 2.5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 2.5-5 mg TID; titrate slowly (long half-life); specialist management",
              "orderSentence": "Methadone 2.5 mg PO"
            },
            "contraindications": "QT prolongation; QT-prolonging drugs",
            "monitoring": "ECG at baseline and with dose changes; QTc monitoring",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Symptomatic Treatments - Other Symptoms": [
          {
            "item": "Midodrine",
            "route": "PO",
            "indication": "Orthostatic hypotension",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2.5 mg TID",
                  "orderSentence": "Midodrine 2.5 mg TID PO"
                },
                {
                  "text": "5 mg TID",
                  "orderSentence": "Midodrine 5 mg TID PO"
                },
                {
                  "text": "7.5 mg TID",
                  "orderSentence": "Midodrine 7.5 mg TID PO"
                },
                {
                  "text": "10 mg TID",
                  "orderSentence": "Midodrine 10 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 2.5 mg TID (awakening, midday, mid-afternoon); increase by 2.5 mg q1-2wk; max 10 mg TID; NOT within 4h of bedtime",
              "orderSentence": "Midodrine 2.5 mg TID PO"
            },
            "contraindications": "Severe heart disease; urinary retention; pheochromocytoma",
            "monitoring": "Supine HTN (avoid lying flat within 4h); urinary retention",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Fludrocortisone",
            "route": "PO",
            "indication": "Orthostatic hypotension",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.1 mg daily",
                  "orderSentence": "Fludrocortisone 0.1 mg daily PO"
                },
                {
                  "text": "0.2 mg daily",
                  "orderSentence": "Fludrocortisone 0.2 mg daily PO"
                },
                {
                  "text": "0.3 mg daily",
                  "orderSentence": "Fludrocortisone 0.3 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.1 mg daily; increase by 0.1 mg q1-2wk; max 0.3 mg daily",
              "orderSentence": "Fludrocortisone 0.1 mg daily PO"
            },
            "contraindications": "CHF; hypertension",
            "monitoring": "Potassium, BP, edema; hypokalemia; supine HTN",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Droxidopa (Northera)",
            "route": "PO",
            "indication": "Neurogenic orthostatic hypotension",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg",
                  "orderSentence": "Droxidopa (Northera) 100 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 100 mg TID; increase by 100 mg TID q24-48h; max 600 mg TID; NOT within 3h of bedtime",
              "orderSentence": "Droxidopa (Northera) 100 mg PO"
            },
            "contraindications": "Concurrent ergot alkaloids",
            "monitoring": "Supine HTN; caution with MAOIs/triptans",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pyridostigmine",
            "route": "PO",
            "indication": "Orthostatic hypotension (off-label)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mg",
                  "orderSentence": "Pyridostigmine 30 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "30-60 mg TID",
              "orderSentence": "Pyridostigmine 30 mg PO"
            },
            "contraindications": "Mechanical GI/GU obstruction; asthma (relative)",
            "monitoring": "Cholinergic effects; less supine HTN than midodrine",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Polyethylene glycol 3350",
            "route": "PO",
            "indication": "Constipation (autonomic)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "17 g",
                  "orderSentence": "Polyethylene glycol 3350 17 g PO"
                }
              ],
              "route": "PO",
              "instructions": "17 g daily; adjust to effect",
              "orderSentence": "Polyethylene glycol 3350 17 g PO"
            },
            "contraindications": "Bowel obstruction",
            "monitoring": "Electrolytes with prolonged use",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Docusate sodium",
            "route": "PO",
            "indication": "Constipation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg",
                  "orderSentence": "Docusate sodium 100 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "100 mg BID; max 500 mg/day",
              "orderSentence": "Docusate sodium 100 mg PO"
            },
            "contraindications": "Intestinal obstruction",
            "monitoring": "Minimal efficacy alone",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Senna",
            "route": "PO",
            "indication": "Constipation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "17.2 mg",
                  "orderSentence": "Senna 17.2 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "8.6-17.2 mg qHS; max 34.4 mg/day",
              "orderSentence": "Senna 17.2 mg PO"
            },
            "contraindications": "Intestinal obstruction; acute abdominal pain",
            "monitoring": "Cramping",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Metoclopramide",
            "route": "PO",
            "indication": "Gastroparesis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Metoclopramide 10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "5-10 mg 30 min before meals and qHS; max 40 mg/day; limit 12 weeks (black box: TD)",
              "orderSentence": "Metoclopramide 10 mg PO"
            },
            "contraindications": "Bowel obstruction; Parkinson; TD history",
            "monitoring": "Tardive dyskinesia; QT prolongation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Domperidone",
            "route": "PO",
            "indication": "Gastroparesis (if metoclopramide CI)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Domperidone 10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "10 mg TID before meals; max 30 mg/day",
              "orderSentence": "Domperidone 10 mg PO"
            },
            "contraindications": "QT prolongation; QT-prolonging drugs",
            "monitoring": "ECG at baseline; not FDA-approved",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Oxybutynin IR",
            "route": "PO",
            "indication": "Bladder urgency",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Oxybutynin IR 5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg BID-TID; max 5 mg QID",
              "orderSentence": "Oxybutynin IR 5 mg PO"
            },
            "contraindications": "Urinary retention; narrow-angle glaucoma",
            "monitoring": "Dry mouth, constipation, cognitive impairment",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Mirabegron",
            "route": "PO",
            "indication": "Bladder urgency",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg",
                  "orderSentence": "Mirabegron 25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg daily; may increase to 50 mg daily",
              "orderSentence": "Mirabegron 25 mg PO"
            },
            "contraindications": "Uncontrolled hypertension",
            "monitoring": "BP monitoring; fewer anticholinergic effects",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Tamsulosin",
            "route": "PO",
            "indication": "Urinary retention",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.4 mg",
                  "orderSentence": "Tamsulosin 0.4 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "0.4 mg daily 30 min after same meal each day",
              "orderSentence": "Tamsulosin 0.4 mg PO"
            },
            "contraindications": "Severe sulfonamide allergy",
            "monitoring": "Orthostatic hypotension (caution if orthostatic)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sildenafil",
            "route": "PO",
            "indication": "Erectile dysfunction",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg",
                  "orderSentence": "Sildenafil 50 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "50 mg 30-60 min before activity; may adjust 25-100 mg; max 100 mg/day",
              "orderSentence": "Sildenafil 50 mg PO"
            },
            "contraindications": "Concurrent nitrates; recent MI/stroke",
            "monitoring": "Hypotension; priapism",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Tadalafil",
            "route": "PO",
            "indication": "Erectile dysfunction",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Tadalafil 10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "10 mg before activity (max once daily) OR 2.5-5 mg daily",
              "orderSentence": "Tadalafil 10 mg PO"
            },
            "contraindications": "Concurrent nitrates; recent MI/stroke",
            "monitoring": "Hypotension; priapism",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Hydroxyzine",
            "route": "PO",
            "indication": "Anxiety, pruritus",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg",
                  "orderSentence": "Hydroxyzine 25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "25-50 mg TID-QID PRN; max 400 mg/day",
              "orderSentence": "Hydroxyzine 25 mg PO"
            },
            "contraindications": "QT prolongation (high doses)",
            "monitoring": "Sedation; anticholinergic effects",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Buspirone",
            "route": "PO",
            "indication": "Generalized anxiety",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Buspirone 5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg TID; increase by 5 mg q2-3d; max 60 mg/day",
              "orderSentence": "Buspirone 5 mg PO"
            },
            "contraindications": "Concurrent MAOIs",
            "monitoring": "Takes 2-4 weeks for effect; no dependence",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Trazodone",
            "route": "PO",
            "indication": "Insomnia with chronic pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg",
                  "orderSentence": "Trazodone 50 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25-50 mg qHS; increase to 100-150 mg; max 200 mg qHS",
              "orderSentence": "Trazodone 50 mg PO"
            },
            "contraindications": "Concurrent MAOIs; QT prolongation",
            "monitoring": "QTc; priapism (rare); sedation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Melatonin",
            "route": "PO",
            "indication": "Insomnia (adjunct)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "3 mg",
                  "orderSentence": "Melatonin 3 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "3-5 mg qHS 30 min before bed",
              "orderSentence": "Melatonin 3 mg PO"
            },
            "contraindications": "None significant",
            "monitoring": "Generally well-tolerated",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Disease-Specific Treatments": [
          {
            "item": "IVIG",
            "route": "IV",
            "indication": "CIDP, MMN, GBS",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 g/kg",
                  "orderSentence": "IVIG 2 g/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "2 g/kg divided over 2-5 days (induction); maintenance 0.4-1 g/kg q2-4wk",
              "orderSentence": "IVIG 2 g/kg IV"
            },
            "pretreatment": "IgA level; renal function; CBC",
            "contraindications": "IgA deficiency (use IgA-depleted); renal failure; thrombosis risk",
            "monitoring": "Renal function, headache, thrombosis, infusion reactions",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Plasma exchange (PLEX)",
            "route": "IV",
            "indication": "CIDP, GBS",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5-7 exchanges",
                  "orderSentence": "Plasma exchange (PLEX) 5-7 exchanges IV"
                }
              ],
              "route": "IV",
              "instructions": "5-7 exchanges over 10-14 days",
              "orderSentence": "Plasma exchange (PLEX) 5-7 exchanges IV"
            },
            "pretreatment": "Coags; fibrinogen; line access",
            "contraindications": "Hemodynamic instability; sepsis",
            "monitoring": "BP, electrolytes, coags, fibrinogen",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT"
          },
          {
            "item": "Prednisone",
            "route": "PO",
            "indication": "CIDP, vasculitic neuropathy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "60 mg",
                  "orderSentence": "Prednisone 60 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "1 mg/kg/day (max 80 mg) x 4-6 weeks; taper over 3-6 months",
              "orderSentence": "Prednisone 60 mg PO"
            },
            "pretreatment": "Glucose; BP; DEXA if prolonged",
            "contraindications": "Active infection; uncontrolled DM; psychosis",
            "monitoring": "Glucose, BP, mood, bone density",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rituximab",
            "route": "IV",
            "indication": "Anti-MAG neuropathy, vasculitic neuropathy, refractory CIDP",
            "dosing": {
              "doseOptions": [
                {
                  "text": "375 mg/m2",
                  "orderSentence": "Rituximab 375 mg/m2 IV"
                }
              ],
              "route": "IV",
              "instructions": "375 mg/m2 IV weekly x 4 weeks OR 1000 mg IV x 2 doses 14 days apart",
              "orderSentence": "Rituximab 375 mg/m2 IV"
            },
            "pretreatment": "HBV serology; CBC; immunoglobulins",
            "contraindications": "Active hepatitis B; active infection",
            "monitoring": "HBV serology, infusion reactions, infection monitoring",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Azathioprine",
            "route": "PO",
            "indication": "Steroid-sparing for CIDP, vasculitis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg",
                  "orderSentence": "Azathioprine 50 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 50 mg daily; increase to 2-3 mg/kg/day over weeks",
              "orderSentence": "Azathioprine 50 mg PO"
            },
            "pretreatment": "TPMT genotype; CBC; LFTs",
            "contraindications": "TPMT deficiency; pregnancy",
            "monitoring": "CBC weekly x 1 month, then q2-4wk; LFTs monthly",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Mycophenolate mofetil",
            "route": "PO",
            "indication": "Steroid-sparing for CIDP, vasculitis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mg",
                  "orderSentence": "Mycophenolate mofetil 500 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "500 mg BID x 2 weeks, then 1000 mg BID",
              "orderSentence": "Mycophenolate mofetil 500 mg PO"
            },
            "pretreatment": "CBC; pregnancy test",
            "contraindications": "Pregnancy (teratogenic); concurrent azathioprine",
            "monitoring": "CBC q2wk x 3 months, then monthly; GI upset",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Cyclophosphamide",
            "route": "IV/PO",
            "indication": "Vasculitic neuropathy (severe)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 mg/kg",
                  "orderSentence": "Cyclophosphamide 1 mg/kg PO"
                }
              ],
              "route": "PO",
              "instructions": "1-2 mg/kg/day PO OR 500-1000 mg/m2 IV monthly x 6 months",
              "orderSentence": "Cyclophosphamide 1 mg/kg PO"
            },
            "pretreatment": "CBC; UA; pregnancy test",
            "contraindications": "Pregnancy; bone marrow suppression; active infection",
            "monitoring": "CBC weekly; UA (hemorrhagic cystitis); cumulative dose limit",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Tafamidis (Vyndamax)",
            "route": "PO",
            "indication": "hATTR amyloidosis with polyneuropathy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "61 mg",
                  "orderSentence": "Tafamidis (Vyndamax) 61 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "61 mg (Vyndamax) or 80 mg (Vyndaqel) daily",
              "orderSentence": "Tafamidis (Vyndamax) 61 mg PO"
            },
            "pretreatment": "LFTs; cardiac eval",
            "contraindications": "None absolute",
            "monitoring": "LFTs; clinical response",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Patisiran (Onpattro)",
            "route": "IV",
            "indication": "hATTR amyloidosis with polyneuropathy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.3 mg/kg",
                  "orderSentence": "Patisiran (Onpattro) 0.3 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "0.3 mg/kg IV every 3 weeks",
              "orderSentence": "Patisiran (Onpattro) 0.3 mg/kg IV"
            },
            "pretreatment": "LFTs; vitamin A level",
            "contraindications": "None absolute",
            "monitoring": "Vitamin A supplementation required (RDA); infusion reactions",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Inotersen (Tegsedi)",
            "route": "SC",
            "indication": "hATTR amyloidosis with polyneuropathy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "284 mg",
                  "orderSentence": "Inotersen (Tegsedi) 284 mg SC"
                }
              ],
              "route": "SC",
              "instructions": "284 mg SC once weekly",
              "orderSentence": "Inotersen (Tegsedi) 284 mg SC"
            },
            "pretreatment": "Platelets; renal function; REMS enrollment",
            "contraindications": "Platelet <100K; prior glomerulonephritis from inotersen",
            "monitoring": "Platelets weekly (more frequent if <75K); renal q2wk; continue 8wk post-discontinuation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neuromuscular neurology referral",
            "indication": "All new neuropathy diagnoses for etiology workup and management",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Electrodiagnostic medicine/EMG referral",
            "indication": "NCS/EMG for characterization (axonal vs demyelinating, pattern)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Physical therapy consult for balance and gait",
            "indication": "Gait instability, weakness, falls prevention",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Occupational therapy consult for hand function",
            "indication": "Fine motor impairment, ADL difficulty",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Podiatry referral",
            "indication": "Diabetic neuropathy, foot care education, orthotics, wound prevention",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Endocrinology referral",
            "indication": "Diabetes management optimization if HbA1c not at goal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pain management/Anesthesia referral",
            "indication": "Refractory neuropathic pain, spinal cord stimulator evaluation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rheumatology referral",
            "indication": "Suspected vasculitic neuropathy, connective tissue disease",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Hematology/Oncology referral",
            "indication": "Paraproteinemic neuropathy, suspected malignancy, amyloidosis",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Genetic counseling referral",
            "indication": "Suspected hereditary neuropathy (CMT, hATTR), family history",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Psychiatry/Psychology referral",
            "indication": "Chronic pain management, depression, anxiety",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Social work consult",
            "indication": "Disability resources, insurance navigation, DME assistance",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Wound care referral",
            "indication": "Diabetic foot ulcers, non-healing wounds",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Orthotics/Prosthetics",
            "indication": "AFOs for foot drop, custom orthotics",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Nutrition/Dietitian referral",
            "indication": "Alcoholic neuropathy, nutritional deficiencies, bariatric surgery patients",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Addiction medicine/Psychiatry",
            "indication": "Alcohol use disorder, opioid risk mitigation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Return to ED if sudden severe weakness, difficulty breathing, or rapid symptom progression",
            "ED": "Ã¢Å“â€œ",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Inspect feet daily for cuts, blisters, or wounds (use mirror for soles)",
            "ED": "Ã¢Å“â€œ",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Wear well-fitting, protective footwear at all times (never barefoot)",
            "ED": "Ã¢Å“â€œ",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Test bath water temperature with elbow or thermometer before entering (avoid burns)",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Avoid prolonged hot or cold exposure to affected extremities (impaired sensation increases injury risk)",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Use night lights and handrails to prevent falls",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Report new numbness, weakness, or autonomic symptoms (dizziness, bladder changes)",
            "ED": "Ã¢Å“â€œ",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Keep pain medication diary to track effectiveness and side effects",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Do not stop gabapentin/pregabalin abruptly - taper under medical guidance",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Neuropathic pain medications take 2-4 weeks to reach full effect",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Avoid alcohol (worsens neuropathy, interacts with pain medications)",
            "ED": "Ã¢Å“â€œ",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Rise slowly from sitting/lying position if orthostatic hypotension present",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Increase salt and fluid intake if orthostatic (unless contraindicated by cardiac/renal disease)",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Wear compression stockings for orthostatic hypotension",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Do not drive until cleared if significant sensory loss or weakness affects pedal control",
            "ED": "Ã¢Å“â€œ",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "B12 injections: if self-administering, use proper technique and rotate injection sites",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Strict glycemic control (HbA1c <7% or individualized target) - most important modifiable factor",
            "ED": "Ã¢Å“â€œ",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Complete alcohol cessation (alcoholic neuropathy is reversible if early)",
            "ED": "Ã¢Å“â€œ",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Smoking cessation (microvascular disease worsens neuropathy)",
            "ED": "Ã¢Å“â€œ",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Regular exercise as tolerated (improves circulation, glycemic control, reduces pain)",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Balance exercises and strength training (PT-guided) to prevent falls",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Pool therapy/aquatic exercise (reduces fall risk while exercising)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Vitamin B12 supplementation if vegan/vegetarian or on metformin",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Review medications for neurotoxic agents (metronidazole, nitrofurantoin, chemotherapy, amiodarone, statins)",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Avoid excessive vitamin B6 supplementation (>100 mg/day can cause neuropathy)",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Blood pressure control (target <130/80 for diabetic patients)",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Weight loss if obese (reduces pressure on nerves, improves metabolic syndrome)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Fall prevention: remove throw rugs, ensure adequate lighting, use assistive devices",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Annual foot exams by podiatry or primary care for diabetic patients",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Regular ophthalmology exams if diabetic (concurrent retinopathy common)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "Ã¢Å“â€œ"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Diabetic polyneuropathy",
        "features": "Symmetric, length-dependent, sensory-predominant, feet before hands, burning/tingling",
        "tests": "HbA1c >6.5% (or 2-hour OGTT >200); NCS shows axonal sensorimotor polyneuropathy"
      },
      {
        "diagnosis": "Alcoholic neuropathy",
        "features": "History of chronic alcohol use, nutritional deficiency, burning feet",
        "tests": "History, thiamine level, liver function tests"
      },
      {
        "diagnosis": "Vitamin B12 deficiency",
        "features": "Subacute combined degeneration, myelopathy features (ataxia, Romberg), macrocytic anemia",
        "tests": "B12 <200 pg/mL or MMA elevated; may have cord signal changes on MRI"
      },
      {
        "diagnosis": "Chronic inflammatory demyelinating polyneuropathy (CIDP)",
        "features": "Progressive or relapsing weakness >8 weeks, proximal and distal, areflexia",
        "tests": "NCS shows demyelination; CSF protein elevated; nerve enlargement on ultrasound"
      },
      {
        "diagnosis": "Guillain-BarrÃƒÂ© syndrome (GBS)",
        "features": "Acute ascending weakness <4 weeks, areflexia, post-infectious",
        "tests": "NCS early may be normal then demyelinating; CSF albuminocytologic dissociation"
      },
      {
        "diagnosis": "Hereditary neuropathy (CMT)",
        "features": "Family history, pes cavus, hammertoes, childhood onset, slowly progressive",
        "tests": "Genetic testing; NCS shows uniform slowing in CMT1"
      },
      {
        "diagnosis": "Hereditary transthyretin amyloidosis (hATTR)",
        "features": "Autonomic dysfunction, carpal tunnel, cardiac involvement, family history",
        "tests": "TTR gene mutation; tissue biopsy with amyloid"
      },
      {
        "diagnosis": "Monoclonal gammopathy-associated neuropathy",
        "features": "Distal sensory-predominant, ataxia (IgM anti-MAG), older patient",
        "tests": "SPEP/UPEP; anti-MAG antibody; may need bone marrow biopsy"
      },
      {
        "diagnosis": "Vasculitic neuropathy",
        "features": "Mononeuritis multiplex pattern (asymmetric, stepwise), pain, systemic symptoms",
        "tests": "Elevated ESR/CRP; ANCA; nerve/muscle biopsy shows necrotizing vasculitis"
      },
      {
        "diagnosis": "Paraneoplastic sensory neuronopathy",
        "features": "Subacute onset, asymmetric, dorsal root ganglia involvement, weight loss",
        "tests": "Anti-Hu antibody; CT chest for small cell lung cancer"
      },
      {
        "diagnosis": "Radiculopathy",
        "features": "Dermatomal distribution, unilateral, neck/back pain, preserved reflexes outside affected root",
        "tests": "MRI spine; NCS/EMG shows radicular pattern"
      },
      {
        "diagnosis": "Lumbosacral plexopathy (diabetic amyotrophy)",
        "features": "Acute/subacute proximal weakness, thigh pain, unilateral then contralateral",
        "tests": "NCS/EMG; MRI lumbosacral plexus; diagnosis of exclusion"
      },
      {
        "diagnosis": "Small fiber neuropathy",
        "features": "Pain/autonomic symptoms with normal NCS, preserved reflexes",
        "tests": "Skin biopsy for IENFD; autonomic testing"
      },
      {
        "diagnosis": "Charcot-Marie-Tooth disease",
        "features": "Childhood/adolescent onset, pes cavus, distal atrophy, family history",
        "tests": "Genetic testing (PMP22 duplication most common)"
      },
      {
        "diagnosis": "Chemotherapy-induced peripheral neuropathy (CIPN)",
        "features": "Temporal relationship to neurotoxic chemotherapy (platinum, taxanes, vincristine)",
        "tests": "History; dose-dependent; may improve after discontinuation"
      },
      {
        "diagnosis": "HIV-associated distal sensory polyneuropathy",
        "features": "HIV+ patient, distal symmetric painful neuropathy",
        "tests": "HIV testing; CD4 count"
      },
      {
        "diagnosis": "Lyme disease",
        "features": "Endemic area, prior tick bite, radiculopathy, cranial neuropathy, polyradiculopathy",
        "tests": "Lyme serology; may need CSF analysis"
      },
      {
        "diagnosis": "Sarcoidosis",
        "features": "Multifocal neuropathy, cranial neuropathy (especially VII), pulmonary symptoms",
        "tests": "ACE level; chest imaging; biopsy (non-caseating granulomas)"
      },
      {
        "diagnosis": "Leprosy",
        "features": "Endemic areas, skin lesions, enlarged palpable nerves, anesthetic patches",
        "tests": "Skin smear/biopsy for AFB; nerve biopsy"
      }
    ],
    "evidence": [
      {
        "recommendation": "Diabetes is most common cause of polyneuropathy in developed countries",
        "evidenceLevel": "Class I",
        "source": "[Dyck PJ et al. Neurology 1993](https://pubmed.ncbi.nlm.nih.gov/8469345/)"
      },
      {
        "recommendation": "HbA1c <7% reduces neuropathy incidence in Type 1 DM",
        "evidenceLevel": "Class I, Level A",
        "source": "[DCCT/EDIC, Martin et al. Diabetes Care 2014](https://pubmed.ncbi.nlm.nih.gov/24356595/)"
      },
      {
        "recommendation": "Gabapentin, pregabalin, duloxetine first-line for painful diabetic neuropathy",
        "evidenceLevel": "Class I, Level A",
        "source": "[AAN/AANEM Practice Guideline 2022](https://pubmed.ncbi.nlm.nih.gov/34965987/)"
      },
      {
        "recommendation": "Tricyclic antidepressants effective for neuropathic pain",
        "evidenceLevel": "Class I, Level A",
        "source": "[Finnerup NB et al. Lancet Neurol 2015](https://pubmed.ncbi.nlm.nih.gov/25575710/)"
      },
      {
        "recommendation": "NCS/EMG for characterization of peripheral neuropathy",
        "evidenceLevel": "Class II, Level B",
        "source": "[AAN Practice Parameter 2009](https://pubmed.ncbi.nlm.nih.gov/19056666/)"
      },
      {
        "recommendation": "SPEP indicated in idiopathic neuropathy workup",
        "evidenceLevel": "Class II, Level B",
        "source": "[England JD et al. Neurology 2009](https://pubmed.ncbi.nlm.nih.gov/19056666/)"
      },
      {
        "recommendation": "OGTT detects IGT in 34-62% of idiopathic neuropathy patients",
        "evidenceLevel": "Class II, Level B",
        "source": "[Singleton et al. Diabetes Care 2001](https://pubmed.ncbi.nlm.nih.gov/11473085/); [Hoffman-Snyder et al. Arch Neurol 2006](https://pubmed.ncbi.nlm.nih.gov/16769858/)"
      },
      {
        "recommendation": "Skin biopsy (IENFD) for small fiber neuropathy",
        "evidenceLevel": "Class II, Level B",
        "source": "[Lauria G et al. Eur J Neurol 2010](https://pubmed.ncbi.nlm.nih.gov/20642627/)"
      },
      {
        "recommendation": "IVIG first-line for CIDP",
        "evidenceLevel": "Class I, Level A",
        "source": "[EAN/PNS Guidelines 2021](https://pubmed.ncbi.nlm.nih.gov/33506534/)"
      },
      {
        "recommendation": "Thiamine supplementation in alcoholic neuropathy",
        "evidenceLevel": "Class II, Level B",
        "source": "[AAN Practice Parameter](https://pubmed.ncbi.nlm.nih.gov/19056666/)"
      },
      {
        "recommendation": "Foot care reduces amputations in diabetic neuropathy",
        "evidenceLevel": "Class I, Level A",
        "source": "[ADA Standards of Care 2023: Foot Care](https://pubmed.ncbi.nlm.nih.gov/36507636/)"
      },
      {
        "recommendation": "Capsaicin 8% patch effective for localized neuropathic pain",
        "evidenceLevel": "Class I, Level A",
        "source": "[Qutenza Prescribing Information](https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022395s012lbl.pdf)"
      },
      {
        "recommendation": "Tafamidis for hATTR polyneuropathy",
        "evidenceLevel": "Class I, Level A",
        "source": "[Coelho T et al. Neurology 2012](https://pubmed.ncbi.nlm.nih.gov/22843282/)"
      },
      {
        "recommendation": "Patisiran/inotersen for hATTR polyneuropathy",
        "evidenceLevel": "Class I, Level A",
        "source": "[Adams D et al. NEJM 2018 (APOLLO)](https://pubmed.ncbi.nlm.nih.gov/29972753/); [Benson MD et al. NEJM 2018 (NEURO-TTR)](https://pubmed.ncbi.nlm.nih.gov/29972757/)"
      },
      {
        "recommendation": "Combination therapy for neuropathic pain improves outcomes",
        "evidenceLevel": "Class II, Level B",
        "source": "[Gilron I et al. Lancet 2009](https://pubmed.ncbi.nlm.nih.gov/19796802/)"
      }
    ],
    "monitoring": [
      {
        "item": "HbA1c",
        "frequency": "Every 3 months until stable, then every 6 months",
        "action": "Intensify glycemic therapy; endocrinology referral",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Vitamin B12",
        "frequency": "1-2 months after starting supplementation, then annually",
        "action": "Continue supplementation; rule out malabsorption",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Pain scores (0-10 NRS)",
        "frequency": "Each visit",
        "action": "Titrate medications; consider adjuncts or referral",
        "ED": "ROUTINE",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "ROUTINE"
      },
      {
        "item": "Foot exam",
        "frequency": "Every visit; comprehensive annually",
        "action": "Podiatry referral; wound care",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Blood pressure (supine and standing)",
        "frequency": "Each visit if orthostatic symptoms",
        "action": "Adjust orthostatic hypotension medications; consider compression",
        "ED": "URGENT",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "ROUTINE"
      },
      {
        "item": "Gait and fall risk assessment",
        "frequency": "Each visit",
        "action": "PT referral; assistive devices; home safety evaluation",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Creatinine clearance",
        "frequency": "Baseline; with renal disease, elderly, or gabapentinoid use; with dose changes",
        "action": "Adjust gabapentin: CrCl 30-59 max 900-1400 mg/day; CrCl 15-29 max 600 mg/day; CrCl <15 max 300 mg/day",
        "ED": "STAT",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "STAT"
      },
      {
        "item": "LFTs (if on high-dose gabapentinoid)",
        "frequency": "Baseline, then annually",
        "action": "Dose adjustment if hepatic impairment",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Renal function",
        "frequency": "Every 6-12 months",
        "action": "Adjust renally cleared medications (gabapentin, pregabalin)",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "CBC (if on immunotherapy)",
        "frequency": "Per medication protocol",
        "action": "Adjust immunosuppression dose; infection evaluation",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "ROUTINE"
      },
      {
        "item": "NCS/EMG follow-up",
        "frequency": "6-12 months if treatment initiated; PRN for symptom change",
        "action": "If progressive despite treatment, reconsider diagnosis or escalate therapy",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "ECG (if on TCAs)",
        "frequency": "Baseline; with dose increases >100 mg",
        "action": "Reduce dose or switch medication",
        "ED": "URGENT",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "URGENT"
      },
      {
        "item": "Weight (if on gabapentinoid)",
        "frequency": "Each visit",
        "action": "Diet/exercise counseling; consider switch",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Depression/anxiety screening (PHQ-9, GAD-7)",
        "frequency": "Annually or with symptom concern",
        "action": "Psychiatry referral; pharmacotherapy",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Respiratory function (if GBS/CIDP suspected)",
        "frequency": "Q4h if concern; FVC and NIF",
        "action": "ICU transfer if FVC <20 or NIF >-30; intubation if declining",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT"
      }
    ],
    "disposition": [
      {
        "disposition": "**Discharge home**",
        "criteria": "Stable symptoms; chronic/slowly progressive course; ambulatory; reliable follow-up with neurology within 2-4 weeks; pain controlled; able to perform ADLs; no fall risk requiring inpatient therapy"
      },
      {
        "disposition": "**Admit to floor**",
        "criteria": "Acute/subacute progression concerning for GBS or CIDP; significant functional decline; falls requiring therapy evaluation; severe uncontrolled pain; new autonomic instability; workup requiring inpatient procedures (nerve biopsy, LP)"
      },
      {
        "disposition": "**Admit to ICU**",
        "criteria": "GBS with respiratory compromise (FVC <20 mL/kg, NIF >-30, or declining trajectory); autonomic instability with cardiac arrhythmia or BP lability; aspiration risk"
      },
      {
        "disposition": "**Transfer to higher level**",
        "criteria": "EMG/NCS not available urgently; neuromuscular specialist not available; PLEX/IVIG needed but not available; rehabilitation services not available"
      }
    ]
  },
  "Acute Ischemic Stroke": {
    "id": "acute-ischemic-stroke",
    "title": "Acute Ischemic Stroke",
    "version": "1.2",
    "icd10": [
      "** I63.9 (Cerebral infarction",
      "unspecified)",
      "I63.50 (Cerebral infarction due to unspecified occlusion or stenosis of unspecified cerebral artery)",
      "I63.30 (Cerebral infarction due to thrombosis of unspecified cerebral artery)",
      "I63.40 (Cerebral infarction due to embolism of unspecified cerebral artery)",
      "G45.9 (Transient cerebral ischemic attack",
      "unspecified)"
    ],
    "scope": "** Emergency evaluation and treatment of acute ischemic stroke, including thrombolysis decision-making, mechanical thrombectomy candidacy, acute stroke unit care, secondary prevention, and etiologic workup. For hemorrhagic stroke, TIA, or venous sinus thrombosis, use dedicated templates.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "Point-of-care glucose",
            "rationale": "Hypoglycemia can mimic stroke; required before tPA",
            "target": "60-180 mg/dL",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "CBC with differential",
            "rationale": "Baseline; thrombocytopenia contraindication to tPA",
            "target": "Platelets >100K",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "PT/INR",
            "rationale": "Anticoagulation status; INR >1.7 contraindication to tPA",
            "target": "INR <1.7",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "PTT",
            "rationale": "Baseline; heparin effect assessment",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Basic metabolic panel",
            "rationale": "Electrolytes, renal function",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Troponin",
            "rationale": "Concurrent MI; cardioembolic source",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "BNP or NT-proBNP",
            "rationale": "Heart failure; atrial cardiopathy",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Lipid panel (fasting preferred)",
            "rationale": "Cardiovascular risk; statin candidacy",
            "target": "LDL target <70",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "HbA1c",
            "rationale": "Diabetes as risk factor",
            "target": "<7% goal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended Workup": [
          {
            "item": "TSH",
            "rationale": "Thyroid disease and atrial fibrillation",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "LFTs",
            "rationale": "Baseline for statin therapy",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Urine drug screen",
            "rationale": "Cocaine, amphetamine-induced stroke",
            "target": "Negative",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Pregnancy test (females of childbearing age)",
            "rationale": "tPA risk assessment",
            "target": "Negative (or counsel risks)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Hemoglobin A1c",
            "rationale": "Glycemic control assessment",
            "target": "<7% goal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "ESR",
            "rationale": "Vasculitis screen",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CRP",
            "rationale": "Inflammation; vasculitis",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Homocysteine",
            "rationale": "Hypercoagulable workup in young stroke",
            "target": "Normal (<15 umol/L)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin B12",
            "rationale": "Hyperhomocysteinemia cause",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Folate",
            "rationale": "Hyperhomocysteinemia cause",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Antiphospholipid antibodies (lupus anticoagulant, anticardiolipin, anti-beta2 glycoprotein)",
            "rationale": "Hypercoagulable workup; repeat in 12 weeks if positive",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Protein C, Protein S, Antithrombin III",
            "rationale": "Inherited thrombophilia (defer acute phase; check 2-4 weeks post-stroke)",
            "target": "Normal",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Factor V Leiden, Prothrombin gene mutation",
            "rationale": "Inherited thrombophilia",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "ANA, anti-dsDNA",
            "rationale": "Vasculitis, SLE",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "ANCA (c-ANCA, p-ANCA)",
            "rationale": "Primary CNS vasculitis; systemic vasculitis",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Syphilis serology (RPR)",
            "rationale": "Infectious vasculopathy",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "HIV antibody",
            "rationale": "HIV-associated vasculopathy",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Hepatitis B and C serology",
            "rationale": "Associated with vasculitis",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lipoprotein(a)",
            "rationale": "Elevated in cryptogenic stroke",
            "target": "Normal (<50 nmol/L or <30 mg/dL)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sickle cell screen",
            "rationale": "If clinical suspicion",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Fabry disease testing (alpha-galactosidase A, GLA gene)",
            "rationale": "Young cryptogenic stroke, especially with other Fabry features",
            "target": "Normal enzyme activity",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "Opening pressure",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "rationale": "Rule out elevated ICP",
            "target": "10-20 cm H2O"
          },
          {
            "item": "Cell count (tubes 1 and 4)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "rationale": "Vasculitis, infection",
            "target": "WBC <5, RBC 0"
          },
          {
            "item": "Protein",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "rationale": "Inflammation",
            "target": "Normal 15-45 mg/dL"
          },
          {
            "item": "Glucose with serum glucose",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "rationale": "Infection",
            "target": "Normal (>60% serum)"
          },
          {
            "item": "Gram stain and culture",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "rationale": "Bacterial meningitis",
            "target": "No organisms"
          },
          {
            "item": "VDRL (CSF)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "rationale": "Neurosyphilis",
            "target": "Negative"
          },
          {
            "item": "Cytology",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "rationale": "Malignancy",
            "target": "Negative"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "Non-contrast CT head (NCCT)",
            "timing": "STAT - door to CT <25 min target",
            "target": "No hemorrhage; early ischemic changes (ASPECTS score)",
            "contraindications": "None",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "CT angiography head and neck (CTA)",
            "timing": "STAT with NCCT",
            "target": "Large vessel occlusion (LVO); carotid/vertebral stenosis",
            "contraindications": "Contrast allergy (premedicate), CKD (benefit usually outweighs risk in acute stroke)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "CT perfusion (CTP)",
            "timing": "If within extended window (6-24 hours) or wake-up stroke",
            "target": "Mismatch (ischemic penumbra salvageable)",
            "contraindications": "Contrast allergy (premedicate), CKD (benefit usually outweighs risk in acute stroke)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "ECG (12-lead)",
            "timing": "STAT",
            "target": "Atrial fibrillation, STEMI, LVH",
            "contraindications": "None",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          }
        ],
        "Extended": [
          {
            "item": "MRI brain with DWI",
            "timing": "Within 24 hours; better for small/posterior strokes",
            "target": "Acute infarct confirmation; lesion pattern",
            "contraindications": "Pacemaker, metallic implants (check compatibility)",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "MRA head and neck",
            "timing": "With MRI if CTA not done",
            "target": "Stenosis, dissection, aneurysm",
            "contraindications": "Pacemaker, metallic implants (check compatibility)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Transthoracic echocardiogram (TTE) with bubble study",
            "timing": "Within 24-48 hours",
            "target": "LV thrombus, PFO, valvular disease, wall motion abnormalities",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Transesophageal echocardiogram (TEE)",
            "timing": "If TTE non-diagnostic and high suspicion for cardiac source; or PFO evaluation",
            "target": "LAA thrombus, aortic atheroma, PFO with atrial septal aneurysm",
            "contraindications": "Esophageal pathology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Carotid duplex ultrasound",
            "timing": "If CTA/MRA not done or for follow-up",
            "target": "Stenosis >50%",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Transcranial Doppler (TCD) with bubble study",
            "timing": "PFO evaluation; vasospasm monitoring",
            "target": "Right-to-left shunt; microembolic signals",
            "contraindications": "Inadequate acoustic windows",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Continuous cardiac telemetry (minimum 24-72 hours)",
            "timing": "Paroxysmal AF detection",
            "target": "Atrial fibrillation",
            "contraindications": "None",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Extended cardiac monitoring (Holter 7-30 days or implantable loop recorder)",
            "timing": "Cryptogenic stroke; AF not detected on telemetry",
            "target": "Paroxysmal AF",
            "contraindications": "None significant",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Conventional cerebral angiography (DSA)",
            "timing": "If vasculitis suspected; CNS vasculitis workup",
            "target": "Beading, stenosis, aneurysm",
            "contraindications": "Contrast allergy, CKD, coagulopathy",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "High-resolution vessel wall MRI",
            "timing": "Vasculitis, intracranial atherosclerosis characterization",
            "target": "Wall enhancement pattern",
            "contraindications": "Pacemaker, metallic implants (check compatibility)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Lumbar puncture",
            "timing": "If vasculitis, infectious, or inflammatory etiology suspected",
            "target": "See LP section",
            "contraindications": "See LP section",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "PET-CT or PET-MRI",
            "timing": "Occult malignancy workup; giant cell arteritis",
            "target": "No malignancy/inflammation",
            "contraindications": "Pregnancy",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Implantable loop recorder (ILR)",
            "timing": "Cryptogenic stroke after negative workup",
            "target": "Paroxysmal AF detection",
            "contraindications": "Active infection",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent (Hyperacute Phase)": [
          {
            "item": "Alteplase (tPA) IV",
            "route": "IV",
            "indication": "Acute ischemic stroke within 4.5h",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.9 mg/kg (max 90 mg)",
                  "orderSentence": "Alteplase (tPA) IV 0.9 mg/kg (max 90 mg) IV"
                }
              ],
              "route": "IV",
              "instructions": "0.9 mg/kg IV (max 90 mg); 10% as bolus over 1 min, remainder over 60 min; within 4.5 hours",
              "orderSentence": "Alteplase (tPA) IV 0.9 mg/kg (max 90 mg) IV"
            },
            "contraindications": "See Appendix A; major: ICH, recent surgery, BP >185/110, INR >1.7, platelets <100K",
            "monitoring": "Neuro checks q15min x 2h, then q30min x 6h, then q1h x 16h; BP q15min x 2h; hold anticoagulants 24h",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Tenecteplase IV",
            "route": "IV",
            "indication": "Acute ischemic stroke within 4.5h",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.25 mg/kg (max 25 mg)",
                  "orderSentence": "Tenecteplase IV 0.25 mg/kg (max 25 mg) IV"
                }
              ],
              "route": "IV",
              "instructions": "0.25 mg/kg IV bolus (max 25 mg); single bolus (no infusion); within 4.5 hours",
              "orderSentence": "Tenecteplase IV 0.25 mg/kg (max 25 mg) IV"
            },
            "contraindications": "See Appendix A; major: ICH, recent surgery, BP >185/110, INR >1.7, platelets <100K",
            "monitoring": "Neuro checks q15min x 2h, then q30min x 6h; BP q15min x 2h; hold anticoagulants 24h",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Labetalol (pre-thrombolysis)",
            "route": "IV",
            "indication": "BP control for tPA eligibility",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Labetalol (pre-thrombolysis) 10 mg IV"
                },
                {
                  "text": "20 mg",
                  "orderSentence": "Labetalol (pre-thrombolysis) 20 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "10-20 mg IV over 1-2 min; may repeat or double q10min; max 300 mg; target BP <185/110",
              "orderSentence": "Labetalol (pre-thrombolysis) 10 mg IV"
            },
            "contraindications": "Asthma, severe bradycardia, decompensated HF, 2nd/3rd degree heart block",
            "monitoring": "Continuous BP; target BP <185/110 for tPA eligibility",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Nicardipine (pre-thrombolysis)",
            "route": "IV",
            "indication": "BP control for tPA eligibility",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg/hr",
                  "orderSentence": "Nicardipine (pre-thrombolysis) 5 mg/hr IV"
                },
                {
                  "text": "10 mg/hr",
                  "orderSentence": "Nicardipine (pre-thrombolysis) 10 mg/hr IV"
                },
                {
                  "text": "15 mg/hr",
                  "orderSentence": "Nicardipine (pre-thrombolysis) 15 mg/hr IV"
                }
              ],
              "route": "IV",
              "instructions": "Start 5 mg/hr IV; increase by 2.5 mg/hr q5-15min; max 15 mg/hr; target BP <185/110",
              "orderSentence": "Nicardipine (pre-thrombolysis) 5 mg/hr IV"
            },
            "contraindications": "None significant",
            "monitoring": "Continuous BP; target <185/110",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Clevidipine (pre-thrombolysis)",
            "route": "IV",
            "indication": "BP control for tPA eligibility",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 mg/hr",
                  "orderSentence": "Clevidipine (pre-thrombolysis) 1 mg/hr IV"
                },
                {
                  "text": "2 mg/hr",
                  "orderSentence": "Clevidipine (pre-thrombolysis) 2 mg/hr IV"
                },
                {
                  "text": "4 mg/hr",
                  "orderSentence": "Clevidipine (pre-thrombolysis) 4 mg/hr IV"
                },
                {
                  "text": "8 mg/hr",
                  "orderSentence": "Clevidipine (pre-thrombolysis) 8 mg/hr IV"
                },
                {
                  "text": "16 mg/hr",
                  "orderSentence": "Clevidipine (pre-thrombolysis) 16 mg/hr IV"
                }
              ],
              "route": "IV",
              "instructions": "Start 1-2 mg/hr IV; titrate by doubling q90sec initially; max 32 mg/hr",
              "orderSentence": "Clevidipine (pre-thrombolysis) 1 mg/hr IV"
            },
            "contraindications": "Soy/egg allergy, severe aortic stenosis, lipid disorders",
            "monitoring": "Continuous BP; rapid onset; short half-life",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "BP management (post-tPA)",
            "route": "IV",
            "indication": "Post-tPA BP control",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Labetalol 10-20 mg IV",
                  "orderSentence": "BP management (post-tPA) Labetalol 10-20 mg IV IV"
                },
                {
                  "text": "Nicardipine 5-15 mg/hr IV",
                  "orderSentence": "BP management (post-tPA) Nicardipine 5-15 mg/hr IV IV"
                },
                {
                  "text": "Clevidipine 1-32 mg/hr IV",
                  "orderSentence": "BP management (post-tPA) Clevidipine 1-32 mg/hr IV IV"
                }
              ],
              "route": "IV",
              "instructions": "Labetalol 10-20 mg IV q10min, nicardipine 5-15 mg/hr, or clevidipine 1-32 mg/hr; target BP <180/105 x 24h",
              "orderSentence": "BP management (post-tPA) Labetalol 10-20 mg IV IV"
            },
            "contraindications": "Asthma (labetalol); soy/egg allergy (clevidipine)",
            "monitoring": "Continuous BP; target BP <180/105 for 24 hours post-tPA",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Mechanical thrombectomy",
            "route": "—",
            "indication": "Large vessel occlusion",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Mechanical thrombectomy N/A —"
                }
              ],
              "route": "—",
              "instructions": "Endovascular clot retrieval; within 6 hours for anterior LVO; up to 24 hours with favorable perfusion imaging",
              "orderSentence": "Mechanical thrombectomy N/A —"
            },
            "contraindications": "Large completed infarct (ASPECTS <6), poor baseline function (mRS >2), no LVO",
            "monitoring": "Post-procedure: BP per protocol, groin site checks, neuro checks q1h",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          }
        ],
        "Acute Supportive Care": [
          {
            "item": "NPO status",
            "route": "—",
            "indication": "All acute stroke",
            "dosing": {
              "doseOptions": [
                {
                  "text": "NPO",
                  "orderSentence": "NPO status NPO —"
                }
              ],
              "route": "—",
              "instructions": "NPO until formal swallow screen passed",
              "orderSentence": "NPO status NPO —"
            },
            "contraindications": "None",
            "monitoring": "Aspiration risk",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "IV fluids - Normal saline",
            "route": "IV",
            "indication": "Volume resuscitation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "NS 500 mL",
                  "orderSentence": "IV fluids - Normal saline NS 500 mL IV"
                },
                {
                  "text": "NS 1000 mL",
                  "orderSentence": "IV fluids - Normal saline NS 1000 mL IV"
                }
              ],
              "route": "IV",
              "instructions": "0.9% NaCl; avoid dextrose-containing fluids (hyperglycemia worsens outcomes)",
              "orderSentence": "IV fluids - Normal saline NS 500 mL IV"
            },
            "contraindications": "Volume overload",
            "monitoring": "I/O, daily weights",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Insulin - Glucose management",
            "route": "IV/SC",
            "indication": "Hyperglycemia in acute stroke",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per protocol",
                  "orderSentence": "Insulin - Glucose management Per protocol IV/SC"
                }
              ],
              "route": "IV/SC",
              "instructions": "Sliding scale or infusion; target glucose 140-180 mg/dL; avoid hypoglycemia",
              "orderSentence": "Insulin - Glucose management Per protocol IV/SC"
            },
            "contraindications": "Hypoglycemia (<60)",
            "monitoring": "Glucose q1-6h depending on regimen",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Intermittent pneumatic compression",
            "route": "—",
            "indication": "DVT prophylaxis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Apply bilateral",
                  "orderSentence": "Intermittent pneumatic compression Apply bilateral —"
                }
              ],
              "route": "—",
              "instructions": "Apply to both legs",
              "orderSentence": "Intermittent pneumatic compression Apply bilateral —"
            },
            "contraindications": "Active DVT",
            "monitoring": "Skin checks",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Enoxaparin",
            "route": "SC",
            "indication": "DVT prophylaxis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mg",
                  "orderSentence": "Enoxaparin 30 mg SC"
                },
                {
                  "text": "40 mg",
                  "orderSentence": "Enoxaparin 40 mg SC"
                }
              ],
              "route": "SC",
              "instructions": "40 mg SC daily; reduce to 30 mg if CrCl <30; start 24-48h post-stroke if no hemorrhage",
              "orderSentence": "Enoxaparin 30 mg SC"
            },
            "contraindications": "Active bleeding, HIT, hemorrhagic transformation",
            "monitoring": "Platelets; signs of bleeding",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE"
          },
          {
            "item": "Heparin (unfractionated)",
            "route": "SC",
            "indication": "DVT prophylaxis (CrCl <30)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5000 units",
                  "orderSentence": "Heparin (unfractionated) 5000 units SC"
                }
              ],
              "route": "SC",
              "instructions": "5000 units SC q8-12h; alternative to enoxaparin if CrCl <30",
              "orderSentence": "Heparin (unfractionated) 5000 units SC"
            },
            "contraindications": "Active bleeding, HIT, hemorrhagic transformation",
            "monitoring": "Platelets; signs of bleeding",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE"
          },
          {
            "item": "Acetaminophen",
            "route": "PO/PR",
            "indication": "Fever management",
            "dosing": {
              "doseOptions": [
                {
                  "text": "650 mg",
                  "orderSentence": "Acetaminophen 650 mg PO"
                },
                {
                  "text": "1000 mg",
                  "orderSentence": "Acetaminophen 1000 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "650-1000 mg PO/PR q4-6h PRN temp >38C; max 4g/day; target normothermia",
              "orderSentence": "Acetaminophen 650 mg PO"
            },
            "contraindications": "Hepatic impairment",
            "monitoring": "Temperature",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Head of bed positioning",
            "route": "—",
            "indication": "Perfusion optimization",
            "dosing": {
              "doseOptions": [
                {
                  "text": "HOB flat to 15°",
                  "orderSentence": "Head of bed positioning HOB flat to 15° —"
                },
                {
                  "text": "HOB 30°",
                  "orderSentence": "Head of bed positioning HOB 30° —"
                }
              ],
              "route": "—",
              "instructions": "Flat to 15° initially if no LVO treated; elevate to 30° if large infarct or aspiration risk",
              "orderSentence": "Head of bed positioning HOB flat to 15° —"
            },
            "contraindications": "None",
            "monitoring": "Neuro exam",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Supplemental oxygen",
            "route": "INH",
            "indication": "Hypoxia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2-4 L/min NC",
                  "orderSentence": "Supplemental oxygen 2-4 L/min NC INH"
                },
                {
                  "text": "NRB PRN",
                  "orderSentence": "Supplemental oxygen NRB PRN INH"
                }
              ],
              "route": "INH",
              "instructions": "Titrate to SpO2 >94%; avoid routine oxygen in non-hypoxic patients",
              "orderSentence": "Supplemental oxygen 2-4 L/min NC INH"
            },
            "contraindications": "None",
            "monitoring": "Continuous SpO2",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          }
        ],
        "Secondary Prevention (Initiate During Hospitalization)": [
          {
            "item": "Aspirin",
            "route": "PO",
            "indication": "Non-cardioembolic stroke",
            "dosing": {
              "doseOptions": [
                {
                  "text": "81 mg daily",
                  "orderSentence": "Aspirin 81 mg daily PO"
                },
                {
                  "text": "325 mg daily",
                  "orderSentence": "Aspirin 325 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Load 325 mg (after tPA, wait 24h, confirm no ICH); Maintenance 81-325 mg daily",
              "orderSentence": "Aspirin 81 mg daily PO"
            },
            "contraindications": "Active bleeding, aspirin allergy, concurrent anticoagulation",
            "monitoring": "Bleeding signs",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Clopidogrel",
            "route": "PO",
            "indication": "Aspirin intolerance; or DAPT",
            "dosing": {
              "doseOptions": [
                {
                  "text": "75 mg daily",
                  "orderSentence": "Clopidogrel 75 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Load 300-600 mg; Maintenance 75 mg daily",
              "orderSentence": "Clopidogrel 75 mg daily PO"
            },
            "contraindications": "Active bleeding, severe hepatic impairment",
            "monitoring": "Bleeding, bruising",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "DAPT - Aspirin + Clopidogrel",
            "route": "PO",
            "indication": "Minor stroke (NIHSS ≤3) or high-risk TIA",
            "dosing": {
              "doseOptions": [
                {
                  "text": "ASA 81 mg + Clopidogrel 75 mg",
                  "orderSentence": "DAPT - Aspirin + Clopidogrel ASA 81 mg + Clopidogrel 75 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Aspirin 81 mg + Clopidogrel 75 mg daily x 21 days; preceded by loading doses; then single agent",
              "orderSentence": "DAPT - Aspirin + Clopidogrel ASA 81 mg + Clopidogrel 75 mg PO"
            },
            "contraindications": "Major stroke, high bleeding risk, planned surgery",
            "monitoring": "Bleeding; discontinue one agent at day 21",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "DAPT - Aspirin + Ticagrelor",
            "route": "PO",
            "indication": "Minor stroke (THALES trial)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "ASA 81 mg + Ticagrelor 90 mg BID",
                  "orderSentence": "DAPT - Aspirin + Ticagrelor ASA 81 mg + Ticagrelor 90 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Aspirin 81 mg + Ticagrelor 90 mg BID x 30 days; then single agent",
              "orderSentence": "DAPT - Aspirin + Ticagrelor ASA 81 mg + Ticagrelor 90 mg BID PO"
            },
            "contraindications": "Major stroke, high bleeding risk, planned surgery; CYP3A4 inhibitors",
            "monitoring": "Bleeding; dyspnea (common)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Atorvastatin",
            "route": "PO",
            "indication": "All ischemic stroke",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg daily",
                  "orderSentence": "Atorvastatin 40 mg daily PO"
                },
                {
                  "text": "80 mg daily",
                  "orderSentence": "Atorvastatin 80 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "40-80 mg daily; start in hospital; high-intensity statin",
              "orderSentence": "Atorvastatin 40 mg daily PO"
            },
            "contraindications": "Active liver disease, pregnancy",
            "monitoring": "LFTs at baseline; CK if myalgia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rosuvastatin",
            "route": "PO",
            "indication": "All ischemic stroke (alternative)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg daily",
                  "orderSentence": "Rosuvastatin 20 mg daily PO"
                },
                {
                  "text": "40 mg daily",
                  "orderSentence": "Rosuvastatin 40 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "20-40 mg daily; dose adjust for Asian patients, CKD",
              "orderSentence": "Rosuvastatin 20 mg daily PO"
            },
            "contraindications": "Active liver disease, pregnancy",
            "monitoring": "LFTs at baseline; CK if myalgia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Apixaban",
            "route": "PO",
            "indication": "Cardioembolic stroke (AF)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg BID",
                  "orderSentence": "Apixaban 5 mg BID PO"
                },
                {
                  "text": "2.5 mg BID",
                  "orderSentence": "Apixaban 2.5 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "5 mg BID; reduce to 2.5 mg BID if 2 of: age ≥80, weight ≤60 kg, Cr ≥1.5; delay 4-14 days post-stroke",
              "orderSentence": "Apixaban 5 mg BID PO"
            },
            "contraindications": "Active bleeding, mechanical valve, severe hepatic impairment",
            "monitoring": "Renal function; bleeding",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rivaroxaban",
            "route": "PO",
            "indication": "Cardioembolic stroke (AF)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "15 mg daily",
                  "orderSentence": "Rivaroxaban 15 mg daily PO"
                },
                {
                  "text": "20 mg daily",
                  "orderSentence": "Rivaroxaban 20 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "20 mg daily with dinner; 15 mg if CrCl 15-50; delay 4-14 days post-stroke",
              "orderSentence": "Rivaroxaban 15 mg daily PO"
            },
            "contraindications": "Active bleeding, mechanical valve, severe hepatic impairment",
            "monitoring": "Renal function; bleeding",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Dabigatran",
            "route": "PO",
            "indication": "Cardioembolic stroke (AF)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "75 mg BID",
                  "orderSentence": "Dabigatran 75 mg BID PO"
                },
                {
                  "text": "150 mg BID",
                  "orderSentence": "Dabigatran 150 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "150 mg BID; 75 mg BID if CrCl 15-30; delay 4-14 days post-stroke",
              "orderSentence": "Dabigatran 75 mg BID PO"
            },
            "contraindications": "Active bleeding, mechanical valve, severe hepatic impairment; GI upset common",
            "monitoring": "Renal function; bleeding; reversal agent availability",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Edoxaban",
            "route": "PO",
            "indication": "Cardioembolic stroke (AF)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mg daily",
                  "orderSentence": "Edoxaban 30 mg daily PO"
                },
                {
                  "text": "60 mg daily",
                  "orderSentence": "Edoxaban 60 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "60 mg daily; 30 mg if CrCl 15-50, weight ≤60 kg, or P-gp inhibitor; delay 4-14 days",
              "orderSentence": "Edoxaban 30 mg daily PO"
            },
            "contraindications": "Active bleeding, mechanical valve, severe hepatic impairment",
            "monitoring": "Renal function; bleeding",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Warfarin",
            "route": "PO",
            "indication": "Mechanical valve, antiphospholipid syndrome",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per INR",
                  "orderSentence": "Warfarin Per INR PO"
                }
              ],
              "route": "PO",
              "instructions": "Start with heparin bridge; target INR 2-3 (2.5-3.5 for mechanical mitral); delay 4-14 days",
              "orderSentence": "Warfarin Per INR PO"
            },
            "contraindications": "Active bleeding, severe hepatic impairment",
            "monitoring": "INR weekly then monthly; bleeding",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lisinopril",
            "route": "PO",
            "indication": "Hypertension",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2.5 mg daily",
                  "orderSentence": "Lisinopril 2.5 mg daily PO"
                },
                {
                  "text": "5 mg daily",
                  "orderSentence": "Lisinopril 5 mg daily PO"
                },
                {
                  "text": "10 mg daily",
                  "orderSentence": "Lisinopril 10 mg daily PO"
                },
                {
                  "text": "20 mg daily",
                  "orderSentence": "Lisinopril 20 mg daily PO"
                },
                {
                  "text": "40 mg daily",
                  "orderSentence": "Lisinopril 40 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 2.5-5 mg daily; titrate to 20-40 mg daily; target BP <130/80",
              "orderSentence": "Lisinopril 2.5 mg daily PO"
            },
            "contraindications": "Bilateral renal artery stenosis, angioedema history, pregnancy",
            "monitoring": "BP, K+, Cr",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Amlodipine",
            "route": "PO",
            "indication": "Hypertension",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg daily",
                  "orderSentence": "Amlodipine 5 mg daily PO"
                },
                {
                  "text": "10 mg daily",
                  "orderSentence": "Amlodipine 10 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg daily; max 10 mg daily",
              "orderSentence": "Amlodipine 5 mg daily PO"
            },
            "contraindications": "Severe aortic stenosis",
            "monitoring": "BP, peripheral edema",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Chlorthalidone",
            "route": "PO",
            "indication": "Hypertension (volume-dependent)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "12.5 mg daily",
                  "orderSentence": "Chlorthalidone 12.5 mg daily PO"
                },
                {
                  "text": "25 mg daily",
                  "orderSentence": "Chlorthalidone 25 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "12.5-25 mg daily",
              "orderSentence": "Chlorthalidone 12.5 mg daily PO"
            },
            "contraindications": "Sulfa allergy (relative), hypokalemia, gout",
            "monitoring": "K+, Na+, uric acid",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Complications Management": [
          {
            "item": "Mannitol",
            "route": "IV",
            "indication": "Cerebral edema; increased ICP",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5 g/kg",
                  "orderSentence": "Mannitol 0.5 g/kg IV"
                },
                {
                  "text": "1 g/kg",
                  "orderSentence": "Mannitol 1 g/kg IV"
                },
                {
                  "text": "1.5 g/kg",
                  "orderSentence": "Mannitol 1.5 g/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "0.5-1.5 g/kg IV over 20-30 min; may repeat q6h; serum osm goal <320",
              "orderSentence": "Mannitol 0.5 g/kg IV"
            },
            "contraindications": "Hypovolemia, anuria",
            "monitoring": "Serum osm, Na+, renal function; Foley required",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Hypertonic saline 23.4%",
            "route": "IV",
            "indication": "Severe cerebral edema; herniation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mL",
                  "orderSentence": "Hypertonic saline 23.4% 30 mL IV"
                }
              ],
              "route": "IV",
              "instructions": "30 mL IV push via central line over 10-20 min",
              "orderSentence": "Hypertonic saline 23.4% 30 mL IV"
            },
            "contraindications": "Severe hypernatremia (Na >160)",
            "monitoring": "Na q4-6h; target Na 145-155 for edema",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Hypertonic saline 3%",
            "route": "IV",
            "indication": "Cerebral edema (less severe)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "150 mL",
                  "orderSentence": "Hypertonic saline 3% 150 mL IV"
                },
                {
                  "text": "250 mL",
                  "orderSentence": "Hypertonic saline 3% 250 mL IV"
                },
                {
                  "text": "500 mL",
                  "orderSentence": "Hypertonic saline 3% 500 mL IV"
                }
              ],
              "route": "IV",
              "instructions": "150-500 mL IV bolus or continuous infusion at 30-50 mL/hr",
              "orderSentence": "Hypertonic saline 3% 150 mL IV"
            },
            "contraindications": "Severe hypernatremia (Na >160)",
            "monitoring": "Na q4-6h; target Na 145-155 for edema",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Decompressive craniectomy",
            "route": "—",
            "indication": "Malignant MCA infarction with edema",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Decompressive craniectomy N/A —"
                }
              ],
              "route": "—",
              "instructions": "Surgical; within 48 hours of stroke onset; age <60",
              "orderSentence": "Decompressive craniectomy N/A —"
            },
            "contraindications": "Poor pre-stroke function, extensive infarct, patient/family preference",
            "monitoring": "Post-op neuro checks, ICP if monitored",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT"
          },
          {
            "item": "Levetiracetam",
            "route": "IV/PO",
            "indication": "Seizure (not routine prophylaxis)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mg BID",
                  "orderSentence": "Levetiracetam 500 mg BID IV/PO"
                },
                {
                  "text": "1000 mg BID",
                  "orderSentence": "Levetiracetam 1000 mg BID IV/PO"
                },
                {
                  "text": "1500 mg BID",
                  "orderSentence": "Levetiracetam 1500 mg BID IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "500-1000 mg IV/PO BID; max 3000 mg/day; use only if seizure occurs",
              "orderSentence": "Levetiracetam 500 mg BID IV/PO"
            },
            "contraindications": "None significant",
            "monitoring": "Mood, behavior",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Ceftriaxone + Metronidazole",
            "route": "IV",
            "indication": "Aspiration pneumonia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Ceftriaxone 1 g daily + Metronidazole 500 mg q8h",
                  "orderSentence": "Ceftriaxone + Metronidazole Ceftriaxone 1 g daily + Metronidazole 500 mg q8h IV"
                }
              ],
              "route": "IV",
              "instructions": "Ceftriaxone 1-2 g IV daily + Metronidazole 500 mg IV/PO q8h",
              "orderSentence": "Ceftriaxone + Metronidazole Ceftriaxone 1 g daily + Metronidazole 500 mg q8h IV"
            },
            "contraindications": "Cephalosporin allergy, alcohol with metronidazole",
            "monitoring": "WBC, fever, respiratory status",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE"
          }
        ],
        "Special Situations": [
          {
            "item": "Heparin infusion",
            "route": "IV",
            "indication": "Cervical artery dissection; warfarin bridge",
            "dosing": {
              "doseOptions": [
                {
                  "text": "80 units/kg bolus",
                  "orderSentence": "Heparin infusion 80 units/kg bolus IV"
                },
                {
                  "text": "18 units/kg/hr",
                  "orderSentence": "Heparin infusion 18 units/kg/hr IV"
                }
              ],
              "route": "IV",
              "instructions": "80 units/kg bolus, then 18 units/kg/hr; titrate to PTT 60-80",
              "orderSentence": "Heparin infusion 80 units/kg bolus IV"
            },
            "contraindications": "Active bleeding, large infarct, hemorrhagic transformation",
            "monitoring": "PTT q6h until therapeutic, then q12-24h",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE"
          },
          {
            "item": "PFO closure (device)",
            "route": "—",
            "indication": "Cryptogenic stroke with high-risk PFO",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "PFO closure (device) N/A —"
                }
              ],
              "route": "—",
              "instructions": "Interventional procedure; typically after stroke recovery; age <60",
              "orderSentence": "PFO closure (device) N/A —"
            },
            "contraindications": "Active infection, other stroke etiology identified",
            "monitoring": "Post-procedure: antiplatelet therapy, bubble study follow-up",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Carotid endarterectomy (CEA)",
            "route": "—",
            "indication": "Symptomatic carotid stenosis 70-99%",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Carotid endarterectomy (CEA) N/A —"
                }
              ],
              "route": "—",
              "instructions": "Surgical; timing 2-14 days post-stroke optimal",
              "orderSentence": "Carotid endarterectomy (CEA) N/A —"
            },
            "contraindications": "Unstable medical condition, near-complete occlusion",
            "monitoring": "Post-op: BP control, neuro checks",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Carotid artery stenting (CAS)",
            "route": "—",
            "indication": "Carotid stenosis (high surgical risk)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Carotid artery stenting (CAS) N/A —"
                }
              ],
              "route": "—",
              "instructions": "Interventional procedure; alternative to CEA",
              "orderSentence": "Carotid artery stenting (CAS) N/A —"
            },
            "contraindications": "Unstable medical condition, near-complete occlusion; unfavorable anatomy",
            "monitoring": "Post-procedure: DAPT x 30 days minimum",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Stroke neurology consult",
            "indication": "All acute ischemic stroke",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Interventional neuroradiology/neuroendovascular",
            "indication": "LVO identified; thrombectomy candidate",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Neurosurgery consult",
            "indication": "Malignant edema; decompressive craniectomy candidate",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Cardiology consult",
            "indication": "AF management, PFO evaluation, cardiac source workup",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Vascular surgery consult",
            "indication": "Symptomatic carotid stenosis; CEA candidate",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Speech-language pathology",
            "indication": "Swallow evaluation; aphasia therapy",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Physical therapy",
            "indication": "Mobility, gait, balance",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Occupational therapy",
            "indication": "ADLs, upper extremity function",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Rehabilitation medicine (PM&R)",
            "indication": "Inpatient rehabilitation placement",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Social work",
            "indication": "Discharge planning, community resources",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Case management",
            "indication": "Insurance authorization, rehab placement",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Palliative care",
            "indication": "Large stroke with poor prognosis; goals of care",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE"
          },
          {
            "item": "Smoking cessation counseling",
            "indication": "All smokers",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Nutrition/Dietitian",
            "indication": "Dysphagia diet, heart-healthy diet education",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Call 911 immediately if new or worsening weakness, numbness, vision changes, speech difficulty, or severe headache",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Know stroke warning signs: F.A.S.T. (Face drooping, Arm weakness, Speech difficulty, Time to call 911)",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Take all prescribed medications as directed; do not stop antiplatelet or anticoagulant without physician guidance",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Attend all follow-up appointments (neurology, cardiology, primary care)",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "No driving until cleared by physician (typically minimum 2-4 weeks; varies by state law and deficit severity)",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Report any bleeding (blood in stool, urine, gums, excessive bruising) while on blood thinners",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Check blood pressure at home daily if hypertensive; keep log for follow-up visits",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Monitor blood glucose if diabetic; maintain good glycemic control",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Follow swallow precautions if dysphagia present (diet modification, positioning, supervision)",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Use fall precautions: clear pathways, use assistive devices as prescribed, adequate lighting",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Smoking cessation (most important modifiable risk factor)",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Blood pressure control: target <130/80 mmHg",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "LDL cholesterol target <70 mg/dL (or 50% reduction) with high-intensity statin",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Diabetes management: HbA1c target <7%",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Limit alcohol: ≤1 drink/day women, ≤2 drinks/day men; abstinence if alcohol-related stroke",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Heart-healthy diet: Mediterranean or DASH diet",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Regular aerobic exercise: 40 min moderate-intensity 3-4 days/week when able",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Weight management: BMI target 18.5-24.9",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Sleep apnea screening and treatment if indicated",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Avoid illicit drugs (cocaine, amphetamines)",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Hormone replacement therapy: avoid or use caution",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Stress management",
            "ED": "-",
            "HOSP": "-",
            "OPD": "✓"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Hypoglycemia",
        "features": "Rapid response to glucose; often diabetic on insulin/sulfonylureas",
        "tests": "Point-of-care glucose; resolves with correction"
      },
      {
        "diagnosis": "Seizure with Todd's paralysis",
        "features": "History of seizure; gradual resolution over hours; post-ictal confusion",
        "tests": "EEG; witnessed seizure; gradual resolution"
      },
      {
        "diagnosis": "Complex migraine with aura",
        "features": "Headache (usually); positive symptoms (scintillating scotoma); history of similar; <60 min",
        "tests": "Clinical history; normal imaging; resolves"
      },
      {
        "diagnosis": "Intracranial hemorrhage",
        "features": "Sudden severe headache; rapid progression; may have anticoagulation history",
        "tests": "CT head shows hemorrhage"
      },
      {
        "diagnosis": "Brain tumor",
        "features": "Gradual onset; headache; seizures; may have mass effect",
        "tests": "MRI brain shows mass lesion"
      },
      {
        "diagnosis": "Subdural hematoma",
        "features": "History of trauma (may be minor); elderly; anticoagulation",
        "tests": "CT shows crescent-shaped collection"
      },
      {
        "diagnosis": "Encephalitis",
        "features": "Fever; altered mental status; seizures; behavioral changes",
        "tests": "MRI (temporal lobe); LP; CSF PCR"
      },
      {
        "diagnosis": "Multiple sclerosis (acute relapse)",
        "features": "Younger patient; prior episodes; MRI pattern (periventricular, Dawson fingers)",
        "tests": "MRI brain/spine; LP (oligoclonal bands)"
      },
      {
        "diagnosis": "Conversion disorder/functional neurological disorder",
        "features": "Inconsistent exam; positive functional signs (Hoover, give-way weakness)",
        "tests": "Clinical; normal imaging; psychiatric history"
      },
      {
        "diagnosis": "Wernicke encephalopathy",
        "features": "Ataxia, ophthalmoplegia, confusion; alcohol/malnutrition history",
        "tests": "Clinical; MRI (mammillary bodies); thiamine response"
      },
      {
        "diagnosis": "Hypertensive encephalopathy",
        "features": "Severely elevated BP; headache; confusion; PRES pattern on MRI",
        "tests": "MRI (PRES); BP reduction reverses symptoms"
      },
      {
        "diagnosis": "Cerebral venous sinus thrombosis",
        "features": "Headache; may have hypercoagulable state or OCP use; hemorrhagic infarcts",
        "tests": "CT/MR venography; D-dimer"
      },
      {
        "diagnosis": "Hyponatremia",
        "features": "Confusion, seizures; recent medication change; SIADH",
        "tests": "BMP shows low sodium"
      },
      {
        "diagnosis": "Hepatic encephalopathy",
        "features": "Liver disease; asterixis; confusion",
        "tests": "Ammonia; LFTs; history"
      },
      {
        "diagnosis": "Drug intoxication",
        "features": "History of substance use; pupils; toxidrome",
        "tests": "Urine drug screen"
      }
    ],
    "evidence": [
      {
        "recommendation": "IV alteplase within 4.5 hours improves outcomes",
        "evidenceLevel": "Class I, Level A",
        "source": "[NINDS, ECASS III](https://pubmed.ncbi.nlm.nih.gov/7477192/)"
      },
      {
        "recommendation": "Tenecteplase non-inferior to alteplase",
        "evidenceLevel": "Class I, Level B",
        "source": "[AcT Trial, Menon et al. Lancet 2022](https://pubmed.ncbi.nlm.nih.gov/35779553/)"
      },
      {
        "recommendation": "Mechanical thrombectomy for LVO within 6 hours",
        "evidenceLevel": "Class I, Level A",
        "source": "[MR CLEAN, ESCAPE, EXTEND-IA, SWIFT PRIME, REVASCAT](https://pubmed.ncbi.nlm.nih.gov/25517348/)"
      },
      {
        "recommendation": "Thrombectomy up to 24 hours with favorable imaging",
        "evidenceLevel": "Class I, Level A",
        "source": "[DAWN](https://pubmed.ncbi.nlm.nih.gov/29129157/); [DEFUSE 3](https://pubmed.ncbi.nlm.nih.gov/29364767/)"
      },
      {
        "recommendation": "DAPT (aspirin + clopidogrel) for minor stroke/high-risk TIA x 21 days",
        "evidenceLevel": "Class I, Level A",
        "source": "[CHANCE](https://pubmed.ncbi.nlm.nih.gov/23803136/); [POINT](https://pubmed.ncbi.nlm.nih.gov/29766750/)"
      },
      {
        "recommendation": "High-intensity statin therapy",
        "evidenceLevel": "Class I, Level A",
        "source": "[SPARCL](https://pubmed.ncbi.nlm.nih.gov/16899775/); AHA/ASA Guidelines"
      },
      {
        "recommendation": "Anticoagulation for AF-related stroke",
        "evidenceLevel": "Class I, Level A",
        "source": "[AHA/ASA Guidelines 2021](https://pubmed.ncbi.nlm.nih.gov/34024117/)"
      },
      {
        "recommendation": "Blood pressure management post-stroke",
        "evidenceLevel": "Class I, Level B",
        "source": "[AHA/ASA Guidelines 2021](https://pubmed.ncbi.nlm.nih.gov/34024117/)"
      },
      {
        "recommendation": "Early mobilization",
        "evidenceLevel": "Class III (Harm), Level A",
        "source": "[AVERT Trial](https://pubmed.ncbi.nlm.nih.gov/25892679/) - very early mobilization harmful"
      },
      {
        "recommendation": "Decompressive craniectomy for malignant MCA stroke",
        "evidenceLevel": "Class I, Level A",
        "source": "[DECIMAL, DESTINY, HAMLET pooled analysis](https://pubmed.ncbi.nlm.nih.gov/17303527/)"
      },
      {
        "recommendation": "PFO closure for cryptogenic stroke",
        "evidenceLevel": "Class I, Level B",
        "source": "[CLOSE](https://pubmed.ncbi.nlm.nih.gov/28902580/); [RESPECT](https://pubmed.ncbi.nlm.nih.gov/28885996/); [DEFENSE-PFO](https://pubmed.ncbi.nlm.nih.gov/29544871/)"
      },
      {
        "recommendation": "Carotid endarterectomy for symptomatic stenosis ≥70%",
        "evidenceLevel": "Class I, Level A",
        "source": "[NASCET](https://pubmed.ncbi.nlm.nih.gov/1852179/); [ECST](https://pubmed.ncbi.nlm.nih.gov/1674060/)"
      },
      {
        "recommendation": "Intensive glucose control (avoid hypoglycemia)",
        "evidenceLevel": "Class I, Level C",
        "source": "AHA/ASA Guidelines"
      },
      {
        "recommendation": "Fever treatment",
        "evidenceLevel": "Class I, Level C",
        "source": "AHA/ASA Guidelines"
      }
    ],
    "monitoring": [
      {
        "item": "NIHSS (National Institutes of Health Stroke Scale)",
        "frequency": "Q1h x 24h, then q4h x 48h, then q shift",
        "action": "If worsening ≥4 points: emergent CT, consider hemorrhage or extension",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT"
      },
      {
        "item": "Blood pressure",
        "frequency": "Q15min x 2h post-tPA, then q30min x 6h, then q1h x 16h; q4h after",
        "action": "Treat per protocol; labetalol, nicardipine",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT"
      },
      {
        "item": "Glucose",
        "frequency": "Q6h; q1h if on insulin infusion",
        "action": "Insulin adjustment",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT"
      },
      {
        "item": "Temperature",
        "frequency": "Q4h",
        "action": "Acetaminophen; cooling; infection workup if fever",
        "ED": "STAT",
        "HOSP": "ROUTINE",
        "OPD": "-",
        "ICU": "STAT"
      },
      {
        "item": "Oxygen saturation",
        "frequency": "Continuous if on supplemental O2",
        "action": "Oxygen titration; evaluate for aspiration, PE",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT"
      },
      {
        "item": "Neurological examination",
        "frequency": "Q1h x 24h, then per protocol",
        "action": "If worsening: emergent imaging",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT"
      },
      {
        "item": "INR (if on warfarin)",
        "frequency": "Daily until therapeutic",
        "action": "Warfarin dose adjustment",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "ROUTINE"
      },
      {
        "item": "Renal function (Cr, BUN)",
        "frequency": "Daily during hospitalization; baseline for DOACs",
        "action": "DOAC dose adjustment; avoid nephrotoxins",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "ROUTINE"
      },
      {
        "item": "Lipid panel",
        "frequency": "Fasting, within 24-48h",
        "action": "Statin intensification",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "HbA1c",
        "frequency": "Once during hospitalization",
        "action": "Diabetes medication optimization",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Swallow evaluation",
        "frequency": "Before any oral intake",
        "action": "NPO; modified diet; SLP consult",
        "ED": "-",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT"
      },
      {
        "item": "Continuous cardiac telemetry",
        "frequency": "Minimum 24-72 hours",
        "action": "Anticoagulation if AF detected",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT"
      },
      {
        "item": "Repeat CT head",
        "frequency": "24 hours post-tPA; or if neurological decline",
        "action": "If hemorrhage: reverse anticoagulation, neurosurgery consult",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "-",
        "ICU": "ROUTINE"
      }
    ],
    "disposition": [
      {
        "disposition": "**Discharge home**",
        "criteria": "Minor stroke or TIA; able to ambulate safely or with minimal assistance; swallow intact; stable on oral medications; adequate home support; follow-up arranged within 1-2 weeks; compliant with secondary prevention"
      },
      {
        "disposition": "**Admit to stroke unit/floor**",
        "criteria": "Most acute ischemic strokes; requires monitoring, workup, rehabilitation assessment; stable vital signs; no respiratory compromise"
      },
      {
        "disposition": "**Admit to ICU**",
        "criteria": "Received tPA or thrombectomy (24h monitoring); large vessel occlusion; declining neurological exam; respiratory compromise; malignant edema risk; BP requiring IV infusion; arrhythmia requiring intervention"
      },
      {
        "disposition": "**Inpatient rehabilitation**",
        "criteria": "Significant functional deficits; able to participate in 3 hours therapy/day; medically stable; expected to benefit"
      },
      {
        "disposition": "**Skilled nursing facility**",
        "criteria": "Functional deficits; unable to tolerate intensive rehabilitation; needs skilled nursing care"
      },
      {
        "disposition": "**Long-term acute care (LTAC)**",
        "criteria": "Prolonged ventilator dependence; complex medical needs"
      },
      {
        "disposition": "**Transfer to comprehensive stroke center**",
        "criteria": "LVO needing thrombectomy not available locally; neurosurgical intervention needed; complex case"
      }
    ]
  },
  "Guillain-Barré Syndrome": {
    "id": "guillain-barre-syndrome",
    "title": "Guillain-Barré Syndrome",
    "version": "1.1",
    "icd10": [
      "** G61.0 (Guillain-Barré syndrome)"
    ],
    "scope": "** Evaluation and management of acute Guillain-Barré Syndrome in adults, including all major variants (AIDP, AMAN, AMSAN, Miller Fisher). Covers respiratory monitoring protocols, immunotherapy (IVIg and plasmapheresis), autonomic dysfunction management, and ICU care. Excludes CIDP (chronic inflammatory demyelinating polyneuropathy) and pediatric GBS.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC with differential",
            "rationale": "Baseline, infection screen",
            "target": "Normal or mild leukocytosis",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "CMP (BMP + LFTs)",
            "rationale": "Electrolytes, renal function for IVIg",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Magnesium",
            "rationale": "Hypomagnesemia worsens weakness",
            "target": ">1.8 mg/dL",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Phosphorus",
            "rationale": "Hypophosphatemia causes weakness",
            "target": ">2.5 mg/dL",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "ESR, CRP",
            "rationale": "Inflammatory markers",
            "target": "May be mildly elevated",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Urinalysis",
            "rationale": "UTI as trigger",
            "target": "Document",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Blood glucose",
            "rationale": "Hyperglycemia worsens outcomes",
            "target": "<180 mg/dL",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "TSH",
            "rationale": "Thyroid myopathy in differential",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "CPK",
            "rationale": "Myopathy in differential",
            "target": "Normal or mildly elevated",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "PT/INR, PTT",
            "rationale": "Pre-LP, pre-PLEX",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Extended Workup": [
          {
            "item": "Anti-ganglioside antibodies (GM1, GD1a, GD1b, GQ1b)",
            "rationale": "Variant classification, prognosis",
            "target": "Document positivity",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Campylobacter jejuni serology",
            "rationale": "Most common trigger",
            "target": "Document if positive",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "CMV IgM/IgG",
            "rationale": "Viral trigger",
            "target": "Document if positive",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "EBV panel",
            "rationale": "Viral trigger",
            "target": "Document if positive",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Mycoplasma pneumoniae IgM",
            "rationale": "Bacterial trigger",
            "target": "Document if positive",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "HIV",
            "rationale": "HIV-associated GBS",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Hepatitis B surface antigen",
            "rationale": "Pre-IVIg screening",
            "target": "Negative",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Hepatitis C antibody",
            "rationale": "Pre-PLEX screening",
            "target": "Negative",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "COVID-19 PCR/antigen",
            "rationale": "COVID-associated GBS",
            "target": "Document",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Quantitative immunoglobulins",
            "rationale": "IgA deficiency (IVIg contraindication)",
            "target": "IgA >7 mg/dL",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Type and screen",
            "rationale": "Pre-PLEX",
            "target": "Available",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Zika virus serology",
            "rationale": "Travel to endemic area",
            "target": "Negative",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "West Nile virus serology",
            "rationale": "Endemic area, summer months",
            "target": "Negative",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "Lyme serology",
            "rationale": "Endemic area, tick exposure",
            "target": "Negative",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "Porphyrins (urine)",
            "rationale": "Motor neuropathy with abdominal pain",
            "target": "Normal",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "Heavy metals (lead, arsenic, thallium)",
            "rationale": "Toxic neuropathy differential",
            "target": "Normal",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "Serum protein electrophoresis",
            "rationale": "Paraproteinemic neuropathy",
            "target": "Normal",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "Anti-acetylcholine receptor antibodies",
            "rationale": "MG in differential",
            "target": "Negative",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "Opening pressure",
            "rationale": "Exclude elevated ICP",
            "target": "Normal (10-20 cmH2O)",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Cell count (tubes 1 and 4)",
            "rationale": "Albuminocytologic dissociation",
            "target": "WBC <10 (usually <5)",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Protein",
            "rationale": "Elevated in GBS",
            "target": "Elevated (>45 mg/dL; often >100)",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Glucose",
            "rationale": "Exclude infection",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Gram stain and culture",
            "rationale": "Exclude bacterial meningitis",
            "target": "Negative",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Cytology",
            "rationale": "If malignancy suspected",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Oligoclonal bands",
            "rationale": "Atypical cases",
            "target": "Usually negative (positive in <10%)",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "Chest X-ray",
            "timing": "On admission",
            "target": "Aspiration, atelectasis",
            "contraindications": "None",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "ECG",
            "timing": "On admission",
            "target": "Autonomic dysfunction (arrhythmia)",
            "contraindications": "None",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Forced vital capacity (FVC)",
            "timing": "Serial q4-6h",
            "target": "FVC >20 mL/kg (stable)",
            "contraindications": "Facial weakness limiting seal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Negative inspiratory force (NIF)",
            "timing": "Serial q4-6h",
            "target": "NIF more negative than -30 cmH2O",
            "contraindications": "Facial weakness",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Nerve conduction studies/EMG",
            "timing": "Within 48-72 hours",
            "target": "Demyelination, conduction block",
            "contraindications": "None",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          }
        ],
        "Extended": [
          {
            "item": "MRI spine with contrast",
            "timing": "If diagnostic uncertainty",
            "target": "Nerve root enhancement (spinal roots)",
            "contraindications": "Pacemaker, hemodynamic instability",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "MRI brain with contrast",
            "timing": "Miller Fisher variant",
            "target": "Cranial nerve enhancement",
            "contraindications": "Pacemaker",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Swallow evaluation",
            "timing": "If bulbar weakness",
            "target": "Aspiration risk",
            "contraindications": "None",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Echocardiogram",
            "timing": "If autonomic instability",
            "target": "Takotsubo, cardiac dysfunction",
            "contraindications": "None",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Repetitive nerve stimulation",
            "timing": "If MG suspected",
            "target": "Normal (vs decrement in MG)",
            "contraindications": "None",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "Autonomic function testing",
            "timing": "Persistent dysautonomia",
            "target": "Abnormal heart rate variability",
            "contraindications": "Unstable patient",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent - Respiratory Support": [
          {
            "item": "Supplemental oxygen",
            "route": "INH",
            "indication": "Hypoxemia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2-6 L/min NC",
                  "orderSentence": "Supplemental oxygen 2-6 L/min NC INH"
                },
                {
                  "text": "15 L/min NRB",
                  "orderSentence": "Supplemental oxygen 15 L/min NRB INH"
                }
              ],
              "route": "INH",
              "instructions": "Titrate to O2 sat >94%; escalate to high-flow if needed",
              "orderSentence": "Supplemental oxygen 2-6 L/min NC INH"
            },
            "contraindications": "None",
            "monitoring": "O2 sat, RR",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Endotracheal intubation",
            "route": "—",
            "indication": "Respiratory failure",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Endotracheal intubation N/A —"
                }
              ],
              "route": "—",
              "instructions": "Intubate if FVC <20 mL/kg, NIF >-30 cmH2O, or clinical deterioration; avoid succinylcholine (hyperkalemia risk)",
              "orderSentence": "Endotracheal intubation N/A —"
            },
            "contraindications": "—",
            "monitoring": "ETT position, ventilator settings",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Mechanical ventilation",
            "route": "—",
            "indication": "Respiratory failure",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Mechanical ventilation N/A —"
                }
              ],
              "route": "—",
              "instructions": "Lung-protective ventilation; TV 6-8 mL/kg IBW; PEEP 5-8 cmH2O",
              "orderSentence": "Mechanical ventilation N/A —"
            },
            "contraindications": "—",
            "monitoring": "ABG, ventilator parameters",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Immunotherapy - First-line": [
          {
            "item": "IVIg (immune globulin IV) - 5-day protocol",
            "route": "IV",
            "indication": "Primary immunotherapy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.4 g/kg/day x 5 days",
                  "orderSentence": "IVIg (immune globulin IV) - 5-day protocol 0.4 g/kg/day x 5 days IV"
                }
              ],
              "route": "IV",
              "instructions": "0.4 g/kg/day IV for 5 days (total 2 g/kg); infuse slowly day 1 (start 0.5-1 mL/kg/hr, advance to max 4 mL/kg/hr)",
              "orderSentence": "IVIg (immune globulin IV) - 5-day protocol 0.4 g/kg/day x 5 days IV"
            },
            "contraindications": "IgA deficiency (<7 mg/dL) with anti-IgA antibodies; severe renal impairment",
            "monitoring": "Renal function, headache, infusion reactions; pre-medicate with acetaminophen/diphenhydramine",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "IVIg (immune globulin IV) - 2-day protocol",
            "route": "IV",
            "indication": "Primary immunotherapy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 g/kg/day x 2 days",
                  "orderSentence": "IVIg (immune globulin IV) - 2-day protocol 1 g/kg/day x 2 days IV"
                }
              ],
              "route": "IV",
              "instructions": "1 g/kg/day IV for 2 days (total 2 g/kg); alternative accelerated protocol; same total dose",
              "orderSentence": "IVIg (immune globulin IV) - 2-day protocol 1 g/kg/day x 2 days IV"
            },
            "contraindications": "IgA deficiency (<7 mg/dL) with anti-IgA antibodies; severe renal impairment",
            "monitoring": "Renal function, headache, infusion reactions; higher daily dose may increase infusion reactions",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Plasmapheresis (PLEX)",
            "route": "—",
            "indication": "Primary immunotherapy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 exchanges over 1-2 weeks",
                  "orderSentence": "Plasmapheresis (PLEX) 5 exchanges over 1-2 weeks —"
                }
              ],
              "route": "—",
              "instructions": "5 exchanges (200-250 mL/kg per exchange) over 7-14 days; typically QOD",
              "orderSentence": "Plasmapheresis (PLEX) 5 exchanges over 1-2 weeks —"
            },
            "contraindications": "Hemodynamic instability; severe sepsis; IV access issues",
            "monitoring": "BP, electrolytes (Ca, Mg, K), coagulation, fibrinogen",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Autonomic Dysfunction Management": [
          {
            "item": "Normal saline",
            "route": "IV",
            "indication": "Hypotension",
            "dosing": {
              "doseOptions": [
                {
                  "text": "250 mL",
                  "orderSentence": "Normal saline 250 mL IV"
                },
                {
                  "text": "500 mL",
                  "orderSentence": "Normal saline 500 mL IV"
                },
                {
                  "text": "1000 mL",
                  "orderSentence": "Normal saline 1000 mL IV"
                }
              ],
              "route": "IV",
              "instructions": "250-500 mL bolus for SBP <90; avoid overhydration",
              "orderSentence": "Normal saline 250 mL IV"
            },
            "contraindications": "Heart failure",
            "monitoring": "BP, I/O, JVD",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Phenylephrine",
            "route": "IV",
            "indication": "Refractory hypotension",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100-200 mcg bolus",
                  "orderSentence": "Phenylephrine 100-200 mcg bolus IV"
                },
                {
                  "text": "0.5-2 mcg/kg/min",
                  "orderSentence": "Phenylephrine 0.5-2 mcg/kg/min IV"
                }
              ],
              "route": "IV",
              "instructions": "Start 0.5 mcg/kg/min; titrate to MAP >65",
              "orderSentence": "Phenylephrine 100-200 mcg bolus IV"
            },
            "contraindications": "Severe bradycardia",
            "monitoring": "Continuous BP, HR",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Esmolol",
            "route": "IV",
            "indication": "Hypertensive crisis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mcg/kg load",
                  "orderSentence": "Esmolol 500 mcg/kg load IV"
                },
                {
                  "text": "50-200 mcg/kg/min",
                  "orderSentence": "Esmolol 50-200 mcg/kg/min IV"
                }
              ],
              "route": "IV",
              "instructions": "Load 500 mcg/kg over 1 min, then 50-200 mcg/kg/min; short-acting preferred in GBS",
              "orderSentence": "Esmolol 500 mcg/kg load IV"
            },
            "contraindications": "Bradycardia, heart block, decompensated HF",
            "monitoring": "HR, BP",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Atropine",
            "route": "IV",
            "indication": "Symptomatic bradycardia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5 mg",
                  "orderSentence": "Atropine 0.5 mg IV"
                },
                {
                  "text": "1 mg",
                  "orderSentence": "Atropine 1 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "0.5-1 mg IV push for HR <50 with symptoms; may repeat q3-5min; max 3 mg",
              "orderSentence": "Atropine 0.5 mg IV"
            },
            "contraindications": "Tachycardia",
            "monitoring": "HR, rhythm",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Temporary pacing",
            "route": "—",
            "indication": "Complete heart block",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Temporary pacing N/A —"
                }
              ],
              "route": "—",
              "instructions": "Transcutaneous or transvenous pacing for refractory bradycardia/asystole",
              "orderSentence": "Temporary pacing N/A —"
            },
            "contraindications": "—",
            "monitoring": "Continuous telemetry",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Fludrocortisone",
            "route": "PO",
            "indication": "Orthostatic hypotension",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.1 mg daily",
                  "orderSentence": "Fludrocortisone 0.1 mg daily PO"
                },
                {
                  "text": "0.2 mg daily",
                  "orderSentence": "Fludrocortisone 0.2 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "0.1-0.2 mg PO daily for persistent orthostatic hypotension",
              "orderSentence": "Fludrocortisone 0.1 mg daily PO"
            },
            "contraindications": "Hypertension, heart failure",
            "monitoring": "BP (supine and standing), edema, K+",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Midodrine",
            "route": "PO",
            "indication": "Orthostatic hypotension",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2.5 mg TID",
                  "orderSentence": "Midodrine 2.5 mg TID PO"
                },
                {
                  "text": "5 mg TID",
                  "orderSentence": "Midodrine 5 mg TID PO"
                },
                {
                  "text": "10 mg TID",
                  "orderSentence": "Midodrine 10 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 2.5-5 mg TID; max 10 mg TID; avoid evening dose",
              "orderSentence": "Midodrine 2.5 mg TID PO"
            },
            "contraindications": "Supine hypertension, urinary retention",
            "monitoring": "BP (supine and standing)",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          }
        ],
        "Symptomatic/Supportive Care": [
          {
            "item": "Gabapentin",
            "route": "PO",
            "indication": "Neuropathic pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg qHS",
                  "orderSentence": "Gabapentin 300 mg qHS PO"
                },
                {
                  "text": "300 mg TID",
                  "orderSentence": "Gabapentin 300 mg TID PO"
                },
                {
                  "text": "600 mg TID",
                  "orderSentence": "Gabapentin 600 mg TID PO"
                },
                {
                  "text": "900 mg TID",
                  "orderSentence": "Gabapentin 900 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 300 mg qHS; titrate by 300 mg/day q1-3d; max 3600 mg/day in 3 divided doses",
              "orderSentence": "Gabapentin 300 mg qHS PO"
            },
            "contraindications": "Severe renal impairment (adjust dose)",
            "monitoring": "Sedation, dizziness; reduce dose if CrCl <60",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Pregabalin",
            "route": "PO",
            "indication": "Neuropathic pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "75 mg BID",
                  "orderSentence": "Pregabalin 75 mg BID PO"
                },
                {
                  "text": "150 mg BID",
                  "orderSentence": "Pregabalin 150 mg BID PO"
                },
                {
                  "text": "300 mg BID",
                  "orderSentence": "Pregabalin 300 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 75 mg BID; may increase to 150 mg BID after 1 week; max 600 mg/day",
              "orderSentence": "Pregabalin 75 mg BID PO"
            },
            "contraindications": "Severe renal impairment (adjust dose)",
            "monitoring": "Sedation, edema, weight gain",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Morphine",
            "route": "IV",
            "indication": "Severe pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 mg q4h PRN",
                  "orderSentence": "Morphine 2 mg q4h PRN IV"
                },
                {
                  "text": "4 mg q4h PRN",
                  "orderSentence": "Morphine 4 mg q4h PRN IV"
                }
              ],
              "route": "IV",
              "instructions": "2-4 mg IV q4h PRN for severe pain; use cautiously with respiratory compromise",
              "orderSentence": "Morphine 2 mg q4h PRN IV"
            },
            "contraindications": "Respiratory depression",
            "monitoring": "RR, sedation, O2 sat",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Enoxaparin",
            "route": "SC",
            "indication": "DVT prophylaxis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg daily",
                  "orderSentence": "Enoxaparin 40 mg daily SC"
                },
                {
                  "text": "30 mg BID",
                  "orderSentence": "Enoxaparin 30 mg BID SC"
                }
              ],
              "route": "SC",
              "instructions": "40 mg SC daily (BMI <40) or 30 mg BID (BMI >40); hold if CrCl <30; **HOLD if LP planned within 12 hours**",
              "orderSentence": "Enoxaparin 40 mg daily SC"
            },
            "contraindications": "Active bleeding, HIT, CrCl <30 (use UFH), pending LP",
            "monitoring": "Platelet count, signs of bleeding",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Heparin (UFH)",
            "route": "SC",
            "indication": "DVT prophylaxis (renal impairment)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5000 units q8h",
                  "orderSentence": "Heparin (UFH) 5000 units q8h SC"
                },
                {
                  "text": "5000 units q12h",
                  "orderSentence": "Heparin (UFH) 5000 units q12h SC"
                }
              ],
              "route": "SC",
              "instructions": "5000 units SC q8-12h if CrCl <30; **HOLD if LP planned within 4-6 hours**",
              "orderSentence": "Heparin (UFH) 5000 units q8h SC"
            },
            "contraindications": "Active bleeding, HIT, pending LP",
            "monitoring": "Platelet count, signs of bleeding",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "SCDs (sequential compression devices)",
            "route": "—",
            "indication": "DVT prophylaxis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "SCDs (sequential compression devices) N/A —"
                }
              ],
              "route": "—",
              "instructions": "Bilateral lower extremity SCDs; use in addition to pharmacologic prophylaxis",
              "orderSentence": "SCDs (sequential compression devices) N/A —"
            },
            "contraindications": "Acute DVT in that extremity",
            "monitoring": "Skin integrity",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Bisacodyl",
            "route": "PO/PR",
            "indication": "Constipation (autonomic)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg daily",
                  "orderSentence": "Bisacodyl 10 mg daily PO/PR"
                },
                {
                  "text": "10 mg suppository",
                  "orderSentence": "Bisacodyl 10 mg suppository PO/PR"
                }
              ],
              "route": "PO/PR",
              "instructions": "10 mg PO or PR daily as needed",
              "orderSentence": "Bisacodyl 10 mg daily PO/PR"
            },
            "contraindications": "Bowel obstruction",
            "monitoring": "Bowel movements",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Polyethylene glycol",
            "route": "PO",
            "indication": "Constipation (autonomic)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "17 g daily",
                  "orderSentence": "Polyethylene glycol 17 g daily PO"
                },
                {
                  "text": "17 g BID",
                  "orderSentence": "Polyethylene glycol 17 g BID PO"
                }
              ],
              "route": "PO",
              "instructions": "17 g (1 capful) PO daily-BID; titrate to 1-2 BMs daily",
              "orderSentence": "Polyethylene glycol 17 g daily PO"
            },
            "contraindications": "Bowel obstruction",
            "monitoring": "Bowel movements",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Metoclopramide",
            "route": "IV/PO",
            "indication": "Gastroparesis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg q6h AC",
                  "orderSentence": "Metoclopramide 10 mg q6h AC IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "10 mg IV/PO before meals and at bedtime; max 40 mg/day; limit to 5 days",
              "orderSentence": "Metoclopramide 10 mg q6h AC IV/PO"
            },
            "contraindications": "Parkinson disease, GI obstruction",
            "monitoring": "EPS, tardive dyskinesia",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Ondansetron",
            "route": "IV/PO",
            "indication": "Nausea",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4 mg q6h PRN",
                  "orderSentence": "Ondansetron 4 mg q6h PRN IV/PO"
                },
                {
                  "text": "8 mg q8h PRN",
                  "orderSentence": "Ondansetron 8 mg q8h PRN IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "4-8 mg IV/PO q6-8h PRN",
              "orderSentence": "Ondansetron 4 mg q6h PRN IV/PO"
            },
            "contraindications": "QT prolongation",
            "monitoring": "QTc if repeated dosing",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Acetaminophen",
            "route": "PO/IV",
            "indication": "Fever, mild pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "650 mg q6h",
                  "orderSentence": "Acetaminophen 650 mg q6h PO/IV"
                },
                {
                  "text": "1000 mg q6h",
                  "orderSentence": "Acetaminophen 1000 mg q6h PO/IV"
                }
              ],
              "route": "PO/IV",
              "instructions": "650-1000 mg PO/IV q6h; max 4 g/day (3 g if hepatic impairment)",
              "orderSentence": "Acetaminophen 650 mg q6h PO/IV"
            },
            "contraindications": "Severe hepatic impairment",
            "monitoring": "LFTs if prolonged use",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Treatment of GBS Variants": [
          {
            "item": "IVIg (Miller Fisher)",
            "route": "IV",
            "indication": "Miller Fisher syndrome",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.4 g/kg/day x 5 days",
                  "orderSentence": "IVIg (Miller Fisher) 0.4 g/kg/day x 5 days IV"
                }
              ],
              "route": "IV",
              "instructions": "Same as standard GBS; benefit less clear for pure MFS without weakness",
              "orderSentence": "IVIg (Miller Fisher) 0.4 g/kg/day x 5 days IV"
            },
            "contraindications": "IgA deficiency",
            "monitoring": "Renal function, infusion reactions",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Observation only (MFS)",
            "route": "—",
            "indication": "Pure MFS (mild)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Observation only (MFS) N/A —"
                }
              ],
              "route": "—",
              "instructions": "Consider observation without immunotherapy for pure MFS with mild symptoms and no limb weakness",
              "orderSentence": "Observation only (MFS) N/A —"
            },
            "contraindications": "If weakness present, treat",
            "monitoring": "Serial neuro exam, FVC",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          }
        ],
        "Refractory/Treatment Failure": [
          {
            "item": "Second course IVIg",
            "route": "IV",
            "indication": "Treatment-related fluctuation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.4 g/kg/day x 5 days",
                  "orderSentence": "Second course IVIg 0.4 g/kg/day x 5 days IV"
                }
              ],
              "route": "IV",
              "instructions": "Consider if deterioration during/after IVIg or PLEX; typically 2-3 weeks after first course",
              "orderSentence": "Second course IVIg 0.4 g/kg/day x 5 days IV"
            },
            "contraindications": "IgA deficiency",
            "monitoring": "Renal function",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "PLEX after IVIg failure",
            "route": "—",
            "indication": "IVIg non-response",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 exchanges over 1-2 weeks",
                  "orderSentence": "PLEX after IVIg failure 5 exchanges over 1-2 weeks —"
                }
              ],
              "route": "—",
              "instructions": "Consider if no improvement 2-4 weeks post-IVIg; wait at least 2 weeks after IVIg completion",
              "orderSentence": "PLEX after IVIg failure 5 exchanges over 1-2 weeks —"
            },
            "contraindications": "Hemodynamic instability",
            "monitoring": "BP, coagulation",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurology consult for diagnosis confirmation, immunotherapy initiation, and prognosis discussion",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Pulmonology consult for respiratory function monitoring and ventilator management if FVC declining",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Critical care consult for ICU admission given FVC <30 mL/kg or rapidly declining respiratory function",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Physical therapy for mobility assessment, fall prevention, and early mobilization when stable",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Occupational therapy for ADL assessment and adaptive equipment to maintain independence",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Speech therapy for swallow evaluation given bulbar weakness and aspiration risk",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Respiratory therapy for airway clearance techniques and ventilator management if intubated",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Pain management consult for refractory neuropathic pain not responding to gabapentin/pregabalin",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Physiatry/PM&R for rehabilitation planning and discharge disposition to optimize functional recovery",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Social work for discharge planning, caregiver support, and GBS Foundation resources",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Return immediately if worsening weakness or breathing difficulty develops (may indicate disease progression requiring intubation)",
            "ED": "STAT",
            "HOSP": "—",
            "OPD": "STAT"
          },
          {
            "item": "Use fall precautions including walker and assistance due to proximal weakness and areflexia",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "STAT"
          },
          {
            "item": "Do not drive until cleared by neurology due to unpredictable weakness and impaired reflexes",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "STAT"
          },
          {
            "item": "Perform physical therapy exercises as prescribed to maintain range of motion and prevent contractures",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "STAT"
          },
          {
            "item": "Expect gradual recovery over weeks to months; most patients recover but pace varies by severity",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Report fevers, severe headache, or new symptoms immediately as these may indicate infection or relapse",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "STAT"
          },
          {
            "item": "Contact GBS-CIDP Foundation (www.gbs-cidp.org) for patient support and educational resources",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Aspiration precautions including thickened liquids and upright positioning given bulbar weakness",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—"
          },
          {
            "item": "Early mobilization when medically stable to prevent DVT and deconditioning (with PT guidance)",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—"
          },
          {
            "item": "Frequent repositioning every 2 hours to prevent pressure ulcers during immobility",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "STAT"
          },
          {
            "item": "Monitor for urinary retention and catheterize if needed due to autonomic dysfunction",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—"
          },
          {
            "item": "Use energy conservation techniques including scheduled rest periods to manage post-GBS fatigue",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Gradual return to activities as strength permits; avoid overexertion which may worsen fatigue",
            "ED": "—",
            "HOSP": "—",
            "OPD": "ROUTINE"
          },
          {
            "item": "Discuss future vaccination timing with neurologist; avoid live vaccines if on immunotherapy",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Myasthenia gravis",
        "features": "Fatigable weakness, ptosis, diplopia; reflexes preserved",
        "tests": "AChR/MuSK antibodies, repetitive nerve stimulation, edrophonium test"
      },
      {
        "diagnosis": "Transverse myelitis",
        "features": "Sensory level, bowel/bladder dysfunction early, UMN signs",
        "tests": "MRI spine with contrast, CSF"
      },
      {
        "diagnosis": "Spinal cord compression",
        "features": "Sensory level, UMN signs below lesion, back pain",
        "tests": "MRI spine emergent"
      },
      {
        "diagnosis": "Botulism",
        "features": "Descending paralysis, pupil involvement, GI symptoms",
        "tests": "Stool/serum toxin assay, EMG (incremental response)"
      },
      {
        "diagnosis": "Poliomyelitis/West Nile",
        "features": "Asymmetric weakness, fever, CSF pleocytosis",
        "tests": "CSF PCR, serology"
      },
      {
        "diagnosis": "Tick paralysis",
        "features": "Recent tick exposure, ascending paralysis",
        "tests": "Physical exam (find tick), rapid improvement with tick removal"
      },
      {
        "diagnosis": "Critical illness polyneuropathy",
        "features": "ICU setting, sepsis, prolonged weakness",
        "tests": "EMG/NCS, clinical context"
      },
      {
        "diagnosis": "Hypokalemic periodic paralysis",
        "features": "Episodic weakness, low K+ during attacks",
        "tests": "Serum K+ during attack, genetic testing"
      },
      {
        "diagnosis": "Acute porphyria",
        "features": "Abdominal pain, psychiatric symptoms, motor neuropathy",
        "tests": "Urine porphyrins, ALA, PBG"
      },
      {
        "diagnosis": "Heavy metal poisoning",
        "features": "Exposure history, other systemic symptoms",
        "tests": "Heavy metal levels"
      },
      {
        "diagnosis": "Diphtheria",
        "features": "Pharyngitis, palatal weakness, cardiac involvement",
        "tests": "Throat culture, toxin assay"
      },
      {
        "diagnosis": "HIV-associated neuropathy",
        "features": "Risk factors, may have CSF pleocytosis",
        "tests": "HIV testing"
      },
      {
        "diagnosis": "CIDP",
        "features": "Chronic course (>8 weeks), relapsing",
        "tests": "Clinical course, EMG/NCS, CSF"
      }
    ],
    "evidence": [
      {
        "recommendation": "IVIg or PLEX equally effective for GBS",
        "evidenceLevel": "Class I, Level A",
        "source": "[Hughes et al. Cochrane 2014](https://pubmed.ncbi.nlm.nih.gov/25238327/)"
      },
      {
        "recommendation": "IVIg 0.4 g/kg x 5 days standard dosing",
        "evidenceLevel": "Class I, Level A",
        "source": "[van der Meché et al. NEJM 1992](https://pubmed.ncbi.nlm.nih.gov/1557426/)"
      },
      {
        "recommendation": "PLEX effective within 4 weeks of onset",
        "evidenceLevel": "Class I, Level A",
        "source": "[Raphaël et al. Cochrane 2012](https://pubmed.ncbi.nlm.nih.gov/22786476/)"
      },
      {
        "recommendation": "Combined IVIg + PLEX not superior",
        "evidenceLevel": "Class I, Level A",
        "source": "[Plasma Exchange/Sandoglobulin GBS Trial Group 1997](https://pubmed.ncbi.nlm.nih.gov/9008066/)"
      },
      {
        "recommendation": "Corticosteroids ineffective in GBS",
        "evidenceLevel": "Class I, Level A",
        "source": "[Hughes et al. Cochrane 2016](https://pubmed.ncbi.nlm.nih.gov/27775812/)"
      },
      {
        "recommendation": "FVC and NIF for respiratory monitoring",
        "evidenceLevel": "Class II, Level B",
        "source": "[Lawn et al. Arch Neurol 2001](https://pubmed.ncbi.nlm.nih.gov/11405803/)"
      },
      {
        "recommendation": "Anti-GQ1b associated with Miller Fisher",
        "evidenceLevel": "Class II, Level B",
        "source": "[Chiba et al. Ann Neurol 1992](https://pubmed.ncbi.nlm.nih.gov/1514781/)"
      },
      {
        "recommendation": "Campylobacter most common antecedent",
        "evidenceLevel": "Class II, Level B",
        "source": "[Jacobs et al. Neurology 1998](https://pubmed.ncbi.nlm.nih.gov/9781538/)"
      },
      {
        "recommendation": "Early IVIg (within 2 weeks) improves outcomes",
        "evidenceLevel": "Class I, Level A",
        "source": "[Hughes et al. Cochrane 2014](https://pubmed.ncbi.nlm.nih.gov/25238327/)"
      },
      {
        "recommendation": "20/30/40 rule for intubation",
        "evidenceLevel": "Class III, Level C",
        "source": "[Lawn et al. Arch Neurol 2001](https://pubmed.ncbi.nlm.nih.gov/11405803/)"
      }
    ],
    "monitoring": [
      {
        "item": "Forced vital capacity (FVC)",
        "frequency": "q4-6h initially; q2h if declining",
        "action": "Intubate if <20 mL/kg or >30% decline",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Negative inspiratory force (NIF)",
        "frequency": "q4-6h initially; q2h if declining",
        "action": "Intubate if weaker than -30 cmH2O",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Oxygen saturation",
        "frequency": "Continuous",
        "action": "Supplement oxygen, consider intubation",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Heart rate",
        "frequency": "Continuous",
        "action": "Treat bradycardia <50 or tachy >120",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Blood pressure",
        "frequency": "q1-4h",
        "action": "Treat hypo/hypertension",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Neurological exam (strength)",
        "frequency": "q4-8h",
        "action": "Escalate care if worsening",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT"
      },
      {
        "item": "Swallow function",
        "frequency": "Daily if bulbar symptoms",
        "action": "NPO, NG tube if unsafe",
        "ED": "—",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Urine output",
        "frequency": "q4-8h",
        "action": "Bladder scan, catheterize if needed",
        "ED": "—",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Renal function",
        "frequency": "Daily during IVIg",
        "action": "Hold IVIg, hydrate if rising",
        "ED": "—",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Skin integrity",
        "frequency": "q shift",
        "action": "Reposition, pressure relief",
        "ED": "—",
        "HOSP": "ROUTINE",
        "OPD": "—",
        "ICU": "ROUTINE"
      },
      {
        "item": "Bowel function",
        "frequency": "Daily",
        "action": "Bowel regimen if constipated",
        "ED": "—",
        "HOSP": "ROUTINE",
        "OPD": "—",
        "ICU": "ROUTINE"
      }
    ],
    "disposition": [
      {
        "disposition": "**ICU admission**",
        "criteria": "FVC <30 mL/kg; NIF weaker than -40 cmH2O; rapid progression; autonomic instability; bulbar dysfunction; need for intubation"
      },
      {
        "disposition": "**Step-down/telemetry**",
        "criteria": "Stable FVC >30 mL/kg; improving or stable exam; no autonomic instability; on telemetry monitoring"
      },
      {
        "disposition": "**General floor**",
        "criteria": "Mild weakness (ambulatory); stable FVC >40 mL/kg; no bulbar symptoms; no autonomic dysfunction"
      },
      {
        "disposition": "**Acute rehabilitation**",
        "criteria": "Medically stable; significant residual weakness requiring intensive therapy; FVC stable >25 mL/kg"
      },
      {
        "disposition": "**Discharge home**",
        "criteria": "Ambulatory or near-ambulatory; stable >48-72 hours; adequate home support; outpatient PT arranged; no respiratory compromise"
      },
      {
        "disposition": "**Skilled nursing facility**",
        "criteria": "Unable to participate in intensive rehab; requires ongoing nursing care; medically stable"
      }
    ]
  },
  "Myasthenia Gravis - Exacerbation/Crisis": {
    "id": "myasthenia-gravis-crisis",
    "title": "Myasthenia Gravis - Exacerbation/Crisis",
    "version": "1.1",
    "icd10": [
      "** G70.00 (Myasthenia gravis without exacerbation)",
      "G70.01 (Myasthenia gravis with exacerbation)",
      "G70.1 (Toxic myoneural disorders)"
    ],
    "scope": "** Evaluation and management of acute myasthenic exacerbation and myasthenic crisis in adults. Covers respiratory monitoring, immunotherapy (IVIg and plasmapheresis), medications to avoid, and ICU management. Excludes new diagnosis workup, chronic maintenance therapy, Lambert-Eaton myasthenic syndrome (LEMS), and congenital myasthenic syndromes.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC with differential",
            "rationale": "Infection as trigger, baseline",
            "target": "Normal or elevated WBC if infected",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "CMP (BMP + LFTs)",
            "rationale": "Electrolytes, renal/hepatic function",
            "target": "Normal; hypokalemia worsens weakness",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Magnesium",
            "rationale": "Hypomagnesemia worsens NMJ transmission",
            "target": ">1.8 mg/dL",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Phosphorus",
            "rationale": "Hypophosphatemia causes weakness",
            "target": ">2.5 mg/dL",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "TSH",
            "rationale": "Thyroid disease common comorbidity",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Blood glucose",
            "rationale": "Hyperglycemia worsens outcomes",
            "target": "<180 mg/dL",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Urinalysis",
            "rationale": "UTI as trigger",
            "target": "Negative for infection",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Blood cultures",
            "rationale": "If febrile or sepsis suspected",
            "target": "Negative",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Procalcitonin",
            "rationale": "Differentiate infection vs non-infectious flare",
            "target": "<0.5 ng/mL if non-infectious",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "ABG or VBG",
            "rationale": "Respiratory status, CO2 retention",
            "target": "PaCO2 <45 mmHg, pH >7.35",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Extended Workup": [
          {
            "item": "AChR (acetylcholine receptor) antibody",
            "rationale": "Confirm diagnosis if unknown",
            "target": "Document if positive (~85% of generalized MG)",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "MuSK antibody",
            "rationale": "If AChR negative",
            "target": "Document if positive (~40% of AChR-negative)",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "LRP4 antibody",
            "rationale": "If AChR and MuSK negative",
            "target": "Document if positive",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "Anti-striated muscle antibody",
            "rationale": "Thymoma association",
            "target": "If positive, CT chest",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Hepatitis B surface antigen",
            "rationale": "Pre-IVIg screening",
            "target": "Negative",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Quantitative immunoglobulins",
            "rationale": "IgA deficiency (IVIg contraindication)",
            "target": "IgA >7 mg/dL",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "PT/INR, PTT",
            "rationale": "Pre-PLEX",
            "target": "Normal",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Type and screen",
            "rationale": "Pre-PLEX",
            "target": "Available",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Fibrinogen",
            "rationale": "Pre-PLEX baseline",
            "target": "Normal",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Troponin",
            "rationale": "Cardiac involvement, stress",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "BNP/NT-proBNP",
            "rationale": "Heart failure assessment",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Cortisol (random or AM)",
            "rationale": "Adrenal insufficiency if on chronic steroids",
            "target": "Normal stress response",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Acetylcholinesterase inhibitor level",
            "rationale": "Cholinergic crisis concern (if available)",
            "target": "Therapeutic range",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "Paraneoplastic panel",
            "rationale": "Occult malignancy",
            "target": "Negative",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "Respiratory viral panel",
            "rationale": "Viral trigger",
            "target": "Document if positive",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "Chest X-ray",
            "timing": "On admission",
            "target": "Aspiration, atelectasis, pneumonia",
            "contraindications": "None",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "ECG",
            "timing": "On admission",
            "target": "Arrhythmia, QT prolongation",
            "contraindications": "None",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Forced vital capacity (FVC)",
            "timing": "Serial q4-6h (q2h if declining)",
            "target": "FVC >15-20 mL/kg",
            "contraindications": "Facial weakness limiting seal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Negative inspiratory force (NIF)",
            "timing": "Serial q4-6h (q2h if declining)",
            "target": "NIF more negative than -20 cmH2O",
            "contraindications": "Facial weakness",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Extended": [
          {
            "item": "CT chest with contrast",
            "timing": "If thymoma not previously evaluated",
            "target": "Thymoma or thymic hyperplasia",
            "contraindications": "Contrast allergy, renal impairment",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "CT chest without contrast",
            "timing": "Thymoma evaluation (if contrast contraindicated)",
            "target": "Thymic abnormality",
            "contraindications": "None",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Swallow evaluation",
            "timing": "Bulbar symptoms",
            "target": "Aspiration risk",
            "contraindications": "None",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Repetitive nerve stimulation",
            "timing": "If diagnosis uncertain",
            "target": "Decremental response >10%",
            "contraindications": "None",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Single-fiber EMG",
            "timing": "If RNS negative but MG suspected",
            "target": "Increased jitter, blocking",
            "contraindications": "None",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "PET-CT",
            "timing": "Occult thymoma or malignancy",
            "target": "Tumor identification",
            "contraindications": "Hemodynamic instability",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "Ice pack test",
            "timing": "Bedside diagnostic (ptosis)",
            "target": "Improvement with cooling",
            "contraindications": "None",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent - Airway and Respiratory Support": [
          {
            "item": "Supplemental oxygen",
            "route": "INH",
            "indication": "Hypoxemia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2-6 L/min NC",
                  "orderSentence": "Supplemental oxygen 2-6 L/min NC INH"
                },
                {
                  "text": "15 L/min NRB",
                  "orderSentence": "Supplemental oxygen 15 L/min NRB INH"
                }
              ],
              "route": "INH",
              "instructions": "Titrate to O2 sat >94%; escalate as needed",
              "orderSentence": "Supplemental oxygen 2-6 L/min NC INH"
            },
            "contraindications": "None",
            "monitoring": "O2 sat, RR",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Endotracheal intubation",
            "route": "—",
            "indication": "Respiratory failure",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Endotracheal intubation N/A —"
                }
              ],
              "route": "—",
              "instructions": "Intubate if FVC <15 mL/kg, NIF >-20 cmH2O, or clinical deterioration; AVOID succinylcholine (may have prolonged block); use rocuronium (may need higher dose)",
              "orderSentence": "Endotracheal intubation N/A —"
            },
            "contraindications": "—",
            "monitoring": "ETT position, ventilator settings",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Non-invasive ventilation (BiPAP)",
            "route": "—",
            "indication": "Bridge to intubation or mild hypoventilation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "IPAP 10-15",
                  "orderSentence": "Non-invasive ventilation (BiPAP) IPAP 10-15 —"
                },
                {
                  "text": "EPAP 5",
                  "orderSentence": "Non-invasive ventilation (BiPAP) EPAP 5 —"
                }
              ],
              "route": "—",
              "instructions": "BiPAP may temporize; NOT a substitute for intubation in true crisis",
              "orderSentence": "Non-invasive ventilation (BiPAP) IPAP 10-15 —"
            },
            "contraindications": "Severe respiratory failure, inability to protect airway",
            "monitoring": "RR, TV, O2 sat, CO2",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Mechanical ventilation",
            "route": "—",
            "indication": "Respiratory failure",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Mechanical ventilation N/A —"
                }
              ],
              "route": "—",
              "instructions": "Lung-protective ventilation; expect prolonged wean; daily SBT when improved",
              "orderSentence": "Mechanical ventilation N/A —"
            },
            "contraindications": "—",
            "monitoring": "ABG, ventilator parameters",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Immunotherapy - First-line for Crisis/Severe Exacerbation": [
          {
            "item": "IVIg (immune globulin IV)",
            "route": "IV",
            "indication": "Myasthenic crisis or severe exacerbation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.4 g/kg/day x 5 days",
                  "orderSentence": "IVIg (immune globulin IV) 0.4 g/kg/day x 5 days IV"
                },
                {
                  "text": "1 g/kg/day x 2 days",
                  "orderSentence": "IVIg (immune globulin IV) 1 g/kg/day x 2 days IV"
                }
              ],
              "route": "IV",
              "instructions": "0.4 g/kg/day IV for 5 days (preferred) OR 1 g/kg/day x 2 days; infuse slowly day 1",
              "orderSentence": "IVIg (immune globulin IV) 0.4 g/kg/day x 5 days IV"
            },
            "contraindications": "IgA deficiency with anti-IgA antibodies; severe renal impairment; recent MI/stroke (thrombosis risk)",
            "monitoring": "Renal function daily, headache, infusion reactions; pre-medicate",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Plasmapheresis (PLEX)",
            "route": "—",
            "indication": "Myasthenic crisis or severe exacerbation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 exchanges over 7-14 days",
                  "orderSentence": "Plasmapheresis (PLEX) 5 exchanges over 7-14 days —"
                }
              ],
              "route": "—",
              "instructions": "5 exchanges (1-1.5 plasma volumes per exchange) over 7-14 days; typically QOD",
              "orderSentence": "Plasmapheresis (PLEX) 5 exchanges over 7-14 days —"
            },
            "contraindications": "Hemodynamic instability, severe sepsis, poor IV access",
            "monitoring": "BP, electrolytes, coagulation, fibrinogen",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Cholinesterase Inhibitors": [
          {
            "item": "Pyridostigmine",
            "route": "PO",
            "indication": "Symptomatic treatment",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mg TID",
                  "orderSentence": "Pyridostigmine 30 mg TID PO"
                },
                {
                  "text": "60 mg TID",
                  "orderSentence": "Pyridostigmine 60 mg TID PO"
                },
                {
                  "text": "60 mg QID",
                  "orderSentence": "Pyridostigmine 60 mg QID PO"
                },
                {
                  "text": "90 mg QID",
                  "orderSentence": "Pyridostigmine 90 mg QID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 30-60 mg TID; titrate by 30 mg/dose q2-3d; max ~120 mg q4h; usual maintenance 60-90 mg q4-6h",
              "orderSentence": "Pyridostigmine 30 mg TID PO"
            },
            "contraindications": "Mechanical bowel/bladder obstruction",
            "monitoring": "Cholinergic symptoms (SLUDGE), HR",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Pyridostigmine (in crisis)",
            "route": "—",
            "indication": "During crisis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "HOLD or reduce",
                  "orderSentence": "Pyridostigmine (in crisis) HOLD or reduce —"
                }
              ],
              "route": "—",
              "instructions": "HOLD pyridostigmine in intubated patients or suspected cholinergic crisis; restart at low dose when improving",
              "orderSentence": "Pyridostigmine (in crisis) HOLD or reduce —"
            },
            "contraindications": "Cholinergic crisis",
            "monitoring": "Secretions, HR",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Neostigmine",
            "route": "IV/IM",
            "indication": "If NPO and needs AChEI",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5 mg IV q3h",
                  "orderSentence": "Neostigmine 0.5 mg IV q3h IV/IM"
                },
                {
                  "text": "1.5 mg IM q3h",
                  "orderSentence": "Neostigmine 1.5 mg IM q3h IV/IM"
                }
              ],
              "route": "IV/IM",
              "instructions": "0.5 mg IV or 1.5 mg IM roughly equivalent to 60 mg PO pyridostigmine; use ONLY if cannot take PO and essential",
              "orderSentence": "Neostigmine 0.5 mg IV q3h IV/IM"
            },
            "contraindications": "Cholinergic toxicity",
            "monitoring": "HR, secretions",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Glycopyrrolate",
            "route": "PO/IV",
            "indication": "Cholinergic side effects",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 mg PO TID",
                  "orderSentence": "Glycopyrrolate 1 mg PO TID PO/IV"
                },
                {
                  "text": "0.2 mg IV PRN",
                  "orderSentence": "Glycopyrrolate 0.2 mg IV PRN PO/IV"
                }
              ],
              "route": "PO/IV",
              "instructions": "1-2 mg PO TID for secretions/GI effects; 0.2 mg IV PRN; does not cross BBB",
              "orderSentence": "Glycopyrrolate 1 mg PO TID PO/IV"
            },
            "contraindications": "Glaucoma, severe cardiac disease",
            "monitoring": "HR, urinary retention",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          }
        ],
        "Corticosteroids (Use with CAUTION)": [
          {
            "item": "Prednisone (high-dose, post-crisis)",
            "route": "PO",
            "indication": "Crisis treated with IVIg/PLEX, improving",
            "dosing": {
              "doseOptions": [
                {
                  "text": "60 mg daily",
                  "orderSentence": "Prednisone (high-dose, post-crisis) 60 mg daily PO"
                },
                {
                  "text": "1 mg/kg daily",
                  "orderSentence": "Prednisone (high-dose, post-crisis) 1 mg/kg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 60 mg (or 1 mg/kg) daily AFTER day 3 of IVIg/PLEX if improving; for patients whose crisis is being treated; taper once stable",
              "orderSentence": "Prednisone (high-dose, post-crisis) 60 mg daily PO"
            },
            "contraindications": "Active infection (relative)",
            "monitoring": "Glucose, BP, K+; already covered by IVIg/PLEX",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Prednisone (low-dose start)",
            "route": "PO",
            "indication": "Stable patient, outpatient, new start",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg daily",
                  "orderSentence": "Prednisone (low-dose start) 10 mg daily PO"
                },
                {
                  "text": "20 mg daily",
                  "orderSentence": "Prednisone (low-dose start) 20 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start LOW (10-20 mg daily) and increase slowly by 10 mg q5-7d to target 1 mg/kg/day; for OUTPATIENT or STABLE inpatients not in crisis; HIGH-DOSE INITIATION CAN WORSEN MG",
              "orderSentence": "Prednisone (low-dose start) 10 mg daily PO"
            },
            "contraindications": "Active infection (relative), brittle MG without IVIg/PLEX cover",
            "monitoring": "Glucose, BP, K+; WATCH FOR TRANSIENT WORSENING days 5-10",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Methylprednisolone",
            "route": "IV",
            "indication": "Severe exacerbation (with IVIg/PLEX cover)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mg daily x 3-5 days",
                  "orderSentence": "Methylprednisolone 500 mg daily x 3-5 days IV"
                },
                {
                  "text": "1000 mg daily x 3-5 days",
                  "orderSentence": "Methylprednisolone 1000 mg daily x 3-5 days IV"
                }
              ],
              "route": "IV",
              "instructions": "500-1000 mg IV daily x 3-5 days; ONLY with IVIg/PLEX coverage due to risk of transient worsening",
              "orderSentence": "Methylprednisolone 500 mg daily x 3-5 days IV"
            },
            "contraindications": "Active untreated infection",
            "monitoring": "Glucose, BP, K+, psychiatric effects",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          }
        ],
        "Supportive Care": [
          {
            "item": "Enoxaparin",
            "route": "SC",
            "indication": "DVT prophylaxis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg daily",
                  "orderSentence": "Enoxaparin 40 mg daily SC"
                },
                {
                  "text": "30 mg BID",
                  "orderSentence": "Enoxaparin 30 mg BID SC"
                }
              ],
              "route": "SC",
              "instructions": "40 mg SC daily; 30 mg BID if BMI >40; hold if CrCl <30; **HOLD if LP planned within 12 hours**",
              "orderSentence": "Enoxaparin 40 mg daily SC"
            },
            "contraindications": "Active bleeding, HIT, pending LP",
            "monitoring": "Platelet count, bleeding",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Heparin (UFH)",
            "route": "SC",
            "indication": "DVT prophylaxis (renal impairment)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5000 units q8h",
                  "orderSentence": "Heparin (UFH) 5000 units q8h SC"
                },
                {
                  "text": "5000 units q12h",
                  "orderSentence": "Heparin (UFH) 5000 units q12h SC"
                }
              ],
              "route": "SC",
              "instructions": "5000 units SC q8-12h if CrCl <30; **HOLD if LP planned within 4-6 hours**",
              "orderSentence": "Heparin (UFH) 5000 units q8h SC"
            },
            "contraindications": "Active bleeding, HIT, pending LP",
            "monitoring": "Platelet count",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Famotidine",
            "route": "IV/PO",
            "indication": "Stress ulcer prophylaxis (if on steroids)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg BID",
                  "orderSentence": "Famotidine 20 mg BID IV/PO"
                },
                {
                  "text": "40 mg daily",
                  "orderSentence": "Famotidine 40 mg daily IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "20 mg IV/PO BID or 40 mg daily",
              "orderSentence": "Famotidine 20 mg BID IV/PO"
            },
            "contraindications": "None significant",
            "monitoring": "None",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Insulin (regular)",
            "route": "IV/SC",
            "indication": "Steroid-induced hyperglycemia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Sliding scale",
                  "orderSentence": "Insulin (regular) Sliding scale IV/SC"
                },
                {
                  "text": "basal-bolus",
                  "orderSentence": "Insulin (regular) basal-bolus IV/SC"
                }
              ],
              "route": "IV/SC",
              "instructions": "Sliding scale or basal-bolus; target glucose <180 mg/dL",
              "orderSentence": "Insulin (regular) Sliding scale IV/SC"
            },
            "contraindications": "Hypoglycemia",
            "monitoring": "Glucose q4-6h",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Acetaminophen",
            "route": "PO/IV",
            "indication": "Fever, mild pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "650 mg q6h",
                  "orderSentence": "Acetaminophen 650 mg q6h PO/IV"
                },
                {
                  "text": "1000 mg q6h",
                  "orderSentence": "Acetaminophen 1000 mg q6h PO/IV"
                }
              ],
              "route": "PO/IV",
              "instructions": "650-1000 mg q6h; max 4 g/day",
              "orderSentence": "Acetaminophen 650 mg q6h PO/IV"
            },
            "contraindications": "Severe hepatic impairment",
            "monitoring": "LFTs if prolonged",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "SCDs (sequential compression devices)",
            "route": "—",
            "indication": "DVT prophylaxis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "SCDs (sequential compression devices) N/A —"
                }
              ],
              "route": "—",
              "instructions": "Bilateral lower extremity SCDs",
              "orderSentence": "SCDs (sequential compression devices) N/A —"
            },
            "contraindications": "DVT in that extremity",
            "monitoring": "Skin integrity",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Long-term Immunosuppression (Initiate/Continue as Indicated)": [
          {
            "item": "Azathioprine",
            "route": "PO",
            "indication": "Steroid-sparing agent",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg daily",
                  "orderSentence": "Azathioprine 50 mg daily PO"
                },
                {
                  "text": "100 mg daily",
                  "orderSentence": "Azathioprine 100 mg daily PO"
                },
                {
                  "text": "150 mg daily",
                  "orderSentence": "Azathioprine 150 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 50 mg daily; increase by 50 mg q2-4wk to 2-3 mg/kg/day; check TPMT before starting",
              "orderSentence": "Azathioprine 50 mg daily PO"
            },
            "contraindications": "TPMT deficiency, pregnancy",
            "monitoring": "CBC weekly x 4, then monthly; LFTs monthly",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "—"
          },
          {
            "item": "Mycophenolate mofetil",
            "route": "PO",
            "indication": "Steroid-sparing agent",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mg BID",
                  "orderSentence": "Mycophenolate mofetil 500 mg BID PO"
                },
                {
                  "text": "1000 mg BID",
                  "orderSentence": "Mycophenolate mofetil 1000 mg BID PO"
                },
                {
                  "text": "1500 mg BID",
                  "orderSentence": "Mycophenolate mofetil 1500 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 500 mg BID; increase to 1000-1500 mg BID over 2-4 weeks",
              "orderSentence": "Mycophenolate mofetil 500 mg BID PO"
            },
            "contraindications": "Pregnancy, hypersensitivity",
            "monitoring": "CBC q2wk x 2mo, then monthly; LFTs",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "—"
          },
          {
            "item": "Rituximab",
            "route": "IV",
            "indication": "Refractory MG, MuSK-positive MG",
            "dosing": {
              "doseOptions": [
                {
                  "text": "375 mg/m² weekly x 4 weeks",
                  "orderSentence": "Rituximab 375 mg/m² weekly x 4 weeks IV"
                },
                {
                  "text": "1000 mg q2wk x 2",
                  "orderSentence": "Rituximab 1000 mg q2wk x 2 IV"
                }
              ],
              "route": "IV",
              "instructions": "375 mg/m² weekly x 4 OR 1000 mg x 2 doses (2 weeks apart); pre-medicate with methylpred, acetaminophen, diphenhydramine",
              "orderSentence": "Rituximab 375 mg/m² weekly x 4 weeks IV"
            },
            "contraindications": "Active infection, HBV (screen first)",
            "monitoring": "Infusion reactions, CD19/CD20, immunoglobulins",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurology consult for crisis management, immunotherapy guidance, and medication safety review",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Pulmonology consult for respiratory function monitoring and ventilator wean planning if intubated",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Critical care consult for ICU admission given FVC <20 mL/kg or impending respiratory failure",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Thoracic surgery consult for thymectomy planning if thymoma identified or considering elective thymectomy",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Speech therapy for swallow evaluation and aspiration risk assessment given bulbar symptoms",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Physical therapy for mobility assessment and safe transfer training given fluctuating weakness",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Occupational therapy for ADL assessment and energy conservation strategies to manage fatigue",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Respiratory therapy for airway clearance and pulmonary toilet given weak cough and secretion management",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Pharmacy consult to review all medications for MG-exacerbating drugs (see medications to avoid list)",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Social work for discharge planning and Myasthenia Gravis Foundation support resources",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Return immediately if worsening weakness or breathing difficulty develops (may indicate crisis requiring intubation)",
            "ED": "STAT",
            "HOSP": "—",
            "OPD": "STAT"
          },
          {
            "item": "Do not skip or suddenly stop immunosuppressive medications as this may trigger severe exacerbation",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "STAT"
          },
          {
            "item": "Carry MG medical alert card listing medications to avoid (aminoglycosides, fluoroquinolones, beta-blockers, etc.)",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "STAT"
          },
          {
            "item": "Take pyridostigmine 30-60 minutes before meals to improve swallowing and reduce aspiration risk",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Report fever or signs of infection promptly as infection is a common exacerbation trigger",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "STAT"
          },
          {
            "item": "Avoid extreme heat as high temperatures worsen neuromuscular transmission and increase weakness",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Get adequate rest and avoid overexertion; fatigue worsens throughout the day in MG",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Do not drive if diplopia or ptosis impairs vision; symptoms may fluctuate unpredictably",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "STAT"
          },
          {
            "item": "Contact Myasthenia Gravis Foundation (www.myasthenia.org) for patient support and educational resources",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Aspiration precautions including thickened liquids and upright positioning given bulbar weakness",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—"
          },
          {
            "item": "Fall precautions including walker and bed rails due to fluctuating proximal weakness",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "STAT"
          },
          {
            "item": "Medication reconciliation before any new prescription to avoid MG-exacerbating drugs",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "STAT"
          },
          {
            "item": "Avoid live vaccines while on immunosuppression; flu and pneumococcal vaccines recommended to prevent infections",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Stress management techniques as psychological stress can trigger MG exacerbations",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Maintain good sleep hygiene as fatigue and sleep deprivation worsen MG symptoms",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Use energy conservation techniques including pacing activities and scheduling rest periods",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Guillain-Barré syndrome",
        "features": "Ascending weakness, areflexia, no fluctuation",
        "tests": "CSF (albuminocytologic dissociation), EMG/NCS"
      },
      {
        "diagnosis": "Lambert-Eaton syndrome",
        "features": "Proximal weakness, autonomic symptoms, reflexes improve with exercise",
        "tests": "VGCC antibodies, EMG (incremental response)"
      },
      {
        "diagnosis": "Botulism",
        "features": "Descending weakness, pupil involvement, GI symptoms",
        "tests": "Stool/serum toxin, EMG"
      },
      {
        "diagnosis": "Brainstem stroke",
        "features": "Acute onset, crossed findings, other cranial nerve signs",
        "tests": "MRI brain"
      },
      {
        "diagnosis": "Multiple sclerosis",
        "features": "CNS symptoms, sensory involvement, different time course",
        "tests": "MRI brain/spine, CSF"
      },
      {
        "diagnosis": "Thyroid eye disease",
        "features": "Thyroid dysfunction, proptosis, restrictive ophthalmopathy",
        "tests": "TFTs, orbital imaging"
      },
      {
        "diagnosis": "Oculopharyngeal muscular dystrophy",
        "features": "Older onset, slowly progressive, no fluctuation",
        "tests": "Genetic testing, muscle biopsy"
      },
      {
        "diagnosis": "Mitochondrial myopathy",
        "features": "Progressive, elevated lactate, other organ involvement",
        "tests": "Lactate, muscle biopsy, genetic testing"
      },
      {
        "diagnosis": "Drug-induced MG",
        "features": "Recent D-penicillamine, checkpoint inhibitors",
        "tests": "Medication history, antibodies"
      },
      {
        "diagnosis": "Cholinergic crisis",
        "features": "SLUDGE symptoms, miosis, bradycardia",
        "tests": "Clinical, response to stopping AChEI"
      }
    ],
    "evidence": [
      {
        "recommendation": "IVIg and PLEX equally effective for MG exacerbation",
        "evidenceLevel": "Class I, Level A",
        "source": "[Gajdos et al. Cochrane 2012](https://pubmed.ncbi.nlm.nih.gov/23235588/)"
      },
      {
        "recommendation": "IVIg 2 g/kg total dose standard",
        "evidenceLevel": "Class I, Level A",
        "source": "[Zinman et al. Lancet Neurol 2007](https://pubmed.ncbi.nlm.nih.gov/17706563/)"
      },
      {
        "recommendation": "PLEX effective for MG crisis",
        "evidenceLevel": "Class I, Level A",
        "source": "[Gajdos et al. Cochrane 2012](https://pubmed.ncbi.nlm.nih.gov/23235588/)"
      },
      {
        "recommendation": "FVC and NIF for respiratory monitoring",
        "evidenceLevel": "Class II, Level B",
        "source": "[Rabinstein & Wijdicks. Neurology 2003](https://pubmed.ncbi.nlm.nih.gov/12654988/)"
      },
      {
        "recommendation": "Pyridostigmine for symptomatic treatment",
        "evidenceLevel": "Class I, Level A",
        "source": "[Mehndiratta et al. Cochrane 2014](https://pubmed.ncbi.nlm.nih.gov/25304970/)"
      },
      {
        "recommendation": "Corticosteroids can cause initial worsening",
        "evidenceLevel": "Class II, Level B",
        "source": "[Palace et al. Lancet Neurol 2012](https://pubmed.ncbi.nlm.nih.gov/22305458/)"
      },
      {
        "recommendation": "Azathioprine as steroid-sparing agent",
        "evidenceLevel": "Class I, Level B",
        "source": "[Palace et al. NEJM 1998](https://pubmed.ncbi.nlm.nih.gov/9771070/)"
      },
      {
        "recommendation": "Rituximab effective in refractory/MuSK+ MG",
        "evidenceLevel": "Class II, Level C",
        "source": "[Nowak et al. Neurology 2022](https://pubmed.ncbi.nlm.nih.gov/34986310/)"
      },
      {
        "recommendation": "Medications to avoid in MG",
        "evidenceLevel": "Class III, Level C",
        "source": "[Juel. Semin Neurol 2004](https://pubmed.ncbi.nlm.nih.gov/15257515/)"
      },
      {
        "recommendation": "Thymectomy beneficial in generalized MG",
        "evidenceLevel": "Class I, Level B",
        "source": "[Wolfe et al. NEJM 2016 (MGTX Trial)](https://pubmed.ncbi.nlm.nih.gov/27509100/)"
      }
    ],
    "monitoring": [
      {
        "item": "Forced vital capacity (FVC)",
        "frequency": "q4-6h; q2h if declining",
        "action": "Intubate if <15 mL/kg",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Negative inspiratory force (NIF)",
        "frequency": "q4-6h; q2h if declining",
        "action": "Intubate if weaker than -20 cmH2O",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Oxygen saturation",
        "frequency": "Continuous",
        "action": "Supplement O2, consider intubation",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Neurological exam (strength)",
        "frequency": "q4-8h",
        "action": "Escalate therapy if worsening",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT"
      },
      {
        "item": "Swallow function",
        "frequency": "Daily if bulbar symptoms",
        "action": "NPO, NG tube if unsafe",
        "ED": "—",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Blood glucose",
        "frequency": "q6h if on steroids",
        "action": "Insulin adjustment",
        "ED": "—",
        "HOSP": "ROUTINE",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Renal function",
        "frequency": "Daily during IVIg",
        "action": "Hold IVIg, hydrate if rising",
        "ED": "—",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Electrolytes (K+, Mg)",
        "frequency": "Daily",
        "action": "Replete aggressively",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Heart rate/rhythm",
        "frequency": "Continuous",
        "action": "Evaluate for autonomic dysfunction",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Blood pressure",
        "frequency": "q4h",
        "action": "Evaluate for autonomic dysfunction",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Cholinergic symptoms",
        "frequency": "Each dose of pyridostigmine",
        "action": "Reduce dose, consider cholinergic crisis",
        "ED": "—",
        "HOSP": "ROUTINE",
        "OPD": "—",
        "ICU": "ROUTINE"
      }
    ],
    "disposition": [
      {
        "disposition": "**ICU admission**",
        "criteria": "FVC <20 mL/kg or declining; NIF weaker than -30 cmH2O; rapid progression; bulbar dysfunction with aspiration risk; need for intubation/BiPAP"
      },
      {
        "disposition": "**Step-down/telemetry**",
        "criteria": "Stable FVC >20 mL/kg; improving or stable exam; receiving IVIg/PLEX; no bulbar symptoms"
      },
      {
        "disposition": "**General floor**",
        "criteria": "Mild exacerbation; FVC >30 mL/kg and stable; no bulbar symptoms; stable on oral medications"
      },
      {
        "disposition": "**Discharge home**",
        "criteria": "Stable or improved x 24-48 hours; FVC stable >30 mL/kg; adequate oral intake; medications optimized; outpatient follow-up arranged"
      },
      {
        "disposition": "**Acute rehabilitation**",
        "criteria": "Significant residual weakness after crisis; requires intensive therapy; medically stable"
      }
    ]
  },
  "Bacterial Meningitis": {
    "id": "bacterial-meningitis",
    "title": "Bacterial Meningitis",
    "version": "1.1",
    "icd10": [
      "** G00.9 (Bacterial meningitis",
      "unspecified)",
      "G00.0 (Hemophilus meningitis)",
      "G00.1 (Pneumococcal meningitis)",
      "G00.2 (Streptococcal meningitis)",
      "G00.3 (Staphylococcal meningitis)",
      "G00.8 (Other bacterial meningitis)",
      "G01 (Meningitis in bacterial diseases classified elsewhere)",
      "G03.9 (Meningitis",
      "unspecified)"
    ],
    "scope": "** Evaluation and empiric treatment of acute community-acquired bacterial meningitis in adults. Covers empiric antibiotic selection by age/risk, dexamethasone adjunctive therapy, lumbar puncture interpretation, and ICU management. Excludes neonatal meningitis, healthcare-associated/post-neurosurgical meningitis, tuberculous meningitis, and fungal meningitis.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "Blood cultures (2 sets)",
            "rationale": "Identify organism (positive in 50-80%)",
            "target": "Organism identification",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "CBC with differential",
            "rationale": "Leukocytosis, left shift; baseline",
            "target": "Elevated WBC; bandemia",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "CMP (BMP + LFTs)",
            "rationale": "Renal/hepatic function for antibiotic dosing",
            "target": "Normal or evidence of sepsis",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Lactate",
            "rationale": "Sepsis severity marker",
            "target": "<2 mmol/L (elevated indicates sepsis)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Procalcitonin",
            "rationale": "Bacterial vs viral differentiation",
            "target": "Elevated (>0.5 ng/mL suggests bacterial)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "PT/INR, PTT",
            "rationale": "Pre-LP coagulation status",
            "target": "INR <1.5, PTT normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Platelet count",
            "rationale": "Pre-LP, DIC screening",
            "target": ">50,000/μL for safe LP",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Blood glucose",
            "rationale": "Compare with CSF glucose",
            "target": "Document for CSF ratio",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Urinalysis",
            "rationale": "Infection source if UTI",
            "target": "Document",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Extended Workup": [
          {
            "item": "CRP",
            "rationale": "Inflammatory marker, follow response",
            "target": "Elevated; trend with treatment",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "D-dimer, fibrinogen",
            "rationale": "DIC screening (meningococcal)",
            "target": "Normal (elevated = DIC)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Type and screen",
            "rationale": "Anticipate transfusion if DIC",
            "target": "Available",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Cortisol (random)",
            "rationale": "Adrenal insufficiency (Waterhouse-Friderichsen)",
            "target": "Normal stress response",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "HIV antibody/antigen",
            "rationale": "Immunocompromise screen",
            "target": "Document status",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "BNP/troponin",
            "rationale": "Cardiac involvement, septic cardiomyopathy",
            "target": "Normal or elevated",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "ABG or VBG",
            "rationale": "Respiratory status, acid-base",
            "target": "Normal or compensated",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Serum cryptococcal antigen",
            "rationale": "If immunocompromised",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Histoplasma/Blastomyces antigen",
            "rationale": "Endemic area, immunocompromised",
            "target": "Negative",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "Quantiferon/T-SPOT",
            "rationale": "TB risk factors",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Complement levels (C3, C4, CH50)",
            "rationale": "Recurrent Neisseria infection",
            "target": "Normal",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "Immunoglobulin levels",
            "rationale": "Recurrent infections",
            "target": "Normal",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "Opening pressure",
            "rationale": "Elevated in bacterial meningitis",
            "target": "10-20 cmH2O normal; often >30 in bacterial",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Cell count with differential (tubes 1 and 4)",
            "rationale": "Pleocytosis pattern",
            "target": "WBC >1000/μL typical; PMN predominant (>80%)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Protein",
            "rationale": "Elevated in bacterial infection",
            "target": ">100 mg/dL (often >200-500)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Glucose with serum glucose",
            "rationale": "Low in bacterial meningitis",
            "target": "<40 mg/dL or CSF:serum ratio <0.4",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Gram stain",
            "rationale": "Rapid organism identification",
            "target": "Positive in 60-90% untreated",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Bacterial culture",
            "rationale": "Definitive organism identification",
            "target": "Positive in 70-85% untreated",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "BioFire FilmArray Meningitis/Encephalitis Panel",
            "rationale": "Rapid multiplex PCR (14 pathogens)",
            "target": "Organism identification within 1 hour",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Latex agglutination (if available)",
            "rationale": "Rapid antigen detection",
            "target": "Organism-specific antigens",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "HSV PCR",
            "rationale": "Exclude HSV encephalitis",
            "target": "Negative",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Procalcitonin (CSF)",
            "rationale": "Bacterial vs aseptic",
            "target": "Elevated in bacterial",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "CT head without contrast",
            "timing": "BEFORE LP if criteria met (see below)",
            "target": "Exclude mass, herniation, hydrocephalus",
            "contraindications": "None in emergency",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Chest X-ray",
            "timing": "On admission",
            "target": "Pneumonia (source), aspiration",
            "contraindications": "None",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Extended": [
          {
            "item": "MRI brain with contrast",
            "timing": "If complications suspected",
            "target": "Abscess, ventriculitis, infarct, subdural empyema",
            "contraindications": "Hemodynamic instability",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "CT venogram",
            "timing": "If venous sinus thrombosis suspected",
            "target": "Sinus thrombosis",
            "contraindications": "Contrast allergy",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "EEG",
            "timing": "If seizures or altered mental status",
            "target": "Seizure activity, encephalopathy",
            "contraindications": "None",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Echocardiogram",
            "timing": "If endocarditis suspected",
            "target": "Vegetation",
            "contraindications": "None",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "CT/MRI spine",
            "timing": "If spinal epidural abscess suspected",
            "target": "Epidural collection",
            "contraindications": "Hemodynamic instability",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          }
        ]
      },
      "Treatment": {
        "Empiric Antibiotic Therapy": [
          {
            "item": "Ceftriaxone",
            "route": "IV",
            "indication": "Empiric coverage (all ages)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 g q12h",
                  "orderSentence": "Ceftriaxone 2 g q12h IV"
                }
              ],
              "route": "IV",
              "instructions": "2 g IV q12h; meningeal dosing required",
              "orderSentence": "Ceftriaxone 2 g q12h IV"
            },
            "contraindications": "Severe cephalosporin allergy",
            "monitoring": "Renal function",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Vancomycin",
            "route": "IV",
            "indication": "DRSP coverage (all patients)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "15-20 mg/kg q8-12h",
                  "orderSentence": "Vancomycin 15-20 mg/kg q8-12h IV"
                },
                {
                  "text": "25-30 mg/kg load",
                  "orderSentence": "Vancomycin 25-30 mg/kg load IV"
                }
              ],
              "route": "IV",
              "instructions": "Load 25-30 mg/kg IV, then 15-20 mg/kg q8-12h (target trough 15-20 mcg/mL); adjust for renal function",
              "orderSentence": "Vancomycin 15-20 mg/kg q8-12h IV"
            },
            "contraindications": "Renal impairment (adjust dose)",
            "monitoring": "Trough levels, renal function, ototoxicity",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Ampicillin",
            "route": "IV",
            "indication": "Listeria coverage (age ≥50-60, immunocompromised, alcoholism)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 g q4h",
                  "orderSentence": "Ampicillin 2 g q4h IV"
                }
              ],
              "route": "IV",
              "instructions": "2 g IV q4h; required for Listeria coverage in at-risk patients; **NOTE: guidelines vary (≥50 vs >60) - use lower threshold if any additional risk factors**",
              "orderSentence": "Ampicillin 2 g q4h IV"
            },
            "contraindications": "Penicillin allergy (use TMP-SMX)",
            "monitoring": "Renal function",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Dexamethasone",
            "route": "IV",
            "indication": "Adjunctive therapy (BEFORE/WITH antibiotics)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.15 mg/kg q6h x 4 days",
                  "orderSentence": "Dexamethasone 0.15 mg/kg q6h x 4 days IV"
                }
              ],
              "route": "IV",
              "instructions": "0.15 mg/kg IV (typically 10 mg) q6h x 4 days; give 15-20 min BEFORE or WITH first antibiotic dose; see immunocompromised guidance below",
              "orderSentence": "Dexamethasone 0.15 mg/kg q6h x 4 days IV"
            },
            "contraindications": "GI bleed (relative), see immunocompromised guidance",
            "monitoring": "Glucose, GI bleeding",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Organism-Directed Therapy (After Culture/Sensitivity)": [
          {
            "item": "Penicillin G",
            "route": "IV",
            "indication": "Penicillin-sensitive pneumococcus, meningococcus",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4 million units q4h",
                  "orderSentence": "Penicillin G 4 million units q4h IV"
                }
              ],
              "route": "IV",
              "instructions": "4 million units IV q4h; can de-escalate if susceptible",
              "orderSentence": "Penicillin G 4 million units q4h IV"
            },
            "contraindications": "Penicillin allergy",
            "monitoring": "Renal function",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Ceftriaxone (continued)",
            "route": "IV",
            "indication": "Pneumococcus (intermediate), meningococcus, H. flu",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 g q12h",
                  "orderSentence": "Ceftriaxone (continued) 2 g q12h IV"
                }
              ],
              "route": "IV",
              "instructions": "Continue 2 g IV q12h if organism susceptible",
              "orderSentence": "Ceftriaxone (continued) 2 g q12h IV"
            },
            "contraindications": "Cephalosporin allergy",
            "monitoring": "Renal function",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Ampicillin (continued)",
            "route": "IV",
            "indication": "Listeria monocytogenes",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 g q4h",
                  "orderSentence": "Ampicillin (continued) 2 g q4h IV"
                }
              ],
              "route": "IV",
              "instructions": "2 g IV q4h x 21 days for Listeria",
              "orderSentence": "Ampicillin (continued) 2 g q4h IV"
            },
            "contraindications": "Penicillin allergy",
            "monitoring": "Renal function",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "TMP-SMX",
            "route": "IV",
            "indication": "Listeria (penicillin-allergic)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg/kg TMP q6h",
                  "orderSentence": "TMP-SMX 5 mg/kg TMP q6h IV"
                }
              ],
              "route": "IV",
              "instructions": "5 mg/kg (TMP component) IV q6h; alternative for Listeria",
              "orderSentence": "TMP-SMX 5 mg/kg TMP q6h IV"
            },
            "contraindications": "Sulfa allergy, severe renal impairment",
            "monitoring": "Renal function, K+, rash",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Meropenem",
            "route": "IV",
            "indication": "Resistant GNR, penicillin allergy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 g q8h",
                  "orderSentence": "Meropenem 2 g q8h IV"
                }
              ],
              "route": "IV",
              "instructions": "2 g IV q8h; meningeal dosing",
              "orderSentence": "Meropenem 2 g q8h IV"
            },
            "contraindications": "Carbapenem allergy",
            "monitoring": "Renal function, seizures",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Dexamethasone Guidance": [
          {
            "item": "Dexamethasone (continue)",
            "route": "IV",
            "indication": "Proven pneumococcal meningitis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.15 mg/kg q6h x 4 days",
                  "orderSentence": "Dexamethasone (continue) 0.15 mg/kg q6h x 4 days IV"
                }
              ],
              "route": "IV",
              "instructions": "Continue full 4-day course if S. pneumoniae confirmed",
              "orderSentence": "Dexamethasone (continue) 0.15 mg/kg q6h x 4 days IV"
            },
            "contraindications": "See below",
            "monitoring": "Glucose, GI bleed",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Dexamethasone (discontinue)",
            "route": "—",
            "indication": "Non-pneumococcal meningitis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Dexamethasone (discontinue) N/A —"
                }
              ],
              "route": "—",
              "instructions": "DISCONTINUE dexamethasone if organism other than S. pneumoniae (benefit unproven)",
              "orderSentence": "Dexamethasone (discontinue) N/A —"
            },
            "contraindications": "—",
            "monitoring": "—",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Supportive Care": [
          {
            "item": "Normal saline",
            "route": "IV",
            "indication": "Fluid resuscitation, maintenance",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mL/kg bolus",
                  "orderSentence": "Normal saline 30 mL/kg bolus IV"
                },
                {
                  "text": "125 mL/hr maintenance",
                  "orderSentence": "Normal saline 125 mL/hr maintenance IV"
                }
              ],
              "route": "IV",
              "instructions": "30 mL/kg bolus for sepsis; avoid over-hydration (cerebral edema risk)",
              "orderSentence": "Normal saline 30 mL/kg bolus IV"
            },
            "contraindications": "Cerebral edema (restrict fluids)",
            "monitoring": "I/O, Na+, mental status",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Norepinephrine",
            "route": "IV",
            "indication": "Septic shock",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.1-0.5 mcg/kg/min",
                  "orderSentence": "Norepinephrine 0.1-0.5 mcg/kg/min IV"
                },
                {
                  "text": "2-30 mcg/min",
                  "orderSentence": "Norepinephrine 2-30 mcg/min IV"
                }
              ],
              "route": "IV",
              "instructions": "Start 2-5 mcg/min; titrate to MAP ≥65",
              "orderSentence": "Norepinephrine 0.1-0.5 mcg/kg/min IV"
            },
            "contraindications": "—",
            "monitoring": "Continuous BP, lactate",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Phenytoin",
            "route": "IV",
            "indication": "Seizure prophylaxis (if seizures occur)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg/kg load",
                  "orderSentence": "Phenytoin 20 mg/kg load IV"
                },
                {
                  "text": "100 mg q8h",
                  "orderSentence": "Phenytoin 100 mg q8h IV"
                }
              ],
              "route": "IV",
              "instructions": "20 mg/kg IV load (max rate 50 mg/min), then 100 mg IV q8h; NOT recommended routinely for prophylaxis",
              "orderSentence": "Phenytoin 20 mg/kg load IV"
            },
            "contraindications": "Bradycardia, heart block",
            "monitoring": "Cardiac monitoring during load, levels",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Levetiracetam",
            "route": "IV",
            "indication": "Seizure treatment/prophylaxis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mg BID",
                  "orderSentence": "Levetiracetam 1000 mg BID IV"
                },
                {
                  "text": "1500 mg BID",
                  "orderSentence": "Levetiracetam 1500 mg BID IV"
                }
              ],
              "route": "IV",
              "instructions": "1000-1500 mg IV BID; preferred for seizure prophylaxis if indicated",
              "orderSentence": "Levetiracetam 1000 mg BID IV"
            },
            "contraindications": "Severe renal impairment (adjust)",
            "monitoring": "Renal function",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Acetaminophen",
            "route": "IV/PO",
            "indication": "Fever, headache",
            "dosing": {
              "doseOptions": [
                {
                  "text": "650 mg q6h",
                  "orderSentence": "Acetaminophen 650 mg q6h IV/PO"
                },
                {
                  "text": "1000 mg q6h",
                  "orderSentence": "Acetaminophen 1000 mg q6h IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "650-1000 mg q6h; max 4 g/day",
              "orderSentence": "Acetaminophen 650 mg q6h IV/PO"
            },
            "contraindications": "Severe hepatic impairment",
            "monitoring": "Temperature",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Mannitol",
            "route": "IV",
            "indication": "Elevated ICP",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5-1 g/kg bolus",
                  "orderSentence": "Mannitol 0.5-1 g/kg bolus IV"
                }
              ],
              "route": "IV",
              "instructions": "0.5-1 g/kg IV bolus over 15-20 min; may repeat q6h PRN; target serum osm <320",
              "orderSentence": "Mannitol 0.5-1 g/kg bolus IV"
            },
            "contraindications": "Renal failure, hypotension",
            "monitoring": "Serum osm, Na+, renal function",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Hypertonic saline (3%)",
            "route": "IV",
            "indication": "Elevated ICP",
            "dosing": {
              "doseOptions": [
                {
                  "text": "250 mL bolus",
                  "orderSentence": "Hypertonic saline (3%) 250 mL bolus IV"
                }
              ],
              "route": "IV",
              "instructions": "250 mL (or 30 mL of 23.4%) bolus for acute herniation; target Na 145-155",
              "orderSentence": "Hypertonic saline (3%) 250 mL bolus IV"
            },
            "contraindications": "—",
            "monitoring": "Na+, serum osm",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Enoxaparin",
            "route": "SC",
            "indication": "DVT prophylaxis (after stabilization)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg daily",
                  "orderSentence": "Enoxaparin 40 mg daily SC"
                }
              ],
              "route": "SC",
              "instructions": "40 mg SC daily; start after 48-72h if no hemorrhagic complications",
              "orderSentence": "Enoxaparin 40 mg daily SC"
            },
            "contraindications": "Active bleeding, recent LP, coagulopathy",
            "monitoring": "Platelet count",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Famotidine",
            "route": "IV",
            "indication": "Stress ulcer prophylaxis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg BID",
                  "orderSentence": "Famotidine 20 mg BID IV"
                }
              ],
              "route": "IV",
              "instructions": "20 mg IV BID if on steroids or intubated",
              "orderSentence": "Famotidine 20 mg BID IV"
            },
            "contraindications": "None significant",
            "monitoring": "GI bleeding",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          }
        ],
        "Chemoprophylaxis for Close Contacts": [
          {
            "item": "Rifampin",
            "route": "PO",
            "indication": "Meningococcal prophylaxis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "600 mg BID x 2 days",
                  "orderSentence": "Rifampin 600 mg BID x 2 days PO"
                }
              ],
              "route": "PO",
              "instructions": "600 mg PO q12h x 4 doses (2 days); for household/close contacts",
              "orderSentence": "Rifampin 600 mg BID x 2 days PO"
            },
            "contraindications": "Pregnancy, liver disease",
            "monitoring": "Orange secretions warning",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "—"
          },
          {
            "item": "Ciprofloxacin",
            "route": "PO",
            "indication": "Meningococcal prophylaxis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mg single dose",
                  "orderSentence": "Ciprofloxacin 500 mg single dose PO"
                }
              ],
              "route": "PO",
              "instructions": "500 mg PO x 1 dose; alternative to rifampin",
              "orderSentence": "Ciprofloxacin 500 mg single dose PO"
            },
            "contraindications": "Pregnancy, children (relative)",
            "monitoring": "Tendon warning",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "—"
          },
          {
            "item": "Ceftriaxone",
            "route": "IM",
            "indication": "Meningococcal prophylaxis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "250 mg single dose",
                  "orderSentence": "Ceftriaxone 250 mg single dose IM"
                }
              ],
              "route": "IM",
              "instructions": "250 mg IM x 1 dose; safe in pregnancy",
              "orderSentence": "Ceftriaxone 250 mg single dose IM"
            },
            "contraindications": "Cephalosporin allergy",
            "monitoring": "None",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "—"
          },
          {
            "item": "Rifampin (H. flu)",
            "route": "PO",
            "indication": "H. influenzae prophylaxis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg/kg daily x 4 days",
                  "orderSentence": "Rifampin (H. flu) 20 mg/kg daily x 4 days PO"
                }
              ],
              "route": "PO",
              "instructions": "20 mg/kg (max 600 mg) PO daily x 4 days; for household contacts if unvaccinated child <4 yo present",
              "orderSentence": "Rifampin (H. flu) 20 mg/kg daily x 4 days PO"
            },
            "contraindications": "Pregnancy, liver disease",
            "monitoring": "Orange secretions warning",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "—"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Infectious disease consult for antibiotic optimization, duration guidance, and organism-specific management",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Neurology consult for seizure management, focal deficits evaluation, and neurological complication monitoring",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Critical care consult for ICU admission given septic shock, hemodynamic instability, or respiratory failure",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Neurosurgery consult for hydrocephalus management, abscess drainage, or elevated ICP requiring intervention",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "ENT consult for hearing evaluation as sensorineural hearing loss is a common complication of bacterial meningitis",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Audiology for formal hearing test before discharge to document baseline and detect early hearing loss",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Infection control for droplet isolation implementation and contact tracing if meningococcal disease confirmed",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Public health notification required for meningococcal disease (reportable condition) to enable contact prophylaxis",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Return immediately if worsening headache, fever, confusion, or seizures develop (may indicate treatment failure or complication)",
            "ED": "STAT",
            "HOSP": "—",
            "OPD": "STAT"
          },
          {
            "item": "Complete full antibiotic course even if feeling better to prevent relapse and resistance",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "STAT"
          },
          {
            "item": "Obtain hearing test after recovery as sensorineural hearing loss is a common complication of bacterial meningitis",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Ensure close contacts receive prophylaxis if meningococcal disease confirmed (rifampin, ciprofloxacin, or ceftriaxone)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—"
          },
          {
            "item": "Report persistent headaches, hearing changes, or cognitive difficulties as these may indicate late complications",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Maintain droplet isolation (meningococcal) until 24h of effective antibiotics to prevent transmission",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—"
          },
          {
            "item": "Meningococcal vaccination for close contacts and patient after recovery to prevent future infection",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Pneumococcal vaccination if not up to date as pneumococcus is the most common cause of bacterial meningitis",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Practice hand hygiene and respiratory etiquette to prevent transmission of respiratory pathogens",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid sharing utensils, drinks, or close contact with respiratory secretions during active infection",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Viral meningitis",
        "features": "Milder course, lymphocytic CSF, normal glucose",
        "tests": "CSF profile, viral PCR"
      },
      {
        "diagnosis": "HSV encephalitis",
        "features": "Altered mental status, temporal lobe findings, seizures",
        "tests": "MRI brain, CSF HSV PCR"
      },
      {
        "diagnosis": "Tuberculous meningitis",
        "features": "Subacute course, basilar enhancement, low glucose",
        "tests": "CSF AFB, adenosine deaminase, PCR"
      },
      {
        "diagnosis": "Fungal meningitis",
        "features": "Immunocompromised, indolent course",
        "tests": "CSF fungal culture, cryptococcal antigen"
      },
      {
        "diagnosis": "Subarachnoid hemorrhage",
        "features": "Thunderclap headache, xanthochromia",
        "tests": "CT head, LP (xanthochromia, RBCs)"
      },
      {
        "diagnosis": "Brain abscess",
        "features": "Focal deficits, ring-enhancing lesion",
        "tests": "MRI brain with contrast"
      },
      {
        "diagnosis": "Subdural empyema",
        "features": "Post-sinusitis/otitis, focal deficits",
        "tests": "MRI brain with contrast"
      },
      {
        "diagnosis": "Autoimmune encephalitis",
        "features": "Subacute, psychiatric symptoms, movement disorder",
        "tests": "Autoimmune panel (serum/CSF)"
      },
      {
        "diagnosis": "Carcinomatous meningitis",
        "features": "Cancer history, cranial neuropathies",
        "tests": "CSF cytology, MRI"
      },
      {
        "diagnosis": "Drug-induced meningitis",
        "features": "NSAIDs, IVIG, TMP-SMX exposure",
        "tests": "Temporal relationship, improvement off drug"
      },
      {
        "diagnosis": "Endocarditis with CNS embolization",
        "features": "Heart murmur, embolic phenomena",
        "tests": "Echocardiogram, blood cultures"
      },
      {
        "diagnosis": "Septic dural sinus thrombosis",
        "features": "Headache, papilledema, focal signs",
        "tests": "CT/MR venography"
      }
    ],
    "evidence": [
      {
        "recommendation": "Dexamethasone before antibiotics improves outcomes in pneumococcal meningitis",
        "evidenceLevel": "Class I, Level A",
        "source": "[de Gans et al. NEJM 2002](https://pubmed.ncbi.nlm.nih.gov/12432041/)"
      },
      {
        "recommendation": "Antibiotics within 1 hour reduce mortality",
        "evidenceLevel": "Class II, Level B",
        "source": "[Proulx et al. QJM 2005](https://pubmed.ncbi.nlm.nih.gov/15728404/)"
      },
      {
        "recommendation": "CT before LP only if criteria met",
        "evidenceLevel": "Class II, Level B",
        "source": "[Hasbun et al. NEJM 2001](https://pubmed.ncbi.nlm.nih.gov/11742046/)"
      },
      {
        "recommendation": "Vancomycin + ceftriaxone empiric for DRSP",
        "evidenceLevel": "Class II, Level B",
        "source": "[Tunkel et al. IDSA Guidelines Clin Infect Dis 2004](https://pubmed.ncbi.nlm.nih.gov/15494903/)"
      },
      {
        "recommendation": "Ampicillin for Listeria coverage in at-risk",
        "evidenceLevel": "Class II, Level B",
        "source": "[IDSA Guidelines 2004](https://pubmed.ncbi.nlm.nih.gov/15494903/)"
      },
      {
        "recommendation": "BioFire Panel for rapid diagnosis",
        "evidenceLevel": "Class II, Level B",
        "source": "[Leber et al. J Clin Microbiol 2016](https://pubmed.ncbi.nlm.nih.gov/27335149/)"
      },
      {
        "recommendation": "Rifampin or ciprofloxacin prophylaxis for meningococcal contacts",
        "evidenceLevel": "Class I, Level A",
        "source": "[CDC MMWR Recommendations](https://pubmed.ncbi.nlm.nih.gov/23486021/)"
      },
      {
        "recommendation": "Antibiotic duration by organism",
        "evidenceLevel": "Class II, Level B",
        "source": "[Tunkel et al. IDSA Guidelines](https://pubmed.ncbi.nlm.nih.gov/15494903/)"
      },
      {
        "recommendation": "Delay in antibiotics increases mortality",
        "evidenceLevel": "Class II, Level B",
        "source": "[Auburtin et al. Crit Care Med 2006](https://pubmed.ncbi.nlm.nih.gov/16940475/)"
      }
    ],
    "monitoring": [
      {
        "item": "Neurological exam (GCS)",
        "frequency": "q1-2h initially, then q4h",
        "action": "Head CT, consider ICP monitoring",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Temperature",
        "frequency": "q4h",
        "action": "Reassess antibiotic coverage",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Blood pressure",
        "frequency": "q1-4h",
        "action": "Vasopressors if septic shock",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Heart rate",
        "frequency": "Continuous",
        "action": "Evaluate for sepsis, arrhythmia",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Oxygen saturation",
        "frequency": "Continuous",
        "action": "Supplement O2, consider intubation",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Urine output",
        "frequency": "q4h",
        "action": "Fluid resuscitation",
        "ED": "—",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Serum sodium",
        "frequency": "q6-12h",
        "action": "Evaluate for SIADH, cerebral salt wasting",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Lactate",
        "frequency": "q6-12h until normal",
        "action": "Optimize resuscitation",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Vancomycin trough",
        "frequency": "Before 4th dose",
        "action": "Dose adjustment",
        "ED": "—",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Renal function",
        "frequency": "Daily",
        "action": "Adjust antibiotic doses",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Glucose",
        "frequency": "q6h if on steroids",
        "action": "Insulin",
        "ED": "—",
        "HOSP": "ROUTINE",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Hearing assessment",
        "frequency": "Before discharge",
        "action": "Audiology referral",
        "ED": "—",
        "HOSP": "ROUTINE",
        "OPD": "—",
        "ICU": "ROUTINE"
      }
    ],
    "disposition": [
      {
        "disposition": "**ICU admission**",
        "criteria": "GCS <12; hemodynamic instability (septic shock); respiratory failure; seizures; signs of elevated ICP; DIC; rapidly worsening"
      },
      {
        "disposition": "**Step-down/telemetry**",
        "criteria": "Stable but requiring close monitoring; improving mental status; weaning vasopressors"
      },
      {
        "disposition": "**General floor**",
        "criteria": "Stable; GCS 15; hemodynamically stable; no seizures; improving on antibiotics"
      },
      {
        "disposition": "**Discharge home**",
        "criteria": "NOT recommended for acute bacterial meningitis; requires IV antibiotics"
      },
      {
        "disposition": "**Transfer to higher level**",
        "criteria": "Need for neurosurgical intervention; refractory elevated ICP; ECMO candidacy"
      }
    ]
  },
  "HSV Encephalitis": {
    "id": "hsv-encephalitis",
    "title": "HSV Encephalitis",
    "version": "1.1",
    "icd10": [
      "** B00.4 (Herpesviral encephalitis)",
      "G05.1 (Encephalitis",
      "myelitis and encephalomyelitis in viral diseases classified elsewhere)"
    ],
    "scope": "** Evaluation and management of herpes simplex virus encephalitis (HSVE) in adults. Covers empiric acyclovir, diagnostic workup including CSF PCR and neuroimaging, seizure management, and ICU care. Primarily addresses HSV-1 encephalitis (most common in adults). Excludes neonatal HSV, HSV-2 meningitis (Mollaret's), and other viral encephalitides.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC with differential",
            "rationale": "Infection workup, baseline",
            "target": "May show leukocytosis",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "CMP (BMP + LFTs)",
            "rationale": "Renal function (acyclovir dosing), hepatic function",
            "target": "Normal or mildly elevated",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "BUN/Creatinine",
            "rationale": "Baseline for acyclovir dosing",
            "target": "Normal (adjust acyclovir if elevated)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Blood glucose",
            "rationale": "Compare with CSF glucose",
            "target": "Document",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "PT/INR, PTT",
            "rationale": "Pre-LP coagulation status",
            "target": "INR <1.5",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Blood cultures (2 sets)",
            "rationale": "Exclude bacterial infection",
            "target": "Negative",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Serum sodium",
            "rationale": "SIADH common in encephalitis",
            "target": "135-145 mEq/L",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "ESR, CRP",
            "rationale": "Inflammatory markers",
            "target": "May be mildly elevated",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "URGENT"
          }
        ],
        "Extended Workup": [
          {
            "item": "HIV antibody/antigen",
            "rationale": "Immunocompromised host evaluation",
            "target": "Document status",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "HSV-1/HSV-2 serology (IgG, IgM)",
            "rationale": "Not useful for acute diagnosis; documents prior exposure",
            "target": "Document (NOT diagnostic of encephalitis)",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Procalcitonin",
            "rationale": "Bacterial vs viral differentiation",
            "target": "Low (<0.5) in viral",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "TSH",
            "rationale": "Altered mental status workup",
            "target": "Normal",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Ammonia",
            "rationale": "Altered mental status workup",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "B12",
            "rationale": "Encephalopathy workup",
            "target": "Normal",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Urine drug screen",
            "rationale": "Altered mental status differential",
            "target": "Document",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Troponin",
            "rationale": "Stress cardiomyopathy",
            "target": "Normal or mildly elevated",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Serum autoimmune encephalitis panel",
            "rationale": "Post-HSV autoimmune encephalitis",
            "target": "Negative initially (may become positive later)",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "VZV serology",
            "rationale": "VZV encephalitis differential",
            "target": "Document",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "EBV serology",
            "rationale": "EBV encephalitis differential",
            "target": "Document",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "CMV PCR",
            "rationale": "Immunocompromised patients",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Serum West Nile IgM",
            "rationale": "Endemic area, summer months",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "Opening pressure",
            "rationale": "May be elevated in encephalitis",
            "target": "10-20 cmH2O normal; often elevated",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Cell count with differential (tubes 1 and 4)",
            "rationale": "Lymphocytic pleocytosis",
            "target": "10-500 WBC/μL; lymphocyte predominant; RBCs may be present",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Protein",
            "rationale": "Elevated in encephalitis",
            "target": "60-100 mg/dL (mildly elevated)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Glucose",
            "rationale": "Usually normal in viral encephalitis",
            "target": "Normal (>40 mg/dL)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "**HSV PCR (CSF)**",
            "rationale": "**Definitive diagnosis**",
            "target": "**Positive (sensitivity 96%, specificity >99%)**",
            "ED": "**STAT**",
            "HOSP": "**STAT**",
            "OPD": "—",
            "ICU": "**STAT**"
          },
          {
            "item": "HSV-1 and HSV-2 specific PCR",
            "rationale": "Distinguish HSV-1 vs HSV-2",
            "target": "Document which type",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "VZV PCR",
            "rationale": "VZV encephalitis differential",
            "target": "Negative",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Enterovirus PCR",
            "rationale": "Viral encephalitis differential",
            "target": "Negative",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "BioFire FilmArray ME Panel",
            "rationale": "Rapid multiplex PCR",
            "target": "HSV and other pathogens",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Gram stain and bacterial culture",
            "rationale": "Exclude bacterial meningitis",
            "target": "Negative",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Cytology",
            "rationale": "If malignancy suspected",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Autoimmune encephalitis panel (CSF)",
            "rationale": "Post-HSV autoimmune encephalitis",
            "target": "Negative initially",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "MRI brain with and without contrast",
            "timing": "STAT (within 24h)",
            "target": "Temporal lobe T2/FLAIR hyperintensity, hemorrhage, edema",
            "contraindications": "Hemodynamic instability (get CT first)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "CT head without contrast",
            "timing": "If MRI delayed or unavailable",
            "target": "Temporal lobe hypodensity, hemorrhage, edema (less sensitive than MRI)",
            "contraindications": "None in emergency",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "EEG",
            "timing": "If seizures or altered mental status",
            "target": "Periodic lateralized epileptiform discharges (PLEDs), temporal slowing",
            "contraindications": "None",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Extended": [
          {
            "item": "MRI brain (repeat)",
            "timing": "Day 3-7 if initial negative",
            "target": "Evolution of findings",
            "contraindications": "Hemodynamic instability",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Continuous EEG (cEEG)",
            "timing": "If seizures, persistent AMS",
            "target": "Nonconvulsive seizures, PLEDs",
            "contraindications": "None",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "CT angiogram",
            "timing": "If vasculitis suspected",
            "target": "Normal (or vasculitic changes)",
            "contraindications": "Contrast allergy",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Brain biopsy",
            "timing": "Refractory to treatment, diagnostic uncertainty",
            "target": "HSV inclusions (Cowdry type A)",
            "contraindications": "Coagulopathy",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "PET scan",
            "timing": "If autoimmune encephalitis suspected post-HSV",
            "target": "Temporal hypermetabolism",
            "contraindications": "Hemodynamic instability",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          }
        ]
      },
      "Treatment": {
        "Antiviral Therapy": [
          {
            "item": "Acyclovir",
            "route": "IV",
            "indication": "Empiric and definitive treatment",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg/kg q8h",
                  "orderSentence": "Acyclovir 10 mg/kg q8h IV"
                }
              ],
              "route": "IV",
              "instructions": "10 mg/kg IV q8h (infuse over 1 hour); adjust for renal function; minimum 14 days, extend to 21 days if severe or immunocompromised",
              "orderSentence": "Acyclovir 10 mg/kg q8h IV"
            },
            "contraindications": "Severe renal impairment (adjust dose)",
            "monitoring": "Renal function daily, hydration status, neurotoxicity",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Acyclovir (renal adjustment)",
            "route": "IV",
            "indication": "CrCl 25-50 mL/min",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg/kg q12h",
                  "orderSentence": "Acyclovir (renal adjustment) 10 mg/kg q12h IV"
                }
              ],
              "route": "IV",
              "instructions": "10 mg/kg IV q12h if CrCl 25-50 mL/min",
              "orderSentence": "Acyclovir (renal adjustment) 10 mg/kg q12h IV"
            },
            "contraindications": "—",
            "monitoring": "Cr daily",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Acyclovir (renal adjustment)",
            "route": "IV",
            "indication": "CrCl 10-25 mL/min",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg/kg q24h",
                  "orderSentence": "Acyclovir (renal adjustment) 10 mg/kg q24h IV"
                }
              ],
              "route": "IV",
              "instructions": "10 mg/kg IV q24h if CrCl 10-25 mL/min",
              "orderSentence": "Acyclovir (renal adjustment) 10 mg/kg q24h IV"
            },
            "contraindications": "—",
            "monitoring": "Cr daily",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Acyclovir (HD)",
            "route": "IV",
            "indication": "Hemodialysis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg/kg post-HD",
                  "orderSentence": "Acyclovir (HD) 10 mg/kg post-HD IV"
                }
              ],
              "route": "IV",
              "instructions": "10 mg/kg IV after each hemodialysis session",
              "orderSentence": "Acyclovir (HD) 10 mg/kg post-HD IV"
            },
            "contraindications": "—",
            "monitoring": "Post-HD levels",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Empiric Bacterial Coverage (Until Bacterial Ruled Out)": [
          {
            "item": "Ceftriaxone",
            "route": "IV",
            "indication": "Empiric bacterial coverage",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 g q12h",
                  "orderSentence": "Ceftriaxone 2 g q12h IV"
                }
              ],
              "route": "IV",
              "instructions": "2 g IV q12h until bacterial meningitis ruled out",
              "orderSentence": "Ceftriaxone 2 g q12h IV"
            },
            "contraindications": "Cephalosporin allergy",
            "monitoring": "Renal function",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Vancomycin",
            "route": "IV",
            "indication": "Empiric DRSP coverage",
            "dosing": {
              "doseOptions": [
                {
                  "text": "15-20 mg/kg q8-12h",
                  "orderSentence": "Vancomycin 15-20 mg/kg q8-12h IV"
                }
              ],
              "route": "IV",
              "instructions": "15-20 mg/kg IV q8-12h until bacterial ruled out",
              "orderSentence": "Vancomycin 15-20 mg/kg q8-12h IV"
            },
            "contraindications": "Renal impairment (adjust)",
            "monitoring": "Trough 15-20, renal function",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Dexamethasone",
            "route": "IV",
            "indication": "If bacterial meningitis possible",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.15 mg/kg q6h",
                  "orderSentence": "Dexamethasone 0.15 mg/kg q6h IV"
                }
              ],
              "route": "IV",
              "instructions": "0.15 mg/kg IV q6h ONLY if bacterial meningitis not ruled out; discontinue if HSV confirmed",
              "orderSentence": "Dexamethasone 0.15 mg/kg q6h IV"
            },
            "contraindications": "—",
            "monitoring": "Glucose",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Seizure Management": [
          {
            "item": "Levetiracetam",
            "route": "IV/PO",
            "indication": "Seizure treatment/prophylaxis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mg BID",
                  "orderSentence": "Levetiracetam 1000 mg BID IV/PO"
                },
                {
                  "text": "1500 mg BID",
                  "orderSentence": "Levetiracetam 1500 mg BID IV/PO"
                },
                {
                  "text": "2000 mg BID",
                  "orderSentence": "Levetiracetam 2000 mg BID IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "Load 1000-2000 mg IV, then 1000-1500 mg BID; preferred first-line",
              "orderSentence": "Levetiracetam 1000 mg BID IV/PO"
            },
            "contraindications": "Severe renal impairment (adjust)",
            "monitoring": "Seizure frequency, behavior",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Phenytoin",
            "route": "IV",
            "indication": "Alternative for seizures",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg/kg load",
                  "orderSentence": "Phenytoin 20 mg/kg load IV"
                },
                {
                  "text": "100 mg TID",
                  "orderSentence": "Phenytoin 100 mg TID IV"
                }
              ],
              "route": "IV",
              "instructions": "20 mg/kg IV load (max 50 mg/min), then 100 mg q8h or 300 mg daily; target level 10-20",
              "orderSentence": "Phenytoin 20 mg/kg load IV"
            },
            "contraindications": "Bradycardia, AV block",
            "monitoring": "Cardiac monitor during load, levels",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Lacosamide",
            "route": "IV/PO",
            "indication": "Alternative/adjunctive",
            "dosing": {
              "doseOptions": [
                {
                  "text": "200 mg BID",
                  "orderSentence": "Lacosamide 200 mg BID IV/PO"
                },
                {
                  "text": "300 mg BID",
                  "orderSentence": "Lacosamide 300 mg BID IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "Load 200-400 mg IV, then 200-300 mg BID",
              "orderSentence": "Lacosamide 200 mg BID IV/PO"
            },
            "contraindications": "PR prolongation, severe cardiac disease",
            "monitoring": "ECG, PR interval",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Lorazepam",
            "route": "IV",
            "indication": "Acute seizure termination",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 mg",
                  "orderSentence": "Lorazepam 2 mg IV"
                },
                {
                  "text": "4 mg",
                  "orderSentence": "Lorazepam 4 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "0.1 mg/kg IV (max 4 mg); may repeat x1 in 5 min",
              "orderSentence": "Lorazepam 2 mg IV"
            },
            "contraindications": "Respiratory depression",
            "monitoring": "RR, O2 sat",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Cerebral Edema / Elevated ICP Management": [
          {
            "item": "Mannitol",
            "route": "IV",
            "indication": "Elevated ICP",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5-1 g/kg bolus",
                  "orderSentence": "Mannitol 0.5-1 g/kg bolus IV"
                }
              ],
              "route": "IV",
              "instructions": "0.5-1 g/kg IV bolus over 15-20 min; may repeat q6h PRN; target serum osm <320",
              "orderSentence": "Mannitol 0.5-1 g/kg bolus IV"
            },
            "contraindications": "Renal failure, hypotension",
            "monitoring": "Serum osm, Na+, renal function",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Hypertonic saline (3%)",
            "route": "IV",
            "indication": "Elevated ICP",
            "dosing": {
              "doseOptions": [
                {
                  "text": "250 mL bolus",
                  "orderSentence": "Hypertonic saline (3%) 250 mL bolus IV"
                }
              ],
              "route": "IV",
              "instructions": "250 mL IV bolus for acute herniation; target Na 145-155",
              "orderSentence": "Hypertonic saline (3%) 250 mL bolus IV"
            },
            "contraindications": "—",
            "monitoring": "Na+, serum osm",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Head of bed elevation",
            "route": "—",
            "indication": "ICP management",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Head of bed elevation N/A —"
                }
              ],
              "route": "—",
              "instructions": "Elevate HOB 30-45 degrees",
              "orderSentence": "Head of bed elevation N/A —"
            },
            "contraindications": "—",
            "monitoring": "ICP (if monitored)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Decompressive craniectomy",
            "route": "—",
            "indication": "Refractory elevated ICP",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Decompressive craniectomy N/A —"
                }
              ],
              "route": "—",
              "instructions": "Consider for malignant cerebral edema with impending herniation",
              "orderSentence": "Decompressive craniectomy N/A —"
            },
            "contraindications": "Multifocal disease, poor prognosis",
            "monitoring": "Neurosurgery consult",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          }
        ],
        "Supportive Care": [
          {
            "item": "IV fluids (isotonic)",
            "route": "IV",
            "indication": "Hydration (prevent acyclovir nephrotoxicity)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "NS 100-150 mL/hr",
                  "orderSentence": "IV fluids (isotonic) NS 100-150 mL/hr IV"
                }
              ],
              "route": "IV",
              "instructions": "Maintain euvolemia; avoid dehydration (acyclovir crystallizes in renal tubules)",
              "orderSentence": "IV fluids (isotonic) NS 100-150 mL/hr IV"
            },
            "contraindications": "Cerebral edema (may need to restrict)",
            "monitoring": "I/O, renal function, Na+",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Acetaminophen",
            "route": "IV/PO",
            "indication": "Fever, headache",
            "dosing": {
              "doseOptions": [
                {
                  "text": "650 mg q6h",
                  "orderSentence": "Acetaminophen 650 mg q6h IV/PO"
                },
                {
                  "text": "1000 mg q6h",
                  "orderSentence": "Acetaminophen 1000 mg q6h IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "650-1000 mg q6h; max 4 g/day",
              "orderSentence": "Acetaminophen 650 mg q6h IV/PO"
            },
            "contraindications": "Severe hepatic impairment",
            "monitoring": "Temperature",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Ondansetron",
            "route": "IV/PO",
            "indication": "Nausea",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4 mg q6h PRN",
                  "orderSentence": "Ondansetron 4 mg q6h PRN IV/PO"
                },
                {
                  "text": "8 mg q8h PRN",
                  "orderSentence": "Ondansetron 8 mg q8h PRN IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "4-8 mg IV/PO q6-8h PRN",
              "orderSentence": "Ondansetron 4 mg q6h PRN IV/PO"
            },
            "contraindications": "QT prolongation",
            "monitoring": "QTc if repeated dosing",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Enoxaparin",
            "route": "SC",
            "indication": "DVT prophylaxis (after stabilization)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg daily",
                  "orderSentence": "Enoxaparin 40 mg daily SC"
                }
              ],
              "route": "SC",
              "instructions": "40 mg SC daily; start after 48-72h if no hemorrhage",
              "orderSentence": "Enoxaparin 40 mg daily SC"
            },
            "contraindications": "Active bleeding, recent hemorrhagic transformation",
            "monitoring": "Platelet count, bleeding",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Famotidine",
            "route": "IV/PO",
            "indication": "Stress ulcer prophylaxis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg BID",
                  "orderSentence": "Famotidine 20 mg BID IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "20 mg IV/PO BID",
              "orderSentence": "Famotidine 20 mg BID IV/PO"
            },
            "contraindications": "None significant",
            "monitoring": "GI bleeding",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          }
        ],
        "Post-HSV Autoimmune Encephalitis": [
          {
            "item": "Methylprednisolone",
            "route": "IV",
            "indication": "Post-HSV autoimmune encephalitis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mg daily x 5 days",
                  "orderSentence": "Methylprednisolone 1000 mg daily x 5 days IV"
                }
              ],
              "route": "IV",
              "instructions": "1000 mg IV daily x 5 days; for secondary deterioration 2-6 weeks post-HSVE",
              "orderSentence": "Methylprednisolone 1000 mg daily x 5 days IV"
            },
            "contraindications": "Active untreated infection",
            "monitoring": "Glucose, BP, psychiatric symptoms",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "IVIg",
            "route": "IV",
            "indication": "Post-HSV autoimmune encephalitis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.4 g/kg/day x 5 days",
                  "orderSentence": "IVIg 0.4 g/kg/day x 5 days IV"
                }
              ],
              "route": "IV",
              "instructions": "0.4 g/kg/day IV x 5 days",
              "orderSentence": "IVIg 0.4 g/kg/day x 5 days IV"
            },
            "contraindications": "IgA deficiency",
            "monitoring": "Renal function, infusion reactions",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurology consult for diagnosis confirmation, antiviral guidance, and seizure management",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Infectious disease consult for atypical course, treatment failure, or diagnostic uncertainty",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Critical care consult for ICU admission given altered mental status, respiratory failure, or elevated ICP",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Neurosurgery consult for elevated ICP management, decompressive surgery, or brain biopsy consideration",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Epilepsy consult for refractory seizures and continuous EEG monitoring interpretation",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Physical therapy for mobility assessment and fall prevention given weakness and cognitive impairment",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Occupational therapy for ADL assessment and early cognitive rehabilitation planning",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Speech therapy for swallow evaluation given aspiration risk and aphasia therapy for temporal lobe involvement",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Neuropsychology for formal cognitive assessment after acute illness to guide rehabilitation",
            "ED": "—",
            "HOSP": "—",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Social work for discharge planning and caregiver support given potential for significant disability",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Return immediately if worsening headache, confusion, or seizures develop (may indicate relapse or post-HSV autoimmune encephalitis)",
            "ED": "STAT",
            "HOSP": "—",
            "OPD": "STAT"
          },
          {
            "item": "Complete full 14-21 day acyclovir course to ensure viral eradication and prevent relapse",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "STAT"
          },
          {
            "item": "Follow seizure precautions including no driving, heights, or operating machinery due to high seizure risk",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "STAT"
          },
          {
            "item": "Report any new neurological symptoms weeks after discharge as post-HSV autoimmune encephalitis can occur 2-6 weeks later",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Attend neurology follow-up in 2-4 weeks to assess recovery and screen for delayed complications",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Expect that cognitive rehabilitation may be needed as memory and behavioral deficits are common after HSVE",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Contact Encephalitis Society (www.encephalitis.info) for patient support and educational resources",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Use fall precautions including walker and supervision due to weakness and cognitive impairment",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "STAT"
          },
          {
            "item": "Aspiration precautions including thickened liquids and upright positioning if bulbar involvement present",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—"
          },
          {
            "item": "Maintain adequate hydration (2-3 L/day) to prevent acyclovir-induced nephrotoxicity",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—"
          },
          {
            "item": "Follow seizure safety including no swimming alone and showers instead of baths due to ongoing seizure risk",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Use cognitive pacing with scheduled rest periods to manage post-encephalitis fatigue",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Do not drive until cleared by neurology due to seizure risk and potential cognitive impairment",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "STAT"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Autoimmune encephalitis",
        "features": "Subacute, psychiatric symptoms, movement disorder, may have tumor",
        "tests": "CSF autoimmune panel, serum panel, CT body"
      },
      {
        "diagnosis": "Bacterial meningitis/abscess",
        "features": "More toxic, CSF with PMNs, low glucose",
        "tests": "CSF Gram stain/culture, MRI"
      },
      {
        "diagnosis": "Other viral encephalitis",
        "features": "Geographic/seasonal clues, different MRI pattern",
        "tests": "CSF viral PCR panel, serology"
      },
      {
        "diagnosis": "Tuberculous meningitis",
        "features": "Subacute, basilar meningitis, low glucose",
        "tests": "CSF AFB, TB PCR, adenosine deaminase"
      },
      {
        "diagnosis": "Fungal meningitis",
        "features": "Immunocompromised, indolent course",
        "tests": "CSF fungal culture, cryptococcal antigen"
      },
      {
        "diagnosis": "Primary CNS lymphoma",
        "features": "Immunocompromised, periventricular lesions",
        "tests": "MRI pattern, CSF cytology"
      },
      {
        "diagnosis": "Glioblastoma",
        "features": "Focal deficits, ring-enhancing mass",
        "tests": "MRI with contrast, biopsy"
      },
      {
        "diagnosis": "Cerebral vasculitis",
        "features": "Multifocal strokes, systemic symptoms",
        "tests": "Angiography, vessel wall MRI, biopsy"
      },
      {
        "diagnosis": "Acute disseminated encephalomyelitis (ADEM)",
        "features": "Post-infectious, multifocal white matter",
        "tests": "MRI pattern (multifocal), CSF"
      },
      {
        "diagnosis": "Posterior reversible encephalopathy (PRES)",
        "features": "Hypertension, posterior predominance",
        "tests": "MRI pattern, BP history"
      },
      {
        "diagnosis": "Status epilepticus",
        "features": "Seizure history, EEG pattern",
        "tests": "EEG, response to antiseizure meds"
      },
      {
        "diagnosis": "Toxic/metabolic encephalopathy",
        "features": "Drug exposure, organ failure",
        "tests": "Toxicology, metabolic panel"
      },
      {
        "diagnosis": "Paraneoplastic encephalitis",
        "features": "Cancer history, antibody-positive",
        "tests": "Paraneoplastic panel, CT body"
      },
      {
        "diagnosis": "Creutzfeldt-Jakob disease",
        "features": "Rapid dementia, myoclonus, DWI restriction",
        "tests": "MRI pattern, 14-3-3, RT-QuIC"
      }
    ],
    "evidence": [
      {
        "recommendation": "Acyclovir 10 mg/kg q8h for HSVE",
        "evidenceLevel": "Class I, Level A",
        "source": "[Whitley et al. NEJM 1986](https://pubmed.ncbi.nlm.nih.gov/3001520/)"
      },
      {
        "recommendation": "CSF HSV PCR for diagnosis",
        "evidenceLevel": "Class I, Level A",
        "source": "[Lakeman & Whitley. J Infect Dis 1995](https://pubmed.ncbi.nlm.nih.gov/7706801/)"
      },
      {
        "recommendation": "Early acyclovir improves outcomes",
        "evidenceLevel": "Class II, Level B",
        "source": "[Raschilas et al. Clin Infect Dis 2002](https://pubmed.ncbi.nlm.nih.gov/12115091/)"
      },
      {
        "recommendation": "MRI superior to CT for HSVE",
        "evidenceLevel": "Class II, Level B",
        "source": "[Domingues et al. J Neurol Sci 1997](https://pubmed.ncbi.nlm.nih.gov/9285472/)"
      },
      {
        "recommendation": "14-21 day treatment duration",
        "evidenceLevel": "Class II, Level B",
        "source": "[Gnann & Whitley. Clin Infect Dis 2002](https://pubmed.ncbi.nlm.nih.gov/12353702/)"
      },
      {
        "recommendation": "Repeat CSF PCR if clinical concern",
        "evidenceLevel": "Class III, Level C",
        "source": "[Tyler. NEJM 2004](https://pubmed.ncbi.nlm.nih.gov/15295046/)"
      },
      {
        "recommendation": "Post-HSV autoimmune encephalitis",
        "evidenceLevel": "Class II, Level B",
        "source": "[Armangue et al. Lancet Neurol 2018](https://pubmed.ncbi.nlm.nih.gov/30049614/)"
      },
      {
        "recommendation": "Seizure prophylaxis consideration",
        "evidenceLevel": "Class III, Level C",
        "source": "[Misra et al. Seizure 2008](https://pubmed.ncbi.nlm.nih.gov/17851101/)"
      },
      {
        "recommendation": "Prognosis with early treatment",
        "evidenceLevel": "Class II, Level B",
        "source": "[Skoldenberg et al. Lancet 1984](https://pubmed.ncbi.nlm.nih.gov/6147584/)"
      }
    ],
    "monitoring": [
      {
        "item": "Neurological exam (GCS, pupils)",
        "frequency": "q1-2h initially, then q4h",
        "action": "Head CT, consider ICP monitoring",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Seizure activity",
        "frequency": "Continuous if cEEG, otherwise q4h assessment",
        "action": "Escalate antiepileptic therapy",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Temperature",
        "frequency": "q4h",
        "action": "Antipyretics, infection workup",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Renal function (Cr, BUN)",
        "frequency": "Daily",
        "action": "Adjust acyclovir dose, increase hydration",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Serum sodium",
        "frequency": "q6-12h initially",
        "action": "Evaluate for SIADH, cerebral salt wasting",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Fluid balance (I/O)",
        "frequency": "q8h",
        "action": "Adjust fluids",
        "ED": "—",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Mental status",
        "frequency": "q4-8h",
        "action": "Re-evaluate, repeat imaging",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Signs of herniation",
        "frequency": "q1-2h if concern",
        "action": "Emergent intervention, neurosurgery",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "CSF HSV PCR (repeat)",
        "frequency": "Day 14-21",
        "action": "Extend acyclovir if still positive",
        "ED": "—",
        "HOSP": "ROUTINE",
        "OPD": "—",
        "ICU": "ROUTINE"
      }
    ],
    "disposition": [
      {
        "disposition": "**ICU admission**",
        "criteria": "GCS <12; seizures; signs of elevated ICP; need for intubation; hemodynamic instability; rapidly worsening"
      },
      {
        "disposition": "**Step-down/telemetry**",
        "criteria": "GCS 12-14; stable on antiepileptics; no ICP concerns; improving"
      },
      {
        "disposition": "**General floor**",
        "criteria": "GCS 15; stable neurologically; no seizures; tolerating PO; can complete IV acyclovir"
      },
      {
        "disposition": "**Discharge home**",
        "criteria": "Completed 14-21 days IV acyclovir; neurologically stable; safe swallow; adequate support; outpatient follow-up arranged"
      },
      {
        "disposition": "**Acute rehabilitation**",
        "criteria": "Significant residual cognitive or motor deficits; requires intensive therapy"
      },
      {
        "disposition": "**Long-term care**",
        "criteria": "Severe persistent deficits; unable to live independently"
      }
    ]
  },
  "Autoimmune Encephalitis": {
    "id": "autoimmune-encephalitis",
    "title": "Autoimmune Encephalitis",
    "version": "1.0",
    "icd10": [
      "** G04.81 (Other encephalitis and encephalomyelitis",
      "autoimmune)",
      "G04.90 (Encephalitis and encephalomyelitis",
      "unspecified)",
      "G13.1 (Other systemic atrophy primarily affecting CNS in neoplastic disease)"
    ],
    "scope": "** Evaluation and management of autoimmune encephalitis in adults, including antibody-mediated (anti-NMDAR, LGI1, CASPR2, GABA-B, AMPA, etc.) and paraneoplastic encephalitis. Covers diagnostic workup, tumor screening, first-line and second-line immunotherapy, and long-term management. Excludes infectious encephalitis, Hashimoto's encephalopathy (SREAT), and pediatric-specific presentations.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC with differential",
            "rationale": "Infection screen, baseline",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "CMP (BMP + LFTs)",
            "rationale": "Electrolytes (hyponatremia in LGI1), renal/hepatic function",
            "target": "Na+ <135 suggests LGI1; otherwise normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "TSH",
            "rationale": "Hashimoto's encephalopathy differential",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Blood glucose",
            "rationale": "Metabolic encephalopathy screen",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "ESR, CRP",
            "rationale": "Inflammatory markers",
            "target": "Usually normal or mildly elevated",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "PT/INR, PTT",
            "rationale": "Pre-LP",
            "target": "INR <1.5",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "HIV antibody/antigen",
            "rationale": "Immunocompromise screen",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "RPR/VDRL",
            "rationale": "Neurosyphilis differential",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Urinalysis, urine drug screen",
            "rationale": "Alternative diagnoses",
            "target": "Negative",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Ammonia",
            "rationale": "Metabolic encephalopathy",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "B12, folate",
            "rationale": "Metabolic causes of encephalopathy",
            "target": "Normal",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          }
        ],
        "Extended Workup": [
          {
            "item": "**Autoimmune encephalitis panel (serum)**",
            "rationale": "Antibody identification",
            "target": "Identify specific antibody (NMDAR, LGI1, CASPR2, GABA-B, AMPA, GAD65, others)",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "**Paraneoplastic panel (serum)**",
            "rationale": "Tumor-associated antibodies",
            "target": "Identify Hu, Yo, Ri, Ma2/Ta, CV2, amphiphysin",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "TPO antibodies",
            "rationale": "Hashimoto's encephalopathy",
            "target": "Document if elevated",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Anti-thyroglobulin antibodies",
            "rationale": "Hashimoto's encephalopathy",
            "target": "Document if elevated",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "ANA, dsDNA",
            "rationale": "Autoimmune disease screen",
            "target": "Usually negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "ANCA",
            "rationale": "Vasculitis screen",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Tumor markers (CEA, AFP, CA-125, CA 19-9, beta-hCG, PSA)",
            "rationale": "Occult malignancy",
            "target": "Normal",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Serum protein electrophoresis",
            "rationale": "Paraproteinemia",
            "target": "Normal",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Quantitative immunoglobulins",
            "rationale": "Pre-IVIg, immunodeficiency",
            "target": "IgA >7 mg/dL",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Hepatitis B surface antigen",
            "rationale": "Pre-rituximab screening",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Cell-based assay for neuronal antibodies",
            "rationale": "More sensitive than commercial panels",
            "target": "Antibody confirmation",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "VGCC antibodies (P/Q and N-type)",
            "rationale": "LEMS, cerebellar degeneration",
            "target": "Negative unless paraneoplastic",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "SOX1 antibody",
            "rationale": "SCLC-associated",
            "target": "Document",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "DPPX antibody",
            "rationale": "GI symptoms + encephalopathy",
            "target": "Document",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "Neurexin-3 antibody",
            "rationale": "Encephalitis, seizures",
            "target": "Document",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "IgLON5 antibody",
            "rationale": "Sleep disorder, brainstem dysfunction",
            "target": "Document",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "Mitochondrial DNA testing",
            "rationale": "Mitochondrial encephalopathy",
            "target": "Normal",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "Opening pressure",
            "rationale": "Usually normal",
            "target": "10-20 cmH2O",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Cell count with differential",
            "rationale": "Lymphocytic pleocytosis",
            "target": "WBC 10-100 (lymphocyte predominant); may be normal",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Protein",
            "rationale": "Often mildly elevated",
            "target": "45-100 mg/dL; may be normal",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Glucose",
            "rationale": "Usually normal",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "**Autoimmune encephalitis panel (CSF)**",
            "rationale": "**Critical for diagnosis**",
            "target": "**Identify neuronal antibodies; CSF more sensitive than serum for some (NMDAR)**",
            "ED": "**STAT**",
            "HOSP": "**STAT**",
            "OPD": "—",
            "ICU": "**STAT**"
          },
          {
            "item": "Oligoclonal bands",
            "rationale": "Intrathecal synthesis",
            "target": "May be positive",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "IgG index",
            "rationale": "Intrathecal synthesis",
            "target": "May be elevated",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "HSV PCR",
            "rationale": "Exclude HSV encephalitis",
            "target": "Negative (but post-HSV autoimmune is possible)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "VZV PCR",
            "rationale": "Exclude VZV encephalitis",
            "target": "Negative",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Bacterial culture, Gram stain",
            "rationale": "Exclude bacterial infection",
            "target": "Negative",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Cytology",
            "rationale": "Carcinomatous meningitis",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "BioFire ME Panel",
            "rationale": "Exclude infectious causes",
            "target": "Negative",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "MRI brain with and without contrast",
            "timing": "STAT",
            "target": "Medial temporal T2/FLAIR hyperintensity (limbic); may be normal in 50%",
            "contraindications": "Hemodynamic instability, pacemaker",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "EEG (routine or continuous)",
            "timing": "STAT if seizures or AMS",
            "target": "Extreme delta brush (NMDAR), temporal slowing, seizures",
            "contraindications": "None",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "CT chest/abdomen/pelvis with contrast",
            "timing": "Tumor search",
            "target": "Occult malignancy (lung, ovary, testes, thymus)",
            "contraindications": "Contrast allergy, renal impairment",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          }
        ],
        "Extended": [
          {
            "item": "Pelvic ultrasound (women)",
            "timing": "If anti-NMDAR positive",
            "target": "Ovarian teratoma",
            "contraindications": "None",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "MRI pelvis with contrast",
            "timing": "If US equivocal",
            "target": "Ovarian teratoma",
            "contraindications": "Pacemaker",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Testicular ultrasound (men <50)",
            "timing": "If anti-Ma2 or clinical concern",
            "target": "Testicular tumor",
            "contraindications": "None",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "CT or PET-CT chest",
            "timing": "Thymoma, lung cancer",
            "target": "Tumor identification",
            "contraindications": "Contrast allergy",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Whole body PET-CT",
            "timing": "Occult malignancy search",
            "target": "Any FDG-avid tumor",
            "contraindications": "Hemodynamic instability",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Mammogram",
            "timing": "Breast cancer screening",
            "target": "Normal",
            "contraindications": "None",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Continuous EEG (cEEG)",
            "timing": "Refractory cases, coma",
            "target": "Nonconvulsive seizures",
            "contraindications": "None",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Brain biopsy",
            "timing": "Diagnostic uncertainty, refractory",
            "target": "Inflammatory infiltrate",
            "contraindications": "Coagulopathy",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "FDG-PET brain",
            "timing": "Clarify extent of involvement",
            "target": "Temporal hypermetabolism",
            "contraindications": "Hemodynamic instability",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "Repeat whole body imaging",
            "timing": "If initial negative, strong suspicion",
            "target": "Occult tumor",
            "contraindications": "—",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          }
        ]
      },
      "Treatment": {
        "First-Line Immunotherapy": [
          {
            "item": "Methylprednisolone",
            "route": "IV",
            "indication": "First-line immunotherapy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mg daily x 5 days",
                  "orderSentence": "Methylprednisolone 1000 mg daily x 5 days IV"
                }
              ],
              "route": "IV",
              "instructions": "1000 mg IV daily x 3-5 days; infuse over 1 hour",
              "orderSentence": "Methylprednisolone 1000 mg daily x 5 days IV"
            },
            "contraindications": "Active untreated infection, uncontrolled diabetes (relative)",
            "monitoring": "Glucose, BP, psychiatric symptoms, GI bleeding",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "IVIg (immune globulin IV)",
            "route": "IV",
            "indication": "First-line immunotherapy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.4 g/kg/day x 5 days",
                  "orderSentence": "IVIg (immune globulin IV) 0.4 g/kg/day x 5 days IV"
                }
              ],
              "route": "IV",
              "instructions": "0.4 g/kg/day IV for 5 days (total 2 g/kg); start slow day 1",
              "orderSentence": "IVIg (immune globulin IV) 0.4 g/kg/day x 5 days IV"
            },
            "contraindications": "IgA deficiency with anti-IgA antibodies; severe renal impairment",
            "monitoring": "Renal function, headache, infusion reactions",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Plasmapheresis (PLEX)",
            "route": "—",
            "indication": "First-line immunotherapy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5-7 exchanges over 10-14 days",
                  "orderSentence": "Plasmapheresis (PLEX) 5-7 exchanges over 10-14 days —"
                }
              ],
              "route": "—",
              "instructions": "5-7 exchanges over 10-14 days; 1-1.5 plasma volumes per exchange",
              "orderSentence": "Plasmapheresis (PLEX) 5-7 exchanges over 10-14 days —"
            },
            "contraindications": "Hemodynamic instability, severe sepsis",
            "monitoring": "BP, electrolytes, coagulation, fibrinogen",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Second-Line Immunotherapy (If First-Line Fails)": [
          {
            "item": "Rituximab",
            "route": "IV",
            "indication": "First-line failure, anti-NMDAR",
            "dosing": {
              "doseOptions": [
                {
                  "text": "375 mg/m² weekly x 4 weeks",
                  "orderSentence": "Rituximab 375 mg/m² weekly x 4 weeks IV"
                },
                {
                  "text": "1000 mg x 2 doses",
                  "orderSentence": "Rituximab 1000 mg x 2 doses IV"
                }
              ],
              "route": "IV",
              "instructions": "375 mg/m² IV weekly x 4 OR 1000 mg IV x 2 doses (2 weeks apart); pre-medicate",
              "orderSentence": "Rituximab 375 mg/m² weekly x 4 weeks IV"
            },
            "contraindications": "Active infection, HBV (screen), live vaccines",
            "monitoring": "Infusion reactions, B-cell counts, immunoglobulins",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Cyclophosphamide",
            "route": "IV",
            "indication": "First-line failure, paraneoplastic",
            "dosing": {
              "doseOptions": [
                {
                  "text": "750 mg/m² monthly x 6",
                  "orderSentence": "Cyclophosphamide 750 mg/m² monthly x 6 IV"
                }
              ],
              "route": "IV",
              "instructions": "750 mg/m² IV monthly x 6 cycles; with mesna for bladder protection",
              "orderSentence": "Cyclophosphamide 750 mg/m² monthly x 6 IV"
            },
            "contraindications": "Cytopenias, active infection, pregnancy",
            "monitoring": "CBC weekly, renal function, hemorrhagic cystitis",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          }
        ],
        "Tumor Treatment": [
          {
            "item": "Tumor resection (ovarian teratoma)",
            "route": "Surgical",
            "indication": "Anti-NMDAR with teratoma",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Tumor resection (ovarian teratoma) N/A —"
                }
              ],
              "route": "—",
              "instructions": "Surgical removal of ovarian teratoma is CRITICAL for recovery; early surgery improves outcomes",
              "orderSentence": "Tumor resection (ovarian teratoma) N/A —"
            },
            "contraindications": "Unstable patient",
            "monitoring": "Post-op neuro status",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Thymectomy",
            "route": "Surgical",
            "indication": "Thymoma-associated encephalitis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Thymectomy N/A —"
                }
              ],
              "route": "—",
              "instructions": "Surgical resection of thymoma",
              "orderSentence": "Thymectomy N/A —"
            },
            "contraindications": "Unstable patient",
            "monitoring": "Post-op neuro status",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Oncology treatment",
            "route": "Various",
            "indication": "Tumor-associated encephalitis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per oncology",
                  "orderSentence": "Oncology treatment Per oncology —"
                }
              ],
              "route": "—",
              "instructions": "Treat underlying malignancy per oncology recommendations",
              "orderSentence": "Oncology treatment Per oncology —"
            },
            "contraindications": "—",
            "monitoring": "Per oncology",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          }
        ],
        "Seizure Management": [
          {
            "item": "Levetiracetam",
            "route": "IV/PO",
            "indication": "Seizures, seizure prophylaxis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mg BID",
                  "orderSentence": "Levetiracetam 1000 mg BID IV/PO"
                },
                {
                  "text": "1500 mg BID",
                  "orderSentence": "Levetiracetam 1500 mg BID IV/PO"
                },
                {
                  "text": "2000 mg BID",
                  "orderSentence": "Levetiracetam 2000 mg BID IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "Load 1000-2000 mg IV, then 1000-1500 mg BID; may need higher doses",
              "orderSentence": "Levetiracetam 1000 mg BID IV/PO"
            },
            "contraindications": "Severe renal impairment (adjust)",
            "monitoring": "Seizure frequency, behavior",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Lacosamide",
            "route": "IV/PO",
            "indication": "Adjunctive seizure control",
            "dosing": {
              "doseOptions": [
                {
                  "text": "200 mg BID",
                  "orderSentence": "Lacosamide 200 mg BID IV/PO"
                },
                {
                  "text": "300 mg BID",
                  "orderSentence": "Lacosamide 300 mg BID IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "Load 200-400 mg IV, then 200-300 mg BID",
              "orderSentence": "Lacosamide 200 mg BID IV/PO"
            },
            "contraindications": "PR prolongation, severe cardiac disease",
            "monitoring": "ECG, PR interval",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Valproate",
            "route": "IV/PO",
            "indication": "Seizures",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg/kg load",
                  "orderSentence": "Valproate 20 mg/kg load IV/PO"
                },
                {
                  "text": "500 mg BID",
                  "orderSentence": "Valproate 500 mg BID IV/PO"
                },
                {
                  "text": "750 mg BID",
                  "orderSentence": "Valproate 750 mg BID IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "Load 20-30 mg/kg IV, then 500-750 mg BID; target level 50-100",
              "orderSentence": "Valproate 20 mg/kg load IV/PO"
            },
            "contraindications": "Liver disease, mitochondrial disease, pregnancy",
            "monitoring": "LFTs, ammonia, levels",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Lorazepam",
            "route": "IV",
            "indication": "Acute seizure termination",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 mg",
                  "orderSentence": "Lorazepam 2 mg IV"
                },
                {
                  "text": "4 mg",
                  "orderSentence": "Lorazepam 4 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "0.1 mg/kg IV (max 4 mg); may repeat x1",
              "orderSentence": "Lorazepam 2 mg IV"
            },
            "contraindications": "Respiratory depression",
            "monitoring": "RR, O2 sat",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Midazolam infusion",
            "route": "IV",
            "indication": "Refractory status epilepticus",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.1-0.4 mg/kg/hr",
                  "orderSentence": "Midazolam infusion 0.1-0.4 mg/kg/hr IV"
                }
              ],
              "route": "IV",
              "instructions": "0.2 mg/kg bolus, then 0.1-0.4 mg/kg/hr infusion; for refractory seizures",
              "orderSentence": "Midazolam infusion 0.1-0.4 mg/kg/hr IV"
            },
            "contraindications": "—",
            "monitoring": "EEG, sedation, respiratory",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Symptomatic/Supportive Care": [
          {
            "item": "Haloperidol",
            "route": "IV/IM",
            "indication": "Agitation, psychosis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2-5 mg q4-6h PRN",
                  "orderSentence": "Haloperidol 2-5 mg q4-6h PRN IV/IM"
                }
              ],
              "route": "IV/IM",
              "instructions": "2-5 mg IV/IM q4-6h PRN for severe agitation; avoid in movement disorders",
              "orderSentence": "Haloperidol 2-5 mg q4-6h PRN IV/IM"
            },
            "contraindications": "QT prolongation, movement disorders, Parkinson",
            "monitoring": "QTc, EPS",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Quetiapine",
            "route": "PO",
            "indication": "Agitation, psychosis (milder)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg BID",
                  "orderSentence": "Quetiapine 25 mg BID PO"
                },
                {
                  "text": "50 mg BID",
                  "orderSentence": "Quetiapine 50 mg BID PO"
                },
                {
                  "text": "100 mg BID",
                  "orderSentence": "Quetiapine 100 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg BID; titrate as needed; lower EPS risk",
              "orderSentence": "Quetiapine 25 mg BID PO"
            },
            "contraindications": "QT prolongation",
            "monitoring": "QTc, sedation",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Lorazepam",
            "route": "IV/PO",
            "indication": "Catatonia, agitation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 mg q6h",
                  "orderSentence": "Lorazepam 1 mg q6h IV/PO"
                },
                {
                  "text": "2 mg q6h",
                  "orderSentence": "Lorazepam 2 mg q6h IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "1-2 mg IV/PO q6h; often effective for catatonia",
              "orderSentence": "Lorazepam 1 mg q6h IV/PO"
            },
            "contraindications": "Respiratory depression",
            "monitoring": "RR, sedation",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Propranolol",
            "route": "PO",
            "indication": "Autonomic instability (tachycardia)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg TID",
                  "orderSentence": "Propranolol 10 mg TID PO"
                },
                {
                  "text": "20 mg TID",
                  "orderSentence": "Propranolol 20 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "10-20 mg PO TID for tachycardia",
              "orderSentence": "Propranolol 10 mg TID PO"
            },
            "contraindications": "Bradycardia, hypotension, asthma",
            "monitoring": "HR, BP",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Clonidine",
            "route": "PO/transdermal",
            "indication": "Autonomic instability",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.1 mg BID",
                  "orderSentence": "Clonidine 0.1 mg BID PO/TD"
                },
                {
                  "text": "0.1 mg patch weekly",
                  "orderSentence": "Clonidine 0.1 mg patch weekly PO/TD"
                }
              ],
              "route": "PO/TD",
              "instructions": "0.1 mg PO BID or 0.1 mg/24h patch; for hypertension/tachycardia",
              "orderSentence": "Clonidine 0.1 mg BID PO/TD"
            },
            "contraindications": "Hypotension",
            "monitoring": "BP, HR",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Enoxaparin",
            "route": "SC",
            "indication": "DVT prophylaxis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg daily",
                  "orderSentence": "Enoxaparin 40 mg daily SC"
                }
              ],
              "route": "SC",
              "instructions": "40 mg SC daily",
              "orderSentence": "Enoxaparin 40 mg daily SC"
            },
            "contraindications": "Active bleeding, coagulopathy",
            "monitoring": "Platelet count",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Famotidine",
            "route": "IV/PO",
            "indication": "Stress ulcer prophylaxis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg BID",
                  "orderSentence": "Famotidine 20 mg BID IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "20 mg BID if on steroids or intubated",
              "orderSentence": "Famotidine 20 mg BID IV/PO"
            },
            "contraindications": "None",
            "monitoring": "GI bleeding",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Insulin",
            "route": "IV/SC",
            "indication": "Steroid-induced hyperglycemia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per sliding scale",
                  "orderSentence": "Insulin Per sliding scale IV/SC"
                }
              ],
              "route": "IV/SC",
              "instructions": "Target glucose <180 mg/dL",
              "orderSentence": "Insulin Per sliding scale IV/SC"
            },
            "contraindications": "Hypoglycemia",
            "monitoring": "Glucose q4-6h",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Long-Term/Maintenance Immunotherapy": [
          {
            "item": "Mycophenolate mofetil",
            "route": "PO",
            "indication": "Maintenance immunosuppression",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mg BID",
                  "orderSentence": "Mycophenolate mofetil 500 mg BID PO"
                },
                {
                  "text": "1000 mg BID",
                  "orderSentence": "Mycophenolate mofetil 1000 mg BID PO"
                },
                {
                  "text": "1500 mg BID",
                  "orderSentence": "Mycophenolate mofetil 1500 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 500 mg BID; increase to 1000-1500 mg BID over 2-4 weeks",
              "orderSentence": "Mycophenolate mofetil 500 mg BID PO"
            },
            "contraindications": "Pregnancy, cytopenias",
            "monitoring": "CBC q2wk x 2 mo, then monthly",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Azathioprine",
            "route": "PO",
            "indication": "Maintenance immunosuppression",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg daily",
                  "orderSentence": "Azathioprine 50 mg daily PO"
                },
                {
                  "text": "100 mg daily",
                  "orderSentence": "Azathioprine 100 mg daily PO"
                },
                {
                  "text": "150 mg daily",
                  "orderSentence": "Azathioprine 150 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 50 mg daily; increase by 50 mg q2-4wk to 2-3 mg/kg/day; check TPMT first",
              "orderSentence": "Azathioprine 50 mg daily PO"
            },
            "contraindications": "TPMT deficiency, pregnancy",
            "monitoring": "CBC weekly x 4, then monthly; LFTs",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Prednisone (oral taper)",
            "route": "PO",
            "indication": "Steroid taper",
            "dosing": {
              "doseOptions": [
                {
                  "text": "60 mg daily",
                  "orderSentence": "Prednisone (oral taper) 60 mg daily PO"
                },
                {
                  "text": "40 mg daily",
                  "orderSentence": "Prednisone (oral taper) 40 mg daily PO"
                },
                {
                  "text": "20 mg daily",
                  "orderSentence": "Prednisone (oral taper) 20 mg daily PO"
                },
                {
                  "text": "10 mg daily",
                  "orderSentence": "Prednisone (oral taper) 10 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Taper over weeks to months; individualize based on response",
              "orderSentence": "Prednisone (oral taper) 60 mg daily PO"
            },
            "contraindications": "—",
            "monitoring": "Glucose, BP, bone density",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Rituximab (maintenance)",
            "route": "IV",
            "indication": "Relapse prevention (NMDAR)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500-1000 mg q6mo",
                  "orderSentence": "Rituximab (maintenance) 500-1000 mg q6mo IV"
                }
              ],
              "route": "IV",
              "instructions": "500-1000 mg IV q6 months for 2 years or longer; recheck antibodies",
              "orderSentence": "Rituximab (maintenance) 500-1000 mg q6mo IV"
            },
            "contraindications": "Active infection",
            "monitoring": "B-cell counts, immunoglobulins",
            "ED": "—",
            "HOSP": "—",
            "OPD": "ROUTINE",
            "ICU": "—"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurology consult for diagnosis confirmation, immunotherapy guidance, and antibody interpretation",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Neuro-immunology consult for complex cases, second-line therapy decisions, and long-term management",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Oncology consult for tumor workup and treatment if paraneoplastic syndrome identified",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Gynecologic oncology for ovarian teratoma removal which is critical for anti-NMDAR encephalitis recovery",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Critical care consult for ICU admission given autonomic instability, coma, or need for sedation/ventilation",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Psychiatry consult for severe psychiatric symptoms, catatonia, or behavioral management in acute phase",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Epilepsy consult for refractory seizures and continuous EEG monitoring guidance",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Physical therapy for mobility assessment and fall prevention given fluctuating weakness and dyskinesias",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Occupational therapy for ADL assessment and cognitive rehabilitation to maximize functional recovery",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Speech therapy for swallow evaluation and communication strategies given dysarthria and aphasia",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Neuropsychology for formal cognitive assessment to document deficits and guide rehabilitation",
            "ED": "—",
            "HOSP": "—",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Social work for discharge planning and family support given prolonged recovery and potential disability",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Return immediately if worsening confusion, seizures, or new symptoms develop (may indicate relapse requiring treatment escalation)",
            "ED": "STAT",
            "HOSP": "—",
            "OPD": "STAT"
          },
          {
            "item": "Continue immunotherapy as prescribed even when feeling better; stopping early increases relapse risk",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "STAT"
          },
          {
            "item": "Report fever or signs of infection promptly as immunosuppression increases infection risk",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "STAT"
          },
          {
            "item": "Follow seizure precautions including no driving, swimming alone, or heights due to unpredictable seizure risk",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "STAT"
          },
          {
            "item": "Attend all follow-up appointments as relapses can occur months to years after initial presentation",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Expect that recovery may take months to years; improvement often continues for 2+ years",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Participate in cognitive rehabilitation as this is essential for optimizing recovery from memory and executive deficits",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Contact Autoimmune Encephalitis Alliance (www.aealliance.org) for patient support and educational resources",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Use fall precautions including walker and supervision due to movement disorders and cognitive impairment",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "STAT"
          },
          {
            "item": "Aspiration precautions including thickened liquids and upright positioning if swallow impaired",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—"
          },
          {
            "item": "DVT prophylaxis with SCDs and/or anticoagulation given prolonged immobility risk",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—"
          },
          {
            "item": "Avoid live vaccines while on immunosuppression; inactivated vaccines are safe and recommended",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Practice infection prevention including hand hygiene and avoiding sick contacts while on immunosuppression",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "STAT"
          },
          {
            "item": "Continue regular cancer screening for paraneoplastic cases as tumor recurrence can trigger relapse",
            "ED": "—",
            "HOSP": "—",
            "OPD": "ROUTINE"
          },
          {
            "item": "Use cognitive pacing with scheduled rest periods to manage post-encephalitis fatigue",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Do not drive until cleared by neurology due to seizure risk and cognitive impairment",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "STAT"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "HSV encephalitis",
        "features": "Acute, temporal lobe predominant, hemorrhagic",
        "tests": "MRI temporal, HSV PCR"
      },
      {
        "diagnosis": "Other viral encephalitis",
        "features": "Fever, CSF pleocytosis, specific epidemiology",
        "tests": "Viral PCRs"
      },
      {
        "diagnosis": "Bacterial meningitis",
        "features": "Acute, toxic, PMN predominant CSF",
        "tests": "CSF Gram stain, culture"
      },
      {
        "diagnosis": "Tuberculous meningitis",
        "features": "Subacute, basilar, low glucose",
        "tests": "CSF AFB, PCR, ADA"
      },
      {
        "diagnosis": "Neurosyphilis",
        "features": "Risk factors, varied presentations",
        "tests": "RPR, CSF VDRL, FTA-ABS"
      },
      {
        "diagnosis": "Primary CNS lymphoma",
        "features": "Immunocompromised, periventricular",
        "tests": "MRI pattern, CSF cytology"
      },
      {
        "diagnosis": "Glioblastoma",
        "features": "Focal deficits, ring-enhancing mass",
        "tests": "MRI, biopsy"
      },
      {
        "diagnosis": "Creutzfeldt-Jakob disease",
        "features": "Rapid dementia, myoclonus, DWI restriction",
        "tests": "MRI pattern, 14-3-3, RT-QuIC"
      },
      {
        "diagnosis": "Hashimoto's encephalopathy (SREAT)",
        "features": "Elevated TPO, responds to steroids",
        "tests": "TPO antibodies, exclusion"
      },
      {
        "diagnosis": "Psychiatric illness (primary)",
        "features": "No CSF/MRI changes, prior history",
        "tests": "Normal workup, psychiatric evaluation"
      },
      {
        "diagnosis": "Toxic/metabolic encephalopathy",
        "features": "Drug/toxin exposure, metabolic derangement",
        "tests": "Toxicology, metabolic panel"
      },
      {
        "diagnosis": "ADEM",
        "features": "Post-infectious, multifocal white matter",
        "tests": "MRI pattern (multifocal), monophasic"
      },
      {
        "diagnosis": "CNS vasculitis",
        "features": "Multifocal strokes, systemic symptoms",
        "tests": "Angiography, vessel wall MRI"
      },
      {
        "diagnosis": "Wernicke encephalopathy",
        "features": "Alcoholism, classic triad, mammillary bodies",
        "tests": "Thiamine trial, MRI"
      },
      {
        "diagnosis": "Seizure-related (postictal)",
        "features": "Seizure witnessed, resolves with time",
        "tests": "EEG, observation"
      }
    ],
    "evidence": [
      {
        "recommendation": "First-line immunotherapy (steroids, IVIg, PLEX)",
        "evidenceLevel": "Class II, Level B",
        "source": "[Titulaer et al. Lancet Neurol 2013](https://pubmed.ncbi.nlm.nih.gov/23290630/)"
      },
      {
        "recommendation": "Early immunotherapy improves outcomes",
        "evidenceLevel": "Class II, Level B",
        "source": "[Titulaer et al. Lancet Neurol 2013](https://pubmed.ncbi.nlm.nih.gov/23290630/)"
      },
      {
        "recommendation": "Second-line therapy (rituximab, cyclophosphamide)",
        "evidenceLevel": "Class III, Level C",
        "source": "[Dalmau et al. Lancet Neurol 2019](https://pubmed.ncbi.nlm.nih.gov/31326280/)"
      },
      {
        "recommendation": "Tumor removal essential for recovery",
        "evidenceLevel": "Class II, Level B",
        "source": "[Titulaer et al. Lancet Neurol 2013](https://pubmed.ncbi.nlm.nih.gov/23290630/)"
      },
      {
        "recommendation": "CSF more sensitive than serum for NMDAR",
        "evidenceLevel": "Class II, Level B",
        "source": "[Gresa-Arribas et al. Lancet Neurol 2014](https://pubmed.ncbi.nlm.nih.gov/24275432/)"
      },
      {
        "recommendation": "Extreme delta brush in anti-NMDAR",
        "evidenceLevel": "Class III, Level C",
        "source": "[Schmitt et al. Neurology 2012](https://pubmed.ncbi.nlm.nih.gov/22966581/)"
      },
      {
        "recommendation": "LGI1 associated with hyponatremia and FBDS",
        "evidenceLevel": "Class II, Level B",
        "source": "[Irani et al. Brain 2010](https://pubmed.ncbi.nlm.nih.gov/20833645/)"
      },
      {
        "recommendation": "Diagnostic criteria for autoimmune encephalitis",
        "evidenceLevel": "Consensus Guidelines",
        "source": "[Graus et al. Lancet Neurol 2016](https://pubmed.ncbi.nlm.nih.gov/26906964/)"
      },
      {
        "recommendation": "Long-term outcomes and relapse risk",
        "evidenceLevel": "Class II, Level B",
        "source": "[Titulaer et al. Lancet Neurol 2013](https://pubmed.ncbi.nlm.nih.gov/23290630/)"
      }
    ],
    "monitoring": [
      {
        "item": "Neurological exam (GCS, MMSE)",
        "frequency": "q4-8h initially",
        "action": "Re-evaluate treatment, escalate",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT"
      },
      {
        "item": "Seizure activity",
        "frequency": "Continuous if cEEG; q4h assessment",
        "action": "Escalate antiepileptic therapy",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Vital signs (autonomic function)",
        "frequency": "q1-4h",
        "action": "Supportive care, ICU if unstable",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Blood glucose",
        "frequency": "q6h if on steroids",
        "action": "Insulin adjustment",
        "ED": "—",
        "HOSP": "ROUTINE",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Renal function",
        "frequency": "q24-48h during IVIg",
        "action": "Hydration, adjust IVIg rate",
        "ED": "—",
        "HOSP": "ROUTINE",
        "OPD": "—",
        "ICU": "ROUTINE"
      },
      {
        "item": "Serum sodium",
        "frequency": "q12-24h (especially LGI1)",
        "action": "Fluid restriction if hyponatremic",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Antibody titers (serum/CSF)",
        "frequency": "q3-6 months",
        "action": "Consider treatment escalation",
        "ED": "—",
        "HOSP": "—",
        "OPD": "ROUTINE",
        "ICU": "—"
      },
      {
        "item": "Tumor surveillance",
        "frequency": "Per oncology",
        "action": "Oncology management",
        "ED": "—",
        "HOSP": "—",
        "OPD": "ROUTINE",
        "ICU": "—"
      },
      {
        "item": "B-cell counts (if on rituximab)",
        "frequency": "Before each infusion",
        "action": "Adjust dosing interval",
        "ED": "—",
        "HOSP": "—",
        "OPD": "ROUTINE",
        "ICU": "—"
      },
      {
        "item": "CBC (if on immunosuppression)",
        "frequency": "q1-4 weeks",
        "action": "Hold medication, infection workup",
        "ED": "—",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "ROUTINE"
      }
    ],
    "disposition": [
      {
        "disposition": "**ICU admission**",
        "criteria": "GCS <12; refractory seizures; autonomic instability; need for intubation; coma; severe psychiatric symptoms requiring restraint"
      },
      {
        "disposition": "**Step-down/telemetry**",
        "criteria": "GCS 12-14; controlled seizures; stable autonomic function; receiving immunotherapy"
      },
      {
        "disposition": "**General floor**",
        "criteria": "GCS 15; stable; no seizures; able to participate in therapies; can complete immunotherapy"
      },
      {
        "disposition": "**Acute rehabilitation**",
        "criteria": "Significant cognitive or motor deficits; requires intensive therapy; medically stable"
      },
      {
        "disposition": "**Discharge home**",
        "criteria": "Significant improvement; safe swallow; adequate support; outpatient immunotherapy arranged; neurology follow-up scheduled"
      },
      {
        "disposition": "**Long-term care**",
        "criteria": "Severe persistent deficits; unable to live independently"
      }
    ]
  },
  "Migraine": {
    "id": "migraine",
    "title": "Migraine",
    "version": "1.0",
    "icd10": [
      "** G43.909 (Migraine",
      "unspecified",
      "not intractable",
      "without status migrainosus)"
    ],
    "scope": "** Acute migraine treatment, preventive therapy initiation, and chronic migraine management. Excludes hemiplegic migraine, migraine with brainstem aura (separate protocols).",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC",
            "rationale": "Rule out anemia, infection as headache trigger",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "BMP",
            "rationale": "Electrolyte abnormalities can trigger or mimic migraine",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "TSH",
            "rationale": "Thyroid dysfunction associated with headache disorders",
            "target": "Normal (0.4-4.0 mIU/L)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended Workup": [
          {
            "item": "ESR, CRP",
            "rationale": "Rule out giant cell arteritis if age >50 with new headache",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin D level",
            "rationale": "Deficiency associated with increased migraine frequency",
            "target": ">30 ng/mL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Magnesium (RBC)",
            "rationale": "Deficiency linked to migraine; RBC level more accurate",
            "target": ">4.2 mg/dL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ferritin",
            "rationale": "Iron deficiency associated with headache",
            "target": ">50 ng/mL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "ANA, anti-dsDNA",
            "rationale": "Rule out CNS lupus in atypical presentations",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Antiphospholipid antibodies",
            "rationale": "Stroke mimic or migraine with aura risk",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Genetic testing (CACNA1A, ATP1A2, SCN1A)",
            "rationale": "Hemiplegic migraine suspected",
            "target": "Variant identified",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "MRI Brain without contrast",
            "timing": "First migraine presentation or change in pattern",
            "target": "Normal; rule out secondary causes",
            "contraindications": "MRI-incompatible devices",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CT Head non-contrast",
            "timing": "Acute severe headache (\"worst headache of life\") to rule out SAH",
            "target": "No hemorrhage",
            "contraindications": "Pregnancy (relative)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          }
        ],
        "Extended": [
          {
            "item": "MRI Brain with contrast",
            "timing": "Atypical features, focal deficits, papilledema",
            "target": "No enhancement",
            "contraindications": "Gadolinium allergy, severe renal impairment",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "MRA Head/Neck",
            "timing": "Suspected vascular etiology (thunderclap, positional)",
            "target": "Patent vessels; no dissection",
            "contraindications": "MRI contraindications",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CTA Head/Neck",
            "timing": "Urgent vascular imaging if MRI unavailable",
            "target": "No aneurysm, dissection",
            "contraindications": "Contrast allergy, CKD",
            "ED": "STAT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "MRV Brain",
            "timing": "Suspected cerebral venous thrombosis",
            "target": "Patent venous sinuses",
            "contraindications": "MRI contraindications",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "PET scan",
            "timing": "Refractory migraine, research protocols",
            "target": "Assess migraine generator activity",
            "contraindications": "Pregnancy, cost",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "Ketorolac",
            "route": "IV/IM",
            "indication": "First-line acute migraine in ED",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mg IV",
                  "orderSentence": "Ketorolac 30 mg IV IV"
                },
                {
                  "text": "15 mg IV",
                  "orderSentence": "Ketorolac 15 mg IV IV"
                }
              ],
              "route": "IV",
              "instructions": "30 mg IV x1 (15 mg if >65y, renal impairment, or <50 kg); max 5 days NSAIDs",
              "orderSentence": "Ketorolac 30 mg IV IV"
            },
            "contraindications": "Renal impairment; GI bleed; aspirin allergy; third trimester",
            "monitoring": "Renal function if repeated dosing",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Metoclopramide",
            "route": "IV",
            "indication": "Antiemetic with anti-migraine properties",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg IV",
                  "orderSentence": "Metoclopramide 10 mg IV IV"
                },
                {
                  "text": "20 mg IV",
                  "orderSentence": "Metoclopramide 20 mg IV IV"
                }
              ],
              "route": "IV",
              "instructions": "10-20 mg IV over 15 min; pretreat with diphenhydramine 25 mg to prevent akathisia",
              "orderSentence": "Metoclopramide 10 mg IV IV"
            },
            "contraindications": "Parkinson's disease; tardive dyskinesia; bowel obstruction",
            "monitoring": "Akathisia, dystonia",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Prochlorperazine",
            "route": "IV",
            "indication": "Dopamine antagonist for acute migraine",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg IV",
                  "orderSentence": "Prochlorperazine 10 mg IV IV"
                }
              ],
              "route": "IV",
              "instructions": "10 mg IV over 2 min; pretreat with diphenhydramine 25 mg",
              "orderSentence": "Prochlorperazine 10 mg IV IV"
            },
            "contraindications": "QT prolongation; Parkinson's; neuroleptic hypersensitivity",
            "monitoring": "Akathisia, dystonia, QTc",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Diphenhydramine",
            "route": "IV",
            "indication": "Prevent akathisia from dopamine antagonists",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg IV",
                  "orderSentence": "Diphenhydramine 25 mg IV IV"
                },
                {
                  "text": "50 mg IV",
                  "orderSentence": "Diphenhydramine 50 mg IV IV"
                }
              ],
              "route": "IV",
              "instructions": "25-50 mg IV with dopamine antagonist",
              "orderSentence": "Diphenhydramine 25 mg IV IV"
            },
            "contraindications": "Glaucoma; urinary retention",
            "monitoring": "Sedation",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Magnesium sulfate",
            "route": "IV",
            "indication": "Migraine with aura; refractory migraine",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 g IV",
                  "orderSentence": "Magnesium sulfate 2 g IV IV"
                }
              ],
              "route": "IV",
              "instructions": "2 g IV over 20 min; may repeat x1",
              "orderSentence": "Magnesium sulfate 2 g IV IV"
            },
            "contraindications": "Heart block; hypermagnesemia; myasthenia gravis",
            "monitoring": "BP, HR during infusion",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Sumatriptan",
            "route": "SC/PO",
            "indication": "Triptan-naive or triptan-responsive patient",
            "dosing": {
              "doseOptions": [
                {
                  "text": "6 mg SC",
                  "orderSentence": "Sumatriptan 6 mg SC SC/PO"
                },
                {
                  "text": "50 mg PO",
                  "orderSentence": "Sumatriptan 50 mg PO SC/PO"
                },
                {
                  "text": "100 mg PO",
                  "orderSentence": "Sumatriptan 100 mg PO SC/PO"
                }
              ],
              "route": "SC/PO",
              "instructions": "6 mg SC (may repeat after 1 hr, max 12 mg/24hr) OR 50-100 mg PO (max 200 mg/24hr)",
              "orderSentence": "Sumatriptan 6 mg SC SC/PO"
            },
            "contraindications": "Uncontrolled HTN; CAD; CVA history; MAOIs; hemiplegic migraine",
            "monitoring": "Chest tightness (triptan sensation vs cardiac)",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Valproate sodium",
            "route": "IV",
            "indication": "Status migrainosus; refractory to first-line",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mg IV",
                  "orderSentence": "Valproate sodium 500 mg IV IV"
                },
                {
                  "text": "1000 mg IV",
                  "orderSentence": "Valproate sodium 1000 mg IV IV"
                }
              ],
              "route": "IV",
              "instructions": "500-1000 mg IV over 5 min",
              "orderSentence": "Valproate sodium 500 mg IV IV"
            },
            "contraindications": "Hepatic disease; pregnancy; urea cycle disorders; pancreatitis history",
            "monitoring": "LFTs, ammonia if altered mental status",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Dihydroergotamine (DHE)",
            "route": "IV",
            "indication": "Refractory migraine; status migrainosus",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5 mg IV",
                  "orderSentence": "Dihydroergotamine (DHE) 0.5 mg IV IV"
                },
                {
                  "text": "1 mg IV",
                  "orderSentence": "Dihydroergotamine (DHE) 1 mg IV IV"
                }
              ],
              "route": "IV",
              "instructions": "0.5-1 mg IV q8h for up to 3 days; pretreat with antiemetic",
              "orderSentence": "Dihydroergotamine (DHE) 0.5 mg IV IV"
            },
            "contraindications": "Pregnancy; CAD; uncontrolled HTN; use within 24h of triptan; severe hepatic/renal impairment",
            "monitoring": "BP, nausea; continuous cardiac monitoring",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Dexamethasone",
            "route": "IV",
            "indication": "Prevent migraine recurrence after ED treatment",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg IV",
                  "orderSentence": "Dexamethasone 10 mg IV IV"
                }
              ],
              "route": "IV",
              "instructions": "10 mg IV x1 at time of ED discharge",
              "orderSentence": "Dexamethasone 10 mg IV IV"
            },
            "contraindications": "Active infection; uncontrolled diabetes",
            "monitoring": "Glucose if diabetic",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          }
        ],
        "Symptomatic Treatments": [
          {
            "item": "Ondansetron",
            "route": "IV/PO",
            "indication": "Nausea/vomiting associated with migraine",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4 mg IV",
                  "orderSentence": "Ondansetron 4 mg IV IV/PO"
                },
                {
                  "text": "8 mg PO",
                  "orderSentence": "Ondansetron 8 mg PO IV/PO"
                },
                {
                  "text": "4 mg ODT",
                  "orderSentence": "Ondansetron 4 mg ODT IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "4 mg IV or 8 mg PO/ODT; may repeat q8h",
              "orderSentence": "Ondansetron 4 mg IV IV/PO"
            },
            "contraindications": "QT prolongation; severe hepatic impairment",
            "monitoring": "QTc if multiple doses",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ibuprofen",
            "route": "PO",
            "indication": "Mild-moderate migraine",
            "dosing": {
              "doseOptions": [
                {
                  "text": "400 mg PO",
                  "orderSentence": "Ibuprofen 400 mg PO PO"
                },
                {
                  "text": "600 mg PO",
                  "orderSentence": "Ibuprofen 600 mg PO PO"
                },
                {
                  "text": "800 mg PO",
                  "orderSentence": "Ibuprofen 800 mg PO PO"
                }
              ],
              "route": "PO",
              "instructions": "400-800 mg PO at onset; max 2400 mg/day",
              "orderSentence": "Ibuprofen 400 mg PO PO"
            },
            "contraindications": "Renal impairment; GI bleed; aspirin allergy",
            "monitoring": "GI symptoms",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Naproxen",
            "route": "PO",
            "indication": "Mild-moderate migraine; menstrual migraine",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mg PO",
                  "orderSentence": "Naproxen 500 mg PO PO"
                },
                {
                  "text": "550 mg PO",
                  "orderSentence": "Naproxen 550 mg PO PO"
                }
              ],
              "route": "PO",
              "instructions": "500-550 mg PO at onset; may repeat 250 mg in 12 hr",
              "orderSentence": "Naproxen 500 mg PO PO"
            },
            "contraindications": "Renal impairment; GI bleed; aspirin allergy",
            "monitoring": "GI symptoms",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Acetaminophen/Aspirin/Caffeine",
            "route": "PO",
            "indication": "Mild-moderate migraine (OTC option)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 tablets PO",
                  "orderSentence": "Acetaminophen/Aspirin/Caffeine 2 tablets PO PO"
                }
              ],
              "route": "PO",
              "instructions": "2 tablets (250/250/65 mg each) at onset; max 2 doses/24hr",
              "orderSentence": "Acetaminophen/Aspirin/Caffeine 2 tablets PO PO"
            },
            "contraindications": "Aspirin allergy; hepatic impairment; avoid if using other acetaminophen",
            "monitoring": "Limit total acetaminophen <3g/day",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rizatriptan",
            "route": "PO",
            "indication": "Acute migraine; faster onset than sumatriptan",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg PO",
                  "orderSentence": "Rizatriptan 5 mg PO PO"
                },
                {
                  "text": "10 mg PO",
                  "orderSentence": "Rizatriptan 10 mg PO PO"
                }
              ],
              "route": "PO",
              "instructions": "5-10 mg PO (5 mg if on propranolol); may repeat after 2 hr; max 30 mg/24hr",
              "orderSentence": "Rizatriptan 5 mg PO PO"
            },
            "contraindications": "Same as sumatriptan; use 5 mg if on propranolol",
            "monitoring": "Triptan sensation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Eletriptan",
            "route": "PO",
            "indication": "Acute migraine; good for return of headache",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg PO",
                  "orderSentence": "Eletriptan 40 mg PO PO"
                },
                {
                  "text": "80 mg PO",
                  "orderSentence": "Eletriptan 80 mg PO PO"
                }
              ],
              "route": "PO",
              "instructions": "40 mg PO; may repeat 40 mg after 2 hr if partial response; max 80 mg/24hr",
              "orderSentence": "Eletriptan 40 mg PO PO"
            },
            "contraindications": "Same as sumatriptan; potent CYP3A4 inhibitors",
            "monitoring": "Triptan sensation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Naratriptan",
            "route": "PO",
            "indication": "Slower onset but longer duration; menstrual migraine",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2.5 mg PO",
                  "orderSentence": "Naratriptan 2.5 mg PO PO"
                }
              ],
              "route": "PO",
              "instructions": "2.5 mg PO; may repeat after 4 hr; max 5 mg/24hr",
              "orderSentence": "Naratriptan 2.5 mg PO PO"
            },
            "contraindications": "Same as sumatriptan; moderate-severe renal/hepatic impairment",
            "monitoring": "Triptan sensation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ubrogepant",
            "route": "PO",
            "indication": "CGRP receptor antagonist; triptan contraindications",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg PO",
                  "orderSentence": "Ubrogepant 50 mg PO PO"
                },
                {
                  "text": "100 mg PO",
                  "orderSentence": "Ubrogepant 100 mg PO PO"
                }
              ],
              "route": "PO",
              "instructions": "50-100 mg PO; may repeat after 2 hr; max 200 mg/24hr",
              "orderSentence": "Ubrogepant 50 mg PO PO"
            },
            "contraindications": "Strong CYP3A4 inhibitors; severe hepatic impairment",
            "monitoring": "None routine",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rimegepant",
            "route": "PO/ODT",
            "indication": "CGRP antagonist; acute and preventive use",
            "dosing": {
              "doseOptions": [
                {
                  "text": "75 mg ODT",
                  "orderSentence": "Rimegepant 75 mg ODT PO"
                }
              ],
              "route": "PO",
              "instructions": "75 mg ODT at onset; max 75 mg/24hr for acute",
              "orderSentence": "Rimegepant 75 mg ODT PO"
            },
            "contraindications": "Strong CYP3A4 inhibitors; severe hepatic impairment",
            "monitoring": "None routine",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Second-line/Refractory": [
          {
            "item": "Nerve block (occipital)",
            "route": "SC",
            "indication": "Refractory migraine; occipital-predominant pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2-3 mL of 2% lidocaine + 40 mg triamcinolone",
                  "orderSentence": "Nerve block (occipital) 2-3 mL of 2% lidocaine + 40 mg triamcinolone SC"
                }
              ],
              "route": "SC",
              "instructions": "Inject at greater occipital nerve bilaterally; may add lesser occipital, supraorbital",
              "orderSentence": "Nerve block (occipital) 2-3 mL of 2% lidocaine + 40 mg triamcinolone SC"
            },
            "contraindications": "Local anesthetic allergy; infection at site",
            "monitoring": "Immediate pain relief; monitor for vasovagal",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sphenopalatine ganglion block",
            "route": "Intranasal",
            "indication": "Refractory migraine; cluster-like features",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Lidocaine 4% via SphenoCath",
                  "orderSentence": "Sphenopalatine ganglion block Lidocaine 4% via SphenoCath Intranasal"
                }
              ],
              "route": "Intranasal",
              "instructions": "Apply via intranasal device; repeat up to 3x/week",
              "orderSentence": "Sphenopalatine ganglion block Lidocaine 4% via SphenoCath Intranasal"
            },
            "contraindications": "Nasal pathology; local anesthetic allergy",
            "monitoring": "Local numbness, epistaxis",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Ketamine",
            "route": "IV",
            "indication": "Status migrainosus refractory to DHE",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.1-0.3 mg/kg/hr IV",
                  "orderSentence": "Ketamine 0.1-0.3 mg/kg/hr IV IV"
                }
              ],
              "route": "IV",
              "instructions": "0.1-0.3 mg/kg/hr infusion for 24-48 hr; subanesthetic dosing",
              "orderSentence": "Ketamine 0.1-0.3 mg/kg/hr IV IV"
            },
            "contraindications": "Uncontrolled HTN; psychosis; increased ICP",
            "monitoring": "Dissociation, BP, HR; requires cardiac monitoring",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "-"
          }
        ],
        "Disease-Modifying or Chronic Therapies (Preventive Medications)": [
          {
            "item": "Propranolol",
            "route": "PO",
            "indication": "First-line prevention; comorbid HTN or anxiety",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg BID",
                  "orderSentence": "Propranolol 40 mg BID PO"
                },
                {
                  "text": "80 mg BID",
                  "orderSentence": "Propranolol 80 mg BID PO"
                },
                {
                  "text": "80 mg daily LA",
                  "orderSentence": "Propranolol 80 mg daily LA PO"
                },
                {
                  "text": "160 mg daily LA",
                  "orderSentence": "Propranolol 160 mg daily LA PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 40 mg BID or 80 mg LA daily; titrate q2wk; target 80-240 mg/day",
              "orderSentence": "Propranolol 40 mg BID PO"
            },
            "pretreatment": "None",
            "contraindications": "Asthma; COPD; bradycardia <50; heart block; decompensated HF",
            "monitoring": "HR, BP; watch for fatigue, depression",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Topiramate",
            "route": "PO",
            "indication": "First-line prevention; comorbid obesity",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Topiramate 25 mg qHS PO"
                },
                {
                  "text": "50 mg BID",
                  "orderSentence": "Topiramate 50 mg BID PO"
                },
                {
                  "text": "75 mg BID",
                  "orderSentence": "Topiramate 75 mg BID PO"
                },
                {
                  "text": "100 mg BID",
                  "orderSentence": "Topiramate 100 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg qHS; increase by 25 mg/wk; target 50-100 mg BID",
              "orderSentence": "Topiramate 25 mg qHS PO"
            },
            "pretreatment": "None",
            "contraindications": "Glaucoma; kidney stones; pregnancy",
            "monitoring": "Cognitive effects, paresthesias, weight, bicarbonate, kidney stones",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Amitriptyline",
            "route": "PO",
            "indication": "Prevention; comorbid insomnia, depression, TTH",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg qHS",
                  "orderSentence": "Amitriptyline 10 mg qHS PO"
                },
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Amitriptyline 25 mg qHS PO"
                },
                {
                  "text": "50 mg qHS",
                  "orderSentence": "Amitriptyline 50 mg qHS PO"
                },
                {
                  "text": "75 mg qHS",
                  "orderSentence": "Amitriptyline 75 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10 mg qHS; titrate by 10-25 mg q1-2wk; target 25-75 mg qHS",
              "orderSentence": "Amitriptyline 10 mg qHS PO"
            },
            "pretreatment": "ECG if >50 or cardiac history",
            "contraindications": "Cardiac conduction abnormality; recent MI; glaucoma; urinary retention",
            "monitoring": "Sedation, weight gain, dry mouth; ECG if >100 mg",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Venlafaxine XR",
            "route": "PO",
            "indication": "Prevention; comorbid depression, anxiety",
            "dosing": {
              "doseOptions": [
                {
                  "text": "37.5 mg daily",
                  "orderSentence": "Venlafaxine XR 37.5 mg daily PO"
                },
                {
                  "text": "75 mg daily",
                  "orderSentence": "Venlafaxine XR 75 mg daily PO"
                },
                {
                  "text": "150 mg daily",
                  "orderSentence": "Venlafaxine XR 150 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 37.5 mg daily; increase by 37.5-75 mg q1wk; target 75-150 mg daily",
              "orderSentence": "Venlafaxine XR 37.5 mg daily PO"
            },
            "pretreatment": "None",
            "contraindications": "Uncontrolled HTN; MAOIs; abrupt discontinuation",
            "monitoring": "BP at higher doses; serotonin syndrome signs",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Valproate/Divalproex",
            "route": "PO",
            "indication": "Prevention; comorbid bipolar or epilepsy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "250 mg BID",
                  "orderSentence": "Valproate/Divalproex 250 mg BID PO"
                },
                {
                  "text": "500 mg BID",
                  "orderSentence": "Valproate/Divalproex 500 mg BID PO"
                },
                {
                  "text": "500 mg ER daily",
                  "orderSentence": "Valproate/Divalproex 500 mg ER daily PO"
                },
                {
                  "text": "1000 mg ER daily",
                  "orderSentence": "Valproate/Divalproex 1000 mg ER daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 250 mg BID or 500 mg ER daily; titrate to 500-1000 mg/day",
              "orderSentence": "Valproate/Divalproex 250 mg BID PO"
            },
            "pretreatment": "LFTs, CBC",
            "contraindications": "Hepatic disease; pregnancy (teratogen); urea cycle disorders; pancreatitis",
            "monitoring": "LFTs q6mo; weight, hair loss, tremor",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Erenumab (Aimovig)",
            "route": "SC",
            "indication": "CGRP mAb; failed 2+ oral preventives or intolerance",
            "dosing": {
              "doseOptions": [
                {
                  "text": "70 mg SC monthly",
                  "orderSentence": "Erenumab (Aimovig) 70 mg SC monthly SC"
                },
                {
                  "text": "140 mg SC monthly",
                  "orderSentence": "Erenumab (Aimovig) 140 mg SC monthly SC"
                }
              ],
              "route": "SC",
              "instructions": "70 mg SC monthly; may increase to 140 mg monthly after 3 months",
              "orderSentence": "Erenumab (Aimovig) 70 mg SC monthly SC"
            },
            "pretreatment": "None",
            "contraindications": "Hypersensitivity to erenumab",
            "monitoring": "Constipation (can be severe), injection site reactions, HTN",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Fremanezumab (Ajovy)",
            "route": "SC",
            "indication": "CGRP mAb; alternative dosing options",
            "dosing": {
              "doseOptions": [
                {
                  "text": "225 mg SC monthly",
                  "orderSentence": "Fremanezumab (Ajovy) 225 mg SC monthly SC"
                },
                {
                  "text": "675 mg SC quarterly",
                  "orderSentence": "Fremanezumab (Ajovy) 675 mg SC quarterly SC"
                }
              ],
              "route": "SC",
              "instructions": "225 mg SC monthly OR 675 mg SC quarterly",
              "orderSentence": "Fremanezumab (Ajovy) 225 mg SC monthly SC"
            },
            "pretreatment": "None",
            "contraindications": "Hypersensitivity",
            "monitoring": "Injection site reactions",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Galcanezumab (Emgality)",
            "route": "SC",
            "indication": "CGRP mAb; also FDA-approved for cluster",
            "dosing": {
              "doseOptions": [
                {
                  "text": "240 mg SC load",
                  "orderSentence": "Galcanezumab (Emgality) 240 mg SC load SC"
                },
                {
                  "text": "120 mg SC monthly",
                  "orderSentence": "Galcanezumab (Emgality) 120 mg SC monthly SC"
                }
              ],
              "route": "SC",
              "instructions": "240 mg SC loading dose (2 x 120 mg), then 120 mg SC monthly",
              "orderSentence": "Galcanezumab (Emgality) 240 mg SC load SC"
            },
            "pretreatment": "None",
            "contraindications": "Hypersensitivity",
            "monitoring": "Injection site reactions",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Eptinezumab (Vyepti)",
            "route": "IV",
            "indication": "CGRP mAb; IV option for rapid onset",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg IV quarterly",
                  "orderSentence": "Eptinezumab (Vyepti) 100 mg IV quarterly IV"
                },
                {
                  "text": "300 mg IV quarterly",
                  "orderSentence": "Eptinezumab (Vyepti) 300 mg IV quarterly IV"
                }
              ],
              "route": "IV",
              "instructions": "100 mg IV q3mo; may increase to 300 mg IV q3mo",
              "orderSentence": "Eptinezumab (Vyepti) 100 mg IV quarterly IV"
            },
            "pretreatment": "None",
            "contraindications": "Hypersensitivity",
            "monitoring": "Infusion reactions (rare), nasopharyngitis",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Onabotulinumtoxin A (Botox)",
            "route": "IM",
            "indication": "Chronic migraine (≥15 days/month); failed oral preventives",
            "dosing": {
              "doseOptions": [
                {
                  "text": "155-195 units IM",
                  "orderSentence": "Onabotulinumtoxin A (Botox) 155-195 units IM IM"
                }
              ],
              "route": "IM",
              "instructions": "155-195 units across 31-39 injection sites q12wk; PREEMPT protocol",
              "orderSentence": "Onabotulinumtoxin A (Botox) 155-195 units IM IM"
            },
            "pretreatment": "None",
            "contraindications": "Infection at injection sites; myasthenia gravis",
            "monitoring": "Neck weakness, ptosis (rare); effect takes 2-3 cycles",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Candesartan",
            "route": "PO",
            "indication": "Prevention; comorbid HTN; beta-blocker intolerant",
            "dosing": {
              "doseOptions": [
                {
                  "text": "8 mg daily",
                  "orderSentence": "Candesartan 8 mg daily PO"
                },
                {
                  "text": "16 mg daily",
                  "orderSentence": "Candesartan 16 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 8 mg daily; may increase to 16 mg daily",
              "orderSentence": "Candesartan 8 mg daily PO"
            },
            "pretreatment": "None",
            "contraindications": "Pregnancy; bilateral renal artery stenosis; hyperkalemia",
            "monitoring": "BP, K+, creatinine",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lisinopril",
            "route": "PO",
            "indication": "Prevention; comorbid HTN",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg daily",
                  "orderSentence": "Lisinopril 10 mg daily PO"
                },
                {
                  "text": "20 mg daily",
                  "orderSentence": "Lisinopril 20 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10 mg daily; may increase to 20 mg daily",
              "orderSentence": "Lisinopril 10 mg daily PO"
            },
            "pretreatment": "None",
            "contraindications": "Pregnancy; angioedema history; bilateral RAS",
            "monitoring": "BP, K+, creatinine, cough",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Magnesium oxide",
            "route": "PO",
            "indication": "Supplement for prevention; migraine with aura",
            "dosing": {
              "doseOptions": [
                {
                  "text": "400 mg daily",
                  "orderSentence": "Magnesium oxide 400 mg daily PO"
                },
                {
                  "text": "400 mg BID",
                  "orderSentence": "Magnesium oxide 400 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "400-800 mg daily in divided doses",
              "orderSentence": "Magnesium oxide 400 mg daily PO"
            },
            "pretreatment": "None",
            "contraindications": "Renal impairment (dose adjust)",
            "monitoring": "Diarrhea; check Mg level if symptomatic",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Riboflavin (B2)",
            "route": "PO",
            "indication": "Supplement for prevention; well-tolerated",
            "dosing": {
              "doseOptions": [
                {
                  "text": "400 mg daily",
                  "orderSentence": "Riboflavin (B2) 400 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "400 mg daily",
              "orderSentence": "Riboflavin (B2) 400 mg daily PO"
            },
            "pretreatment": "None",
            "contraindications": "None",
            "monitoring": "Fluorescent yellow urine (reassure patient)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Coenzyme Q10",
            "route": "PO",
            "indication": "Supplement; may benefit mitochondrial function",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg TID",
                  "orderSentence": "Coenzyme Q10 100 mg TID PO"
                },
                {
                  "text": "300 mg daily",
                  "orderSentence": "Coenzyme Q10 300 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "100-300 mg daily",
              "orderSentence": "Coenzyme Q10 100 mg TID PO"
            },
            "pretreatment": "None",
            "contraindications": "None",
            "monitoring": "None",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurology/Headache specialist referral for chronic or refractory migraine management and preventive optimization",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pain management referral for interventional procedures (nerve blocks, Botox) in chronic refractory cases",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Behavioral medicine/Psychology for cognitive behavioral therapy addressing pain catastrophizing and comorbid anxiety/depression",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Physical therapy for cervicogenic component and postural contribution to headaches",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sleep medicine evaluation if sleep disorder contributing to migraine frequency",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ophthalmology evaluation to rule out visual triggers and ensure appropriate vision correction",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "OB/GYN consultation for menstrual migraine management and hormonal contraception optimization",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Return immediately for sudden severe headache different from typical migraine (\"worst headache of life\") which may indicate hemorrhage",
            "ED": "STAT",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Return immediately for headache with fever, stiff neck, or altered mental status which may indicate infection",
            "ED": "STAT",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Maintain headache diary tracking frequency, triggers, and medication use to guide treatment optimization",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Limit acute medication use to ≤10 days/month to prevent medication overuse headache",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Take acute medications at first sign of migraine for best efficacy rather than waiting for severe pain",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Identify and avoid personal triggers (stress, sleep changes, skipped meals, alcohol, specific foods)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Regular sleep schedule (7-8 hours, consistent bedtime/wake time) as irregular sleep is a major trigger",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Regular meals to avoid fasting-triggered migraine; do not skip breakfast",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Aerobic exercise (30 min moderate activity 5x/week) shown to reduce migraine frequency",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Stress management through relaxation techniques, mindfulness, or biofeedback",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Caffeine moderation (≤200 mg/day equivalent to 2 cups coffee) and consistent daily intake",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Adequate hydration (at least 64 oz water daily) as dehydration can trigger migraine",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Limit alcohol especially red wine which is a common trigger",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Tension-type headache",
        "features": "Bilateral, pressing/tightening quality, mild-moderate intensity, no nausea/vomiting, no photo/phonophobia (may have one)",
        "tests": "Clinical criteria; no specific test"
      },
      {
        "diagnosis": "Cluster headache",
        "features": "Unilateral, periorbital, severe, autonomic features (lacrimation, rhinorrhea, ptosis), 15-180 min, occurs in clusters",
        "tests": "Clinical history; may see MRI normal"
      },
      {
        "diagnosis": "Medication overuse headache",
        "features": "Daily or near-daily headache; using acute medications ≥10-15 days/month",
        "tests": "Headache diary; improves with medication withdrawal"
      },
      {
        "diagnosis": "Secondary headache (intracranial pathology)",
        "features": "New onset, progressive, positional, neurological deficits, thunderclap",
        "tests": "MRI/MRA brain; consider LP"
      },
      {
        "diagnosis": "Giant cell arteritis",
        "features": "Age >50, scalp tenderness, jaw claudication, visual changes, elevated ESR/CRP",
        "tests": "ESR, CRP, temporal artery biopsy"
      },
      {
        "diagnosis": "Idiopathic intracranial hypertension",
        "features": "Positional headache, papilledema, pulsatile tinnitus, visual obscurations, obesity",
        "tests": "LP with opening pressure; MRI/MRV"
      },
      {
        "diagnosis": "Cervicogenic headache",
        "features": "Unilateral, occipital-frontal radiation, neck movement triggers, reduced ROM",
        "tests": "Physical exam; C-spine imaging; diagnostic block"
      },
      {
        "diagnosis": "Trigeminal neuralgia",
        "features": "Brief electric shock-like pain, unilateral V2/V3, triggered by touch/eating",
        "tests": "MRI for vascular loop; clinical criteria"
      }
    ],
    "evidence": [
      {
        "recommendation": "Triptans effective for acute migraine",
        "evidenceLevel": "Class I, Level A",
        "source": "[Marmura et al. Headache 2015](https://pubmed.ncbi.nlm.nih.gov/25600718/)"
      },
      {
        "recommendation": "CGRP monoclonal antibodies for prevention",
        "evidenceLevel": "Class I, Level A",
        "source": "[Goadsby et al. NEJM 2017 (erenumab STRIVE)](https://pubmed.ncbi.nlm.nih.gov/29171821/)"
      },
      {
        "recommendation": "OnabotulinumtoxinA for chronic migraine",
        "evidenceLevel": "Class I, Level A",
        "source": "[Dodick et al. Headache 2010 (PREEMPT pooled)](https://pubmed.ncbi.nlm.nih.gov/20487038/)"
      },
      {
        "recommendation": "Topiramate for migraine prevention",
        "evidenceLevel": "Class I, Level A",
        "source": "[Silberstein et al. Arch Neurol 2004](https://pubmed.ncbi.nlm.nih.gov/15096395/)"
      },
      {
        "recommendation": "Metoclopramide effective for acute migraine",
        "evidenceLevel": "Class II, Level B",
        "source": "[Friedman et al. Ann Emerg Med 2008](https://pubmed.ncbi.nlm.nih.gov/17933425/)"
      },
      {
        "recommendation": "Dexamethasone reduces recurrence",
        "evidenceLevel": "Class I, Level B",
        "source": "[Singh et al. Acad Emerg Med 2008](https://pubmed.ncbi.nlm.nih.gov/18958636/)"
      },
      {
        "recommendation": "Propranolol for migraine prevention",
        "evidenceLevel": "Class I, Level A",
        "source": "[Linde et al. Cochrane 2004](https://pubmed.ncbi.nlm.nih.gov/15106218/)"
      },
      {
        "recommendation": "Gepants (ubrogepant, rimegepant) for acute migraine",
        "evidenceLevel": "Class I, Level A",
        "source": "[Dodick et al. JAMA 2019 (ubrogepant)](https://pubmed.ncbi.nlm.nih.gov/31742631/)"
      },
      {
        "recommendation": "Magnesium for migraine with aura prevention",
        "evidenceLevel": "Class II, Level B",
        "source": "[Peikert et al. Cephalalgia 1996](https://pubmed.ncbi.nlm.nih.gov/8792038/)"
      },
      {
        "recommendation": "Exercise as effective as topiramate for prevention",
        "evidenceLevel": "Class II, Level B",
        "source": "[Varkey et al. Cephalalgia 2011](https://pubmed.ncbi.nlm.nih.gov/21816772/)"
      }
    ],
    "monitoring": [
      {
        "item": "Headache diary (frequency, severity, duration)",
        "frequency": "Continuous at home",
        "action": "Adjust preventive therapy; consider Botox or CGRP mAb",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Acute medication use days",
        "frequency": "Monthly",
        "action": "Counsel on MOH; may need withdrawal protocol",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "HIT-6 or MIDAS score",
        "frequency": "Every 3 months",
        "action": "Escalate preventive therapy",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "BP (if on beta-blocker or ARB)",
        "frequency": "Each visit",
        "action": "Adjust dose; switch agent if bradycardia",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "LFTs (if on valproate)",
        "frequency": "Baseline, 3 months, then q6mo",
        "action": "Discontinue if >3x ULN",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Bicarbonate (if on topiramate)",
        "frequency": "Baseline, 3 months",
        "action": "Consider dose reduction or discontinuation",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Weight",
        "frequency": "Each visit",
        "action": "Adjust medications based on weight changes",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Cognitive function (if on topiramate)",
        "frequency": "Each visit",
        "action": "Reduce dose or switch agent",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      }
    ],
    "disposition": [
      {
        "disposition": "Discharge home",
        "criteria": "Pain controlled; able to tolerate PO; no red flags; follow-up arranged"
      },
      {
        "disposition": "Admit to floor",
        "criteria": "Status migrainosus requiring IV therapy >24hr; inability to tolerate PO; need for DHE protocol"
      },
      {
        "disposition": "Admit to ICU",
        "criteria": "Rare; only if hemodynamic instability from medications or concern for secondary cause requiring monitoring"
      },
      {
        "disposition": "Outpatient follow-up",
        "criteria": "Within 2-4 weeks for new diagnosis; 4-12 weeks for established patients on preventives"
      }
    ]
  },
  "Transient Ischemic Attack (TIA)": {
    "id": "tia",
    "title": "Transient Ischemic Attack (TIA)",
    "version": "1.0",
    "icd10": [
      "** G45.9 (Transient cerebral ischemic attack",
      "unspecified)"
    ],
    "scope": "** Urgent evaluation, risk stratification (ABCD2), and secondary stroke prevention. Excludes completed stroke (see Acute Ischemic Stroke protocol).",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC with differential",
            "rationale": "Polycythemia, thrombocytosis as stroke risk; anemia evaluation",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "BMP",
            "rationale": "Electrolytes; glucose for hypoglycemia mimic; creatinine for contrast",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Glucose (fingerstick)",
            "rationale": "Rule out hypoglycemia as TIA mimic",
            "target": "70-180 mg/dL",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "PT/INR, PTT",
            "rationale": "Baseline coagulation; evaluate if on anticoagulation",
            "target": "Normal or therapeutic",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lipid panel (fasting)",
            "rationale": "LDL target <70 for secondary prevention",
            "target": "LDL <70 mg/dL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "HbA1c",
            "rationale": "Diabetes assessment; target <7%",
            "target": "<7%",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "TSH",
            "rationale": "Hyperthyroidism associated with atrial fibrillation",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Troponin",
            "rationale": "Concurrent cardiac ischemia; AF with rapid rate",
            "target": "Negative",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          }
        ],
        "Extended Workup": [
          {
            "item": "Homocysteine",
            "rationale": "Elevated levels increase stroke risk",
            "target": "<15 μmol/L",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lipoprotein(a)",
            "rationale": "Independent cardiovascular risk marker",
            "target": "<30 mg/dL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "hsCRP",
            "rationale": "Inflammatory marker; guides statin intensity",
            "target": "<2 mg/L",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "BNP/NT-proBNP",
            "rationale": "Heart failure; cardiac strain; AF risk",
            "target": "Age-adjusted normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Uric acid",
            "rationale": "Elevated associated with increased stroke risk",
            "target": "<6 mg/dL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Hypercoagulability panel",
            "rationale": "Age <50, cryptogenic, recurrent events; includes Factor V Leiden, prothrombin mutation, protein C/S, antithrombin III",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Antiphospholipid antibodies",
            "rationale": "Lupus anticoagulant, anticardiolipin, anti-β2GP1; young stroke",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Hemoglobin electrophoresis",
            "rationale": "Sickle cell disease if not known",
            "target": "No sickling",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "ESR, ANA",
            "rationale": "Suspected vasculitis",
            "target": "Normal/Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Fabry disease testing (α-galactosidase A)",
            "rationale": "Young cryptogenic stroke, family history, angiokeratomas",
            "target": "Normal enzyme activity",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "CT Head non-contrast",
            "timing": "Immediate",
            "target": "No hemorrhage; rule out stroke mimic",
            "contraindications": "None",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "MRI Brain with DWI",
            "timing": "Within 24 hours",
            "target": "No restricted diffusion (DWI+/ADC-) confirming infarct vs true TIA",
            "contraindications": "MRI-incompatible devices",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "CTA Head and Neck",
            "timing": "Same visit",
            "target": "No significant stenosis (>50%) in carotid, vertebral, or intracranial vessels",
            "contraindications": "Contrast allergy, CKD (relative)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "MRA Head and Neck",
            "timing": "Alternative to CTA",
            "target": "Patent vessels; no stenosis >50%",
            "contraindications": "MRI contraindications",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Carotid duplex ultrasound",
            "timing": "Within 24-48 hours",
            "target": "<50% stenosis bilaterally",
            "contraindications": "None",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "ECG (12-lead)",
            "timing": "Immediate",
            "target": "Sinus rhythm; no AF, LVH, or acute changes",
            "contraindications": "None",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Transthoracic echocardiogram",
            "timing": "Within 24-48 hours",
            "target": "No thrombus, PFO, or significant valvular disease",
            "contraindications": "None",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended": [
          {
            "item": "Cardiac telemetry (continuous)",
            "timing": "24-72 hours minimum",
            "target": "No atrial fibrillation or flutter",
            "contraindications": "None",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Holter monitor (24-48 hour)",
            "timing": "Outpatient",
            "target": "No paroxysmal AF",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Extended cardiac monitoring (14-30 day)",
            "timing": "Cryptogenic stroke/TIA",
            "target": "Detect paroxysmal AF",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Transesophageal echocardiogram",
            "timing": "Cryptogenic, young, embolic",
            "target": "No PFO, LAA thrombus, aortic arch atheroma",
            "contraindications": "Esophageal pathology",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Bubble study (TTE or TEE)",
            "timing": "Suspected paradoxical embolism",
            "target": "No right-to-left shunt",
            "contraindications": "None specific",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "CT/MR perfusion",
            "timing": "Uncertain timing, large vessel occlusion symptoms",
            "target": "No mismatch suggesting salvageable tissue",
            "contraindications": "Contrast issues",
            "ED": "EXT",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Vessel wall MRI",
            "timing": "Suspected intracranial vasculitis or dissection",
            "target": "No vessel wall enhancement",
            "contraindications": "MRI contraindications",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "DSA (cerebral angiogram)",
            "timing": "Vasculitis workup, moyamoya, uncertain vessel status",
            "target": "Define vascular anatomy",
            "contraindications": "Contrast allergy, bleeding risk",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Implantable loop recorder",
            "timing": "Recurrent cryptogenic events after negative workup",
            "target": "Detect occult AF",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "Aspirin",
            "route": "PO",
            "indication": "Immediate antiplatelet therapy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "325 mg PO x1 load",
                  "orderSentence": "Aspirin 325 mg PO x1 load PO"
                },
                {
                  "text": "81 mg PO daily",
                  "orderSentence": "Aspirin 81 mg PO daily PO"
                }
              ],
              "route": "PO",
              "instructions": "325 mg loading dose, then 81 mg daily ongoing",
              "orderSentence": "Aspirin 325 mg PO x1 load PO"
            },
            "contraindications": "Active GI bleed; aspirin allergy; planned thrombolysis",
            "monitoring": "GI symptoms, bleeding",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Clopidogrel (DAPT with aspirin)",
            "route": "PO",
            "indication": "ABCD2 ≥4 or minor stroke; first 21 days",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg PO x1 load",
                  "orderSentence": "Clopidogrel (DAPT with aspirin) 300 mg PO x1 load PO"
                },
                {
                  "text": "75 mg PO daily",
                  "orderSentence": "Clopidogrel (DAPT with aspirin) 75 mg PO daily PO"
                }
              ],
              "route": "PO",
              "instructions": "300 mg load then 75 mg daily with aspirin x21 days (POINT/CHANCE protocol)",
              "orderSentence": "Clopidogrel (DAPT with aspirin) 300 mg PO x1 load PO"
            },
            "contraindications": "Active bleeding; planned surgery within 7 days",
            "monitoring": "Bleeding, bruising",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ticagrelor (alternative DAPT)",
            "route": "PO",
            "indication": "Aspirin + ticagrelor if clopidogrel contraindicated",
            "dosing": {
              "doseOptions": [
                {
                  "text": "180 mg PO x1 load",
                  "orderSentence": "Ticagrelor (alternative DAPT) 180 mg PO x1 load PO"
                },
                {
                  "text": "90 mg PO BID",
                  "orderSentence": "Ticagrelor (alternative DAPT) 90 mg PO BID PO"
                }
              ],
              "route": "PO",
              "instructions": "180 mg load then 90 mg BID with aspirin x30 days (THALES protocol)",
              "orderSentence": "Ticagrelor (alternative DAPT) 180 mg PO x1 load PO"
            },
            "contraindications": "Active bleeding; prior ICH; severe hepatic impairment",
            "monitoring": "Bleeding, dyspnea",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Atorvastatin",
            "route": "PO",
            "indication": "High-intensity statin for LDL <70",
            "dosing": {
              "doseOptions": [
                {
                  "text": "80 mg PO daily",
                  "orderSentence": "Atorvastatin 80 mg PO daily PO"
                }
              ],
              "route": "PO",
              "instructions": "80 mg daily (high-intensity); target LDL <70 mg/dL",
              "orderSentence": "Atorvastatin 80 mg PO daily PO"
            },
            "contraindications": "Active liver disease; pregnancy",
            "monitoring": "LFTs at baseline; myalgias",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Blood pressure management",
            "route": "-",
            "indication": "Permissive hypertension acutely; goal <140/90 long-term",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Target <180/110 first 24h",
                  "orderSentence": "Blood pressure management Target <180/110 first 24h -"
                },
                {
                  "text": "<140/90 after",
                  "orderSentence": "Blood pressure management <140/90 after -"
                }
              ],
              "route": "-",
              "instructions": "Do NOT lower BP aggressively in first 24h unless >220/120 or end-organ damage",
              "orderSentence": "Blood pressure management Target <180/110 first 24h -"
            },
            "contraindications": "Symptomatic hypotension",
            "monitoring": "BP q1h x24h, then q4h",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Symptomatic Treatments": [
          {
            "item": "IV fluids (isotonic saline)",
            "route": "IV",
            "indication": "Maintain euvolemia; avoid hypotension",
            "dosing": {
              "doseOptions": [
                {
                  "text": "75-125 mL/hr NS",
                  "orderSentence": "IV fluids (isotonic saline) 75-125 mL/hr NS IV"
                }
              ],
              "route": "IV",
              "instructions": "75-125 mL/hr; adjust to maintain euvolemia; avoid D5W",
              "orderSentence": "IV fluids (isotonic saline) 75-125 mL/hr NS IV"
            },
            "contraindications": "Fluid overload, CHF",
            "monitoring": "Fluid balance, I/Os",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Pantoprazole",
            "route": "IV/PO",
            "indication": "GI protection with DAPT",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg IV daily",
                  "orderSentence": "Pantoprazole 40 mg IV daily IV/PO"
                },
                {
                  "text": "40 mg PO daily",
                  "orderSentence": "Pantoprazole 40 mg PO daily IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "40 mg daily",
              "orderSentence": "Pantoprazole 40 mg IV daily IV/PO"
            },
            "contraindications": "None",
            "monitoring": "None",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Second-line/Refractory": [
          {
            "item": "Cilostazol (triple antiplatelet)",
            "route": "PO",
            "indication": "Asian populations; high-risk stenosis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg PO BID",
                  "orderSentence": "Cilostazol (triple antiplatelet) 100 mg PO BID PO"
                }
              ],
              "route": "PO",
              "instructions": "100 mg BID; add to aspirin in select cases",
              "orderSentence": "Cilostazol (triple antiplatelet) 100 mg PO BID PO"
            },
            "contraindications": "Heart failure; bleeding",
            "monitoring": "Bleeding, headache, palpitations",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Prasugrel",
            "route": "PO",
            "indication": "Clopidogrel resistance or failure",
            "dosing": {
              "doseOptions": [
                {
                  "text": "60 mg PO x1 load",
                  "orderSentence": "Prasugrel 60 mg PO x1 load PO"
                },
                {
                  "text": "10 mg PO daily",
                  "orderSentence": "Prasugrel 10 mg PO daily PO"
                }
              ],
              "route": "PO",
              "instructions": "60 mg load then 10 mg daily; avoid if >75y or <60 kg",
              "orderSentence": "Prasugrel 60 mg PO x1 load PO"
            },
            "contraindications": "Prior TIA/stroke (black box); bleeding risk",
            "monitoring": "Bleeding",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Disease-Modifying or Chronic Therapies (Secondary Prevention)": [
          {
            "item": "Aspirin (long-term)",
            "route": "PO",
            "indication": "Lifelong secondary prevention",
            "dosing": {
              "doseOptions": [
                {
                  "text": "81 mg PO daily",
                  "orderSentence": "Aspirin (long-term) 81 mg PO daily PO"
                }
              ],
              "route": "PO",
              "instructions": "81 mg daily indefinitely",
              "orderSentence": "Aspirin (long-term) 81 mg PO daily PO"
            },
            "pretreatment": "None",
            "contraindications": "Active GI bleed",
            "monitoring": "GI symptoms; annual CBC",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Clopidogrel (monotherapy)",
            "route": "PO",
            "indication": "Alternative to aspirin if aspirin-intolerant",
            "dosing": {
              "doseOptions": [
                {
                  "text": "75 mg PO daily",
                  "orderSentence": "Clopidogrel (monotherapy) 75 mg PO daily PO"
                }
              ],
              "route": "PO",
              "instructions": "75 mg daily",
              "orderSentence": "Clopidogrel (monotherapy) 75 mg PO daily PO"
            },
            "pretreatment": "None",
            "contraindications": "Active bleeding",
            "monitoring": "Bleeding",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Aspirin + extended-release dipyridamole (Aggrenox)",
            "route": "PO",
            "indication": "Alternative antiplatelet regimen",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25/200 mg PO BID",
                  "orderSentence": "Aspirin + extended-release dipyridamole (Aggrenox) 25/200 mg PO BID PO"
                }
              ],
              "route": "PO",
              "instructions": "One capsule (25 mg ASA/200 mg ER dipyridamole) BID",
              "orderSentence": "Aspirin + extended-release dipyridamole (Aggrenox) 25/200 mg PO BID PO"
            },
            "pretreatment": "None",
            "contraindications": "Coronary stenosis (coronary steal); severe headache",
            "monitoring": "Headache (often limits use); GI",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Apixaban",
            "route": "PO",
            "indication": "Atrial fibrillation-related TIA",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg PO BID",
                  "orderSentence": "Apixaban 5 mg PO BID PO"
                },
                {
                  "text": "2.5 mg PO BID",
                  "orderSentence": "Apixaban 2.5 mg PO BID PO"
                }
              ],
              "route": "PO",
              "instructions": "5 mg BID (2.5 mg BID if ≥2 of: age ≥80, weight ≤60 kg, Cr ≥1.5)",
              "orderSentence": "Apixaban 5 mg PO BID PO"
            },
            "pretreatment": "Active major bleeding; mechanical valve",
            "contraindications": "CrCl, bleeding signs",
            "monitoring": "-",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "-"
          },
          {
            "item": "Rivaroxaban",
            "route": "PO",
            "indication": "AF-related TIA",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg PO daily",
                  "orderSentence": "Rivaroxaban 20 mg PO daily PO"
                },
                {
                  "text": "15 mg PO daily",
                  "orderSentence": "Rivaroxaban 15 mg PO daily PO"
                }
              ],
              "route": "PO",
              "instructions": "20 mg daily with food (15 mg if CrCl 15-50)",
              "orderSentence": "Rivaroxaban 20 mg PO daily PO"
            },
            "pretreatment": "Active major bleeding; mechanical valve",
            "contraindications": "CrCl, bleeding",
            "monitoring": "-",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "-"
          },
          {
            "item": "Dabigatran",
            "route": "PO",
            "indication": "AF-related TIA",
            "dosing": {
              "doseOptions": [
                {
                  "text": "150 mg PO BID",
                  "orderSentence": "Dabigatran 150 mg PO BID PO"
                },
                {
                  "text": "110 mg PO BID",
                  "orderSentence": "Dabigatran 110 mg PO BID PO"
                }
              ],
              "route": "PO",
              "instructions": "150 mg BID (110 mg BID if CrCl 30-50 or age >80)",
              "orderSentence": "Dabigatran 150 mg PO BID PO"
            },
            "pretreatment": "Active bleeding; CrCl <30; mechanical valve",
            "contraindications": "CrCl, bleeding",
            "monitoring": "-",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "-"
          },
          {
            "item": "Warfarin",
            "route": "PO",
            "indication": "Mechanical valve; some hypercoagulable states",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2-10 mg PO daily adjusted",
                  "orderSentence": "Warfarin 2-10 mg PO daily adjusted PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg daily; adjust to INR 2-3 (2.5-3.5 for mechanical valve)",
              "orderSentence": "Warfarin 2-10 mg PO daily adjusted PO"
            },
            "pretreatment": "Baseline INR",
            "contraindications": "Pregnancy; active bleeding; frequent falls",
            "monitoring": "INR weekly then monthly",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lisinopril",
            "route": "PO",
            "indication": "Blood pressure control for secondary prevention",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg PO daily",
                  "orderSentence": "Lisinopril 5 mg PO daily PO"
                },
                {
                  "text": "10 mg PO daily",
                  "orderSentence": "Lisinopril 10 mg PO daily PO"
                },
                {
                  "text": "20 mg PO daily",
                  "orderSentence": "Lisinopril 20 mg PO daily PO"
                },
                {
                  "text": "40 mg PO daily",
                  "orderSentence": "Lisinopril 40 mg PO daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5-10 mg daily; titrate to goal BP <130/80; max 40 mg",
              "orderSentence": "Lisinopril 5 mg PO daily PO"
            },
            "pretreatment": "None",
            "contraindications": "Angioedema; pregnancy; bilateral RAS; hyperkalemia",
            "monitoring": "K+, Cr, BP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Amlodipine",
            "route": "PO",
            "indication": "BP control; add-on therapy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg PO daily",
                  "orderSentence": "Amlodipine 5 mg PO daily PO"
                },
                {
                  "text": "10 mg PO daily",
                  "orderSentence": "Amlodipine 10 mg PO daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg daily; may increase to 10 mg daily",
              "orderSentence": "Amlodipine 5 mg PO daily PO"
            },
            "pretreatment": "None",
            "contraindications": "Severe aortic stenosis (relative)",
            "monitoring": "Peripheral edema, BP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Chlorthalidone",
            "route": "PO",
            "indication": "BP control; thiazide-like diuretic",
            "dosing": {
              "doseOptions": [
                {
                  "text": "12.5 mg PO daily",
                  "orderSentence": "Chlorthalidone 12.5 mg PO daily PO"
                },
                {
                  "text": "25 mg PO daily",
                  "orderSentence": "Chlorthalidone 25 mg PO daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 12.5 mg daily; may increase to 25 mg daily",
              "orderSentence": "Chlorthalidone 12.5 mg PO daily PO"
            },
            "pretreatment": "None",
            "contraindications": "Severe hypokalemia; severe hyponatremia",
            "monitoring": "K+, Na+, uric acid, glucose",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ezetimibe",
            "route": "PO",
            "indication": "Add-on for LDL not at goal on statin",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg PO daily",
                  "orderSentence": "Ezetimibe 10 mg PO daily PO"
                }
              ],
              "route": "PO",
              "instructions": "10 mg daily",
              "orderSentence": "Ezetimibe 10 mg PO daily PO"
            },
            "pretreatment": "None",
            "contraindications": "Severe hepatic impairment",
            "monitoring": "LFTs",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "PCSK9 inhibitor (evolocumab, alirocumab)",
            "route": "SC",
            "indication": "LDL >70 despite maximal statin + ezetimibe",
            "dosing": {
              "doseOptions": [
                {
                  "text": "140 mg SC q2wk",
                  "orderSentence": "PCSK9 inhibitor (evolocumab, alirocumab) 140 mg SC q2wk SC"
                },
                {
                  "text": "420 mg SC monthly",
                  "orderSentence": "PCSK9 inhibitor (evolocumab, alirocumab) 420 mg SC monthly SC"
                }
              ],
              "route": "SC",
              "instructions": "Evolocumab 140 mg q2wk or 420 mg monthly; alirocumab 75-150 mg q2wk",
              "orderSentence": "PCSK9 inhibitor (evolocumab, alirocumab) 140 mg SC q2wk SC"
            },
            "pretreatment": "LFTs, lipid panel",
            "contraindications": "None",
            "monitoring": "Injection site reactions; LDL",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Icosapent ethyl (Vascepa)",
            "route": "PO",
            "indication": "Triglycerides ≥150 despite statin; reduces CV events",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 g PO BID",
                  "orderSentence": "Icosapent ethyl (Vascepa) 2 g PO BID PO"
                }
              ],
              "route": "PO",
              "instructions": "2 g BID with meals",
              "orderSentence": "Icosapent ethyl (Vascepa) 2 g PO BID PO"
            },
            "pretreatment": "None",
            "contraindications": "Seafood/fish allergy (relative)",
            "monitoring": "AF monitoring (slightly increased risk)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Carotid endarterectomy (CEA)",
            "route": "Surgical",
            "indication": "Symptomatic carotid stenosis 70-99%; 50-69% in select",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Surgery",
                  "orderSentence": "Carotid endarterectomy (CEA) Surgery Surgical"
                }
              ],
              "route": "Surgical",
              "instructions": "Perform within 2 weeks of TIA if stable; high-volume surgeon",
              "orderSentence": "Carotid endarterectomy (CEA) Surgery Surgical"
            },
            "pretreatment": "None",
            "contraindications": "Unstable plaque with delay; total occlusion",
            "monitoring": "Surgical complications; stroke",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Carotid artery stenting (CAS)",
            "route": "Endovascular",
            "indication": "CEA high-risk; radiation neck; recurrent stenosis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Stenting",
                  "orderSentence": "Carotid artery stenting (CAS) Stenting Endovascular"
                }
              ],
              "route": "Endovascular",
              "instructions": "Alternative to CEA; requires DAPT",
              "orderSentence": "Carotid artery stenting (CAS) Stenting Endovascular"
            },
            "pretreatment": "None",
            "contraindications": "Tortuous anatomy; heavy calcification",
            "monitoring": "Hyperperfusion syndrome; stroke",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "PFO closure",
            "route": "Endovascular",
            "indication": "Age <60, PFO with shunt, cryptogenic stroke/TIA",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Device closure",
                  "orderSentence": "PFO closure Device closure Endovascular"
                }
              ],
              "route": "Endovascular",
              "instructions": "Consider after comprehensive evaluation; DAPT post-procedure",
              "orderSentence": "PFO closure Device closure Endovascular"
            },
            "pretreatment": "None",
            "contraindications": "Small PFO without shunt",
            "monitoring": "AF (transient); device complications",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurology/Stroke consult for urgent evaluation, risk stratification, and secondary prevention optimization",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Cardiology consultation for atrial fibrillation management, anticoagulation decisions, and PFO evaluation",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vascular surgery consultation for symptomatic carotid stenosis ≥50% to evaluate for endarterectomy timing",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Interventional neurology for carotid stenting evaluation if CEA high-risk or anatomically unsuitable",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Cardiac electrophysiology for recurrent AF management and potential ablation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Registered dietitian for Mediterranean diet counseling and sodium restriction education",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Smoking cessation counseling and pharmacotherapy initiation if current smoker",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Call 911 immediately if symptoms return as this indicates high stroke risk (up to 10% in first 48 hours)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Do not drive for at least 2-4 weeks after TIA per state regulations and stroke risk",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Take all medications as prescribed especially antiplatelet therapy which significantly reduces stroke risk",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Know stroke warning signs (FAST: Face drooping, Arm weakness, Speech difficulty, Time to call 911)",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Keep follow-up appointments as early intervention reduces stroke risk by up to 80%",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Blood pressure target <130/80 mmHg to significantly reduce stroke recurrence risk",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "LDL target <70 mg/dL with high-intensity statin for secondary prevention",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Smoking cessation (reduces stroke risk by 50% within 1 year of quitting)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Mediterranean diet emphasizing fruits, vegetables, whole grains, fish, and olive oil",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Limit alcohol to ≤1 drink/day for women, ≤2 drinks/day for men",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Regular aerobic exercise (150 min/week moderate or 75 min/week vigorous)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Weight management with target BMI 18.5-24.9 kg/m²",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Sodium restriction <2300 mg/day (ideally <1500 mg if hypertensive)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Migraine with aura",
        "features": "Gradual onset (minutes), visual scintillations, headache follows; younger patient",
        "tests": "Clinical history; normal DWI"
      },
      {
        "diagnosis": "Seizure with Todd's paralysis",
        "features": "Preceding convulsion; confusion; gradual resolution over hours",
        "tests": "EEG; clinical history"
      },
      {
        "diagnosis": "Hypoglycemia",
        "features": "Altered mentation, diaphoresis, tremor; resolves with glucose",
        "tests": "Fingerstick glucose"
      },
      {
        "diagnosis": "Peripheral vertigo (BPPV, vestibular neuritis)",
        "features": "Isolated vertigo with nystagmus; positive Dix-Hallpike",
        "tests": "HINTS exam; no central signs"
      },
      {
        "diagnosis": "Transient global amnesia",
        "features": "Isolated anterograde amnesia; repetitive questioning; resolves <24h",
        "tests": "Clinical criteria; DWI may show hippocampal lesions"
      },
      {
        "diagnosis": "Functional neurological disorder",
        "features": "Inconsistent exam; incongruent symptoms; often with psychiatric comorbidity",
        "tests": "Clinical exam; normal workup"
      },
      {
        "diagnosis": "Bell's palsy",
        "features": "Peripheral facial weakness (forehead involved); no other deficits",
        "tests": "Clinical exam"
      },
      {
        "diagnosis": "Hypertensive encephalopathy",
        "features": "Severe HTN; headache; confusion; visual changes",
        "tests": "BP, posterior MRI findings"
      },
      {
        "diagnosis": "Demyelinating disease (MS)",
        "features": "Younger patient; prior episodes; MRI with characteristic lesions",
        "tests": "MRI brain/spine; CSF"
      }
    ],
    "evidence": [
      {
        "recommendation": "Dual antiplatelet therapy (DAPT) for 21 days after minor stroke/TIA",
        "evidenceLevel": "Class I, Level A",
        "source": "[Wang et al. NEJM 2021 (CHANCE-2)](https://pubmed.ncbi.nlm.nih.gov/34265411/); [Johnston et al. NEJM 2018 (POINT)](https://pubmed.ncbi.nlm.nih.gov/29766749/)"
      },
      {
        "recommendation": "High-intensity statin for LDL <70 mg/dL",
        "evidenceLevel": "Class I, Level A",
        "source": "[Amarenco et al. NEJM 2006 (SPARCL)](https://pubmed.ncbi.nlm.nih.gov/16899775/)"
      },
      {
        "recommendation": "CEA for symptomatic carotid stenosis 70-99%",
        "evidenceLevel": "Class I, Level A",
        "source": "[NASCET Collaborators. NEJM 1991](https://pubmed.ncbi.nlm.nih.gov/1852179/)"
      },
      {
        "recommendation": "ABCD2 score for TIA risk stratification",
        "evidenceLevel": "Class IIa, Level B",
        "source": "[Johnston et al. Lancet 2007](https://pubmed.ncbi.nlm.nih.gov/17258668/)"
      },
      {
        "recommendation": "Extended cardiac monitoring for cryptogenic stroke",
        "evidenceLevel": "Class IIa, Level B",
        "source": "[Sanna et al. NEJM 2014 (CRYSTAL-AF)](https://pubmed.ncbi.nlm.nih.gov/24963567/)"
      },
      {
        "recommendation": "PFO closure in cryptogenic stroke <60 years",
        "evidenceLevel": "Class IIa, Level B",
        "source": "[Mas et al. NEJM 2017 (CLOSE)](https://pubmed.ncbi.nlm.nih.gov/28902593/)"
      },
      {
        "recommendation": "BP target <130/80 for secondary prevention",
        "evidenceLevel": "Class I, Level B",
        "source": "[AHA/ASA Guidelines 2021](https://pubmed.ncbi.nlm.nih.gov/34024117/)"
      },
      {
        "recommendation": "Urgent TIA evaluation reduces stroke risk",
        "evidenceLevel": "Class I, Level B",
        "source": "[Rothwell et al. Lancet 2007 (EXPRESS)](https://pubmed.ncbi.nlm.nih.gov/17928046/)"
      },
      {
        "recommendation": "DOACs preferred over warfarin for NVAF",
        "evidenceLevel": "Class I, Level A",
        "source": "[Ruff et al. Lancet 2014 (meta-analysis)](https://pubmed.ncbi.nlm.nih.gov/24315724/)"
      }
    ],
    "monitoring": [
      {
        "item": "Neurological exam",
        "frequency": "q1h x 24h then q4h",
        "action": "Immediate imaging if worsening",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "-"
      },
      {
        "item": "Blood pressure",
        "frequency": "q1h x 24h then q4h",
        "action": "Titrate antihypertensives",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Cardiac rhythm (telemetry)",
        "frequency": "Continuous x 24-72h",
        "action": "Anticoagulation if AF detected",
        "ED": "URGENT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "-"
      },
      {
        "item": "Extended cardiac monitoring",
        "frequency": "14-30 days outpatient",
        "action": "Anticoagulation if AF detected",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "ABCD2 score",
        "frequency": "At presentation",
        "action": "High-risk patients need admission or rapid TIA clinic",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "-"
      },
      {
        "item": "LDL cholesterol",
        "frequency": "Baseline, 6 weeks, then annually",
        "action": "Intensify statin or add ezetimibe/PCSK9i",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "HbA1c",
        "frequency": "Baseline, then q3mo if diabetic",
        "action": "Optimize diabetes management",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Creatinine/eGFR",
        "frequency": "With contrast; then annually",
        "action": "Dose-adjust medications",
        "ED": "STAT",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      }
    ],
    "disposition": [
      {
        "disposition": "Rapid TIA clinic (<24-48h)",
        "criteria": "ABCD2 <4; no acute findings on imaging; reliable patient with close follow-up"
      },
      {
        "disposition": "Admit to stroke unit",
        "criteria": "ABCD2 ≥4; DWI positive (minor stroke); symptomatic carotid stenosis; new AF; unable to complete workup as outpatient"
      },
      {
        "disposition": "Admit to ICU",
        "criteria": "Rare for isolated TIA; only if concurrent acute coronary syndrome or hemodynamic instability"
      },
      {
        "disposition": "Discharge with urgent follow-up",
        "criteria": "Completed rapid workup; started on secondary prevention; ABCD2 <4; no high-risk features"
      }
    ]
  },
  "Dementia Evaluation": {
    "id": "dementia-evaluation",
    "title": "Dementia Evaluation",
    "version": "1.0",
    "icd10": [
      "** G31.9 (Degenerative disease of nervous system",
      "unspecified)",
      "R41.81 (Age-related cognitive decline)",
      "F03.90 (Unspecified dementia without behavioral disturbance)"
    ],
    "scope": "** Comprehensive evaluation for cognitive impairment, identification of reversible causes, dementia subtype diagnosis, and symptomatic management. Covers Alzheimer's disease, vascular dementia, frontotemporal dementia, and dementia with Lewy bodies.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC with differential",
            "rationale": "Infection, anemia, malignancy contributing to cognitive changes",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "BMP",
            "rationale": "Hyponatremia, uremia, hypercalcemia as causes",
            "target": "Normal electrolytes, BUN, Cr",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "TSH",
            "rationale": "Hypothyroidism is reversible cause of cognitive impairment",
            "target": "0.4-4.0 mIU/L",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin B12",
            "rationale": "Deficiency causes reversible dementia",
            "target": ">300 pg/mL (>400 optimal)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Folate",
            "rationale": "Deficiency contributes to cognitive impairment",
            "target": ">3 ng/mL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Glucose (fasting)",
            "rationale": "Diabetes management affects cognition",
            "target": "70-100 mg/dL",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Hepatic panel (LFTs, albumin)",
            "rationale": "Hepatic encephalopathy; nutritional status",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Urinalysis",
            "rationale": "UTI common cause of acute confusion in elderly",
            "target": "Negative for infection",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended Workup": [
          {
            "item": "Vitamin D, 25-hydroxy",
            "rationale": "Deficiency associated with cognitive decline",
            "target": ">30 ng/mL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Hemoglobin A1c",
            "rationale": "Chronic glucose control affects cognition",
            "target": "<7%",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lipid panel",
            "rationale": "Vascular risk factor for vascular dementia",
            "target": "LDL <100 mg/dL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Homocysteine",
            "rationale": "Elevated levels associated with AD and vascular dementia",
            "target": "<15 μmol/L",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "RPR or VDRL",
            "rationale": "Neurosyphilis (rare but treatable)",
            "target": "Nonreactive",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "HIV testing",
            "rationale": "HIV-associated neurocognitive disorder",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "ESR, CRP",
            "rationale": "Inflammatory/autoimmune causes",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Heavy metal panel (lead, mercury, arsenic)",
            "rationale": "Toxic exposure history",
            "target": "Normal",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Copper, ceruloplasmin",
            "rationale": "Wilson's disease if age <50",
            "target": "Normal",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Paraneoplastic antibody panel",
            "rationale": "Autoimmune dementia; occult malignancy",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Anti-neuronal antibodies (NMDA-R, LGI1, CASPR2, GABA-B, AMPA-R)",
            "rationale": "Autoimmune encephalitis",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Genetic testing (APOE, PSEN1, PSEN2, APP)",
            "rationale": "Family history early-onset AD; prognostic",
            "target": "Variable",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Prion protein gene testing",
            "rationale": "Suspected CJD with family history",
            "target": "No mutation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "Cell count, protein, glucose",
            "rationale": "Rule out infection, inflammation",
            "target": "WBC <5, protein <45 mg/dL, glucose >60% serum",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CSF Aβ42 (amyloid beta 1-42)",
            "rationale": "Low in Alzheimer's disease",
            "target": "<600 pg/mL suggests AD",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CSF total tau",
            "rationale": "Elevated in neurodegeneration",
            "target": "<400 pg/mL normal; elevated in AD",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CSF p-tau (phosphorylated tau 181)",
            "rationale": "Specific for AD pathology",
            "target": "Elevated in AD; Aβ42/p-tau ratio most predictive",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CSF Aβ42/Aβ40 ratio",
            "rationale": "More accurate than Aβ42 alone",
            "target": "<0.05-0.08 suggests AD (assay-dependent)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "14-3-3 protein",
            "rationale": "Creutzfeldt-Jakob disease",
            "target": "Positive in CJD (not specific)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "RT-QuIC",
            "rationale": "Prion disease confirmation",
            "target": "Positive indicates CJD",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Autoimmune encephalitis panel",
            "rationale": "Autoimmune dementia",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "VDRL",
            "rationale": "Neurosyphilis",
            "target": "Nonreactive",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "MRI Brain without contrast",
            "timing": "At initial evaluation",
            "target": "Assess atrophy pattern; rule out structural causes (tumor, SDH, NPH)",
            "contraindications": "MRI-incompatible devices",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CT Head non-contrast",
            "timing": "If MRI unavailable or contraindicated",
            "target": "Rule out mass, hemorrhage, hydrocephalus",
            "contraindications": "None",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended": [
          {
            "item": "MRI Brain volumetrics",
            "timing": "Disease monitoring; clinical trials",
            "target": "Hippocampal and whole brain atrophy quantification",
            "contraindications": "MRI contraindications",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "FDG-PET Brain",
            "timing": "Differentiate AD from FTD; atypical presentations",
            "target": "AD: temporoparietal hypometabolism; FTD: frontal/temporal hypometabolism",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Amyloid PET (florbetapir, florbetaben, flutemetamol)",
            "timing": "Atypical age/presentation; clinical trial eligibility",
            "target": "Positive: amyloid deposition; negative rules out AD",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Tau PET (flortaucipir)",
            "timing": "Research; staging AD pathology",
            "target": "Pattern correlates with clinical phenotype",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "DaTscan (ioflupane I-123)",
            "timing": "Differentiate DLB from AD",
            "target": "Reduced: DLB/PDD; Normal: AD",
            "contraindications": "Iodine hypersensitivity",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "EEG",
            "timing": "Encephalopathy; CJD; seizures",
            "target": "AD: mild slowing; CJD: periodic sharp wave complexes",
            "contraindications": "None",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sleep study (polysomnography)",
            "timing": "Sleep apnea contributing to cognition; RBD suggesting DLB",
            "target": "Assess AHI; REM without atonia",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "SPECT (perfusion)",
            "timing": "Alternative to PET if unavailable",
            "target": "Regional hypoperfusion patterns",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "MRI with SWI/GRE sequences",
            "timing": "Cerebral amyloid angiopathy; microbleeds",
            "target": "Lobar microbleeds pattern",
            "contraindications": "MRI contraindications",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Whole body PET-CT",
            "timing": "Paraneoplastic workup",
            "target": "Identify occult malignancy",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "Treat reversible causes",
            "route": "Various",
            "indication": "Identified metabolic/infectious etiology",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per cause",
                  "orderSentence": "Treat reversible causes Per cause Various"
                }
              ],
              "route": "Various",
              "instructions": "Correct hyponatremia, treat UTI, replace B12, treat hypothyroidism",
              "orderSentence": "Treat reversible causes Per cause Various"
            },
            "contraindications": "Depends on intervention",
            "monitoring": "Cognitive reassessment after treatment",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Thiamine (if nutritional risk)",
            "route": "IV/PO",
            "indication": "Suspected Wernicke's; alcoholism; malnutrition",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mg IV TID x 3 days",
                  "orderSentence": "Thiamine (if nutritional risk) 500 mg IV TID x 3 days IV/PO"
                },
                {
                  "text": "100 mg PO daily",
                  "orderSentence": "Thiamine (if nutritional risk) 100 mg PO daily IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "500 mg IV TID x 3 days if Wernicke suspected; then 100 mg PO daily",
              "orderSentence": "Thiamine (if nutritional risk) 500 mg IV TID x 3 days IV/PO"
            },
            "contraindications": "None",
            "monitoring": "Clinical improvement",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin B12",
            "route": "IM/PO",
            "indication": "B12 deficiency",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mcg IM daily x 7 days",
                  "orderSentence": "Vitamin B12 1000 mcg IM daily x 7 days IM/PO"
                },
                {
                  "text": "1000 mcg IM weekly x 4",
                  "orderSentence": "Vitamin B12 1000 mcg IM weekly x 4 IM/PO"
                },
                {
                  "text": "1000-2000 mcg PO daily",
                  "orderSentence": "Vitamin B12 1000-2000 mcg PO daily IM/PO"
                }
              ],
              "route": "IM/PO",
              "instructions": "1000 mcg IM daily x 7d, then weekly x 4wk, then monthly; or high-dose oral 1000-2000 mcg daily",
              "orderSentence": "Vitamin B12 1000 mcg IM daily x 7 days IM/PO"
            },
            "contraindications": "None",
            "monitoring": "B12 level, MMA; neuro improvement over months",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Symptomatic Treatments (Behavioral)": [
          {
            "item": "Citalopram",
            "route": "PO",
            "indication": "Depression; agitation in dementia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg daily",
                  "orderSentence": "Citalopram 10 mg daily PO"
                },
                {
                  "text": "20 mg daily",
                  "orderSentence": "Citalopram 20 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10 mg daily; max 20 mg in elderly (QT risk)",
              "orderSentence": "Citalopram 10 mg daily PO"
            },
            "contraindications": "QT prolongation; concurrent QT-prolonging drugs",
            "monitoring": "QTc (especially >20 mg)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sertraline",
            "route": "PO",
            "indication": "Depression; anxiety in dementia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg daily",
                  "orderSentence": "Sertraline 25 mg daily PO"
                },
                {
                  "text": "50 mg daily",
                  "orderSentence": "Sertraline 50 mg daily PO"
                },
                {
                  "text": "100 mg daily",
                  "orderSentence": "Sertraline 100 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg daily; titrate by 25 mg q1-2wk; typical 50-100 mg",
              "orderSentence": "Sertraline 25 mg daily PO"
            },
            "contraindications": "MAOIs",
            "monitoring": "GI upset initially",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Mirtazapine",
            "route": "PO",
            "indication": "Depression with poor appetite and insomnia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "7.5 mg qHS",
                  "orderSentence": "Mirtazapine 7.5 mg qHS PO"
                },
                {
                  "text": "15 mg qHS",
                  "orderSentence": "Mirtazapine 15 mg qHS PO"
                },
                {
                  "text": "30 mg qHS",
                  "orderSentence": "Mirtazapine 30 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 7.5-15 mg qHS; may increase to 30 mg qHS",
              "orderSentence": "Mirtazapine 7.5 mg qHS PO"
            },
            "contraindications": "MAOIs",
            "monitoring": "Weight gain, sedation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Trazodone",
            "route": "PO",
            "indication": "Insomnia; sundowning; agitation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Trazodone 25 mg qHS PO"
                },
                {
                  "text": "50 mg qHS",
                  "orderSentence": "Trazodone 50 mg qHS PO"
                },
                {
                  "text": "100 mg qHS",
                  "orderSentence": "Trazodone 100 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25-50 mg qHS; titrate by 25-50 mg; typical 50-150 mg qHS",
              "orderSentence": "Trazodone 25 mg qHS PO"
            },
            "contraindications": "Concurrent MAOIs; QT prolongation",
            "monitoring": "Orthostatic hypotension, priapism (rare)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Quetiapine",
            "route": "PO",
            "indication": "Severe agitation/psychosis when non-pharmacologic fails",
            "dosing": {
              "doseOptions": [
                {
                  "text": "12.5 mg qHS",
                  "orderSentence": "Quetiapine 12.5 mg qHS PO"
                },
                {
                  "text": "25 mg BID",
                  "orderSentence": "Quetiapine 25 mg BID PO"
                },
                {
                  "text": "50 mg BID",
                  "orderSentence": "Quetiapine 50 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 12.5-25 mg qHS; titrate slowly; keep dose as low as possible",
              "orderSentence": "Quetiapine 12.5 mg qHS PO"
            },
            "contraindications": "Black box: increased mortality in dementia",
            "monitoring": "Metabolic effects, sedation, QTc",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Risperidone",
            "route": "PO",
            "indication": "Severe aggression/psychosis (short-term use only)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.25 mg BID",
                  "orderSentence": "Risperidone 0.25 mg BID PO"
                },
                {
                  "text": "0.5 mg BID",
                  "orderSentence": "Risperidone 0.5 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.25 mg BID; max 1 mg BID; short-term use only",
              "orderSentence": "Risperidone 0.25 mg BID PO"
            },
            "contraindications": "Black box: increased mortality in dementia",
            "monitoring": "EPS, metabolic, stroke risk",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Haloperidol",
            "route": "IM/IV/PO",
            "indication": "Acute severe agitation in delirium (not chronic)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5 mg IM",
                  "orderSentence": "Haloperidol 0.5 mg IM IM/IV/PO"
                },
                {
                  "text": "1 mg IM",
                  "orderSentence": "Haloperidol 1 mg IM IM/IV/PO"
                },
                {
                  "text": "2 mg IM",
                  "orderSentence": "Haloperidol 2 mg IM IM/IV/PO"
                }
              ],
              "route": "IM/IV/PO",
              "instructions": "0.5-2 mg IM/IV q4-6h PRN; short-term only; avoid chronic use",
              "orderSentence": "Haloperidol 0.5 mg IM IM/IV/PO"
            },
            "contraindications": "QT prolongation; Parkinson's; DLB",
            "monitoring": "QTc, EPS",
            "ED": "STAT",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Melatonin",
            "route": "PO",
            "indication": "Sleep disturbance; sundowning",
            "dosing": {
              "doseOptions": [
                {
                  "text": "3 mg qHS",
                  "orderSentence": "Melatonin 3 mg qHS PO"
                },
                {
                  "text": "6 mg qHS",
                  "orderSentence": "Melatonin 6 mg qHS PO"
                },
                {
                  "text": "9 mg qHS",
                  "orderSentence": "Melatonin 9 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 3 mg qHS; may increase to 9 mg; give 30 min before bed",
              "orderSentence": "Melatonin 3 mg qHS PO"
            },
            "contraindications": "None",
            "monitoring": "Daytime sedation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Cognitive Enhancers": [
          {
            "item": "Donepezil",
            "route": "PO",
            "indication": "Mild-moderate AD; vascular dementia; DLB",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg qHS",
                  "orderSentence": "Donepezil 5 mg qHS PO"
                },
                {
                  "text": "10 mg qHS",
                  "orderSentence": "Donepezil 10 mg qHS PO"
                },
                {
                  "text": "23 mg daily",
                  "orderSentence": "Donepezil 23 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg qHS x 4-6 weeks; increase to 10 mg qHS; 23 mg for moderate-severe",
              "orderSentence": "Donepezil 5 mg qHS PO"
            },
            "contraindications": "Sick sinus syndrome; GI bleeding; COPD exacerbation",
            "monitoring": "Bradycardia, GI symptoms, vivid dreams",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rivastigmine oral",
            "route": "PO",
            "indication": "Mild-moderate AD; Parkinson's dementia; DLB",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1.5 mg BID",
                  "orderSentence": "Rivastigmine oral 1.5 mg BID PO"
                },
                {
                  "text": "3 mg BID",
                  "orderSentence": "Rivastigmine oral 3 mg BID PO"
                },
                {
                  "text": "4.5 mg BID",
                  "orderSentence": "Rivastigmine oral 4.5 mg BID PO"
                },
                {
                  "text": "6 mg BID",
                  "orderSentence": "Rivastigmine oral 6 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 1.5 mg BID; increase by 1.5 mg BID q2wk; target 6 mg BID",
              "orderSentence": "Rivastigmine oral 1.5 mg BID PO"
            },
            "contraindications": "Same as donepezil; severe hepatic impairment",
            "monitoring": "GI symptoms, weight loss",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rivastigmine patch",
            "route": "TD",
            "indication": "Mild-moderate AD; better GI tolerability",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4.6 mg/24hr",
                  "orderSentence": "Rivastigmine patch 4.6 mg/24hr TD"
                },
                {
                  "text": "9.5 mg/24hr",
                  "orderSentence": "Rivastigmine patch 9.5 mg/24hr TD"
                },
                {
                  "text": "13.3 mg/24hr",
                  "orderSentence": "Rivastigmine patch 13.3 mg/24hr TD"
                }
              ],
              "route": "TD",
              "instructions": "Start 4.6 mg/24hr patch; increase q4wk; target 9.5-13.3 mg/24hr",
              "orderSentence": "Rivastigmine patch 4.6 mg/24hr TD"
            },
            "contraindications": "Same as oral",
            "monitoring": "Skin irritation, GI symptoms",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Galantamine",
            "route": "PO",
            "indication": "Mild-moderate AD",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4 mg BID",
                  "orderSentence": "Galantamine 4 mg BID PO"
                },
                {
                  "text": "8 mg BID",
                  "orderSentence": "Galantamine 8 mg BID PO"
                },
                {
                  "text": "12 mg BID",
                  "orderSentence": "Galantamine 12 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 4 mg BID x 4wk; increase to 8 mg BID x 4wk; target 8-12 mg BID",
              "orderSentence": "Galantamine 4 mg BID PO"
            },
            "contraindications": "Same as donepezil; severe renal/hepatic",
            "monitoring": "GI symptoms, bradycardia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Galantamine ER",
            "route": "PO",
            "indication": "Once daily option",
            "dosing": {
              "doseOptions": [
                {
                  "text": "8 mg daily",
                  "orderSentence": "Galantamine ER 8 mg daily PO"
                },
                {
                  "text": "16 mg daily",
                  "orderSentence": "Galantamine ER 16 mg daily PO"
                },
                {
                  "text": "24 mg daily",
                  "orderSentence": "Galantamine ER 24 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 8 mg daily x 4wk; increase q4wk; target 16-24 mg daily",
              "orderSentence": "Galantamine ER 8 mg daily PO"
            },
            "contraindications": "Same as IR",
            "monitoring": "Same as IR",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Memantine",
            "route": "PO",
            "indication": "Moderate-severe AD; add to cholinesterase inhibitor",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg daily",
                  "orderSentence": "Memantine 5 mg daily PO"
                },
                {
                  "text": "5 mg BID",
                  "orderSentence": "Memantine 5 mg BID PO"
                },
                {
                  "text": "10 mg BID",
                  "orderSentence": "Memantine 10 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg daily; increase by 5 mg/wk; target 10 mg BID",
              "orderSentence": "Memantine 5 mg daily PO"
            },
            "contraindications": "Severe renal impairment (dose adjust CrCl <30)",
            "monitoring": "Confusion, dizziness, constipation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Memantine XR",
            "route": "PO",
            "indication": "Once daily option",
            "dosing": {
              "doseOptions": [
                {
                  "text": "7 mg daily",
                  "orderSentence": "Memantine XR 7 mg daily PO"
                },
                {
                  "text": "14 mg daily",
                  "orderSentence": "Memantine XR 14 mg daily PO"
                },
                {
                  "text": "21 mg daily",
                  "orderSentence": "Memantine XR 21 mg daily PO"
                },
                {
                  "text": "28 mg daily",
                  "orderSentence": "Memantine XR 28 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 7 mg daily; increase by 7 mg/wk; target 28 mg daily",
              "orderSentence": "Memantine XR 7 mg daily PO"
            },
            "contraindications": "Same as IR",
            "monitoring": "Same as IR",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Memantine + Donepezil (Namzaric)",
            "route": "PO",
            "indication": "Moderate-severe AD on both medications",
            "dosing": {
              "doseOptions": [
                {
                  "text": "28/10 mg daily",
                  "orderSentence": "Memantine + Donepezil (Namzaric) 28/10 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "28 mg memantine XR + 10 mg donepezil; take qHS",
              "orderSentence": "Memantine + Donepezil (Namzaric) 28/10 mg daily PO"
            },
            "contraindications": "Same as individual drugs",
            "monitoring": "Same as individual drugs",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Disease-Modifying Therapies (Anti-Amyloid)": [
          {
            "item": "Lecanemab (Leqembi)",
            "route": "IV",
            "indication": "Early AD with confirmed amyloid pathology (MCI or mild dementia)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg/kg IV q2wk",
                  "orderSentence": "Lecanemab (Leqembi) 10 mg/kg IV q2wk IV"
                }
              ],
              "route": "IV",
              "instructions": "10 mg/kg IV every 2 weeks; infuse over 1 hour",
              "orderSentence": "Lecanemab (Leqembi) 10 mg/kg IV q2wk IV"
            },
            "pretreatment": "Amyloid PET or CSF confirming amyloid; MRI baseline; APOE genotyping recommended",
            "contraindications": "ARIA risk with anticoagulation; >4 microbleeds on MRI; recent stroke/TIA",
            "monitoring": "MRI at baseline, weeks 14, 52, 78; monitor for ARIA-E/H",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Donanemab (Kisunla)",
            "route": "IV",
            "indication": "Early AD with confirmed amyloid and tau pathology",
            "dosing": {
              "doseOptions": [
                {
                  "text": "700 mg IV q4wk x 3",
                  "orderSentence": "Donanemab (Kisunla) 700 mg IV q4wk x 3 IV"
                },
                {
                  "text": "1400 mg IV q4wk",
                  "orderSentence": "Donanemab (Kisunla) 1400 mg IV q4wk IV"
                }
              ],
              "route": "IV",
              "instructions": "700 mg q4wk x 3 doses, then 1400 mg q4wk until amyloid cleared",
              "orderSentence": "Donanemab (Kisunla) 700 mg IV q4wk x 3 IV"
            },
            "pretreatment": "Amyloid PET positive; tau PET intermediate/high",
            "contraindications": "Similar to lecanemab; higher ARIA risk with APOE4 homozygotes",
            "monitoring": "MRI at baseline, weeks 16, 24, 52, 76; ARIA monitoring",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Aducanumab (Aduhelm)",
            "route": "IV",
            "indication": "Early AD with confirmed amyloid (limited use)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Titration to 10 mg/kg IV q4wk",
                  "orderSentence": "Aducanumab (Aduhelm) Titration to 10 mg/kg IV q4wk IV"
                }
              ],
              "route": "IV",
              "instructions": "Slow titration: 1→3→6→10 mg/kg monthly",
              "orderSentence": "Aducanumab (Aduhelm) Titration to 10 mg/kg IV q4wk IV"
            },
            "pretreatment": "Same as lecanemab",
            "contraindications": "Same as lecanemab; limited clinical adoption",
            "monitoring": "MRI for ARIA monitoring",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurology/Cognitive neurology for diagnosis confirmation, subtype classification, and treatment planning",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Neuropsychology for comprehensive cognitive testing to establish baseline and guide diagnosis",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Geriatric psychiatry for behavioral symptoms, medication management, and capacity evaluation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Occupational therapy for ADL assessment, cognitive strategies, and home safety evaluation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Speech therapy for communication strategies and swallowing evaluation if dysphagia present",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Social work for caregiver support, community resources, and long-term care planning",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Palliative care for advanced dementia symptom management and goals of care discussions",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Legal/Elder law attorney for advance directives, healthcare proxy, and financial planning while patient has capacity",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Genetics counseling if familial/early-onset AD for family members",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Return immediately if sudden confusion worsens which may indicate stroke, infection, or medication effect",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Complete advance directives while patient has capacity to document wishes for future care",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Establish healthcare proxy/power of attorney for future decision-making",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Do not drive if cognitive impairment affects judgment or reaction time (formal driving evaluation may be needed)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Take all medications as prescribed and use pill organizers or reminders to ensure adherence",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Keep a consistent daily routine which helps with orientation and reduces confusion",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Engage in mentally stimulating activities (reading, puzzles, social interaction) to support cognitive reserve",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Regular physical exercise (150 min/week moderate aerobic) may slow cognitive decline",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Mediterranean or MIND diet emphasizing vegetables, berries, fish, nuts, and olive oil",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Adequate sleep (7-8 hours) and treat sleep disorders (sleep apnea assessment)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Social engagement and cognitive stimulation through activities, hobbies, and relationships",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Cardiovascular risk factor control (BP <130/80, diabetes control, cholesterol management) reduces vascular contribution",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Hearing loss correction with hearing aids as untreated hearing loss is modifiable dementia risk factor",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Limit alcohol to ≤1 drink daily as excess alcohol accelerates cognitive decline",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Fall prevention with home modifications as dementia increases fall and injury risk",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Delirium",
        "features": "Acute onset; fluctuating attention; identifiable cause (infection, medication, metabolic)",
        "tests": "Resolve cause; reassess cognition when clear"
      },
      {
        "diagnosis": "Depression (pseudodementia)",
        "features": "Prominent mood symptoms; often aware of deficits; improves with antidepressants",
        "tests": "GDS, PHQ-9; trial of antidepressant"
      },
      {
        "diagnosis": "Alzheimer's disease",
        "features": "Insidious onset; short-term memory most affected; language and visuospatial later",
        "tests": "MRI hippocampal atrophy; amyloid/tau PET or CSF biomarkers"
      },
      {
        "diagnosis": "Vascular dementia",
        "features": "Stepwise decline; focal findings; executive dysfunction; vascular risk factors",
        "tests": "MRI with significant white matter disease, strategic infarcts"
      },
      {
        "diagnosis": "Dementia with Lewy bodies",
        "features": "Visual hallucinations; parkinsonism; REM sleep behavior disorder; fluctuating cognition",
        "tests": "DaTscan; clinical criteria"
      },
      {
        "diagnosis": "Frontotemporal dementia (behavioral)",
        "features": "Personality change; disinhibition; apathy; hyperorality; age <65 often",
        "tests": "FDG-PET frontal hypometabolism; genetics"
      },
      {
        "diagnosis": "Primary progressive aphasia",
        "features": "Language predominates; word-finding, grammar, or comprehension primarily affected",
        "tests": "Neuropsychological testing; FDG-PET language areas"
      },
      {
        "diagnosis": "Creutzfeldt-Jakob disease",
        "features": "Rapid progression (weeks-months); myoclonus; periodic sharp waves on EEG",
        "tests": "EEG, MRI DWI cortical ribboning, CSF RT-QuIC"
      },
      {
        "diagnosis": "Normal pressure hydrocephalus",
        "features": "Gait disturbance prominent; urinary incontinence; dementia triad",
        "tests": "MRI ventriculomegaly; LP with gait improvement test"
      },
      {
        "diagnosis": "Autoimmune encephalitis",
        "features": "Subacute onset; seizures; psychiatric features; often younger",
        "tests": "Autoantibody panel (serum/CSF); MRI"
      }
    ],
    "evidence": [
      {
        "recommendation": "Cholinesterase inhibitors for mild-moderate AD",
        "evidenceLevel": "Class I, Level A",
        "source": "[Birks J. Cochrane 2006](https://pubmed.ncbi.nlm.nih.gov/16437532/)"
      },
      {
        "recommendation": "Memantine for moderate-severe AD",
        "evidenceLevel": "Class I, Level A",
        "source": "[Reisberg et al. NEJM 2003](https://pubmed.ncbi.nlm.nih.gov/12672860/)"
      },
      {
        "recommendation": "Combination therapy (ChEI + memantine)",
        "evidenceLevel": "Class I, Level A",
        "source": "[Tariot et al. JAMA 2004](https://pubmed.ncbi.nlm.nih.gov/14970063/)"
      },
      {
        "recommendation": "Lecanemab slows cognitive decline in early AD",
        "evidenceLevel": "Class I, Level A",
        "source": "[van Dyck et al. NEJM 2023 (Clarity AD)](https://pubmed.ncbi.nlm.nih.gov/36449413/)"
      },
      {
        "recommendation": "Donanemab slows cognitive decline",
        "evidenceLevel": "Class I, Level A",
        "source": "[Sims et al. JAMA 2023 (TRAILBLAZER-ALZ 2)](https://pubmed.ncbi.nlm.nih.gov/37459141/)"
      },
      {
        "recommendation": "CSF biomarkers accurate for AD diagnosis",
        "evidenceLevel": "Class I, Level A",
        "source": "[Hansson et al. Lancet Neurol 2018](https://pubmed.ncbi.nlm.nih.gov/30244989/)"
      },
      {
        "recommendation": "Mediterranean diet associated with lower dementia risk",
        "evidenceLevel": "Class II, Level B",
        "source": "[Scarmeas et al. Ann Neurol 2006](https://pubmed.ncbi.nlm.nih.gov/16832238/)"
      },
      {
        "recommendation": "Physical exercise may slow cognitive decline",
        "evidenceLevel": "Class II, Level B",
        "source": "[Livingston et al. Lancet 2020 (Lancet Commission)](https://pubmed.ncbi.nlm.nih.gov/32738937/)"
      },
      {
        "recommendation": "Avoid antipsychotics long-term (mortality risk)",
        "evidenceLevel": "Class I, Level A",
        "source": "[Schneider et al. JAMA 2005](https://pubmed.ncbi.nlm.nih.gov/16219884/)"
      },
      {
        "recommendation": "B12 supplementation reverses deficiency-related cognitive impairment",
        "evidenceLevel": "Class II, Level B",
        "source": "[Smith et al. PLoS One 2010](https://pubmed.ncbi.nlm.nih.gov/20838622/)"
      }
    ],
    "monitoring": [
      {
        "item": "MMSE or MoCA",
        "frequency": "Every 6-12 months",
        "action": "Adjust treatment; reassess diagnosis if unexpected decline",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "ADL/IADL function (FAQ, DAD)",
        "frequency": "Every 6-12 months",
        "action": "Increase support services; OT referral",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Behavioral symptoms (NPI)",
        "frequency": "Each visit",
        "action": "Behavioral interventions; consider medications",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Weight",
        "frequency": "Each visit",
        "action": "Nutritional assessment; speech therapy for swallowing",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Caregiver burden (Zarit scale)",
        "frequency": "Every 6-12 months",
        "action": "Support resources; respite care; social work",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "MRI (ARIA monitoring if on anti-amyloid)",
        "frequency": "Per protocol",
        "action": "Hold infusion; follow protocol for resumption",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "ECG (if on donepezil or citalopram)",
        "frequency": "Baseline; if dose increased",
        "action": "Reduce dose or switch agent",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Metabolic panel",
        "frequency": "Annually",
        "action": "Adjust medications",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      }
    ],
    "disposition": [
      {
        "disposition": "Discharge home",
        "criteria": "Reversible causes treated; safe environment; caregiver support; follow-up arranged"
      },
      {
        "disposition": "Admit to floor",
        "criteria": "Acute delirium requiring workup; behavioral crisis unsafe for home; aspiration pneumonia"
      },
      {
        "disposition": "Admit to psychiatry",
        "criteria": "Severe behavioral disturbance requiring specialized psychiatric management"
      },
      {
        "disposition": "Outpatient follow-up",
        "criteria": "Neurology/geriatrics 1-3 months after diagnosis; then every 6-12 months"
      },
      {
        "disposition": "Long-term care",
        "criteria": "Progressive decline; caregiver unable to manage; safety concerns; 24-hour supervision needed"
      }
    ]
  },
  "Essential Tremor": {
    "id": "essential-tremor",
    "title": "Essential Tremor",
    "version": "1.0",
    "icd10": [
      "** G25.0 (Essential tremor)"
    ],
    "scope": "** Diagnosis confirmation, differentiation from Parkinson's disease and other tremors, and symptomatic treatment. Covers classic essential tremor and ET-plus syndrome.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "TSH",
            "rationale": "Hyperthyroidism causes action tremor",
            "target": "Normal (0.4-4.0 mIU/L)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Free T4",
            "rationale": "If TSH abnormal",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "BMP",
            "rationale": "Electrolyte abnormalities (hypomagnesemia) can cause tremor",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Glucose",
            "rationale": "Hypoglycemia causes tremor",
            "target": "70-180 mg/dL",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Hepatic panel",
            "rationale": "Hepatic encephalopathy can cause asterixis/tremor; baseline before medications",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended Workup": [
          {
            "item": "Magnesium",
            "rationale": "Hypomagnesemia causes tremor",
            "target": "1.8-2.4 mg/dL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ceruloplasmin, serum copper",
            "rationale": "Wilson's disease if age <50",
            "target": "Normal",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "24-hour urine copper",
            "rationale": "Wilson's confirmation",
            "target": "<100 μg/24hr",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Drug/toxin screen",
            "rationale": "Caffeine, stimulants, alcohol withdrawal",
            "target": "Negative or explains tremor",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Vitamin B12",
            "rationale": "Deficiency can cause tremor",
            "target": ">300 pg/mL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Heavy metal panel (mercury, lead, arsenic)",
            "rationale": "Occupational exposure; toxin-induced tremor",
            "target": "Normal",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Paraneoplastic antibody panel",
            "rationale": "Atypical tremor; occult malignancy",
            "target": "Negative",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Anti-GAD65 antibodies",
            "rationale": "Stiff-person spectrum; autoimmune etiology",
            "target": "Negative",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Genetic testing (LINGO1, SLC1A2)",
            "rationale": "Research; strong family history",
            "target": "Variable",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "Clinical examination (spiral drawing, water pouring)",
            "timing": "At evaluation",
            "target": "Symmetric action tremor; improves with alcohol; family history",
            "contraindications": "None",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended": [
          {
            "item": "MRI Brain",
            "timing": "Atypical features; focal signs; concern for structural lesion",
            "target": "Normal",
            "contraindications": "MRI-incompatible devices",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "DaTscan (ioflupane I-123)",
            "timing": "Differentiate ET from Parkinson's disease",
            "target": "NORMAL in ET (abnormal in PD)",
            "contraindications": "Iodine hypersensitivity",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "EMG with accelerometry",
            "timing": "Characterize tremor frequency (8-12 Hz typical ET)",
            "target": "4-12 Hz, predominantly postural/kinetic",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "MRI Brain with SWI",
            "timing": "Wilson's disease evaluation; iron deposition",
            "target": "No basal ganglia abnormalities",
            "contraindications": "MRI contraindications",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "PET scan",
            "timing": "Research; rule out neurodegenerative parkinsonian syndromes",
            "target": "Normal nigrostriatal pathway",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Slit lamp examination",
            "timing": "Wilson's disease (Kayser-Fleischer rings)",
            "target": "No KF rings",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "Propranolol (as needed)",
            "route": "PO",
            "indication": "Situational tremor (performance anxiety, important meeting)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg PO",
                  "orderSentence": "Propranolol (as needed) 20 mg PO PO"
                },
                {
                  "text": "40 mg PO",
                  "orderSentence": "Propranolol (as needed) 40 mg PO PO"
                }
              ],
              "route": "PO",
              "instructions": "20-40 mg PO 30-60 min before anxiety-provoking situation; single dose PRN",
              "orderSentence": "Propranolol (as needed) 20 mg PO PO"
            },
            "contraindications": "Asthma; severe bradycardia; decompensated HF",
            "monitoring": "HR, BP if first dose",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Symptomatic Treatments (First-line)": [
          {
            "item": "Propranolol",
            "route": "PO",
            "indication": "First-line chronic therapy; most evidence",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg BID",
                  "orderSentence": "Propranolol 20 mg BID PO"
                },
                {
                  "text": "40 mg BID",
                  "orderSentence": "Propranolol 40 mg BID PO"
                },
                {
                  "text": "60 mg BID",
                  "orderSentence": "Propranolol 60 mg BID PO"
                },
                {
                  "text": "80 mg BID",
                  "orderSentence": "Propranolol 80 mg BID PO"
                },
                {
                  "text": "120 mg daily LA",
                  "orderSentence": "Propranolol 120 mg daily LA PO"
                },
                {
                  "text": "160 mg daily LA",
                  "orderSentence": "Propranolol 160 mg daily LA PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 20 mg BID or 60 mg LA daily; titrate q2wk; target 60-240 mg/day",
              "orderSentence": "Propranolol 20 mg BID PO"
            },
            "contraindications": "Asthma/COPD; bradycardia <50; heart block; decompensated HF",
            "monitoring": "HR (>50 bpm), BP, fatigue, depression",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Propranolol LA",
            "route": "PO",
            "indication": "Once daily option for adherence",
            "dosing": {
              "doseOptions": [
                {
                  "text": "60 mg daily",
                  "orderSentence": "Propranolol LA 60 mg daily PO"
                },
                {
                  "text": "80 mg daily",
                  "orderSentence": "Propranolol LA 80 mg daily PO"
                },
                {
                  "text": "120 mg daily",
                  "orderSentence": "Propranolol LA 120 mg daily PO"
                },
                {
                  "text": "160 mg daily",
                  "orderSentence": "Propranolol LA 160 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 60-80 mg daily; titrate q2wk; max 320 mg/day",
              "orderSentence": "Propranolol LA 60 mg daily PO"
            },
            "contraindications": "Same as IR",
            "monitoring": "Same as IR",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Primidone",
            "route": "PO",
            "indication": "First-line; equal efficacy to propranolol",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Primidone 25 mg qHS PO"
                },
                {
                  "text": "50 mg qHS",
                  "orderSentence": "Primidone 50 mg qHS PO"
                },
                {
                  "text": "50 mg TID",
                  "orderSentence": "Primidone 50 mg TID PO"
                },
                {
                  "text": "125 mg TID",
                  "orderSentence": "Primidone 125 mg TID PO"
                },
                {
                  "text": "250 mg TID",
                  "orderSentence": "Primidone 250 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg qHS (VERY LOW to avoid acute toxicity); increase by 25-50 mg q1wk; target 250-750 mg/day divided",
              "orderSentence": "Primidone 25 mg qHS PO"
            },
            "contraindications": "Porphyria; severe hepatic impairment",
            "monitoring": "Sedation (especially initial), ataxia, GI upset",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Propranolol + Primidone",
            "route": "PO",
            "indication": "Combination for better efficacy than monotherapy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per individual drug",
                  "orderSentence": "Propranolol + Primidone Per individual drug PO"
                }
              ],
              "route": "PO",
              "instructions": "Add second agent if monotherapy insufficient; use lower doses of each",
              "orderSentence": "Propranolol + Primidone Per individual drug PO"
            },
            "contraindications": "Per individual drug",
            "monitoring": "Monitor both sets of side effects",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Second-line/Refractory": [
          {
            "item": "Topiramate",
            "route": "PO",
            "indication": "Beta-blocker contraindicated; weight concern",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Topiramate 25 mg qHS PO"
                },
                {
                  "text": "50 mg BID",
                  "orderSentence": "Topiramate 50 mg BID PO"
                },
                {
                  "text": "100 mg BID",
                  "orderSentence": "Topiramate 100 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg qHS; increase by 25 mg q1wk; target 100-400 mg/day divided",
              "orderSentence": "Topiramate 25 mg qHS PO"
            },
            "contraindications": "Glaucoma; kidney stones; pregnancy",
            "monitoring": "Cognitive effects, paresthesias, weight loss, metabolic acidosis",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Gabapentin",
            "route": "PO",
            "indication": "Mild benefit; good tolerability; neuropathic pain comorbidity",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg qHS",
                  "orderSentence": "Gabapentin 300 mg qHS PO"
                },
                {
                  "text": "300 mg TID",
                  "orderSentence": "Gabapentin 300 mg TID PO"
                },
                {
                  "text": "600 mg TID",
                  "orderSentence": "Gabapentin 600 mg TID PO"
                },
                {
                  "text": "900 mg TID",
                  "orderSentence": "Gabapentin 900 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 300 mg qHS; titrate by 300 mg q3-7d; target 1200-3600 mg/day divided TID",
              "orderSentence": "Gabapentin 300 mg qHS PO"
            },
            "contraindications": "Severe renal impairment (dose adjust)",
            "monitoring": "Sedation, dizziness, edema",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Alprazolam",
            "route": "PO",
            "indication": "Anxiolytic benefit; use with caution",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.25 mg TID",
                  "orderSentence": "Alprazolam 0.25 mg TID PO"
                },
                {
                  "text": "0.5 mg TID",
                  "orderSentence": "Alprazolam 0.5 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.25 mg TID; titrate slowly; max 3 mg/day; avoid long-term if possible",
              "orderSentence": "Alprazolam 0.25 mg TID PO"
            },
            "contraindications": "Respiratory depression; history of substance use",
            "monitoring": "Dependence, sedation, falls",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Clonazepam",
            "route": "PO",
            "indication": "Orthostatic tremor; head tremor; refractory cases",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.25 mg BID",
                  "orderSentence": "Clonazepam 0.25 mg BID PO"
                },
                {
                  "text": "0.5 mg BID",
                  "orderSentence": "Clonazepam 0.5 mg BID PO"
                },
                {
                  "text": "1 mg BID",
                  "orderSentence": "Clonazepam 1 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.25 mg BID; titrate slowly; typical 0.5-2 mg/day",
              "orderSentence": "Clonazepam 0.25 mg BID PO"
            },
            "contraindications": "Same as alprazolam",
            "monitoring": "Same as alprazolam",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Atenolol",
            "route": "PO",
            "indication": "Beta-blocker alternative (more beta-1 selective)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg daily",
                  "orderSentence": "Atenolol 25 mg daily PO"
                },
                {
                  "text": "50 mg daily",
                  "orderSentence": "Atenolol 50 mg daily PO"
                },
                {
                  "text": "100 mg daily",
                  "orderSentence": "Atenolol 100 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25-50 mg daily; max 100 mg daily",
              "orderSentence": "Atenolol 25 mg daily PO"
            },
            "contraindications": "Heart block; severe bradycardia",
            "monitoring": "HR, BP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Nadolol",
            "route": "PO",
            "indication": "Long-acting beta-blocker alternative",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg daily",
                  "orderSentence": "Nadolol 40 mg daily PO"
                },
                {
                  "text": "80 mg daily",
                  "orderSentence": "Nadolol 80 mg daily PO"
                },
                {
                  "text": "120 mg daily",
                  "orderSentence": "Nadolol 120 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 40 mg daily; titrate q1-2wk; max 240 mg daily",
              "orderSentence": "Nadolol 40 mg daily PO"
            },
            "contraindications": "Same as propranolol",
            "monitoring": "Same as propranolol",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sotalol",
            "route": "PO",
            "indication": "Beta-blocker with additional antiarrhythmic properties",
            "dosing": {
              "doseOptions": [
                {
                  "text": "80 mg BID",
                  "orderSentence": "Sotalol 80 mg BID PO"
                },
                {
                  "text": "120 mg BID",
                  "orderSentence": "Sotalol 120 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 80 mg BID; max 240 mg/day; requires QTc monitoring",
              "orderSentence": "Sotalol 80 mg BID PO"
            },
            "contraindications": "QT prolongation; severe renal impairment",
            "monitoring": "QTc, electrolytes",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Nimodipine",
            "route": "PO",
            "indication": "Limited evidence; calcium channel blocker",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mg TID",
                  "orderSentence": "Nimodipine 30 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "30 mg TID",
              "orderSentence": "Nimodipine 30 mg TID PO"
            },
            "contraindications": "Hypotension",
            "monitoring": "BP",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Zonisamide",
            "route": "PO",
            "indication": "Limited evidence; weight neutral",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg daily",
                  "orderSentence": "Zonisamide 100 mg daily PO"
                },
                {
                  "text": "200 mg daily",
                  "orderSentence": "Zonisamide 200 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 100 mg daily; may increase to 200 mg daily",
              "orderSentence": "Zonisamide 100 mg daily PO"
            },
            "contraindications": "Sulfonamide allergy; renal stones",
            "monitoring": "Kidney stones, rash",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Interventional/Advanced Therapies": [
          {
            "item": "Botulinum toxin (head tremor)",
            "route": "IM",
            "indication": "Head/neck tremor refractory to oral medications",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100-200 units total",
                  "orderSentence": "Botulinum toxin (head tremor) 100-200 units total IM"
                }
              ],
              "route": "IM",
              "instructions": "Inject into sternocleidomastoid and splenius capitis bilaterally; repeat q3-4mo",
              "orderSentence": "Botulinum toxin (head tremor) 100-200 units total IM"
            },
            "pretreatment": "EMG guidance recommended",
            "contraindications": "Infection at site; myasthenia gravis",
            "monitoring": "Dysphagia, neck weakness",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Botulinum toxin (hand tremor)",
            "route": "IM",
            "indication": "Hand tremor refractory to oral medications",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50-100 units per hand",
                  "orderSentence": "Botulinum toxin (hand tremor) 50-100 units per hand IM"
                }
              ],
              "route": "IM",
              "instructions": "Inject into forearm flexors/extensors; EMG-guided; repeat q3mo",
              "orderSentence": "Botulinum toxin (hand tremor) 50-100 units per hand IM"
            },
            "pretreatment": "EMG guidance required",
            "contraindications": "Same as above",
            "monitoring": "Finger weakness (limits use)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Deep brain stimulation (DBS)",
            "route": "Surgical",
            "indication": "Medication-refractory disabling tremor",
            "dosing": {
              "doseOptions": [
                {
                  "text": "VIM thalamus stimulation",
                  "orderSentence": "Deep brain stimulation (DBS) VIM thalamus stimulation Surgical"
                }
              ],
              "route": "Surgical",
              "instructions": "Unilateral or bilateral VIM thalamus; programming over weeks",
              "orderSentence": "Deep brain stimulation (DBS) VIM thalamus stimulation Surgical"
            },
            "pretreatment": "MRI; neuropsych testing; multidisciplinary evaluation",
            "contraindications": "Cognitive impairment; unstable psychiatric disease; coagulopathy",
            "monitoring": "Programming optimization; speech side effects (bilateral)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "MRI-guided focused ultrasound (MRgFUS)",
            "route": "Non-invasive",
            "indication": "Unilateral tremor; DBS declined or contraindicated",
            "dosing": {
              "doseOptions": [
                {
                  "text": "VIM thalamotomy",
                  "orderSentence": "MRI-guided focused ultrasound (MRgFUS) VIM thalamotomy Non-invasive"
                }
              ],
              "route": "Non-invasive",
              "instructions": "Unilateral lesion of VIM thalamus; immediate effect",
              "orderSentence": "MRI-guided focused ultrasound (MRgFUS) VIM thalamotomy Non-invasive"
            },
            "pretreatment": "Must tolerate prolonged MRI",
            "contraindications": "Bilateral procedure not recommended (speech risk); skull density ratio",
            "monitoring": "Numbness, ataxia, speech changes (usually transient)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Gamma Knife radiosurgery",
            "route": "Non-invasive",
            "indication": "VIM thalamotomy; DBS contraindicated",
            "dosing": {
              "doseOptions": [
                {
                  "text": "130-150 Gy to VIM",
                  "orderSentence": "Gamma Knife radiosurgery 130-150 Gy to VIM Non-invasive"
                }
              ],
              "route": "Non-invasive",
              "instructions": "Unilateral lesion; delayed effect (months)",
              "orderSentence": "Gamma Knife radiosurgery 130-150 Gy to VIM Non-invasive"
            },
            "pretreatment": "MRI compatible",
            "contraindications": "Same as MRgFUS",
            "monitoring": "Same as MRgFUS; delayed effect",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Movement disorders neurology for diagnosis confirmation if uncertain and treatment optimization",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Neurosurgery consultation for DBS or MRgFUS evaluation if medication-refractory",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Occupational therapy for adaptive devices and hand-writing strategies",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Physical therapy for postural training and coordination exercises",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Psychology/counseling for anxiety management and coping strategies",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Avoid or minimize caffeine which can worsen tremor",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Limit alcohol (may temporarily improve tremor but rebound worsening occurs and dependence risk)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Get adequate sleep as fatigue worsens tremor",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Manage stress and anxiety which exacerbate tremor (relaxation techniques, regular exercise)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Use weighted utensils and adaptive devices for eating and writing if tremor interferes",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Report any new symptoms such as slowness, stiffness, or balance problems which may indicate progression to ET-plus or Parkinson's",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Consider alerting employer/school if tremor affects work performance to discuss accommodations",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Regular physical exercise improves overall motor function and stress management",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Relaxation techniques (yoga, meditation, deep breathing) reduce stress-related tremor exacerbation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid medications that worsen tremor (lithium, valproate, some antidepressants, stimulants) when alternatives exist",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Use larger-grip pens and utensils to improve function",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Voice-to-text software if writing is significantly impaired",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Limit alcohol despite temporary improvement to avoid dependence and rebound tremor",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Parkinson's disease",
        "features": "Rest tremor predominant; bradykinesia; rigidity; asymmetric onset",
        "tests": "DaTscan (abnormal in PD, normal in ET); clinical exam"
      },
      {
        "diagnosis": "Enhanced physiologic tremor",
        "features": "Typically bilateral, postural; related to caffeine, anxiety, medications, hyperthyroidism",
        "tests": "Remove triggers; check TSH, caffeine history"
      },
      {
        "diagnosis": "Drug-induced tremor",
        "features": "Temporal relationship with medication; bilateral",
        "tests": "Medication review; trial withdrawal"
      },
      {
        "diagnosis": "Dystonic tremor",
        "features": "Irregular, jerky; task-specific; associated dystonic posturing; null point",
        "tests": "Clinical exam; may see dystonia at rest"
      },
      {
        "diagnosis": "Cerebellar tremor",
        "features": "Intention tremor (worsens at target); associated ataxia, dysarthria",
        "tests": "MRI brain (cerebellar pathology); clinical exam"
      },
      {
        "diagnosis": "Psychogenic tremor",
        "features": "Variable frequency; distractible; entrainment with contralateral movement",
        "tests": "Clinical maneuvers; psychiatric evaluation"
      },
      {
        "diagnosis": "Wilson's disease",
        "features": "Age <50; liver disease; psychiatric symptoms; Kayser-Fleischer rings",
        "tests": "Ceruloplasmin, 24h urine copper, slit lamp"
      },
      {
        "diagnosis": "Orthostatic tremor",
        "features": "Tremor in legs/trunk when standing; relief with sitting/walking",
        "tests": "EMG (13-18 Hz characteristic)"
      },
      {
        "diagnosis": "Rubral tremor",
        "features": "Rest + postural + intention (\"Holmes tremor\"); midbrain lesion history",
        "tests": "MRI (midbrain pathology)"
      },
      {
        "diagnosis": "Neuropathic tremor",
        "features": "Associated with peripheral neuropathy (CIDP, IgM paraprotein)",
        "tests": "EMG/NCS; protein electrophoresis"
      }
    ],
    "evidence": [
      {
        "recommendation": "Propranolol first-line for ET",
        "evidenceLevel": "Class I, Level A",
        "source": "[Zesiewicz et al. Neurology 2011 (AAN Guideline)](https://pubmed.ncbi.nlm.nih.gov/22013182/)"
      },
      {
        "recommendation": "Primidone first-line for ET",
        "evidenceLevel": "Class I, Level A",
        "source": "[Zesiewicz et al. Neurology 2011](https://pubmed.ncbi.nlm.nih.gov/22013182/)"
      },
      {
        "recommendation": "Topiramate effective for ET",
        "evidenceLevel": "Class II, Level B",
        "source": "[Ondo et al. Neurology 2006](https://pubmed.ncbi.nlm.nih.gov/16636234/)"
      },
      {
        "recommendation": "DBS effective for medication-refractory ET",
        "evidenceLevel": "Class I, Level A",
        "source": "[Flora et al. Cochrane 2010](https://pubmed.ncbi.nlm.nih.gov/20927732/)"
      },
      {
        "recommendation": "MRI-guided focused ultrasound for ET",
        "evidenceLevel": "Class I, Level A",
        "source": "[Elias et al. NEJM 2016](https://pubmed.ncbi.nlm.nih.gov/27557301/)"
      },
      {
        "recommendation": "DaTscan differentiates ET from PD",
        "evidenceLevel": "Class II, Level B",
        "source": "[Benamer et al. Mov Disord 2000](https://pubmed.ncbi.nlm.nih.gov/10752577/)"
      },
      {
        "recommendation": "Botulinum toxin for head tremor",
        "evidenceLevel": "Class II, Level B",
        "source": "[Pahwa et al. Neurology 1995](https://pubmed.ncbi.nlm.nih.gov/7617193/)"
      },
      {
        "recommendation": "Gabapentin modest benefit",
        "evidenceLevel": "Class II, Level U",
        "source": "[Ondo et al. Neurology 2000](https://pubmed.ncbi.nlm.nih.gov/10680798/)"
      },
      {
        "recommendation": "Combination therapy superior to monotherapy",
        "evidenceLevel": "Class II, Level B",
        "source": "[Koller et al. Neurology 1989](https://pubmed.ncbi.nlm.nih.gov/2668781/)"
      }
    ],
    "monitoring": [
      {
        "item": "Tremor severity (clinical rating scales: Fahn-Tolosa-Marin, TETRAS)",
        "frequency": "Each visit",
        "action": "Adjust medication dose; consider second agent or intervention",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Functional impact (writing, eating, drinking)",
        "frequency": "Each visit",
        "action": "OT referral; adaptive devices; consider advanced therapy",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Heart rate (if on beta-blocker)",
        "frequency": "Each visit",
        "action": "Reduce dose or switch agent",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Blood pressure (if on beta-blocker)",
        "frequency": "Each visit",
        "action": "Reduce dose or switch agent",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Sedation/cognition (if on primidone or benzodiazepines)",
        "frequency": "Each visit",
        "action": "Reduce dose; slow titration",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Signs of parkinsonism",
        "frequency": "Each visit",
        "action": "Re-evaluate diagnosis; DaTscan if uncertain",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Weight (if on topiramate)",
        "frequency": "Every 3 months",
        "action": "Adjust dose",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "QTc (if on sotalol)",
        "frequency": "Baseline, with dose changes",
        "action": "Reduce dose or discontinue",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      }
    ],
    "disposition": [
      {
        "disposition": "Discharge home",
        "criteria": "New diagnosis with treatment started; follow-up arranged; no red flags"
      },
      {
        "disposition": "Admit to floor",
        "criteria": "Rare; only if tremor is severe and workup needed urgently (e.g., Wilson's disease suspected)"
      },
      {
        "disposition": "Outpatient follow-up",
        "criteria": "4-8 weeks for medication titration; then every 6-12 months when stable"
      }
    ]
  },
  "Diabetic Neuropathy": {
    "id": "diabetic-neuropathy",
    "title": "Diabetic Neuropathy",
    "version": "1.0",
    "icd10": [
      "** G63.2 (Diabetic polyneuropathy)",
      "E11.42 (Type 2 DM with diabetic polyneuropathy)",
      "E10.42 (Type 1 DM with diabetic polyneuropathy)"
    ],
    "scope": "** Distal symmetric polyneuropathy (most common), painful diabetic neuropathy treatment, foot care, and screening for other diabetic neuropathy types. Excludes diabetic amyotrophy (separate protocol) and autonomic neuropathy (mentioned but not primary focus).",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "HbA1c",
            "rationale": "Assess glycemic control; primary modifiable risk factor",
            "target": "<7% (individualized goals for elderly)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Fasting glucose",
            "rationale": "Current glycemic status",
            "target": "70-130 mg/dL",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "BMP (including creatinine, eGFR)",
            "rationale": "Renal function for medication dosing; CKD common in diabetes",
            "target": "eGFR >60 preferred; adjust meds if lower",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lipid panel",
            "rationale": "Cardiovascular risk; dyslipidemia common comorbidity",
            "target": "LDL <100 mg/dL (or <70 if ASCVD)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin B12",
            "rationale": "Metformin causes B12 deficiency; mimics diabetic neuropathy",
            "target": ">300 pg/mL (>400 optimal)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "TSH",
            "rationale": "Hypothyroidism causes neuropathy; common comorbidity",
            "target": "0.4-4.0 mIU/L",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CBC",
            "rationale": "Anemia evaluation; baseline",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended Workup": [
          {
            "item": "Methylmalonic acid (MMA)",
            "rationale": "More sensitive for B12 deficiency if B12 borderline",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Folate",
            "rationale": "Deficiency contributes to neuropathy",
            "target": ">3 ng/mL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin D",
            "rationale": "Deficiency associated with neuropathic pain",
            "target": ">30 ng/mL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "SPEP/UPEP with immunofixation",
            "rationale": "Rule out paraproteinemia if atypical features",
            "target": "No monoclonal protein",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "ANA",
            "rationale": "Autoimmune/vasculitic neuropathy if atypical",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "ESR, CRP",
            "rationale": "Inflammatory markers if vasculitis suspected",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Hepatitis B, C serologies",
            "rationale": "Hepatitis C associated with neuropathy; prevalence in diabetics",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "HIV",
            "rationale": "HIV neuropathy if risk factors",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Cryoglobulins",
            "rationale": "Cryoglobulinemic neuropathy (esp. with Hep C)",
            "target": "Negative",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Anti-MAG antibodies",
            "rationale": "IgM paraprotein-associated neuropathy",
            "target": "Negative",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Genetic neuropathy panel (CMT genes)",
            "rationale": "Family history; atypical presentation",
            "target": "Negative",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Nerve biopsy",
            "rationale": "Vasculitic neuropathy suspected; atypical non-length-dependent",
            "target": "Diagnostic findings",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Skin biopsy for IENFD",
            "rationale": "Quantify small fiber neuropathy",
            "target": "Reduced intraepidermal nerve fiber density",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "Monofilament testing (10g)",
            "timing": "At every diabetic visit; annually minimum",
            "target": "Intact sensation 8-10 sites",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Tuning fork (128 Hz)",
            "timing": "Vibration sense at great toe",
            "target": "Intact vibration sense",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ankle reflexes",
            "timing": "Deep tendon reflex assessment",
            "target": "Present (may be diminished/absent in neuropathy)",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Foot examination",
            "timing": "Inspect for ulcers, calluses, deformities, pulses",
            "target": "No ulcers or pre-ulcerative lesions",
            "contraindications": "None",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended": [
          {
            "item": "EMG/NCS (nerve conduction study)",
            "timing": "Atypical presentation; asymmetric; rapid progression",
            "target": "Length-dependent sensory > motor polyneuropathy",
            "contraindications": "Anticoagulation (relative for EMG)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Autonomic testing (QSART, HR variability, tilt table)",
            "timing": "Symptoms of autonomic neuropathy; syncope; gastroparesis",
            "target": "Abnormal sudomotor, cardiovagal, or adrenergic function",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "MRI lumbar spine",
            "timing": "Radiculopathy suspected; focal deficits",
            "target": "Rule out compressive lesion",
            "contraindications": "MRI contraindications",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Skin biopsy (punch biopsy at ankle and thigh)",
            "timing": "Confirm small fiber neuropathy; normal NCS",
            "target": "Reduced IENFD (<threshold for age/sex)",
            "contraindications": "Bleeding diathesis; anticoagulation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Corneal confocal microscopy",
            "timing": "Research; non-invasive small fiber assessment",
            "target": "Reduced corneal nerve fiber length/density",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Sudoscan",
            "timing": "Screening for sudomotor dysfunction; small fiber",
            "target": "Abnormal electrochemical skin conductance",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "Wound care",
            "route": "Topical",
            "indication": "Diabetic foot ulcer",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Debridement",
                  "orderSentence": "Wound care Debridement Topical"
                },
                {
                  "text": "offloading",
                  "orderSentence": "Wound care offloading Topical"
                },
                {
                  "text": "appropriate dressing",
                  "orderSentence": "Wound care appropriate dressing Topical"
                }
              ],
              "route": "Topical",
              "instructions": "Wound assessment; debridement if needed; offload pressure; moist wound healing",
              "orderSentence": "Wound care Debridement Topical"
            },
            "contraindications": "None",
            "monitoring": "Signs of infection; healing progress",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Antibiotics (diabetic foot infection)",
            "route": "PO/IV",
            "indication": "Infected diabetic foot ulcer",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per culture/severity",
                  "orderSentence": "Antibiotics (diabetic foot infection) Per culture/severity PO/IV"
                }
              ],
              "route": "PO/IV",
              "instructions": "Mild: oral (cephalexin, amox/clav); Moderate-severe: IV (piptazo, vanc); per wound culture",
              "orderSentence": "Antibiotics (diabetic foot infection) Per culture/severity PO/IV"
            },
            "contraindications": "Drug allergy",
            "monitoring": "Infection markers; wound healing",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Pain crisis management",
            "route": "IV/PO",
            "indication": "Severe acute neuropathic pain flare",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Multimodal",
                  "orderSentence": "Pain crisis management Multimodal IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "Consider IV lidocaine if refractory; short-term low-dose opioid for acute crisis",
              "orderSentence": "Pain crisis management Multimodal IV/PO"
            },
            "contraindications": "Per specific agent",
            "monitoring": "Pain scores; sedation",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          }
        ],
        "Symptomatic Treatments (Neuropathic Pain - First-line)": [
          {
            "item": "Duloxetine",
            "route": "PO",
            "indication": "First-line for painful diabetic neuropathy; FDA-approved",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mg daily",
                  "orderSentence": "Duloxetine 30 mg daily PO"
                },
                {
                  "text": "60 mg daily",
                  "orderSentence": "Duloxetine 60 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 30 mg daily x 1 week; increase to 60 mg daily; max 120 mg/day (limited evidence for higher doses)",
              "orderSentence": "Duloxetine 30 mg daily PO"
            },
            "contraindications": "MAOIs; uncontrolled glaucoma; severe renal impairment (CrCl <30)",
            "monitoring": "Hepatic function; BP; suicidal ideation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pregabalin",
            "route": "PO",
            "indication": "First-line; FDA-approved for DPN",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg TID",
                  "orderSentence": "Pregabalin 50 mg TID PO"
                },
                {
                  "text": "75 mg BID",
                  "orderSentence": "Pregabalin 75 mg BID PO"
                },
                {
                  "text": "100 mg TID",
                  "orderSentence": "Pregabalin 100 mg TID PO"
                },
                {
                  "text": "150 mg BID",
                  "orderSentence": "Pregabalin 150 mg BID PO"
                },
                {
                  "text": "200 mg TID",
                  "orderSentence": "Pregabalin 200 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 50 mg TID or 75 mg BID; titrate q3-7d based on response; max 300 mg/day (CrCl 30-60: reduce dose)",
              "orderSentence": "Pregabalin 50 mg TID PO"
            },
            "contraindications": "Angioedema to pregabalin/gabapentin",
            "monitoring": "Dizziness, somnolence, weight gain, peripheral edema",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Gabapentin",
            "route": "PO",
            "indication": "First-line alternative; less expensive; similar efficacy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg qHS",
                  "orderSentence": "Gabapentin 300 mg qHS PO"
                },
                {
                  "text": "300 mg TID",
                  "orderSentence": "Gabapentin 300 mg TID PO"
                },
                {
                  "text": "600 mg TID",
                  "orderSentence": "Gabapentin 600 mg TID PO"
                },
                {
                  "text": "900 mg TID",
                  "orderSentence": "Gabapentin 900 mg TID PO"
                },
                {
                  "text": "1200 mg TID",
                  "orderSentence": "Gabapentin 1200 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 300 mg qHS; titrate by 300 mg q3-7d; target 1800-3600 mg/day divided TID; reduce dose if CrCl <60",
              "orderSentence": "Gabapentin 300 mg qHS PO"
            },
            "contraindications": "Severe renal impairment (dose adjust)",
            "monitoring": "Same as pregabalin; less edema",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Amitriptyline",
            "route": "PO",
            "indication": "TCA option; also helps sleep; less expensive",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg qHS",
                  "orderSentence": "Amitriptyline 10 mg qHS PO"
                },
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Amitriptyline 25 mg qHS PO"
                },
                {
                  "text": "50 mg qHS",
                  "orderSentence": "Amitriptyline 50 mg qHS PO"
                },
                {
                  "text": "75 mg qHS",
                  "orderSentence": "Amitriptyline 75 mg qHS PO"
                },
                {
                  "text": "100 mg qHS",
                  "orderSentence": "Amitriptyline 100 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10-25 mg qHS; titrate by 10-25 mg q1-2wk; typical 25-75 mg qHS; max 150 mg",
              "orderSentence": "Amitriptyline 10 mg qHS PO"
            },
            "contraindications": "Cardiac conduction abnormality; recent MI; urinary retention; glaucoma; elderly (use with caution)",
            "monitoring": "ECG if >40y or cardiac history; anticholinergic effects",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Nortriptyline",
            "route": "PO",
            "indication": "TCA with less sedation and anticholinergic effects than amitriptyline",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg qHS",
                  "orderSentence": "Nortriptyline 10 mg qHS PO"
                },
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Nortriptyline 25 mg qHS PO"
                },
                {
                  "text": "50 mg qHS",
                  "orderSentence": "Nortriptyline 50 mg qHS PO"
                },
                {
                  "text": "75 mg qHS",
                  "orderSentence": "Nortriptyline 75 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10-25 mg qHS; titrate by 10-25 mg q1-2wk; typical 25-75 mg qHS",
              "orderSentence": "Nortriptyline 10 mg qHS PO"
            },
            "contraindications": "Same as amitriptyline",
            "monitoring": "Same as amitriptyline; ECG if >100 mg",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Venlafaxine XR",
            "route": "PO",
            "indication": "SNRI alternative to duloxetine",
            "dosing": {
              "doseOptions": [
                {
                  "text": "37.5 mg daily",
                  "orderSentence": "Venlafaxine XR 37.5 mg daily PO"
                },
                {
                  "text": "75 mg daily",
                  "orderSentence": "Venlafaxine XR 75 mg daily PO"
                },
                {
                  "text": "150 mg daily",
                  "orderSentence": "Venlafaxine XR 150 mg daily PO"
                },
                {
                  "text": "225 mg daily",
                  "orderSentence": "Venlafaxine XR 225 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 37.5 mg daily; titrate by 37.5-75 mg q1wk; target 150-225 mg daily",
              "orderSentence": "Venlafaxine XR 37.5 mg daily PO"
            },
            "contraindications": "MAOIs; uncontrolled HTN",
            "monitoring": "BP at higher doses; withdrawal if abrupt discontinuation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Second-line/Refractory (Neuropathic Pain)": [
          {
            "item": "Capsaicin 8% patch (Qutenza)",
            "route": "Topical",
            "indication": "Localized neuropathic pain; add-on therapy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Apply for 30 min",
                  "orderSentence": "Capsaicin 8% patch (Qutenza) Apply for 30 min Topical"
                }
              ],
              "route": "Topical",
              "instructions": "Applied by healthcare provider; local anesthetic pre-treatment; repeat q3mo",
              "orderSentence": "Capsaicin 8% patch (Qutenza) Apply for 30 min Topical"
            },
            "contraindications": "Application to face; broken skin",
            "monitoring": "Local pain during application; burning",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lidocaine 5% patch",
            "route": "Topical",
            "indication": "Localized pain; adjunctive therapy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1-3 patches to painful area",
                  "orderSentence": "Lidocaine 5% patch 1-3 patches to painful area Topical"
                }
              ],
              "route": "Topical",
              "instructions": "Apply to most painful area; up to 3 patches for 12h on/12h off",
              "orderSentence": "Lidocaine 5% patch 1-3 patches to painful area Topical"
            },
            "contraindications": "Allergy to local anesthetics",
            "monitoring": "Skin irritation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Tapentadol ER",
            "route": "PO",
            "indication": "Refractory pain; opioid with norepinephrine reuptake inhibition",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg BID",
                  "orderSentence": "Tapentadol ER 50 mg BID PO"
                },
                {
                  "text": "100 mg BID",
                  "orderSentence": "Tapentadol ER 100 mg BID PO"
                },
                {
                  "text": "150 mg BID",
                  "orderSentence": "Tapentadol ER 150 mg BID PO"
                },
                {
                  "text": "200 mg BID",
                  "orderSentence": "Tapentadol ER 200 mg BID PO"
                },
                {
                  "text": "250 mg BID",
                  "orderSentence": "Tapentadol ER 250 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 50 mg BID; titrate by 50 mg BID q3d; max 500 mg/day; FDA-approved for DPN",
              "orderSentence": "Tapentadol ER 50 mg BID PO"
            },
            "contraindications": "Severe respiratory depression; MAOIs; paralytic ileus",
            "monitoring": "Constipation, sedation, respiratory status",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Tramadol",
            "route": "PO",
            "indication": "Moderate pain; opioid-like with serotonergic properties",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg q6h PRN",
                  "orderSentence": "Tramadol 50 mg q6h PRN PO"
                },
                {
                  "text": "100 mg ER BID",
                  "orderSentence": "Tramadol 100 mg ER BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 50 mg q6h PRN; max 400 mg/day; reduce if renal/hepatic impairment",
              "orderSentence": "Tramadol 50 mg q6h PRN PO"
            },
            "contraindications": "Seizure disorder; concurrent MAOIs/SSRIs (serotonin syndrome risk)",
            "monitoring": "Seizures, serotonin syndrome, sedation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Desipramine",
            "route": "PO",
            "indication": "TCA with minimal anticholinergic effects",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Desipramine 25 mg qHS PO"
                },
                {
                  "text": "50 mg qHS",
                  "orderSentence": "Desipramine 50 mg qHS PO"
                },
                {
                  "text": "100 mg qHS",
                  "orderSentence": "Desipramine 100 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg qHS; titrate by 25 mg q1-2wk; target 50-100 mg",
              "orderSentence": "Desipramine 25 mg qHS PO"
            },
            "contraindications": "Same as other TCAs",
            "monitoring": "ECG; therapeutic drug monitoring available",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Oxcarbazepine",
            "route": "PO",
            "indication": "Second-line anticonvulsant; less evidence",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg BID",
                  "orderSentence": "Oxcarbazepine 300 mg BID PO"
                },
                {
                  "text": "600 mg BID",
                  "orderSentence": "Oxcarbazepine 600 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 300 mg BID; titrate by 300 mg/wk; typical 600-1200 mg/day",
              "orderSentence": "Oxcarbazepine 300 mg BID PO"
            },
            "contraindications": "Hyponatremia risk",
            "monitoring": "Sodium level; rash (SJS rare)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Combination therapy",
            "route": "Various",
            "indication": "Inadequate response to single agent",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Combine agents from different classes",
                  "orderSentence": "Combination therapy Combine agents from different classes Various"
                }
              ],
              "route": "Various",
              "instructions": "Use lower doses of each; duloxetine + pregabalin; TCA + gabapentinoid",
              "orderSentence": "Combination therapy Combine agents from different classes Various"
            },
            "contraindications": "Per individual agents",
            "monitoring": "Additive side effects",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Buprenorphine patch",
            "route": "TD",
            "indication": "Severe refractory pain; opioid option",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mcg/hr",
                  "orderSentence": "Buprenorphine patch 5 mcg/hr TD"
                },
                {
                  "text": "10 mcg/hr",
                  "orderSentence": "Buprenorphine patch 10 mcg/hr TD"
                },
                {
                  "text": "20 mcg/hr",
                  "orderSentence": "Buprenorphine patch 20 mcg/hr TD"
                }
              ],
              "route": "TD",
              "instructions": "Start 5 mcg/hr weekly patch; titrate slowly",
              "orderSentence": "Buprenorphine patch 5 mcg/hr TD"
            },
            "contraindications": "Severe respiratory depression; QT prolongation",
            "monitoring": "Respiratory status, QTc",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Spinal cord stimulation",
            "route": "Implant",
            "indication": "Refractory painful DPN; failed multiple medications",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per implant protocol",
                  "orderSentence": "Spinal cord stimulation Per implant protocol Implant"
                }
              ],
              "route": "Implant",
              "instructions": "Trial stimulation before permanent; high-frequency or burst stimulation",
              "orderSentence": "Spinal cord stimulation Per implant protocol Implant"
            },
            "contraindications": "Infection; coagulopathy; psychiatric instability",
            "monitoring": "Device function; pain relief",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Disease-Modifying / Preventive Therapies": [
          {
            "item": "Glycemic control optimization",
            "route": "Various",
            "indication": "Primary prevention and slowing progression",
            "dosing": {
              "doseOptions": [
                {
                  "text": "HbA1c target <7%",
                  "orderSentence": "Glycemic control optimization HbA1c target <7% Various"
                }
              ],
              "route": "Various",
              "instructions": "Individualized; tighter control (6-6.5%) in younger patients; less strict (7.5-8%) in elderly/comorbid",
              "orderSentence": "Glycemic control optimization HbA1c target <7% Various"
            },
            "pretreatment": "None",
            "contraindications": "Hypoglycemia risk",
            "monitoring": "HbA1c q3mo until at goal, then q6mo",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Alpha-lipoic acid",
            "route": "PO/IV",
            "indication": "Antioxidant; European data for DPN",
            "dosing": {
              "doseOptions": [
                {
                  "text": "600 mg daily",
                  "orderSentence": "Alpha-lipoic acid 600 mg daily PO/IV"
                },
                {
                  "text": "600 mg IV daily",
                  "orderSentence": "Alpha-lipoic acid 600 mg IV daily PO/IV"
                }
              ],
              "route": "PO/IV",
              "instructions": "600 mg PO daily; IV form (600 mg daily x 3wk) for acute symptom relief; limited evidence",
              "orderSentence": "Alpha-lipoic acid 600 mg daily PO/IV"
            },
            "pretreatment": "None",
            "contraindications": "GI upset; may lower glucose",
            "monitoring": "Glucose (may enhance insulin sensitivity)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin B12 supplementation",
            "route": "PO/IM",
            "indication": "B12 deficiency or metformin use",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mcg PO daily",
                  "orderSentence": "Vitamin B12 supplementation 1000 mcg PO daily PO/IM"
                },
                {
                  "text": "1000 mcg IM monthly",
                  "orderSentence": "Vitamin B12 supplementation 1000 mcg IM monthly PO/IM"
                }
              ],
              "route": "PO/IM",
              "instructions": "1000-2000 mcg PO daily; or 1000 mcg IM monthly if poor absorption",
              "orderSentence": "Vitamin B12 supplementation 1000 mcg PO daily PO/IM"
            },
            "pretreatment": "None",
            "contraindications": "None",
            "monitoring": "B12 level q6-12mo",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Benfotiamine",
            "route": "PO",
            "indication": "Thiamine derivative; AGE inhibition",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg BID",
                  "orderSentence": "Benfotiamine 300 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "300 mg BID; limited evidence",
              "orderSentence": "Benfotiamine 300 mg BID PO"
            },
            "pretreatment": "None",
            "contraindications": "GI upset",
            "monitoring": "None specific",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "ACE inhibitor or ARB",
            "route": "PO",
            "indication": "Nephroprotection; may slow neuropathy progression",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per agent",
                  "orderSentence": "ACE inhibitor or ARB Per agent PO"
                }
              ],
              "route": "PO",
              "instructions": "Standard doses; benefit for kidney protection proven; neuropathy benefit theoretical",
              "orderSentence": "ACE inhibitor or ARB Per agent PO"
            },
            "pretreatment": "Angioedema; pregnancy; hyperkalemia; bilateral RAS",
            "contraindications": "K+, creatinine",
            "monitoring": "-",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "-"
          },
          {
            "item": "Statin therapy",
            "route": "PO",
            "indication": "Cardiovascular protection; anti-inflammatory",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per agent",
                  "orderSentence": "Statin therapy Per agent PO"
                }
              ],
              "route": "PO",
              "instructions": "High-intensity statin for most diabetics",
              "orderSentence": "Statin therapy Per agent PO"
            },
            "pretreatment": "Active liver disease",
            "contraindications": "LFTs, myalgias",
            "monitoring": "-",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Endocrinology for diabetes optimization if HbA1c not at goal or complex regimen needed",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Podiatry for foot exam, nail care, custom orthotics, and offloading devices",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vascular surgery if peripheral arterial disease suspected (ABI <0.9 or absent pulses)",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pain management for refractory neuropathic pain and interventional options (SCS)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Physical therapy for balance training and gait assessment to reduce fall risk",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Wound care specialist for diabetic foot ulcers not healing with standard care",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ophthalmology for annual diabetic retinopathy screening",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Nephrology if eGFR <30 or rapidly declining renal function",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Inspect feet daily using mirror for soles; look for cuts, blisters, redness, or swelling",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Never walk barefoot, even indoors, to prevent foot injuries",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Wear properly fitted shoes with adequate support; have shoes fitted by professional",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Test bath water temperature with elbow (not feet) to prevent burns from impaired sensation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Report any foot wounds, color changes, or pain immediately as diabetic foot ulcers can progress rapidly",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Take all prescribed medications as directed; do not skip doses of pain medications abruptly",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Monitor blood glucose as directed; excellent glycemic control is the most important factor to slow progression",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid alcohol which can worsen neuropathy and interact with pain medications",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Optimal glycemic control (HbA1c <7%) is the primary intervention to prevent and slow neuropathy progression",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Smoking cessation as smoking worsens peripheral vascular disease and neuropathy",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Blood pressure control (<130/80) reduces microvascular complications",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "LDL cholesterol control with statin therapy reduces cardiovascular risk",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Regular physical activity (150 min/week moderate) improves glycemic control and overall health",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Healthy diet (Mediterranean or DASH) supports glycemic and cardiovascular goals",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Limit alcohol which worsens neuropathy independently and affects glycemic control",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Annual comprehensive foot examination by healthcare provider",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Fall prevention with home safety modifications given impaired proprioception",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "B12 deficiency neuropathy",
        "features": "Sensory > motor; may have subacute combined degeneration; metformin use",
        "tests": "B12, MMA levels"
      },
      {
        "diagnosis": "Chronic inflammatory demyelinating polyneuropathy (CIDP)",
        "features": "Motor involvement; areflexia; elevated CSF protein; demyelinating NCS",
        "tests": "EMG/NCS (demyelinating pattern); CSF protein"
      },
      {
        "diagnosis": "Uremic neuropathy",
        "features": "Advanced CKD (eGFR <15); improves with dialysis",
        "tests": "BUN, creatinine, eGFR"
      },
      {
        "diagnosis": "Alcoholic neuropathy",
        "features": "Heavy alcohol use history; painful; coexisting thiamine deficiency",
        "tests": "History; thiamine level"
      },
      {
        "diagnosis": "Hypothyroid neuropathy",
        "features": "Other hypothyroid symptoms; CTS common",
        "tests": "TSH, free T4"
      },
      {
        "diagnosis": "Paraproteinemic neuropathy",
        "features": "IgM most common; anti-MAG antibodies; may have ataxia",
        "tests": "SPEP/UPEP; immunofixation; anti-MAG"
      },
      {
        "diagnosis": "Chemotherapy-induced neuropathy",
        "features": "Temporal relationship with chemotherapy (platinum, taxanes, vincristine)",
        "tests": "Medication history"
      },
      {
        "diagnosis": "Hereditary neuropathy (CMT)",
        "features": "Family history; high arches (pes cavus); hammer toes; slowly progressive",
        "tests": "Genetic testing; NCS pattern"
      },
      {
        "diagnosis": "Vasculitic neuropathy",
        "features": "Asymmetric; mononeuritis multiplex pattern; systemic symptoms",
        "tests": "Nerve biopsy; inflammatory markers; angiography"
      },
      {
        "diagnosis": "Amyloid neuropathy",
        "features": "Autonomic involvement; cardiomyopathy; carpal tunnel; paraprotein may be present",
        "tests": "Fat pad or nerve biopsy; genetic testing (TTR); SPEP"
      }
    ],
    "evidence": [
      {
        "recommendation": "Duloxetine for painful DPN (FDA-approved)",
        "evidenceLevel": "Class I, Level A",
        "source": "[Wernicke et al. Neurology 2006](https://pubmed.ncbi.nlm.nih.gov/17060567/)"
      },
      {
        "recommendation": "Pregabalin for painful DPN (FDA-approved)",
        "evidenceLevel": "Class I, Level A",
        "source": "[Derry et al. Cochrane 2019](https://pubmed.ncbi.nlm.nih.gov/30673120/)"
      },
      {
        "recommendation": "Gabapentin effective for DPN",
        "evidenceLevel": "Class II, Level B",
        "source": "[Wiffen et al. Cochrane 2017](https://pubmed.ncbi.nlm.nih.gov/28597471/)"
      },
      {
        "recommendation": "Tricyclic antidepressants effective",
        "evidenceLevel": "Class II, Level B",
        "source": "[Moore et al. Cochrane 2015](https://pubmed.ncbi.nlm.nih.gov/25879104/)"
      },
      {
        "recommendation": "Glycemic control prevents neuropathy progression",
        "evidenceLevel": "Class I, Level A",
        "source": "[DCCT/EDIC Research Group. NEJM 1993](https://pubmed.ncbi.nlm.nih.gov/8366922/)"
      },
      {
        "recommendation": "Alpha-lipoic acid may improve symptoms",
        "evidenceLevel": "Class II, Level B",
        "source": "[Ziegler et al. Diabetes Care 2011](https://pubmed.ncbi.nlm.nih.gov/21994426/)"
      },
      {
        "recommendation": "Comprehensive foot exam reduces amputations",
        "evidenceLevel": "Class II, Level B",
        "source": "[ADA Standards of Care 2024 (Section 12)](https://pubmed.ncbi.nlm.nih.gov/38078577/)"
      },
      {
        "recommendation": "Tapentadol effective for DPN (FDA-approved)",
        "evidenceLevel": "Class I, Level A",
        "source": "[Vinik et al. Diabetes Care 2014](https://pubmed.ncbi.nlm.nih.gov/24947790/)"
      },
      {
        "recommendation": "Spinal cord stimulation for refractory DPN",
        "evidenceLevel": "Class II, Level B",
        "source": "[Slangen et al. Diabetes Care 2014](https://pubmed.ncbi.nlm.nih.gov/24947789/)"
      },
      {
        "recommendation": "Capsaicin 8% patch effective",
        "evidenceLevel": "Class I, Level A",
        "source": "[Simpson et al. Pain 2017](https://pubmed.ncbi.nlm.nih.gov/27479770/)"
      }
    ],
    "monitoring": [
      {
        "item": "HbA1c",
        "frequency": "Every 3-6 months",
        "action": "Intensify diabetes management",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Comprehensive foot exam",
        "frequency": "Annually (more often if high risk)",
        "action": "Podiatry referral; offloading; wound care",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Monofilament testing",
        "frequency": "At least annually",
        "action": "High-risk foot care; education",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Pain scores (VAS, NRS)",
        "frequency": "Each visit",
        "action": "Adjust therapy; consider combination or referral",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "B12 level",
        "frequency": "Annually if on metformin",
        "action": "Supplement B12",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Kidney function (eGFR)",
        "frequency": "At least annually",
        "action": "Adjust medication doses; nephrology referral if declining",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Blood pressure",
        "frequency": "Each visit",
        "action": "Optimize antihypertensives",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Autonomic symptoms screen",
        "frequency": "Each visit",
        "action": "Autonomic testing; cardiology referral if cardiac autonomic neuropathy",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Depression screen (PHQ-9)",
        "frequency": "Annually or if symptoms",
        "action": "Treatment; referral",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      }
    ],
    "disposition": [
      {
        "disposition": "Discharge home",
        "criteria": "Symptoms managed; no foot infection; follow-up arranged"
      },
      {
        "disposition": "Admit to floor",
        "criteria": "Diabetic foot infection requiring IV antibiotics; severe uncontrolled pain; associated acute kidney injury"
      },
      {
        "disposition": "Surgical admission",
        "criteria": "Foot infection requiring debridement or amputation"
      },
      {
        "disposition": "Outpatient follow-up",
        "criteria": "Every 3-6 months for medication optimization; annually for comprehensive foot exam"
      }
    ]
  },
  "Parkinson's Disease": {
    "id": "parkinsons-disease",
    "title": "Parkinson's Disease",
    "version": "1.0",
    "icd10": [
      "** G20 (Parkinson's disease)"
    ],
    "scope": "** Diagnosis confirmation, dopaminergic therapy initiation and optimization, motor fluctuation management, and non-motor symptom treatment. Excludes Parkinson-plus syndromes (MSA, PSP, CBD, DLB - separate protocols).",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC",
            "rationale": "Baseline; rule out anemia contributing to fatigue",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "BMP",
            "rationale": "Renal function for medication dosing; electrolytes",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Hepatic panel (LFTs)",
            "rationale": "Baseline before COMT inhibitors",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "TSH",
            "rationale": "Rule out hypothyroidism mimicking bradykinesia",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin B12",
            "rationale": "Deficiency can cause parkinsonism; common in elderly",
            "target": ">300 pg/mL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin D, 25-hydroxy",
            "rationale": "Deficiency common; associated with falls and disease severity",
            "target": ">30 ng/mL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended Workup": [
          {
            "item": "Ceruloplasmin, serum copper",
            "rationale": "Wilson's disease if age <50",
            "target": "Normal",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "24-hour urine copper",
            "rationale": "Wilson's disease confirmation",
            "target": "<100 μg/24hr",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Ferritin, iron studies",
            "rationale": "Neurodegeneration with brain iron accumulation",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "RPR or VDRL",
            "rationale": "Syphilis can cause parkinsonism",
            "target": "Nonreactive",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "HIV testing",
            "rationale": "HIV-associated parkinsonism",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Genetic testing (LRRK2, GBA, SNCA, PARK2, PINK1, DJ-1)",
            "rationale": "Family history or early-onset (<50 years)",
            "target": "Identifies genetic form",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "CSF biomarkers (alpha-synuclein, tau, amyloid)",
            "rationale": "Research/atypical; synuclein seed amplification assay",
            "target": "Abnormal synuclein aggregation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Skin biopsy for alpha-synuclein",
            "rationale": "Research; confirms synucleinopathy",
            "target": "Phosphorylated synuclein deposits",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "MRI Brain without contrast",
            "timing": "At diagnosis",
            "target": "Normal (rules out structural causes, vascular parkinsonism, NPH)",
            "contraindications": "MRI-incompatible devices",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended": [
          {
            "item": "DaTscan (ioflupane I-123 SPECT)",
            "timing": "Diagnostic uncertainty; essential tremor vs PD",
            "target": "Reduced dopamine transporter uptake in striatum",
            "contraindications": "Hypersensitivity to iodine",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "MRI Brain with SWI sequence",
            "timing": "Suspected atypical parkinsonism or iron deposition",
            "target": "No \"hot cross bun\" (MSA) or \"hummingbird\" (PSP) signs",
            "contraindications": "MRI contraindications",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Cardiac MIBG scan",
            "timing": "Differentiate PD from MSA",
            "target": "Reduced uptake in PD (preserved in MSA)",
            "contraindications": "Recent MI; drugs affecting uptake",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Sleep study (polysomnography)",
            "timing": "REM sleep behavior disorder evaluation",
            "target": "Confirms RBD (prodromal marker)",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Autonomic function testing",
            "timing": "Dysautonomia assessment",
            "target": "Orthostatic hypotension, abnormal HR variability",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "FDG-PET",
            "timing": "Atypical parkinsonism differentiation",
            "target": "Pattern recognition for PD vs PSP vs MSA",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Transcranial ultrasound",
            "timing": "Screening tool",
            "target": "Hyperechogenicity of substantia nigra",
            "contraindications": "Inadequate bone window",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "Carbidopa-Levodopa (continue home dose)",
            "route": "PO/NG",
            "indication": "Admitted PD patient; DO NOT HOLD",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Home dose, same timing",
                  "orderSentence": "Carbidopa-Levodopa (continue home dose) Home dose, same timing PO"
                }
              ],
              "route": "PO",
              "instructions": "Give at EXACT same times as home; crushing allowed; use NG if NPO",
              "orderSentence": "Carbidopa-Levodopa (continue home dose) Home dose, same timing PO"
            },
            "contraindications": "Active psychosis; MAOIs within 14 days",
            "monitoring": "Dyskinesias, confusion",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Carbidopa-Levodopa (NPO protocol)",
            "route": "IV/NG",
            "indication": "Patient NPO >4 hours",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Home dose equivalent",
                  "orderSentence": "Carbidopa-Levodopa (NPO protocol) Home dose equivalent NG"
                }
              ],
              "route": "NG",
              "instructions": "Crush tablets; give via NG at home schedule; consult neurology for IV options if unavailable",
              "orderSentence": "Carbidopa-Levodopa (NPO protocol) Home dose equivalent NG"
            },
            "contraindications": "Same as PO",
            "monitoring": "Same as PO",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Apomorphine SC",
            "route": "SC",
            "indication": "Off episode in clinic/ED; NPO patient",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 mg SC",
                  "orderSentence": "Apomorphine SC 2 mg SC SC"
                },
                {
                  "text": "3 mg SC",
                  "orderSentence": "Apomorphine SC 3 mg SC SC"
                },
                {
                  "text": "4 mg SC",
                  "orderSentence": "Apomorphine SC 4 mg SC SC"
                },
                {
                  "text": "5 mg SC",
                  "orderSentence": "Apomorphine SC 5 mg SC SC"
                },
                {
                  "text": "6 mg SC",
                  "orderSentence": "Apomorphine SC 6 mg SC SC"
                }
              ],
              "route": "SC",
              "instructions": "Test dose 2 mg; titrate by 1 mg to effect; max 6 mg; pretreat with trimethobenzamide",
              "orderSentence": "Apomorphine SC 2 mg SC SC"
            },
            "contraindications": "Concurrent 5-HT3 antagonists (ondansetron); severe hypotension",
            "monitoring": "BP, nausea; may cause severe hypotension",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rotigotine patch",
            "route": "TD",
            "indication": "NPO patient; bridge therapy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 mg/24hr",
                  "orderSentence": "Rotigotine patch 2 mg/24hr TD"
                },
                {
                  "text": "4 mg/24hr",
                  "orderSentence": "Rotigotine patch 4 mg/24hr TD"
                },
                {
                  "text": "6 mg/24hr patch",
                  "orderSentence": "Rotigotine patch 6 mg/24hr patch TD"
                }
              ],
              "route": "TD",
              "instructions": "Apply patch equivalent to oral dopamine agonist dose; onset 2-3 hours",
              "orderSentence": "Rotigotine patch 2 mg/24hr TD"
            },
            "contraindications": "Sulfite allergy (adhesive)",
            "monitoring": "Application site reactions",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Trimethobenzamide",
            "route": "IM/PO",
            "indication": "Pretreat before apomorphine to prevent nausea",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg IM/PO",
                  "orderSentence": "Trimethobenzamide 300 mg IM/PO IM/PO"
                }
              ],
              "route": "IM/PO",
              "instructions": "300 mg TID starting 3 days before apomorphine initiation",
              "orderSentence": "Trimethobenzamide 300 mg IM/PO IM/PO"
            },
            "contraindications": "Hypersensitivity",
            "monitoring": "Drowsiness",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Symptomatic Treatments": [
          {
            "item": "Carbidopa-Levodopa IR (Sinemet)",
            "route": "PO",
            "indication": "Motor symptoms; first-line dopaminergic therapy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25/100 TID",
                  "orderSentence": "Carbidopa-Levodopa IR (Sinemet) 25/100 TID PO"
                },
                {
                  "text": "25/250 TID",
                  "orderSentence": "Carbidopa-Levodopa IR (Sinemet) 25/250 TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25/100 TID; titrate by 1 tablet q1-2wk; typical target 25/100-25/250 TID",
              "orderSentence": "Carbidopa-Levodopa IR (Sinemet) 25/100 TID PO"
            },
            "contraindications": "Active psychosis; MAOIs within 14 days",
            "monitoring": "Dyskinesias, nausea, orthostatic hypotension",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Carbidopa-Levodopa CR (Sinemet CR)",
            "route": "PO",
            "indication": "Nocturnal symptoms; wearing off",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25/100 CR qHS",
                  "orderSentence": "Carbidopa-Levodopa CR (Sinemet CR) 25/100 CR qHS PO"
                },
                {
                  "text": "50/200 CR BID",
                  "orderSentence": "Carbidopa-Levodopa CR (Sinemet CR) 50/200 CR BID PO"
                }
              ],
              "route": "PO",
              "instructions": "25/100 to 50/200 CR at bedtime or BID; 70% bioavailability vs IR",
              "orderSentence": "Carbidopa-Levodopa CR (Sinemet CR) 25/100 CR qHS PO"
            },
            "contraindications": "Same as IR",
            "monitoring": "Same as IR",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Carbidopa-Levodopa ER (Rytary)",
            "route": "PO",
            "indication": "Motor fluctuations; extend levodopa effect",
            "dosing": {
              "doseOptions": [
                {
                  "text": "23.75/95 TID",
                  "orderSentence": "Carbidopa-Levodopa ER (Rytary) 23.75/95 TID PO"
                },
                {
                  "text": "36.25/145 TID",
                  "orderSentence": "Carbidopa-Levodopa ER (Rytary) 36.25/145 TID PO"
                },
                {
                  "text": "48.75/195 TID",
                  "orderSentence": "Carbidopa-Levodopa ER (Rytary) 48.75/195 TID PO"
                },
                {
                  "text": "61.25/245 TID",
                  "orderSentence": "Carbidopa-Levodopa ER (Rytary) 61.25/245 TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Convert from IR using manufacturer table; typically TID dosing",
              "orderSentence": "Carbidopa-Levodopa ER (Rytary) 23.75/95 TID PO"
            },
            "contraindications": "Same as IR",
            "monitoring": "Same as IR",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pramipexole",
            "route": "PO",
            "indication": "Adjunct to levodopa; monotherapy in early PD; tremor",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.125 mg TID",
                  "orderSentence": "Pramipexole 0.125 mg TID PO"
                },
                {
                  "text": "0.25 mg TID",
                  "orderSentence": "Pramipexole 0.25 mg TID PO"
                },
                {
                  "text": "0.5 mg TID",
                  "orderSentence": "Pramipexole 0.5 mg TID PO"
                },
                {
                  "text": "1 mg TID",
                  "orderSentence": "Pramipexole 1 mg TID PO"
                },
                {
                  "text": "1.5 mg TID",
                  "orderSentence": "Pramipexole 1.5 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.125 mg TID; titrate by 0.125-0.25 mg TID q5-7 days; max 1.5 mg TID",
              "orderSentence": "Pramipexole 0.125 mg TID PO"
            },
            "contraindications": "Impulse control history",
            "monitoring": "Impulse control disorders, somnolence, leg edema",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ropinirole",
            "route": "PO",
            "indication": "Adjunct or monotherapy; similar to pramipexole",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.25 mg TID",
                  "orderSentence": "Ropinirole 0.25 mg TID PO"
                },
                {
                  "text": "0.5 mg TID",
                  "orderSentence": "Ropinirole 0.5 mg TID PO"
                },
                {
                  "text": "1 mg TID",
                  "orderSentence": "Ropinirole 1 mg TID PO"
                },
                {
                  "text": "2 mg TID",
                  "orderSentence": "Ropinirole 2 mg TID PO"
                },
                {
                  "text": "3 mg TID",
                  "orderSentence": "Ropinirole 3 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.25 mg TID; titrate weekly; max 8 mg TID",
              "orderSentence": "Ropinirole 0.25 mg TID PO"
            },
            "contraindications": "Same as pramipexole",
            "monitoring": "Same as pramipexole",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ropinirole XL",
            "route": "PO",
            "indication": "Extended-release option for adherence",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 mg daily",
                  "orderSentence": "Ropinirole XL 2 mg daily PO"
                },
                {
                  "text": "4 mg daily",
                  "orderSentence": "Ropinirole XL 4 mg daily PO"
                },
                {
                  "text": "6 mg daily",
                  "orderSentence": "Ropinirole XL 6 mg daily PO"
                },
                {
                  "text": "8 mg daily",
                  "orderSentence": "Ropinirole XL 8 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 2 mg daily; titrate by 2 mg q1-2wk; max 24 mg daily",
              "orderSentence": "Ropinirole XL 2 mg daily PO"
            },
            "contraindications": "Same as IR",
            "monitoring": "Same as IR",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Selegiline",
            "route": "PO",
            "indication": "MAO-B inhibitor; adjunct; mild neuroprotection theory",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg BID",
                  "orderSentence": "Selegiline 5 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "5 mg at breakfast and lunch (avoid evening due to insomnia); max 10 mg/day",
              "orderSentence": "Selegiline 5 mg BID PO"
            },
            "contraindications": "MAOIs; meperidine; TCAs (caution)",
            "monitoring": "Insomnia, hypertensive crisis with tyramine (rare at this dose)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rasagiline",
            "route": "PO",
            "indication": "MAO-B inhibitor; once daily; adjunct or monotherapy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5 mg daily",
                  "orderSentence": "Rasagiline 0.5 mg daily PO"
                },
                {
                  "text": "1 mg daily",
                  "orderSentence": "Rasagiline 1 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.5-1 mg daily; max 1 mg daily",
              "orderSentence": "Rasagiline 0.5 mg daily PO"
            },
            "contraindications": "Same as selegiline",
            "monitoring": "Hypertensive crisis (rare); serotonin syndrome with other serotonergics",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Safinamide",
            "route": "PO",
            "indication": "MAO-B inhibitor with additional mechanisms; adjunct in fluctuations",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg daily",
                  "orderSentence": "Safinamide 50 mg daily PO"
                },
                {
                  "text": "100 mg daily",
                  "orderSentence": "Safinamide 100 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 50 mg daily; may increase to 100 mg daily after 2 weeks",
              "orderSentence": "Safinamide 50 mg daily PO"
            },
            "contraindications": "Severe hepatic impairment; MAOIs; opioids",
            "monitoring": "Same as rasagiline; may improve dyskinesia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Entacapone",
            "route": "PO",
            "indication": "COMT inhibitor; extends levodopa effect; wearing off",
            "dosing": {
              "doseOptions": [
                {
                  "text": "200 mg with each levodopa dose",
                  "orderSentence": "Entacapone 200 mg with each levodopa dose PO"
                }
              ],
              "route": "PO",
              "instructions": "200 mg with each levodopa dose; max 8 doses (1600 mg)/day",
              "orderSentence": "Entacapone 200 mg with each levodopa dose PO"
            },
            "contraindications": "Hepatic impairment; concurrent MAOIs",
            "monitoring": "Diarrhea, orange urine, dyskinesias",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Opicapone",
            "route": "PO",
            "indication": "COMT inhibitor; once daily alternative to entacapone",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg qHS",
                  "orderSentence": "Opicapone 50 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "50 mg once daily at bedtime; take 1 hour before or after levodopa",
              "orderSentence": "Opicapone 50 mg qHS PO"
            },
            "contraindications": "Pheochromocytoma; paraganglioma",
            "monitoring": "Dyskinesias, constipation, dry mouth",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Amantadine",
            "route": "PO",
            "indication": "Dyskinesia reduction; mild motor benefit",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg BID",
                  "orderSentence": "Amantadine 100 mg BID PO"
                },
                {
                  "text": "100 mg TID",
                  "orderSentence": "Amantadine 100 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 100 mg daily; titrate to 100 mg BID-TID; max 400 mg/day; dose-reduce in renal impairment",
              "orderSentence": "Amantadine 100 mg BID PO"
            },
            "contraindications": "End-stage renal disease; seizure history",
            "monitoring": "Livedo reticularis, ankle edema, confusion, hallucinations",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Amantadine ER (Gocovri)",
            "route": "PO",
            "indication": "Dyskinesia; extended-release taken at bedtime",
            "dosing": {
              "doseOptions": [
                {
                  "text": "137 mg qHS",
                  "orderSentence": "Amantadine ER (Gocovri) 137 mg qHS PO"
                },
                {
                  "text": "274 mg qHS",
                  "orderSentence": "Amantadine ER (Gocovri) 274 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 137 mg qHS; increase to 274 mg qHS after 1 week",
              "orderSentence": "Amantadine ER (Gocovri) 137 mg qHS PO"
            },
            "contraindications": "Same as IR",
            "monitoring": "Same as IR",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Trihexyphenidyl",
            "route": "PO",
            "indication": "Tremor-dominant PD; younger patients",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 mg TID",
                  "orderSentence": "Trihexyphenidyl 1 mg TID PO"
                },
                {
                  "text": "2 mg TID",
                  "orderSentence": "Trihexyphenidyl 2 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 1 mg TID; titrate by 2 mg/day q3-5 days; max 15 mg/day",
              "orderSentence": "Trihexyphenidyl 1 mg TID PO"
            },
            "contraindications": "Glaucoma; urinary retention; dementia; age >70",
            "monitoring": "Cognitive impairment, dry mouth, constipation, urinary retention",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Benztropine",
            "route": "PO",
            "indication": "Alternative anticholinergic for tremor",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5 mg BID",
                  "orderSentence": "Benztropine 0.5 mg BID PO"
                },
                {
                  "text": "1 mg BID",
                  "orderSentence": "Benztropine 1 mg BID PO"
                },
                {
                  "text": "2 mg BID",
                  "orderSentence": "Benztropine 2 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.5 mg BID; titrate slowly; max 6 mg/day",
              "orderSentence": "Benztropine 0.5 mg BID PO"
            },
            "contraindications": "Same as trihexyphenidyl",
            "monitoring": "Same as trihexyphenidyl",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Istradefylline",
            "route": "PO",
            "indication": "Adenosine A2A antagonist; adjunct for OFF time",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg daily",
                  "orderSentence": "Istradefylline 20 mg daily PO"
                },
                {
                  "text": "40 mg daily",
                  "orderSentence": "Istradefylline 40 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 20 mg daily; may increase to 40 mg daily",
              "orderSentence": "Istradefylline 20 mg daily PO"
            },
            "contraindications": "Strong CYP3A4 inducers",
            "monitoring": "Dyskinesias, dizziness, constipation, hallucinations",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Non-Motor Symptom Treatments": [
          {
            "item": "Pimavanserin (Nuplazid)",
            "route": "PO",
            "indication": "Parkinson's disease psychosis (hallucinations, delusions)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "34 mg daily",
                  "orderSentence": "Pimavanserin (Nuplazid) 34 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "34 mg once daily; takes 4-6 weeks for effect; no titration needed",
              "orderSentence": "Pimavanserin (Nuplazid) 34 mg daily PO"
            },
            "contraindications": "Severe hepatic impairment; QT prolongation",
            "monitoring": "QTc, efficacy assessment at 6 weeks",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Quetiapine",
            "route": "PO",
            "indication": "Psychosis; alternative if pimavanserin unavailable",
            "dosing": {
              "doseOptions": [
                {
                  "text": "12.5 mg qHS",
                  "orderSentence": "Quetiapine 12.5 mg qHS PO"
                },
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Quetiapine 25 mg qHS PO"
                },
                {
                  "text": "50 mg qHS",
                  "orderSentence": "Quetiapine 50 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 12.5-25 mg qHS; titrate slowly by 12.5-25 mg q3-7d; typical max 150 mg/day",
              "orderSentence": "Quetiapine 12.5 mg qHS PO"
            },
            "contraindications": "Dementia with Lewy bodies (black box)",
            "monitoring": "Sedation, metabolic effects, QTc",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Clozapine",
            "route": "PO",
            "indication": "Refractory psychosis; best evidence but monitoring required",
            "dosing": {
              "doseOptions": [
                {
                  "text": "6.25 mg qHS",
                  "orderSentence": "Clozapine 6.25 mg qHS PO"
                },
                {
                  "text": "12.5 mg qHS",
                  "orderSentence": "Clozapine 12.5 mg qHS PO"
                },
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Clozapine 25 mg qHS PO"
                },
                {
                  "text": "50 mg qHS",
                  "orderSentence": "Clozapine 50 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 6.25-12.5 mg qHS; titrate by 12.5 mg q1-2wk; max 50-100 mg/day in PD",
              "orderSentence": "Clozapine 6.25 mg qHS PO"
            },
            "contraindications": "REMS enrollment required",
            "monitoring": "ANC weekly x 6 mo, then q2wk x 6 mo, then monthly; agranulocytosis risk",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rivastigmine (Exelon)",
            "route": "PO/Patch",
            "indication": "Parkinson's disease dementia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1.5 mg BID",
                  "orderSentence": "Rivastigmine (Exelon) 1.5 mg BID PO/Patch"
                },
                {
                  "text": "3 mg BID",
                  "orderSentence": "Rivastigmine (Exelon) 3 mg BID PO/Patch"
                },
                {
                  "text": "4.5 mg BID",
                  "orderSentence": "Rivastigmine (Exelon) 4.5 mg BID PO/Patch"
                },
                {
                  "text": "6 mg BID",
                  "orderSentence": "Rivastigmine (Exelon) 6 mg BID PO/Patch"
                },
                {
                  "text": "9.5 mg/24hr patch",
                  "orderSentence": "Rivastigmine (Exelon) 9.5 mg/24hr patch PO/Patch"
                },
                {
                  "text": "13.3 mg/24hr patch",
                  "orderSentence": "Rivastigmine (Exelon) 13.3 mg/24hr patch PO/Patch"
                }
              ],
              "route": "PO/Patch",
              "instructions": "Start 1.5 mg BID or 4.6 mg/24hr patch; titrate monthly; max 6 mg BID or 13.3 mg/24hr",
              "orderSentence": "Rivastigmine (Exelon) 1.5 mg BID PO/Patch"
            },
            "contraindications": "Severe hepatic impairment",
            "monitoring": "Nausea, weight loss, tremor worsening",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Donepezil",
            "route": "PO",
            "indication": "Parkinson's disease dementia; once daily option",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg qHS",
                  "orderSentence": "Donepezil 5 mg qHS PO"
                },
                {
                  "text": "10 mg qHS",
                  "orderSentence": "Donepezil 10 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg qHS; increase to 10 mg after 4-6 weeks",
              "orderSentence": "Donepezil 5 mg qHS PO"
            },
            "contraindications": "GI bleeding; sick sinus syndrome",
            "monitoring": "Nausea, bradycardia, vivid dreams",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Memantine",
            "route": "PO",
            "indication": "Moderate-severe dementia; add to cholinesterase inhibitor",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg daily",
                  "orderSentence": "Memantine 5 mg daily PO"
                },
                {
                  "text": "10 mg BID",
                  "orderSentence": "Memantine 10 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg daily; titrate by 5 mg/wk; target 10 mg BID",
              "orderSentence": "Memantine 5 mg daily PO"
            },
            "contraindications": "Severe renal impairment (dose adjust)",
            "monitoring": "Confusion, constipation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Midodrine",
            "route": "PO",
            "indication": "Orthostatic hypotension",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2.5 mg TID",
                  "orderSentence": "Midodrine 2.5 mg TID PO"
                },
                {
                  "text": "5 mg TID",
                  "orderSentence": "Midodrine 5 mg TID PO"
                },
                {
                  "text": "10 mg TID",
                  "orderSentence": "Midodrine 10 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 2.5 mg TID (before arising, before lunch, mid-afternoon); titrate by 2.5 mg/dose; max 10 mg TID; last dose by 6 PM",
              "orderSentence": "Midodrine 2.5 mg TID PO"
            },
            "contraindications": "Supine hypertension; urinary retention; severe cardiac disease",
            "monitoring": "Supine BP (must avoid lying flat for 4 hours after dose)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Droxidopa (Northera)",
            "route": "PO",
            "indication": "Neurogenic orthostatic hypotension",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg TID",
                  "orderSentence": "Droxidopa (Northera) 100 mg TID PO"
                },
                {
                  "text": "200 mg TID",
                  "orderSentence": "Droxidopa (Northera) 200 mg TID PO"
                },
                {
                  "text": "300 mg TID",
                  "orderSentence": "Droxidopa (Northera) 300 mg TID PO"
                },
                {
                  "text": "600 mg TID",
                  "orderSentence": "Droxidopa (Northera) 600 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 100 mg TID; titrate by 100 mg/dose q24-48h; max 600 mg TID",
              "orderSentence": "Droxidopa (Northera) 100 mg TID PO"
            },
            "contraindications": "Supine hypertension",
            "monitoring": "Supine BP, headache",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Fludrocortisone",
            "route": "PO",
            "indication": "Orthostatic hypotension adjunct",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.1 mg daily",
                  "orderSentence": "Fludrocortisone 0.1 mg daily PO"
                },
                {
                  "text": "0.2 mg daily",
                  "orderSentence": "Fludrocortisone 0.2 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.1 mg daily; may increase to 0.2 mg daily; max 0.3 mg",
              "orderSentence": "Fludrocortisone 0.1 mg daily PO"
            },
            "contraindications": "CHF; renal failure; severe hypertension",
            "monitoring": "K+, edema, supine BP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sertraline",
            "route": "PO",
            "indication": "Depression in PD",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg daily",
                  "orderSentence": "Sertraline 25 mg daily PO"
                },
                {
                  "text": "50 mg daily",
                  "orderSentence": "Sertraline 50 mg daily PO"
                },
                {
                  "text": "100 mg daily",
                  "orderSentence": "Sertraline 100 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg daily; titrate by 25 mg q1-2wk; typical 50-100 mg daily",
              "orderSentence": "Sertraline 25 mg daily PO"
            },
            "contraindications": "MAOIs within 14 days",
            "monitoring": "Serotonin syndrome (caution with MAO-B inhibitors)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Venlafaxine XR",
            "route": "PO",
            "indication": "Depression; anxiety in PD",
            "dosing": {
              "doseOptions": [
                {
                  "text": "37.5 mg daily",
                  "orderSentence": "Venlafaxine XR 37.5 mg daily PO"
                },
                {
                  "text": "75 mg daily",
                  "orderSentence": "Venlafaxine XR 75 mg daily PO"
                },
                {
                  "text": "150 mg daily",
                  "orderSentence": "Venlafaxine XR 150 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 37.5 mg daily; titrate q1-2wk; typical 75-150 mg daily",
              "orderSentence": "Venlafaxine XR 37.5 mg daily PO"
            },
            "contraindications": "Same as sertraline",
            "monitoring": "BP at higher doses",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Polyethylene glycol (MiraLAX)",
            "route": "PO",
            "indication": "Constipation (ubiquitous in PD)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "17 g daily",
                  "orderSentence": "Polyethylene glycol (MiraLAX) 17 g daily PO"
                },
                {
                  "text": "17 g BID",
                  "orderSentence": "Polyethylene glycol (MiraLAX) 17 g BID PO"
                }
              ],
              "route": "PO",
              "instructions": "17 g (1 capful) in 8 oz liquid daily; may increase to BID",
              "orderSentence": "Polyethylene glycol (MiraLAX) 17 g daily PO"
            },
            "contraindications": "Bowel obstruction",
            "monitoring": "Diarrhea if excessive",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Senna + docusate",
            "route": "PO",
            "indication": "Constipation stimulant",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 tablets qHS",
                  "orderSentence": "Senna + docusate 2 tablets qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "2 tablets qHS; may increase to 4 tablets",
              "orderSentence": "Senna + docusate 2 tablets qHS PO"
            },
            "contraindications": "Bowel obstruction; undiagnosed abdominal pain",
            "monitoring": "Electrolytes with chronic use",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Clonazepam",
            "route": "PO",
            "indication": "REM sleep behavior disorder",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.25 mg qHS",
                  "orderSentence": "Clonazepam 0.25 mg qHS PO"
                },
                {
                  "text": "0.5 mg qHS",
                  "orderSentence": "Clonazepam 0.5 mg qHS PO"
                },
                {
                  "text": "1 mg qHS",
                  "orderSentence": "Clonazepam 1 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.25-0.5 mg qHS; titrate to effect; typical 0.5-1 mg",
              "orderSentence": "Clonazepam 0.25 mg qHS PO"
            },
            "contraindications": "Severe sleep apnea; respiratory compromise",
            "monitoring": "Sedation, falls, cognitive effects",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Melatonin",
            "route": "PO",
            "indication": "REM sleep behavior disorder; sleep disturbance",
            "dosing": {
              "doseOptions": [
                {
                  "text": "3 mg qHS",
                  "orderSentence": "Melatonin 3 mg qHS PO"
                },
                {
                  "text": "6 mg qHS",
                  "orderSentence": "Melatonin 6 mg qHS PO"
                },
                {
                  "text": "9 mg qHS",
                  "orderSentence": "Melatonin 9 mg qHS PO"
                },
                {
                  "text": "12 mg qHS",
                  "orderSentence": "Melatonin 12 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 3-6 mg qHS; may increase to 12 mg",
              "orderSentence": "Melatonin 3 mg qHS PO"
            },
            "contraindications": "None",
            "monitoring": "Generally well-tolerated",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Glycopyrrolate",
            "route": "PO",
            "indication": "Sialorrhea (drooling)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 mg TID",
                  "orderSentence": "Glycopyrrolate 1 mg TID PO"
                },
                {
                  "text": "2 mg TID",
                  "orderSentence": "Glycopyrrolate 2 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 1 mg TID; titrate to effect; max 2 mg TID",
              "orderSentence": "Glycopyrrolate 1 mg TID PO"
            },
            "contraindications": "Glaucoma; urinary retention; GI obstruction",
            "monitoring": "Dry mouth, constipation, urinary retention",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "OnabotulinumtoxinA (salivary glands)",
            "route": "IM",
            "indication": "Sialorrhea refractory to oral therapy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 units total",
                  "orderSentence": "OnabotulinumtoxinA (salivary glands) 100 units total IM"
                }
              ],
              "route": "IM",
              "instructions": "30-50 units per parotid, 10-20 units per submandibular; repeat q3-4 months",
              "orderSentence": "OnabotulinumtoxinA (salivary glands) 100 units total IM"
            },
            "contraindications": "Infection at site",
            "monitoring": "Dysphagia (rare), dry mouth",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Advanced Therapies": [
          {
            "item": "Deep brain stimulation (DBS)",
            "route": "Surgical",
            "indication": "Motor fluctuations or tremor refractory to optimal medication",
            "dosing": {
              "doseOptions": [
                {
                  "text": "STN or GPi stimulation",
                  "orderSentence": "Deep brain stimulation (DBS) STN or GPi stimulation Surgical"
                }
              ],
              "route": "Surgical",
              "instructions": "Unilateral or bilateral; programming done over weeks post-op",
              "orderSentence": "Deep brain stimulation (DBS) STN or GPi stimulation Surgical"
            },
            "pretreatment": "Neuropsych testing, MRI, off-medication evaluation",
            "contraindications": "Dementia; active psychiatric disease; medical comorbidities",
            "monitoring": "Programming optimization; battery checks",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Levodopa-carbidopa intestinal gel (Duopa)",
            "route": "Enteral",
            "indication": "Severe motor fluctuations; 4+ hours OFF/day",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Continuous infusion",
                  "orderSentence": "Levodopa-carbidopa intestinal gel (Duopa) Continuous infusion Enteral"
                }
              ],
              "route": "Enteral",
              "instructions": "Via PEG-J; 16-hour infusion; morning bolus + continuous rate + extra doses",
              "orderSentence": "Levodopa-carbidopa intestinal gel (Duopa) Continuous infusion Enteral"
            },
            "pretreatment": "GI tract accessible",
            "contraindications": "GI disease preventing PEG-J; coagulopathy",
            "monitoring": "Tube site, infections, GI complications",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Apomorphine continuous infusion",
            "route": "SC",
            "indication": "Severe motor fluctuations; not DBS candidate",
            "dosing": {
              "doseOptions": [
                {
                  "text": "3-8 mg/hr continuous",
                  "orderSentence": "Apomorphine continuous infusion 3-8 mg/hr continuous SC"
                }
              ],
              "route": "SC",
              "instructions": "Via subcutaneous pump; typical 3-8 mg/hr during waking hours",
              "orderSentence": "Apomorphine continuous infusion 3-8 mg/hr continuous SC"
            },
            "pretreatment": "Caregiver training",
            "contraindications": "Same as SC apomorphine",
            "monitoring": "Same as SC apomorphine",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Movement disorders specialist for diagnosis confirmation and advanced therapy evaluation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Physical therapy for gait training, balance exercises, and LSVT BIG program",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Occupational therapy for ADL adaptation and fine motor strategies",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Speech therapy (LSVT LOUD) for hypophonia and swallowing evaluation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Neuropsychology for cognitive assessment and DBS candidacy evaluation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Psychiatry for depression, anxiety, impulse control disorders, or psychosis management",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Palliative care for advanced disease symptom management and goals of care",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Social work for caregiver support, community resources, and disability planning",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Urology for urinary symptoms not responsive to first-line treatment",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Gastroenterology for severe constipation or Duopa tube placement",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "CRITICAL: Do not skip or delay levodopa doses as this can cause severe OFF episodes and immobility",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Take levodopa 30-60 minutes before meals for better absorption (protein competes with levodopa transport)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Rise slowly from sitting or lying to prevent falls from orthostatic hypotension",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Inform all healthcare providers about PD medications to avoid drug interactions (especially antipsychotics, antiemetics)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Report any new impulsive behaviors (gambling, shopping, hypersexuality) which may indicate impulse control disorder from dopamine agonists",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Report hallucinations early as these can be managed with medication adjustment",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Engage in regular exercise which may slow disease progression and improves mobility",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Regular aerobic exercise (30-60 min, 3-5x/week) improves motor function and may be neuroprotective",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Tai chi or dance-based exercise programs improve balance and reduce falls",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "High-fiber diet and adequate hydration to prevent constipation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid medications that worsen parkinsonism (metoclopramide, prochlorperazine, haloperidol, risperidone)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Fall prevention: remove home hazards, adequate lighting, grab bars, non-slip surfaces",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Mediterranean diet may have protective benefits based on observational studies",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Coffee consumption associated with reduced PD risk; continued moderate use reasonable",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Drug-induced parkinsonism",
        "features": "Medication exposure (antipsychotics, metoclopramide); symmetric; no levodopa response",
        "tests": "DaTscan normal; history of causative medication"
      },
      {
        "diagnosis": "Vascular parkinsonism",
        "features": "Stepwise progression; lower body predominant; vascular risk factors; pyramidal signs",
        "tests": "MRI with subcortical/basal ganglia infarcts"
      },
      {
        "diagnosis": "Progressive supranuclear palsy (PSP)",
        "features": "Early falls; vertical gaze palsy; axial rigidity > limb; poor levodopa response",
        "tests": "MRI \"hummingbird sign\"; clinical criteria"
      },
      {
        "diagnosis": "Multiple system atrophy (MSA)",
        "features": "Severe dysautonomia; cerebellar signs; stridor; poor levodopa response",
        "tests": "MRI \"hot cross bun\" sign; MIBG preserved"
      },
      {
        "diagnosis": "Corticobasal degeneration (CBD)",
        "features": "Asymmetric rigidity; apraxia; alien limb; cortical sensory loss",
        "tests": "MRI asymmetric cortical atrophy"
      },
      {
        "diagnosis": "Dementia with Lewy bodies (DLB)",
        "features": "Dementia before or within 1 year of motor symptoms; fluctuating cognition; visual hallucinations",
        "tests": "Clinical criteria; DaTscan may be abnormal"
      },
      {
        "diagnosis": "Essential tremor",
        "features": "Action tremor > rest tremor; improves with alcohol; family history; no bradykinesia",
        "tests": "DaTscan normal; clinical criteria"
      },
      {
        "diagnosis": "Normal pressure hydrocephalus",
        "features": "Gait apraxia (\"magnetic gait\"); urinary incontinence; dementia",
        "tests": "MRI ventricular enlargement; LP with gait improvement"
      }
    ],
    "evidence": [
      {
        "recommendation": "Levodopa most effective symptomatic treatment",
        "evidenceLevel": "Class I, Level A",
        "source": "[Fahn et al. NEJM 2004 (ELLDOPA)](https://pubmed.ncbi.nlm.nih.gov/15590952/)"
      },
      {
        "recommendation": "MAO-B inhibitors provide mild motor benefit",
        "evidenceLevel": "Class I, Level A",
        "source": "[Rascol et al. NEJM 2005 (rasagiline)](https://pubmed.ncbi.nlm.nih.gov/15728780/)"
      },
      {
        "recommendation": "Pimavanserin for PD psychosis",
        "evidenceLevel": "Class I, Level A",
        "source": "[Cummings et al. Lancet 2014](https://pubmed.ncbi.nlm.nih.gov/24315521/)"
      },
      {
        "recommendation": "DBS improves motor fluctuations",
        "evidenceLevel": "Class I, Level A",
        "source": "[Weaver et al. JAMA 2009](https://pubmed.ncbi.nlm.nih.gov/19126699/)"
      },
      {
        "recommendation": "Rivastigmine for PD dementia",
        "evidenceLevel": "Class I, Level A",
        "source": "[Emre et al. NEJM 2004](https://pubmed.ncbi.nlm.nih.gov/15590953/)"
      },
      {
        "recommendation": "Exercise improves motor function",
        "evidenceLevel": "Class II, Level B",
        "source": "[Schenkman et al. JAMA Neurol 2018](https://pubmed.ncbi.nlm.nih.gov/29228079/)"
      },
      {
        "recommendation": "LSVT LOUD improves speech",
        "evidenceLevel": "Class I, Level B",
        "source": "[Ramig et al. JSLHR 2001](https://pubmed.ncbi.nlm.nih.gov/11407973/)"
      },
      {
        "recommendation": "Clonazepam and melatonin for RBD",
        "evidenceLevel": "Class II, Level B",
        "source": "[Aurora et al. AASM 2010](https://pubmed.ncbi.nlm.nih.gov/21135521/)"
      },
      {
        "recommendation": "Amantadine reduces dyskinesia",
        "evidenceLevel": "Class I, Level A",
        "source": "[Ory-Magne et al. Lancet Neurol 2014](https://pubmed.ncbi.nlm.nih.gov/24726067/)"
      },
      {
        "recommendation": "Duopa for motor fluctuations",
        "evidenceLevel": "Class I, Level A",
        "source": "[Olanow et al. Lancet Neurol 2014](https://pubmed.ncbi.nlm.nih.gov/24184024/)"
      }
    ],
    "monitoring": [
      {
        "item": "Motor function (UPDRS-III or MDS-UPDRS)",
        "frequency": "Every visit",
        "action": "Adjust medications if worsening",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "ON/OFF time diary",
        "frequency": "Daily for 1 week before visits",
        "action": "Add adjunct therapy; consider advanced options",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Dyskinesia severity",
        "frequency": "Each visit",
        "action": "Reduce levodopa; add amantadine; adjust timing",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Orthostatic blood pressure",
        "frequency": "Each visit",
        "action": "Add midodrine or droxidopa",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Cognition (MoCA)",
        "frequency": "Annually, more often if concerns",
        "action": "Add cholinesterase inhibitor; adjust anticholinergics",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Mood (GDS, PHQ-9)",
        "frequency": "Annually",
        "action": "Add antidepressant; psychiatry referral",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Impulse control screen (QUIP)",
        "frequency": "Each visit if on dopamine agonist",
        "action": "Reduce or discontinue dopamine agonist",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Falls frequency",
        "frequency": "Each visit",
        "action": "PT referral; medication review; home safety evaluation",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Swallowing function",
        "frequency": "Annually or if symptoms",
        "action": "Speech therapy; modify diet",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "ANC (if on clozapine)",
        "frequency": "Per REMS protocol",
        "action": "Hold clozapine if ANC <1000; discontinue if <500",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      }
    ],
    "disposition": [
      {
        "disposition": "Discharge home",
        "criteria": "Stable motor status; able to take PO; adequate caregiver support; follow-up arranged"
      },
      {
        "disposition": "Admit to floor",
        "criteria": "Unable to take PO medications >24 hours; severe OFF episode; aspiration pneumonia; acute infection"
      },
      {
        "disposition": "Admit to ICU",
        "criteria": "Neuroleptic malignant syndrome; severe rigidity with rhabdomyolysis; respiratory compromise"
      },
      {
        "disposition": "Outpatient follow-up",
        "criteria": "Every 3-6 months for stable patients; more frequently during medication adjustments"
      }
    ]
  },
  "Cluster Headache": {
    "id": "cluster-headache",
    "title": "Cluster Headache",
    "version": "1.0",
    "icd10": [
      "** G44.009 (Cluster headache syndrome",
      "unspecified)"
    ],
    "scope": "** Acute cluster headache attack treatment, transitional therapy, and preventive therapy for episodic and chronic cluster headache. Excludes other trigeminal autonomic cephalalgias (paroxysmal hemicrania, SUNCT/SUNA - separate protocols).",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC",
            "rationale": "Baseline before starting preventive therapy; rule out infection",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "BMP",
            "rationale": "Baseline renal function before lithium or other preventives",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "TSH",
            "rationale": "Thyroid dysfunction can mimic or exacerbate headache; baseline for lithium",
            "target": "Normal (0.4-4.0 mIU/L)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "LFTs",
            "rationale": "Baseline hepatic function before verapamil, valproate",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended Workup": [
          {
            "item": "Pituitary function panel (FSH, LH, prolactin, IGF-1, cortisol)",
            "rationale": "Atypical features or pituitary lesion on imaging",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lithium level",
            "rationale": "Monitoring when on lithium therapy",
            "target": "0.6-1.0 mEq/L therapeutic range",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Calcium, PTH",
            "rationale": "Lithium-induced hypercalcemia monitoring",
            "target": "Normal calcium; PTH not elevated",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Free T4",
            "rationale": "Lithium-induced thyroid dysfunction monitoring",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "BUN, creatinine",
            "rationale": "Lithium nephrotoxicity monitoring",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "ESR, CRP",
            "rationale": "Atypical features; rule out giant cell arteritis in older patients",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Growth hormone stimulation test",
            "rationale": "Suspected pituitary adenoma with GH deficiency",
            "target": "Normal response",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Sleep study (polysomnography)",
            "rationale": "Suspected obstructive sleep apnea as trigger",
            "target": "AHI <5 (normal)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "MRI Brain with pituitary protocol",
            "timing": "New diagnosis of cluster headache",
            "target": "Normal; exclude pituitary lesion, hypothalamic lesion, cavernous sinus pathology",
            "contraindications": "MRI-incompatible devices, severe claustrophobia",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "MRA Head",
            "timing": "Suspected vascular etiology; atypical features",
            "target": "No aneurysm, dissection, vascular malformation",
            "contraindications": "MRI contraindications",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended": [
          {
            "item": "MRI orbits with contrast",
            "timing": "Orbital pain, suspected retro-orbital pathology",
            "target": "No orbital mass, Tolosa-Hunt syndrome",
            "contraindications": "Gadolinium allergy, severe renal impairment",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "CT Head non-contrast",
            "timing": "MRI unavailable; acute presentation",
            "target": "No acute pathology",
            "contraindications": "Pregnancy (relative)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "CTA Head/Neck",
            "timing": "Urgent vascular imaging if MRI unavailable",
            "target": "No aneurysm, dissection",
            "contraindications": "Contrast allergy, CKD",
            "ED": "STAT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "MRV Brain",
            "timing": "Suspected cerebral venous thrombosis",
            "target": "Patent venous sinuses",
            "contraindications": "MRI contraindications",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "CT sinuses",
            "timing": "Suspected sinus pathology contributing",
            "target": "No sinusitis, mucocele",
            "contraindications": "Pregnancy (relative)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Carotid Doppler ultrasound",
            "timing": "Suspected carotid dissection",
            "target": "No dissection",
            "contraindications": "None",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent (Abortive Therapy for Active Attacks)": [
          {
            "item": "High-flow oxygen",
            "route": "INH",
            "indication": "First-line abortive; most effective acute treatment",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100% at 12-15 L/min x 15-20 min",
                  "orderSentence": "High-flow oxygen 100% at 12-15 L/min x 15-20 min INH"
                }
              ],
              "route": "INH",
              "instructions": "100% O2 via non-rebreather mask at 12-15 L/min for 15-20 min; patient seated, leaning forward; may repeat",
              "orderSentence": "High-flow oxygen 100% at 12-15 L/min x 15-20 min INH"
            },
            "contraindications": "Severe COPD with CO2 retention (relative)",
            "monitoring": "SpO2; symptom resolution typically within 15 min",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sumatriptan",
            "route": "SC",
            "indication": "First-line abortive; rapid onset",
            "dosing": {
              "doseOptions": [
                {
                  "text": "6 mg SC",
                  "orderSentence": "Sumatriptan 6 mg SC SC"
                }
              ],
              "route": "SC",
              "instructions": "6 mg SC at onset; may repeat after 1 hr if needed; max 12 mg/24hr",
              "orderSentence": "Sumatriptan 6 mg SC SC"
            },
            "contraindications": "Uncontrolled HTN; CAD; prior MI/stroke; hemiplegic migraine; MAOIs; within 24h of ergot",
            "monitoring": "Triptan sensation; monitor BP if cardiac risk factors",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sumatriptan",
            "route": "Intranasal",
            "indication": "Alternative to SC when injection not preferred",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg intranasal",
                  "orderSentence": "Sumatriptan 20 mg intranasal Intranasal"
                }
              ],
              "route": "Intranasal",
              "instructions": "20 mg intranasal at onset; may repeat after 2 hr; max 40 mg/24hr",
              "orderSentence": "Sumatriptan 20 mg intranasal Intranasal"
            },
            "contraindications": "Same as SC sumatriptan",
            "monitoring": "Nasal irritation; triptan sensation",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Zolmitriptan",
            "route": "Intranasal",
            "indication": "Alternative triptan; effective nasal delivery",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg intranasal",
                  "orderSentence": "Zolmitriptan 5 mg intranasal Intranasal"
                }
              ],
              "route": "Intranasal",
              "instructions": "5 mg intranasal at onset; may repeat after 2 hr; max 10 mg/24hr",
              "orderSentence": "Zolmitriptan 5 mg intranasal Intranasal"
            },
            "contraindications": "Same as sumatriptan",
            "monitoring": "Triptan sensation; nasal discomfort",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Zolmitriptan",
            "route": "PO",
            "indication": "Oral option when SC/nasal unavailable",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg PO",
                  "orderSentence": "Zolmitriptan 5 mg PO PO"
                },
                {
                  "text": "10 mg PO",
                  "orderSentence": "Zolmitriptan 10 mg PO PO"
                }
              ],
              "route": "PO",
              "instructions": "5-10 mg PO at onset; may repeat after 2 hr; max 10 mg/24hr",
              "orderSentence": "Zolmitriptan 5 mg PO PO"
            },
            "contraindications": "Same as sumatriptan",
            "monitoring": "Triptan sensation",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Octreotide",
            "route": "SC",
            "indication": "Second-line; triptan contraindications or failure",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mcg SC",
                  "orderSentence": "Octreotide 100 mcg SC SC"
                }
              ],
              "route": "SC",
              "instructions": "100 mcg SC at onset; may repeat once after 1 hr",
              "orderSentence": "Octreotide 100 mcg SC SC"
            },
            "contraindications": "Gallbladder disease; diabetes (may alter glucose)",
            "monitoring": "Blood glucose; GI symptoms",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Lidocaine",
            "route": "Intranasal",
            "indication": "Adjunctive therapy; sphenopalatine ganglion block",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 mL of 4-10% solution",
                  "orderSentence": "Lidocaine 1 mL of 4-10% solution Intranasal"
                }
              ],
              "route": "Intranasal",
              "instructions": "Instill 1 mL of 4-10% lidocaine into nostril ipsilateral to pain; head tilted back 45 degrees toward affected side; may repeat x1",
              "orderSentence": "Lidocaine 1 mL of 4-10% solution Intranasal"
            },
            "contraindications": "Local anesthetic allergy",
            "monitoring": "Numbness; bitter taste",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Transitional Therapy (Bridge Until Preventive Takes Effect)": [
          {
            "item": "Prednisone",
            "route": "PO",
            "indication": "Rapid cluster suppression; bridge to verapamil",
            "dosing": {
              "doseOptions": [
                {
                  "text": "60 mg daily x 5 days",
                  "orderSentence": "Prednisone 60 mg daily x 5 days PO"
                },
                {
                  "text": "40 mg daily x 5 days",
                  "orderSentence": "Prednisone 40 mg daily x 5 days PO"
                },
                {
                  "text": "20 mg daily x 5 days",
                  "orderSentence": "Prednisone 20 mg daily x 5 days PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 60-80 mg daily x 5 days, taper by 10-20 mg q5d over 2-3 weeks; limit to 2-3 courses/year",
              "orderSentence": "Prednisone 60 mg daily x 5 days PO"
            },
            "contraindications": "Active infection; uncontrolled diabetes; GI bleeding; psychosis history",
            "monitoring": "Glucose; BP; mood changes; sleep",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Dexamethasone",
            "route": "IV/PO",
            "indication": "Alternative steroid; hospitalized patients",
            "dosing": {
              "doseOptions": [
                {
                  "text": "8 mg IV/PO daily x 3-5 days",
                  "orderSentence": "Dexamethasone 8 mg IV/PO daily x 3-5 days IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "4-8 mg IV or PO daily x 3-5 days, then taper or switch to prednisone",
              "orderSentence": "Dexamethasone 8 mg IV/PO daily x 3-5 days IV/PO"
            },
            "contraindications": "Same as prednisone",
            "monitoring": "Glucose; BP",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Greater occipital nerve block",
            "route": "SC",
            "indication": "Transitional therapy; rapid reduction in attack frequency",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2-3 mL 2% lidocaine + 40 mg triamcinolone",
                  "orderSentence": "Greater occipital nerve block 2-3 mL 2% lidocaine + 40 mg triamcinolone SC"
                }
              ],
              "route": "SC",
              "instructions": "Inject 2-3 mL of 2% lidocaine + 40 mg triamcinolone (or 6 mg betamethasone) at greater occipital nerve ipsilateral to pain; may do bilaterally",
              "orderSentence": "Greater occipital nerve block 2-3 mL 2% lidocaine + 40 mg triamcinolone SC"
            },
            "contraindications": "Local anesthetic allergy; infection at site; anticoagulation (relative)",
            "monitoring": "Immediate relief; vasovagal reaction; alopecia at injection site",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Dihydroergotamine (DHE)",
            "route": "IV",
            "indication": "Status cluster; refractory attacks; inpatient protocol",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5 mg IV q8h x 5 days",
                  "orderSentence": "Dihydroergotamine (DHE) 0.5 mg IV q8h x 5 days IV"
                },
                {
                  "text": "1 mg IV q8h x 5 days",
                  "orderSentence": "Dihydroergotamine (DHE) 1 mg IV q8h x 5 days IV"
                }
              ],
              "route": "IV",
              "instructions": "0.5-1 mg IV q8h (after test dose 0.25-0.5 mg) for 3-5 days; pretreat with antiemetic; requires telemetry",
              "orderSentence": "Dihydroergotamine (DHE) 0.5 mg IV q8h x 5 days IV"
            },
            "contraindications": "Pregnancy; CAD; uncontrolled HTN; peripheral vascular disease; use within 24h of triptan; hepatic/renal impairment; sepsis",
            "monitoring": "BP; ECG monitoring; nausea; leg cramps; paresthesias",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Dihydroergotamine (DHE)",
            "route": "SC/IM",
            "indication": "Home transitional therapy; bridge after inpatient protocol",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 mg SC/IM at onset",
                  "orderSentence": "Dihydroergotamine (DHE) 1 mg SC/IM at onset SC/IM"
                }
              ],
              "route": "SC/IM",
              "instructions": "1 mg SC or IM at onset of attack; max 3 mg/24hr; max 6 mg/week",
              "orderSentence": "Dihydroergotamine (DHE) 1 mg SC/IM at onset SC/IM"
            },
            "contraindications": "Same as IV DHE",
            "monitoring": "Same as IV DHE",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Second-line/Refractory (Acute Treatments)": [
          {
            "item": "Sphenopalatine ganglion block",
            "route": "Intranasal",
            "indication": "Refractory acute attacks; alternative to nerve block",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.3 mL 0.5% bupivacaine",
                  "orderSentence": "Sphenopalatine ganglion block 0.3 mL 0.5% bupivacaine Intranasal"
                }
              ],
              "route": "Intranasal",
              "instructions": "Apply 0.3 mL of 0.5% bupivacaine via intranasal catheter (Tx360, SphenoCath) to sphenopalatine ganglion",
              "orderSentence": "Sphenopalatine ganglion block 0.3 mL 0.5% bupivacaine Intranasal"
            },
            "contraindications": "Local anesthetic allergy; nasal pathology",
            "monitoring": "Local numbness; epistaxis; vasovagal",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ketamine",
            "route": "Intranasal",
            "indication": "Refractory attacks; investigational",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50-75 mg intranasal",
                  "orderSentence": "Ketamine 50-75 mg intranasal Intranasal"
                }
              ],
              "route": "Intranasal",
              "instructions": "50-75 mg intranasal via atomizer; may repeat x1",
              "orderSentence": "Ketamine 50-75 mg intranasal Intranasal"
            },
            "contraindications": "Uncontrolled HTN; psychosis; increased ICP",
            "monitoring": "Dissociation; BP; HR",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Ergotamine tartrate",
            "route": "SL/PO",
            "indication": "Alternative when DHE unavailable",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 mg SL at onset",
                  "orderSentence": "Ergotamine tartrate 2 mg SL at onset SL"
                }
              ],
              "route": "SL",
              "instructions": "2 mg sublingual at onset; may repeat 1-2 mg q30min; max 6 mg/attack, 10 mg/week",
              "orderSentence": "Ergotamine tartrate 2 mg SL at onset SL"
            },
            "contraindications": "Same as DHE",
            "monitoring": "Nausea; peripheral vasoconstriction",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Preventive Therapies": [
          {
            "item": "Verapamil",
            "route": "PO",
            "indication": "First-line preventive; episodic and chronic CH",
            "dosing": {
              "doseOptions": [
                {
                  "text": "80 mg TID",
                  "orderSentence": "Verapamil 80 mg TID PO"
                },
                {
                  "text": "120 mg TID",
                  "orderSentence": "Verapamil 120 mg TID PO"
                },
                {
                  "text": "160 mg TID",
                  "orderSentence": "Verapamil 160 mg TID PO"
                },
                {
                  "text": "240 mg TID",
                  "orderSentence": "Verapamil 240 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 80 mg TID; increase by 80 mg q10-14d as tolerated; target 240-480 mg TID (720-960 mg/day total); some patients require up to 960 mg/day",
              "orderSentence": "Verapamil 80 mg TID PO"
            },
            "pretreatment": "Baseline ECG; repeat ECG with each dose increase",
            "contraindications": "Second/third-degree heart block; sick sinus syndrome; severe hypotension; decompensated HF; concurrent beta-blocker (relative)",
            "monitoring": "ECG before each dose increase (monitor PR interval >0.24s or 40% increase); HR; BP; constipation; edema",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lithium carbonate",
            "route": "PO",
            "indication": "Chronic cluster headache; verapamil failure/intolerance",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg BID",
                  "orderSentence": "Lithium carbonate 300 mg BID PO"
                },
                {
                  "text": "300 mg TID",
                  "orderSentence": "Lithium carbonate 300 mg TID PO"
                },
                {
                  "text": "450 mg BID",
                  "orderSentence": "Lithium carbonate 450 mg BID PO"
                },
                {
                  "text": "600 mg BID",
                  "orderSentence": "Lithium carbonate 600 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 300 mg BID; titrate by 300 mg q3-7d to target level 0.6-1.0 mEq/L; typical dose 600-1200 mg/day",
              "orderSentence": "Lithium carbonate 300 mg BID PO"
            },
            "pretreatment": "Baseline TSH, BMP, calcium, ECG",
            "contraindications": "Renal impairment; sick sinus syndrome; pregnancy; Brugada syndrome; concurrent NSAIDs/ACE-I/thiazides",
            "monitoring": "Lithium level q1wk during titration, then q1-3mo; TSH, creatinine, calcium q3-6mo; tremor; polyuria",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Topiramate",
            "route": "PO",
            "indication": "Preventive; especially with comorbid migraine",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Topiramate 25 mg qHS PO"
                },
                {
                  "text": "50 mg BID",
                  "orderSentence": "Topiramate 50 mg BID PO"
                },
                {
                  "text": "75 mg BID",
                  "orderSentence": "Topiramate 75 mg BID PO"
                },
                {
                  "text": "100 mg BID",
                  "orderSentence": "Topiramate 100 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg qHS; increase by 25 mg/wk; target 100-200 mg/day divided BID",
              "orderSentence": "Topiramate 25 mg qHS PO"
            },
            "pretreatment": "None",
            "contraindications": "Glaucoma; kidney stones; pregnancy; metabolic acidosis",
            "monitoring": "Cognitive effects; paresthesias; weight; serum bicarbonate; kidney stones",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Galcanezumab (Emgality)",
            "route": "SC",
            "indication": "FDA-approved for episodic cluster headache; CGRP mAb",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg SC monthly",
                  "orderSentence": "Galcanezumab (Emgality) 300 mg SC monthly SC"
                }
              ],
              "route": "SC",
              "instructions": "300 mg SC (3 consecutive 100 mg injections) at onset of cluster period; repeat monthly during cluster period",
              "orderSentence": "Galcanezumab (Emgality) 300 mg SC monthly SC"
            },
            "pretreatment": "None",
            "contraindications": "Hypersensitivity to galcanezumab",
            "monitoring": "Injection site reactions; constipation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Melatonin",
            "route": "PO",
            "indication": "Adjunctive prevention; circadian dysregulation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg qHS",
                  "orderSentence": "Melatonin 10 mg qHS PO"
                },
                {
                  "text": "15 mg qHS",
                  "orderSentence": "Melatonin 15 mg qHS PO"
                },
                {
                  "text": "20 mg qHS",
                  "orderSentence": "Melatonin 20 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "10-20 mg PO 30 min before bedtime; may help regulate cluster periodicity",
              "orderSentence": "Melatonin 10 mg qHS PO"
            },
            "pretreatment": "None",
            "contraindications": "None significant",
            "monitoring": "Sedation; morning grogginess",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Valproate/Divalproex",
            "route": "PO",
            "indication": "Alternative preventive; especially with comorbid epilepsy/mood disorder",
            "dosing": {
              "doseOptions": [
                {
                  "text": "250 mg BID",
                  "orderSentence": "Valproate/Divalproex 250 mg BID PO"
                },
                {
                  "text": "500 mg BID",
                  "orderSentence": "Valproate/Divalproex 500 mg BID PO"
                },
                {
                  "text": "500 mg ER daily",
                  "orderSentence": "Valproate/Divalproex 500 mg ER daily PO"
                },
                {
                  "text": "1000 mg ER daily",
                  "orderSentence": "Valproate/Divalproex 1000 mg ER daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 250 mg BID or 500 mg ER daily; titrate to 500-1500 mg/day",
              "orderSentence": "Valproate/Divalproex 250 mg BID PO"
            },
            "pretreatment": "LFTs, CBC",
            "contraindications": "Hepatic disease; pregnancy (teratogen); urea cycle disorders; pancreatitis history",
            "monitoring": "LFTs q6mo; CBC; ammonia if AMS; weight; hair loss; tremor",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Baclofen",
            "route": "PO",
            "indication": "Alternative preventive; trigeminal autonomic pathway modulation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg TID",
                  "orderSentence": "Baclofen 5 mg TID PO"
                },
                {
                  "text": "10 mg TID",
                  "orderSentence": "Baclofen 10 mg TID PO"
                },
                {
                  "text": "20 mg TID",
                  "orderSentence": "Baclofen 20 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg TID; titrate by 5 mg/dose q3d; target 30-60 mg/day divided TID",
              "orderSentence": "Baclofen 5 mg TID PO"
            },
            "pretreatment": "None",
            "contraindications": "Withdrawal if abrupt discontinuation; renal impairment (reduce dose)",
            "monitoring": "Sedation; weakness; withdrawal syndrome; do not stop abruptly",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Gabapentin",
            "route": "PO",
            "indication": "Alternative preventive; neuropathic pain component",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg qHS",
                  "orderSentence": "Gabapentin 300 mg qHS PO"
                },
                {
                  "text": "300 mg TID",
                  "orderSentence": "Gabapentin 300 mg TID PO"
                },
                {
                  "text": "600 mg TID",
                  "orderSentence": "Gabapentin 600 mg TID PO"
                },
                {
                  "text": "900 mg TID",
                  "orderSentence": "Gabapentin 900 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 300 mg qHS; titrate by 300 mg q1-3d; target 1800-3600 mg/day divided TID",
              "orderSentence": "Gabapentin 300 mg qHS PO"
            },
            "pretreatment": "None",
            "contraindications": "Reduce dose in renal impairment",
            "monitoring": "Sedation; dizziness; edema; weight gain",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Refractory/Interventional Therapies": [
          {
            "item": "Occipital nerve stimulation",
            "route": "Implant",
            "indication": "Chronic refractory cluster headache; failed multiple preventives",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A - surgical implant",
                  "orderSentence": "Occipital nerve stimulation N/A - surgical implant Implant"
                }
              ],
              "route": "Implant",
              "instructions": "Percutaneous or surgical implantation of occipital nerve stimulator; specialist referral required",
              "orderSentence": "Occipital nerve stimulation N/A - surgical implant Implant"
            },
            "pretreatment": "Neurosurgical evaluation; psychological screening; failed at least 3 preventive medications",
            "contraindications": "Active infection; coagulopathy; psychiatric instability",
            "monitoring": "Post-implant follow-up; battery life; lead migration",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Deep brain stimulation",
            "route": "Implant",
            "indication": "Severe refractory chronic CH; last resort",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A - surgical implant",
                  "orderSentence": "Deep brain stimulation N/A - surgical implant Implant"
                }
              ],
              "route": "Implant",
              "instructions": "Targeting posterior hypothalamus; investigational; specialist center only",
              "orderSentence": "Deep brain stimulation N/A - surgical implant Implant"
            },
            "pretreatment": "Extensive workup; ethics committee review; failed all other options",
            "contraindications": "Same as ONS; structural brain abnormality",
            "monitoring": "Long-term neurological monitoring",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Sphenopalatine ganglion stimulation",
            "route": "Implant",
            "indication": "Refractory CH; acute and preventive effects",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A - surgical implant",
                  "orderSentence": "Sphenopalatine ganglion stimulation N/A - surgical implant Implant"
                }
              ],
              "route": "Implant",
              "instructions": "Pulsante SPG microstimulator; patient-controlled acute therapy",
              "orderSentence": "Sphenopalatine ganglion stimulation N/A - surgical implant Implant"
            },
            "pretreatment": "Neurosurgical evaluation; imaging confirmation",
            "contraindications": "Facial/jaw abnormalities; active infection",
            "monitoring": "Lead integrity; battery; efficacy",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Radiofrequency ablation trigeminal ganglion",
            "route": "Procedure",
            "indication": "Refractory chronic CH; trigeminal nerve modulation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A - procedure",
                  "orderSentence": "Radiofrequency ablation trigeminal ganglion N/A - procedure Procedure"
                }
              ],
              "route": "Procedure",
              "instructions": "Percutaneous RF ablation; provides 6-18 months relief; may need repeat",
              "orderSentence": "Radiofrequency ablation trigeminal ganglion N/A - procedure Procedure"
            },
            "pretreatment": "Facial imaging; failed medical therapy",
            "contraindications": "Anticoagulation; infection; facial numbness intolerance",
            "monitoring": "Facial sensation; corneal reflex; recurrence",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Headache specialist/Neurology referral for diagnosis confirmation and preventive therapy optimization",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pain management referral for interventional procedures (nerve blocks, neuromodulation evaluation) in refractory cases",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sleep medicine evaluation for polysomnography if obstructive sleep apnea suspected as cluster trigger",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Endocrinology referral if pituitary abnormality identified on imaging or atypical hormone levels",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Neurosurgery consultation for neuromodulation or ablative procedures in medically refractory cases",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Cardiology clearance before initiating high-dose verapamil in patients with cardiac history",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Psychiatry referral for suicidal ideation screening given high depression/suicide risk in cluster headache patients",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Return immediately for sudden severe headache different from typical cluster attacks which may indicate new pathology",
            "ED": "STAT",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Keep high-flow oxygen available at home during cluster period for acute attack treatment",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Use sumatriptan injection at first sign of attack for fastest relief; do not wait for pain to worsen",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Maintain detailed headache diary including attack timing, duration, severity, and treatment response",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid known triggers during cluster period especially alcohol (even small amounts), strong odors, and napping",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Do not abruptly stop preventive medications especially lithium and baclofen which require gradual taper",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Carry injectable sumatriptan at all times during active cluster period for emergency use",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Alert healthcare providers to cluster headache diagnosis as this affects anesthesia and medication choices",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Strict alcohol avoidance during entire cluster period as even small amounts trigger attacks",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Maintain regular sleep schedule with consistent bedtime and wake time to regulate circadian rhythm",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid daytime napping during cluster period as sleep transitions can trigger attacks",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Smoking cessation to reduce vascular risk and potential cluster exacerbation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid high altitude exposure during cluster period if altitude is a known trigger",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid vasodilators (nitroglycerin, sildenafil) during cluster period as these trigger attacks",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Screen for and treat obstructive sleep apnea as treatment may reduce cluster frequency",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Stress management techniques as emotional stress may influence cluster cycle onset",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid strong chemical odors (solvents, perfumes, gasoline) which can trigger attacks in some patients",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Migraine",
        "features": "Longer duration (4-72 hrs); bilateral or alternating sides; nausea/vomiting prominent; photophobia/phonophobia; no autonomic features",
        "tests": "Clinical criteria (ICHD-3); MRI if new onset"
      },
      {
        "diagnosis": "Paroxysmal hemicrania",
        "features": "Shorter attacks (2-30 min); more frequent (>5/day); absolute response to indomethacin",
        "tests": "Indomethacin trial (150-225 mg/day); complete response diagnostic"
      },
      {
        "diagnosis": "SUNCT/SUNA",
        "features": "Very brief attacks (seconds to minutes); very frequent (up to 200/day); triggered by cutaneous stimuli",
        "tests": "Clinical criteria; may have refractory period; no response to indomethacin"
      },
      {
        "diagnosis": "Trigeminal neuralgia",
        "features": "Electric shock-like pain; seconds duration; triggered by touch, chewing, talking; refractory period",
        "tests": "MRI for vascular compression; response to carbamazepine"
      },
      {
        "diagnosis": "Hemicrania continua",
        "features": "Continuous baseline pain with superimposed exacerbations; unilateral; autonomic features",
        "tests": "Absolute response to indomethacin diagnostic"
      },
      {
        "diagnosis": "Primary stabbing headache",
        "features": "Ultra-short jabs (seconds); unpredictable location; no autonomic features",
        "tests": "Clinical diagnosis; exclusion of secondary causes"
      },
      {
        "diagnosis": "Secondary cluster headache",
        "features": "Atypical features; pituitary or hypothalamic lesion; carotid dissection",
        "tests": "MRI with pituitary protocol; MRA head/neck"
      },
      {
        "diagnosis": "Tolosa-Hunt syndrome",
        "features": "Painful ophthalmoplegia; orbital pain; CN III, IV, VI involvement",
        "tests": "MRI orbits with contrast; CSF if needed; steroid response"
      },
      {
        "diagnosis": "Giant cell arteritis",
        "features": "Age >50; scalp tenderness; jaw claudication; visual symptoms; elevated ESR/CRP",
        "tests": "ESR, CRP; temporal artery biopsy"
      },
      {
        "diagnosis": "Carotid dissection",
        "features": "Neck pain; Horner syndrome; stroke symptoms",
        "tests": "CTA or MRA neck; carotid ultrasound"
      }
    ],
    "evidence": [
      {
        "recommendation": "High-flow oxygen (100% at 12-15 L/min) first-line abortive",
        "evidenceLevel": "Class I, Level A",
        "source": "[Cohen et al. JAMA 2009](https://pubmed.ncbi.nlm.nih.gov/20040554/)"
      },
      {
        "recommendation": "Subcutaneous sumatriptan 6 mg effective for acute attacks",
        "evidenceLevel": "Class I, Level A",
        "source": "[The Sumatriptan Cluster Headache Study Group. NEJM 1991](https://pubmed.ncbi.nlm.nih.gov/1652413/)"
      },
      {
        "recommendation": "Intranasal zolmitriptan 5-10 mg effective for acute attacks",
        "evidenceLevel": "Class I, Level A",
        "source": "[Cittadini et al. Neurology 2006](https://pubmed.ncbi.nlm.nih.gov/17101886/)"
      },
      {
        "recommendation": "Verapamil first-line preventive for episodic and chronic CH",
        "evidenceLevel": "Class I, Level C (expert consensus)",
        "source": "[May et al. Cephalalgia 2006](https://pubmed.ncbi.nlm.nih.gov/16919064/)"
      },
      {
        "recommendation": "Galcanezumab FDA-approved for episodic cluster headache",
        "evidenceLevel": "Class I, Level A",
        "source": "[Goadsby et al. NEJM 2019](https://pubmed.ncbi.nlm.nih.gov/31291515/)"
      },
      {
        "recommendation": "Greater occipital nerve block effective as transitional therapy",
        "evidenceLevel": "Class II, Level B",
        "source": "[Ambrosini et al. Pain 2005](https://pubmed.ncbi.nlm.nih.gov/15885916/)"
      },
      {
        "recommendation": "Lithium effective for chronic cluster headache prevention",
        "evidenceLevel": "Class II, Level B",
        "source": "[Steiner et al. Headache 1997](https://pubmed.ncbi.nlm.nih.gov/9227503/)"
      },
      {
        "recommendation": "Prednisone taper effective transitional therapy",
        "evidenceLevel": "Class II, Level C",
        "source": "[Obermann et al. Curr Pain Headache Rep 2011](https://pubmed.ncbi.nlm.nih.gov/21069491/)"
      },
      {
        "recommendation": "Octreotide effective when triptans contraindicated",
        "evidenceLevel": "Class II, Level B",
        "source": "[Matharu et al. Ann Neurol 2004](https://pubmed.ncbi.nlm.nih.gov/15349875/)"
      },
      {
        "recommendation": "Melatonin 10 mg may reduce attack frequency",
        "evidenceLevel": "Class II, Level C",
        "source": "[Leone et al. Cephalalgia 1996](https://pubmed.ncbi.nlm.nih.gov/8980856/)"
      },
      {
        "recommendation": "Occipital nerve stimulation for refractory chronic CH",
        "evidenceLevel": "Class III, Level C",
        "source": "[Burns et al. Lancet 2007](https://pubmed.ncbi.nlm.nih.gov/17336639/)"
      },
      {
        "recommendation": "European Headache Federation cluster headache guidelines",
        "evidenceLevel": "Guideline",
        "source": "[Mitsikostas et al. J Headache Pain 2023](https://pubmed.ncbi.nlm.nih.gov/36577931/)"
      }
    ],
    "monitoring": [
      {
        "item": "Attack frequency diary",
        "frequency": "Daily during cluster",
        "action": "Escalate preventive therapy; consider transitional bridge",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "ECG (if on verapamil)",
        "frequency": "Baseline and with each dose increase",
        "action": "Hold dose increase; may need cardiology clearance",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Heart rate (if on verapamil)",
        "frequency": "Each visit",
        "action": "Reduce dose; consider alternative",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Lithium level",
        "frequency": "Weekly during titration, then q1-3 months",
        "action": "Adjust dose; assess renal function if unexpected level",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "TSH (if on lithium)",
        "frequency": "Baseline, 3 months, then q6 months",
        "action": "Endocrine referral; may need thyroid replacement",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "BUN/Creatinine (if on lithium)",
        "frequency": "Baseline, q1-3 months",
        "action": "Dose reduction; nephrology referral if progressive",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Calcium (if on lithium)",
        "frequency": "Baseline, q6 months",
        "action": "Evaluate for hyperparathyroidism",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Serum bicarbonate (if on topiramate)",
        "frequency": "Baseline, 3 months",
        "action": "Reduce dose or discontinue",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Depression/Suicidal ideation screening",
        "frequency": "Each visit",
        "action": "Urgent psychiatric referral; crisis intervention",
        "ED": "URGENT",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Oxygen saturation (during O2 therapy)",
        "frequency": "During treatment",
        "action": "Adjust flow rate",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "-"
      }
    ],
    "disposition": [
      {
        "disposition": "Discharge home",
        "criteria": "Acute attack aborted with oxygen/triptan; stable; access to home oxygen and rescue medications; follow-up arranged"
      },
      {
        "disposition": "Admit to floor",
        "criteria": "Status cluster (continuous attacks); requires IV DHE protocol; suicidal ideation requiring monitoring; oral intake compromised"
      },
      {
        "disposition": "Admit to ICU",
        "criteria": "Rare; only if hemodynamic instability, cardiac arrhythmia from verapamil, or severe psychiatric crisis"
      },
      {
        "disposition": "Outpatient follow-up",
        "criteria": "Within 1-2 weeks if in active cluster period; 2-4 weeks after initiating new preventive; q3 months during remission"
      },
      {
        "disposition": "Transfer to headache center",
        "criteria": "Refractory to multiple preventives; candidate for neuromodulation; requires specialized interventional procedures"
      }
    ]
  },
  "Mild Cognitive Impairment (MCI)": {
    "id": "mild-cognitive-impairment",
    "title": "Mild Cognitive Impairment (MCI)",
    "version": "1.0",
    "icd10": [
      "** G31.84"
    ],
    "scope": "** Outpatient-focused evaluation for MCI, identification of reversible causes, subtype classification (amnestic vs non-amnestic), risk factor modification, monitoring for progression, and symptomatic treatment. Includes guidance on disease-modifying therapy eligibility (anti-amyloid agents) and advance care planning.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC with differential",
            "rationale": "Anemia, infection, or malignancy contributing to cognitive changes",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CMP (BMP + hepatic panel)",
            "rationale": "Hyponatremia, uremia, hypercalcemia, hepatic encephalopathy as reversible causes",
            "target": "Normal electrolytes, renal, hepatic function",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "TSH",
            "rationale": "Hypothyroidism is reversible cause of cognitive impairment",
            "target": "0.4-4.0 mIU/L",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin B12",
            "rationale": "Deficiency causes reversible cognitive impairment; common in elderly",
            "target": ">300 pg/mL (>400 pg/mL optimal for neurological function)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Folate",
            "rationale": "Deficiency contributes to cognitive impairment; check with B12",
            "target": ">3 ng/mL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "HbA1c",
            "rationale": "Diabetes management affects cognition; vascular risk factor",
            "target": "<7% (individualize in elderly)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Fasting lipid panel",
            "rationale": "Vascular risk factor assessment; hyperlipidemia accelerates cognitive decline",
            "target": "LDL <100 mg/dL; <70 if established CVD",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Glucose (fasting)",
            "rationale": "Diabetes screening; glycemic control affects cognition",
            "target": "70-100 mg/dL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended Workup": [
          {
            "item": "RPR or VDRL",
            "rationale": "Neurosyphilis is rare but treatable cause of cognitive impairment",
            "target": "Nonreactive",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "HIV testing",
            "rationale": "HIV-associated neurocognitive disorder; if risk factors present",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin D, 25-hydroxy",
            "rationale": "Deficiency associated with cognitive decline and dementia risk",
            "target": ">30 ng/mL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Homocysteine",
            "rationale": "Elevated levels associated with Alzheimer's disease and vascular cognitive impairment",
            "target": "<15 μmol/L",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "ESR, CRP",
            "rationale": "Inflammatory or autoimmune causes; vasculitis screen",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Urinalysis",
            "rationale": "UTI in elderly can present as cognitive changes; rule out reversible cause",
            "target": "Negative for infection",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Methylmalonic acid (MMA)",
            "rationale": "More sensitive than B12 level for functional B12 deficiency",
            "target": "<0.4 μmol/L",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Heavy metal panel (lead, mercury, arsenic)",
            "rationale": "Toxic exposure history; occupational risk",
            "target": "Normal",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Copper, ceruloplasmin",
            "rationale": "Wilson's disease if age <50; hepatic symptoms",
            "target": "Normal",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Paraneoplastic antibody panel",
            "rationale": "Autoimmune cognitive impairment; unexplained rapid progression",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Anti-neuronal antibodies (NMDA-R, LGI1, CASPR2, GABA-B)",
            "rationale": "Autoimmune encephalitis presenting as MCI",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Genetic testing (APOE genotyping)",
            "rationale": "Risk stratification for AD progression; anti-amyloid therapy planning",
            "target": "Informational (APOE4 increases risk)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Genetic testing (PSEN1, PSEN2, APP)",
            "rationale": "Familial early-onset AD (<65); family history of early-onset dementia",
            "target": "No pathogenic variants",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Lyme serology",
            "rationale": "Endemic area; outdoor exposure; systemic symptoms",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "Cell count, protein, glucose",
            "rationale": "Rule out infection, inflammation",
            "target": "WBC <5, protein <45 mg/dL, glucose >60% serum",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CSF Aβ42 (amyloid beta 1-42)",
            "rationale": "Low in Alzheimer's pathology; biomarker confirmation",
            "target": "Low Aβ42 (<600 pg/mL) suggests AD pathology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CSF total tau (t-tau)",
            "rationale": "Elevated in neurodegeneration; nonspecific",
            "target": "Mildly elevated in MCI due to AD; marked elevation suggests rapid progression",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CSF p-tau (phosphorylated tau 181)",
            "rationale": "Specific for AD pathology; predictor of progression",
            "target": "Elevated p-tau with low Aβ42 = high risk of AD progression",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CSF Aβ42/Aβ40 ratio",
            "rationale": "More accurate than Aβ42 alone for amyloid status",
            "target": "<0.05-0.08 suggests amyloid positivity (assay-dependent)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CSF neurofilament light chain (NfL)",
            "rationale": "Nonspecific neurodegeneration marker; prognostic",
            "target": "Elevated suggests active neurodegeneration",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "VDRL",
            "rationale": "Neurosyphilis if RPR positive or high suspicion",
            "target": "Nonreactive",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "MRI Brain without contrast",
            "timing": "At initial evaluation",
            "target": "Hippocampal volume, medial temporal atrophy (Scheltens scale), white matter disease burden, rule out structural causes (tumor, SDH, NPH)",
            "contraindications": "MRI-incompatible devices",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Neuropsychological testing (formal)",
            "timing": "At diagnosis; gold standard for MCI characterization",
            "target": "Objective impairment 1-1.5 SD below age/education norms; preserved ADLs; characterize domain(s) affected",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Mini-Mental State Examination (MMSE)",
            "timing": "Screening; serial monitoring",
            "target": "24-30 (MCI often 24-27); <24 suggests dementia",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Montreal Cognitive Assessment (MoCA)",
            "timing": "More sensitive than MMSE for MCI",
            "target": "<26 abnormal; typically 18-25 in MCI",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended": [
          {
            "item": "CT Head non-contrast",
            "timing": "If MRI contraindicated or unavailable",
            "target": "Rule out mass, hemorrhage, hydrocephalus",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "MRI Brain volumetrics",
            "timing": "Quantitative assessment; research/clinical trials",
            "target": "Hippocampal volume percentile for age; whole brain atrophy rate",
            "contraindications": "MRI contraindications",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "FDG-PET Brain",
            "timing": "Differentiate underlying pathology when diagnosis uncertain",
            "target": "AD pattern: temporoparietal hypometabolism; FTD: frontal/temporal hypometabolism",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Amyloid PET (florbetapir, florbetaben, flutemetamol)",
            "timing": "Diagnostic uncertainty; early-onset; anti-amyloid therapy eligibility",
            "target": "Positive confirms amyloid pathology (at risk for AD); negative makes AD unlikely",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sleep study (polysomnography)",
            "timing": "Sleep apnea screening; sleep disturbance affecting cognition",
            "target": "AHI <5 normal; treat if elevated",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "EEG",
            "timing": "Atypical features; concern for seizures or encephalopathy",
            "target": "Normal or mild nonspecific slowing in MCI",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Tau PET (flortaucipir)",
            "timing": "Research; disease staging; clinical trial eligibility",
            "target": "Pattern correlates with clinical syndrome; elevated tau predicts faster progression",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "DaTscan (ioflupane I-123)",
            "timing": "MCI with parkinsonism; differentiate DLB prodrome",
            "target": "Reduced uptake suggests Lewy body pathology",
            "contraindications": "Iodine hypersensitivity",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "SPECT (perfusion)",
            "timing": "Alternative to PET if unavailable",
            "target": "Regional hypoperfusion patterns",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "MRI with SWI/GRE sequences",
            "timing": "Cerebral amyloid angiopathy; microbleed assessment",
            "target": "Lobar microbleeds suggest CAA; affects anti-amyloid eligibility",
            "contraindications": "MRI contraindications",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "Treat reversible causes",
            "route": "Various",
            "indication": "Identified metabolic, nutritional, or infectious etiology",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per cause",
                  "orderSentence": "Treat reversible causes Per cause Various"
                }
              ],
              "route": "Various",
              "instructions": "Correct hypothyroidism, replace B12/folate, treat infections, adjust medications",
              "orderSentence": "Treat reversible causes Per cause Various"
            },
            "contraindications": "Depends on intervention",
            "monitoring": "Cognitive reassessment 3-6 months after treatment",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Thiamine",
            "route": "IV/PO",
            "indication": "Suspected Wernicke's; alcoholism; malnutrition",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mg IV TID x 3 days",
                  "orderSentence": "Thiamine 500 mg IV TID x 3 days IV/PO"
                },
                {
                  "text": "100 mg PO daily",
                  "orderSentence": "Thiamine 100 mg PO daily IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "500 mg IV TID x 3 days if Wernicke suspected; then 100 mg PO daily maintenance",
              "orderSentence": "Thiamine 500 mg IV TID x 3 days IV/PO"
            },
            "contraindications": "None",
            "monitoring": "Clinical improvement",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin B12",
            "route": "IM/PO",
            "indication": "B12 deficiency (<300 pg/mL or elevated MMA)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mcg IM daily x 7 days",
                  "orderSentence": "Vitamin B12 1000 mcg IM daily x 7 days IM/PO"
                },
                {
                  "text": "1000 mcg IM weekly x 4",
                  "orderSentence": "Vitamin B12 1000 mcg IM weekly x 4 IM/PO"
                },
                {
                  "text": "1000-2000 mcg PO daily",
                  "orderSentence": "Vitamin B12 1000-2000 mcg PO daily IM/PO"
                }
              ],
              "route": "IM/PO",
              "instructions": "1000 mcg IM daily x 7d, then weekly x 4wk, then monthly; or high-dose oral 1000-2000 mcg daily",
              "orderSentence": "Vitamin B12 1000 mcg IM daily x 7 days IM/PO"
            },
            "contraindications": "None",
            "monitoring": "B12 level, MMA at 3 months; neurological improvement over months",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Folate",
            "route": "PO",
            "indication": "Folate deficiency",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 mg PO daily",
                  "orderSentence": "Folate 1 mg PO daily PO"
                }
              ],
              "route": "PO",
              "instructions": "1 mg PO daily; ensure B12 adequate before treating to avoid masking deficiency",
              "orderSentence": "Folate 1 mg PO daily PO"
            },
            "contraindications": "None",
            "monitoring": "Folate level at 3 months",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Symptomatic Treatments": [
          {
            "item": "Donepezil",
            "route": "PO",
            "indication": "MCI with high likelihood of AD pathology (amnestic MCI, positive biomarkers); modest symptomatic benefit",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg qHS",
                  "orderSentence": "Donepezil 5 mg qHS PO"
                },
                {
                  "text": "10 mg qHS",
                  "orderSentence": "Donepezil 10 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg qHS x 4-6 weeks; may increase to 10 mg qHS; limited evidence in MCI but may offer modest benefit",
              "orderSentence": "Donepezil 5 mg qHS PO"
            },
            "contraindications": "Sick sinus syndrome; GI bleeding; severe COPD",
            "monitoring": "Bradycardia, GI symptoms, vivid dreams; limited efficacy data in MCI",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rivastigmine patch",
            "route": "TD",
            "indication": "Alternative to donepezil; better GI tolerability; MCI with positive AD biomarkers",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4.6 mg/24hr",
                  "orderSentence": "Rivastigmine patch 4.6 mg/24hr TD"
                },
                {
                  "text": "9.5 mg/24hr",
                  "orderSentence": "Rivastigmine patch 9.5 mg/24hr TD"
                }
              ],
              "route": "TD",
              "instructions": "Start 4.6 mg/24hr; increase q4wk to 9.5 mg/24hr; limited evidence in MCI",
              "orderSentence": "Rivastigmine patch 4.6 mg/24hr TD"
            },
            "contraindications": "Same as donepezil; severe hepatic impairment",
            "monitoring": "Skin irritation, GI symptoms",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Citalopram",
            "route": "PO",
            "indication": "Depression contributing to cognitive symptoms (pseudodementia component)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg daily",
                  "orderSentence": "Citalopram 10 mg daily PO"
                },
                {
                  "text": "20 mg daily",
                  "orderSentence": "Citalopram 20 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10 mg daily; max 20 mg in elderly due to QT risk",
              "orderSentence": "Citalopram 10 mg daily PO"
            },
            "contraindications": "QT prolongation; concurrent QT-prolonging drugs",
            "monitoring": "QTc at baseline and if dose >20 mg",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sertraline",
            "route": "PO",
            "indication": "Depression; anxiety contributing to cognitive complaints",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg daily",
                  "orderSentence": "Sertraline 25 mg daily PO"
                },
                {
                  "text": "50 mg daily",
                  "orderSentence": "Sertraline 50 mg daily PO"
                },
                {
                  "text": "100 mg daily",
                  "orderSentence": "Sertraline 100 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg daily; titrate by 25 mg q1-2wk; typical 50-100 mg",
              "orderSentence": "Sertraline 25 mg daily PO"
            },
            "contraindications": "MAOIs; caution with bleeding risk",
            "monitoring": "GI upset initially; reassess cognition after mood improves",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Escitalopram",
            "route": "PO",
            "indication": "Depression; anxiety with cognitive symptoms",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg daily",
                  "orderSentence": "Escitalopram 5 mg daily PO"
                },
                {
                  "text": "10 mg daily",
                  "orderSentence": "Escitalopram 10 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg daily; increase to 10 mg after 1 week; max 10 mg in elderly",
              "orderSentence": "Escitalopram 5 mg daily PO"
            },
            "contraindications": "QT prolongation; MAOIs",
            "monitoring": "QTc monitoring",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Mirtazapine",
            "route": "PO",
            "indication": "Depression with poor appetite, insomnia, and weight loss",
            "dosing": {
              "doseOptions": [
                {
                  "text": "7.5 mg qHS",
                  "orderSentence": "Mirtazapine 7.5 mg qHS PO"
                },
                {
                  "text": "15 mg qHS",
                  "orderSentence": "Mirtazapine 15 mg qHS PO"
                },
                {
                  "text": "30 mg qHS",
                  "orderSentence": "Mirtazapine 30 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 7.5-15 mg qHS; may increase to 30 mg qHS",
              "orderSentence": "Mirtazapine 7.5 mg qHS PO"
            },
            "contraindications": "MAOIs",
            "monitoring": "Weight gain (may be beneficial), sedation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Bupropion",
            "route": "PO",
            "indication": "Depression with fatigue; avoid if seizure risk",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg BID",
                  "orderSentence": "Bupropion 100 mg BID PO"
                },
                {
                  "text": "150 mg SR BID",
                  "orderSentence": "Bupropion 150 mg SR BID PO"
                },
                {
                  "text": "300 mg XL daily",
                  "orderSentence": "Bupropion 300 mg XL daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 100 mg BID or 150 mg SR daily; increase after 1 week; max 300 mg/day",
              "orderSentence": "Bupropion 100 mg BID PO"
            },
            "contraindications": "Seizure disorder; eating disorder; abrupt alcohol/benzo withdrawal",
            "monitoring": "Seizure risk; may improve alertness",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Trazodone",
            "route": "PO",
            "indication": "Insomnia in MCI patients",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Trazodone 25 mg qHS PO"
                },
                {
                  "text": "50 mg qHS",
                  "orderSentence": "Trazodone 50 mg qHS PO"
                },
                {
                  "text": "100 mg qHS",
                  "orderSentence": "Trazodone 100 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25-50 mg qHS; titrate to effect; typical 50-100 mg qHS",
              "orderSentence": "Trazodone 25 mg qHS PO"
            },
            "contraindications": "Concurrent MAOIs; QT prolongation",
            "monitoring": "Orthostatic hypotension, morning sedation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Melatonin",
            "route": "PO",
            "indication": "Sleep disturbance; circadian rhythm support",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 mg qHS",
                  "orderSentence": "Melatonin 1 mg qHS PO"
                },
                {
                  "text": "3 mg qHS",
                  "orderSentence": "Melatonin 3 mg qHS PO"
                },
                {
                  "text": "5 mg qHS",
                  "orderSentence": "Melatonin 5 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 1-3 mg qHS; may increase to 5 mg; take 30 min before bed",
              "orderSentence": "Melatonin 1 mg qHS PO"
            },
            "contraindications": "None",
            "monitoring": "Daytime sedation; limited long-term data",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Cardiovascular Risk Factor Management": [
          {
            "item": "Atorvastatin",
            "route": "PO",
            "indication": "Hyperlipidemia; vascular risk reduction; may slow cognitive decline",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg daily",
                  "orderSentence": "Atorvastatin 10 mg daily PO"
                },
                {
                  "text": "20 mg daily",
                  "orderSentence": "Atorvastatin 20 mg daily PO"
                },
                {
                  "text": "40 mg daily",
                  "orderSentence": "Atorvastatin 40 mg daily PO"
                },
                {
                  "text": "80 mg daily",
                  "orderSentence": "Atorvastatin 80 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10-20 mg daily; titrate to LDL goal; target LDL <100 (or <70 if established CVD)",
              "orderSentence": "Atorvastatin 10 mg daily PO"
            },
            "contraindications": "Active liver disease; pregnancy",
            "monitoring": "LFTs at baseline; lipid panel q3-6mo initially",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rosuvastatin",
            "route": "PO",
            "indication": "Hyperlipidemia; alternative statin",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg daily",
                  "orderSentence": "Rosuvastatin 5 mg daily PO"
                },
                {
                  "text": "10 mg daily",
                  "orderSentence": "Rosuvastatin 10 mg daily PO"
                },
                {
                  "text": "20 mg daily",
                  "orderSentence": "Rosuvastatin 20 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5-10 mg daily; adjust to LDL goal",
              "orderSentence": "Rosuvastatin 5 mg daily PO"
            },
            "contraindications": "Active liver disease; severe renal impairment (dose adjust)",
            "monitoring": "LFTs, lipid panel",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lisinopril",
            "route": "PO",
            "indication": "Hypertension; target BP <130/80 for vascular protection",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg daily",
                  "orderSentence": "Lisinopril 5 mg daily PO"
                },
                {
                  "text": "10 mg daily",
                  "orderSentence": "Lisinopril 10 mg daily PO"
                },
                {
                  "text": "20 mg daily",
                  "orderSentence": "Lisinopril 20 mg daily PO"
                },
                {
                  "text": "40 mg daily",
                  "orderSentence": "Lisinopril 40 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5-10 mg daily; titrate q2wk to BP goal",
              "orderSentence": "Lisinopril 5 mg daily PO"
            },
            "contraindications": "Angioedema history; pregnancy; bilateral renal artery stenosis",
            "monitoring": "K+, Cr, BP; cough",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Amlodipine",
            "route": "PO",
            "indication": "Hypertension; especially if ACE-I intolerant",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2.5 mg daily",
                  "orderSentence": "Amlodipine 2.5 mg daily PO"
                },
                {
                  "text": "5 mg daily",
                  "orderSentence": "Amlodipine 5 mg daily PO"
                },
                {
                  "text": "10 mg daily",
                  "orderSentence": "Amlodipine 10 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 2.5-5 mg daily; increase q2wk; max 10 mg",
              "orderSentence": "Amlodipine 2.5 mg daily PO"
            },
            "contraindications": "Severe aortic stenosis",
            "monitoring": "Peripheral edema, BP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Losartan",
            "route": "PO",
            "indication": "Hypertension; alternative if ACE-I intolerant",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg daily",
                  "orderSentence": "Losartan 25 mg daily PO"
                },
                {
                  "text": "50 mg daily",
                  "orderSentence": "Losartan 50 mg daily PO"
                },
                {
                  "text": "100 mg daily",
                  "orderSentence": "Losartan 100 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25-50 mg daily; titrate to BP goal; max 100 mg",
              "orderSentence": "Losartan 25 mg daily PO"
            },
            "contraindications": "Same as lisinopril",
            "monitoring": "K+, Cr, BP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Metformin",
            "route": "PO",
            "indication": "Type 2 diabetes; potential neuroprotective effects",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mg daily",
                  "orderSentence": "Metformin 500 mg daily PO"
                },
                {
                  "text": "500 mg BID",
                  "orderSentence": "Metformin 500 mg BID PO"
                },
                {
                  "text": "1000 mg BID",
                  "orderSentence": "Metformin 1000 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 500 mg daily with meal; increase by 500 mg weekly; max 2000 mg/day",
              "orderSentence": "Metformin 500 mg daily PO"
            },
            "contraindications": "eGFR <30; risk of lactic acidosis",
            "monitoring": "HbA1c q3mo; B12 annually (metformin reduces absorption)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Aspirin (low-dose)",
            "route": "PO",
            "indication": "Secondary prevention if established CVD; not for primary prevention in MCI",
            "dosing": {
              "doseOptions": [
                {
                  "text": "81 mg daily",
                  "orderSentence": "Aspirin (low-dose) 81 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "81 mg daily; only if established CVD or high vascular risk",
              "orderSentence": "Aspirin (low-dose) 81 mg daily PO"
            },
            "contraindications": "Active bleeding; aspirin allergy; high bleeding risk",
            "monitoring": "GI symptoms; bleeding",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Disease-Modifying Therapies (Anti-Amyloid)": [
          {
            "item": "Lecanemab (Leqembi)",
            "route": "IV",
            "indication": "MCI due to AD with confirmed amyloid pathology (positive amyloid PET or CSF biomarkers)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg/kg IV q2wk",
                  "orderSentence": "Lecanemab (Leqembi) 10 mg/kg IV q2wk IV"
                }
              ],
              "route": "IV",
              "instructions": "10 mg/kg IV every 2 weeks; infuse over 1 hour; continue as long as benefit maintained",
              "orderSentence": "Lecanemab (Leqembi) 10 mg/kg IV q2wk IV"
            },
            "pretreatment": "Amyloid PET or CSF confirming amyloid positivity; MRI baseline (within 1 year); APOE genotyping recommended; informed consent for ARIA risk",
            "contraindications": ">4 microbleeds on MRI; superficial siderosis; anticoagulation (increased ARIA risk); recent stroke/TIA",
            "monitoring": "MRI at baseline, weeks 14, 52, 78; monitor for ARIA-E/H symptoms (headache, confusion, vision changes)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Donanemab (Kisunla)",
            "route": "IV",
            "indication": "MCI due to AD with confirmed amyloid and intermediate/high tau pathology",
            "dosing": {
              "doseOptions": [
                {
                  "text": "700 mg IV q4wk x 3",
                  "orderSentence": "Donanemab (Kisunla) 700 mg IV q4wk x 3 IV"
                },
                {
                  "text": "1400 mg IV q4wk",
                  "orderSentence": "Donanemab (Kisunla) 1400 mg IV q4wk IV"
                }
              ],
              "route": "IV",
              "instructions": "700 mg q4wk x 3 doses, then 1400 mg q4wk until amyloid cleared (PET-guided discontinuation)",
              "orderSentence": "Donanemab (Kisunla) 700 mg IV q4wk x 3 IV"
            },
            "pretreatment": "Amyloid PET positive; tau PET intermediate/high; MRI baseline; APOE genotyping",
            "contraindications": "APOE4 homozygotes have higher ARIA risk; >4 microbleeds; anticoagulation",
            "monitoring": "MRI at baseline, weeks 16, 24, 52, 76; amyloid PET to guide discontinuation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurology/Cognitive neurology for MCI subtype characterization, biomarker interpretation, and treatment planning",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Neuropsychology for comprehensive cognitive testing to establish baseline, characterize affected domains, and distinguish MCI subtypes",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Geriatrics for comprehensive geriatric assessment, polypharmacy review, and functional optimization",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Occupational therapy for cognitive strategies, compensatory techniques, and home safety evaluation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Occupational therapy driving evaluation to assess fitness to drive given cognitive impairment",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Social work for community resources, support services, and early care planning guidance",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Speech therapy for communication strategies if language domain affected (non-amnestic MCI)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sleep medicine for sleep apnea evaluation if symptoms present (snoring, daytime sleepiness, witnessed apneas)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Psychiatry for depression evaluation if significant mood symptoms confounding cognitive assessment",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Genetics counseling if early-onset (<65), family history of early-onset dementia, or considering genetic testing",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Clinical trial referral for eligible patients interested in research studies targeting MCI and early AD",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Elder law attorney for advance directives, healthcare proxy, and financial planning while patient has full capacity",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "PCP follow-up for cardiovascular risk factor management and coordination of vascular prevention",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Return if sudden confusion worsens or new neurological symptoms develop which may indicate stroke or other acute process",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Complete advance directives and establish healthcare proxy NOW while you have full capacity to make decisions",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Consider long-term care preferences, financial planning, and legal arrangements with family while fully competent",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Discuss driving safety with physician; formal driving evaluation recommended as MCI may affect reaction time and judgment",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Use memory aids (calendars, smartphone reminders, pill organizers, written lists) to compensate for memory difficulties",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Keep a consistent daily routine which helps with memory and reduces confusion",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Take all medications as prescribed; bring medication list to all appointments",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Return for follow-up cognitive testing every 6-12 months to monitor for progression",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Report new memory concerns, personality changes, or functional difficulties to physician promptly",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid anticholinergic medications (diphenhydramine, PM sleep aids) as they can worsen cognition",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Engage in regular aerobic exercise (150 minutes/week moderate intensity) which may slow cognitive decline and improve brain health",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Follow Mediterranean or MIND diet emphasizing vegetables, berries, fish, nuts, whole grains, and olive oil to reduce dementia risk",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Participate in cognitively stimulating activities (reading, puzzles, learning new skills, social engagement) to build cognitive reserve",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Maintain active social connections and relationships as social isolation is a modifiable dementia risk factor",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Achieve adequate sleep (7-8 hours nightly) and treat sleep disorders (CPAP for sleep apnea) as poor sleep accelerates cognitive decline",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Cardiovascular risk factor control with target BP <130/80, HbA1c <7%, LDL <100 to reduce vascular contribution to cognitive decline",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Address hearing loss with hearing aids as untreated hearing loss is a modifiable risk factor for cognitive decline",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Limit alcohol to maximum 1 drink daily as excess alcohol accelerates brain atrophy and cognitive decline",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Smoking cessation to reduce vascular risk and improve overall brain health",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Manage stress through relaxation techniques, mindfulness, or counseling as chronic stress impairs cognition",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Review all medications with physician to identify and discontinue drugs that impair cognition (anticholinergics, benzodiazepines, opioids)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Normal aging",
        "features": "Subjective memory concerns without objective impairment; no functional decline; normal neuropsych testing",
        "tests": "Neuropsychological testing within 1 SD of norms"
      },
      {
        "diagnosis": "Subjective cognitive decline",
        "features": "Memory complaints but normal objective testing; may be earliest preclinical stage",
        "tests": "Neuropsychological testing normal; monitor annually"
      },
      {
        "diagnosis": "Depression (pseudodementia)",
        "features": "Prominent mood symptoms; often aware of and distressed by deficits; improves with antidepressants",
        "tests": "GDS, PHQ-9; trial of antidepressant; reassess cognition"
      },
      {
        "diagnosis": "Medication-induced cognitive impairment",
        "features": "Temporal relationship to medication initiation; improvement with discontinuation",
        "tests": "Medication review; trial discontinuation of suspect agents"
      },
      {
        "diagnosis": "Sleep apnea-related cognitive impairment",
        "features": "Excessive daytime sleepiness; snoring; morning headaches; reversible with CPAP",
        "tests": "Polysomnography; cognitive reassessment after CPAP"
      },
      {
        "diagnosis": "Alzheimer's disease (dementia stage)",
        "features": "Functional impairment in ADLs (not just IADLs); more severe cognitive deficits",
        "tests": "Functional assessment; neuropsychological testing"
      },
      {
        "diagnosis": "Vascular cognitive impairment",
        "features": "Stepwise decline; focal findings; executive dysfunction prominent; significant white matter disease",
        "tests": "MRI with confluent white matter disease; vascular risk factors"
      },
      {
        "diagnosis": "Dementia with Lewy bodies (prodromal)",
        "features": "Visual hallucinations; REM sleep behavior disorder; parkinsonism; fluctuating cognition",
        "tests": "DaTscan; clinical features; sleep study for RBD"
      },
      {
        "diagnosis": "Frontotemporal dementia (prodromal)",
        "features": "Behavioral/personality changes; disinhibition; apathy; language variants; typically <65",
        "tests": "FDG-PET frontal/temporal hypometabolism; neuropsychological profile"
      },
      {
        "diagnosis": "Thyroid dysfunction",
        "features": "Fatigue, weight changes, cold/heat intolerance; reversible with treatment",
        "tests": "TSH, free T4; reassess after treatment"
      },
      {
        "diagnosis": "Vitamin B12 deficiency",
        "features": "Peripheral neuropathy; macrocytic anemia; reversible with replacement",
        "tests": "B12, MMA; improvement with supplementation"
      }
    ],
    "evidence": [
      {
        "recommendation": "MCI diagnostic criteria and subtypes",
        "evidenceLevel": "Class I, Level A",
        "source": "[Petersen et al. Arch Neurol 2004](https://pubmed.ncbi.nlm.nih.gov/15477521/); [Albert et al. Alzheimers Dement 2011](https://pubmed.ncbi.nlm.nih.gov/21514249/)"
      },
      {
        "recommendation": "Neuropsychological testing for MCI diagnosis",
        "evidenceLevel": "Class I, Level A",
        "source": "[AAN Practice Parameter 2018](https://pubmed.ncbi.nlm.nih.gov/29282327/)"
      },
      {
        "recommendation": "CSF biomarkers for AD pathology",
        "evidenceLevel": "Class I, Level A",
        "source": "[Hansson et al. Lancet Neurol 2018](https://pubmed.ncbi.nlm.nih.gov/30244989/)"
      },
      {
        "recommendation": "Amyloid PET for AD diagnosis in MCI",
        "evidenceLevel": "Class I, Level A",
        "source": "[Johnson et al. Alzheimers Dement 2013](https://pubmed.ncbi.nlm.nih.gov/23360977/)"
      },
      {
        "recommendation": "Cholinesterase inhibitors limited benefit in MCI",
        "evidenceLevel": "Class I, Level B",
        "source": "[Petersen et al. NEJM 2005](https://pubmed.ncbi.nlm.nih.gov/15800226/); [Russ & Morling, Cochrane 2012](https://pubmed.ncbi.nlm.nih.gov/22972104/)"
      },
      {
        "recommendation": "Lecanemab slows decline in MCI due to AD",
        "evidenceLevel": "Class I, Level A",
        "source": "[van Dyck et al. NEJM 2023 (Clarity AD)](https://pubmed.ncbi.nlm.nih.gov/36449413/)"
      },
      {
        "recommendation": "Donanemab slows decline in early AD",
        "evidenceLevel": "Class I, Level A",
        "source": "[Sims et al. JAMA 2023 (TRAILBLAZER-ALZ 2)](https://pubmed.ncbi.nlm.nih.gov/37459141/)"
      },
      {
        "recommendation": "Physical exercise may slow cognitive decline",
        "evidenceLevel": "Class II, Level B",
        "source": "[Livingston et al. Lancet 2020 (Lancet Commission on Dementia)](https://pubmed.ncbi.nlm.nih.gov/32738937/)"
      },
      {
        "recommendation": "Mediterranean/MIND diet reduces dementia risk",
        "evidenceLevel": "Class II, Level B",
        "source": "[Morris et al. Alzheimers Dement 2015](https://pubmed.ncbi.nlm.nih.gov/25681666/)"
      },
      {
        "recommendation": "Cardiovascular risk factor control protects cognition",
        "evidenceLevel": "Class I, Level A",
        "source": "[Ngandu et al. Lancet 2015 (FINGER trial)](https://pubmed.ncbi.nlm.nih.gov/25771249/)"
      },
      {
        "recommendation": "Sleep apnea treatment improves cognition",
        "evidenceLevel": "Class II, Level B",
        "source": "[Osorio et al. Neurology 2015](https://pubmed.ncbi.nlm.nih.gov/25878179/)"
      },
      {
        "recommendation": "MCI progression rate to dementia (~10-15%/year)",
        "evidenceLevel": "Epidemiological",
        "source": "[Mitchell & Shiri-Feshki, Acta Psychiatr Scand 2009](https://pubmed.ncbi.nlm.nih.gov/19327298/)"
      },
      {
        "recommendation": "Hearing loss as modifiable dementia risk factor",
        "evidenceLevel": "Class II, Level B",
        "source": "[Lin et al. Arch Neurol 2011](https://pubmed.ncbi.nlm.nih.gov/21320988/)"
      },
      {
        "recommendation": "Modifiable risk factors for dementia prevention",
        "evidenceLevel": "Class II, Level A",
        "source": "[Livingston et al. Lancet 2024 (Lancet Commission Update)](https://pubmed.ncbi.nlm.nih.gov/39096926/)"
      }
    ],
    "monitoring": [
      {
        "item": "MoCA or MMSE",
        "frequency": "Every 6-12 months",
        "action": "Decline >3 points or reaching dementia threshold warrants reassessment; consider biomarker workup if not done",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Full neuropsychological testing",
        "frequency": "Every 1-2 years or if significant change",
        "action": "Decline suggests progression to dementia; adjust care plan",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "IADL/ADL function (FAQ, Lawton)",
        "frequency": "Every 6-12 months",
        "action": "Functional decline suggests progression to dementia; increase supports",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Depression screening (GDS, PHQ-9)",
        "frequency": "Annually or if symptoms",
        "action": "Treat depression; reassess cognition after treatment",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Blood pressure",
        "frequency": "Each visit",
        "action": "Optimize antihypertensive therapy",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "HbA1c (if diabetic)",
        "frequency": "Every 3-6 months",
        "action": "Optimize glycemic control",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Lipid panel",
        "frequency": "Annually",
        "action": "Optimize statin therapy",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Vitamin B12",
        "frequency": "Annually",
        "action": "Supplement if low",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "TSH",
        "frequency": "Annually",
        "action": "Treat thyroid dysfunction",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "MRI (ARIA monitoring if on anti-amyloid)",
        "frequency": "Per protocol (baseline, weeks 14, 52, 78 for lecanemab)",
        "action": "Hold infusion per protocol; resume after resolution",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Driving safety",
        "frequency": "Annually or with decline",
        "action": "Recommend driving cessation or OT driving evaluation",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Weight",
        "frequency": "Each visit",
        "action": "Nutritional assessment if declining",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Caregiver/family concerns",
        "frequency": "Each visit",
        "action": "Investigate reported changes; adjust care plan",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      }
    ],
    "disposition": [
      {
        "disposition": "Outpatient management (most MCI)",
        "criteria": "Stable MCI; reversible causes addressed; care plan established; follow-up arranged"
      },
      {
        "disposition": "Admit to floor",
        "criteria": "Acute delirium requiring workup; safety concerns at home; caregiver crisis"
      },
      {
        "disposition": "Outpatient neurology follow-up",
        "criteria": "Every 6-12 months for cognitive monitoring; sooner if concerns"
      },
      {
        "disposition": "Outpatient neuropsychology",
        "criteria": "At diagnosis for baseline; repeat in 1-2 years or if significant change"
      },
      {
        "disposition": "Referral to memory care program",
        "criteria": "Progressive decline; need for specialized multidisciplinary management"
      },
      {
        "disposition": "Clinical trial referral",
        "criteria": "Eligible patient interested in research; positive biomarkers; early stage"
      }
    ]
  },
  "Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)": {
    "id": "cidp",
    "title": "Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)",
    "version": "1.0",
    "icd10": [
      "** G61.81"
    ],
    "scope": "** Evaluation, diagnosis, treatment initiation, and long-term management of CIDP in adults. Covers typical CIDP, CIDP variants (MADSAM, DADS, sensory CIDP), first-line immunotherapy (IVIg, corticosteroids, plasmapheresis), second-line immunosuppressants, and subcutaneous immunoglobulin therapy. Primary focus is outpatient management with coverage for acute presentations and hospitalizations. Excludes Guillain-Barré syndrome (acute onset <8 weeks), hereditary neuropathies (CMT), and pediatric CIDP.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC with differential",
            "rationale": "Baseline, infection screen, pre-treatment",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "CMP (BMP + LFTs)",
            "rationale": "Electrolytes, renal/hepatic function for IVIg",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "ESR",
            "rationale": "Inflammatory marker; elevated in some CIDP",
            "target": "Document baseline",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "CRP",
            "rationale": "Inflammatory marker",
            "target": "Document baseline",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "HbA1c",
            "rationale": "Diabetic neuropathy in differential; diabetes worsens CIDP",
            "target": "<5.7% (normal); >6.5% diagnostic for diabetes",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Fasting glucose",
            "rationale": "Diabetes screening",
            "target": "<100 mg/dL",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "TSH",
            "rationale": "Thyroid disease causing neuropathy",
            "target": "Normal (0.4-4.0 mIU/L)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Vitamin B12",
            "rationale": "B12 deficiency neuropathy",
            "target": ">300 pg/mL",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Methylmalonic acid",
            "rationale": "If B12 borderline (200-400 pg/mL)",
            "target": "Normal if B12 sufficient",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Serum protein electrophoresis (SPEP)",
            "rationale": "Paraproteinemic neuropathy screen",
            "target": "No monoclonal spike",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Serum immunofixation",
            "rationale": "Confirms monoclonal protein if SPEP abnormal",
            "target": "Characterize M-protein",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "HIV antibody",
            "rationale": "HIV-associated neuropathy/CIDP",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Hepatitis B surface antigen",
            "rationale": "Pre-IVIg screening; HBV reactivation risk",
            "target": "Negative",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Hepatitis B core antibody",
            "rationale": "Prior HBV exposure; reactivation risk with immunosuppression",
            "target": "Negative",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Hepatitis C antibody",
            "rationale": "HCV-associated cryoglobulinemic neuropathy",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          }
        ],
        "Extended Workup": [
          {
            "item": "Urine protein electrophoresis (UPEP)",
            "rationale": "Light chain deposition in neuropathy",
            "target": "No monoclonal protein",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Serum free light chains",
            "rationale": "AL amyloidosis, POEMS screening",
            "target": "Normal kappa:lambda ratio",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "VEGF level",
            "rationale": "Elevated in POEMS syndrome",
            "target": "Normal (<200 pg/mL)",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Anti-MAG antibody",
            "rationale": "DADS variant; IgM paraproteinemic neuropathy",
            "target": "Negative (if positive, suggests DADS-CIDP or anti-MAG neuropathy)",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Anti-ganglioside antibodies (GM1, GD1a, GD1b)",
            "rationale": "MMN differentiation; axonal GBS variants",
            "target": "Document if positive",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Anti-GQ1b antibody",
            "rationale": "Miller Fisher variant if ophthalmoplegia",
            "target": "Document if positive",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Quantitative immunoglobulins (IgG, IgA, IgM)",
            "rationale": "IgA deficiency (IVIg contraindication); IgM elevation",
            "target": "IgA >7 mg/dL; document IgM",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "ANA",
            "rationale": "Connective tissue disease screen",
            "target": "Negative or low titer",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Rheumatoid factor",
            "rationale": "Vasculitic neuropathy screen",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Anti-SSA/SSB",
            "rationale": "Sjogren syndrome neuropathy",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "ACE level",
            "rationale": "Sarcoid neuropathy",
            "target": "Normal",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "PT/INR, PTT",
            "rationale": "Pre-LP, pre-PLEX",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Type and screen",
            "rationale": "Pre-PLEX",
            "target": "Available",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Anti-contactin-1 (CNTN1) antibody",
            "rationale": "Aggressive CIDP variant; poor IVIg response",
            "target": "Document if positive",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "Anti-neurofascin-155 (NF155) antibody",
            "rationale": "Young onset, tremor, poor IVIg response",
            "target": "Document if positive",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "Anti-caspr-1 antibody",
            "rationale": "Nodopathy; aggressive course",
            "target": "Document if positive",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "Anti-NF186/NF140 antibodies",
            "rationale": "Nodal/paranodal antibodies",
            "target": "Document if positive",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "Genetic testing for CMT",
            "rationale": "If family history or atypical features",
            "target": "Negative (excludes CMT)",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "Lyme serology",
            "rationale": "Endemic area, outdoor exposure",
            "target": "Negative",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Heavy metals (lead, arsenic)",
            "rationale": "Toxic neuropathy differential",
            "target": "Normal",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "Urine porphyrins",
            "rationale": "Motor neuropathy with systemic symptoms",
            "target": "Normal",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "Bone marrow biopsy",
            "rationale": "If POEMS or amyloidosis suspected",
            "target": "Normal or diagnostic",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "Fat pad biopsy for amyloid",
            "rationale": "If amyloidosis suspected",
            "target": "Negative",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "Cryoglobulins",
            "rationale": "If HCV positive or vasculitic features",
            "target": "Negative",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "—"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "Opening pressure",
            "rationale": "Baseline; usually normal in CIDP",
            "target": "10-20 cmH2O",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Cell count (tubes 1 and 4)",
            "rationale": "Albuminocytologic dissociation",
            "target": "WBC <10/mm³ (usually <5)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Protein",
            "rationale": "Elevated in CIDP",
            "target": "Elevated (>45 mg/dL; often 50-200 mg/dL)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Glucose",
            "rationale": "Exclude infection",
            "target": "Normal (>60% serum glucose)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Gram stain and culture",
            "rationale": "Exclude infection",
            "target": "Negative",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "—"
          },
          {
            "item": "Cytology",
            "rationale": "Exclude carcinomatous meningitis",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "VDRL",
            "rationale": "Neurosyphilis in differential",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Oligoclonal bands",
            "rationale": "MS or CNS inflammation in differential",
            "target": "Usually negative; may be mildly positive",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "Nerve conduction studies (NCS)",
            "timing": "At diagnosis; before treatment",
            "target": "Demyelinating features: prolonged distal latencies (>125% ULN), slow conduction velocities (<80% LLN), conduction block, temporal dispersion, prolonged F-waves",
            "contraindications": "None",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Electromyography (EMG)",
            "timing": "At diagnosis; with NCS",
            "target": "Secondary axonal loss; fibrillations in severe cases",
            "contraindications": "Severe coagulopathy",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Chest X-ray",
            "timing": "Pre-treatment baseline",
            "target": "Normal (rule out mass if paraneoplastic concern)",
            "contraindications": "None",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          }
        ],
        "Extended": [
          {
            "item": "MRI spine with contrast (cervical/lumbar)",
            "timing": "Diagnostic workup",
            "target": "Nerve root enhancement, cauda equina hypertrophy",
            "contraindications": "Pacemaker, severe claustrophobia",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "MRI brachial plexus with contrast",
            "timing": "If asymmetric or plexus involvement",
            "target": "Nerve hypertrophy, enhancement",
            "contraindications": "Pacemaker",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "MRI lumbosacral plexus with contrast",
            "timing": "If lower extremity predominant",
            "target": "Plexus enhancement, thickening",
            "contraindications": "Pacemaker",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Nerve ultrasound",
            "timing": "Complementary to MRI; assess nerve enlargement",
            "target": "Increased cross-sectional area of peripheral nerves",
            "contraindications": "None",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "CT chest/abdomen/pelvis",
            "timing": "If POEMS or malignancy suspected",
            "target": "Sclerotic bone lesions (POEMS), organomegaly",
            "contraindications": "Contrast allergy, renal impairment",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "—"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "PET-CT",
            "timing": "Occult malignancy, lymphoma, Castleman disease",
            "target": "Tumor identification",
            "contraindications": "Hemodynamic instability",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "Nerve biopsy (sural)",
            "timing": "Diagnostic uncertainty, vasculitis suspected",
            "target": "Demyelination, inflammation, onion bulbs",
            "contraindications": "Active infection at site",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "Skeletal survey",
            "timing": "POEMS evaluation",
            "target": "Sclerotic or lytic lesions",
            "contraindications": "None",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "—"
          }
        ]
      },
      "Treatment": {
        "First-line Immunotherapy - Induction": [
          {
            "item": "IVIg (immune globulin IV) - Loading",
            "route": "IV",
            "indication": "First-line induction",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 g/kg over 2-5 days",
                  "orderSentence": "IVIg (immune globulin IV) - Loading 2 g/kg over 2-5 days IV"
                }
              ],
              "route": "IV",
              "instructions": "2 g/kg total divided over 2-5 days (e.g., 0.4 g/kg/day x 5 days or 1 g/kg/day x 2 days); infuse slowly day 1 (start 0.5-1 mL/kg/hr, max 4 mL/kg/hr)",
              "orderSentence": "IVIg (immune globulin IV) - Loading 2 g/kg over 2-5 days IV"
            },
            "contraindications": "IgA deficiency with anti-IgA antibodies; uncontrolled heart failure; recent thrombosis; severe renal impairment",
            "monitoring": "Renal function, headache, infusion reactions; pre-medicate with acetaminophen and diphenhydramine",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Prednisone - Daily",
            "route": "PO",
            "indication": "First-line induction (if IVIg unavailable or contraindicated)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "60 mg daily",
                  "orderSentence": "Prednisone - Daily 60 mg daily PO"
                },
                {
                  "text": "1 mg/kg daily",
                  "orderSentence": "Prednisone - Daily 1 mg/kg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 60 mg (or 1 mg/kg) daily for 4-8 weeks until clinical improvement, then begin slow taper",
              "orderSentence": "Prednisone - Daily 60 mg daily PO"
            },
            "contraindications": "Uncontrolled diabetes, active infection, psychosis, osteoporosis",
            "monitoring": "Glucose, BP, bone density, mood, infection signs",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Prednisone - Pulse",
            "route": "PO",
            "indication": "Alternative oral pulse therapy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg daily x 5 days monthly",
                  "orderSentence": "Prednisone - Pulse 40 mg daily x 5 days monthly PO"
                }
              ],
              "route": "PO",
              "instructions": "40-60 mg daily for 5 consecutive days each month; may have fewer side effects than daily",
              "orderSentence": "Prednisone - Pulse 40 mg daily x 5 days monthly PO"
            },
            "contraindications": "Uncontrolled diabetes, active infection",
            "monitoring": "Glucose, BP during pulse",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Methylprednisolone - IV Pulse",
            "route": "IV",
            "indication": "Severe CIDP, rapid induction needed",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mg daily x 3-5 days",
                  "orderSentence": "Methylprednisolone - IV Pulse 1000 mg daily x 3-5 days IV"
                }
              ],
              "route": "IV",
              "instructions": "1000 mg IV daily for 3-5 days; can repeat monthly as needed; transition to oral",
              "orderSentence": "Methylprednisolone - IV Pulse 1000 mg daily x 3-5 days IV"
            },
            "contraindications": "Active untreated infection, uncontrolled HTN/diabetes",
            "monitoring": "Glucose, BP, K+, psychiatric effects",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Plasma exchange (PLEX)",
            "route": "—",
            "indication": "First-line if IVIg/steroids contraindicated or failed",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5-10 exchanges over 2-4 weeks",
                  "orderSentence": "Plasma exchange (PLEX) 5-10 exchanges over 2-4 weeks —"
                }
              ],
              "route": "—",
              "instructions": "5-10 exchanges (1-1.5 plasma volumes each) over 2-4 weeks; typically 2-3 sessions per week",
              "orderSentence": "Plasma exchange (PLEX) 5-10 exchanges over 2-4 weeks —"
            },
            "contraindications": "Hemodynamic instability, severe sepsis, poor vascular access",
            "monitoring": "BP, electrolytes, coagulation, fibrinogen",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          }
        ],
        "First-line Immunotherapy - Maintenance": [
          {
            "item": "IVIg - Maintenance",
            "route": "IV",
            "indication": "Maintenance after loading response",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.4 g/kg q3wk",
                  "orderSentence": "IVIg - Maintenance 0.4 g/kg q3wk IV"
                },
                {
                  "text": "0.5 g/kg q3wk",
                  "orderSentence": "IVIg - Maintenance 0.5 g/kg q3wk IV"
                },
                {
                  "text": "1 g/kg q3-4wk",
                  "orderSentence": "IVIg - Maintenance 1 g/kg q3-4wk IV"
                }
              ],
              "route": "IV",
              "instructions": "0.4-1 g/kg every 3-4 weeks; titrate to lowest effective dose and longest interval; some patients need 1 g/kg q2-3wk",
              "orderSentence": "IVIg - Maintenance 0.4 g/kg q3wk IV"
            },
            "contraindications": "IgA deficiency, renal impairment, recent thrombosis",
            "monitoring": "Renal function q3-6mo; trough IgG levels optional",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "SCIg (Hizentra) - Maintenance",
            "route": "SC",
            "indication": "Home maintenance after IVIg response",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Weekly dose = IVIg monthly dose ÷ 4",
                  "orderSentence": "SCIg (Hizentra) - Maintenance Weekly dose = IVIg monthly dose ÷ 4 SC"
                }
              ],
              "route": "SC",
              "instructions": "Convert from IVIg: weekly SC dose equals monthly IV dose divided by 4; typical range 0.2-0.4 g/kg/week; divide into 1-7 infusions/week",
              "orderSentence": "SCIg (Hizentra) - Maintenance Weekly dose = IVIg monthly dose ÷ 4 SC"
            },
            "contraindications": "Severe thrombocytopenia, skin conditions at injection site",
            "monitoring": "Local site reactions; IgG trough levels q6mo",
            "ED": "—",
            "HOSP": "—",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "SCIg (Gamunex-C 10%) - Maintenance",
            "route": "SC",
            "indication": "Home maintenance alternative",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Weekly dose = IVIg monthly dose ÷ 4",
                  "orderSentence": "SCIg (Gamunex-C 10%) - Maintenance Weekly dose = IVIg monthly dose ÷ 4 SC"
                }
              ],
              "route": "SC",
              "instructions": "Same as Hizentra; 10% concentration; can give larger volume per site",
              "orderSentence": "SCIg (Gamunex-C 10%) - Maintenance Weekly dose = IVIg monthly dose ÷ 4 SC"
            },
            "contraindications": "Severe thrombocytopenia",
            "monitoring": "Local reactions, IgG levels",
            "ED": "—",
            "HOSP": "—",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Prednisone - Maintenance taper",
            "route": "PO",
            "indication": "Continuation after steroid induction",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Taper by 5-10 mg q2-4wk",
                  "orderSentence": "Prednisone - Maintenance taper Taper by 5-10 mg q2-4wk PO"
                }
              ],
              "route": "PO",
              "instructions": "After improvement, taper by 5-10 mg every 2-4 weeks; target lowest effective dose (often 5-20 mg daily or QOD); add steroid-sparing agent if unable to taper below 15-20 mg",
              "orderSentence": "Prednisone - Maintenance taper Taper by 5-10 mg q2-4wk PO"
            },
            "contraindications": "Ongoing infection",
            "monitoring": "Glucose, BP, bone density, cataracts",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          }
        ],
        "Second-line/Steroid-Sparing Agents": [
          {
            "item": "Azathioprine",
            "route": "PO",
            "indication": "Steroid-sparing; maintenance",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg daily",
                  "orderSentence": "Azathioprine 50 mg daily PO"
                },
                {
                  "text": "100 mg daily",
                  "orderSentence": "Azathioprine 100 mg daily PO"
                },
                {
                  "text": "150 mg daily",
                  "orderSentence": "Azathioprine 150 mg daily PO"
                },
                {
                  "text": "2-3 mg/kg daily",
                  "orderSentence": "Azathioprine 2-3 mg/kg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 50 mg daily; increase by 50 mg every 2-4 weeks to target 2-3 mg/kg/day; check TPMT before starting; onset 3-6 months",
              "orderSentence": "Azathioprine 50 mg daily PO"
            },
            "contraindications": "TPMT deficiency, pregnancy, myelosuppression",
            "monitoring": "CBC weekly x 4 weeks, then monthly x 3 months, then q3mo; LFTs monthly",
            "ED": "—",
            "HOSP": "—",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Mycophenolate mofetil",
            "route": "PO",
            "indication": "Steroid-sparing; maintenance",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mg BID",
                  "orderSentence": "Mycophenolate mofetil 500 mg BID PO"
                },
                {
                  "text": "1000 mg BID",
                  "orderSentence": "Mycophenolate mofetil 1000 mg BID PO"
                },
                {
                  "text": "1500 mg BID",
                  "orderSentence": "Mycophenolate mofetil 1500 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 500 mg BID; increase to 1000-1500 mg BID over 2-4 weeks; onset 2-4 months",
              "orderSentence": "Mycophenolate mofetil 500 mg BID PO"
            },
            "contraindications": "Pregnancy (teratogenic), severe renal impairment",
            "monitoring": "CBC q2wk x 2 months, then monthly; LFTs",
            "ED": "—",
            "HOSP": "—",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Rituximab",
            "route": "IV",
            "indication": "Refractory CIDP, nodal antibody-positive",
            "dosing": {
              "doseOptions": [
                {
                  "text": "375 mg/m² weekly x 4 weeks",
                  "orderSentence": "Rituximab 375 mg/m² weekly x 4 weeks IV"
                },
                {
                  "text": "1000 mg q2wk x 2",
                  "orderSentence": "Rituximab 1000 mg q2wk x 2 IV"
                }
              ],
              "route": "IV",
              "instructions": "375 mg/m² weekly x 4 doses OR 1000 mg x 2 doses (2 weeks apart); repeat q6-12mo PRN; pre-medicate",
              "orderSentence": "Rituximab 375 mg/m² weekly x 4 weeks IV"
            },
            "contraindications": "Active infection, HBV (screen first; may reactivate)",
            "monitoring": "Infusion reactions, CD19/CD20 counts, immunoglobulins; HBV DNA if prior exposure",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "Cyclophosphamide",
            "route": "IV",
            "indication": "Severe refractory CIDP",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 g/m² monthly x 6 months",
                  "orderSentence": "Cyclophosphamide 1 g/m² monthly x 6 months IV"
                }
              ],
              "route": "IV",
              "instructions": "1 g/m² IV monthly for 6 months; reserve for severe refractory cases",
              "orderSentence": "Cyclophosphamide 1 g/m² monthly x 6 months IV"
            },
            "contraindications": "Pregnancy, active infection, hemorrhagic cystitis",
            "monitoring": "CBC, urinalysis, fertility counseling; MESNA for bladder protection",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "Cyclosporine",
            "route": "PO",
            "indication": "Steroid-sparing alternative",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2.5-5 mg/kg/day divided BID",
                  "orderSentence": "Cyclosporine 2.5-5 mg/kg/day divided BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 2.5 mg/kg/day divided BID; increase to 5 mg/kg/day based on levels and response; target trough 100-200 ng/mL",
              "orderSentence": "Cyclosporine 2.5-5 mg/kg/day divided BID PO"
            },
            "contraindications": "Uncontrolled HTN, renal impairment",
            "monitoring": "Cr, BP, drug levels, K+, Mg",
            "ED": "—",
            "HOSP": "—",
            "OPD": "EXT",
            "ICU": "—"
          }
        ],
        "Disease-Modifying Therapy - Special Populations": [
          {
            "item": "IVIg - Anti-MAG positive",
            "route": "IV",
            "indication": "Anti-MAG neuropathy (may have partial response)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 g/kg loading then 0.4-1 g/kg q3-4wk",
                  "orderSentence": "IVIg - Anti-MAG positive 2 g/kg loading then 0.4-1 g/kg q3-4wk IV"
                }
              ],
              "route": "IV",
              "instructions": "Anti-MAG neuropathy often less responsive to IVIg; may require rituximab if poor response",
              "orderSentence": "IVIg - Anti-MAG positive 2 g/kg loading then 0.4-1 g/kg q3-4wk IV"
            },
            "pretreatment": "SPEP/UPEP to assess for underlying plasma cell dyscrasia",
            "contraindications": "IgA deficiency",
            "monitoring": "Response may be slower; consider rituximab if no improvement",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Rituximab - Anti-MAG positive",
            "route": "IV",
            "indication": "Anti-MAG neuropathy preferred therapy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "375 mg/m² weekly x 4 weeks",
                  "orderSentence": "Rituximab - Anti-MAG positive 375 mg/m² weekly x 4 weeks IV"
                },
                {
                  "text": "1000 mg q2wk x 2",
                  "orderSentence": "Rituximab - Anti-MAG positive 1000 mg q2wk x 2 IV"
                }
              ],
              "route": "IV",
              "instructions": "First-line for anti-MAG neuropathy given superior efficacy; repeat q6-12mo",
              "orderSentence": "Rituximab - Anti-MAG positive 375 mg/m² weekly x 4 weeks IV"
            },
            "pretreatment": "HBV/HCV screening, quantitative immunoglobulins, CBC",
            "contraindications": "Active HBV, active infection",
            "monitoring": "Anti-MAG titers, CD19/20, immunoglobulins",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Rituximab - Nodal antibody positive (NF155, CNTN1)",
            "route": "IV",
            "indication": "CIDP with nodal/paranodal antibodies",
            "dosing": {
              "doseOptions": [
                {
                  "text": "375 mg/m² weekly x 4 weeks",
                  "orderSentence": "Rituximab - Nodal antibody positive (NF155, CNTN1) 375 mg/m² weekly x 4 weeks IV"
                },
                {
                  "text": "1000 mg q2wk x 2",
                  "orderSentence": "Rituximab - Nodal antibody positive (NF155, CNTN1) 1000 mg q2wk x 2 IV"
                }
              ],
              "route": "IV",
              "instructions": "Preferred for NF155/CNTN1/CASPR1 positive CIDP (poor IVIg response); repeat q6mo",
              "orderSentence": "Rituximab - Nodal antibody positive (NF155, CNTN1) 375 mg/m² weekly x 4 weeks IV"
            },
            "pretreatment": "HBV/HCV screening, immunoglobulins",
            "contraindications": "Active HBV",
            "monitoring": "Antibody titers, B-cell counts",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "—"
          }
        ],
        "Symptomatic Treatments": [
          {
            "item": "Gabapentin",
            "route": "PO",
            "indication": "Neuropathic pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg qHS",
                  "orderSentence": "Gabapentin 300 mg qHS PO"
                },
                {
                  "text": "300 mg TID",
                  "orderSentence": "Gabapentin 300 mg TID PO"
                },
                {
                  "text": "600 mg TID",
                  "orderSentence": "Gabapentin 600 mg TID PO"
                },
                {
                  "text": "900 mg TID",
                  "orderSentence": "Gabapentin 900 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 300 mg qHS; titrate by 300 mg/day q3d; target 900-1800 mg TID; max 3600 mg/day",
              "orderSentence": "Gabapentin 300 mg qHS PO"
            },
            "contraindications": "Severe renal impairment (adjust dose)",
            "monitoring": "Sedation, dizziness, edema; reduce dose if CrCl <60",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Pregabalin",
            "route": "PO",
            "indication": "Neuropathic pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "75 mg BID",
                  "orderSentence": "Pregabalin 75 mg BID PO"
                },
                {
                  "text": "150 mg BID",
                  "orderSentence": "Pregabalin 150 mg BID PO"
                },
                {
                  "text": "300 mg BID",
                  "orderSentence": "Pregabalin 300 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 75 mg BID; increase to 150 mg BID after 1 week; max 600 mg/day",
              "orderSentence": "Pregabalin 75 mg BID PO"
            },
            "contraindications": "Severe renal impairment (adjust dose)",
            "monitoring": "Sedation, edema, weight gain",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Duloxetine",
            "route": "PO",
            "indication": "Neuropathic pain, depression",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mg daily",
                  "orderSentence": "Duloxetine 30 mg daily PO"
                },
                {
                  "text": "60 mg daily",
                  "orderSentence": "Duloxetine 60 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 30 mg daily; increase to 60 mg daily after 1-2 weeks; max 120 mg/day",
              "orderSentence": "Duloxetine 30 mg daily PO"
            },
            "contraindications": "Uncontrolled glaucoma, severe hepatic impairment, MAOIs",
            "monitoring": "BP, hepatic function, serotonin syndrome",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Amitriptyline",
            "route": "PO",
            "indication": "Neuropathic pain, sleep",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg qHS",
                  "orderSentence": "Amitriptyline 10 mg qHS PO"
                },
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Amitriptyline 25 mg qHS PO"
                },
                {
                  "text": "50 mg qHS",
                  "orderSentence": "Amitriptyline 50 mg qHS PO"
                },
                {
                  "text": "75 mg qHS",
                  "orderSentence": "Amitriptyline 75 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10 mg qHS; titrate by 10-25 mg q1-2wk; max 150 mg qHS",
              "orderSentence": "Amitriptyline 10 mg qHS PO"
            },
            "contraindications": "Cardiac arrhythmias, recent MI, glaucoma, urinary retention",
            "monitoring": "ECG if >100 mg/day; anticholinergic effects",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Acetaminophen",
            "route": "PO",
            "indication": "Mild pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "650 mg q6h PRN",
                  "orderSentence": "Acetaminophen 650 mg q6h PRN PO"
                },
                {
                  "text": "1000 mg q6h PRN",
                  "orderSentence": "Acetaminophen 1000 mg q6h PRN PO"
                }
              ],
              "route": "PO",
              "instructions": "650-1000 mg q6h PRN; max 4 g/day (3 g if hepatic impairment)",
              "orderSentence": "Acetaminophen 650 mg q6h PRN PO"
            },
            "contraindications": "Severe hepatic impairment",
            "monitoring": "LFTs if prolonged use",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Mexiletine",
            "route": "PO",
            "indication": "Muscle cramps, neuropathic pain (refractory)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "150 mg TID",
                  "orderSentence": "Mexiletine 150 mg TID PO"
                },
                {
                  "text": "200 mg TID",
                  "orderSentence": "Mexiletine 200 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 150 mg TID; may increase to 200-300 mg TID; max 1200 mg/day",
              "orderSentence": "Mexiletine 150 mg TID PO"
            },
            "contraindications": "Cardiac arrhythmia, heart block",
            "monitoring": "ECG, hepatic function",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "Baclofen",
            "route": "PO",
            "indication": "Muscle cramps, spasms",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg TID",
                  "orderSentence": "Baclofen 5 mg TID PO"
                },
                {
                  "text": "10 mg TID",
                  "orderSentence": "Baclofen 10 mg TID PO"
                },
                {
                  "text": "20 mg TID",
                  "orderSentence": "Baclofen 20 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg TID; increase by 5 mg/dose every 3 days; max 80 mg/day",
              "orderSentence": "Baclofen 5 mg TID PO"
            },
            "contraindications": "Severe renal impairment",
            "monitoring": "Sedation; do not stop abruptly",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          }
        ],
        "Prophylaxis and Supportive Care": [
          {
            "item": "Calcium + Vitamin D",
            "route": "PO",
            "indication": "Bone protection on steroids",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Calcium 1000-1200 mg daily",
                  "orderSentence": "Calcium + Vitamin D Calcium 1000-1200 mg daily PO"
                },
                {
                  "text": "Vitamin D 800-2000 IU daily",
                  "orderSentence": "Calcium + Vitamin D Vitamin D 800-2000 IU daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Calcium 500-600 mg BID (with food) + Vitamin D 800-2000 IU daily for all patients on chronic steroids",
              "orderSentence": "Calcium + Vitamin D Calcium 1000-1200 mg daily PO"
            },
            "contraindications": "Hypercalcemia, kidney stones",
            "monitoring": "Calcium levels, 25-OH vitamin D",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Bisphosphonate (alendronate)",
            "route": "PO",
            "indication": "Osteoporosis prevention on steroids",
            "dosing": {
              "doseOptions": [
                {
                  "text": "70 mg weekly",
                  "orderSentence": "Bisphosphonate (alendronate) 70 mg weekly PO"
                }
              ],
              "route": "PO",
              "instructions": "70 mg PO weekly if prednisone >7.5 mg for >3 months; take with water, remain upright 30 min",
              "orderSentence": "Bisphosphonate (alendronate) 70 mg weekly PO"
            },
            "contraindications": "Esophageal disorders, CrCl <35, hypocalcemia",
            "monitoring": "DEXA scan at baseline and q1-2yr; dental exam",
            "ED": "—",
            "HOSP": "—",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Omeprazole",
            "route": "PO",
            "indication": "GI protection on steroids",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg daily",
                  "orderSentence": "Omeprazole 20 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "20 mg daily for patients on high-dose steroids or with GI symptoms",
              "orderSentence": "Omeprazole 20 mg daily PO"
            },
            "contraindications": "Long-term use concerns (Mg, B12, fractures)",
            "monitoring": "Mg levels if prolonged",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Aspirin (low-dose)",
            "route": "PO",
            "indication": "Thrombosis prevention with IVIg",
            "dosing": {
              "doseOptions": [
                {
                  "text": "81 mg daily",
                  "orderSentence": "Aspirin (low-dose) 81 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "81 mg daily during IVIg infusions for patients with thrombosis risk factors (age >60, obesity, immobility, prior VTE, hyperviscosity)",
              "orderSentence": "Aspirin (low-dose) 81 mg daily PO"
            },
            "contraindications": "Active bleeding, allergy",
            "monitoring": "None routine",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Enoxaparin",
            "route": "SC",
            "indication": "DVT prophylaxis (immobile patients)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg daily",
                  "orderSentence": "Enoxaparin 40 mg daily SC"
                }
              ],
              "route": "SC",
              "instructions": "40 mg SC daily for immobile hospitalized patients; continue until ambulating",
              "orderSentence": "Enoxaparin 40 mg daily SC"
            },
            "contraindications": "Active bleeding, HIT, CrCl <30",
            "monitoring": "Platelet count",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "PCP prophylaxis (TMP-SMX)",
            "route": "PO",
            "indication": "Pneumocystis prevention on high-dose steroids",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 DS tablet 3x/week",
                  "orderSentence": "PCP prophylaxis (TMP-SMX) 1 DS tablet 3x/week PO"
                }
              ],
              "route": "PO",
              "instructions": "TMP-SMX DS (160/800 mg) 3x/week or daily if prednisone >20 mg for >4 weeks + another immunosuppressant",
              "orderSentence": "PCP prophylaxis (TMP-SMX) 1 DS tablet 3x/week PO"
            },
            "contraindications": "Sulfa allergy (use dapsone or atovaquone)",
            "monitoring": "CBC, renal function",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurology consult for diagnosis confirmation, treatment initiation, and long-term management planning",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Neuromuscular specialist referral for diagnostic uncertainty, treatment-refractory cases, or consideration of advanced therapies",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Infusion center referral for ongoing IVIg administration and monitoring",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Home infusion service referral for SCIg training and home therapy setup",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Physical therapy for gait training, fall prevention, strengthening exercises, and mobility optimization",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Occupational therapy for ADL assessment, adaptive equipment, and energy conservation strategies",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Pain management consult for refractory neuropathic pain not responding to gabapentin/pregabalin/duloxetine",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Endocrinology consult for steroid-induced diabetes management or osteoporosis prevention",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Hematology consult if monoclonal protein detected for POEMS or myeloma workup",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Pulmonology consult if respiratory symptoms develop (rare in CIDP; consider GBS overlap)",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Rheumatology consult if connective tissue disease suspected based on labs or clinical features",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Social work for disability resources, transportation assistance, and community support services",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "PCP follow-up for chronic disease management, steroid side effect monitoring, and preventive care",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Return immediately if progressive weakness, difficulty walking, or breathing problems develop (may indicate disease progression or acute worsening)",
            "ED": "STAT",
            "HOSP": "—",
            "OPD": "STAT"
          },
          {
            "item": "Keep all IVIg/infusion appointments as scheduled to maintain disease control and prevent relapses",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Do not stop immunosuppressive medications suddenly as this may cause disease flare; taper only under physician guidance",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "STAT"
          },
          {
            "item": "Report signs of infection (fever, cough, dysuria) promptly as immunosuppression increases infection risk",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "STAT"
          },
          {
            "item": "Use fall precautions including handrails, non-slip surfaces, and assistive devices due to balance and weakness",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "STAT"
          },
          {
            "item": "Perform home exercises as prescribed by physical therapy to maintain strength and flexibility",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Monitor for IVIg side effects including headache, fever, chills, or rash during infusions; report severe symptoms",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Keep a symptom diary tracking strength, numbness, and functional abilities to share at follow-up visits",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Carry a medical ID card indicating CIDP diagnosis and current treatments in case of emergency",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Contact GBS-CIDP Foundation (www.gbs-cidp.org) for patient education, support groups, and resources",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Maintain glycemic control (HbA1c <7%) to prevent worsening of neuropathy if diabetic",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Limit alcohol consumption as alcohol worsens peripheral neuropathy and interacts with medications",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Ensure adequate vitamin B12 and folate intake through diet or supplementation to support nerve health",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid smoking as it impairs circulation and may worsen neuropathy",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Stay up to date on vaccinations (flu, pneumonia, COVID-19, shingles) but avoid live vaccines while on immunosuppression",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Wear protective footwear to prevent injury to numb feet and avoid burns or trauma",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Perform daily foot inspections for wounds or ulcers given sensory loss",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Engage in low-impact exercise (swimming, stationary cycling, walking) to maintain cardiovascular health and strength",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Maintain bone health with calcium, vitamin D, and weight-bearing exercise, especially if on steroids",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Manage stress and get adequate sleep as fatigue worsens CIDP symptoms",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Guillain-Barré syndrome (GBS)",
        "features": "Acute onset (<4 weeks to nadir); monophasic; often post-infectious",
        "tests": "Time course (<8 weeks); NCS; CSF"
      },
      {
        "diagnosis": "Multifocal motor neuropathy (MMN)",
        "features": "Pure motor; asymmetric; conduction block; no sensory involvement",
        "tests": "Anti-GM1 antibodies; NCS (conduction block without sensory abnormality)"
      },
      {
        "diagnosis": "POEMS syndrome",
        "features": "Polyneuropathy, organomegaly, endocrinopathy, M-protein, skin changes",
        "tests": "VEGF, bone survey, SPEP/UPEP (lambda light chain)"
      },
      {
        "diagnosis": "Anti-MAG neuropathy",
        "features": "Distal, sensory-predominant; IgM paraprotein; tremor",
        "tests": "Anti-MAG antibody; SPEP/UPEP"
      },
      {
        "diagnosis": "Hereditary neuropathy (CMT)",
        "features": "Family history; pes cavus, hammer toes; slowly progressive since childhood",
        "tests": "Genetic testing; NCS pattern"
      },
      {
        "diagnosis": "Diabetic polyneuropathy",
        "features": "Length-dependent sensory > motor; diabetes history",
        "tests": "HbA1c; NCS (axonal predominantly)"
      },
      {
        "diagnosis": "Vasculitic neuropathy",
        "features": "Painful; asymmetric; multifocal (mononeuritis multiplex); systemic symptoms",
        "tests": "ESR/CRP, ANA, ANCA, nerve biopsy"
      },
      {
        "diagnosis": "Amyloid neuropathy",
        "features": "Autonomic involvement; carpal tunnel; cardiac involvement",
        "tests": "Fat pad/nerve biopsy; genetic testing (TTR); serum free light chains"
      },
      {
        "diagnosis": "Lymphoma/paraneoplastic",
        "features": "Weight loss, lymphadenopathy; subacute course",
        "tests": "CT/PET; paraneoplastic panel"
      },
      {
        "diagnosis": "Sarcoid neuropathy",
        "features": "Multisystem involvement; skin, lungs, lymph nodes",
        "tests": "ACE level; chest imaging; biopsy"
      },
      {
        "diagnosis": "Paraproteinemic neuropathy (other)",
        "features": "IgG or IgA monoclonal; may mimic CIDP",
        "tests": "SPEP/UPEP; bone marrow biopsy"
      },
      {
        "diagnosis": "Drug-induced neuropathy",
        "features": "Temporal relationship to drug; axonal pattern",
        "tests": "Medication review; NCS"
      },
      {
        "diagnosis": "HIV-associated neuropathy",
        "features": "HIV risk factors; may have CSF pleocytosis",
        "tests": "HIV testing; CD4 count"
      },
      {
        "diagnosis": "Lyme neuroborreliosis",
        "features": "Endemic area; facial palsy; radicular pain; CSF pleocytosis",
        "tests": "Lyme serology; CSF Lyme antibodies"
      }
    ],
    "evidence": [
      {
        "recommendation": "IVIg effective for CIDP",
        "evidenceLevel": "Class I, Level A",
        "source": "[Hughes et al. Lancet Neurol 2008 (ICE Trial)](https://pubmed.ncbi.nlm.nih.gov/18178525/)"
      },
      {
        "recommendation": "IVIg dosing 2 g/kg loading, 1 g/kg maintenance",
        "evidenceLevel": "Class I, Level A",
        "source": "[Hughes et al. Lancet Neurol 2008 (ICE Trial)](https://pubmed.ncbi.nlm.nih.gov/18178525/)"
      },
      {
        "recommendation": "Corticosteroids effective for CIDP",
        "evidenceLevel": "Class I, Level A",
        "source": "[Hughes et al. Cochrane 2017](https://pubmed.ncbi.nlm.nih.gov/29185258/)"
      },
      {
        "recommendation": "Plasma exchange effective for CIDP",
        "evidenceLevel": "Class I, Level A",
        "source": "[Mehndiratta et al. Cochrane 2015](https://pubmed.ncbi.nlm.nih.gov/26378276/)"
      },
      {
        "recommendation": "SCIg non-inferior to IVIg for maintenance",
        "evidenceLevel": "Class I, Level A",
        "source": "[van Schaik et al. Lancet Neurol 2018 (PATH Trial)](https://pubmed.ncbi.nlm.nih.gov/29288189/)"
      },
      {
        "recommendation": "EFNS/PNS diagnostic criteria for CIDP",
        "evidenceLevel": "Expert Consensus",
        "source": "[Van den Bergh et al. J Peripher Nerv Syst 2021](https://pubmed.ncbi.nlm.nih.gov/34085743/)"
      },
      {
        "recommendation": "Rituximab for anti-MAG neuropathy",
        "evidenceLevel": "Class II, Level B",
        "source": "[Dalakas et al. Ann Neurol 2009](https://pubmed.ncbi.nlm.nih.gov/19937997/)"
      },
      {
        "recommendation": "Rituximab for refractory CIDP",
        "evidenceLevel": "Class III, Level C",
        "source": "[Benedetti et al. Neurology 2011](https://pubmed.ncbi.nlm.nih.gov/21411742/)"
      },
      {
        "recommendation": "Nodal/paranodal antibodies predict IVIg response",
        "evidenceLevel": "Class II, Level B",
        "source": "[Querol et al. Neurology 2017](https://pubmed.ncbi.nlm.nih.gov/28566549/)"
      },
      {
        "recommendation": "Azathioprine as steroid-sparing agent",
        "evidenceLevel": "Class III, Level C",
        "source": "[Hughes et al. Cochrane 2017](https://pubmed.ncbi.nlm.nih.gov/29185258/)"
      },
      {
        "recommendation": "Mycophenolate for CIDP",
        "evidenceLevel": "Class III, Level C",
        "source": "[Gorson et al. Neurology 2004](https://pubmed.ncbi.nlm.nih.gov/15477545/)"
      },
      {
        "recommendation": "MRI nerve root enhancement supportive criterion",
        "evidenceLevel": "Class II, Level B",
        "source": "[Van den Bergh et al. J Peripher Nerv Syst 2021](https://pubmed.ncbi.nlm.nih.gov/34085743/)"
      },
      {
        "recommendation": "INCAT scale for disability measurement",
        "evidenceLevel": "Expert Consensus",
        "source": "[Merkies et al. Neurology 2002](https://pubmed.ncbi.nlm.nih.gov/11781402/)"
      },
      {
        "recommendation": "Treatment-related fluctuations in CIDP",
        "evidenceLevel": "Class II, Level B",
        "source": "[Kuitwaard et al. J Peripher Nerv Syst 2009](https://pubmed.ncbi.nlm.nih.gov/20021564/)"
      }
    ],
    "monitoring": [
      {
        "item": "Clinical strength exam (MRC grading)",
        "frequency": "Each visit; q3-6mo stable",
        "action": "Adjust therapy if declining",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT"
      },
      {
        "item": "INCAT disability score",
        "frequency": "Baseline and q6-12mo",
        "action": "Consider therapy change if worsening",
        "ED": "—",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "—"
      },
      {
        "item": "ONLS (Overall Neuropathy Limitations Scale)",
        "frequency": "Baseline and q6-12mo",
        "action": "Consider therapy change if worsening",
        "ED": "—",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "—"
      },
      {
        "item": "Grip strength (dynamometer)",
        "frequency": "Each visit",
        "action": "Document trend; correlate with symptoms",
        "ED": "—",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "—"
      },
      {
        "item": "Timed 10-meter walk",
        "frequency": "Baseline and q6-12mo",
        "action": "Consider PT intensification if slowing",
        "ED": "—",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "—"
      },
      {
        "item": "Nerve conduction studies",
        "frequency": "Baseline, 6mo after treatment, then annually if stable",
        "action": "Guides treatment effectiveness",
        "ED": "—",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "—"
      },
      {
        "item": "Renal function (BUN/Cr)",
        "frequency": "Before each IVIg; q3-6mo on IVIg",
        "action": "Hold IVIg if rising; hydrate; may need dose adjustment",
        "ED": "—",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT"
      },
      {
        "item": "CBC",
        "frequency": "q3mo on immunosuppressants",
        "action": "Hold azathioprine/MMF if cytopenic",
        "ED": "—",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "—"
      },
      {
        "item": "LFTs",
        "frequency": "q3mo on immunosuppressants",
        "action": "Hold azathioprine/MMF if significantly elevated",
        "ED": "—",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "—"
      },
      {
        "item": "Blood glucose",
        "frequency": "Each visit on steroids; HbA1c q3mo",
        "action": "Intensify diabetes management",
        "ED": "—",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "—"
      },
      {
        "item": "Blood pressure",
        "frequency": "Each visit on steroids",
        "action": "Initiate antihypertensive if elevated",
        "ED": "—",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "—"
      },
      {
        "item": "DEXA bone density",
        "frequency": "Baseline if steroids >3mo; repeat q1-2yr",
        "action": "Bisphosphonate if osteopenia/osteoporosis",
        "ED": "—",
        "HOSP": "—",
        "OPD": "ROUTINE",
        "ICU": "—"
      },
      {
        "item": "IgG trough level",
        "frequency": "q6mo on IVIg/SCIg (optional)",
        "action": "Adjust dose if low and clinically worsening",
        "ED": "—",
        "HOSP": "—",
        "OPD": "ROUTINE",
        "ICU": "—"
      },
      {
        "item": "Anti-MAG titer",
        "frequency": "q6-12mo if positive",
        "action": "Guides treatment response for anti-MAG",
        "ED": "—",
        "HOSP": "—",
        "OPD": "EXT",
        "ICU": "—"
      },
      {
        "item": "CD19/CD20 B-cell count",
        "frequency": "After rituximab q3-6mo",
        "action": "Guides retreatment timing",
        "ED": "—",
        "HOSP": "—",
        "OPD": "EXT",
        "ICU": "—"
      }
    ],
    "disposition": [
      {
        "disposition": "**Discharge home**",
        "criteria": "Stable neurological exam; able to ambulate (with assistance if needed); oral medications tolerated; outpatient infusion arranged if needed; follow-up scheduled; adequate social support"
      },
      {
        "disposition": "**Admit to hospital**",
        "criteria": "Significant new weakness affecting ambulation; need for IV therapy initiation and monitoring; respiratory symptoms (rare but assess); unable to care for self at home"
      },
      {
        "disposition": "**ICU admission**",
        "criteria": "Respiratory compromise (FVC <30 mL/kg); rapidly progressive weakness raising concern for GBS overlap; severe autonomic dysfunction; hemodynamic instability"
      },
      {
        "disposition": "**Outpatient infusion center**",
        "criteria": "Stable CIDP on maintenance IVIg; appropriate for regular outpatient infusions every 3-4 weeks"
      },
      {
        "disposition": "**Home infusion (SCIg)**",
        "criteria": "Stable on IVIg who prefers home therapy; trained in self-injection; appropriate venous access not required"
      },
      {
        "disposition": "**Rehabilitation facility**",
        "criteria": "Significant residual weakness requiring intensive PT/OT; medically stable; goals for functional improvement"
      }
    ]
  },
  "Medication Overuse Headache": {
    "id": "medication-overuse-headache",
    "title": "Medication Overuse Headache",
    "version": "1.0",
    "icd10": [
      "** G44.41 (Drug-induced headache",
      "not elsewhere classified)"
    ],
    "scope": "** Diagnosis, withdrawal management, bridge therapy, and preventive therapy for medication overuse headache. Covers simple analgesic, triptan, combination analgesic, opioid, and barbiturate overuse. Excludes acute migraine management (see Migraine plan) and primary headache disorder initial workup.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC",
            "rationale": "Rule out anemia contributing to headache; baseline before treatment",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "BMP",
            "rationale": "Electrolyte abnormalities; renal function for medication selection",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "LFTs (AST, ALT, Alk Phos)",
            "rationale": "Required if acetaminophen or butalbital overuse suspected; baseline for preventives",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "TSH",
            "rationale": "Thyroid dysfunction can worsen headache frequency",
            "target": "Normal (0.4-4.0 mIU/L)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended Workup": [
          {
            "item": "ESR, CRP",
            "rationale": "Rule out giant cell arteritis if age >50 with new or changed headache",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin D level",
            "rationale": "Deficiency associated with increased headache frequency",
            "target": ">30 ng/mL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Magnesium (RBC preferred)",
            "rationale": "Deficiency linked to migraine; common in frequent headache",
            "target": ">4.2 mg/dL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Urine drug screen",
            "rationale": "If opioid overuse suspected; document substances for treatment planning",
            "target": "Identifies substances",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Acetaminophen level",
            "rationale": "If acute APAP toxicity suspected (>4g/day use or intentional overdose)",
            "target": "<10 mcg/mL",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Ammonia level",
            "rationale": "If on valproate and altered mental status",
            "target": "Normal (<35 umol/L)",
            "ED": "STAT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "INR, PT",
            "rationale": "If concern for coagulopathy from chronic NSAID use",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Ferritin",
            "rationale": "Iron deficiency associated with increased headache",
            "target": ">50 ng/mL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "HbA1c",
            "rationale": "Diabetes screening in patients with chronic pain",
            "target": "<5.7% (normal)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "MRI Brain without contrast",
            "timing": "New headache pattern, atypical features, or first MOH evaluation",
            "target": "Normal; rule out secondary causes",
            "contraindications": "MRI-incompatible devices",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended": [
          {
            "item": "MRI Brain with contrast",
            "timing": "Focal neurological deficits, papilledema, or suspected mass",
            "target": "No enhancing lesions",
            "contraindications": "Gadolinium allergy; severe renal impairment",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "MRA Head",
            "timing": "Thunderclap headache component or suspected vascular etiology",
            "target": "Patent vessels; no aneurysm",
            "contraindications": "MRI contraindications",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "MRV Brain",
            "timing": "Suspected cerebral venous thrombosis (papilledema, positional)",
            "target": "Patent venous sinuses",
            "contraindications": "MRI contraindications",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "CT Head non-contrast",
            "timing": "Acute severe headache if MRI unavailable; rule out hemorrhage",
            "target": "No hemorrhage",
            "contraindications": "Pregnancy (relative)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Cervical spine MRI",
            "timing": "Cervicogenic component suspected",
            "target": "No cord compression or radiculopathy",
            "contraindications": "MRI contraindications",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent (Bridge Therapy During Withdrawal)": [
          {
            "item": "Prednisone",
            "route": "PO",
            "indication": "Bridge therapy during withdrawal; reduces rebound severity",
            "dosing": {
              "doseOptions": [
                {
                  "text": "60 mg daily x 5 days",
                  "orderSentence": "Prednisone 60 mg daily x 5 days PO"
                },
                {
                  "text": "60 mg daily x 3d then taper",
                  "orderSentence": "Prednisone 60 mg daily x 3d then taper PO"
                }
              ],
              "route": "PO",
              "instructions": "60 mg daily x 5 days OR 60 mg x 3d, 40 mg x 3d, 20 mg x 3d",
              "orderSentence": "Prednisone 60 mg daily x 5 days PO"
            },
            "contraindications": "Active infection; uncontrolled diabetes; GI ulcer; psychosis",
            "monitoring": "Glucose if diabetic; mood changes; insomnia",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Methylprednisolone",
            "route": "IV",
            "indication": "Severe rebound headache requiring IV therapy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mg IV daily x 3-5 days",
                  "orderSentence": "Methylprednisolone 500 mg IV daily x 3-5 days IV"
                }
              ],
              "route": "IV",
              "instructions": "500 mg IV daily for 3-5 days; infuse over 1 hour",
              "orderSentence": "Methylprednisolone 500 mg IV daily x 3-5 days IV"
            },
            "contraindications": "Active infection; uncontrolled diabetes",
            "monitoring": "Glucose; BP; mood changes",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Naproxen",
            "route": "PO",
            "indication": "Bridge therapy; standing dose to prevent rebound",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mg BID x 2-4 weeks",
                  "orderSentence": "Naproxen 500 mg BID x 2-4 weeks PO"
                }
              ],
              "route": "PO",
              "instructions": "500 mg PO BID for 2-4 weeks during withdrawal; not PRN use",
              "orderSentence": "Naproxen 500 mg BID x 2-4 weeks PO"
            },
            "contraindications": "Renal impairment; GI bleed; aspirin allergy; third trimester",
            "monitoring": "GI symptoms; renal function if prolonged",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Dihydroergotamine (DHE)",
            "route": "IV",
            "indication": "Inpatient DHE protocol for severe MOH; status migrainosus",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5 mg IV q8h",
                  "orderSentence": "Dihydroergotamine (DHE) 0.5 mg IV q8h IV"
                },
                {
                  "text": "1 mg IV q8h",
                  "orderSentence": "Dihydroergotamine (DHE) 1 mg IV q8h IV"
                }
              ],
              "route": "IV",
              "instructions": "0.5-1 mg IV q8h for 3-5 days; pretreat with antiemetic; requires cardiac monitoring",
              "orderSentence": "Dihydroergotamine (DHE) 0.5 mg IV q8h IV"
            },
            "contraindications": "Pregnancy; CAD; uncontrolled HTN; peripheral vascular disease; severe hepatic/renal impairment; basilar/hemiplegic migraine",
            "monitoring": "BP; nausea; continuous cardiac monitoring; leg cramping",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Greater occipital nerve block",
            "route": "SC",
            "indication": "Bridge therapy; occipital-predominant pain; opioid overuse",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2-3 mL 2% lidocaine + 40 mg triamcinolone",
                  "orderSentence": "Greater occipital nerve block 2-3 mL 2% lidocaine + 40 mg triamcinolone SC"
                }
              ],
              "route": "SC",
              "instructions": "Inject at greater occipital nerve bilaterally; may repeat q4-6 weeks",
              "orderSentence": "Greater occipital nerve block 2-3 mL 2% lidocaine + 40 mg triamcinolone SC"
            },
            "contraindications": "Local anesthetic allergy; infection at site",
            "monitoring": "Immediate pain relief; vasovagal reaction",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ketorolac",
            "route": "IV/IM",
            "indication": "Acute severe headache during withdrawal",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mg IV",
                  "orderSentence": "Ketorolac 30 mg IV IV"
                },
                {
                  "text": "15 mg IV",
                  "orderSentence": "Ketorolac 15 mg IV IV"
                }
              ],
              "route": "IV",
              "instructions": "30 mg IV x1 (15 mg if age >65, renal impairment, or <50 kg); max 5 days",
              "orderSentence": "Ketorolac 30 mg IV IV"
            },
            "contraindications": "Renal impairment; GI bleed; aspirin allergy; third trimester",
            "monitoring": "Renal function",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Metoclopramide",
            "route": "IV",
            "indication": "Nausea during withdrawal; anti-migraine properties",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg IV",
                  "orderSentence": "Metoclopramide 10 mg IV IV"
                },
                {
                  "text": "20 mg IV",
                  "orderSentence": "Metoclopramide 20 mg IV IV"
                }
              ],
              "route": "IV",
              "instructions": "10-20 mg IV over 15 min; pretreat with diphenhydramine 25 mg to prevent akathisia",
              "orderSentence": "Metoclopramide 10 mg IV IV"
            },
            "contraindications": "Parkinson's disease; tardive dyskinesia; bowel obstruction",
            "monitoring": "Akathisia; dystonia",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Prochlorperazine",
            "route": "IV",
            "indication": "Nausea and headache during severe withdrawal",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg IV",
                  "orderSentence": "Prochlorperazine 10 mg IV IV"
                }
              ],
              "route": "IV",
              "instructions": "10 mg IV over 2 min; pretreat with diphenhydramine 25 mg",
              "orderSentence": "Prochlorperazine 10 mg IV IV"
            },
            "contraindications": "QT prolongation; Parkinson's; neuroleptic hypersensitivity",
            "monitoring": "Akathisia; dystonia; QTc",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Ondansetron",
            "route": "IV/PO",
            "indication": "Nausea associated with withdrawal or bridge therapy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4 mg IV",
                  "orderSentence": "Ondansetron 4 mg IV IV/PO"
                },
                {
                  "text": "8 mg PO",
                  "orderSentence": "Ondansetron 8 mg PO IV/PO"
                },
                {
                  "text": "4 mg ODT",
                  "orderSentence": "Ondansetron 4 mg ODT IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "4 mg IV or 8 mg PO/ODT; may repeat q8h",
              "orderSentence": "Ondansetron 4 mg IV IV/PO"
            },
            "contraindications": "QT prolongation; severe hepatic impairment",
            "monitoring": "QTc if multiple doses",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Symptomatic Treatments (Withdrawal Support)": [
          {
            "item": "Clonidine",
            "route": "PO",
            "indication": "Opioid withdrawal symptoms (anxiety, sweating, tachycardia)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.1 mg BID",
                  "orderSentence": "Clonidine 0.1 mg BID PO"
                },
                {
                  "text": "0.1 mg TID",
                  "orderSentence": "Clonidine 0.1 mg TID PO"
                },
                {
                  "text": "0.2 mg TID",
                  "orderSentence": "Clonidine 0.2 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.1 mg BID-TID; titrate to effect; max 0.6 mg/day; taper over 1-2 weeks",
              "orderSentence": "Clonidine 0.1 mg BID PO"
            },
            "contraindications": "Hypotension; bradycardia; heart block",
            "monitoring": "BP, HR; rebound HTN if stopped abruptly",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Hydroxyzine",
            "route": "PO",
            "indication": "Anxiety and insomnia during withdrawal",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg TID",
                  "orderSentence": "Hydroxyzine 25 mg TID PO"
                },
                {
                  "text": "50 mg qHS",
                  "orderSentence": "Hydroxyzine 50 mg qHS PO"
                },
                {
                  "text": "25 mg q6h PRN",
                  "orderSentence": "Hydroxyzine 25 mg q6h PRN PO"
                }
              ],
              "route": "PO",
              "instructions": "25 mg TID or 50 mg qHS; may use 25 mg q6h PRN for anxiety",
              "orderSentence": "Hydroxyzine 25 mg TID PO"
            },
            "contraindications": "Glaucoma; urinary retention; QT prolongation",
            "monitoring": "Sedation; QTc",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Trazodone",
            "route": "PO",
            "indication": "Insomnia during withdrawal period",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg qHS",
                  "orderSentence": "Trazodone 50 mg qHS PO"
                },
                {
                  "text": "100 mg qHS",
                  "orderSentence": "Trazodone 100 mg qHS PO"
                },
                {
                  "text": "150 mg qHS",
                  "orderSentence": "Trazodone 150 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 50 mg qHS; may increase to 100-150 mg qHS",
              "orderSentence": "Trazodone 50 mg qHS PO"
            },
            "contraindications": "MAOIs; QT prolongation",
            "monitoring": "Sedation; orthostatic hypotension; priapism (rare)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Loperamide",
            "route": "PO",
            "indication": "Diarrhea during opioid withdrawal",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4 mg initial, then 2 mg PRN",
                  "orderSentence": "Loperamide 4 mg initial, then 2 mg PRN PO"
                }
              ],
              "route": "PO",
              "instructions": "4 mg initial, then 2 mg after each loose stool; max 16 mg/day",
              "orderSentence": "Loperamide 4 mg initial, then 2 mg PRN PO"
            },
            "contraindications": "Toxic megacolon; C. diff colitis",
            "monitoring": "Avoid excessive use",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Dicyclomine",
            "route": "PO",
            "indication": "Abdominal cramping during opioid withdrawal",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg QID",
                  "orderSentence": "Dicyclomine 20 mg QID PO"
                },
                {
                  "text": "10 mg QID",
                  "orderSentence": "Dicyclomine 10 mg QID PO"
                }
              ],
              "route": "PO",
              "instructions": "10-20 mg QID PRN cramping; max 80 mg/day",
              "orderSentence": "Dicyclomine 20 mg QID PO"
            },
            "contraindications": "Glaucoma; GI obstruction; myasthenia gravis",
            "monitoring": "Anticholinergic effects",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Second-line/Refractory (Opioid/Barbiturate Taper Protocols)": [
          {
            "item": "Butalbital taper",
            "route": "PO",
            "indication": "Barbiturate-containing medication overuse; requires slow taper",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Reduce by 1 tablet every 3-5 days",
                  "orderSentence": "Butalbital taper Reduce by 1 tablet every 3-5 days PO"
                }
              ],
              "route": "PO",
              "instructions": "Reduce by 1 dose (1 tablet) every 3-5 days; typical taper 2-4 weeks; abrupt stop risks seizure",
              "orderSentence": "Butalbital taper Reduce by 1 tablet every 3-5 days PO"
            },
            "contraindications": "None (taper required)",
            "monitoring": "Seizure risk; anxiety; tremor; abrupt withdrawal can be fatal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Phenobarbital taper",
            "route": "PO",
            "indication": "Severe barbiturate dependence; substitution taper",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mg q6h",
                  "orderSentence": "Phenobarbital taper 30 mg q6h PO"
                },
                {
                  "text": "15 mg q6h",
                  "orderSentence": "Phenobarbital taper 15 mg q6h PO"
                },
                {
                  "text": "taper by 15-30 mg q3-5d",
                  "orderSentence": "Phenobarbital taper taper by 15-30 mg q3-5d PO"
                }
              ],
              "route": "PO",
              "instructions": "Convert butalbital to phenobarbital (30 mg phenobarbital per butalbital dose); taper by 15-30 mg every 3-5 days",
              "orderSentence": "Phenobarbital taper 30 mg q6h PO"
            },
            "contraindications": "Porphyria; severe hepatic impairment",
            "monitoring": "Sedation; ataxia; respiratory depression",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Buprenorphine/naloxone",
            "route": "SL",
            "indication": "Opioid overuse with dependence; OUD treatment",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 mg/0.5 mg SL",
                  "orderSentence": "Buprenorphine/naloxone 2 mg/0.5 mg SL SL"
                },
                {
                  "text": "4 mg/1 mg SL",
                  "orderSentence": "Buprenorphine/naloxone 4 mg/1 mg SL SL"
                },
                {
                  "text": "8 mg/2 mg SL",
                  "orderSentence": "Buprenorphine/naloxone 8 mg/2 mg SL SL"
                }
              ],
              "route": "SL",
              "instructions": "Start 2-4 mg SL when in mild withdrawal (COWS >8); titrate to 8-16 mg daily; requires X-waiver or OTP",
              "orderSentence": "Buprenorphine/naloxone 2 mg/0.5 mg SL SL"
            },
            "contraindications": "Severe hepatic impairment; respiratory depression",
            "monitoring": "COWS score; precipitated withdrawal; sedation",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Opioid taper (long-acting)",
            "route": "PO",
            "indication": "Opioid overuse without OUD; slow outpatient taper",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Reduce 10-20% every 1-4 weeks",
                  "orderSentence": "Opioid taper (long-acting) Reduce 10-20% every 1-4 weeks PO"
                }
              ],
              "route": "PO",
              "instructions": "Convert to long-acting opioid; reduce by 10-20% every 1-4 weeks; slower if prolonged use",
              "orderSentence": "Opioid taper (long-acting) Reduce 10-20% every 1-4 weeks PO"
            },
            "contraindications": "None (taper required)",
            "monitoring": "Withdrawal symptoms; pain control; functional status",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Disease-Modifying or Chronic Therapies (Preventive Medications)": [
          {
            "item": "Topiramate",
            "route": "PO",
            "indication": "First-line prevention; especially if overweight",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Topiramate 25 mg qHS PO"
                },
                {
                  "text": "50 mg BID",
                  "orderSentence": "Topiramate 50 mg BID PO"
                },
                {
                  "text": "75 mg BID",
                  "orderSentence": "Topiramate 75 mg BID PO"
                },
                {
                  "text": "100 mg BID",
                  "orderSentence": "Topiramate 100 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg qHS; increase by 25 mg/wk; target 50-100 mg BID",
              "orderSentence": "Topiramate 25 mg qHS PO"
            },
            "pretreatment": "None",
            "contraindications": "Glaucoma; kidney stones; pregnancy (teratogen)",
            "monitoring": "Cognitive effects; paresthesias; weight; bicarbonate; kidney stones",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Amitriptyline",
            "route": "PO",
            "indication": "First-line prevention; comorbid insomnia, depression, TTH component",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg qHS",
                  "orderSentence": "Amitriptyline 10 mg qHS PO"
                },
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Amitriptyline 25 mg qHS PO"
                },
                {
                  "text": "50 mg qHS",
                  "orderSentence": "Amitriptyline 50 mg qHS PO"
                },
                {
                  "text": "75 mg qHS",
                  "orderSentence": "Amitriptyline 75 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10 mg qHS; titrate by 10-25 mg q1-2wk; target 25-75 mg qHS",
              "orderSentence": "Amitriptyline 10 mg qHS PO"
            },
            "pretreatment": "ECG if age >50 or cardiac history",
            "contraindications": "Cardiac conduction abnormality; recent MI; glaucoma; urinary retention",
            "monitoring": "Sedation; weight gain; dry mouth; ECG if dose >100 mg",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Nortriptyline",
            "route": "PO",
            "indication": "Prevention; less sedating than amitriptyline",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg qHS",
                  "orderSentence": "Nortriptyline 10 mg qHS PO"
                },
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Nortriptyline 25 mg qHS PO"
                },
                {
                  "text": "50 mg qHS",
                  "orderSentence": "Nortriptyline 50 mg qHS PO"
                },
                {
                  "text": "75 mg qHS",
                  "orderSentence": "Nortriptyline 75 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10 mg qHS; titrate by 10-25 mg q1-2wk; target 25-75 mg qHS",
              "orderSentence": "Nortriptyline 10 mg qHS PO"
            },
            "pretreatment": "ECG if age >50 or cardiac history",
            "contraindications": "Cardiac conduction abnormality; recent MI; urinary retention; glaucoma",
            "monitoring": "Less sedation than amitriptyline; ECG if dose >100 mg",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Venlafaxine XR",
            "route": "PO",
            "indication": "Prevention; comorbid depression, anxiety",
            "dosing": {
              "doseOptions": [
                {
                  "text": "37.5 mg daily",
                  "orderSentence": "Venlafaxine XR 37.5 mg daily PO"
                },
                {
                  "text": "75 mg daily",
                  "orderSentence": "Venlafaxine XR 75 mg daily PO"
                },
                {
                  "text": "150 mg daily",
                  "orderSentence": "Venlafaxine XR 150 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 37.5 mg daily; increase by 37.5-75 mg q1wk; target 75-150 mg daily",
              "orderSentence": "Venlafaxine XR 37.5 mg daily PO"
            },
            "pretreatment": "None",
            "contraindications": "Uncontrolled HTN; MAOIs; abrupt discontinuation",
            "monitoring": "BP at higher doses; serotonin syndrome signs",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Propranolol",
            "route": "PO",
            "indication": "Prevention; comorbid HTN or anxiety",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg BID",
                  "orderSentence": "Propranolol 40 mg BID PO"
                },
                {
                  "text": "80 mg BID",
                  "orderSentence": "Propranolol 80 mg BID PO"
                },
                {
                  "text": "80 mg daily LA",
                  "orderSentence": "Propranolol 80 mg daily LA PO"
                },
                {
                  "text": "160 mg daily LA",
                  "orderSentence": "Propranolol 160 mg daily LA PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 40 mg BID or 80 mg LA daily; titrate q2wk; target 80-240 mg/day",
              "orderSentence": "Propranolol 40 mg BID PO"
            },
            "pretreatment": "None",
            "contraindications": "Asthma; COPD; bradycardia <50; heart block; decompensated HF",
            "monitoring": "HR, BP; fatigue; depression",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Onabotulinumtoxin A (Botox)",
            "route": "IM",
            "indication": "Chronic migraine with MOH; failed 2+ oral preventives",
            "dosing": {
              "doseOptions": [
                {
                  "text": "155-195 units IM",
                  "orderSentence": "Onabotulinumtoxin A (Botox) 155-195 units IM IM"
                }
              ],
              "route": "IM",
              "instructions": "155-195 units across 31-39 injection sites q12wk; PREEMPT protocol",
              "orderSentence": "Onabotulinumtoxin A (Botox) 155-195 units IM IM"
            },
            "pretreatment": "None",
            "contraindications": "Infection at injection sites; myasthenia gravis",
            "monitoring": "Neck weakness; ptosis (rare); effect takes 2-3 cycles",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Erenumab (Aimovig)",
            "route": "SC",
            "indication": "CGRP mAb; especially for MOH; no washout period needed",
            "dosing": {
              "doseOptions": [
                {
                  "text": "70 mg SC monthly",
                  "orderSentence": "Erenumab (Aimovig) 70 mg SC monthly SC"
                },
                {
                  "text": "140 mg SC monthly",
                  "orderSentence": "Erenumab (Aimovig) 140 mg SC monthly SC"
                }
              ],
              "route": "SC",
              "instructions": "70 mg SC monthly; may increase to 140 mg monthly after 3 months",
              "orderSentence": "Erenumab (Aimovig) 70 mg SC monthly SC"
            },
            "pretreatment": "None",
            "contraindications": "Hypersensitivity to erenumab",
            "monitoring": "Constipation (can be severe); injection site reactions; HTN",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Fremanezumab (Ajovy)",
            "route": "SC",
            "indication": "CGRP mAb; alternative dosing options",
            "dosing": {
              "doseOptions": [
                {
                  "text": "225 mg SC monthly",
                  "orderSentence": "Fremanezumab (Ajovy) 225 mg SC monthly SC"
                },
                {
                  "text": "675 mg SC quarterly",
                  "orderSentence": "Fremanezumab (Ajovy) 675 mg SC quarterly SC"
                }
              ],
              "route": "SC",
              "instructions": "225 mg SC monthly OR 675 mg SC quarterly",
              "orderSentence": "Fremanezumab (Ajovy) 225 mg SC monthly SC"
            },
            "pretreatment": "None",
            "contraindications": "Hypersensitivity",
            "monitoring": "Injection site reactions",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Galcanezumab (Emgality)",
            "route": "SC",
            "indication": "CGRP mAb; proven efficacy in MOH",
            "dosing": {
              "doseOptions": [
                {
                  "text": "240 mg SC load",
                  "orderSentence": "Galcanezumab (Emgality) 240 mg SC load SC"
                },
                {
                  "text": "120 mg SC monthly",
                  "orderSentence": "Galcanezumab (Emgality) 120 mg SC monthly SC"
                }
              ],
              "route": "SC",
              "instructions": "240 mg SC loading dose (2 x 120 mg), then 120 mg SC monthly",
              "orderSentence": "Galcanezumab (Emgality) 240 mg SC load SC"
            },
            "pretreatment": "None",
            "contraindications": "Hypersensitivity",
            "monitoring": "Injection site reactions",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Valproate/Divalproex",
            "route": "PO",
            "indication": "Prevention; comorbid bipolar or epilepsy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "250 mg BID",
                  "orderSentence": "Valproate/Divalproex 250 mg BID PO"
                },
                {
                  "text": "500 mg BID",
                  "orderSentence": "Valproate/Divalproex 500 mg BID PO"
                },
                {
                  "text": "500 mg ER daily",
                  "orderSentence": "Valproate/Divalproex 500 mg ER daily PO"
                },
                {
                  "text": "1000 mg ER daily",
                  "orderSentence": "Valproate/Divalproex 1000 mg ER daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 250 mg BID or 500 mg ER daily; titrate to 500-1000 mg/day",
              "orderSentence": "Valproate/Divalproex 250 mg BID PO"
            },
            "pretreatment": "LFTs, CBC",
            "contraindications": "Hepatic disease; pregnancy (teratogen); urea cycle disorders; pancreatitis",
            "monitoring": "LFTs q6mo; weight; hair loss; tremor",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Candesartan",
            "route": "PO",
            "indication": "Prevention; comorbid HTN; beta-blocker intolerant",
            "dosing": {
              "doseOptions": [
                {
                  "text": "8 mg daily",
                  "orderSentence": "Candesartan 8 mg daily PO"
                },
                {
                  "text": "16 mg daily",
                  "orderSentence": "Candesartan 16 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 8 mg daily; may increase to 16 mg daily",
              "orderSentence": "Candesartan 8 mg daily PO"
            },
            "pretreatment": "None",
            "contraindications": "Pregnancy; bilateral renal artery stenosis; hyperkalemia",
            "monitoring": "BP; K+; creatinine",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Headache specialist/Neurology referral for refractory MOH management and preventive optimization",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pain psychology/Behavioral medicine referral for cognitive behavioral therapy addressing medication-seeking behaviors and pain catastrophizing",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Addiction medicine consultation for opioid-overuse MOH with features of opioid use disorder",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Primary care physician coordination for chronic disease management and medication reconciliation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Psychiatry referral for comorbid depression, anxiety, or substance use disorder requiring pharmacotherapy",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Physical therapy for cervicogenic headache component and postural evaluation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Social work consultation for disability resources, work accommodations, or financial assistance for medications",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Expect temporary worsening of headaches during the first 1-2 weeks of withdrawal (rebound headache period); this is normal and necessary for improvement",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Most patients experience significant improvement within 2-3 months after successful withdrawal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Return immediately for severe headache with fever, stiff neck, or altered mental status which may indicate infection requiring emergency evaluation",
            "ED": "STAT",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Return immediately for sudden severe headache different from usual (\"worst headache of life\") which may indicate hemorrhage",
            "ED": "STAT",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Return if experiencing severe withdrawal symptoms including seizure, tremor, or hallucinations (especially with barbiturate or opioid overuse)",
            "ED": "STAT",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Limit acute headache medication use to maximum 2 days per week to prevent recurrent MOH",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Maintain detailed headache diary tracking headache days, medication use days, and triggers",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Do not abruptly stop butalbital-containing medications (Fioricet, Fiorinal) as this may cause seizures; must taper under physician guidance",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Preventive medications may take 4-8 weeks to show full benefit; continue as prescribed even if headaches persist initially",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Regular sleep schedule (7-8 hours, consistent bedtime/wake time) as irregular sleep triggers headache",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Regular meals to avoid fasting-triggered headache; do not skip meals",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Aerobic exercise (30 min moderate activity 5x/week) shown to reduce headache frequency and improve mood",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Stress management through relaxation techniques, mindfulness, or biofeedback to reduce headache triggers",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Adequate hydration (at least 64 oz water daily) as dehydration can trigger headache",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Caffeine consistency: if using caffeine, maintain consistent daily intake; if tapering, reduce gradually over 2 weeks",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Alcohol avoidance during withdrawal period as it can worsen headaches and interact with medications",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid keeping overused medications at home during withdrawal to reduce temptation and relapse risk",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Chronic migraine without MOH",
        "features": "≥15 headache days/month but <10-15 medication days/month; no improvement with medication withdrawal",
        "tests": "Headache diary showing medication use <10-15 days/month"
      },
      {
        "diagnosis": "Chronic tension-type headache",
        "features": "Bilateral, pressing/tightening quality, mild-moderate intensity, no nausea, minimal photo/phonophobia",
        "tests": "Clinical criteria (ICHD-3); no medication overuse pattern"
      },
      {
        "diagnosis": "New daily persistent headache (NDPH)",
        "features": "Distinct onset remembered; daily headache from onset; often no prior headache history",
        "tests": "Clinical history; MRI to exclude secondary causes; no MOH pattern"
      },
      {
        "diagnosis": "Idiopathic intracranial hypertension",
        "features": "Positional headache worse with lying down; papilledema; pulsatile tinnitus; visual obscurations",
        "tests": "LP opening pressure >25 cm H2O; MRI/MRV showing empty sella, transverse sinus stenosis"
      },
      {
        "diagnosis": "Cervicogenic headache",
        "features": "Unilateral, occipital-frontal radiation, triggered by neck movement or posture",
        "tests": "C-spine imaging; diagnostic occipital nerve block"
      },
      {
        "diagnosis": "Secondary headache (structural)",
        "features": "Progressive headache, focal neurological deficits, papilledema, new onset >50 years",
        "tests": "MRI brain with contrast; consider LP"
      },
      {
        "diagnosis": "Chronic subdural hematoma",
        "features": "Elderly, anticoagulation, history of fall/trauma; progressive headache",
        "tests": "CT head; MRI brain"
      },
      {
        "diagnosis": "Cerebral venous thrombosis",
        "features": "Positional headache; papilledema; hypercoagulable state; pregnancy/postpartum",
        "tests": "MRV brain; D-dimer (if negative, unlikely)"
      },
      {
        "diagnosis": "Giant cell arteritis",
        "features": "Age >50; scalp tenderness; jaw claudication; visual changes; elevated inflammatory markers",
        "tests": "ESR, CRP elevated; temporal artery biopsy"
      }
    ],
    "evidence": [
      {
        "recommendation": "ICHD-3 diagnostic criteria for MOH",
        "evidenceLevel": "Consensus",
        "source": "[Headache Classification Committee. Cephalalgia 2018](https://pubmed.ncbi.nlm.nih.gov/29368949/)"
      },
      {
        "recommendation": "Withdrawal as primary treatment for MOH",
        "evidenceLevel": "Class I, Level A",
        "source": "[Diener et al. Lancet Neurol 2019](https://pubmed.ncbi.nlm.nih.gov/31174999/)"
      },
      {
        "recommendation": "Abrupt vs gradual withdrawal for simple analgesics/triptans",
        "evidenceLevel": "Class II, Level B",
        "source": "[Rossi et al. Cephalalgia 2006](https://pubmed.ncbi.nlm.nih.gov/16961795/)"
      },
      {
        "recommendation": "Bridge therapy with corticosteroids during withdrawal",
        "evidenceLevel": "Class II, Level B",
        "source": "[Krymchantowski et al. Headache 2000](https://pubmed.ncbi.nlm.nih.gov/10759919/)"
      },
      {
        "recommendation": "Preventive therapy initiation during withdrawal",
        "evidenceLevel": "Class II, Level B",
        "source": "[Hagen et al. Cephalalgia 2009](https://pubmed.ncbi.nlm.nih.gov/18823363/)"
      },
      {
        "recommendation": "Topiramate effective in MOH prevention",
        "evidenceLevel": "Class I, Level A",
        "source": "[Silberstein et al. Headache 2012](https://pubmed.ncbi.nlm.nih.gov/22994844/)"
      },
      {
        "recommendation": "OnabotulinumtoxinA for chronic migraine with MOH",
        "evidenceLevel": "Class I, Level A",
        "source": "[Silberstein et al. Headache 2015](https://pubmed.ncbi.nlm.nih.gov/26178694/)"
      },
      {
        "recommendation": "CGRP mAbs effective in MOH without prior withdrawal",
        "evidenceLevel": "Class I, Level A",
        "source": "[Tepper et al. Cephalalgia 2019 (erenumab in MOH)](https://pubmed.ncbi.nlm.nih.gov/31694388/)"
      },
      {
        "recommendation": "Greater occipital nerve block as bridge therapy",
        "evidenceLevel": "Class II, Level B",
        "source": "[Cuadrado et al. Headache 2017](https://pubmed.ncbi.nlm.nih.gov/28267181/)"
      },
      {
        "recommendation": "DHE protocol for status migrainosus and refractory MOH",
        "evidenceLevel": "Class II, Level C",
        "source": "[Raskin et al. Neurology 1986](https://pubmed.ncbi.nlm.nih.gov/3520368/)"
      },
      {
        "recommendation": "Behavioral therapy as adjunct in MOH treatment",
        "evidenceLevel": "Class II, Level B",
        "source": "[Katsarava et al. Neurology 2003](https://pubmed.ncbi.nlm.nih.gov/12682334/)"
      },
      {
        "recommendation": "Relapse rate up to 40% at 1 year without preventive",
        "evidenceLevel": "Class II, Level B",
        "source": "[Katsarava et al. Neurology 2005](https://pubmed.ncbi.nlm.nih.gov/15911756/)"
      },
      {
        "recommendation": "Opioid MOH has worst prognosis and highest relapse",
        "evidenceLevel": "Class II, Level B",
        "source": "[Bigal et al. Neurology 2008](https://pubmed.ncbi.nlm.nih.gov/18474848/)"
      }
    ],
    "monitoring": [
      {
        "item": "Headache diary (frequency, severity, medication use)",
        "frequency": "Daily during withdrawal, then weekly",
        "action": "Continue withdrawal protocol; optimize preventive therapy",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Acute medication use days",
        "frequency": "Weekly during withdrawal, then monthly",
        "action": "Reinforce limits; address triggers; consider inpatient withdrawal",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "COWS score (Clinical Opiate Withdrawal Scale)",
        "frequency": "q4-6h during opioid withdrawal",
        "action": "Provide symptomatic treatment; adjust taper if severe",
        "ED": "-",
        "HOSP": "URGENT",
        "OPD": "-",
        "ICU": "-"
      },
      {
        "item": "Vital signs (HR, BP)",
        "frequency": "Each visit during withdrawal",
        "action": "Treat withdrawal symptoms; hold clonidine if hypotensive",
        "ED": "STAT",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Mood assessment (PHQ-9, GAD-7)",
        "frequency": "Each visit",
        "action": "Psychiatry referral; adjust antidepressant",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "LFTs (if on valproate or prior APAP overuse)",
        "frequency": "Baseline, 3 months, then q6mo",
        "action": "Discontinue valproate if >3x ULN; evaluate hepatic injury",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Weight (if on topiramate, amitriptyline, valproate)",
        "frequency": "Each visit",
        "action": "Adjust medication; diet counseling",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Bicarbonate (if on topiramate)",
        "frequency": "Baseline, 3 months",
        "action": "Consider dose reduction or discontinuation",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "HIT-6 or MIDAS disability score",
        "frequency": "Every 3 months",
        "action": "Escalate preventive therapy; consider CGRP mAb or Botox",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      }
    ],
    "disposition": [
      {
        "disposition": "Discharge home",
        "criteria": "Mild-moderate MOH; able to comply with outpatient withdrawal; no opioid/barbiturate dependence requiring medical supervision; support system in place"
      },
      {
        "disposition": "Admit to floor",
        "criteria": "Severe rebound headache not controlled with outpatient therapy; opioid or barbiturate withdrawal requiring medical supervision; need for DHE protocol; intractable nausea/vomiting; severe comorbid psychiatric illness"
      },
      {
        "disposition": "Admit to ICU",
        "criteria": "Rare; barbiturate withdrawal with seizure risk or autonomic instability; severe opioid withdrawal with hemodynamic instability"
      },
      {
        "disposition": "Outpatient withdrawal",
        "criteria": "Most patients; simple analgesic or triptan overuse; reliable follow-up within 1-2 weeks"
      },
      {
        "disposition": "Outpatient follow-up timing",
        "criteria": "Initial: within 1-2 weeks of starting withdrawal; then every 2-4 weeks during transition; monthly once stable on preventive"
      }
    ]
  },
  "Multiple Sclerosis - Chronic Management": {
    "id": "ms-chronic-management",
    "title": "Multiple Sclerosis - Chronic Management",
    "version": "1.0",
    "icd10": [
      "** G35 (Multiple sclerosis)"
    ],
    "scope": "** Long-term management of established MS including disease-modifying therapy (DMT) monitoring, symptom management optimization, surveillance imaging, preventive care, and special populations (pregnancy planning). Excludes acute MS relapse (see \"MS - Exacerbation\") and initial diagnostic workup (see \"MS - New Diagnosis\"). Primary focus is outpatient management with guidance for ED/hospital presentation of established MS patients.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC with differential",
            "rationale": "Baseline monitoring; DMT safety; infection assessment",
            "target": "Normal; ALC varies by DMT (see 1B)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "CMP",
            "rationale": "Metabolic panel; renal/hepatic function for DMT dosing",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "LFTs (AST, ALT, ALP, bilirubin)",
            "rationale": "DMT hepatotoxicity monitoring (interferons, teriflunomide, S1P modulators)",
            "target": "AST/ALT <3x ULN",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Urinalysis with culture",
            "rationale": "UTI common MS comorbidity; can trigger pseudorelapse",
            "target": "Negative",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "TSH",
            "rationale": "Thyroid dysfunction (interferons, alemtuzumab)",
            "target": "Normal (0.4-4.0 mIU/L)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin D, 25-hydroxy",
            "rationale": "Deficiency associated with disease activity",
            "target": ">40 ng/mL (target >50)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended Workup": [
          {
            "item": "**INTERFERONS (Avonex, Rebif, Betaseron, Plegridy)**"
          },
          {
            "item": "CBC with differential",
            "rationale": "Leukopenia, thrombocytopenia monitoring",
            "target": "WBC >3000, ANC >1500, Plt >100K",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "LFTs",
            "rationale": "Hepatotoxicity",
            "target": "AST/ALT <3x ULN",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "TSH",
            "rationale": "Thyroid dysfunction",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "**GLATIRAMER ACETATE (Copaxone, Glatopa)**"
          },
          {
            "item": "No routine labs required",
            "rationale": "Minimal systemic toxicity",
            "target": "N/A",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "**DIMETHYL/DIROXIMEL FUMARATE (Tecfidera, Vumerity)**"
          },
          {
            "item": "CBC with differential",
            "rationale": "Lymphopenia (PML risk if ALC <500 for >6 months)",
            "target": "ALC >500/uL; discontinue if ALC <500 x6mo",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "LFTs",
            "rationale": "Hepatotoxicity",
            "target": "AST/ALT <3x ULN",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "**TERIFLUNOMIDE (Aubagio)**"
          },
          {
            "item": "CBC with differential",
            "rationale": "Leukopenia",
            "target": "WBC >3000, ANC >1500",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "LFTs",
            "rationale": "Hepatotoxicity (black box warning)",
            "target": "ALT <3x ULN; discontinue if >3x with symptoms",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Blood pressure",
            "rationale": "Hypertension",
            "target": "<140/90 mmHg",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pregnancy test",
            "rationale": "Teratogenic (Category X)",
            "target": "Negative",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "**FINGOLIMOD (Gilenya)**"
          },
          {
            "item": "CBC with differential",
            "rationale": "Lymphopenia expected (therapeutic effect)",
            "target": "ALC 200-600/uL typical; concern if <200",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "LFTs",
            "rationale": "Hepatotoxicity",
            "target": "AST/ALT <3x ULN",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "VZV IgG",
            "rationale": "Pre-treatment; vaccinate if negative",
            "target": "Positive (immune)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "**SIPONIMOD (Mayzent)**"
          },
          {
            "item": "CBC with differential",
            "rationale": "Lymphopenia",
            "target": "ALC 200-600/uL typical",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "LFTs",
            "rationale": "Hepatotoxicity",
            "target": "AST/ALT <3x ULN",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CYP2C9 genotype",
            "rationale": "Required before initiation; determines dosing",
            "target": "*1/*3 or *2/*3: 1 mg dose; *3/*3: contraindicated",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "**OZANIMOD (Zeposia) / PONESIMOD (Ponvory)**"
          },
          {
            "item": "CBC with differential",
            "rationale": "Lymphopenia",
            "target": "ALC 200-600/uL typical",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "LFTs",
            "rationale": "Hepatotoxicity",
            "target": "AST/ALT <3x ULN",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "**NATALIZUMAB (Tysabri)**"
          },
          {
            "item": "JCV antibody with index",
            "rationale": "PML risk stratification",
            "target": "Negative preferred; if positive, index <0.9 lower risk",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "CBC with differential",
            "rationale": "Infusion reactions; general monitoring",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "LFTs",
            "rationale": "Hepatotoxicity",
            "target": "AST/ALT <3x ULN",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "**OCRELIZUMAB (Ocrevus) / OFATUMUMAB (Kesimpta) / UBLITUXIMAB (Briumvi)**"
          },
          {
            "item": "Hepatitis B surface antigen, core antibody",
            "rationale": "Reactivation risk",
            "target": "Negative; if positive, HBV DNA and GI/ID consult",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Quantitative immunoglobulins (IgG, IgA, IgM)",
            "rationale": "Hypogammaglobulinemia risk",
            "target": "IgG >400 mg/dL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CD19/CD20 B-cell count",
            "rationale": "Therapeutic monitoring",
            "target": "B-cell depletion expected",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "**ALEMTUZUMAB (Lemtrada)**"
          },
          {
            "item": "CBC with platelet count",
            "rationale": "ITP, neutropenia (monthly x 48 months after last dose)",
            "target": "Platelets >100K; report petechiae/bruising",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Serum creatinine, urinalysis",
            "rationale": "Anti-GBM nephropathy (monthly x 48 months)",
            "target": "Creatinine stable; UA negative for RBCs/protein",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "TSH",
            "rationale": "Autoimmune thyroid disease (quarterly x 48 months)",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "**CLADRIBINE (Mavenclad)**"
          },
          {
            "item": "CBC with differential",
            "rationale": "Lymphopenia (target); timing critical",
            "target": "ALC >800 before year 2; monitoring at months 2 and 6",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "LFTs",
            "rationale": "Hepatotoxicity",
            "target": "AST/ALT <3x ULN",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "JCV PCR (CSF)",
            "rationale": "Suspected PML (focal neuro symptoms on natalizumab/DMF/fingolimod)",
            "target": "Negative (if positive, confirms PML)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Serum natalizumab antibodies",
            "rationale": "Suspected infusion reactions or loss of efficacy",
            "target": "Negative",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Anti-drug antibodies (interferon)",
            "rationale": "Suspected neutralizing antibodies with breakthrough disease",
            "target": "Negative",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Serum neurofilament light chain (NfL)",
            "rationale": "Research/emerging; monitor subclinical disease activity",
            "target": "Low/stable (no established threshold)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Pregnancy test (urine or serum)",
            "rationale": "Before DMT initiation or if pregnancy suspected",
            "target": "Negative before teratogenic DMTs",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "MRI brain with and without contrast (MS protocol)",
            "timing": "Annual surveillance; 3-6 months after DMT change",
            "target": "No new/enlarging T2 lesions; no new enhancing lesions (NEDA-3)",
            "contraindications": "GFR <30; gadolinium allergy; pacemaker",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "MRI C-spine with and without contrast",
            "timing": "Annual or with new symptoms; baseline if not done",
            "target": "No new cord lesions",
            "contraindications": "GFR <30; gadolinium allergy; pacemaker",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "MRI T-spine with and without contrast",
            "timing": "Baseline; repeat if new lower extremity symptoms",
            "target": "No new cord lesions",
            "contraindications": "GFR <30; gadolinium allergy; pacemaker",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          }
        ],
        "Extended": [
          {
            "item": "MRI brain for PML surveillance (natalizumab, DMF, fingolimod)",
            "timing": "q3-6 months if high JCV risk; q12 months if low risk",
            "target": "No new periventricular or subcortical lesions without enhancement",
            "contraindications": "Standard MRI contraindications",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "OCT (optical coherence tomography)",
            "timing": "Annual; baseline; after optic neuritis",
            "target": "Stable RNFL thickness (>5 micron/year loss is pathological)",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Visual evoked potentials",
            "timing": "Baseline; suspected subclinical optic nerve involvement",
            "target": "Stable P100 latency",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "ECG",
            "timing": "S1P modulators (fingolimod, siponimod) first dose; baseline and annually",
            "target": "Normal sinus rhythm; PR <200 ms; QTc <500 ms",
            "contraindications": "None",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ophthalmology exam (macular OCT)",
            "timing": "S1P modulators at 3-4 months; then annually",
            "target": "No macular edema",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pulmonary function tests",
            "timing": "If respiratory symptoms; alemtuzumab monitoring",
            "target": "FVC >80% predicted",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "PET-CT",
            "timing": "Suspected malignancy (lymphoma risk with immunosuppression)",
            "target": "No FDG-avid lesions",
            "contraindications": "Pregnancy; uncontrolled diabetes",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Urodynamic studies",
            "timing": "Refractory bladder symptoms",
            "target": "Defines neurogenic bladder type (hyperreflexic vs hyporeflexic)",
            "contraindications": "Active UTI",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Video swallow study",
            "timing": "Dysphagia or recurrent aspiration",
            "target": "Safe swallow; define texture modifications",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sleep study (polysomnography)",
            "timing": "Severe fatigue; suspected sleep apnea",
            "target": "AHI <5/hour",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "DEXA scan",
            "timing": "Long-term steroid exposure; mobility impairment; menopause",
            "target": "T-score >-2.5",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent (MS Patient Presenting to ED/Hospital)": [
          {
            "item": "Continue home DMT",
            "route": "Various",
            "indication": "Established MS patient on DMT",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Home dose",
                  "orderSentence": "Continue home DMT Home dose Home route"
                }
              ],
              "route": "Home route",
              "instructions": "Verify home DMT and continue unless contraindicated; consult neurology for infusion therapies",
              "orderSentence": "Continue home DMT Home dose Home route"
            },
            "contraindications": "Varies by DMT",
            "monitoring": "Per DMT",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Methylprednisolone IV",
            "route": "IV",
            "indication": "Acute MS relapse",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mg",
                  "orderSentence": "Methylprednisolone IV 1000 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "1000 mg IV daily for 3-5 days; infuse over 1 hour",
              "orderSentence": "Methylprednisolone IV 1000 mg IV"
            },
            "contraindications": "Active infection; uncontrolled diabetes; psychosis",
            "monitoring": "Glucose q6h; BP; mood",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Omeprazole",
            "route": "PO",
            "indication": "GI prophylaxis during steroids",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg daily",
                  "orderSentence": "Omeprazole 20 mg daily PO"
                },
                {
                  "text": "40 mg daily",
                  "orderSentence": "Omeprazole 40 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "20-40 mg PO daily during steroids",
              "orderSentence": "Omeprazole 20 mg daily PO"
            },
            "contraindications": "PPI allergy",
            "monitoring": "None",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Insulin sliding scale",
            "route": "SC",
            "indication": "Steroid-induced hyperglycemia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per protocol",
                  "orderSentence": "Insulin sliding scale Per protocol SC"
                }
              ],
              "route": "SC",
              "instructions": "Per protocol if glucose >180 mg/dL",
              "orderSentence": "Insulin sliding scale Per protocol SC"
            },
            "contraindications": "Hypoglycemia risk",
            "monitoring": "Glucose q6h",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          }
        ],
        "Symptomatic Treatments - Fatigue": [
          {
            "item": "Amantadine",
            "route": "PO",
            "indication": "MS-related fatigue (first-line)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg qAM",
                  "orderSentence": "Amantadine 100 mg qAM PO"
                },
                {
                  "text": "100 mg BID",
                  "orderSentence": "Amantadine 100 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 100 mg every morning; may add 100 mg early afternoon (before 2 PM to avoid insomnia); max 200 mg/day",
              "orderSentence": "Amantadine 100 mg qAM PO"
            },
            "contraindications": "Renal impairment (adjust dose CrCl <50); seizure history; uncontrolled glaucoma",
            "monitoring": "Livedo reticularis; ankle edema; hallucinations; insomnia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Modafinil",
            "route": "PO",
            "indication": "MS-related fatigue (second-line); Schedule IV",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg qAM",
                  "orderSentence": "Modafinil 100 mg qAM PO"
                },
                {
                  "text": "200 mg qAM",
                  "orderSentence": "Modafinil 200 mg qAM PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 100 mg every morning; may increase to 200 mg; max 200 mg daily; take early AM",
              "orderSentence": "Modafinil 100 mg qAM PO"
            },
            "contraindications": "Cardiac arrhythmia; left ventricular hypertrophy; mitral valve prolapse",
            "monitoring": "BP; HR; may reduce hormonal contraception efficacy",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Armodafinil",
            "route": "PO",
            "indication": "MS-related fatigue; longer half-life; Schedule IV",
            "dosing": {
              "doseOptions": [
                {
                  "text": "150 mg qAM",
                  "orderSentence": "Armodafinil 150 mg qAM PO"
                }
              ],
              "route": "PO",
              "instructions": "150 mg every morning; longer duration than modafinil",
              "orderSentence": "Armodafinil 150 mg qAM PO"
            },
            "contraindications": "Same as modafinil",
            "monitoring": "Same as modafinil",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Methylphenidate",
            "route": "PO",
            "indication": "Refractory fatigue; Schedule II",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg BID",
                  "orderSentence": "Methylphenidate 5 mg BID PO"
                },
                {
                  "text": "10 mg BID",
                  "orderSentence": "Methylphenidate 10 mg BID PO"
                },
                {
                  "text": "20 mg BID",
                  "orderSentence": "Methylphenidate 20 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg morning and noon; titrate by 5-10 mg/week; max 60 mg/day; avoid afternoon dosing",
              "orderSentence": "Methylphenidate 5 mg BID PO"
            },
            "contraindications": "Marked anxiety; glaucoma; motor tics; MAOIs; severe hypertension",
            "monitoring": "BP; HR; appetite; mood; growth (rare in adults)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Second-line/Refractory Acute Treatments": [
          {
            "item": "Plasmapheresis (PLEX)",
            "route": "—",
            "indication": "Steroid-refractory acute relapse",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5-7 exchanges",
                  "orderSentence": "Plasmapheresis (PLEX) 5-7 exchanges —"
                }
              ],
              "route": "—",
              "instructions": "5-7 exchanges over 10-14 days; 1-1.5 plasma volumes per exchange",
              "orderSentence": "Plasmapheresis (PLEX) 5-7 exchanges —"
            },
            "contraindications": "Hemodynamic instability; sepsis; central line contraindication",
            "monitoring": "BP; electrolytes; coagulation; fibrinogen; line infection",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT"
          },
          {
            "item": "IVIG",
            "route": "IV",
            "indication": "Steroid-refractory relapse (alternative to PLEX)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.4 g/kg/day",
                  "orderSentence": "IVIG 0.4 g/kg/day IV"
                }
              ],
              "route": "IV",
              "instructions": "0.4 g/kg/day x 5 days (total 2 g/kg)",
              "orderSentence": "IVIG 0.4 g/kg/day IV"
            },
            "contraindications": "IgA deficiency; renal failure; thrombosis history",
            "monitoring": "Renal function; headache; aseptic meningitis; thrombosis",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT"
          }
        ],
        "Disease-Modifying Therapies - Monitoring Protocols": [
          {
            "item": "**INJECTABLE DMTs**"
          },
          {
            "item": "Interferon beta (any formulation)",
            "route": "IM/SC",
            "indication": "RRMS; established patient on therapy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per product labeling",
                  "orderSentence": "Interferon beta (any formulation) Per product labeling IM/SC"
                }
              ],
              "route": "IM/SC",
              "instructions": "Continue established regimen",
              "orderSentence": "Interferon beta (any formulation) Per product labeling IM/SC"
            },
            "pretreatment": "CBC, LFTs, TSH at baseline",
            "contraindications": "Decompensated liver disease; depression (relative)",
            "monitoring": "CBC, LFTs q3-6 months; TSH annually; depression screening",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Glatiramer acetate (any formulation)",
            "route": "SC",
            "indication": "RRMS; established patient",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg daily or 40 mg TIW",
                  "orderSentence": "Glatiramer acetate (any formulation) 20 mg daily or 40 mg TIW SC"
                }
              ],
              "route": "SC",
              "instructions": "Continue established regimen",
              "orderSentence": "Glatiramer acetate (any formulation) 20 mg daily or 40 mg TIW SC"
            },
            "pretreatment": "None required",
            "contraindications": "Hypersensitivity",
            "monitoring": "Injection site reactions; post-injection reaction (self-limited)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "**ORAL DMTs - MODERATE EFFICACY**"
          },
          {
            "item": "Dimethyl fumarate (Tecfidera)",
            "route": "PO",
            "indication": "RRMS; established patient",
            "dosing": {
              "doseOptions": [
                {
                  "text": "240 mg BID",
                  "orderSentence": "Dimethyl fumarate (Tecfidera) 240 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Continue 240 mg BID with food",
              "orderSentence": "Dimethyl fumarate (Tecfidera) 240 mg BID PO"
            },
            "pretreatment": "CBC, LFTs",
            "contraindications": "ALC <500 for >6 months (discontinue); PML risk",
            "monitoring": "CBC q6 months; LFTs periodically; MRI surveillance for PML",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Diroximel fumarate (Vumerity)",
            "route": "PO",
            "indication": "RRMS; less GI side effects than Tecfidera",
            "dosing": {
              "doseOptions": [
                {
                  "text": "462 mg BID",
                  "orderSentence": "Diroximel fumarate (Vumerity) 462 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Continue 462 mg BID with food",
              "orderSentence": "Diroximel fumarate (Vumerity) 462 mg BID PO"
            },
            "pretreatment": "CBC, LFTs",
            "contraindications": "ALC <500 for >6 months (discontinue); PML risk",
            "monitoring": "CBC q6 months; LFTs periodically; MRI surveillance for PML",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Teriflunomide (Aubagio)",
            "route": "PO",
            "indication": "RRMS; established patient",
            "dosing": {
              "doseOptions": [
                {
                  "text": "7 mg or 14 mg daily",
                  "orderSentence": "Teriflunomide (Aubagio) 7 mg or 14 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Continue established dose",
              "orderSentence": "Teriflunomide (Aubagio) 7 mg or 14 mg daily PO"
            },
            "pretreatment": "LFTs monthly x 6 months; TB test; BP; pregnancy test",
            "contraindications": "Pregnancy (Category X); severe hepatic impairment",
            "monitoring": "LFTs monthly x 6 months, then periodically; BP; pregnancy test PRN",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "**ORAL DMTs - S1P MODULATORS (HIGH EFFICACY)**"
          },
          {
            "item": "Fingolimod (Gilenya)",
            "route": "PO",
            "indication": "RRMS; established patient",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5 mg daily",
                  "orderSentence": "Fingolimod (Gilenya) 0.5 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Continue 0.5 mg daily",
              "orderSentence": "Fingolimod (Gilenya) 0.5 mg daily PO"
            },
            "pretreatment": "First-dose observation completed; VZV immune; macular OCT; ECG",
            "contraindications": "Cardiac conduction issues; recent MI/stroke; macular edema",
            "monitoring": "Macular OCT annually; CBC q6-12 months; LFTs annually; MRI for PML surveillance",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Siponimod (Mayzent)",
            "route": "PO",
            "indication": "SPMS or RRMS; established patient",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 mg or 2 mg daily (per CYP2C9)",
                  "orderSentence": "Siponimod (Mayzent) 1 mg or 2 mg daily (per CYP2C9) PO"
                }
              ],
              "route": "PO",
              "instructions": "Continue established dose per genotype",
              "orderSentence": "Siponimod (Mayzent) 1 mg or 2 mg daily (per CYP2C9) PO"
            },
            "pretreatment": "CYP2C9 genotype; first-dose observation; macular OCT",
            "contraindications": "CYP2C9 *3/*3; cardiac conduction issues; macular edema",
            "monitoring": "Macular OCT annually; CBC q6-12 months; LFTs annually",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ozanimod (Zeposia)",
            "route": "PO",
            "indication": "RRMS; established patient",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.92 mg daily",
                  "orderSentence": "Ozanimod (Zeposia) 0.92 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Continue 0.92 mg daily",
              "orderSentence": "Ozanimod (Zeposia) 0.92 mg daily PO"
            },
            "pretreatment": "Macular OCT; ECG (no first-dose observation required)",
            "contraindications": "Cardiac conduction issues; recent MI/stroke; MAOIs",
            "monitoring": "Macular OCT at 3-4 months then annually; CBC; LFTs",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ponesimod (Ponvory)",
            "route": "PO",
            "indication": "RRMS; established patient",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg daily",
                  "orderSentence": "Ponesimod (Ponvory) 20 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Continue 20 mg daily",
              "orderSentence": "Ponesimod (Ponvory) 20 mg daily PO"
            },
            "pretreatment": "Macular OCT; ECG (no first-dose observation required)",
            "contraindications": "Cardiac conduction issues; recent MI/stroke",
            "monitoring": "Macular OCT at 3-4 months then annually; CBC; LFTs",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "**ORAL DMTs - HIGH EFFICACY OTHER**"
          },
          {
            "item": "Cladribine (Mavenclad)",
            "route": "PO",
            "indication": "RRMS/SPMS; induction therapy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1.75 mg/kg/year x 2 years",
                  "orderSentence": "Cladribine (Mavenclad) 1.75 mg/kg/year x 2 years PO"
                }
              ],
              "route": "PO",
              "instructions": "Year 1 and Year 2 only; no treatment years 3-4",
              "orderSentence": "Cladribine (Mavenclad) 1.75 mg/kg/year x 2 years PO"
            },
            "pretreatment": "ALC >800 before each year; LFTs; HIV; Hep B/C",
            "contraindications": "Active infection; HIV; malignancy; pregnancy",
            "monitoring": "CBC at months 2 and 6 each treatment year; malignancy screening",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "**INFUSION DMTs - HIGH EFFICACY**"
          },
          {
            "item": "Natalizumab (Tysabri)",
            "route": "IV",
            "indication": "RRMS; established patient",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg q4 weeks or extended q6 weeks",
                  "orderSentence": "Natalizumab (Tysabri) 300 mg q4 weeks or extended q6 weeks IV"
                }
              ],
              "route": "IV",
              "instructions": "Standard interval q4 weeks; extended interval dosing (EID) q6 weeks if stable and JCV negative",
              "orderSentence": "Natalizumab (Tysabri) 300 mg q4 weeks or extended q6 weeks IV"
            },
            "pretreatment": "JCV antibody q6 months; REMS enrollment",
            "contraindications": "JCV+ with index >1.5 and prior immunosuppression (high PML risk)",
            "monitoring": "JCV q6 months; MRI q3-6 months (high risk) or q6-12 months (low risk) for PML surveillance",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ocrelizumab (Ocrevus)",
            "route": "IV",
            "indication": "RRMS/PPMS; established patient",
            "dosing": {
              "doseOptions": [
                {
                  "text": "600 mg q6 months",
                  "orderSentence": "Ocrelizumab (Ocrevus) 600 mg q6 months IV"
                }
              ],
              "route": "IV",
              "instructions": "600 mg IV every 6 months; premedicate",
              "orderSentence": "Ocrelizumab (Ocrevus) 600 mg q6 months IV"
            },
            "pretreatment": "Hepatitis B screening; TB test; immunoglobulins",
            "contraindications": "Active Hepatitis B; active infection",
            "monitoring": "IgG annually; infection monitoring; infusion reactions",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ofatumumab (Kesimpta)",
            "route": "SC",
            "indication": "RRMS; established patient",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg monthly",
                  "orderSentence": "Ofatumumab (Kesimpta) 20 mg monthly SC"
                }
              ],
              "route": "SC",
              "instructions": "20 mg SC monthly; self-administered at home",
              "orderSentence": "Ofatumumab (Kesimpta) 20 mg monthly SC"
            },
            "pretreatment": "Hepatitis B screening; TB test; immunoglobulins",
            "contraindications": "Active Hepatitis B; active infection",
            "monitoring": "IgG annually; infection monitoring",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ublituximab (Briumvi)",
            "route": "IV",
            "indication": "RRMS; established patient",
            "dosing": {
              "doseOptions": [
                {
                  "text": "450 mg q6 months",
                  "orderSentence": "Ublituximab (Briumvi) 450 mg q6 months IV"
                }
              ],
              "route": "IV",
              "instructions": "450 mg IV every 24 weeks (after initial doses); 1-hour infusion",
              "orderSentence": "Ublituximab (Briumvi) 450 mg q6 months IV"
            },
            "pretreatment": "Hepatitis B screening; TB test; immunoglobulins",
            "contraindications": "Active Hepatitis B; active infection",
            "monitoring": "IgG annually; infection monitoring; infusion reactions",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Alemtuzumab (Lemtrada)",
            "route": "IV",
            "indication": "RRMS; established patient post-induction",
            "dosing": {
              "doseOptions": [
                {
                  "text": "No further dosing unless rebound",
                  "orderSentence": "Alemtuzumab (Lemtrada) No further dosing unless rebound IV"
                }
              ],
              "route": "IV",
              "instructions": "Monitoring continues 48 months after last infusion even without additional dosing",
              "orderSentence": "Alemtuzumab (Lemtrada) No further dosing unless rebound IV"
            },
            "pretreatment": "REMS enrollment; extensive baseline labs",
            "contraindications": "Active infection; ongoing autoimmune disease",
            "monitoring": "CBC monthly x 48 months; TSH q3 months x 48 months; creatinine/UA monthly x 48 months",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "MS specialist/Neuroimmunology for annual comprehensive review and DMT optimization",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Neuro-ophthalmology for visual complaints, OCT monitoring, or suspected optic neuritis",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Physical therapy for gait training, balance exercises, and fall prevention given progressive mobility decline",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Occupational therapy for ADL assessment, energy conservation strategies, and adaptive equipment",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Speech therapy for dysphagia evaluation given brainstem involvement or swallowing concerns",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Neuropsychology for formal cognitive testing if subjective or objective cognitive decline",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Cognitive rehabilitation (speech therapy or neuropsychology) for documented cognitive impairment",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Urology for refractory bladder symptoms, recurrent UTIs, or urodynamic testing consideration",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Psychiatry for depression, anxiety, or adjustment disorders not responding to first-line treatment",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pain management for refractory neuropathic pain not responding to multiple first-line agents",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Physiatry/Rehabilitation medicine for comprehensive rehabilitation planning and spasticity management",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Social work for disability planning, insurance navigation, and community resource connection",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Genetic counseling if considering pregnancy with strong family history or known genetic mutations",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "High-risk OB for pregnancy planning discussion in women on DMTs",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Infusion center for DMT administration and monitoring",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Palliative care for advanced MS with significant symptom burden or goals of care discussions",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Return immediately if rapid vision loss, new weakness, numbness, or difficulty walking develops (may indicate relapse requiring steroids)",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Report fever or signs of infection promptly as immunomodulatory DMTs increase infection risk",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Continue DMT as prescribed unless instructed otherwise by neurology - do not stop without discussing",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid live vaccines while on immunosuppressive DMTs (fingolimod, siponimod, cladribine, anti-CD20 therapies, alemtuzumab)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Heat may temporarily worsen symptoms (Uhthoff phenomenon) - use cooling strategies; this is NOT a new relapse",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Maintain symptom diary noting new symptoms, fatigue levels, and bladder/bowel patterns",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Do not stop baclofen or tizanidine abruptly - taper under medical supervision to avoid withdrawal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Report any skin changes, new moles, or suspicious lesions given increased malignancy risk with some DMTs",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Women of childbearing potential: discuss pregnancy plans with MS specialist before conception given DMT-specific washout requirements",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Report unusual fatigue, shortness of breath, chest pain, or palpitations if on S1P modulators (cardiac effects)",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "If on natalizumab: report any new neurological symptoms, especially if subtle (confusion, personality change, clumsiness) as may indicate PML",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Take dalfampridine exactly 12 hours apart and never exceed 2 doses per day (seizure risk)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Smoking cessation - smoking accelerates MS progression, increases relapse rate, and worsens disability",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Vitamin D supplementation 2000-5000 IU daily to maintain serum 25-OH vitamin D >40 ng/mL (target >50 ng/mL)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Regular aerobic exercise 150 minutes per week as tolerated - improves fatigue, mood, mobility, and may slow progression",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Aquatic therapy/swimming - allows exercise with built-in cooling and reduced fall risk",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Resistance training 2-3 times weekly for strength maintenance and bone health",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Stress management techniques as stress may trigger pseudorelapses and worsen fatigue",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Sleep hygiene - ensure 7-8 hours nightly; address sleep disorders contributing to fatigue",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid excessive heat exposure (hot tubs, saunas, exercising in heat) - use cooling vests for outdoor activities",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Fall prevention: remove loose rugs, ensure adequate lighting, use assistive devices (cane, walker) as needed",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Complete recommended vaccinations before starting immunosuppressive DMTs - inactivated vaccines safe on most DMTs",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Annual influenza vaccine (inactivated) and COVID-19 vaccines per current guidelines (timing around infusions for anti-CD20)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Limit alcohol intake as it can worsen balance, cognitive symptoms, and interact with medications",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Mediterranean diet pattern may have anti-inflammatory benefits based on observational data",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "DEXA scan for bone density monitoring if prolonged steroid exposure, immobility, or menopause",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "MS relapse vs pseudorelapse",
        "features": "True relapse: new neuroinflammation; Pseudorelapse: symptom worsening from infection, heat, stress without new inflammation",
        "tests": "MRI with contrast (new enhancing lesions = true relapse); infection workup (UTI, URI)"
      },
      {
        "diagnosis": "Progressive multifocal leukoencephalopathy (PML)",
        "features": "Subacute cognitive/behavioral change, visual, motor symptoms; on natalizumab, DMF, fingolimod",
        "tests": "MRI (subcortical non-enhancing lesions); CSF JCV PCR"
      },
      {
        "diagnosis": "CNS infection",
        "features": "Fever, meningeal signs, rapid deterioration; immunosuppressed",
        "tests": "Lumbar puncture; blood cultures; imaging"
      },
      {
        "diagnosis": "Comorbid stroke/TIA",
        "features": "Sudden onset; vascular risk factors; non-MS territory",
        "tests": "MRI DWI; vascular imaging"
      },
      {
        "diagnosis": "Medication side effect",
        "features": "Temporal relationship to new medication or dose change",
        "tests": "Medication review; trial discontinuation"
      },
      {
        "diagnosis": "Functional neurological disorder",
        "features": "Inconsistent exam; non-anatomical patterns; psychiatric comorbidity",
        "tests": "Clinical assessment; normal MRI"
      },
      {
        "diagnosis": "B12 deficiency myelopathy",
        "features": "Progressive; dorsal column signs; may coexist with MS",
        "tests": "B12, MMA, homocysteine"
      },
      {
        "diagnosis": "Secondary malignancy",
        "features": "Progressive; atypical pattern; on immunosuppressive DMT",
        "tests": "PET-CT; biopsy if indicated"
      }
    ],
    "evidence": [
      {
        "recommendation": "Annual MRI surveillance for subclinical disease activity",
        "evidenceLevel": "Class II, Level B",
        "source": "[Wattjes MP et al. Lancet Neurol 2021 (MAGNIMS-CMSC-NAIMS)](https://pubmed.ncbi.nlm.nih.gov/34139157/)"
      },
      {
        "recommendation": "NEDA (No Evidence of Disease Activity) as treatment target",
        "evidenceLevel": "Class II, Level B",
        "source": "[Giovannoni G et al. Neurology 2017](https://pubmed.ncbi.nlm.nih.gov/28698253/)"
      },
      {
        "recommendation": "JCV antibody monitoring for PML risk stratification",
        "evidenceLevel": "Class I, Level A",
        "source": "[Bloomgren G et al. NEJM 2012](https://pubmed.ncbi.nlm.nih.gov/22316447/)"
      },
      {
        "recommendation": "Extended interval dosing of natalizumab reduces PML risk",
        "evidenceLevel": "Class II, Level B",
        "source": "[Zhovtis Ryerson L et al. Ann Neurol 2019](https://pubmed.ncbi.nlm.nih.gov/30938869/)"
      },
      {
        "recommendation": "Anti-CD20 therapies effective in RRMS and PPMS",
        "evidenceLevel": "Class I, Level A",
        "source": "[Hauser SL et al. NEJM 2017 (OPERA)](https://pubmed.ncbi.nlm.nih.gov/28002679/)"
      },
      {
        "recommendation": "Vitamin D supplementation reduces relapse rate",
        "evidenceLevel": "Class I, Level B",
        "source": "[Hupperts R et al. Neurology 2019 (SOLAR)](https://pubmed.ncbi.nlm.nih.gov/31594857/)"
      },
      {
        "recommendation": "Dalfampridine improves walking speed",
        "evidenceLevel": "Class I, Level A",
        "source": "[Goodman AD et al. Lancet 2009](https://pubmed.ncbi.nlm.nih.gov/19249634/)"
      },
      {
        "recommendation": "Exercise improves fatigue and quality of life",
        "evidenceLevel": "Class I, Level B",
        "source": "[Heine M et al. Cochrane 2015](https://pubmed.ncbi.nlm.nih.gov/26358158/)"
      },
      {
        "recommendation": "Smoking cessation slows disability progression",
        "evidenceLevel": "Class II, Level B",
        "source": "[Hedstrom AK et al. Brain 2013](https://pubmed.ncbi.nlm.nih.gov/23365092/)"
      },
      {
        "recommendation": "Cognitive rehabilitation improves cognitive outcomes",
        "evidenceLevel": "Class II, Level B",
        "source": "[Chiaravalloti ND et al. Neurology 2013](https://pubmed.ncbi.nlm.nih.gov/23091072/)"
      },
      {
        "recommendation": "S1P modulators: macular edema and cardiac monitoring required",
        "evidenceLevel": "Class I, Level A",
        "source": "[FDA label; Cohen JA et al. NEJM 2010 (fingolimod)](https://pubmed.ncbi.nlm.nih.gov/20089954/)"
      },
      {
        "recommendation": "Alemtuzumab: secondary autoimmunity monitoring for 48 months",
        "evidenceLevel": "Class I, Level A",
        "source": "[CAMMS223 investigators NEJM 2008](https://pubmed.ncbi.nlm.nih.gov/18946064/)"
      },
      {
        "recommendation": "Pregnancy planning with DMT washout periods",
        "evidenceLevel": "Class III, Level B",
        "source": "[Bove R et al. Nat Rev Neurol 2014](https://pubmed.ncbi.nlm.nih.gov/24614515/)"
      },
      {
        "recommendation": "Vaccinations before immunosuppressive DMTs",
        "evidenceLevel": "Expert consensus",
        "source": "[Farez MF et al. Neurology 2019 (AAN guidelines)](https://pubmed.ncbi.nlm.nih.gov/30366971/)"
      }
    ],
    "monitoring": [
      {
        "item": "**CLINICAL**"
      },
      {
        "item": "Neurologic examination (EDSS)",
        "frequency": "Every visit; minimum annually",
        "action": "If worsening: MRI, DMT optimization discussion",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Relapse frequency",
        "frequency": "Continuous; review at each visit",
        "action": "Any relapse triggers MRI and DMT reassessment",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Walking speed (T25FW)",
        "frequency": "Annually",
        "action": "If worsening: PT referral, dalfampridine consideration",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Cognition (SDMT or MoCA)",
        "frequency": "Annually",
        "action": "Cognitive rehab referral; medication review",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Depression screening (PHQ-9)",
        "frequency": "Annually; more often if symptoms",
        "action": "Antidepressant; psychiatry referral",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Fatigue (MFIS or FSS)",
        "frequency": "Each visit",
        "action": "Fatigue management optimization",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "**IMAGING**"
      },
      {
        "item": "MRI brain with contrast",
        "frequency": "Annually; 3-6 months after DMT switch",
        "action": "New activity: DMT escalation discussion",
        "ED": "URGENT",
        "HOSP": "URGENT",
        "OPD": "ROUTINE",
        "ICU": "URGENT"
      },
      {
        "item": "MRI spine",
        "frequency": "Annually or with new symptoms",
        "action": "New lesions: DMT reassessment",
        "ED": "URGENT",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Macular OCT",
        "frequency": "Baseline; 3-4 months on S1P modulators; then annually",
        "action": "Macular edema: discontinue S1P modulator; ophthalmology",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "**LABORATORY**"
      },
      {
        "item": "CBC with differential",
        "frequency": "q6 months on lymphocyte-depleting DMTs; annually others",
        "action": "Adjust or discontinue DMT per protocol",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "LFTs",
        "frequency": "Per DMT schedule; more frequent early on",
        "action": "Hold DMT if >3x; resume if resolves",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "JCV antibody with index",
        "frequency": "q6 months on natalizumab",
        "action": "Rising index: risk counseling; consider DMT switch",
        "ED": "URGENT",
        "HOSP": "URGENT",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Immunoglobulins (IgG)",
        "frequency": "Annually on anti-CD20 therapies",
        "action": "If low: infection precautions; consider IVIG replacement",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Vitamin D, 25-OH",
        "frequency": "Annually",
        "action": "Increase supplementation if low",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "**ALEMTUZUMAB-SPECIFIC (48 months after last infusion)**"
      },
      {
        "item": "CBC with platelets",
        "frequency": "Monthly x 48 months",
        "action": "If low: hold; hematology consult for ITP",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT"
      },
      {
        "item": "TSH",
        "frequency": "q3 months x 48 months",
        "action": "If abnormal: endocrine consult",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Serum creatinine + UA",
        "frequency": "Monthly x 48 months",
        "action": "If abnormal: nephrology consult for anti-GBM disease",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT"
      }
    ],
    "disposition": [
      {
        "disposition": "**Discharge home**",
        "criteria": "Mild symptom worsening attributable to pseudorelapse (infection treated, heat exposure resolved); stable neurologic exam; able to care for self or adequate caregiver support; reliable follow-up"
      },
      {
        "disposition": "**Admit to floor**",
        "criteria": "Moderate-severe acute relapse requiring IV steroids; functional decline preventing safe discharge; diagnostic workup for suspected PML or CNS infection; severe medication side effect requiring monitoring"
      },
      {
        "disposition": "**Admit to ICU**",
        "criteria": "Severe myelitis with respiratory compromise (NIF declining toward -20 cm H2O); brainstem involvement with airway risk; severe infusion reaction; suspected PML with rapid deterioration"
      },
      {
        "disposition": "**Transfer to higher level**",
        "criteria": "PLEX needed but unavailable; MS specialist not available for complex decision-making (PML management, severe breakthrough); MRI unavailable for urgent imaging"
      },
      {
        "disposition": "**Outpatient follow-up**",
        "criteria": "Every 3-6 months for stable patients; q1-3 months during DMT transition or active disease; annually minimum for established stable patients"
      }
    ]
  },
  "Restless Legs Syndrome": {
    "id": "restless-legs-syndrome",
    "title": "Restless Legs Syndrome",
    "version": "1.0",
    "icd10": [
      "** G25.81 (Restless legs syndrome)"
    ],
    "scope": "** Diagnosis confirmation using IRLSSG criteria, workup for secondary causes, pharmacologic and non-pharmacologic management, and augmentation prevention/treatment. Primarily outpatient management with limited ED/HOSP coverage for severe refractory cases.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "Ferritin",
            "rationale": "Iron deficiency is most common treatable cause; target >75 ng/mL for RLS (higher than general population)",
            "target": ">75 ng/mL (ideally >100)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Transferrin saturation (TSAT)",
            "rationale": "Iron availability; TSAT <20% suggests iron deficiency even with normal ferritin",
            "target": ">20%",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Serum iron",
            "rationale": "Complete iron panel assessment",
            "target": "Normal range",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "TIBC",
            "rationale": "Iron binding capacity; elevated in iron deficiency",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CBC with differential",
            "rationale": "Anemia evaluation; MCV for iron vs B12 deficiency",
            "target": "Normal; MCV 80-100 fL",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "BMP (Creatinine, BUN, electrolytes)",
            "rationale": "Renal function (uremia causes secondary RLS)",
            "target": "eGFR >60 mL/min",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "TSH",
            "rationale": "Thyroid dysfunction can mimic or exacerbate RLS",
            "target": "0.4-4.0 mIU/L",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "HbA1c",
            "rationale": "Diabetes screening (diabetic neuropathy commonly coexists)",
            "target": "<5.7% (normal); <7% if diabetic",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Fasting glucose",
            "rationale": "Diabetes screening",
            "target": "70-99 mg/dL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended Workup": [
          {
            "item": "Vitamin B12",
            "rationale": "Deficiency causes neuropathy and may worsen RLS",
            "target": ">300 pg/mL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Folate",
            "rationale": "Deficiency associated with RLS; often low with B12",
            "target": ">3 ng/mL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Magnesium",
            "rationale": "Deficiency can cause leg cramps and muscle symptoms",
            "target": "1.8-2.4 mg/dL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CRP, ESR",
            "rationale": "Inflammatory markers; chronic inflammation affects iron metabolism",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Comprehensive metabolic panel",
            "rationale": "Hepatic function; renal clearance",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pregnancy test (if applicable)",
            "rationale": "RLS common in pregnancy (up to 25%); affects treatment choices",
            "target": "Negative or positive (determines treatment)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "24-hour urine protein",
            "rationale": "Nephrotic syndrome workup if renal disease suspected",
            "target": "<150 mg/24hr",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Parathyroid hormone",
            "rationale": "Hyperparathyroidism can cause RLS",
            "target": "Normal",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Anti-GAD65 antibodies",
            "rationale": "Autoimmune etiology in atypical cases",
            "target": "Negative",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Paraneoplastic panel",
            "rationale": "Occult malignancy with neurological symptoms",
            "target": "Negative",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Hemoglobin electrophoresis",
            "rationale": "Thalassemia trait; chronic hemolytic conditions",
            "target": "Normal",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Vitamin D",
            "rationale": "Deficiency associated with RLS in some studies",
            "target": ">30 ng/mL",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "Clinical examination and history",
            "timing": "At evaluation",
            "target": "IRLSSG criteria met; no mimicking conditions",
            "contraindications": "None",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "IRLS Rating Scale (IRLS)",
            "timing": "At diagnosis and follow-up",
            "target": "Score 0-40; mild <10, moderate 11-20, severe 21-30, very severe >30",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended": [
          {
            "item": "Polysomnography (PSG)",
            "timing": "If sleep apnea suspected; PLMS quantification",
            "target": "PLMI <15/hr normal; RLS typically >15/hr",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "EMG/Nerve conduction studies",
            "timing": "If peripheral neuropathy suspected (numbness, weakness, areflexia)",
            "target": "Normal or peripheral neuropathy pattern",
            "contraindications": "Pacemaker (relative)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Actigraphy",
            "timing": "Objective assessment of sleep and limb movements",
            "target": "Activity pattern consistent with RLS",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "MRI Brain",
            "timing": "Atypical presentation; concern for structural lesion or secondary parkinsonism",
            "target": "Normal",
            "contraindications": "MRI contraindications",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "MRI Lumbar spine",
            "timing": "Radiculopathy suspected; nerve root compression symptoms",
            "target": "Normal or explains symptoms",
            "contraindications": "MRI contraindications",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Suggested immobilization test (SIT)",
            "timing": "Research/specialized; objective RLS measurement",
            "target": "Increased leg movements during immobility",
            "contraindications": "Time-intensive",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent (Severe Symptom Relief)": [
          {
            "item": "Gabapentin",
            "route": "PO",
            "indication": "Acute severe symptoms requiring immediate relief",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg",
                  "orderSentence": "Gabapentin 300 mg PO"
                },
                {
                  "text": "600 mg",
                  "orderSentence": "Gabapentin 600 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "300-600 mg PO for immediate symptom relief; may repeat once in 4-6 hours",
              "orderSentence": "Gabapentin 300 mg PO"
            },
            "contraindications": "Severe renal impairment (adjust dose)",
            "monitoring": "Sedation, dizziness",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Pregabalin",
            "route": "PO",
            "indication": "Acute severe symptoms; faster onset than gabapentin",
            "dosing": {
              "doseOptions": [
                {
                  "text": "75 mg",
                  "orderSentence": "Pregabalin 75 mg PO"
                },
                {
                  "text": "150 mg",
                  "orderSentence": "Pregabalin 150 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "75-150 mg PO for immediate relief; onset 30-60 min",
              "orderSentence": "Pregabalin 75 mg PO"
            },
            "contraindications": "Severe renal impairment (adjust dose)",
            "monitoring": "Sedation, dizziness",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Oxycodone (severe refractory)",
            "route": "PO",
            "indication": "Severe acute symptoms refractory to alpha-2-delta ligands",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Oxycodone (severe refractory) 5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "5 mg PO once for severe refractory symptoms; short-term only",
              "orderSentence": "Oxycodone (severe refractory) 5 mg PO"
            },
            "contraindications": "Respiratory depression; opioid use disorder; concurrent CNS depressants",
            "monitoring": "Respiratory status, sedation",
            "ED": "EXT",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "-"
          }
        ],
        "First-line Treatments (Iron Therapy)": [
          {
            "item": "Ferrous sulfate + Vitamin C",
            "route": "PO",
            "indication": "First-line if ferritin <75 ng/mL; oral iron repletion",
            "dosing": {
              "doseOptions": [
                {
                  "text": "325 mg with 100 mg vitamin C daily",
                  "orderSentence": "Ferrous sulfate + Vitamin C 325 mg with 100 mg vitamin C daily PO"
                },
                {
                  "text": "325 mg with 200 mg vitamin C daily",
                  "orderSentence": "Ferrous sulfate + Vitamin C 325 mg with 200 mg vitamin C daily PO"
                }
              ],
              "route": "PO",
              "instructions": "325 mg ferrous sulfate (65 mg elemental iron) with 100-200 mg vitamin C on empty stomach every other day; evening dosing preferred; treat 3-4 months minimum",
              "orderSentence": "Ferrous sulfate + Vitamin C 325 mg with 100 mg vitamin C daily PO"
            },
            "contraindications": "Hemochromatosis; iron overload; GI bleeding",
            "monitoring": "Ferritin, TSAT at 3-4 months; GI tolerability",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ferrous gluconate",
            "route": "PO",
            "indication": "Alternative oral iron if ferrous sulfate not tolerated",
            "dosing": {
              "doseOptions": [
                {
                  "text": "325 mg daily",
                  "orderSentence": "Ferrous gluconate 325 mg daily PO"
                },
                {
                  "text": "325 mg BID",
                  "orderSentence": "Ferrous gluconate 325 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "325 mg (38 mg elemental iron) daily to BID; better GI tolerability; lower elemental iron",
              "orderSentence": "Ferrous gluconate 325 mg daily PO"
            },
            "contraindications": "Same as above",
            "monitoring": "Same as above",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Iron sucrose",
            "route": "IV",
            "indication": "Oral iron failure or intolerance; rapid repletion needed; ferritin <75",
            "dosing": {
              "doseOptions": [
                {
                  "text": "200 mg per infusion",
                  "orderSentence": "Iron sucrose 200 mg per infusion IV"
                },
                {
                  "text": "200 mg x 5 doses",
                  "orderSentence": "Iron sucrose 200 mg x 5 doses IV"
                }
              ],
              "route": "IV",
              "instructions": "200 mg IV over 15-30 min; give 1000 mg total in 5 divided doses over 2 weeks",
              "orderSentence": "Iron sucrose 200 mg per infusion IV"
            },
            "contraindications": "Iron overload; hypersensitivity",
            "monitoring": "Ferritin, TSAT at 4-8 weeks; infusion reaction monitoring",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ferric carboxymaltose (Injectafer)",
            "route": "IV",
            "indication": "Rapid iron repletion; single or two-dose regimen preferred",
            "dosing": {
              "doseOptions": [
                {
                  "text": "750 mg x 2 doses",
                  "orderSentence": "Ferric carboxymaltose (Injectafer) 750 mg x 2 doses IV"
                },
                {
                  "text": "1000 mg x 1 dose",
                  "orderSentence": "Ferric carboxymaltose (Injectafer) 1000 mg x 1 dose IV"
                }
              ],
              "route": "IV",
              "instructions": "750 mg IV, repeat in 1 week (max 1500 mg total); OR 1000 mg single dose if weight >50 kg",
              "orderSentence": "Ferric carboxymaltose (Injectafer) 750 mg x 2 doses IV"
            },
            "contraindications": "Hypersensitivity to IV iron",
            "monitoring": "Hypophosphatemia (common); infusion reaction; ferritin at 4-8 weeks",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ferric derisomaltose (Monoferric)",
            "route": "IV",
            "indication": "Single-dose IV iron repletion",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mg single dose",
                  "orderSentence": "Ferric derisomaltose (Monoferric) 1000 mg single dose IV"
                }
              ],
              "route": "IV",
              "instructions": "1000 mg IV over 20+ min as single dose; may repeat if needed after 4 weeks",
              "orderSentence": "Ferric derisomaltose (Monoferric) 1000 mg single dose IV"
            },
            "contraindications": "Same as ferric carboxymaltose",
            "monitoring": "Same; lower hypophosphatemia risk",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "First-line Treatments (Alpha-2-Delta Ligands - Preferred)": [
          {
            "item": "Gabapentin",
            "route": "PO",
            "indication": "First-line pharmacotherapy; no augmentation risk; good for pain component",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg qHS",
                  "orderSentence": "Gabapentin 300 mg qHS PO"
                },
                {
                  "text": "300 mg BID",
                  "orderSentence": "Gabapentin 300 mg BID PO"
                },
                {
                  "text": "600 mg qHS",
                  "orderSentence": "Gabapentin 600 mg qHS PO"
                },
                {
                  "text": "300 mg TID",
                  "orderSentence": "Gabapentin 300 mg TID PO"
                },
                {
                  "text": "600 mg BID",
                  "orderSentence": "Gabapentin 600 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 300 mg qHS; titrate by 300 mg q3-7 days; target 600-1800 mg/day in 1-3 doses; max 2400 mg/day; give largest dose in evening",
              "orderSentence": "Gabapentin 300 mg qHS PO"
            },
            "contraindications": "Severe renal impairment (dose adjust); respiratory depression with opioids",
            "monitoring": "Sedation, dizziness, peripheral edema, weight gain; renal function",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Gabapentin enacarbil (Horizant)",
            "route": "PO",
            "indication": "FDA-approved for RLS; better bioavailability than immediate release gabapentin",
            "dosing": {
              "doseOptions": [
                {
                  "text": "600 mg daily",
                  "orderSentence": "Gabapentin enacarbil (Horizant) 600 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "600 mg PO once daily at 5 PM with food; no titration needed; extended release formulation",
              "orderSentence": "Gabapentin enacarbil (Horizant) 600 mg daily PO"
            },
            "contraindications": "Same as gabapentin; do NOT substitute mg-for-mg with regular gabapentin",
            "monitoring": "Same as gabapentin",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pregabalin",
            "route": "PO",
            "indication": "First-line; faster onset than gabapentin; helpful if comorbid anxiety or fibromyalgia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "75 mg qHS",
                  "orderSentence": "Pregabalin 75 mg qHS PO"
                },
                {
                  "text": "150 mg qHS",
                  "orderSentence": "Pregabalin 150 mg qHS PO"
                },
                {
                  "text": "75 mg BID",
                  "orderSentence": "Pregabalin 75 mg BID PO"
                },
                {
                  "text": "150 mg BID",
                  "orderSentence": "Pregabalin 150 mg BID PO"
                },
                {
                  "text": "300 mg qHS",
                  "orderSentence": "Pregabalin 300 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 75 mg qHS; titrate by 75 mg q1wk; target 150-450 mg/day; max 300 mg in evening",
              "orderSentence": "Pregabalin 75 mg qHS PO"
            },
            "contraindications": "Severe renal impairment (adjust dose); avoid abrupt discontinuation",
            "monitoring": "Same as gabapentin; Schedule V controlled",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Second-line Treatments (Dopamine Agonists - Use with Caution)": [
          {
            "item": "Pramipexole (Mirapex)",
            "route": "PO",
            "indication": "Alpha-2-delta failure/intolerance; use LOWEST effective dose; augmentation risk ~7%/year",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.125 mg qHS",
                  "orderSentence": "Pramipexole (Mirapex) 0.125 mg qHS PO"
                },
                {
                  "text": "0.25 mg qHS",
                  "orderSentence": "Pramipexole (Mirapex) 0.25 mg qHS PO"
                },
                {
                  "text": "0.5 mg qHS",
                  "orderSentence": "Pramipexole (Mirapex) 0.5 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.125 mg 2-3 hrs before symptoms; titrate by 0.125 mg q4-7 days; max 0.5 mg/day for RLS (lower than Parkinson's doses)",
              "orderSentence": "Pramipexole (Mirapex) 0.125 mg qHS PO"
            },
            "pretreatment": "Warn patient about augmentation, ICDs",
            "contraindications": "Severe renal impairment (reduce dose by 50% if CrCl <60); pathological gambling risk",
            "monitoring": "AUGMENTATION (symptoms earlier, more intense, spread to arms); impulse control disorders; excessive daytime sleepiness; renal function",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ropinirole (Requip)",
            "route": "PO",
            "indication": "Alpha-2-delta failure/intolerance; augmentation risk similar to pramipexole",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.25 mg qHS",
                  "orderSentence": "Ropinirole (Requip) 0.25 mg qHS PO"
                },
                {
                  "text": "0.5 mg qHS",
                  "orderSentence": "Ropinirole (Requip) 0.5 mg qHS PO"
                },
                {
                  "text": "1 mg qHS",
                  "orderSentence": "Ropinirole (Requip) 1 mg qHS PO"
                },
                {
                  "text": "2 mg qHS",
                  "orderSentence": "Ropinirole (Requip) 2 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.25 mg 1-3 hrs before symptoms; titrate by 0.25 mg q2-3 days; max 4 mg/day for RLS",
              "orderSentence": "Ropinirole (Requip) 0.25 mg qHS PO"
            },
            "pretreatment": "Warn patient about augmentation, ICDs",
            "contraindications": "Hepatic impairment; concurrent CYP1A2 inhibitors (adjust dose)",
            "monitoring": "Same as pramipexole; nausea common initially",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rotigotine patch (Neupro)",
            "route": "Transdermal",
            "indication": "Once-daily patch; less pulsatile dopaminergic stimulation; may reduce augmentation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 mg/24hr",
                  "orderSentence": "Rotigotine patch (Neupro) 1 mg/24hr Transdermal"
                },
                {
                  "text": "2 mg/24hr",
                  "orderSentence": "Rotigotine patch (Neupro) 2 mg/24hr Transdermal"
                },
                {
                  "text": "3 mg/24hr",
                  "orderSentence": "Rotigotine patch (Neupro) 3 mg/24hr Transdermal"
                }
              ],
              "route": "Transdermal",
              "instructions": "Start 1 mg/24hr patch; titrate by 1 mg/24hr weekly; max 3 mg/24hr for RLS",
              "orderSentence": "Rotigotine patch (Neupro) 1 mg/24hr Transdermal"
            },
            "pretreatment": "Warn patient about augmentation, ICDs",
            "contraindications": "Sulfite sensitivity; MRI (remove patch - contains aluminum)",
            "monitoring": "Site reactions; augmentation; impulse control disorders",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Third-line/Refractory Treatments": [
          {
            "item": "Tramadol",
            "route": "PO",
            "indication": "Refractory RLS; failed alpha-2-delta and dopamine agonists",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg qHS",
                  "orderSentence": "Tramadol 50 mg qHS PO"
                },
                {
                  "text": "50 mg BID",
                  "orderSentence": "Tramadol 50 mg BID PO"
                },
                {
                  "text": "100 mg qHS",
                  "orderSentence": "Tramadol 100 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 50 mg qHS; max 100 mg BID; use lowest effective dose",
              "orderSentence": "Tramadol 50 mg qHS PO"
            },
            "contraindications": "Seizure history; concurrent MAOIs/SSRIs (serotonin syndrome); opioid use disorder",
            "monitoring": "Constipation, sedation, nausea; seizure risk; dependence",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Oxycodone (low-dose)",
            "route": "PO",
            "indication": "Severe refractory RLS; augmentation from dopamine agonists",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg qHS",
                  "orderSentence": "Oxycodone (low-dose) 5 mg qHS PO"
                },
                {
                  "text": "5 mg BID",
                  "orderSentence": "Oxycodone (low-dose) 5 mg BID PO"
                },
                {
                  "text": "10 mg qHS",
                  "orderSentence": "Oxycodone (low-dose) 10 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg qHS; max 5-10 mg BID; lowest effective dose; long-term monitoring required",
              "orderSentence": "Oxycodone (low-dose) 5 mg qHS PO"
            },
            "contraindications": "Opioid use disorder; severe respiratory disease; concurrent CNS depressants",
            "monitoring": "Constipation, sedation, dependence; respiratory depression; prescribe conservatively",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Oxycodone/naloxone (Targiniq ER)",
            "route": "PO",
            "indication": "Refractory RLS with constipation concern",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5/2.5 mg BID",
                  "orderSentence": "Oxycodone/naloxone (Targiniq ER) 5/2.5 mg BID PO"
                },
                {
                  "text": "10/5 mg BID",
                  "orderSentence": "Oxycodone/naloxone (Targiniq ER) 10/5 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5/2.5 mg BID; max 20/10 mg BID; naloxone reduces constipation",
              "orderSentence": "Oxycodone/naloxone (Targiniq ER) 5/2.5 mg BID PO"
            },
            "contraindications": "Same as oxycodone",
            "monitoring": "Same; monitor bowel function",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Methadone",
            "route": "PO",
            "indication": "Severe refractory RLS failing other opioids",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg qHS",
                  "orderSentence": "Methadone 5 mg qHS PO"
                },
                {
                  "text": "5 mg BID",
                  "orderSentence": "Methadone 5 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "5 mg qHS to BID; requires experienced prescriber; ECG monitoring for QTc",
              "orderSentence": "Methadone 5 mg qHS PO"
            },
            "contraindications": "QTc prolongation; opioid use disorder; respiratory disease",
            "monitoring": "QTc interval; respiratory status; requires DEA registration",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Clonazepam",
            "route": "PO",
            "indication": "Adjunct for sleep; helps with PLMS-related arousals",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.25 mg qHS",
                  "orderSentence": "Clonazepam 0.25 mg qHS PO"
                },
                {
                  "text": "0.5 mg qHS",
                  "orderSentence": "Clonazepam 0.5 mg qHS PO"
                },
                {
                  "text": "1 mg qHS",
                  "orderSentence": "Clonazepam 1 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.25 mg qHS; max 2 mg qHS; use short-term or intermittently",
              "orderSentence": "Clonazepam 0.25 mg qHS PO"
            },
            "contraindications": "Fall risk in elderly; respiratory depression; substance use history",
            "monitoring": "Sedation, dependence, falls, cognitive effects; avoid long-term in elderly",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Clonidine",
            "route": "PO",
            "indication": "Alternative for mild symptoms; alpha-2 agonist",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.1 mg qHS",
                  "orderSentence": "Clonidine 0.1 mg qHS PO"
                },
                {
                  "text": "0.2 mg qHS",
                  "orderSentence": "Clonidine 0.2 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.1 mg qHS; max 0.3 mg qHS",
              "orderSentence": "Clonidine 0.1 mg qHS PO"
            },
            "contraindications": "Hypotension; bradycardia",
            "monitoring": "BP, HR; rebound hypertension if stopped abruptly",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Buprenorphine patch",
            "route": "Transdermal",
            "indication": "Severe refractory RLS; concern for opioid misuse",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mcg/hr",
                  "orderSentence": "Buprenorphine patch 5 mcg/hr Transdermal"
                },
                {
                  "text": "10 mcg/hr",
                  "orderSentence": "Buprenorphine patch 10 mcg/hr Transdermal"
                }
              ],
              "route": "Transdermal",
              "instructions": "Start 5 mcg/hr weekly patch; titrate slowly",
              "orderSentence": "Buprenorphine patch 5 mcg/hr Transdermal"
            },
            "contraindications": "Same as other opioids",
            "monitoring": "Same; requires REMS prescriber certification (changing)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Dipyridamole",
            "route": "PO",
            "indication": "Limited evidence; adenosine modulation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg qHS",
                  "orderSentence": "Dipyridamole 100 mg qHS PO"
                },
                {
                  "text": "200 mg qHS",
                  "orderSentence": "Dipyridamole 200 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "100-200 mg qHS; off-label; variable response",
              "orderSentence": "Dipyridamole 100 mg qHS PO"
            },
            "contraindications": "Hypotension; bleeding disorders",
            "monitoring": "Headache, hypotension",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Augmentation Management": [
          {
            "item": "Dopamine agonist taper",
            "route": "PO",
            "indication": "Augmentation from dopamine agonist; must taper slowly",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10-25% dose reduction q1-2wk",
                  "orderSentence": "Dopamine agonist taper 10-25% dose reduction q1-2wk PO"
                }
              ],
              "route": "PO",
              "instructions": "Reduce dopamine agonist by 10-25% every 1-2 weeks; expect 1-2 weeks worsening (\"washout\"); bridge with alpha-2-delta or opioid",
              "orderSentence": "Dopamine agonist taper 10-25% dose reduction q1-2wk PO"
            },
            "contraindications": "Do NOT stop abruptly (dopamine agonist withdrawal syndrome)",
            "monitoring": "Worsening symptoms during taper (expected); DAWS symptoms",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Alpha-2-delta ligand bridge",
            "route": "PO",
            "indication": "Cover augmentation symptoms during dopamine agonist taper",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per gabapentin or pregabalin dosing",
                  "orderSentence": "Alpha-2-delta ligand bridge Per gabapentin or pregabalin dosing PO"
                }
              ],
              "route": "PO",
              "instructions": "Start alpha-2-delta at therapeutic dose before or during dopamine agonist taper; provides symptom coverage",
              "orderSentence": "Alpha-2-delta ligand bridge Per gabapentin or pregabalin dosing PO"
            },
            "contraindications": "Per individual drug",
            "monitoring": "Sedation; adjust as dopamine agonist tapers",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Low-dose opioid bridge",
            "route": "PO",
            "indication": "Severe augmentation; alpha-2-delta insufficient",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per tramadol or oxycodone dosing",
                  "orderSentence": "Low-dose opioid bridge Per tramadol or oxycodone dosing PO"
                }
              ],
              "route": "PO",
              "instructions": "Short-term opioid coverage during dopamine agonist washout; plan transition to non-dopaminergic maintenance",
              "orderSentence": "Low-dose opioid bridge Per tramadol or oxycodone dosing PO"
            },
            "contraindications": "History of opioid use disorder",
            "monitoring": "Dependence; use short-term",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Sleep medicine referral for polysomnography if sleep apnea suspected or PLMS quantification needed",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Neurology/movement disorders consultation for refractory RLS or diagnostic uncertainty",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Hematology referral for IV iron infusion coordination or complex iron deficiency management",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pain management consultation for severe refractory cases requiring opioid therapy",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Nephrology referral if chronic kidney disease contributing to secondary RLS",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Psychiatry consultation if impulse control disorders develop on dopamine agonist therapy",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "OB/GYN coordination for RLS management during pregnancy (common; limits treatment options)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Take iron supplements on an empty stomach every other day (better absorption) with vitamin C; avoid taking with calcium, coffee, or tea",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Take evening medications 2-3 hours before typical symptom onset for best effect",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Report symptoms spreading to arms, occurring earlier in day, or becoming more intense (signs of augmentation)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Report new gambling urges, compulsive shopping, or hypersexuality if taking dopamine agonists (impulse control disorders)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid antihistamines (diphenhydramine, Benadryl) which significantly worsen RLS - use alternatives for allergies or sleep",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Inform prescribers about RLS before starting new medications as many can worsen symptoms",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Keep a symptom diary tracking severity, timing, and potential triggers to optimize treatment",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Return if symptoms become severe enough to affect sleep, daytime function, or quality of life",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Avoid caffeine especially in afternoon and evening as it worsens RLS symptoms",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Limit or avoid alcohol which disrupts sleep architecture and can worsen RLS",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid nicotine/smoking which can exacerbate symptoms through vasoconstriction and sleep disruption",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Regular moderate exercise (walking, swimming, yoga) earlier in day reduces symptoms; avoid vigorous exercise near bedtime",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Maintain regular sleep schedule with consistent bed and wake times (sleep hygiene)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Leg massage, warm baths, or heating pads in the evening may provide temporary symptomatic relief",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Cooling measures (cold compresses, leg wraps) may help some patients",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Mental distraction activities (engaging video games, puzzles) can reduce symptom awareness",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Compression stockings or pneumatic compression may provide relief in some patients",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Review all current medications with provider to identify and eliminate RLS-exacerbating drugs",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Nocturnal leg cramps",
        "features": "Painful muscle contraction; visible/palpable muscle tightness; no urge to move",
        "tests": "Clinical history; no relief with movement"
      },
      {
        "diagnosis": "Peripheral neuropathy",
        "features": "Numbness, tingling, burning in stocking-glove distribution; not circadian",
        "tests": "EMG/NCS; exam findings (reflexes, sensation)"
      },
      {
        "diagnosis": "Akathisia",
        "features": "Inner restlessness; not limited to legs; associated with antipsychotic use",
        "tests": "Medication history; generalized restlessness"
      },
      {
        "diagnosis": "Positional discomfort",
        "features": "Relieved by position change; no urge to move specifically",
        "tests": "Clinical history"
      },
      {
        "diagnosis": "Periodic limb movement disorder (PLMD)",
        "features": "PLMS without RLS symptoms; bed partner may report jerking",
        "tests": "PSG shows PLMS; no waking leg discomfort"
      },
      {
        "diagnosis": "Venous insufficiency",
        "features": "Aching worse with standing; varicosities visible; edema",
        "tests": "Doppler ultrasound; worse during day"
      },
      {
        "diagnosis": "Arthritis (hip, knee, ankle)",
        "features": "Joint pain; stiffness; localized to joints",
        "tests": "X-ray; rheumatologic workup"
      },
      {
        "diagnosis": "Radiculopathy/sciatica",
        "features": "Dermatomal pattern; worsened by spine movement; back pain",
        "tests": "MRI spine; positive straight leg raise"
      },
      {
        "diagnosis": "Growing pains (pediatric)",
        "features": "Children; bilateral leg pain; no urge to move",
        "tests": "Clinical history; self-limited"
      },
      {
        "diagnosis": "Fibromyalgia",
        "features": "Widespread pain; tender points; fatigue",
        "tests": "Clinical criteria; no specific test"
      },
      {
        "diagnosis": "Anxiety/stress-related symptoms",
        "features": "Generalized restlessness; racing thoughts; no circadian pattern",
        "tests": "Psychiatric evaluation"
      },
      {
        "diagnosis": "Drug-induced restlessness",
        "features": "Temporal relationship with offending medication",
        "tests": "Medication review; trial withdrawal"
      }
    ],
    "evidence": [
      {
        "recommendation": "Alpha-2-delta ligands (gabapentin, pregabalin) first-line for RLS",
        "evidenceLevel": "Class I, Level A",
        "source": "[Silber et al. Mayo Clin Proc 2021](https://pubmed.ncbi.nlm.nih.gov/34218864/)"
      },
      {
        "recommendation": "Gabapentin enacarbil FDA-approved for RLS",
        "evidenceLevel": "Class I, Level A",
        "source": "[Kushida et al. Neurology 2009](https://pubmed.ncbi.nlm.nih.gov/19487651/)"
      },
      {
        "recommendation": "Pregabalin effective for RLS",
        "evidenceLevel": "Class I, Level A",
        "source": "[Allen et al. Sleep Med 2014](https://pubmed.ncbi.nlm.nih.gov/25023924/)"
      },
      {
        "recommendation": "Iron supplementation if ferritin <75 ng/mL",
        "evidenceLevel": "Class I, Level A",
        "source": "[Allen et al. Sleep Med 2018](https://pubmed.ncbi.nlm.nih.gov/29425576/)"
      },
      {
        "recommendation": "IV iron effective for RLS with iron deficiency",
        "evidenceLevel": "Class I, Level B",
        "source": "[Trotti et al. J Clin Sleep Med 2012](https://pubmed.ncbi.nlm.nih.gov/22851808/)"
      },
      {
        "recommendation": "Dopamine agonist augmentation risk",
        "evidenceLevel": "Class II, Level B",
        "source": "[Garcia-Borreguero et al. Sleep Med 2016](https://pubmed.ncbi.nlm.nih.gov/27091377/)"
      },
      {
        "recommendation": "Low-dose opioids for refractory RLS",
        "evidenceLevel": "Class II, Level B",
        "source": "[Trenkwalder et al. Lancet Neurol 2013](https://pubmed.ncbi.nlm.nih.gov/24140442/)"
      },
      {
        "recommendation": "IRLSSG diagnostic criteria",
        "evidenceLevel": "Consensus, Level A",
        "source": "[Allen et al. Sleep Med 2014](https://pubmed.ncbi.nlm.nih.gov/25023924/)"
      },
      {
        "recommendation": "Dopamine agonists effective but augmentation concern",
        "evidenceLevel": "Class I, Level A",
        "source": "[Silber et al. Mayo Clin Proc 2013](https://pubmed.ncbi.nlm.nih.gov/24012413/)"
      },
      {
        "recommendation": "Pregnancy-associated RLS prevalence up to 25%",
        "evidenceLevel": "Class II, Level B",
        "source": "[Manconi et al. Neurology 2004](https://pubmed.ncbi.nlm.nih.gov/15365141/)"
      },
      {
        "recommendation": "Medications that worsen RLS",
        "evidenceLevel": "Class II-III, Level B-C",
        "source": "[Mackie & Winkelman. Drugs 2015](https://pubmed.ncbi.nlm.nih.gov/25899894/)"
      },
      {
        "recommendation": "Long-term management recommendations",
        "evidenceLevel": "Consensus, Level C",
        "source": "[Garcia-Borreguero et al. Sleep Med Rev 2013](https://pubmed.ncbi.nlm.nih.gov/23357083/)"
      }
    ],
    "monitoring": [
      {
        "item": "IRLS severity scale",
        "frequency": "Each visit",
        "action": "Titrate medication; consider alternative agent",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Sleep quality (subjective and actigraphy if available)",
        "frequency": "Each visit",
        "action": "Assess compliance; consider adjuncts",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Ferritin level",
        "frequency": "Every 3-4 months during repletion; annually when stable",
        "action": "Continue or restart iron supplementation",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Transferrin saturation",
        "frequency": "With ferritin",
        "action": "Continue iron therapy",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Augmentation assessment",
        "frequency": "Each visit if on dopamine agonist",
        "action": "Taper dopamine agonist; switch to non-dopaminergic",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Impulse control disorders (ICDs)",
        "frequency": "Each visit if on dopamine agonist",
        "action": "Stop or reduce dopamine agonist",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Daytime somnolence",
        "frequency": "Each visit",
        "action": "Reduce dose; evaluate for sleep apnea",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Renal function (if on gabapentin/pregabalin)",
        "frequency": "Annually or with changes",
        "action": "Dose adjust per renal function",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Weight, edema (if on gabapentin/pregabalin)",
        "frequency": "Each visit",
        "action": "Dose reduction; switch agent",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "QTc (if on methadone)",
        "frequency": "Baseline, 2-4 weeks, annually",
        "action": "Reduce dose; consider alternative",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      }
    ],
    "disposition": [
      {
        "disposition": "Discharge home with outpatient follow-up",
        "criteria": "Typical RLS diagnosis; initial workup ordered; treatment started or planned; follow-up arranged"
      },
      {
        "disposition": "Outpatient management (primary)",
        "criteria": "All patients with RLS; return 2-4 weeks for medication titration; then q3-6 months when stable"
      },
      {
        "disposition": "Admit to hospital (rare)",
        "criteria": "Severe refractory RLS preventing all sleep (unusual); IV iron infusion coordination if outpatient not available; acute decompensation with comorbidities"
      },
      {
        "disposition": "ED evaluation",
        "criteria": "Rarely needed; may see for severe acute symptoms or secondary cause evaluation"
      }
    ]
  },
  "Tension-Type Headache": {
    "id": "tension-headache",
    "title": "Tension-Type Headache",
    "version": "1.0",
    "icd10": [
      "** G44.209 (Tension-type headache",
      "unspecified",
      "not intractable)"
    ],
    "scope": "** Episodic and chronic tension-type headache diagnosis, acute treatment, and preventive therapy. Excludes secondary headaches, medication overuse headache (separate protocol), and trigeminal autonomic cephalalgias.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC",
            "rationale": "Rule out anemia or infection as headache trigger",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "BMP",
            "rationale": "Electrolyte abnormalities can trigger headaches",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "TSH",
            "rationale": "Hypothyroidism associated with chronic headache",
            "target": "Normal (0.4-4.0 mIU/L)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended Workup": [
          {
            "item": "ESR, CRP",
            "rationale": "Rule out giant cell arteritis if age >50 with new headache",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin D level",
            "rationale": "Deficiency associated with chronic pain and headache",
            "target": ">30 ng/mL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ferritin",
            "rationale": "Iron deficiency associated with headache",
            "target": ">50 ng/mL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Magnesium (RBC)",
            "rationale": "Low magnesium linked to headache disorders",
            "target": ">4.2 mg/dL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "ANA",
            "rationale": "Rule out autoimmune disorder in atypical presentations",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Sleep study",
            "rationale": "Evaluate for sleep apnea contributing to chronic headache",
            "target": "AHI <5",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Lyme serology",
            "rationale": "Consider in endemic areas with refractory symptoms",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "MRI Brain without contrast",
            "timing": "Only if red flags present (see SNNOOP10 below)",
            "target": "Normal",
            "contraindications": "MRI-incompatible devices",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CT Head non-contrast",
            "timing": "Acute severe headache or new neurological deficits",
            "target": "No hemorrhage, mass, or hydrocephalus",
            "contraindications": "Pregnancy (relative)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          }
        ],
        "Extended": [
          {
            "item": "MRI Brain with contrast",
            "timing": "Atypical features, focal deficits, suspected secondary cause",
            "target": "No enhancement or mass lesion",
            "contraindications": "Gadolinium allergy, severe renal impairment",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "MRA Head/Neck",
            "timing": "Suspected vascular etiology or cervical artery dissection",
            "target": "Patent vessels; no dissection",
            "contraindications": "MRI contraindications",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "C-spine X-ray or MRI",
            "timing": "Cervicogenic component suspected",
            "target": "Normal alignment; no disc disease",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "MRV Brain",
            "timing": "Suspected cerebral venous thrombosis",
            "target": "Patent venous sinuses",
            "contraindications": "MRI contraindications",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "LP with opening pressure",
            "timing": "Suspected idiopathic intracranial hypertension",
            "target": "Normal (10-20 cm H2O)",
            "contraindications": "Coagulopathy; mass lesion",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "Ketorolac",
            "route": "IV/IM",
            "indication": "Severe acute TTH in ED; NSAID-responsive headache",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mg IV",
                  "orderSentence": "Ketorolac 30 mg IV IV"
                },
                {
                  "text": "15 mg IV",
                  "orderSentence": "Ketorolac 15 mg IV IV"
                }
              ],
              "route": "IV",
              "instructions": "30 mg IV x1 (15 mg if >65y, renal impairment, or <50 kg); do not exceed 5 days total NSAIDs",
              "orderSentence": "Ketorolac 30 mg IV IV"
            },
            "contraindications": "Renal impairment; GI bleed history; aspirin allergy; third trimester pregnancy",
            "monitoring": "Renal function if repeated dosing",
            "ED": "STAT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Metoclopramide",
            "route": "IV",
            "indication": "Acute headache with nausea; has anti-headache properties",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg IV",
                  "orderSentence": "Metoclopramide 10 mg IV IV"
                }
              ],
              "route": "IV",
              "instructions": "10 mg IV over 15 min; pretreat with diphenhydramine 25 mg to prevent akathisia",
              "orderSentence": "Metoclopramide 10 mg IV IV"
            },
            "contraindications": "Parkinson's disease; tardive dyskinesia history; bowel obstruction",
            "monitoring": "Akathisia, dystonic reaction",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Diphenhydramine",
            "route": "IV",
            "indication": "Adjunct to prevent akathisia from dopamine antagonists",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg IV",
                  "orderSentence": "Diphenhydramine 25 mg IV IV"
                }
              ],
              "route": "IV",
              "instructions": "25 mg IV prior to metoclopramide",
              "orderSentence": "Diphenhydramine 25 mg IV IV"
            },
            "contraindications": "Narrow-angle glaucoma; urinary retention",
            "monitoring": "Sedation",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          }
        ],
        "Symptomatic Treatments": [
          {
            "item": "Ibuprofen",
            "route": "PO",
            "indication": "First-line acute treatment for episodic TTH",
            "dosing": {
              "doseOptions": [
                {
                  "text": "400 mg PO",
                  "orderSentence": "Ibuprofen 400 mg PO PO"
                },
                {
                  "text": "600 mg PO",
                  "orderSentence": "Ibuprofen 600 mg PO PO"
                },
                {
                  "text": "800 mg PO",
                  "orderSentence": "Ibuprofen 800 mg PO PO"
                }
              ],
              "route": "PO",
              "instructions": "400-800 mg PO at onset; may repeat q6-8h; max 2400 mg/day; limit to <10 days/month",
              "orderSentence": "Ibuprofen 400 mg PO PO"
            },
            "contraindications": "Renal impairment; GI bleed history; aspirin allergy; third trimester",
            "monitoring": "GI symptoms; renal function if prolonged use",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Naproxen",
            "route": "PO",
            "indication": "First-line acute treatment; longer duration than ibuprofen",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mg PO",
                  "orderSentence": "Naproxen 500 mg PO PO"
                },
                {
                  "text": "550 mg PO",
                  "orderSentence": "Naproxen 550 mg PO PO"
                }
              ],
              "route": "PO",
              "instructions": "500-550 mg PO at onset; may repeat 250 mg in 12 hr; max 1250 mg/day; limit to <10 days/month",
              "orderSentence": "Naproxen 500 mg PO PO"
            },
            "contraindications": "Renal impairment; GI bleed history; aspirin allergy; third trimester",
            "monitoring": "GI symptoms; renal function if prolonged use",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Acetaminophen",
            "route": "PO",
            "indication": "First-line if NSAID contraindicated; mild-moderate TTH",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mg PO",
                  "orderSentence": "Acetaminophen 1000 mg PO PO"
                }
              ],
              "route": "PO",
              "instructions": "1000 mg PO at onset; may repeat q6h; max 3000 mg/day (2000 mg if liver disease); limit to <10 days/month",
              "orderSentence": "Acetaminophen 1000 mg PO PO"
            },
            "contraindications": "Severe hepatic impairment; avoid if >3 alcoholic drinks/day",
            "monitoring": "LFTs if chronic use; total daily dose from all sources",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Aspirin",
            "route": "PO",
            "indication": "First-line acute treatment; anti-inflammatory",
            "dosing": {
              "doseOptions": [
                {
                  "text": "650 mg PO",
                  "orderSentence": "Aspirin 650 mg PO PO"
                },
                {
                  "text": "1000 mg PO",
                  "orderSentence": "Aspirin 1000 mg PO PO"
                }
              ],
              "route": "PO",
              "instructions": "650-1000 mg PO at onset; max 4000 mg/day; limit to <10 days/month",
              "orderSentence": "Aspirin 650 mg PO PO"
            },
            "contraindications": "Bleeding disorders; GI ulcer; aspirin allergy; children/teens (Reye syndrome); third trimester",
            "monitoring": "GI symptoms; bleeding",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Caffeine/Analgesic combination",
            "route": "PO",
            "indication": "Enhanced efficacy with caffeine adjunct",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 tablets PO",
                  "orderSentence": "Caffeine/Analgesic combination 2 tablets PO PO"
                }
              ],
              "route": "PO",
              "instructions": "Acetaminophen 250 mg/aspirin 250 mg/caffeine 65 mg: 2 tablets at onset; max 2 doses/24hr",
              "orderSentence": "Caffeine/Analgesic combination 2 tablets PO PO"
            },
            "contraindications": "Aspirin or acetaminophen contraindications",
            "monitoring": "Limit use to prevent caffeine dependence and MOH",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Second-line/Refractory": [
          {
            "item": "Trigger point injection",
            "route": "IM",
            "indication": "Pericranial muscle tenderness; refractory to oral therapy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1-2 mL 1% lidocaine",
                  "orderSentence": "Trigger point injection 1-2 mL 1% lidocaine IM"
                }
              ],
              "route": "IM",
              "instructions": "Inject 1-2 mL 1% lidocaine into tender points in trapezius, temporalis, or cervical paraspinals; may repeat q2-4wk",
              "orderSentence": "Trigger point injection 1-2 mL 1% lidocaine IM"
            },
            "contraindications": "Local anesthetic allergy; infection at site",
            "monitoring": "Local bruising; vasovagal response",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Greater occipital nerve block",
            "route": "SC",
            "indication": "Occipital-predominant pain; refractory cases",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2-3 mL 2% lidocaine",
                  "orderSentence": "Greater occipital nerve block 2-3 mL 2% lidocaine SC"
                }
              ],
              "route": "SC",
              "instructions": "2-3 mL 2% lidocaine with or without 40 mg triamcinolone at greater occipital nerve bilaterally",
              "orderSentence": "Greater occipital nerve block 2-3 mL 2% lidocaine SC"
            },
            "contraindications": "Local anesthetic allergy; infection at site",
            "monitoring": "Immediate pain relief; monitor for vasovagal",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Physical therapy",
            "route": "N/A",
            "indication": "Musculoskeletal dysfunction; postural abnormalities",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Physical therapy N/A N/A"
                }
              ],
              "route": "N/A",
              "instructions": "1-2 sessions/week for 6-8 weeks focusing on cervical/shoulder mobility, posture, and relaxation techniques",
              "orderSentence": "Physical therapy N/A N/A"
            },
            "contraindications": "None",
            "monitoring": "Symptom improvement over 6-8 weeks",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Biofeedback/Relaxation therapy",
            "route": "N/A",
            "indication": "Stress-related TTH; patient preference for non-pharmacologic",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Biofeedback/Relaxation therapy N/A N/A"
                }
              ],
              "route": "N/A",
              "instructions": "Weekly sessions for 8-12 weeks; EMG biofeedback targeting frontalis/temporalis; may combine with CBT",
              "orderSentence": "Biofeedback/Relaxation therapy N/A N/A"
            },
            "contraindications": "None",
            "monitoring": "Symptom diary; headache frequency reduction",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Cognitive behavioral therapy (CBT)",
            "route": "N/A",
            "indication": "Stress, anxiety, or depression contributing to headache",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Cognitive behavioral therapy (CBT) N/A N/A"
                }
              ],
              "route": "N/A",
              "instructions": "Weekly sessions for 8-12 weeks; focus on pain coping, stress management, and cognitive restructuring",
              "orderSentence": "Cognitive behavioral therapy (CBT) N/A N/A"
            },
            "contraindications": "None",
            "monitoring": "Symptom diary; validated headache disability measures",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Disease-Modifying or Chronic Therapies (Preventive Medications)": [
          {
            "item": "Amitriptyline",
            "route": "PO",
            "indication": "First-line prevention for chronic TTH; ≥15 days/month",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg qHS",
                  "orderSentence": "Amitriptyline 10 mg qHS PO"
                },
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Amitriptyline 25 mg qHS PO"
                },
                {
                  "text": "50 mg qHS",
                  "orderSentence": "Amitriptyline 50 mg qHS PO"
                },
                {
                  "text": "75 mg qHS",
                  "orderSentence": "Amitriptyline 75 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10 mg qHS; titrate by 10-25 mg every 1-2 weeks; target 25-75 mg qHS; max 150 mg qHS",
              "orderSentence": "Amitriptyline 10 mg qHS PO"
            },
            "pretreatment": "ECG if age >50 or cardiac history",
            "contraindications": "Cardiac conduction abnormality (QTc >450 ms); recent MI; narrow-angle glaucoma; urinary retention; concurrent MAOIs",
            "monitoring": "Sedation, dry mouth, weight gain, constipation; ECG if dose >100 mg/day",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Nortriptyline",
            "route": "PO",
            "indication": "Prevention if amitriptyline not tolerated (less sedating); chronic TTH",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg qHS",
                  "orderSentence": "Nortriptyline 10 mg qHS PO"
                },
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Nortriptyline 25 mg qHS PO"
                },
                {
                  "text": "50 mg qHS",
                  "orderSentence": "Nortriptyline 50 mg qHS PO"
                },
                {
                  "text": "75 mg qHS",
                  "orderSentence": "Nortriptyline 75 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10 mg qHS; titrate by 10-25 mg every 1-2 weeks; target 25-75 mg qHS; max 150 mg qHS",
              "orderSentence": "Nortriptyline 10 mg qHS PO"
            },
            "pretreatment": "ECG if age >50 or cardiac history",
            "contraindications": "Cardiac conduction abnormality (QTc >450 ms); recent MI; narrow-angle glaucoma; urinary retention; concurrent MAOIs",
            "monitoring": "Sedation (less than amitriptyline), dry mouth, weight gain, constipation; ECG if dose >100 mg/day",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Venlafaxine XR",
            "route": "PO",
            "indication": "Prevention; comorbid depression or anxiety; TCA intolerant",
            "dosing": {
              "doseOptions": [
                {
                  "text": "37.5 mg daily",
                  "orderSentence": "Venlafaxine XR 37.5 mg daily PO"
                },
                {
                  "text": "75 mg daily",
                  "orderSentence": "Venlafaxine XR 75 mg daily PO"
                },
                {
                  "text": "150 mg daily",
                  "orderSentence": "Venlafaxine XR 150 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 37.5 mg daily; increase by 37.5-75 mg every 1 week; target 75-150 mg daily",
              "orderSentence": "Venlafaxine XR 37.5 mg daily PO"
            },
            "pretreatment": "None",
            "contraindications": "Uncontrolled hypertension; concurrent MAOIs; abrupt discontinuation (taper required)",
            "monitoring": "Blood pressure at higher doses (>150 mg); serotonin syndrome signs",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Mirtazapine",
            "route": "PO",
            "indication": "Prevention; comorbid insomnia, depression, or poor appetite",
            "dosing": {
              "doseOptions": [
                {
                  "text": "7.5 mg qHS",
                  "orderSentence": "Mirtazapine 7.5 mg qHS PO"
                },
                {
                  "text": "15 mg qHS",
                  "orderSentence": "Mirtazapine 15 mg qHS PO"
                },
                {
                  "text": "30 mg qHS",
                  "orderSentence": "Mirtazapine 30 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 7.5-15 mg qHS; may increase to 30 mg qHS; more sedating at lower doses",
              "orderSentence": "Mirtazapine 7.5 mg qHS PO"
            },
            "pretreatment": "None",
            "contraindications": "Concurrent MAOIs; severe hepatic impairment",
            "monitoring": "Sedation, increased appetite, weight gain",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Tizanidine",
            "route": "PO",
            "indication": "Prevention; prominent pericranial muscle tension",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 mg qHS",
                  "orderSentence": "Tizanidine 2 mg qHS PO"
                },
                {
                  "text": "4 mg qHS",
                  "orderSentence": "Tizanidine 4 mg qHS PO"
                },
                {
                  "text": "2 mg TID",
                  "orderSentence": "Tizanidine 2 mg TID PO"
                },
                {
                  "text": "4 mg TID",
                  "orderSentence": "Tizanidine 4 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 2 mg qHS; may increase by 2-4 mg every 3-7 days; max 36 mg/day in 3 divided doses",
              "orderSentence": "Tizanidine 2 mg qHS PO"
            },
            "pretreatment": "LFTs at baseline",
            "contraindications": "Concurrent ciprofloxacin or fluvoxamine (CYP1A2 inhibitors); hepatic impairment",
            "monitoring": "LFTs monthly for first 6 months then periodically; sedation, hypotension, dry mouth",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Topiramate",
            "route": "PO",
            "indication": "Prevention; comorbid migraine or obesity",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Topiramate 25 mg qHS PO"
                },
                {
                  "text": "50 mg BID",
                  "orderSentence": "Topiramate 50 mg BID PO"
                },
                {
                  "text": "75 mg BID",
                  "orderSentence": "Topiramate 75 mg BID PO"
                },
                {
                  "text": "100 mg BID",
                  "orderSentence": "Topiramate 100 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg qHS; increase by 25 mg/week; target 50-100 mg BID",
              "orderSentence": "Topiramate 25 mg qHS PO"
            },
            "pretreatment": "None",
            "contraindications": "Narrow-angle glaucoma; kidney stones; pregnancy (teratogen); metabolic acidosis",
            "monitoring": "Cognitive effects (word-finding), paresthesias, weight loss, kidney stones, bicarbonate",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Gabapentin",
            "route": "PO",
            "indication": "Prevention; comorbid neuropathic pain or anxiety",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg qHS",
                  "orderSentence": "Gabapentin 300 mg qHS PO"
                },
                {
                  "text": "300 mg TID",
                  "orderSentence": "Gabapentin 300 mg TID PO"
                },
                {
                  "text": "600 mg TID",
                  "orderSentence": "Gabapentin 600 mg TID PO"
                },
                {
                  "text": "900 mg TID",
                  "orderSentence": "Gabapentin 900 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 300 mg qHS; titrate by 300 mg every 3-5 days; target 900-1800 mg/day in 3 divided doses",
              "orderSentence": "Gabapentin 300 mg qHS PO"
            },
            "pretreatment": "None",
            "contraindications": "Severe renal impairment (dose adjust for CrCl)",
            "monitoring": "Sedation, dizziness, peripheral edema",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurology/Headache specialist referral for chronic TTH (≥15 days/month) not responding to first-line preventives",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Physical therapy for cervicogenic component, postural dysfunction, and pericranial muscle tension",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Behavioral medicine/Psychology for stress management, biofeedback, and cognitive behavioral therapy",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sleep medicine evaluation if underlying sleep disorder (insomnia, apnea) contributing to chronic headache",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ophthalmology evaluation to rule out refractive error or eye strain as contributing factor",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Dentistry/TMJ specialist if temporomandibular joint dysfunction contributing to headache",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Psychiatry referral for comorbid depression or anxiety requiring pharmacologic management beyond preventive therapy",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Return immediately for sudden severe headache (\"worst headache of life\") which may indicate hemorrhage or other serious cause",
            "ED": "STAT",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Return immediately for headache with fever, stiff neck, or altered mental status which may indicate infection",
            "ED": "STAT",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Return if new neurological symptoms develop (weakness, numbness, vision changes, speech difficulty)",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Maintain headache diary tracking frequency, triggers, medication use, and response to guide treatment optimization",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Limit acute pain medication use to no more than 10 days per month to prevent medication overuse headache",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Take acute medications early at headache onset for best efficacy rather than waiting for severe pain",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Identify and modify personal triggers (stress, poor posture, inadequate sleep, screen time, skipped meals)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Regular sleep schedule (7-8 hours, consistent bedtime and wake time) as sleep disturbance is a common trigger",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Stress management through relaxation techniques, mindfulness meditation, or progressive muscle relaxation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Regular aerobic exercise (30 minutes moderate activity 5 times/week) shown to reduce chronic headache frequency",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Ergonomic workplace assessment to optimize posture and reduce neck/shoulder strain during computer work",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Limit screen time and take regular breaks (20-20-20 rule: every 20 minutes, look 20 feet away for 20 seconds)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Adequate hydration (at least 64 oz water daily) as dehydration can trigger headache",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Regular meals to avoid fasting-triggered headache; do not skip meals",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Limit caffeine to moderate consistent intake (≤200 mg/day or ~2 cups coffee) to prevent withdrawal headaches",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Stretching exercises for neck and shoulders daily, especially if sedentary work",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Migraine",
        "features": "Unilateral, pulsating, moderate-severe intensity; nausea/vomiting; photo AND phonophobia; aggravated by physical activity",
        "tests": "Clinical criteria (ICHD-3); normal imaging"
      },
      {
        "diagnosis": "Medication overuse headache",
        "features": "Daily or near-daily headache; acute medication use ≥10-15 days/month for ≥3 months",
        "tests": "Headache diary documenting medication use; improves with withdrawal"
      },
      {
        "diagnosis": "Cervicogenic headache",
        "features": "Unilateral, starts in neck, radiates frontally; triggered by neck movement or sustained posture; reduced ROM",
        "tests": "Physical exam (decreased ROM, tenderness); C-spine imaging; diagnostic block"
      },
      {
        "diagnosis": "Temporomandibular joint dysfunction",
        "features": "Pain in jaw, temple, or preauricular area; worse with chewing; clicking/popping of jaw; bruxism history",
        "tests": "TMJ exam; panoramic dental X-ray; may need MRI TMJ"
      },
      {
        "diagnosis": "Giant cell arteritis",
        "features": "Age >50; new headache type; scalp tenderness; jaw claudication; visual changes; elevated ESR/CRP",
        "tests": "ESR, CRP; temporal artery biopsy (gold standard)"
      },
      {
        "diagnosis": "Idiopathic intracranial hypertension",
        "features": "Positional headache (worse lying flat); papilledema; pulsatile tinnitus; visual obscurations; obesity",
        "tests": "LP with opening pressure >25 cm H2O; MRI/MRV normal"
      },
      {
        "diagnosis": "Intracranial mass lesion",
        "features": "Progressive headache; worse in morning or with Valsalva; focal neurological signs",
        "tests": "MRI brain with contrast"
      },
      {
        "diagnosis": "Cervical artery dissection",
        "features": "Sudden severe headache or neck pain; may have Horner syndrome; history of trauma or neck manipulation",
        "tests": "MRA or CTA neck"
      },
      {
        "diagnosis": "Trigeminal neuralgia",
        "features": "Brief (seconds) electric shock-like pain; unilateral V2/V3 distribution; triggered by touch, chewing, or talking",
        "tests": "MRI for vascular loop; clinical criteria"
      },
      {
        "diagnosis": "Cluster headache",
        "features": "Unilateral, periorbital, severe; autonomic features (lacrimation, rhinorrhea, ptosis, miosis); 15-180 min duration",
        "tests": "Clinical history; attacks occur in clusters"
      }
    ],
    "evidence": [
      {
        "recommendation": "ICHD-3 diagnostic criteria for tension-type headache",
        "evidenceLevel": "Expert Consensus",
        "source": "[Headache Classification Committee. Cephalalgia 2018](https://pubmed.ncbi.nlm.nih.gov/29368949/)"
      },
      {
        "recommendation": "Amitriptyline effective for chronic TTH prevention",
        "evidenceLevel": "Class I, Level A",
        "source": "[Bendtsen et al. Neurology 1996](https://pubmed.ncbi.nlm.nih.gov/8710059/)"
      },
      {
        "recommendation": "Simple analgesics (acetaminophen, NSAIDs, aspirin) for acute TTH",
        "evidenceLevel": "Class I, Level A",
        "source": "[Stephens et al. Cochrane 2016](https://pubmed.ncbi.nlm.nih.gov/27306653/)"
      },
      {
        "recommendation": "Tricyclic antidepressants for chronic TTH prevention",
        "evidenceLevel": "Class I, Level A",
        "source": "[Jackson et al. Neurology 2017](https://pubmed.ncbi.nlm.nih.gov/28179565/)"
      },
      {
        "recommendation": "Biofeedback and relaxation training reduce headache frequency",
        "evidenceLevel": "Class II, Level B",
        "source": "[Nestoriuc et al. Pain 2008](https://pubmed.ncbi.nlm.nih.gov/18455618/)"
      },
      {
        "recommendation": "Physical therapy for tension-type headache",
        "evidenceLevel": "Class II, Level B",
        "source": "[Espí-López et al. Phys Ther 2014](https://pubmed.ncbi.nlm.nih.gov/24903113/)"
      },
      {
        "recommendation": "Cognitive behavioral therapy reduces headache disability",
        "evidenceLevel": "Class I, Level B",
        "source": "[Holroyd et al. JAMA 2001](https://pubmed.ncbi.nlm.nih.gov/11565519/)"
      },
      {
        "recommendation": "Medication overuse headache prevalence and management",
        "evidenceLevel": "Expert Consensus",
        "source": "[Diener et al. Nat Rev Neurol 2016](https://pubmed.ncbi.nlm.nih.gov/27615420/)"
      },
      {
        "recommendation": "Ibuprofen 400-800 mg effective for acute TTH",
        "evidenceLevel": "Class I, Level A",
        "source": "[Steiner et al. Headache 2003](https://pubmed.ncbi.nlm.nih.gov/12656706/)"
      },
      {
        "recommendation": "Combination analgesics (aspirin/acetaminophen/caffeine) effective",
        "evidenceLevel": "Class I, Level A",
        "source": "[Diener et al. Cephalalgia 2006](https://pubmed.ncbi.nlm.nih.gov/16472332/)"
      },
      {
        "recommendation": "Venlafaxine for chronic TTH prevention",
        "evidenceLevel": "Class II, Level B",
        "source": "[Zissis et al. Headache 2007](https://pubmed.ncbi.nlm.nih.gov/17371352/)"
      },
      {
        "recommendation": "Topiramate for chronic TTH (limited evidence)",
        "evidenceLevel": "Class III, Level C",
        "source": "[Lampl et al. J Neurol 2006](https://pubmed.ncbi.nlm.nih.gov/16485112/)"
      },
      {
        "recommendation": "Greater occipital nerve block for refractory headache",
        "evidenceLevel": "Class II, Level B",
        "source": "[Afridi et al. Brain 2006](https://pubmed.ncbi.nlm.nih.gov/16330505/)"
      },
      {
        "recommendation": "SNNOOP10 red flags for secondary headache",
        "evidenceLevel": "Expert Consensus",
        "source": "[Do et al. Neurology 2019](https://pubmed.ncbi.nlm.nih.gov/30587518/)"
      }
    ],
    "monitoring": [
      {
        "item": "Headache diary (frequency, severity, duration, medication use)",
        "frequency": "Continuous at home; review each visit",
        "action": "Optimize preventive therapy; consider referral",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Acute medication use days per month",
        "frequency": "Monthly",
        "action": "Counsel on MOH risk; consider prevention; detox if MOH",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "HIT-6 disability score",
        "frequency": "Every 3 months",
        "action": "Escalate preventive therapy if disability persists",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "LFTs (if on tizanidine)",
        "frequency": "Baseline, monthly x 6 months, then q6mo",
        "action": "Hold or discontinue if >3x ULN",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "ECG (if on TCA)",
        "frequency": "Baseline if age >50 or cardiac history; if dose >100 mg",
        "action": "Reduce dose or switch agent if QTc prolonged",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Blood pressure (if on venlafaxine or SNRI)",
        "frequency": "Each visit",
        "action": "Reduce dose or add antihypertensive",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Weight (if on TCA or mirtazapine)",
        "frequency": "Each visit",
        "action": "Dietary counseling; consider switching agent",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Cognitive function (if on topiramate)",
        "frequency": "Each visit",
        "action": "Reduce dose or switch agent",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Bicarbonate (if on topiramate)",
        "frequency": "Baseline, 3 months",
        "action": "Consider dose reduction or discontinuation if acidosis",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      }
    ],
    "disposition": [
      {
        "disposition": "Discharge home",
        "criteria": "Pain controlled with oral medications; able to tolerate PO; no red flags; follow-up arranged; MOH counseling provided"
      },
      {
        "disposition": "Admit to floor",
        "criteria": "Rare; consider if: intractable headache requiring IV therapy; need for medication overuse headache detoxification protocol"
      },
      {
        "disposition": "Outpatient neurology follow-up",
        "criteria": "Within 4-8 weeks for chronic TTH not responding to first-line treatment; sooner if diagnostic uncertainty"
      },
      {
        "disposition": "Primary care follow-up",
        "criteria": "Within 2-4 weeks for new episodic TTH to assess response to acute treatment and need for prevention"
      }
    ]
  },
  "Migraine with Aura": {
    "id": "migraine-with-aura",
    "title": "Migraine with Aura",
    "version": "1.0",
    "icd10": [
      "** G43.109 (Migraine with aura",
      "not intractable",
      "without status migrainosus)"
    ],
    "scope": "** Diagnosis and management of migraine with typical aura (visual, sensory, language) and hemiplegic migraine. Focuses on outpatient management with acute care considerations. Covers differentiation from TIA/stroke, contraceptive counseling, and preventive therapy. Excludes migraine with brainstem aura (separate protocol) and retinal migraine.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC",
            "rationale": "Rule out anemia, infection; baseline before treatment",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "BMP",
            "rationale": "Electrolyte abnormalities; renal function for medication dosing",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Glucose",
            "rationale": "Hypoglycemia can mimic aura; hyperglycemia raises stroke risk",
            "target": "70-180 mg/dL",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "PT/INR, PTT",
            "rationale": "Coagulation screen if stroke consideration; before LP",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "HbA1c",
            "rationale": "Vascular risk assessment",
            "target": "<7% optimal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lipid panel",
            "rationale": "Vascular risk stratification",
            "target": "LDL <100 mg/dL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended Workup": [
          {
            "item": "ESR, CRP",
            "rationale": "Rule out GCA if age >50 with new visual symptoms",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "TSH",
            "rationale": "Thyroid dysfunction can trigger headache/aura-like symptoms",
            "target": "Normal (0.4-4.0 mIU/L)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Magnesium (RBC)",
            "rationale": "Deficiency linked to migraine with aura specifically",
            "target": ">4.2 mg/dL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Homocysteine",
            "rationale": "Elevated levels associated with migraine with aura and stroke",
            "target": "<15 μmol/L",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin B12, folate",
            "rationale": "Deficiency can elevate homocysteine; sensory symptoms",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin D, 25-OH",
            "rationale": "Deficiency associated with increased migraine frequency",
            "target": ">30 ng/mL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Antiphospholipid antibodies (lupus anticoagulant, anticardiolipin, anti-β2GP1)",
            "rationale": "Thrombophilia workup if young stroke or recurrent prolonged aura",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Factor V Leiden, prothrombin G20210A",
            "rationale": "Hereditary thrombophilia if recurrent aura or stroke-like events",
            "target": "Negative",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "ANA, anti-dsDNA",
            "rationale": "CNS lupus in atypical presentations",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "MTHFR mutation",
            "rationale": "Elevated homocysteine with aura",
            "target": "Wild type or heterozygous",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Genetic testing (CACNA1A, ATP1A2, SCN1A)",
            "rationale": "Hemiplegic migraine suspected; family history",
            "target": "Variant identified",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "CSF analysis",
            "rationale": "Rule out meningitis, SAH if atypical presentation",
            "target": "Normal; no xanthochromia",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "MRI Brain without contrast",
            "timing": "First presentation with aura; rule out stroke/structural lesion",
            "target": "Normal; no acute infarct; no WMH concerning for vasculopathy",
            "contraindications": "MRI-incompatible devices",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CT Head non-contrast",
            "timing": "Acute presentation if MRI unavailable; rule out hemorrhage",
            "target": "No hemorrhage or mass",
            "contraindications": "Pregnancy (relative)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "MRA Head",
            "timing": "First aura or prolonged aura to assess intracranial vessels",
            "target": "No stenosis, aneurysm, or dissection",
            "contraindications": "MRI contraindications",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended": [
          {
            "item": "MRI Brain with contrast",
            "timing": "Atypical features; persistent deficits; concern for mass",
            "target": "No enhancement; no mass",
            "contraindications": "Gadolinium allergy; severe renal impairment",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "MRA Neck",
            "timing": "Suspected cervical dissection (neck pain, Horner syndrome)",
            "target": "No dissection",
            "contraindications": "MRI contraindications",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CTA Head/Neck",
            "timing": "Acute vascular imaging if MRI unavailable",
            "target": "No aneurysm, dissection, occlusion",
            "contraindications": "Contrast allergy; CKD (eGFR <30)",
            "ED": "STAT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "TTE with bubble study",
            "timing": "Evaluate for PFO if recurrent aura or cryptogenic stroke history",
            "target": "No PFO; if present, assess shunt size",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "TEE",
            "timing": "Detailed cardiac source evaluation if TTE positive or high suspicion",
            "target": "No cardiac thrombus; characterize PFO",
            "contraindications": "Esophageal pathology",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "MRI with perfusion/DWI",
            "timing": "Prolonged aura to differentiate migrainous infarct from stroke",
            "target": "No DWI restriction",
            "contraindications": "MRI contraindications",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Transcranial Doppler with bubble",
            "timing": "PFO screening; noninvasive alternative to TTE bubble",
            "target": "No right-to-left shunt",
            "contraindications": "Inadequate acoustic windows",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "EEG",
            "timing": "Aura with altered consciousness; differentiate from seizure",
            "target": "No epileptiform activity",
            "contraindications": "None",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "Ketorolac",
            "route": "IV/IM",
            "indication": "First-line acute migraine with aura in ED",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mg IV x1",
                  "orderSentence": "Ketorolac 30 mg IV x1 IV"
                },
                {
                  "text": "15 mg IV x1",
                  "orderSentence": "Ketorolac 15 mg IV x1 IV"
                }
              ],
              "route": "IV",
              "instructions": "30 mg IV (15 mg if >65y, renal impairment, or <50 kg); max 5 days NSAIDs",
              "orderSentence": "Ketorolac 30 mg IV x1 IV"
            },
            "contraindications": "Renal impairment (CrCl <30); active GI bleed; aspirin/NSAID allergy; third trimester",
            "monitoring": "Renal function if repeated dosing",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Metoclopramide",
            "route": "IV",
            "indication": "Antiemetic with anti-migraine properties",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg IV over 15 min",
                  "orderSentence": "Metoclopramide 10 mg IV over 15 min IV"
                },
                {
                  "text": "20 mg IV over 15 min",
                  "orderSentence": "Metoclopramide 20 mg IV over 15 min IV"
                }
              ],
              "route": "IV",
              "instructions": "10-20 mg IV over 15 min; pretreat with diphenhydramine 25 mg IV to prevent akathisia",
              "orderSentence": "Metoclopramide 10 mg IV over 15 min IV"
            },
            "contraindications": "Parkinson's disease; tardive dyskinesia history; bowel obstruction; pheochromocytoma",
            "monitoring": "Akathisia, dystonia; discontinue if EPS",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Prochlorperazine",
            "route": "IV",
            "indication": "Dopamine antagonist for acute migraine with prominent nausea",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg IV over 2 min",
                  "orderSentence": "Prochlorperazine 10 mg IV over 2 min IV"
                }
              ],
              "route": "IV",
              "instructions": "10 mg IV slowly over 2 min; pretreat with diphenhydramine 25 mg IV",
              "orderSentence": "Prochlorperazine 10 mg IV over 2 min IV"
            },
            "contraindications": "QT prolongation (QTc >500ms); Parkinson's disease; neuroleptic malignant syndrome history",
            "monitoring": "QTc if baseline prolonged; EPS",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Diphenhydramine",
            "route": "IV",
            "indication": "Prevent akathisia from dopamine antagonists; sedation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg IV",
                  "orderSentence": "Diphenhydramine 25 mg IV IV"
                },
                {
                  "text": "50 mg IV",
                  "orderSentence": "Diphenhydramine 50 mg IV IV"
                }
              ],
              "route": "IV",
              "instructions": "25-50 mg IV given concurrently with dopamine antagonist",
              "orderSentence": "Diphenhydramine 25 mg IV IV"
            },
            "contraindications": "Narrow-angle glaucoma; urinary retention; severe prostatic hypertrophy",
            "monitoring": "Sedation; anticholinergic effects",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Magnesium sulfate",
            "route": "IV",
            "indication": "Migraine with aura - particularly effective; refractory migraine",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 g IV over 20 min",
                  "orderSentence": "Magnesium sulfate 2 g IV over 20 min IV"
                }
              ],
              "route": "IV",
              "instructions": "2 g IV in 50 mL NS over 20-30 min; may repeat x1 after 2 hr",
              "orderSentence": "Magnesium sulfate 2 g IV over 20 min IV"
            },
            "contraindications": "Heart block; severe hypermagnesemia; myasthenia gravis; severe renal impairment",
            "monitoring": "BP, HR during infusion; flushing is common and benign",
            "ED": "STAT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Sumatriptan",
            "route": "SC/PO",
            "indication": "Acute migraine with TYPICAL aura (visual, sensory, language) - SAFE",
            "dosing": {
              "doseOptions": [
                {
                  "text": "6 mg SC x1",
                  "orderSentence": "Sumatriptan 6 mg SC x1 SC/PO"
                },
                {
                  "text": "50 mg PO x1",
                  "orderSentence": "Sumatriptan 50 mg PO x1 SC/PO"
                },
                {
                  "text": "100 mg PO x1",
                  "orderSentence": "Sumatriptan 100 mg PO x1 SC/PO"
                }
              ],
              "route": "SC/PO",
              "instructions": "6 mg SC (may repeat after 1 hr, max 12 mg/24hr) OR 50-100 mg PO (may repeat after 2 hr, max 200 mg/24hr); take AFTER aura resolves or at headache onset",
              "orderSentence": "Sumatriptan 6 mg SC x1 SC/PO"
            },
            "contraindications": "**HEMIPLEGIC MIGRAINE (motor aura)**; uncontrolled HTN; CAD; prior stroke/TIA; MAOIs within 14 days; ergots within 24 hr",
            "monitoring": "Chest tightness (triptan sensation vs cardiac); assess cardiovascular risk",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Valproate sodium",
            "route": "IV",
            "indication": "Status migrainosus with aura; refractory to first-line",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mg IV over 5 min",
                  "orderSentence": "Valproate sodium 500 mg IV over 5 min IV"
                },
                {
                  "text": "1000 mg IV over 5 min",
                  "orderSentence": "Valproate sodium 1000 mg IV over 5 min IV"
                }
              ],
              "route": "IV",
              "instructions": "500-1000 mg IV over 5-10 min; may repeat 500 mg in 8 hr",
              "orderSentence": "Valproate sodium 500 mg IV over 5 min IV"
            },
            "contraindications": "Hepatic disease; pregnancy (teratogenic); urea cycle disorders; pancreatitis history",
            "monitoring": "LFTs; ammonia if altered mental status",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Dexamethasone",
            "route": "IV",
            "indication": "Prevent headache recurrence after acute treatment",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg IV x1",
                  "orderSentence": "Dexamethasone 10 mg IV x1 IV"
                }
              ],
              "route": "IV",
              "instructions": "10 mg IV x1 at time of discharge or admission; single dose",
              "orderSentence": "Dexamethasone 10 mg IV x1 IV"
            },
            "contraindications": "Active untreated infection; known hypersensitivity",
            "monitoring": "Glucose if diabetic",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          }
        ],
        "Symptomatic Treatments": [
          {
            "item": "Rizatriptan",
            "route": "PO",
            "indication": "Acute typical migraine with aura; fast onset",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg PO x1",
                  "orderSentence": "Rizatriptan 5 mg PO x1 PO"
                },
                {
                  "text": "10 mg PO x1",
                  "orderSentence": "Rizatriptan 10 mg PO x1 PO"
                }
              ],
              "route": "PO",
              "instructions": "5-10 mg PO (use 5 mg if on propranolol); may repeat after 2 hr; max 30 mg/24hr",
              "orderSentence": "Rizatriptan 5 mg PO x1 PO"
            },
            "contraindications": "Same as sumatriptan; **HEMIPLEGIC MIGRAINE**; use 5 mg max if on propranolol",
            "monitoring": "Triptan sensation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Eletriptan",
            "route": "PO",
            "indication": "Acute typical migraine with aura; good for recurrence",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg PO x1",
                  "orderSentence": "Eletriptan 40 mg PO x1 PO"
                },
                {
                  "text": "80 mg PO x1",
                  "orderSentence": "Eletriptan 80 mg PO x1 PO"
                }
              ],
              "route": "PO",
              "instructions": "40 mg PO; may repeat 40 mg after 2 hr if partial response; max 80 mg/24hr",
              "orderSentence": "Eletriptan 40 mg PO x1 PO"
            },
            "contraindications": "Same as sumatriptan; **HEMIPLEGIC MIGRAINE**; potent CYP3A4 inhibitors (ketoconazole, clarithromycin)",
            "monitoring": "Triptan sensation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Naratriptan",
            "route": "PO",
            "indication": "Migraine with aura; longer duration; menstrual migraine",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2.5 mg PO x1",
                  "orderSentence": "Naratriptan 2.5 mg PO x1 PO"
                }
              ],
              "route": "PO",
              "instructions": "2.5 mg PO; may repeat after 4 hr; max 5 mg/24hr; slower onset but longer lasting",
              "orderSentence": "Naratriptan 2.5 mg PO x1 PO"
            },
            "contraindications": "Same as sumatriptan; **HEMIPLEGIC MIGRAINE**; moderate-severe renal/hepatic impairment",
            "monitoring": "Triptan sensation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ubrogepant",
            "route": "PO",
            "indication": "CGRP antagonist; use if triptan contraindicated or cardiovascular risk",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg PO x1",
                  "orderSentence": "Ubrogepant 50 mg PO x1 PO"
                },
                {
                  "text": "100 mg PO x1",
                  "orderSentence": "Ubrogepant 100 mg PO x1 PO"
                }
              ],
              "route": "PO",
              "instructions": "50-100 mg PO; may repeat after 2 hr; max 200 mg/24hr",
              "orderSentence": "Ubrogepant 50 mg PO x1 PO"
            },
            "contraindications": "Strong CYP3A4 inhibitors; severe hepatic impairment",
            "monitoring": "None routine; no cardiovascular contraindications",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rimegepant",
            "route": "PO/ODT",
            "indication": "CGRP antagonist; can use for acute and prevention",
            "dosing": {
              "doseOptions": [
                {
                  "text": "75 mg ODT x1",
                  "orderSentence": "Rimegepant 75 mg ODT x1 PO"
                }
              ],
              "route": "PO",
              "instructions": "75 mg ODT at onset; max 75 mg/24hr for acute; also approved 75 mg every other day for prevention",
              "orderSentence": "Rimegepant 75 mg ODT x1 PO"
            },
            "contraindications": "Strong CYP3A4 inhibitors/inducers; severe hepatic impairment",
            "monitoring": "None routine",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lasmiditan",
            "route": "PO",
            "indication": "5-HT1F agonist; safe in cardiovascular disease; ditan class",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg PO x1",
                  "orderSentence": "Lasmiditan 50 mg PO x1 PO"
                },
                {
                  "text": "100 mg PO x1",
                  "orderSentence": "Lasmiditan 100 mg PO x1 PO"
                },
                {
                  "text": "200 mg PO x1",
                  "orderSentence": "Lasmiditan 200 mg PO x1 PO"
                }
              ],
              "route": "PO",
              "instructions": "50-200 mg PO x1; max 200 mg/24hr; DO NOT DRIVE for 8 hours after dose",
              "orderSentence": "Lasmiditan 50 mg PO x1 PO"
            },
            "contraindications": "Concurrent alcohol; CYP3A4 substrates with narrow TI",
            "monitoring": "CNS depression; dizziness; NO driving for 8 hr",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ibuprofen",
            "route": "PO",
            "indication": "Mild-moderate aura migraine",
            "dosing": {
              "doseOptions": [
                {
                  "text": "400 mg PO x1",
                  "orderSentence": "Ibuprofen 400 mg PO x1 PO"
                },
                {
                  "text": "600 mg PO x1",
                  "orderSentence": "Ibuprofen 600 mg PO x1 PO"
                },
                {
                  "text": "800 mg PO x1",
                  "orderSentence": "Ibuprofen 800 mg PO x1 PO"
                }
              ],
              "route": "PO",
              "instructions": "400-800 mg PO at onset; max 2400 mg/day",
              "orderSentence": "Ibuprofen 400 mg PO x1 PO"
            },
            "contraindications": "Renal impairment; active GI bleed; aspirin/NSAID allergy; third trimester",
            "monitoring": "GI symptoms; renal function if prolonged use",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Naproxen sodium",
            "route": "PO",
            "indication": "Mild-moderate aura migraine; menstrual migraine prevention",
            "dosing": {
              "doseOptions": [
                {
                  "text": "550 mg PO x1",
                  "orderSentence": "Naproxen sodium 550 mg PO x1 PO"
                }
              ],
              "route": "PO",
              "instructions": "550 mg PO at onset; may add 275 mg in 12 hr; max 1375 mg day 1, then 1100 mg/day",
              "orderSentence": "Naproxen sodium 550 mg PO x1 PO"
            },
            "contraindications": "Renal impairment; active GI bleed; aspirin/NSAID allergy",
            "monitoring": "GI symptoms",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Acetaminophen-Aspirin-Caffeine",
            "route": "PO",
            "indication": "Mild-moderate migraine with aura (OTC option)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 tablets PO x1",
                  "orderSentence": "Acetaminophen-Aspirin-Caffeine 2 tablets PO x1 PO"
                }
              ],
              "route": "PO",
              "instructions": "2 tablets (250/250/65 mg each) at onset; max 2 doses/24hr",
              "orderSentence": "Acetaminophen-Aspirin-Caffeine 2 tablets PO x1 PO"
            },
            "contraindications": "Aspirin allergy; hepatic impairment; avoid if using other acetaminophen sources",
            "monitoring": "Limit total acetaminophen <3 g/day",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ondansetron",
            "route": "IV/PO",
            "indication": "Nausea/vomiting with migraine",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4 mg IV x1",
                  "orderSentence": "Ondansetron 4 mg IV x1 IV/PO"
                },
                {
                  "text": "8 mg ODT x1",
                  "orderSentence": "Ondansetron 8 mg ODT x1 IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "4 mg IV or 8 mg PO/ODT; may repeat q8h as needed",
              "orderSentence": "Ondansetron 4 mg IV x1 IV/PO"
            },
            "contraindications": "QT prolongation (QTc >500ms); severe hepatic impairment",
            "monitoring": "QTc if multiple doses or baseline prolongation",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Second-line/Refractory": [
          {
            "item": "Dihydroergotamine (DHE)",
            "route": "IV/SC/Nasal",
            "indication": "Refractory migraine; status migrainosus; **NOT for hemiplegic**",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5 mg IV q8h",
                  "orderSentence": "Dihydroergotamine (DHE) 0.5 mg IV q8h IV/SC/Nasal"
                },
                {
                  "text": "1 mg SC x1",
                  "orderSentence": "Dihydroergotamine (DHE) 1 mg SC x1 IV/SC/Nasal"
                },
                {
                  "text": "1 spray per nostril",
                  "orderSentence": "Dihydroergotamine (DHE) 1 spray per nostril IV/SC/Nasal"
                }
              ],
              "route": "IV/SC/Nasal",
              "instructions": "IV: 0.5-1 mg q8h for up to 3 days (pretreat with antiemetic); SC: 1 mg, may repeat in 1 hr; Nasal: 1 spray each nostril, repeat in 15 min",
              "orderSentence": "Dihydroergotamine (DHE) 0.5 mg IV q8h IV/SC/Nasal"
            },
            "contraindications": "Pregnancy; CAD; uncontrolled HTN; peripheral vascular disease; **HEMIPLEGIC MIGRAINE**; triptan use within 24hr; severe hepatic/renal impairment",
            "monitoring": "BP; nausea; chest pain; continuous cardiac monitoring for IV",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Occipital nerve block",
            "route": "SC",
            "indication": "Refractory migraine; occipital-predominant pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Bupivacaine 0.5% 2-3 mL + triamcinolone 40 mg",
                  "orderSentence": "Occipital nerve block Bupivacaine 0.5% 2-3 mL + triamcinolone 40 mg SC"
                }
              ],
              "route": "SC",
              "instructions": "Inject at greater occipital nerve bilaterally; may add lesser occipital, supraorbital",
              "orderSentence": "Occipital nerve block Bupivacaine 0.5% 2-3 mL + triamcinolone 40 mg SC"
            },
            "contraindications": "Local anesthetic allergy; infection at injection site; anticoagulation (relative)",
            "monitoring": "Vasovagal reaction; immediate pain assessment",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ketamine",
            "route": "IV",
            "indication": "Status migrainosus refractory to DHE",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.1-0.3 mg/kg/hr infusion",
                  "orderSentence": "Ketamine 0.1-0.3 mg/kg/hr infusion IV"
                }
              ],
              "route": "IV",
              "instructions": "0.1-0.3 mg/kg/hr continuous infusion for 24-48 hr; subanesthetic dosing only",
              "orderSentence": "Ketamine 0.1-0.3 mg/kg/hr infusion IV"
            },
            "contraindications": "Uncontrolled HTN; psychosis history; elevated ICP; pregnancy",
            "monitoring": "Dissociation; BP; HR; requires continuous cardiac monitoring",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Verapamil",
            "route": "IV",
            "indication": "Hemiplegic migraine acute (if severe); status migrainosus",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg IV over 2 min",
                  "orderSentence": "Verapamil 5 mg IV over 2 min IV"
                }
              ],
              "route": "IV",
              "instructions": "5 mg IV over 2-3 min; may repeat in 30 min (max 20 mg)",
              "orderSentence": "Verapamil 5 mg IV over 2 min IV"
            },
            "contraindications": "Heart block (2nd/3rd degree); severe LV dysfunction; hypotension",
            "monitoring": "Continuous ECG; BP; for hemiplegic migraine when triptans contraindicated",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Intranasal lidocaine",
            "route": "Intranasal",
            "indication": "Acute migraine with aura; rapid onset option",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4% lidocaine 0.5 mL per nostril",
                  "orderSentence": "Intranasal lidocaine 4% lidocaine 0.5 mL per nostril Intranasal"
                }
              ],
              "route": "Intranasal",
              "instructions": "4% lidocaine, 0.5 mL per nostril directed at sphenopalatine fossa; may repeat x1 in 15 min",
              "orderSentence": "Intranasal lidocaine 4% lidocaine 0.5 mL per nostril Intranasal"
            },
            "contraindications": "Local anesthetic allergy",
            "monitoring": "Local numbness; cardiac arrhythmia (rare with low dose)",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Disease-Modifying or Chronic Therapies (Preventive Medications)": [
          {
            "item": "Magnesium oxide",
            "route": "PO",
            "indication": "First-line supplement for migraine with aura prevention",
            "dosing": {
              "doseOptions": [
                {
                  "text": "400 mg daily",
                  "orderSentence": "Magnesium oxide 400 mg daily PO"
                },
                {
                  "text": "400 mg BID",
                  "orderSentence": "Magnesium oxide 400 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 400 mg daily; may increase to 400 mg BID; take with food to reduce GI upset",
              "orderSentence": "Magnesium oxide 400 mg daily PO"
            },
            "pretreatment": "None",
            "contraindications": "Renal impairment (CrCl <30) - dose reduce",
            "monitoring": "Diarrhea; check Mg level if symptomatic or renal disease",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Topiramate",
            "route": "PO",
            "indication": "First-line oral prevention; reduces aura frequency; weight loss",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Topiramate 25 mg qHS PO"
                },
                {
                  "text": "50 mg BID",
                  "orderSentence": "Topiramate 50 mg BID PO"
                },
                {
                  "text": "100 mg BID",
                  "orderSentence": "Topiramate 100 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg qHS; increase by 25 mg/wk; target 50-100 mg BID",
              "orderSentence": "Topiramate 25 mg qHS PO"
            },
            "pretreatment": "None",
            "contraindications": "**PREGNANCY (teratogenic)**; glaucoma; kidney stones; metabolic acidosis",
            "monitoring": "Cognitive effects; paresthesias; weight; serum bicarbonate; kidney stones",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Propranolol",
            "route": "PO",
            "indication": "First-line prevention; comorbid HTN, anxiety, tremor",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg BID",
                  "orderSentence": "Propranolol 40 mg BID PO"
                },
                {
                  "text": "80 mg BID",
                  "orderSentence": "Propranolol 80 mg BID PO"
                },
                {
                  "text": "80 mg LA daily",
                  "orderSentence": "Propranolol 80 mg LA daily PO"
                },
                {
                  "text": "160 mg LA daily",
                  "orderSentence": "Propranolol 160 mg LA daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 40 mg BID or 80 mg LA daily; titrate q2wk; target 80-240 mg/day",
              "orderSentence": "Propranolol 40 mg BID PO"
            },
            "pretreatment": "None",
            "contraindications": "Asthma; COPD with bronchospasm; bradycardia <50; 2nd/3rd degree heart block; decompensated HF",
            "monitoring": "HR (goal >50); BP; fatigue; depression; exercise intolerance",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Amitriptyline",
            "route": "PO",
            "indication": "Prevention with comorbid insomnia, depression, tension-type headache",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg qHS",
                  "orderSentence": "Amitriptyline 10 mg qHS PO"
                },
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Amitriptyline 25 mg qHS PO"
                },
                {
                  "text": "50 mg qHS",
                  "orderSentence": "Amitriptyline 50 mg qHS PO"
                },
                {
                  "text": "75 mg qHS",
                  "orderSentence": "Amitriptyline 75 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10 mg qHS; titrate by 10-25 mg q1-2wk; target 25-75 mg qHS",
              "orderSentence": "Amitriptyline 10 mg qHS PO"
            },
            "pretreatment": "ECG if >50 y/o or cardiac history",
            "contraindications": "Cardiac conduction disease; recent MI; glaucoma; urinary retention; elderly (anticholinergic burden)",
            "monitoring": "Sedation; weight; dry mouth; ECG if dose >100 mg or cardiac history",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Venlafaxine XR",
            "route": "PO",
            "indication": "Prevention with comorbid depression, anxiety",
            "dosing": {
              "doseOptions": [
                {
                  "text": "37.5 mg daily",
                  "orderSentence": "Venlafaxine XR 37.5 mg daily PO"
                },
                {
                  "text": "75 mg daily",
                  "orderSentence": "Venlafaxine XR 75 mg daily PO"
                },
                {
                  "text": "150 mg daily",
                  "orderSentence": "Venlafaxine XR 150 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 37.5 mg daily; increase by 37.5-75 mg q1wk; target 75-150 mg daily",
              "orderSentence": "Venlafaxine XR 37.5 mg daily PO"
            },
            "pretreatment": "None",
            "contraindications": "Uncontrolled HTN; MAOIs within 14 days; abrupt discontinuation risk",
            "monitoring": "BP at doses >150 mg; serotonin syndrome signs; taper to discontinue",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Candesartan",
            "route": "PO",
            "indication": "Prevention; comorbid HTN; beta-blocker intolerant",
            "dosing": {
              "doseOptions": [
                {
                  "text": "8 mg daily",
                  "orderSentence": "Candesartan 8 mg daily PO"
                },
                {
                  "text": "16 mg daily",
                  "orderSentence": "Candesartan 16 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 8 mg daily; may increase to 16 mg daily after 4 wk",
              "orderSentence": "Candesartan 8 mg daily PO"
            },
            "pretreatment": "None",
            "contraindications": "**Pregnancy**; bilateral renal artery stenosis; hyperkalemia",
            "monitoring": "BP; potassium; creatinine",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Valproate/Divalproex",
            "route": "PO",
            "indication": "Prevention with comorbid bipolar or epilepsy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "250 mg BID",
                  "orderSentence": "Valproate/Divalproex 250 mg BID PO"
                },
                {
                  "text": "500 mg BID",
                  "orderSentence": "Valproate/Divalproex 500 mg BID PO"
                },
                {
                  "text": "500 mg ER daily",
                  "orderSentence": "Valproate/Divalproex 500 mg ER daily PO"
                },
                {
                  "text": "1000 mg ER daily",
                  "orderSentence": "Valproate/Divalproex 1000 mg ER daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 250 mg BID or 500 mg ER daily; titrate to 500-1000 mg/day",
              "orderSentence": "Valproate/Divalproex 250 mg BID PO"
            },
            "pretreatment": "LFTs; CBC",
            "contraindications": "**Pregnancy (teratogenic - neural tube defects)**; hepatic disease; urea cycle disorders; pancreatitis history",
            "monitoring": "LFTs q6mo; weight; hair loss; tremor; CBC",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Riboflavin (Vitamin B2)",
            "route": "PO",
            "indication": "Supplement for prevention; well-tolerated; may reduce aura",
            "dosing": {
              "doseOptions": [
                {
                  "text": "400 mg daily",
                  "orderSentence": "Riboflavin (Vitamin B2) 400 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "400 mg daily",
              "orderSentence": "Riboflavin (Vitamin B2) 400 mg daily PO"
            },
            "pretreatment": "None",
            "contraindications": "None",
            "monitoring": "Fluorescent yellow urine (reassure patient); benign",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Coenzyme Q10",
            "route": "PO",
            "indication": "Supplement; mitochondrial support",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg TID",
                  "orderSentence": "Coenzyme Q10 100 mg TID PO"
                },
                {
                  "text": "300 mg daily",
                  "orderSentence": "Coenzyme Q10 300 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "100-300 mg daily",
              "orderSentence": "Coenzyme Q10 100 mg TID PO"
            },
            "pretreatment": "None",
            "contraindications": "None",
            "monitoring": "None",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Erenumab (Aimovig)",
            "route": "SC",
            "indication": "CGRP mAb; failed 2+ oral preventives or intolerance",
            "dosing": {
              "doseOptions": [
                {
                  "text": "70 mg SC monthly",
                  "orderSentence": "Erenumab (Aimovig) 70 mg SC monthly SC"
                },
                {
                  "text": "140 mg SC monthly",
                  "orderSentence": "Erenumab (Aimovig) 140 mg SC monthly SC"
                }
              ],
              "route": "SC",
              "instructions": "70 mg SC monthly; may increase to 140 mg monthly after 3 months if suboptimal response",
              "orderSentence": "Erenumab (Aimovig) 70 mg SC monthly SC"
            },
            "pretreatment": "None",
            "contraindications": "Hypersensitivity to erenumab",
            "monitoring": "Constipation (can be severe - may need laxatives); injection site reactions; HTN monitoring",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Fremanezumab (Ajovy)",
            "route": "SC",
            "indication": "CGRP mAb; flexible dosing options",
            "dosing": {
              "doseOptions": [
                {
                  "text": "225 mg SC monthly",
                  "orderSentence": "Fremanezumab (Ajovy) 225 mg SC monthly SC"
                },
                {
                  "text": "675 mg SC quarterly",
                  "orderSentence": "Fremanezumab (Ajovy) 675 mg SC quarterly SC"
                }
              ],
              "route": "SC",
              "instructions": "225 mg SC monthly OR 675 mg SC quarterly (three 225 mg injections)",
              "orderSentence": "Fremanezumab (Ajovy) 225 mg SC monthly SC"
            },
            "pretreatment": "None",
            "contraindications": "Hypersensitivity",
            "monitoring": "Injection site reactions",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Galcanezumab (Emgality)",
            "route": "SC",
            "indication": "CGRP mAb; requires loading dose",
            "dosing": {
              "doseOptions": [
                {
                  "text": "240 mg SC load then 120 mg SC monthly",
                  "orderSentence": "Galcanezumab (Emgality) 240 mg SC load then 120 mg SC monthly SC"
                }
              ],
              "route": "SC",
              "instructions": "240 mg SC loading dose (2 x 120 mg injections), then 120 mg SC monthly",
              "orderSentence": "Galcanezumab (Emgality) 240 mg SC load then 120 mg SC monthly SC"
            },
            "pretreatment": "None",
            "contraindications": "Hypersensitivity",
            "monitoring": "Injection site reactions; vertigo",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Onabotulinumtoxin A (Botox)",
            "route": "IM",
            "indication": "Chronic migraine with aura (≥15 days/month); failed oral preventives",
            "dosing": {
              "doseOptions": [
                {
                  "text": "155-195 units IM q12wk",
                  "orderSentence": "Onabotulinumtoxin A (Botox) 155-195 units IM q12wk IM"
                }
              ],
              "route": "IM",
              "instructions": "155-195 units across 31-39 injection sites per PREEMPT protocol; repeat q12 weeks; effect may take 2-3 cycles",
              "orderSentence": "Onabotulinumtoxin A (Botox) 155-195 units IM q12wk IM"
            },
            "pretreatment": "None",
            "contraindications": "Infection at injection sites; myasthenia gravis; neuromuscular disorder",
            "monitoring": "Neck weakness; ptosis; antibody formation if loss of effect",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Flunarizine",
            "route": "PO",
            "indication": "Calcium channel blocker for prevention; especially hemiplegic migraine",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg qHS",
                  "orderSentence": "Flunarizine 5 mg qHS PO"
                },
                {
                  "text": "10 mg qHS",
                  "orderSentence": "Flunarizine 10 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg qHS; may increase to 10 mg qHS; especially useful for hemiplegic migraine (not available in US)",
              "orderSentence": "Flunarizine 5 mg qHS PO"
            },
            "pretreatment": "None",
            "contraindications": "Depression; Parkinson's disease; extrapyramidal disorders",
            "monitoring": "Weight gain; depression; parkinsonism with prolonged use",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lamotrigine",
            "route": "PO",
            "indication": "May reduce aura frequency specifically; hemiplegic migraine",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg daily",
                  "orderSentence": "Lamotrigine 25 mg daily PO"
                },
                {
                  "text": "50 mg BID",
                  "orderSentence": "Lamotrigine 50 mg BID PO"
                },
                {
                  "text": "100 mg BID",
                  "orderSentence": "Lamotrigine 100 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg daily; increase by 25 mg q2wk to 50-100 mg BID; SLOW titration to prevent rash",
              "orderSentence": "Lamotrigine 25 mg daily PO"
            },
            "pretreatment": "None",
            "contraindications": "History of lamotrigine-related rash; interacting drugs (valproate halves dose)",
            "monitoring": "**RASH (stop immediately if rash develops - SJS risk)**; monitor closely during titration",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Acetazolamide",
            "route": "PO",
            "indication": "Hemiplegic migraine prevention; familial hemiplegic migraine",
            "dosing": {
              "doseOptions": [
                {
                  "text": "250 mg BID",
                  "orderSentence": "Acetazolamide 250 mg BID PO"
                },
                {
                  "text": "500 mg BID",
                  "orderSentence": "Acetazolamide 500 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 250 mg BID; may increase to 500 mg BID",
              "orderSentence": "Acetazolamide 250 mg BID PO"
            },
            "pretreatment": "None",
            "contraindications": "Sulfa allergy; severe hepatic/renal disease; hypokalemia; acidosis",
            "monitoring": "Paresthesias; metabolic acidosis; K+; bicarbonate",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurology/Headache specialist referral for aura characterization, preventive optimization, and differentiation from other neurological conditions",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "OB/GYN consultation for contraceptive counseling - **estrogen-containing contraceptives contraindicated** in migraine with aura due to elevated ischemic stroke risk",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Cardiology referral if TTE shows PFO for discussion of closure in select cases (recurrent cryptogenic stroke or debilitating aura despite medical therapy)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Genetics consultation if hemiplegic migraine suspected for CACNA1A, ATP1A2, SCN1A testing and family counseling",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Physical therapy for cervicogenic component and trigger point management",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Psychology/Behavioral medicine for CBT addressing aura anxiety, attack anticipation, and comorbid mood disorders",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ophthalmology if visual aura atypical or concern for retinal pathology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sleep medicine if sleep disorder contributing to migraine frequency (OSA, insomnia)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Return immediately for new/different headache, \"worst headache of life,\" or thunderclap onset which may indicate subarachnoid hemorrhage",
            "ED": "STAT",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Return immediately if aura persists >60 minutes or if new weakness on one side of body develops (need to rule out stroke)",
            "ED": "STAT",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Return immediately for headache with fever, stiff neck, or altered mental status which may indicate CNS infection",
            "ED": "STAT",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "**AVOID estrogen-containing contraceptives** (combined birth control pills, patch, ring) - use progestin-only methods (mini-pill, Depo-Provera, Mirena IUD, Nexplanon) or non-hormonal methods",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Triptans ARE safe for your typical visual/sensory aura - take at headache onset or when aura ends; do NOT take if you experience weakness (motor aura)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Maintain headache/aura diary tracking aura type, duration, triggers, and medication use to guide treatment optimization",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Limit acute medication use to ≤10 days/month to prevent medication overuse headache which worsens both headache and aura",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Learn your personal aura warning signs and take acute medication promptly when headache begins",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Do not drive or operate machinery during visual or motor aura as vision and coordination may be impaired",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Regular sleep schedule (7-8 hours, consistent bedtime) as sleep changes are a major aura trigger",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid known aura triggers (bright/flashing lights, high altitude, significant sleep deprivation, extreme stress)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Regular aerobic exercise (30 min moderate activity 5x/week) reduces migraine frequency; avoid if currently in aura",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Magnesium-rich diet (leafy greens, nuts, whole grains) or supplementation as magnesium specifically helps aura",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Stress management techniques (mindfulness, biofeedback, relaxation training) as stress is a major trigger",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Adequate hydration (at least 64 oz water daily) as dehydration can trigger attacks",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Smoking cessation to reduce vascular risk, particularly important given aura-associated stroke risk",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Caffeine moderation (≤200 mg/day) and consistent daily intake to avoid withdrawal triggers",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Blood pressure control (target <130/80) given elevated vascular risk with aura",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid high altitude or rapid altitude changes if altitude is a known aura trigger",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Transient ischemic attack (TIA)",
        "features": "Sudden onset (maximal at onset vs gradual aura spread); negative symptoms (vision loss vs positive scintillations); vascular risk factors; older age; duration usually <1 hr",
        "tests": "MRI DWI (no restriction in aura); MRA/CTA (no vessel occlusion); aura has visual \"march\""
      },
      {
        "diagnosis": "Ischemic stroke",
        "features": "Fixed deficit; sudden onset; vascular territory distribution; risk factors",
        "tests": "MRI DWI (shows restriction); CT may be normal early"
      },
      {
        "diagnosis": "Migraine with brainstem aura",
        "features": "Aura includes brainstem symptoms (vertigo, tinnitus, decreased hearing, diplopia, ataxia, dysarthria, decreased LOC)",
        "tests": "Clinical criteria; MRI to exclude posterior fossa lesion"
      },
      {
        "diagnosis": "Retinal migraine",
        "features": "Monocular visual symptoms (vs binocular in typical aura); complete vision loss in one eye",
        "tests": "Ophthalmology exam; cover/uncover test during symptoms"
      },
      {
        "diagnosis": "Focal seizure with visual phenomena",
        "features": "Shorter duration (seconds to minutes); positive phenomena; may have automatisms; post-ictal confusion",
        "tests": "EEG may show epileptiform activity; MRI for structural lesion"
      },
      {
        "diagnosis": "Transient global amnesia",
        "features": "Anterograde amnesia; repetitive questioning; no visual or motor symptoms; resolves <24 hr",
        "tests": "Clinical diagnosis; MRI may show hippocampal DWI changes"
      },
      {
        "diagnosis": "Giant cell arteritis",
        "features": "Age >50; scalp tenderness; jaw claudication; visual loss (not scintillations); elevated ESR/CRP",
        "tests": "ESR, CRP (elevated); temporal artery biopsy"
      },
      {
        "diagnosis": "Carotid/vertebral dissection",
        "features": "Neck pain; Horner syndrome; pulsatile tinnitus; stroke symptoms",
        "tests": "MRA/CTA neck showing dissection"
      },
      {
        "diagnosis": "CADASIL",
        "features": "Migraine with aura often first symptom; subcortical strokes; family history; cognitive decline",
        "tests": "MRI shows characteristic WMH (anterior temporal, external capsule); NOTCH3 mutation"
      },
      {
        "diagnosis": "Mitochondrial encephalopathy (MELAS)",
        "features": "Stroke-like episodes not following vascular territory; seizures; elevated lactate; short stature",
        "tests": "MRI (non-vascular stroke pattern); genetic testing; muscle biopsy"
      }
    ],
    "evidence": [
      {
        "recommendation": "Migraine with aura increases ischemic stroke risk, especially in women using combined oral contraceptives",
        "evidenceLevel": "Class II, Level B",
        "source": "[Etminan et al. BMJ 2005](https://pubmed.ncbi.nlm.nih.gov/15647264/)"
      },
      {
        "recommendation": "ACOG: Combined hormonal contraceptives contraindicated in migraine with aura",
        "evidenceLevel": "Class I (Guideline)",
        "source": "[ACOG Practice Bulletin 2019](https://pubmed.ncbi.nlm.nih.gov/31568397/)"
      },
      {
        "recommendation": "Triptans safe and effective in migraine with typical aura",
        "evidenceLevel": "Class I, Level A",
        "source": "[Marmura et al. Headache 2015](https://pubmed.ncbi.nlm.nih.gov/25600718/)"
      },
      {
        "recommendation": "Triptans contraindicated in hemiplegic migraine (expert consensus)",
        "evidenceLevel": "Class III, Level C",
        "source": "Expert consensus; [IHS Classification ICHD-3 2018](https://pubmed.ncbi.nlm.nih.gov/29368949/)"
      },
      {
        "recommendation": "Magnesium particularly effective for migraine with aura prevention",
        "evidenceLevel": "Class II, Level B",
        "source": "[Peikert et al. Cephalalgia 1996](https://pubmed.ncbi.nlm.nih.gov/8792038/)"
      },
      {
        "recommendation": "Lamotrigine may reduce aura frequency specifically",
        "evidenceLevel": "Class II, Level C",
        "source": "[Lampl et al. Neurology 2005](https://pubmed.ncbi.nlm.nih.gov/16087905/)"
      },
      {
        "recommendation": "Topiramate effective for migraine prevention",
        "evidenceLevel": "Class I, Level A",
        "source": "[Silberstein et al. Arch Neurol 2004](https://pubmed.ncbi.nlm.nih.gov/15096395/)"
      },
      {
        "recommendation": "Propranolol effective for migraine prevention",
        "evidenceLevel": "Class I, Level A",
        "source": "[Linde et al. Cochrane 2004](https://pubmed.ncbi.nlm.nih.gov/15106218/)"
      },
      {
        "recommendation": "CGRP monoclonal antibodies effective for prevention",
        "evidenceLevel": "Class I, Level A",
        "source": "[Goadsby et al. NEJM 2017 (erenumab STRIVE)](https://pubmed.ncbi.nlm.nih.gov/29171821/)"
      },
      {
        "recommendation": "Gepants safe in patients with cardiovascular contraindications to triptans",
        "evidenceLevel": "Class I, Level B",
        "source": "[Dodick et al. JAMA 2019 (ubrogepant ACHIEVE I)](https://pubmed.ncbi.nlm.nih.gov/31742631/)"
      },
      {
        "recommendation": "Lasmiditan (ditan) does not have cardiovascular contraindications",
        "evidenceLevel": "Class I, Level A",
        "source": "[Kuca et al. Headache 2018](https://pubmed.ncbi.nlm.nih.gov/30091160/)"
      },
      {
        "recommendation": "IV magnesium effective for acute migraine with aura",
        "evidenceLevel": "Class II, Level B",
        "source": "[Bigal et al. Headache 2002](https://pubmed.ncbi.nlm.nih.gov/11903546/)"
      },
      {
        "recommendation": "Aura duration >60 minutes warrants stroke evaluation",
        "evidenceLevel": "Class III, Level C",
        "source": "Expert consensus; [Lipton et al. Headache 2004](https://pubmed.ncbi.nlm.nih.gov/15147249/)"
      },
      {
        "recommendation": "PFO closure may benefit select patients with migraine with aura",
        "evidenceLevel": "Class II, Level B",
        "source": "[Tobis et al. JACC 2017 (RESPECT trial long-term)](https://pubmed.ncbi.nlm.nih.gov/28359515/)"
      },
      {
        "recommendation": "Acetazolamide effective for familial hemiplegic migraine",
        "evidenceLevel": "Class III, Level C",
        "source": "[Battistini et al. Neurology 1999](https://pubmed.ncbi.nlm.nih.gov/10489058/)"
      },
      {
        "recommendation": "Verapamil may be used acutely in hemiplegic migraine",
        "evidenceLevel": "Class III, Level C",
        "source": "Expert consensus; [Mathew et al. Headache 2005](https://pubmed.ncbi.nlm.nih.gov/15836583/)"
      },
      {
        "recommendation": "OnabotulinumtoxinA effective for chronic migraine",
        "evidenceLevel": "Class I, Level A",
        "source": "[Dodick et al. Headache 2010 (PREEMPT pooled)](https://pubmed.ncbi.nlm.nih.gov/20487038/)"
      },
      {
        "recommendation": "Exercise as effective as topiramate for migraine prevention",
        "evidenceLevel": "Class II, Level B",
        "source": "[Varkey et al. Cephalalgia 2011](https://pubmed.ncbi.nlm.nih.gov/21816772/)"
      }
    ],
    "monitoring": [
      {
        "item": "Aura characteristics (type, duration, frequency)",
        "frequency": "Each visit; diary",
        "action": "Prolonged aura needs stroke rule-out; increasing frequency reassess prevention",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Headache days/month",
        "frequency": "Monthly",
        "action": "Escalate therapy if not meeting target; consider CGRP mAb or Botox",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Acute medication use days",
        "frequency": "Monthly",
        "action": "MOH education; consider preventive escalation; may need withdrawal",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Blood pressure",
        "frequency": "Each visit",
        "action": "Optimize BP control given elevated vascular risk with aura",
        "ED": "STAT",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "HIT-6 or MIDAS disability score",
        "frequency": "Every 3 months",
        "action": "Escalate preventive therapy if severely disabled",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Topiramate: serum bicarbonate",
        "frequency": "Baseline, 3 months",
        "action": "Consider dose reduction or switch if metabolic acidosis",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Valproate: LFTs",
        "frequency": "Baseline, 3 months, then q6mo",
        "action": "Discontinue if significant elevation",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "CGRP mAb: constipation assessment",
        "frequency": "Each visit",
        "action": "Add fiber/laxatives; reduce dose or discontinue if severe",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Lamotrigine: rash monitoring",
        "frequency": "Weekly during titration",
        "action": "**STOP IMMEDIATELY if rash develops** - SJS risk",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Contraceptive status",
        "frequency": "Each visit (women of reproductive age)",
        "action": "Remove estrogen-containing contraceptives; counsel on alternatives",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      }
    ],
    "disposition": [
      {
        "disposition": "Discharge home",
        "criteria": "Typical aura pattern confirmed; no stroke symptoms; pain controlled; able to tolerate PO; follow-up arranged; contraceptive counseling if needed"
      },
      {
        "disposition": "Admit to floor",
        "criteria": "Prolonged aura (>60 min) requiring observation; status migrainosus requiring IV therapy; first aura with abnormal imaging requiring further workup; hemiplegic migraine with prolonged weakness"
      },
      {
        "disposition": "Admit to ICU",
        "criteria": "Migrainous infarction (stroke occurring during typical aura); hemodynamic instability; severe refractory status migrainosus requiring ketamine infusion"
      },
      {
        "disposition": "Transfer to higher level",
        "criteria": "Stroke mimicking aura requiring thrombectomy evaluation; complex hemiplegic migraine requiring tertiary headache center"
      },
      {
        "disposition": "Outpatient follow-up",
        "criteria": "New diagnosis: 2-4 weeks; Stable on prevention: 3-6 months; After preventive change: 4-8 weeks"
      }
    ]
  },
  "Trigeminal Neuralgia": {
    "id": "trigeminal-neuralgia",
    "title": "Trigeminal Neuralgia",
    "version": "1.0",
    "icd10": [
      "** G50.0 (Trigeminal neuralgia)"
    ],
    "scope": "** Diagnosis, differentiation of classic (idiopathic) vs secondary TN (MS, tumor, vascular), medical and surgical management. Covers typical TN (TN1), atypical TN (TN2), and secondary TN.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC with differential",
            "rationale": "Baseline before carbamazepine (bone marrow suppression risk); exclude infection",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CMP (comprehensive metabolic panel)",
            "rationale": "Baseline renal/hepatic function before carbamazepine; SIADH risk",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "HLA-B*1502 genotype",
            "rationale": "Screen Asian patients before carbamazepine/oxcarbazepine (SJS/TEN risk)",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended Workup": [
          {
            "item": "ESR, CRP",
            "rationale": "Inflammatory causes; giant cell arteritis if age >50 with atypical features",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "ANA, anti-dsDNA",
            "rationale": "SLE or connective tissue disease with trigeminal involvement",
            "target": "Negative",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lyme antibodies",
            "rationale": "Endemic areas; if facial numbness or other cranial nerve involvement",
            "target": "Negative",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin B12",
            "rationale": "Deficiency can cause neuropathy",
            "target": ">300 pg/mL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "TSH",
            "rationale": "Exclude thyroid dysfunction",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Glucose (fasting) or HbA1c",
            "rationale": "Diabetes screening; diabetic neuropathy",
            "target": "FBG <126 mg/dL; HbA1c <6.5%",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "CSF analysis (cell count, protein, oligoclonal bands)",
            "rationale": "MS suspected; atypical presentation",
            "target": "Normal or OCBs if MS",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Anti-aquaporin-4 (NMO-IgG)",
            "rationale": "Neuromyelitis optica with trigeminal involvement",
            "target": "Negative",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Paraneoplastic antibody panel",
            "rationale": "Atypical facial pain; occult malignancy",
            "target": "Negative",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "ACE level",
            "rationale": "Sarcoidosis with cranial nerve involvement",
            "target": "Normal",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "MRI Brain with trigeminal protocol (3T preferred; CISS/FIESTA sequences)",
            "timing": "Initial workup",
            "target": "Neurovascular compression (SCA, AICA); rule out MS plaques, tumor, other structural cause",
            "contraindications": "MRI-incompatible devices",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "MRA Brain (circle of Willis)",
            "timing": "If MRI suggests vascular compression",
            "target": "Confirm vascular loop (SCA, AICA) compressing trigeminal nerve",
            "contraindications": "Same as MRI",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended": [
          {
            "item": "MRI Brain with contrast",
            "timing": "Tumor suspected; atypical presentation",
            "target": "Rule out schwannoma, meningioma, epidermoid cyst",
            "contraindications": "Contrast allergy; renal impairment",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "MRI Spine (cervical/thoracic)",
            "timing": "MS suspected; other neurological symptoms",
            "target": "Demyelinating lesions",
            "contraindications": "MRI contraindications",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CT Head",
            "timing": "MRI contraindicated; acute presentation",
            "target": "Rule out mass, hemorrhage",
            "contraindications": "None",
            "ED": "STAT",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Trigeminal reflex testing (blink reflex, masseter reflex)",
            "timing": "Sensory loss; atypical TN",
            "target": "Normal or abnormal R1/R2 latencies",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Visual evoked potentials (VEPs)",
            "timing": "MS suspected",
            "target": "Prolonged P100 latency if demyelinating",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "CT angiography",
            "timing": "MRA non-diagnostic; surgical planning",
            "target": "Vascular anatomy for MVD",
            "contraindications": "Contrast allergy; renal impairment",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "Carbamazepine",
            "route": "PO",
            "indication": "Severe acute TN flare requiring rapid loading",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg BID",
                  "orderSentence": "Carbamazepine 100 mg BID PO"
                },
                {
                  "text": "200 mg BID",
                  "orderSentence": "Carbamazepine 200 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 100-200 mg BID; may increase by 100 mg q12h if severe; max 1200 mg/day",
              "orderSentence": "Carbamazepine 100 mg BID PO"
            },
            "contraindications": "AV block; bone marrow suppression; concurrent MAOIs; HLA-B*1502 positive",
            "monitoring": "CBC, sodium, LFTs at baseline; sodium q2-4wk initially",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Oxcarbazepine",
            "route": "PO",
            "indication": "Alternative if carbamazepine not tolerated; fewer drug interactions",
            "dosing": {
              "doseOptions": [
                {
                  "text": "150 mg BID",
                  "orderSentence": "Oxcarbazepine 150 mg BID PO"
                },
                {
                  "text": "300 mg BID",
                  "orderSentence": "Oxcarbazepine 300 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 150-300 mg BID; may increase by 150-300 mg q3d if severe; max 1800 mg/day",
              "orderSentence": "Oxcarbazepine 150 mg BID PO"
            },
            "contraindications": "Hypersensitivity; HLA-B*1502 positive",
            "monitoring": "Sodium q2-4wk initially (higher SIADH risk than CBZ)",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "IV Fosphenytoin",
            "route": "IV",
            "indication": "Status trigeminus (severe, refractory, continuous attacks); oral medications not tolerated",
            "dosing": {
              "doseOptions": [
                {
                  "text": "15 mg PE/kg IV",
                  "orderSentence": "IV Fosphenytoin 15 mg PE/kg IV IV"
                }
              ],
              "route": "IV",
              "instructions": "15 mg PE/kg IV load over 30 min; followed by phenytoin PO or IV 100 mg TID",
              "orderSentence": "IV Fosphenytoin 15 mg PE/kg IV IV"
            },
            "contraindications": "Complete heart block; sinus bradycardia",
            "monitoring": "Continuous cardiac monitoring; BP",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Lidocaine 4% topical",
            "route": "TOP",
            "indication": "Adjunctive for trigger point relief",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Apply to trigger zone",
                  "orderSentence": "Lidocaine 4% topical Apply to trigger zone TOP"
                }
              ],
              "route": "TOP",
              "instructions": "Apply to trigger zone TID-QID PRN; temporary relief",
              "orderSentence": "Lidocaine 4% topical Apply to trigger zone TOP"
            },
            "contraindications": "None significant",
            "monitoring": "None",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Symptomatic Treatments (First-line)": [
          {
            "item": "Carbamazepine (Tegretol)",
            "route": "PO",
            "indication": "First-line for classic TN; strongest evidence",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg BID",
                  "orderSentence": "Carbamazepine (Tegretol) 100 mg BID PO"
                },
                {
                  "text": "200 mg BID",
                  "orderSentence": "Carbamazepine (Tegretol) 200 mg BID PO"
                },
                {
                  "text": "200 mg TID",
                  "orderSentence": "Carbamazepine (Tegretol) 200 mg TID PO"
                },
                {
                  "text": "300 mg TID",
                  "orderSentence": "Carbamazepine (Tegretol) 300 mg TID PO"
                },
                {
                  "text": "400 mg TID",
                  "orderSentence": "Carbamazepine (Tegretol) 400 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 100 mg BID; increase by 100 mg q3-7d; target 600-1200 mg/day divided BID-TID; max 1200 mg/day",
              "orderSentence": "Carbamazepine (Tegretol) 100 mg BID PO"
            },
            "contraindications": "AV block; bone marrow suppression; MAOIs; porphyria; HLA-B*1502 positive",
            "monitoring": "CBC, sodium, LFTs at baseline, 4wk, 8wk, then q3-6mo; drug level if needed (4-12 mcg/mL)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Carbamazepine XR (Carbatrol, Tegretol-XR)",
            "route": "PO",
            "indication": "Better tolerability with extended-release formulation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "200 mg BID",
                  "orderSentence": "Carbamazepine XR (Carbatrol, Tegretol-XR) 200 mg BID PO"
                },
                {
                  "text": "300 mg BID",
                  "orderSentence": "Carbamazepine XR (Carbatrol, Tegretol-XR) 300 mg BID PO"
                },
                {
                  "text": "400 mg BID",
                  "orderSentence": "Carbamazepine XR (Carbatrol, Tegretol-XR) 400 mg BID PO"
                },
                {
                  "text": "600 mg BID",
                  "orderSentence": "Carbamazepine XR (Carbatrol, Tegretol-XR) 600 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 200 mg BID; increase by 200 mg q1wk; max 1200 mg/day",
              "orderSentence": "Carbamazepine XR (Carbatrol, Tegretol-XR) 200 mg BID PO"
            },
            "contraindications": "Same as IR",
            "monitoring": "Same as IR",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Oxcarbazepine (Trileptal)",
            "route": "PO",
            "indication": "First-line alternative; fewer drug interactions; similar efficacy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "150 mg BID",
                  "orderSentence": "Oxcarbazepine (Trileptal) 150 mg BID PO"
                },
                {
                  "text": "300 mg BID",
                  "orderSentence": "Oxcarbazepine (Trileptal) 300 mg BID PO"
                },
                {
                  "text": "450 mg BID",
                  "orderSentence": "Oxcarbazepine (Trileptal) 450 mg BID PO"
                },
                {
                  "text": "600 mg BID",
                  "orderSentence": "Oxcarbazepine (Trileptal) 600 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 150-300 mg BID; increase by 150-300 mg q1wk; target 600-1800 mg/day; max 1800 mg/day",
              "orderSentence": "Oxcarbazepine (Trileptal) 150 mg BID PO"
            },
            "contraindications": "Hypersensitivity; HLA-B*1502 positive",
            "monitoring": "Sodium at baseline, 2wk, 4wk, then q3-6mo (SIADH more common than CBZ)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Second-line/Refractory": [
          {
            "item": "Baclofen",
            "route": "PO",
            "indication": "Add-on to carbamazepine; or monotherapy if CBZ/OXC not tolerated",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg TID",
                  "orderSentence": "Baclofen 5 mg TID PO"
                },
                {
                  "text": "10 mg TID",
                  "orderSentence": "Baclofen 10 mg TID PO"
                },
                {
                  "text": "20 mg TID",
                  "orderSentence": "Baclofen 20 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg TID; increase by 5 mg/dose q3d; target 30-80 mg/day divided TID; max 80 mg/day",
              "orderSentence": "Baclofen 5 mg TID PO"
            },
            "contraindications": "Severe renal impairment",
            "monitoring": "Sedation, dizziness; taper slowly to avoid withdrawal seizures",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lamotrigine",
            "route": "PO",
            "indication": "Add-on therapy; refractory TN",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg daily",
                  "orderSentence": "Lamotrigine 25 mg daily PO"
                },
                {
                  "text": "50 mg daily",
                  "orderSentence": "Lamotrigine 50 mg daily PO"
                },
                {
                  "text": "50 mg BID",
                  "orderSentence": "Lamotrigine 50 mg BID PO"
                },
                {
                  "text": "100 mg BID",
                  "orderSentence": "Lamotrigine 100 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg daily x2wk; then 50 mg daily x2wk; increase by 50 mg q2wk; target 200-400 mg/day",
              "orderSentence": "Lamotrigine 25 mg daily PO"
            },
            "contraindications": "History of serious rash; concurrent valproate (reduce dose)",
            "monitoring": "Rash (SJS risk - titrate slowly)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Gabapentin",
            "route": "PO",
            "indication": "Add-on therapy; mild benefit as monotherapy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg qHS",
                  "orderSentence": "Gabapentin 300 mg qHS PO"
                },
                {
                  "text": "300 mg TID",
                  "orderSentence": "Gabapentin 300 mg TID PO"
                },
                {
                  "text": "600 mg TID",
                  "orderSentence": "Gabapentin 600 mg TID PO"
                },
                {
                  "text": "900 mg TID",
                  "orderSentence": "Gabapentin 900 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 300 mg qHS; increase by 300 mg q3d; target 900-2400 mg/day divided TID; max 3600 mg/day",
              "orderSentence": "Gabapentin 300 mg qHS PO"
            },
            "contraindications": "Severe renal impairment (dose adjust)",
            "monitoring": "Sedation, dizziness, edema; reduce dose in renal impairment",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pregabalin",
            "route": "PO",
            "indication": "Add-on therapy; possibly better tolerability than gabapentin",
            "dosing": {
              "doseOptions": [
                {
                  "text": "75 mg BID",
                  "orderSentence": "Pregabalin 75 mg BID PO"
                },
                {
                  "text": "150 mg BID",
                  "orderSentence": "Pregabalin 150 mg BID PO"
                },
                {
                  "text": "225 mg BID",
                  "orderSentence": "Pregabalin 225 mg BID PO"
                },
                {
                  "text": "300 mg BID",
                  "orderSentence": "Pregabalin 300 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 75 mg BID; increase by 75-150 mg q1wk; target 150-600 mg/day; max 600 mg/day",
              "orderSentence": "Pregabalin 75 mg BID PO"
            },
            "contraindications": "Severe renal impairment (dose adjust)",
            "monitoring": "Sedation, dizziness, weight gain, edema",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Phenytoin",
            "route": "PO",
            "indication": "Historical use; add-on if other agents fail",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg TID",
                  "orderSentence": "Phenytoin 100 mg TID PO"
                },
                {
                  "text": "200 mg TID",
                  "orderSentence": "Phenytoin 200 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 100 mg TID; target 300-500 mg/day; adjust by levels",
              "orderSentence": "Phenytoin 100 mg TID PO"
            },
            "contraindications": "Complete heart block; porphyria",
            "monitoring": "Drug level (10-20 mcg/mL); gingival hyperplasia; CBC",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Botulinum toxin type A",
            "route": "SC",
            "indication": "Refractory to oral medications; localized trigger zone",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25-75 units",
                  "orderSentence": "Botulinum toxin type A 25-75 units SC"
                }
              ],
              "route": "SC",
              "instructions": "25-75 units subcutaneously into trigger zone; repeat q12wk",
              "orderSentence": "Botulinum toxin type A 25-75 units SC"
            },
            "contraindications": "Infection at injection site; neuromuscular disease",
            "monitoring": "Facial weakness, bruising",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Duloxetine",
            "route": "PO",
            "indication": "Comorbid depression; neuropathic pain component",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mg daily",
                  "orderSentence": "Duloxetine 30 mg daily PO"
                },
                {
                  "text": "60 mg daily",
                  "orderSentence": "Duloxetine 60 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 30 mg daily x1wk; increase to 60 mg daily; max 120 mg/day",
              "orderSentence": "Duloxetine 30 mg daily PO"
            },
            "contraindications": "MAOIs; uncontrolled glaucoma; severe renal impairment",
            "monitoring": "BP, serotonin syndrome signs",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pimozide",
            "route": "PO",
            "indication": "Refractory cases; limited evidence",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 mg daily",
                  "orderSentence": "Pimozide 2 mg daily PO"
                },
                {
                  "text": "4 mg daily",
                  "orderSentence": "Pimozide 4 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 2 mg daily; may increase to 4-8 mg daily; max 12 mg/day",
              "orderSentence": "Pimozide 2 mg daily PO"
            },
            "contraindications": "QT prolongation; concurrent QT-prolonging drugs; Parkinson's",
            "monitoring": "ECG (QTc); extrapyramidal symptoms",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Surgical/Interventional Therapies": [
          {
            "item": "Microvascular decompression (MVD)",
            "route": "Surgical",
            "indication": "Classic TN with vascular compression on MRI; good surgical candidate",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Open craniotomy",
                  "orderSentence": "Microvascular decompression (MVD) Open craniotomy Surgical"
                }
              ],
              "route": "Surgical",
              "instructions": "Retromastoid craniectomy; Teflon felt between nerve and vessel; definitive treatment",
              "orderSentence": "Microvascular decompression (MVD) Open craniotomy Surgical"
            },
            "pretreatment": "MRI confirming vascular compression; cardiac clearance; anesthesia clearance",
            "contraindications": "Poor surgical candidate; significant comorbidities; short life expectancy",
            "monitoring": "Post-op neuro checks; hearing assessment; CSF leak",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Percutaneous glycerol rhizotomy",
            "route": "Surgical",
            "indication": "Elderly; poor surgical candidate; MS-related TN; recurrence after MVD",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Glycerol injection into Meckel's cave",
                  "orderSentence": "Percutaneous glycerol rhizotomy Glycerol injection into Meckel's cave Percutaneous"
                }
              ],
              "route": "Percutaneous",
              "instructions": "Inject 0.2-0.4 mL glycerol via foramen ovale under fluoroscopy",
              "orderSentence": "Percutaneous glycerol rhizotomy Glycerol injection into Meckel's cave Percutaneous"
            },
            "pretreatment": "Coagulation studies; informed consent regarding numbness",
            "contraindications": "Active infection; bleeding diathesis",
            "monitoring": "Facial numbness (expected); corneal reflex; anesthesia dolorosa risk",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Percutaneous balloon compression",
            "route": "Surgical",
            "indication": "V1 predominant TN (preserves corneal reflex); poor surgical candidate",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Balloon compression",
                  "orderSentence": "Percutaneous balloon compression Balloon compression Percutaneous"
                }
              ],
              "route": "Percutaneous",
              "instructions": "Inflate balloon via foramen ovale for 60-120 seconds",
              "orderSentence": "Percutaneous balloon compression Balloon compression Percutaneous"
            },
            "pretreatment": "Coagulation studies",
            "contraindications": "Uncontrolled hypertension during procedure",
            "monitoring": "Facial numbness; masseter weakness; corneal reflex",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Percutaneous radiofrequency thermocoagulation",
            "route": "Surgical",
            "indication": "Poor surgical candidate; recurrence after other procedures",
            "dosing": {
              "doseOptions": [
                {
                  "text": "RF lesioning",
                  "orderSentence": "Percutaneous radiofrequency thermocoagulation RF lesioning Percutaneous"
                }
              ],
              "route": "Percutaneous",
              "instructions": "Create lesion via foramen ovale at affected division(s)",
              "orderSentence": "Percutaneous radiofrequency thermocoagulation RF lesioning Percutaneous"
            },
            "pretreatment": "Coagulation studies; patient cooperation (awake procedure)",
            "contraindications": "Cannot cooperate with awake procedure",
            "monitoring": "Facial numbness; corneal reflex; anesthesia dolorosa risk",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Gamma Knife radiosurgery (GKRS)",
            "route": "Non-invasive",
            "indication": "Poor surgical candidate; anticoagulated; MS-related TN; recurrence",
            "dosing": {
              "doseOptions": [
                {
                  "text": "70-90 Gy to root entry zone",
                  "orderSentence": "Gamma Knife radiosurgery (GKRS) 70-90 Gy to root entry zone Non-invasive"
                }
              ],
              "route": "Non-invasive",
              "instructions": "Single fraction to trigeminal root entry zone; effect delayed 1-3 months",
              "orderSentence": "Gamma Knife radiosurgery (GKRS) 70-90 Gy to root entry zone Non-invasive"
            },
            "pretreatment": "MRI for targeting; stereotactic frame placement",
            "contraindications": "Tumor causing TN (requires resection)",
            "monitoring": "Delayed effect (weeks-months); facial numbness (10-30%); can repeat",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CyberKnife stereotactic radiosurgery",
            "route": "Non-invasive",
            "indication": "Alternative to Gamma Knife; frameless option",
            "dosing": {
              "doseOptions": [
                {
                  "text": "60-75 Gy",
                  "orderSentence": "CyberKnife stereotactic radiosurgery 60-75 Gy Non-invasive"
                }
              ],
              "route": "Non-invasive",
              "instructions": "Frameless stereotactic radiosurgery to trigeminal root",
              "orderSentence": "CyberKnife stereotactic radiosurgery 60-75 Gy Non-invasive"
            },
            "pretreatment": "MRI for targeting",
            "contraindications": "Same as GKRS",
            "monitoring": "Same as GKRS",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurology referral for diagnosis confirmation, medication optimization, and long-term management",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Neurosurgery consultation for surgical evaluation if medication refractory or vascular compression on imaging",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pain management referral for multidisciplinary approach and interventional options",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Oral surgery or dentistry to rule out dental pathology mimicking TN",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Neuro-ophthalmology if V1 involvement with corneal reflex concerns",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Psychiatry or psychology for coping strategies given chronic severe pain and depression risk",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ophthalmology for corneal protection if reduced corneal sensation after procedure",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Avoid known triggers such as cold wind, touching face, eating, brushing teeth, or talking when possible",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Return immediately if facial weakness, hearing changes, or fever develop after procedure (may indicate serious complication)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Do not stop carbamazepine or oxcarbazepine abruptly as this may cause rebound pain or seizures",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Report any skin rash, mouth sores, or fever immediately (may indicate serious drug reaction SJS/TEN)",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Monitor for signs of low sodium (confusion, nausea, headache, muscle cramps) especially in first weeks on carbamazepine/oxcarbazepine",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Report any easy bruising, bleeding, or frequent infections (may indicate bone marrow suppression)",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Keep a pain diary to track triggers, severity, and medication effectiveness",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Protect eye on affected side if corneal sensation reduced after surgery (use lubricating drops, protective eyewear)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Soft diet may reduce triggered attacks during flares",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Avoid extreme cold or wind to face (use scarf or mask in cold weather)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Maintain good dental hygiene to prevent dental infections that may worsen or mimic TN",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Stress reduction techniques (meditation, relaxation) as stress can exacerbate attacks",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Use lukewarm water for face washing; avoid very cold water",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Consider electric toothbrush with soft bristles to minimize trigger stimulation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Eat softer foods during flare periods to reduce chewing-triggered attacks",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid alcohol which may interact with medications and worsen symptoms",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Join TN support groups for coping strategies and emotional support",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Dental pathology (pulpitis, periapical abscess, cracked tooth)",
        "features": "Constant aching pain; thermal sensitivity; localized to tooth; percussion tenderness",
        "tests": "Dental exam and imaging; periapical X-rays"
      },
      {
        "diagnosis": "Temporomandibular joint disorder (TMD)",
        "features": "Jaw pain; clicking/popping; pain with chewing; muscle tenderness",
        "tests": "TMJ exam; imaging if needed"
      },
      {
        "diagnosis": "Cluster headache",
        "features": "Severe unilateral orbital pain; autonomic symptoms (lacrimation, rhinorrhea, ptosis); lasts 15-180 min",
        "tests": "Clinical history; no trigger by light touch"
      },
      {
        "diagnosis": "Short-lasting unilateral neuralgiform headache attacks (SUNCT/SUNA)",
        "features": "Very brief attacks (seconds); prominent autonomic features; no refractory period",
        "tests": "Clinical features; MRI to rule out pituitary lesion"
      },
      {
        "diagnosis": "Persistent idiopathic facial pain (atypical facial pain)",
        "features": "Constant daily pain; poorly localized; no triggers; often psychological component",
        "tests": "Diagnosis of exclusion; normal imaging"
      },
      {
        "diagnosis": "Postherpetic neuralgia",
        "features": "History of shingles in trigeminal distribution; constant burning pain; allodynia",
        "tests": "History of vesicles; sensory loss in dermatome"
      },
      {
        "diagnosis": "Multiple sclerosis (secondary TN)",
        "features": "Younger age; bilateral TN; other neurological symptoms/signs; MS lesion on MRI",
        "tests": "MRI brain/spine; CSF oligoclonal bands; evoked potentials"
      },
      {
        "diagnosis": "Trigeminal schwannoma",
        "features": "Progressive sensory loss; facial weakness; may have TN-like pain",
        "tests": "MRI with contrast (enhancing mass at cerebellopontine angle)"
      },
      {
        "diagnosis": "Meningioma (skull base)",
        "features": "Progressive symptoms; may have cranial nerve palsies",
        "tests": "MRI with contrast (dural-based enhancing mass)"
      },
      {
        "diagnosis": "Glossopharyngeal neuralgia",
        "features": "Pain in throat, ear, tongue; triggered by swallowing; similar shock-like quality",
        "tests": "Clinical localization; pain in different distribution"
      },
      {
        "diagnosis": "Giant cell arteritis",
        "features": "Age >50; temporal headache; jaw claudication; elevated ESR/CRP",
        "tests": "ESR, CRP, temporal artery biopsy"
      },
      {
        "diagnosis": "Trigeminal neuropathy",
        "features": "Constant numbness or pain; sensory loss on exam; not shock-like",
        "tests": "Trigeminal reflex testing; MRI for cause"
      }
    ],
    "evidence": [
      {
        "recommendation": "Carbamazepine first-line for classic TN",
        "evidenceLevel": "Class I, Level A",
        "source": "[Cruccu et al. Eur J Neurol 2008 (EFNS Guidelines)](https://pubmed.ncbi.nlm.nih.gov/18853928/)"
      },
      {
        "recommendation": "Oxcarbazepine effective alternative to carbamazepine",
        "evidenceLevel": "Class II, Level B",
        "source": "[Di Stefano et al. Drugs 2018](https://pubmed.ncbi.nlm.nih.gov/30238407/)"
      },
      {
        "recommendation": "HLA-B*1502 screening in Asian patients before carbamazepine",
        "evidenceLevel": "Class I, Level A",
        "source": "[Chen et al. NEJM 2011](https://pubmed.ncbi.nlm.nih.gov/21488763/)"
      },
      {
        "recommendation": "Baclofen add-on therapy for TN",
        "evidenceLevel": "Class III, Level C",
        "source": "[Fromm et al. Arch Neurol 1984](https://pubmed.ncbi.nlm.nih.gov/6712708/)"
      },
      {
        "recommendation": "Lamotrigine add-on for refractory TN",
        "evidenceLevel": "Class III, Level C",
        "source": "[Zakrzewska et al. Pain 1997](https://pubmed.ncbi.nlm.nih.gov/9121808/)"
      },
      {
        "recommendation": "MVD superior long-term outcomes",
        "evidenceLevel": "Class II, Level B",
        "source": "[Barker et al. NEJM 1996](https://pubmed.ncbi.nlm.nih.gov/8538706/)"
      },
      {
        "recommendation": "Gamma Knife for TN",
        "evidenceLevel": "Class II, Level B",
        "source": "[Kondziolka et al. Stereotact Funct Neurosurg 2010](https://pubmed.ncbi.nlm.nih.gov/20606495/)"
      },
      {
        "recommendation": "Percutaneous procedures for TN",
        "evidenceLevel": "Class III, Level C",
        "source": "[Kanpolat et al. Neurosurgery 2001](https://pubmed.ncbi.nlm.nih.gov/11504095/)"
      },
      {
        "recommendation": "Botulinum toxin for refractory TN",
        "evidenceLevel": "Class II, Level B",
        "source": "[Shehata et al. J Headache Pain 2013](https://pubmed.ncbi.nlm.nih.gov/24225575/)"
      },
      {
        "recommendation": "MRI with CISS/FIESTA for TN evaluation",
        "evidenceLevel": "Class II, Level B",
        "source": "[Becker et al. Radiology 2010](https://pubmed.ncbi.nlm.nih.gov/20720068/)"
      },
      {
        "recommendation": "ICHD-3 classification of TN",
        "evidenceLevel": "Expert consensus",
        "source": "[Headache Classification Committee. Cephalalgia 2018](https://pubmed.ncbi.nlm.nih.gov/29368949/)"
      },
      {
        "recommendation": "Comprehensive TN management review",
        "evidenceLevel": "Expert review",
        "source": "[Cruccu et al. Nat Rev Neurol 2020](https://pubmed.ncbi.nlm.nih.gov/32712665/)"
      }
    ],
    "monitoring": [
      {
        "item": "Pain severity (NRS 0-10, attack frequency)",
        "frequency": "Each visit",
        "action": "Uptitrate medication; add second agent; consider surgery",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "CBC with differential (carbamazepine)",
        "frequency": "Baseline, 4wk, 8wk, then q3-6mo",
        "action": "Hold medication if bone marrow suppression; hematology consult",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Serum sodium (carbamazepine/oxcarbazepine)",
        "frequency": "Baseline, 2wk, 4wk, 8wk, then q3-6mo",
        "action": "Fluid restriction; consider dose reduction or switch; severe hyponatremia requires urgent treatment",
        "ED": "STAT",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "LFTs (AST, ALT, ALP)",
        "frequency": "Baseline, 4wk, 8wk, then q3-6mo",
        "action": "Reduce dose or discontinue if significant elevation",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Carbamazepine level",
        "frequency": "If toxicity suspected; adherence concerns; drug interactions",
        "action": "Adjust dose accordingly",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Skin exam",
        "frequency": "Each visit; urgent if rash",
        "action": "Discontinue immediately if rash with systemic symptoms (SJS risk)",
        "ED": "STAT",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Corneal reflex (if V1 TN or post-procedure)",
        "frequency": "Post-procedure; each follow-up",
        "action": "Eye protection; ophthalmology referral; lubricating drops",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Neurological exam (sensory, motor, reflexes)",
        "frequency": "Each visit",
        "action": "Re-evaluate diagnosis if progressive; repeat imaging",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "ECG (if on phenytoin, pimozide)",
        "frequency": "Baseline; with dose changes",
        "action": "Reduce dose or discontinue if QTc prolonged",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      }
    ],
    "disposition": [
      {
        "disposition": "Discharge home",
        "criteria": "Mild-moderate pain controlled with oral medications; able to eat and drink; no concerning symptoms; follow-up arranged"
      },
      {
        "disposition": "Admit to floor",
        "criteria": "Severe uncontrolled pain requiring IV medications or monitoring; unable to take oral medications; significant hyponatremia; new neurological deficits requiring workup"
      },
      {
        "disposition": "Admit to ICU",
        "criteria": "Rarely needed; severe hyponatremia with altered mental status; anaphylaxis to medication"
      },
      {
        "disposition": "Outpatient follow-up",
        "criteria": "2-4 weeks initially for medication titration and lab monitoring; then every 3-6 months when stable"
      },
      {
        "disposition": "Surgical referral criteria",
        "criteria": "Failed 2+ medications at adequate doses; intolerable side effects; vascular compression on MRI; patient preference for definitive treatment"
      }
    ]
  },
  "Bell's Palsy": {
    "id": "bells-palsy",
    "title": "Bell's Palsy",
    "version": "1.0",
    "icd10": [
      "** G51.0 (Bell's palsy)"
    ],
    "scope": "** Acute unilateral peripheral facial nerve palsy of presumed idiopathic etiology. Covers initial evaluation, treatment, and follow-up. Excludes Ramsay Hunt syndrome (herpes zoster oticus), central facial palsy, bilateral facial palsy, and secondary causes.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "Glucose or HbA1c",
            "rationale": "Diabetes is risk factor and affects prognosis",
            "target": "Normal glucose; HbA1c <7%",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended Workup": [
          {
            "item": "Lyme serology (ELISA + Western blot)",
            "rationale": "Endemic areas or tick exposure; bilateral palsy",
            "target": "Negative",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CBC with differential",
            "rationale": "Concern for leukemia or infection",
            "target": "Normal",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "ESR, CRP",
            "rationale": "Inflammatory etiology suspected",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "HIV testing",
            "rationale": "Risk factors present; atypical or recurrent",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "RPR/VDRL",
            "rationale": "Syphilis can cause cranial neuropathies",
            "target": "Nonreactive",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "ACE level, chest imaging",
            "rationale": "Sarcoidosis suspected (bilateral, recurrent, uveitis)",
            "target": "Normal ACE; clear CXR",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "ANA, anti-Ro/La",
            "rationale": "Autoimmune etiology suspected",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "CSF analysis",
            "rationale": "Lyme neuroborreliosis, GBS, or carcinomatous meningitis suspected",
            "target": "Normal; negative Lyme",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "None routinely required",
            "timing": "N/A",
            "target": "Clinical diagnosis sufficient for typical Bell's palsy",
            "contraindications": "N/A",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          }
        ],
        "Extended": [
          {
            "item": "MRI Brain with contrast",
            "timing": "Atypical features, no improvement by 4 months, recurrent",
            "target": "Enhancement of facial nerve (may be normal in Bell's); exclude tumor",
            "contraindications": "MRI-incompatible devices; gadolinium allergy",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "MRI IAC/Temporal bone",
            "timing": "Suspected tumor, Ramsay Hunt, or recurrent palsy",
            "target": "Exclude schwannoma, hemangioma, cholesteatoma",
            "contraindications": "MRI-incompatible devices",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "CT Head non-contrast",
            "timing": "Concern for stroke (upper and lower face affected)",
            "target": "Exclude acute CVA",
            "contraindications": "Pregnancy (relative)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Electroneuronography (ENoG)",
            "timing": "Days 3-14 for severe palsy",
            "target": ">90% degeneration may indicate need for decompression",
            "contraindications": "Too early (<3 days) or late (>3 weeks)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "EMG facial nerve",
            "timing": "After 2-3 weeks if complete palsy; at 4 months if no recovery",
            "target": "Evidence of reinnervation; fibrillations indicate denervation",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Needle EMG (blink reflex)",
            "timing": "Assessing recovery potential",
            "target": "Present R1 response indicates favorable prognosis",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "Prednisone",
            "route": "PO",
            "indication": "First-line treatment; must start within 72 hours of onset",
            "dosing": {
              "doseOptions": [
                {
                  "text": "60 mg daily x 5 days",
                  "orderSentence": "Prednisone 60 mg daily x 5 days PO"
                },
                {
                  "text": "60 mg daily x 5 days then taper",
                  "orderSentence": "Prednisone 60 mg daily x 5 days then taper PO"
                }
              ],
              "route": "PO",
              "instructions": "60-80 mg daily for 5 days, then taper over 5 days (or 60 mg x 5d then 10 mg daily decrease); total 10 days",
              "orderSentence": "Prednisone 60 mg daily x 5 days PO"
            },
            "contraindications": "Uncontrolled diabetes (relative); active systemic infection; psychosis",
            "monitoring": "Glucose in diabetics; mood changes",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "URGENT",
            "ICU": "-"
          },
          {
            "item": "Prednisolone",
            "route": "PO",
            "indication": "Alternative to prednisone; may have better bioavailability",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg daily x 10 days",
                  "orderSentence": "Prednisolone 50 mg daily x 10 days PO"
                },
                {
                  "text": "25 mg BID x 10 days",
                  "orderSentence": "Prednisolone 25 mg BID x 10 days PO"
                }
              ],
              "route": "PO",
              "instructions": "50 mg daily (or 25 mg BID) for 10 days",
              "orderSentence": "Prednisolone 50 mg daily x 10 days PO"
            },
            "contraindications": "Same as prednisone",
            "monitoring": "Glucose in diabetics",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "URGENT",
            "ICU": "-"
          },
          {
            "item": "Valacyclovir",
            "route": "PO",
            "indication": "Adjunct for severe (HB V-VI) or complete facial paralysis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mg TID x 7 days",
                  "orderSentence": "Valacyclovir 1000 mg TID x 7 days PO"
                }
              ],
              "route": "PO",
              "instructions": "1000 mg PO TID for 7 days; start within 72 hours; always combine with corticosteroid",
              "orderSentence": "Valacyclovir 1000 mg TID x 7 days PO"
            },
            "contraindications": "Renal impairment (dose adjust); hypersensitivity",
            "monitoring": "Renal function in CKD",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Acyclovir",
            "route": "PO",
            "indication": "Alternative antiviral if valacyclovir unavailable",
            "dosing": {
              "doseOptions": [
                {
                  "text": "400 mg 5x/day x 10 days",
                  "orderSentence": "Acyclovir 400 mg 5x/day x 10 days PO"
                }
              ],
              "route": "PO",
              "instructions": "400 mg PO 5 times daily for 10 days; always combine with corticosteroid",
              "orderSentence": "Acyclovir 400 mg 5x/day x 10 days PO"
            },
            "contraindications": "Renal impairment (dose adjust); hypersensitivity",
            "monitoring": "Renal function in CKD",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Symptomatic Treatments": [
          {
            "item": "Artificial tears (carboxymethylcellulose)",
            "route": "TOP",
            "indication": "Eye protection during waking hours; prevents exposure keratopathy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1-2 drops q1-2h while awake",
                  "orderSentence": "Artificial tears (carboxymethylcellulose) 1-2 drops q1-2h while awake TOP"
                }
              ],
              "route": "TOP",
              "instructions": "1-2 drops to affected eye every 1-2 hours while awake; increase frequency as needed",
              "orderSentence": "Artificial tears (carboxymethylcellulose) 1-2 drops q1-2h while awake TOP"
            },
            "contraindications": "None",
            "monitoring": "Corneal status",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lubricating eye ointment (lacri-lube)",
            "route": "TOP",
            "indication": "Nighttime eye protection; prevents corneal drying during sleep",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Apply qHS",
                  "orderSentence": "Lubricating eye ointment (lacri-lube) Apply qHS TOP"
                }
              ],
              "route": "TOP",
              "instructions": "Apply 1/4 inch ribbon to affected eye at bedtime",
              "orderSentence": "Lubricating eye ointment (lacri-lube) Apply qHS TOP"
            },
            "contraindications": "None",
            "monitoring": "Corneal status",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Eye patch/Moisture chamber",
            "route": "TOP",
            "indication": "Corneal protection especially at night or outdoors",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Use during sleep and windy conditions",
                  "orderSentence": "Eye patch/Moisture chamber Use during sleep and windy conditions TOP"
                }
              ],
              "route": "TOP",
              "instructions": "Tape eye closed at night; use moisture chamber glasses during day if severe lagophthalmos",
              "orderSentence": "Eye patch/Moisture chamber Use during sleep and windy conditions TOP"
            },
            "contraindications": "None",
            "monitoring": "Ensure complete closure; no corneal contact",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Surgical tape (for eye closure)",
            "route": "TOP",
            "indication": "Ensure complete eyelid closure during sleep",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Apply at bedtime",
                  "orderSentence": "Surgical tape (for eye closure) Apply at bedtime TOP"
                }
              ],
              "route": "TOP",
              "instructions": "Use hypoallergenic tape to gently tape eyelid closed at night; vertical taping preferred",
              "orderSentence": "Surgical tape (for eye closure) Apply at bedtime TOP"
            },
            "contraindications": "Skin sensitivity; ensure no tape touches cornea",
            "monitoring": "Skin irritation; corneal status",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Acetaminophen",
            "route": "PO",
            "indication": "Postauricular pain associated with Bell's palsy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "650 mg q6h PRN",
                  "orderSentence": "Acetaminophen 650 mg q6h PRN PO"
                },
                {
                  "text": "1000 mg q6h PRN",
                  "orderSentence": "Acetaminophen 1000 mg q6h PRN PO"
                }
              ],
              "route": "PO",
              "instructions": "650-1000 mg PO q6h PRN pain; max 3000 mg/day",
              "orderSentence": "Acetaminophen 650 mg q6h PRN PO"
            },
            "contraindications": "Hepatic impairment; avoid with alcohol",
            "monitoring": "Hepatic function with prolonged use",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ibuprofen",
            "route": "PO",
            "indication": "Postauricular pain; mild anti-inflammatory effect",
            "dosing": {
              "doseOptions": [
                {
                  "text": "400 mg q6h PRN",
                  "orderSentence": "Ibuprofen 400 mg q6h PRN PO"
                },
                {
                  "text": "600 mg q6h PRN",
                  "orderSentence": "Ibuprofen 600 mg q6h PRN PO"
                }
              ],
              "route": "PO",
              "instructions": "400-600 mg PO q6h PRN pain; max 2400 mg/day",
              "orderSentence": "Ibuprofen 400 mg q6h PRN PO"
            },
            "contraindications": "Renal impairment; GI bleed; aspirin allergy",
            "monitoring": "GI symptoms; renal function",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Second-line/Refractory": [
          {
            "item": "Botulinum toxin A",
            "route": "IM",
            "indication": "Synkinesis or hemifacial spasm following recovery",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2.5-5 units per site",
                  "orderSentence": "Botulinum toxin A 2.5-5 units per site IM"
                }
              ],
              "route": "IM",
              "instructions": "Inject 2.5-5 units per site in affected muscles; dose varies by target muscle; repeat q3-4 months",
              "orderSentence": "Botulinum toxin A 2.5-5 units per site IM"
            },
            "contraindications": "Infection at site; myasthenia gravis; aminoglycosides",
            "monitoring": "Weakness, ptosis, asymmetry",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Physical therapy (facial)",
            "route": "N/A",
            "indication": "Facilitate recovery; prevent contracture; treat synkinesis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per PT protocol",
                  "orderSentence": "Physical therapy (facial) Per PT protocol N/A"
                }
              ],
              "route": "N/A",
              "instructions": "Facial exercises, massage, mirror biofeedback; start after acute phase",
              "orderSentence": "Physical therapy (facial) Per PT protocol N/A"
            },
            "contraindications": "None",
            "monitoring": "Compliance; progress",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Facial nerve decompression",
            "route": "Surgical",
            "indication": "ENoG shows >90% degeneration within 14 days; controversial",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Surgical referral",
                  "orderSentence": "Facial nerve decompression Surgical referral N/A"
                }
              ],
              "route": "N/A",
              "instructions": "Consider if >90% degeneration on ENoG within 2 weeks of onset; rarely performed",
              "orderSentence": "Facial nerve decompression Surgical referral N/A"
            },
            "contraindications": "Surgical contraindications",
            "monitoring": "Post-operative course; hearing",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Gold weight implant",
            "route": "Surgical",
            "indication": "Chronic lagophthalmos with corneal exposure risk",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Surgical referral",
                  "orderSentence": "Gold weight implant Surgical referral N/A"
                }
              ],
              "route": "N/A",
              "instructions": "For persistent incomplete eye closure after 6-12 months",
              "orderSentence": "Gold weight implant Surgical referral N/A"
            },
            "contraindications": "Surgical contraindications",
            "monitoring": "Corneal protection; cosmesis",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Tarsorrhaphy",
            "route": "Surgical",
            "indication": "Severe corneal exposure not controlled medically",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Surgical referral",
                  "orderSentence": "Tarsorrhaphy Surgical referral N/A"
                }
              ],
              "route": "N/A",
              "instructions": "Temporary or permanent suturing of eyelids for corneal protection",
              "orderSentence": "Tarsorrhaphy Surgical referral N/A"
            },
            "contraindications": "Surgical contraindications",
            "monitoring": "Corneal status",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Ophthalmology referral urgently if corneal involvement, severe lagophthalmos, or eye pain concerning for exposure keratopathy",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "URGENT",
            "ICU": "-"
          },
          {
            "item": "Neurology referral if atypical features, no improvement by 3-4 weeks, or concern for central etiology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "ENT/Otolaryngology referral if Ramsay Hunt suspected, recurrent palsy, or consideration of surgical decompression",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Physical therapy referral for facial rehabilitation, particularly if incomplete recovery or synkinesis",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Plastic surgery/Oculoplastic referral for chronic lagophthalmos requiring surgical intervention (gold weight, tarsorrhaphy)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Return immediately for eye pain, redness, or vision changes which may indicate corneal injury from exposure",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Return if facial weakness worsens after initial improvement or new symptoms develop (numbness, hearing loss, other weakness)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Protect affected eye from wind, dust, and debris with glasses or moisture chamber during recovery",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Use artificial tears frequently during the day and lubricating ointment at night; tape eye closed if unable to fully close",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Most patients (70-85%) recover completely; recovery typically begins within 3 weeks and completes within 3-4 months",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Do not discontinue steroids abruptly as this may cause adrenal insufficiency; complete the full taper as prescribed",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Facial exercises may help recovery; gently massage face and practice facial movements in mirror several times daily",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Adequate sleep and stress management as viral reactivation may be triggered by stress and immunosuppression",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid extreme cold and wind exposure to face during recovery period to prevent irritation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Diabetic patients should maintain strict glycemic control as hyperglycemia worsens prognosis and slows recovery",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid driving if unable to fully close eye or if vision is significantly impaired",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Stroke (central facial palsy)",
        "features": "Forehead sparing; upper face moves normally; other neurological deficits",
        "tests": "CT/MRI brain; complete neurological exam"
      },
      {
        "diagnosis": "Ramsay Hunt syndrome (VZV)",
        "features": "Vesicles in ear canal or on pinna; severe otalgia; worse prognosis",
        "tests": "Clinical exam for vesicles; VZV PCR if needed"
      },
      {
        "diagnosis": "Lyme disease (facial palsy)",
        "features": "Endemic area; tick exposure; bilateral (25%); erythema migrans; arthralgias",
        "tests": "Lyme ELISA + Western blot"
      },
      {
        "diagnosis": "Otitis media with facial palsy",
        "features": "Ear pain, otorrhea, conductive hearing loss, fever",
        "tests": "Otoscopic exam; CT temporal bone"
      },
      {
        "diagnosis": "Parotid tumor/malignancy",
        "features": "Slow onset; parotid mass; progressive; no recovery",
        "tests": "MRI parotid; FNA or biopsy"
      },
      {
        "diagnosis": "Acoustic neuroma (schwannoma)",
        "features": "Gradual onset; hearing loss; tinnitus; facial numbness",
        "tests": "MRI IAC with contrast"
      },
      {
        "diagnosis": "Cholesteatoma",
        "features": "Chronic ear disease; hearing loss; otorrhea",
        "tests": "Otoscopy; CT temporal bone"
      },
      {
        "diagnosis": "Guillain-Barré syndrome",
        "features": "Bilateral facial weakness; limb weakness; areflexia",
        "tests": "LP (albuminocytologic dissociation); EMG/NCS"
      },
      {
        "diagnosis": "Sarcoidosis (Heerfordt syndrome)",
        "features": "Bilateral; uveitis; parotid swelling; fever",
        "tests": "ACE level; chest imaging; biopsy"
      },
      {
        "diagnosis": "Melkersson-Rosenthal syndrome",
        "features": "Recurrent palsy; facial edema; fissured tongue",
        "tests": "Clinical triad; biopsy if needed"
      }
    ],
    "evidence": [
      {
        "recommendation": "Corticosteroids improve recovery rates",
        "evidenceLevel": "Class I, Level A",
        "source": "[Sullivan et al. NEJM 2007 (Scottish Bell's Palsy Study)](https://pubmed.ncbi.nlm.nih.gov/17942873/)"
      },
      {
        "recommendation": "Antiviral monotherapy not effective; corticosteroids superior",
        "evidenceLevel": "Class I, Level A",
        "source": "[Engstrom et al. NEJM 2008](https://pubmed.ncbi.nlm.nih.gov/18784101/)"
      },
      {
        "recommendation": "Combination corticosteroid + antiviral may benefit severe cases",
        "evidenceLevel": "Class I, Level B",
        "source": "[de Almeida et al. JAMA 2009 (meta-analysis)](https://pubmed.ncbi.nlm.nih.gov/19773587/)"
      },
      {
        "recommendation": "Early treatment (within 72 hours) improves outcomes",
        "evidenceLevel": "Class II, Level B",
        "source": "[Madhok et al. Cochrane 2016](https://pubmed.ncbi.nlm.nih.gov/27251627/)"
      },
      {
        "recommendation": "AAN Practice Parameter: Steroids highly effective",
        "evidenceLevel": "Class I, Level A",
        "source": "[Gronseth & Paduga. Neurology 2012 (AAN Guideline)](https://pubmed.ncbi.nlm.nih.gov/23091073/)"
      },
      {
        "recommendation": "Eye protection prevents corneal complications",
        "evidenceLevel": "Class III, Level C",
        "source": "Expert consensus; standard of care"
      },
      {
        "recommendation": "House-Brackmann grading system for assessment",
        "evidenceLevel": "Clinical standard",
        "source": "[House & Brackmann. Otolaryngol Head Neck Surg 1985](https://pubmed.ncbi.nlm.nih.gov/3921901/)"
      },
      {
        "recommendation": "ENoG >90% degeneration predicts poor outcome",
        "evidenceLevel": "Class II, Level B",
        "source": "[Fisch. Otolaryngol Head Neck Surg 1984](https://pubmed.ncbi.nlm.nih.gov/6440089/)"
      },
      {
        "recommendation": "Physical therapy may improve recovery",
        "evidenceLevel": "Class III, Level C",
        "source": "[Teixeira et al. Cochrane 2011](https://pubmed.ncbi.nlm.nih.gov/22161378/)"
      },
      {
        "recommendation": "Botulinum toxin effective for post-paralytic synkinesis",
        "evidenceLevel": "Class II, Level B",
        "source": "[Mehdizadeh et al. Plast Reconstr Surg 2008](https://pubmed.ncbi.nlm.nih.gov/19258585/)"
      }
    ],
    "monitoring": [
      {
        "item": "House-Brackmann grade",
        "frequency": "Each visit",
        "action": "EMG if no improvement; consider referral",
        "ED": "ROUTINE",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Corneal examination (fluorescein)",
        "frequency": "Initial and PRN symptoms",
        "action": "Urgent ophthalmology; increase eye protection",
        "ED": "URGENT",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Eye closure (lagophthalmos)",
        "frequency": "Each visit",
        "action": "Intensify lubrication; consider tarsorrhaphy referral",
        "ED": "ROUTINE",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Glucose (if on steroids)",
        "frequency": "Daily if diabetic x 10 days",
        "action": "Adjust diabetes medications; endocrine consult",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Synkinesis development",
        "frequency": "Starting at 4-8 weeks",
        "action": "Physical therapy; consider botulinum toxin",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Recovery timeline",
        "frequency": "Weeks 3, 6, 12, and 6 months",
        "action": "EMG at 4 months; consider secondary causes",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      }
    ],
    "disposition": [
      {
        "disposition": "Discharge home",
        "criteria": "Typical presentation; able to protect eye; steroids initiated within 72 hours; follow-up arranged"
      },
      {
        "disposition": "Admit to floor",
        "criteria": "Rare; only if unable to protect eye and no caregiver; severe comorbidities affecting steroid use; concern for secondary cause requiring inpatient workup"
      },
      {
        "disposition": "Admit to ICU",
        "criteria": "Not applicable for Bell's palsy"
      },
      {
        "disposition": "Outpatient follow-up",
        "criteria": "2-3 weeks initial follow-up to assess recovery; earlier if corneal symptoms; neurology referral if no improvement by 4-6 weeks"
      }
    ]
  },
  "Vertigo Evaluation": {
    "id": "vertigo-evaluation",
    "title": "Vertigo Evaluation",
    "version": "1.0",
    "icd10": [
      "** R42 (Dizziness and giddiness)"
    ],
    "scope": "** Evaluation of acute and chronic vertigo including differentiation of peripheral vs central causes. Covers BPPV, vestibular neuritis, labyrinthitis, and Meniere's disease workup. Includes red flag identification for posterior circulation stroke. Excludes presyncope, orthostatic hypotension, and cardiac causes of dizziness.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "Glucose (fingerstick or serum)",
            "rationale": "Hypoglycemia can cause dizziness/lightheadedness mimicking vertigo",
            "target": "Normal (70-100 mg/dL)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "CBC",
            "rationale": "Rule out anemia (causes lightheadedness), infection (labyrinthitis)",
            "target": "Normal Hgb, WBC",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "BMP",
            "rationale": "Electrolyte disturbance can cause dizziness; assess renal function",
            "target": "Normal Na, K, glucose, creatinine",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "TSH",
            "rationale": "Thyroid dysfunction can cause vestibular symptoms",
            "target": "Normal (0.4-4.0 mIU/L)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended Workup": [
          {
            "item": "HbA1c",
            "rationale": "Screen for diabetes if neuropathy suspected contributing to imbalance",
            "target": "<5.7% (normal); <7% (controlled DM)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin B12",
            "rationale": "Deficiency causes peripheral neuropathy affecting balance",
            "target": ">300 pg/mL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "RPR/VDRL",
            "rationale": "Neurosyphilis can cause vestibular symptoms",
            "target": "Nonreactive",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "ESR, CRP",
            "rationale": "Elevated in vasculitis, autoimmune inner ear disease",
            "target": "Normal ESR (<20 mm/hr), CRP (<3 mg/L)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lipid panel",
            "rationale": "Vascular risk assessment if central cause suspected",
            "target": "LDL <100 mg/dL; HDL >40 mg/dL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "ANA, anti-dsDNA",
            "rationale": "Autoimmune inner ear disease (AIED) suspected",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Anti-HSP70 antibody",
            "rationale": "Specific marker for autoimmune inner ear disease",
            "target": "Negative",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Lyme serology",
            "rationale": "Endemic area with vestibular and facial nerve involvement",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "FTA-ABS",
            "rationale": "Confirmatory test if RPR positive; otosyphilis",
            "target": "Nonreactive",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Genetic testing (COCH, MYO7A)",
            "rationale": "Familial vestibular disorders, Usher syndrome",
            "target": "No pathogenic variant",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "CT Head non-contrast",
            "timing": "Acute vertigo with concern for hemorrhage or when MRI unavailable",
            "target": "No hemorrhage, mass, or acute stroke",
            "contraindications": "Pregnancy (relative)",
            "ED": "STAT",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "MRI Brain with DWI",
            "timing": "Central vertigo suspected; abnormal HINTS exam; risk factors for stroke",
            "target": "No acute infarct; normal brainstem/cerebellum",
            "contraindications": "MRI-incompatible devices, severe claustrophobia",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "MRA Head (Circle of Willis)",
            "timing": "Posterior circulation stroke suspected; vertebral/basilar stenosis",
            "target": "Patent posterior circulation; no stenosis",
            "contraindications": "MRI contraindications",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended": [
          {
            "item": "MRI Internal Auditory Canals (IAC) with contrast",
            "timing": "Unilateral hearing loss with vertigo; acoustic neuroma suspected",
            "target": "No vestibular schwannoma or CPA lesion",
            "contraindications": "Gadolinium allergy, severe CKD",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CTA Head/Neck",
            "timing": "Vertebral dissection suspected; if MRA unavailable",
            "target": "No dissection; patent vertebral arteries",
            "contraindications": "Contrast allergy, CKD",
            "ED": "STAT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Audiometry",
            "timing": "Sensorineural hearing loss; Meniere's suspected",
            "target": "Symmetric hearing; low-frequency loss in Meniere's",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Videonystagmography (VNG)",
            "timing": "Quantify vestibular function; localize peripheral lesion",
            "target": "Identify unilateral weakness; canal paresis",
            "contraindications": "Acute severe vertigo (defer until improved)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Electrocochleography (ECoG)",
            "timing": "Meniere's disease confirmation",
            "target": "Elevated SP/AP ratio >0.4",
            "contraindications": "Recent ear surgery",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Vestibular evoked myogenic potentials (VEMP)",
            "timing": "Superior canal dehiscence; saccular function",
            "target": "Abnormal thresholds or amplitudes",
            "contraindications": "Hearing aids (remove first)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "High-resolution CT temporal bones",
            "timing": "Superior canal dehiscence; cholesteatoma",
            "target": "Identify bony abnormalities",
            "contraindications": "Pregnancy",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Rotary chair testing",
            "timing": "Bilateral vestibular loss; compensation assessment",
            "target": "Assess VOR gain and phase",
            "contraindications": "Severe vertigo (defer)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Video head impulse test (vHIT)",
            "timing": "Quantify VOR for each semicircular canal",
            "target": "Normal gain >0.8; refixation saccades",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "Meclizine",
            "route": "PO",
            "indication": "Acute vertigo; vestibular suppressant",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg PO",
                  "orderSentence": "Meclizine 25 mg PO PO"
                },
                {
                  "text": "25 mg TID",
                  "orderSentence": "Meclizine 25 mg TID PO"
                },
                {
                  "text": "50 mg TID",
                  "orderSentence": "Meclizine 50 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "25-50 mg PO q6-8h PRN vertigo; max 150 mg/day",
              "orderSentence": "Meclizine 25 mg PO PO"
            },
            "contraindications": "Glaucoma; urinary retention; elderly (fall risk)",
            "monitoring": "Sedation, anticholinergic effects",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Dimenhydrinate (Dramamine)",
            "route": "PO/IV",
            "indication": "Acute vertigo with significant nausea",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg PO",
                  "orderSentence": "Dimenhydrinate (Dramamine) 50 mg PO PO/IV"
                },
                {
                  "text": "50 mg IV",
                  "orderSentence": "Dimenhydrinate (Dramamine) 50 mg IV PO/IV"
                }
              ],
              "route": "PO/IV",
              "instructions": "50 mg PO q6h or 50 mg IV q6h PRN; max 400 mg/day",
              "orderSentence": "Dimenhydrinate (Dramamine) 50 mg PO PO/IV"
            },
            "contraindications": "Same as meclizine; IV form may cause hypotension",
            "monitoring": "Sedation, BP if IV",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ondansetron",
            "route": "IV/PO",
            "indication": "Nausea/vomiting with acute vertigo",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4 mg IV",
                  "orderSentence": "Ondansetron 4 mg IV IV/PO"
                },
                {
                  "text": "8 mg PO",
                  "orderSentence": "Ondansetron 8 mg PO IV/PO"
                },
                {
                  "text": "4 mg ODT",
                  "orderSentence": "Ondansetron 4 mg ODT IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "4 mg IV or 4-8 mg PO/ODT q8h PRN",
              "orderSentence": "Ondansetron 4 mg IV IV/PO"
            },
            "contraindications": "QT prolongation; severe hepatic impairment",
            "monitoring": "QTc if multiple doses or risk factors",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Promethazine",
            "route": "IV/IM/PO",
            "indication": "Severe nausea with acute vertigo",
            "dosing": {
              "doseOptions": [
                {
                  "text": "12.5 mg IV",
                  "orderSentence": "Promethazine 12.5 mg IV IV/IM/PO"
                },
                {
                  "text": "25 mg IV",
                  "orderSentence": "Promethazine 25 mg IV IV/IM/PO"
                },
                {
                  "text": "25 mg PO",
                  "orderSentence": "Promethazine 25 mg PO IV/IM/PO"
                }
              ],
              "route": "IV/IM/PO",
              "instructions": "12.5-25 mg IV/IM/PO q4-6h PRN; max 100 mg/day",
              "orderSentence": "Promethazine 12.5 mg IV IV/IM/PO"
            },
            "contraindications": "Respiratory depression; Parkinson's; children <2 years",
            "monitoring": "Sedation, respiratory status, dystonia",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Lorazepam",
            "route": "IV/PO",
            "indication": "Severe acute vertigo refractory to antihistamines",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5 mg IV",
                  "orderSentence": "Lorazepam 0.5 mg IV IV/PO"
                },
                {
                  "text": "1 mg IV",
                  "orderSentence": "Lorazepam 1 mg IV IV/PO"
                },
                {
                  "text": "0.5 mg PO",
                  "orderSentence": "Lorazepam 0.5 mg PO IV/PO"
                },
                {
                  "text": "1 mg PO",
                  "orderSentence": "Lorazepam 1 mg PO IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "0.5-1 mg IV/PO q8h PRN severe vertigo; short-term use only",
              "orderSentence": "Lorazepam 0.5 mg IV IV/PO"
            },
            "contraindications": "Respiratory depression; severe hepatic impairment; angle-closure glaucoma",
            "monitoring": "Sedation, respiratory status",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Diazepam",
            "route": "PO",
            "indication": "Vestibular suppressant; more sedating",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 mg PO",
                  "orderSentence": "Diazepam 2 mg PO PO"
                },
                {
                  "text": "5 mg PO",
                  "orderSentence": "Diazepam 5 mg PO PO"
                }
              ],
              "route": "PO",
              "instructions": "2-5 mg PO q8-12h PRN vertigo; limit to 3-5 days",
              "orderSentence": "Diazepam 2 mg PO PO"
            },
            "contraindications": "Same as lorazepam",
            "monitoring": "Sedation, respiratory status",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "IV Normal Saline",
            "route": "IV",
            "indication": "Dehydration from vomiting",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mL IV bolus",
                  "orderSentence": "IV Normal Saline 1000 mL IV bolus IV"
                },
                {
                  "text": "125 mL/hr IV",
                  "orderSentence": "IV Normal Saline 125 mL/hr IV IV"
                }
              ],
              "route": "IV",
              "instructions": "1-2 L bolus then maintenance as needed",
              "orderSentence": "IV Normal Saline 1000 mL IV bolus IV"
            },
            "contraindications": "Heart failure; volume overload",
            "monitoring": "Intake/output, signs of overload",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          }
        ],
        "Symptomatic Treatments": [
          {
            "item": "Epley maneuver (canalith repositioning)",
            "route": "Physical",
            "indication": "BPPV - posterior canal (most common)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Perform once",
                  "orderSentence": "Epley maneuver (canalith repositioning) Perform once Physical"
                },
                {
                  "text": "may repeat x2 same session",
                  "orderSentence": "Epley maneuver (canalith repositioning) may repeat x2 same session Physical"
                }
              ],
              "route": "Physical",
              "instructions": "Modified Epley: 5 positions held 30-60 sec each; may repeat if persistent nystagmus",
              "orderSentence": "Epley maneuver (canalith repositioning) Perform once Physical"
            },
            "contraindications": "Severe cervical spine disease; carotid stenosis (relative)",
            "monitoring": "Nystagmus resolution; post-maneuver restrictions controversial",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Semont maneuver",
            "route": "Physical",
            "indication": "BPPV - alternative to Epley",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Perform once",
                  "orderSentence": "Semont maneuver Perform once Physical"
                }
              ],
              "route": "Physical",
              "instructions": "Side-lying liberatory maneuver; faster but more uncomfortable",
              "orderSentence": "Semont maneuver Perform once Physical"
            },
            "contraindications": "Same as Epley",
            "monitoring": "Nystagmus resolution",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Brandt-Daroff exercises",
            "route": "Physical",
            "indication": "BPPV - home exercise; residual symptoms",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Twice daily home exercise",
                  "orderSentence": "Brandt-Daroff exercises Twice daily home exercise Physical"
                }
              ],
              "route": "Physical",
              "instructions": "Sit-to-side x5 each side, 30 sec holds, BID for 2 weeks",
              "orderSentence": "Brandt-Daroff exercises Twice daily home exercise Physical"
            },
            "contraindications": "Severe nausea (defer until improved)",
            "monitoring": "Symptom diary",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lempert maneuver (BBQ roll)",
            "route": "Physical",
            "indication": "BPPV - horizontal canal variant",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Perform once",
                  "orderSentence": "Lempert maneuver (BBQ roll) Perform once Physical"
                },
                {
                  "text": "may repeat",
                  "orderSentence": "Lempert maneuver (BBQ roll) may repeat Physical"
                }
              ],
              "route": "Physical",
              "instructions": "Serial 90-degree rolls toward unaffected ear (360 total)",
              "orderSentence": "Lempert maneuver (BBQ roll) Perform once Physical"
            },
            "contraindications": "Cervical spine disease",
            "monitoring": "Nystagmus resolution",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Prochlorperazine",
            "route": "IV/PO",
            "indication": "Vertigo with significant nausea",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg IV",
                  "orderSentence": "Prochlorperazine 10 mg IV IV/PO"
                },
                {
                  "text": "10 mg PO",
                  "orderSentence": "Prochlorperazine 10 mg PO IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "5-10 mg IV/PO q6-8h PRN; max 40 mg/day",
              "orderSentence": "Prochlorperazine 10 mg IV IV/PO"
            },
            "contraindications": "Parkinson's; QT prolongation; tardive dyskinesia history",
            "monitoring": "Akathisia, dystonia, QTc",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Scopolamine patch",
            "route": "Transdermal",
            "indication": "Motion sickness; prolonged vertigo episodes",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 patch q72h",
                  "orderSentence": "Scopolamine patch 1 patch q72h Transdermal"
                }
              ],
              "route": "Transdermal",
              "instructions": "Apply 1 patch behind ear; replace q72h; remove if symptoms resolve",
              "orderSentence": "Scopolamine patch 1 patch q72h Transdermal"
            },
            "contraindications": "Glaucoma; urinary retention; elderly",
            "monitoring": "Anticholinergic effects, dry mouth",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Second-line/Refractory": [
          {
            "item": "Methylprednisolone",
            "route": "PO",
            "indication": "Vestibular neuritis - may improve recovery",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg daily x 3 days",
                  "orderSentence": "Methylprednisolone 100 mg daily x 3 days PO"
                },
                {
                  "text": "80 mg daily",
                  "orderSentence": "Methylprednisolone 80 mg daily PO"
                },
                {
                  "text": "60 mg daily",
                  "orderSentence": "Methylprednisolone 60 mg daily PO"
                },
                {
                  "text": "40 mg daily",
                  "orderSentence": "Methylprednisolone 40 mg daily PO"
                },
                {
                  "text": "20 mg daily",
                  "orderSentence": "Methylprednisolone 20 mg daily PO"
                },
                {
                  "text": "10 mg daily",
                  "orderSentence": "Methylprednisolone 10 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "100 mg daily x3 days, then taper over 3 weeks (total 22-day course)",
              "orderSentence": "Methylprednisolone 100 mg daily x 3 days PO"
            },
            "contraindications": "Active infection; uncontrolled diabetes; psychosis",
            "monitoring": "Glucose, BP, mood",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Prednisone",
            "route": "PO",
            "indication": "Vestibular neuritis - alternative steroid",
            "dosing": {
              "doseOptions": [
                {
                  "text": "60 mg daily",
                  "orderSentence": "Prednisone 60 mg daily PO"
                },
                {
                  "text": "40 mg daily",
                  "orderSentence": "Prednisone 40 mg daily PO"
                },
                {
                  "text": "20 mg daily",
                  "orderSentence": "Prednisone 20 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "1 mg/kg/day (max 60 mg) x 5 days, taper over 2 weeks",
              "orderSentence": "Prednisone 60 mg daily PO"
            },
            "contraindications": "Same as methylprednisolone",
            "monitoring": "Glucose, BP, mood",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Valacyclovir",
            "route": "PO",
            "indication": "Vestibular neuritis - if viral etiology suspected",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mg TID x 7 days",
                  "orderSentence": "Valacyclovir 1000 mg TID x 7 days PO"
                }
              ],
              "route": "PO",
              "instructions": "1000 mg PO TID x 7 days; most effective if started within 72 hrs",
              "orderSentence": "Valacyclovir 1000 mg TID x 7 days PO"
            },
            "contraindications": "Renal impairment (dose adjust)",
            "monitoring": "Renal function",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Betahistine",
            "route": "PO",
            "indication": "Meniere's disease - vestibular blood flow",
            "dosing": {
              "doseOptions": [
                {
                  "text": "16 mg TID",
                  "orderSentence": "Betahistine 16 mg TID PO"
                },
                {
                  "text": "24 mg TID",
                  "orderSentence": "Betahistine 24 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "8-16 mg PO TID; titrate to 24 mg TID if needed; not FDA approved in US",
              "orderSentence": "Betahistine 16 mg TID PO"
            },
            "contraindications": "Pheochromocytoma; active peptic ulcer",
            "monitoring": "GI upset, headache",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Hydrochlorothiazide",
            "route": "PO",
            "indication": "Meniere's disease - reduce endolymphatic pressure",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg daily",
                  "orderSentence": "Hydrochlorothiazide 25 mg daily PO"
                },
                {
                  "text": "50 mg daily",
                  "orderSentence": "Hydrochlorothiazide 50 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "12.5-50 mg PO daily",
              "orderSentence": "Hydrochlorothiazide 25 mg daily PO"
            },
            "contraindications": "Sulfa allergy; hypokalemia; severe renal impairment",
            "monitoring": "K+, Na+, creatinine, glucose",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Triamterene/HCTZ",
            "route": "PO",
            "indication": "Meniere's disease - potassium-sparing diuretic",
            "dosing": {
              "doseOptions": [
                {
                  "text": "37.5/25 mg daily",
                  "orderSentence": "Triamterene/HCTZ 37.5/25 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "37.5/25 mg PO daily",
              "orderSentence": "Triamterene/HCTZ 37.5/25 mg daily PO"
            },
            "contraindications": "Hyperkalemia; severe renal impairment",
            "monitoring": "K+, creatinine",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Intratympanic dexamethasone",
            "route": "IT",
            "indication": "Refractory Meniere's disease",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4 mg/mL IT injection",
                  "orderSentence": "Intratympanic dexamethasone 4 mg/mL IT injection Intratympanic"
                }
              ],
              "route": "Intratympanic",
              "instructions": "0.4-0.8 mL of 4-24 mg/mL solution injected through TM; repeat x3-4 over 2 weeks",
              "orderSentence": "Intratympanic dexamethasone 4 mg/mL IT injection Intratympanic"
            },
            "contraindications": "Active ear infection; perforated TM",
            "monitoring": "Hearing, vertigo control",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Intratympanic gentamicin",
            "route": "IT",
            "indication": "Refractory Meniere's disease - ablative",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg/mL IT injection",
                  "orderSentence": "Intratympanic gentamicin 40 mg/mL IT injection Intratympanic"
                }
              ],
              "route": "Intratympanic",
              "instructions": "Chemical labyrinthectomy; 0.5 mL of 40 mg/mL; may repeat in 4 weeks",
              "orderSentence": "Intratympanic gentamicin 40 mg/mL IT injection Intratympanic"
            },
            "contraindications": "Only hearing ear; bilateral disease",
            "monitoring": "Hearing loss (expected), vertigo control",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Disease-Modifying or Chronic Therapies": [
          {
            "item": "Vestibular rehabilitation therapy",
            "route": "Physical",
            "indication": "Vestibular hypofunction; chronic imbalance",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1-2x weekly sessions",
                  "orderSentence": "Vestibular rehabilitation therapy 1-2x weekly sessions Physical"
                }
              ],
              "route": "Physical",
              "instructions": "6-12 week program with home exercises; gaze stabilization, balance training, habituation",
              "orderSentence": "Vestibular rehabilitation therapy 1-2x weekly sessions Physical"
            },
            "pretreatment": "Audiometry, VNG to define deficit",
            "contraindications": "Acute vertigo (defer)",
            "monitoring": "Fall risk, symptom diary, DHI scores",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Low-sodium diet",
            "route": "Dietary",
            "indication": "Meniere's disease - reduce endolymph",
            "dosing": {
              "doseOptions": [
                {
                  "text": "<1500-2000 mg Na/day",
                  "orderSentence": "Low-sodium diet <1500-2000 mg Na/day Dietary"
                }
              ],
              "route": "Dietary",
              "instructions": "Strict sodium restriction; avoid processed foods, add no salt",
              "orderSentence": "Low-sodium diet <1500-2000 mg Na/day Dietary"
            },
            "pretreatment": "Dietitian consultation",
            "contraindications": "Hypotension if on diuretics",
            "monitoring": "BP, symptoms, dietary compliance",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Caffeine/alcohol avoidance",
            "route": "Lifestyle",
            "indication": "Meniere's disease; vestibular migraine",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Eliminate or minimize",
                  "orderSentence": "Caffeine/alcohol avoidance Eliminate or minimize Lifestyle"
                }
              ],
              "route": "Lifestyle",
              "instructions": "Avoid caffeine and alcohol which may trigger episodes",
              "orderSentence": "Caffeine/alcohol avoidance Eliminate or minimize Lifestyle"
            },
            "pretreatment": "None",
            "contraindications": "None",
            "monitoring": "Symptom diary",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Migraine preventive therapy",
            "route": "PO",
            "indication": "Vestibular migraine confirmed",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per migraine protocol",
                  "orderSentence": "Migraine preventive therapy Per migraine protocol PO"
                }
              ],
              "route": "PO",
              "instructions": "See Migraine plan for preventive options (topiramate, propranolol, amitriptyline)",
              "orderSentence": "Migraine preventive therapy Per migraine protocol PO"
            },
            "pretreatment": "HIS/Barany criteria for vestibular migraine",
            "contraindications": "Per specific medication",
            "monitoring": "Per specific medication",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurology consultation for central vertigo evaluation when HINTS exam suggests central lesion or stroke suspected",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "ENT/Otology referral for refractory BPPV, Meniere's disease management, or hearing loss evaluation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vestibular physical therapy for vestibular rehabilitation and balance retraining after acute vertigo resolves",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Audiology for formal hearing assessment and vestibular function testing (VNG, VEMP)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Neuro-ophthalmology if ocular motor abnormalities persist or skew deviation concerning for brainstem lesion",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Stroke neurology for urgent evaluation if HINTS-plus exam suggests posterior circulation stroke",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Cardiology if presyncope suspected or arrhythmia contributing to dizziness",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Return immediately if vertigo associated with new headache, diplopia, dysarthria, dysphagia, or weakness (signs of stroke)",
            "ED": "STAT",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Return immediately if sudden hearing loss occurs which requires urgent treatment within 72 hours",
            "ED": "STAT",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid driving, operating machinery, or working at heights until vertigo resolves completely due to fall and accident risk",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Use assistive devices (cane, walker) if balance impaired to prevent falls",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Perform Brandt-Daroff exercises twice daily as instructed if diagnosed with BPPV",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Keep head elevated 30-45 degrees when sleeping for 24-48 hours after Epley maneuver (controversial but commonly recommended)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid sudden head movements and rapid position changes which may trigger vertigo",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Maintain hydration and avoid skipping meals as dehydration and hypoglycemia can worsen symptoms",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Sodium restriction (<2000 mg/day) if Meniere's disease diagnosed to reduce attack frequency",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Caffeine reduction or elimination as caffeine can exacerbate vestibular symptoms",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Alcohol avoidance as alcohol directly affects vestibular function and can trigger episodes",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Stress management through relaxation techniques as stress can trigger vestibular migraine and Meniere's attacks",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Regular sleep schedule as sleep deprivation can worsen vestibular symptoms",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Fall prevention measures including removing throw rugs, installing grab bars, adequate lighting at home",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Smoking cessation to reduce vascular risk factors that contribute to central vertigo",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "BPPV (posterior canal)",
        "features": "Brief episodes (<1 min) triggered by position change; positive Dix-Hallpike with upbeat-torsional nystagmus",
        "tests": "Dix-Hallpike maneuver; resolves with Epley"
      },
      {
        "diagnosis": "BPPV (horizontal canal)",
        "features": "Horizontal nystagmus with supine roll test; direction-changing or direction-fixed",
        "tests": "Supine roll test; treat with BBQ roll maneuver"
      },
      {
        "diagnosis": "Vestibular neuritis",
        "features": "Acute severe vertigo lasting days; unidirectional horizontal nystagmus; normal hearing",
        "tests": "HINTS exam (peripheral pattern); MRI to rule out stroke"
      },
      {
        "diagnosis": "Labyrinthitis",
        "features": "Same as vestibular neuritis PLUS hearing loss; may follow URI",
        "tests": "Audiometry shows sensorineural loss; HINTS peripheral"
      },
      {
        "diagnosis": "Meniere's disease",
        "features": "Recurrent episodes (20 min - 12 hr) with hearing loss, tinnitus, aural fullness",
        "tests": "Audiometry (low-frequency loss); ECoG; MRI IAC"
      },
      {
        "diagnosis": "Vestibular migraine",
        "features": "Vertigo with migraine features; variable duration (5 min - 72 hr); motion sensitivity",
        "tests": "HIS/Barany criteria; diagnosis of exclusion; MRI normal"
      },
      {
        "diagnosis": "Posterior circulation stroke",
        "features": "Acute vertigo + neurological signs; HINTS central pattern; vascular risk factors",
        "tests": "MRI DWI (may be negative early); HINTS exam"
      },
      {
        "diagnosis": "Cerebellar hemorrhage/infarct",
        "features": "Severe imbalance; unable to walk; may have headache, vomiting",
        "tests": "CT head (hemorrhage); MRI DWI (infarct)"
      },
      {
        "diagnosis": "Multiple sclerosis",
        "features": "Vertigo with other demyelinating symptoms; younger patient",
        "tests": "MRI brain/spine with contrast; CSF oligoclonal bands"
      },
      {
        "diagnosis": "Acoustic neuroma",
        "features": "Progressive unilateral hearing loss, tinnitus; vertigo less prominent",
        "tests": "MRI IAC with gadolinium"
      },
      {
        "diagnosis": "Perilymphatic fistula",
        "features": "Vertigo/hearing loss after trauma, straining, or barotrauma",
        "tests": "History; may need surgical exploration"
      },
      {
        "diagnosis": "Superior canal dehiscence",
        "features": "Vertigo triggered by loud sounds (Tullio) or pressure; autophony",
        "tests": "High-resolution CT temporal bone; VEMP"
      },
      {
        "diagnosis": "Central positional vertigo",
        "features": "Down-beating nystagmus with Dix-Hallpike; doesn't fatigue",
        "tests": "MRI cerebellum; Dix-Hallpike pattern"
      },
      {
        "diagnosis": "Drug-induced vestibulotoxicity",
        "features": "Bilateral vestibular loss; aminoglycosides, loop diuretics, chemotherapy",
        "tests": "History; bilateral caloric weakness on VNG"
      },
      {
        "diagnosis": "Presyncope (cardiac)",
        "features": "Near-fainting rather than spinning; palpitations; exertional",
        "tests": "ECG, Holter, echocardiogram; orthostatic vitals"
      },
      {
        "diagnosis": "Orthostatic hypotension",
        "features": "Dizziness on standing; BP drop >20/10 mmHg",
        "tests": "Orthostatic vital signs"
      },
      {
        "diagnosis": "Anxiety/panic disorder",
        "features": "Chronic dizziness; associated anxiety; no objective vestibular findings",
        "tests": "Normal vestibular testing; psychiatric evaluation"
      }
    ],
    "evidence": [
      {
        "recommendation": "HINTS exam superior to early MRI for detecting stroke",
        "evidenceLevel": "Class II, Level B",
        "source": "[Kattah et al. Stroke 2009](https://pubmed.ncbi.nlm.nih.gov/19762709/)"
      },
      {
        "recommendation": "Epley maneuver effective for posterior canal BPPV",
        "evidenceLevel": "Class I, Level A",
        "source": "[Hilton et al. Cochrane Database Syst Rev 2014](https://pubmed.ncbi.nlm.nih.gov/25513198/)"
      },
      {
        "recommendation": "Corticosteroids improve vestibular neuritis recovery",
        "evidenceLevel": "Class I, Level B",
        "source": "[Strupp et al. NEJM 2004](https://pubmed.ncbi.nlm.nih.gov/15254283/)"
      },
      {
        "recommendation": "Vestibular rehabilitation effective for chronic vestibular hypofunction",
        "evidenceLevel": "Class I, Level A",
        "source": "[McDonnell & Hillier Cochrane 2015](https://pubmed.ncbi.nlm.nih.gov/25581507/)"
      },
      {
        "recommendation": "HINTS-plus (HINTS + hearing) increases stroke detection",
        "evidenceLevel": "Class II, Level B",
        "source": "[Newman-Toker et al. Stroke 2013](https://pubmed.ncbi.nlm.nih.gov/23686976/)"
      },
      {
        "recommendation": "Betahistine for Meniere's disease symptoms",
        "evidenceLevel": "Class II, Level B",
        "source": "[James & Burton Cochrane 2001](https://pubmed.ncbi.nlm.nih.gov/11279756/)"
      },
      {
        "recommendation": "Intratympanic gentamicin for refractory Meniere's",
        "evidenceLevel": "Class II, Level B",
        "source": "[Pullens & van Benthem Cochrane 2011](https://pubmed.ncbi.nlm.nih.gov/21412877/)"
      },
      {
        "recommendation": "Meclizine comparable to diazepam for acute vertigo",
        "evidenceLevel": "Class II, Level B",
        "source": "[McClure & Willett Arch Otolaryngol 1980](https://pubmed.ncbi.nlm.nih.gov/6986909/)"
      },
      {
        "recommendation": "Low sodium diet for Meniere's disease management",
        "evidenceLevel": "Class III, Level C",
        "source": "[Luxford et al. Otolaryngol Head Neck Surg 2013](https://pubmed.ncbi.nlm.nih.gov/23886564/)"
      },
      {
        "recommendation": "Diagnostic criteria for vestibular migraine",
        "evidenceLevel": "Consensus",
        "source": "[Lempert et al. Barany Society/IHS 2012](https://pubmed.ncbi.nlm.nih.gov/22287185/)"
      },
      {
        "recommendation": "Video head impulse test for vestibular function",
        "evidenceLevel": "Class II, Level B",
        "source": "[MacDougall et al. Neurology 2009](https://pubmed.ncbi.nlm.nih.gov/19273827/)"
      },
      {
        "recommendation": "Central vs peripheral vertigo differentiation",
        "evidenceLevel": "Consensus",
        "source": "[Baloh & Honrubia. Clinical Neurophysiology of Vestibular System 2011](https://pubmed.ncbi.nlm.nih.gov/21332419/)"
      }
    ],
    "monitoring": [
      {
        "item": "HINTS exam (Head Impulse, Nystagmus, Test of Skew)",
        "frequency": "Initial presentation",
        "action": "Central pattern requires urgent MRI and neurology consult",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT"
      },
      {
        "item": "Nystagmus characteristics",
        "frequency": "Serial exam in ED",
        "action": "Direction-changing, vertical, or non-suppressing suggests central",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT"
      },
      {
        "item": "Gait and balance assessment",
        "frequency": "Each encounter",
        "action": "Unable to walk suggests central lesion or severe peripheral",
        "ED": "STAT",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Hearing assessment (bedside)",
        "frequency": "Initial and follow-up",
        "action": "Asymmetric loss requires audiometry and MRI IAC",
        "ED": "URGENT",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Symptom severity (VAS or DHI)",
        "frequency": "Each visit",
        "action": "Persistent or worsening requires imaging, reassessment",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Dix-Hallpike test",
        "frequency": "If BPPV suspected; follow-up",
        "action": "Positive requires repositioning; recurrence common",
        "ED": "STAT",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Fall risk assessment",
        "frequency": "Each encounter",
        "action": "High risk requires PT, home safety evaluation, assistive devices",
        "ED": "URGENT",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Vestibular function (VNG/VEMP)",
        "frequency": "After acute phase; follow-up",
        "action": "Persistent deficit requires vestibular rehabilitation",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      }
    ],
    "disposition": [
      {
        "disposition": "Discharge home",
        "criteria": "Peripheral vertigo confirmed (HINTS peripheral); symptoms controlled; able to ambulate safely; able to tolerate PO; follow-up arranged; no red flags"
      },
      {
        "disposition": "Observation",
        "criteria": "Severe symptoms requiring IV fluids/medications; unable to ambulate safely; awaiting MRI to rule out central cause"
      },
      {
        "disposition": "Admit to floor",
        "criteria": "Central vertigo confirmed requiring workup; stroke suspected but stable; severe dehydration; unable to tolerate PO for >24 hours"
      },
      {
        "disposition": "Admit to ICU",
        "criteria": "Cerebellar stroke with risk of herniation; cerebellar hemorrhage; posterior circulation stroke with fluctuating symptoms"
      },
      {
        "disposition": "Transfer to higher level",
        "criteria": "Central vertigo suspected and MRI/neurology not available; cerebellar stroke requiring neurosurgical evaluation"
      },
      {
        "disposition": "Outpatient follow-up",
        "criteria": "Within 1-2 weeks for new vertigo; sooner if symptoms persist; ENT referral for Meniere's or hearing loss"
      }
    ]
  },
  "Syncope Evaluation": {
    "id": "syncope-evaluation",
    "title": "Syncope Evaluation",
    "version": "1.0",
    "icd10": [
      "** R55 (Syncope and collapse)"
    ],
    "scope": "** Comprehensive evaluation of transient loss of consciousness (TLOC) due to cerebral hypoperfusion. Covers vasovagal/reflex syncope, orthostatic hypotension, cardiac arrhythmias, and neurologic mimics. Includes risk stratification, diagnostic workup, and management. Excludes seizure-related loss of consciousness (see Seizure plan), stroke, and metabolic causes of altered mental status.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "ECG (12-lead)",
            "rationale": "Rule out arrhythmia, conduction abnormality, ischemia, cardiomyopathy (prolonged QT, Brugada, WPW, ARVC)",
            "target": "Normal sinus rhythm; QTc <450 ms (M), <460 ms (F); no preexcitation or Brugada pattern",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Glucose (fingerstick or serum)",
            "rationale": "Rule out hypoglycemia as cause of altered consciousness",
            "target": "Normal (70-100 mg/dL)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "CBC",
            "rationale": "Evaluate for anemia causing reduced oxygen delivery; infection",
            "target": "Hgb >12 g/dL; no leukocytosis",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "BMP",
            "rationale": "Electrolyte abnormalities can cause arrhythmias or contribute to syncope",
            "target": "Normal Na, K, Mg, Ca, glucose, creatinine",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Troponin",
            "rationale": "Cardiac ischemia as cause of syncope; elevated in PE, aortic dissection",
            "target": "Negative (<0.04 ng/mL or institution-specific)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Orthostatic vital signs",
            "rationale": "Diagnose orthostatic hypotension (BP drop >20/10 mmHg or HR increase >30 bpm)",
            "target": "No significant change; BP stable within 3 min of standing",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended Workup": [
          {
            "item": "BNP or NT-proBNP",
            "rationale": "Screen for heart failure; elevated in cardiac syncope",
            "target": "BNP <100 pg/mL; NT-proBNP <300 pg/mL",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "D-dimer",
            "rationale": "Pulmonary embolism suspected (consider Wells score)",
            "target": "<500 ng/mL (age-adjusted: age x 10 if >50 yo)",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT"
          },
          {
            "item": "TSH",
            "rationale": "Thyroid dysfunction contributing to arrhythmias or autonomic dysfunction",
            "target": "Normal (0.4-4.0 mIU/L)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Magnesium",
            "rationale": "Hypomagnesemia can precipitate arrhythmias",
            "target": "Normal (1.7-2.2 mg/dL)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Lactic acid",
            "rationale": "Tissue hypoperfusion; consider if prolonged LOC or concern for cardiogenic shock",
            "target": "Normal (<2.0 mmol/L)",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT"
          },
          {
            "item": "Pregnancy test (urine or serum)",
            "rationale": "Ectopic pregnancy can present with syncope; all reproductive-age women",
            "target": "Negative (unless known pregnancy)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Plasma catecholamines (supine and standing)",
            "rationale": "Autonomic failure workup; pure autonomic failure vs MSA",
            "target": "Normal increase with standing; absence suggests autonomic failure",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Cortisol (AM)",
            "rationale": "Adrenal insufficiency causing orthostatic hypotension",
            "target": ">10 mcg/dL (AM); consider ACTH stim test if borderline",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Prolactin (within 20 min of event)",
            "rationale": "Distinguish seizure from syncope; elevated post-ictally",
            "target": "Normal (<20 ng/mL); >2x baseline suggests seizure",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "HbA1c",
            "rationale": "Screen for diabetes contributing to autonomic neuropathy",
            "target": "<5.7% (normal); diabetic autonomic neuropathy if elevated with symptoms",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Genetic testing (SCN5A, KCNQ1, KCNH2)",
            "rationale": "Long QT syndrome, Brugada syndrome suspected",
            "target": "No pathogenic variant",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Autoimmune panel (ganglionic AChR Ab, GAD65)",
            "rationale": "Autoimmune autonomic ganglionopathy suspected",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "Continuous cardiac monitoring (telemetry)",
            "timing": "Ongoing in ED/hospital",
            "target": "No arrhythmia detected",
            "contraindications": "None",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Echocardiogram (TTE)",
            "timing": "If structural heart disease suspected, abnormal ECG, cardiac murmur, or high-risk features",
            "target": "Normal LV function (EF >50%); no structural abnormality",
            "contraindications": "None",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "CT Head non-contrast",
            "timing": "Head trauma from fall; focal neurological deficits; concern for SAH",
            "target": "No hemorrhage, mass, or acute abnormality",
            "contraindications": "Pregnancy (relative)",
            "ED": "STAT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Chest X-ray",
            "timing": "Cardiac silhouette, pulmonary edema, widened mediastinum (dissection)",
            "target": "Normal heart size; clear lungs",
            "contraindications": "None",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "URGENT"
          }
        ],
        "Extended": [
          {
            "item": "CTA Chest",
            "timing": "Pulmonary embolism suspected (high Wells score, elevated D-dimer)",
            "target": "No PE; patent pulmonary arteries",
            "contraindications": "Contrast allergy, CKD (eGFR <30)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Holter monitor (24-48 hour)",
            "timing": "Recurrent syncope; arrhythmia suspected but not captured",
            "target": "No significant arrhythmia; correlate with symptoms",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Event recorder (30 days)",
            "timing": "Infrequent syncope (monthly); need longer monitoring",
            "target": "Symptom-rhythm correlation",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Insertable loop recorder (ILR)",
            "timing": "Recurrent unexplained syncope despite workup; infrequent events",
            "target": "Diagnose arrhythmia at time of syncope",
            "contraindications": "None (minor procedure)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Tilt table testing",
            "timing": "Suspected vasovagal syncope with unclear diagnosis; recurrent syncope affecting QOL",
            "target": "Positive (reproduces symptoms with hypotension/bradycardia); or negative excluding reflex syncope",
            "contraindications": "Recent MI, severe aortic stenosis, severe CAD",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Carotid ultrasound",
            "timing": "Syncope with head rotation; carotid bruit",
            "target": "No significant stenosis (>70%); no hypersensitivity",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Stress testing (exercise or pharmacologic)",
            "timing": "Exertional syncope; ischemia suspected",
            "target": "No ischemia; normal BP response",
            "contraindications": "Unstable angina, uncontrolled arrhythmia",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "EEG (routine or ambulatory)",
            "timing": "Seizure vs syncope uncertain; convulsive movements reported; prolonged confusion",
            "target": "Normal; no epileptiform discharges",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "MRI Brain",
            "timing": "Neurological symptoms; focal deficits; posterior circulation insufficiency suspected",
            "target": "Normal; no structural abnormality",
            "contraindications": "MRI-incompatible devices, severe claustrophobia",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Autonomic function testing (QSART, HRV, Valsalva)",
            "timing": "Orthostatic hypotension; suspected autonomic neuropathy or failure",
            "target": "Normal autonomic responses",
            "contraindications": "Recent MI, uncontrolled HTN",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Electrophysiology study (EPS)",
            "timing": "High-risk structural heart disease; non-diagnostic workup; suspected Brugada",
            "target": "No inducible arrhythmia",
            "contraindications": "Anticoagulation issues, active infection",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Carotid sinus massage",
            "timing": "Syncope with head turning or tight collars; age >40; after ruling out carotid stenosis",
            "target": "No pause >3 sec; no BP drop >50 mmHg",
            "contraindications": "Carotid bruit, recent stroke/TIA, carotid stenosis",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Cardiac MRI",
            "timing": "Arrhythmogenic cardiomyopathy (ARVC) suspected; infiltrative disease",
            "target": "No fibrosis, fat infiltration, or structural abnormality",
            "contraindications": "MRI contraindications; CKD for gadolinium",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Exercise tilt test",
            "timing": "Exercise-induced syncope with negative standard testing",
            "target": "No abnormal response",
            "contraindications": "Same as tilt table and exercise testing",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "IV Normal Saline",
            "route": "IV",
            "indication": "Volume depletion; orthostatic hypotension; vagal syncope recovery",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mL IV bolus",
                  "orderSentence": "IV Normal Saline 500 mL IV bolus IV"
                },
                {
                  "text": "1000 mL IV bolus",
                  "orderSentence": "IV Normal Saline 1000 mL IV bolus IV"
                },
                {
                  "text": "125 mL/hr IV",
                  "orderSentence": "IV Normal Saline 125 mL/hr IV IV"
                }
              ],
              "route": "IV",
              "instructions": "500-1000 mL bolus for acute syncope; maintenance if dehydrated",
              "orderSentence": "IV Normal Saline 500 mL IV bolus IV"
            },
            "contraindications": "Heart failure; volume overload",
            "monitoring": "Intake/output; signs of overload; reassess orthostatics",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Atropine",
            "route": "IV",
            "indication": "Symptomatic bradycardia causing syncope",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5 mg IV push",
                  "orderSentence": "Atropine 0.5 mg IV push IV"
                },
                {
                  "text": "1 mg IV push",
                  "orderSentence": "Atropine 1 mg IV push IV"
                }
              ],
              "route": "IV",
              "instructions": "0.5-1 mg IV push; may repeat q3-5min; max 3 mg total",
              "orderSentence": "Atropine 0.5 mg IV push IV"
            },
            "contraindications": "Tachyarrhythmia; glaucoma",
            "monitoring": "HR, BP, rhythm",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Transcutaneous pacing",
            "route": "External",
            "indication": "Symptomatic bradycardia unresponsive to atropine",
            "dosing": {
              "doseOptions": [
                {
                  "text": "60-80 mA",
                  "orderSentence": "Transcutaneous pacing 60-80 mA External"
                },
                {
                  "text": "adjust for capture",
                  "orderSentence": "Transcutaneous pacing adjust for capture External"
                }
              ],
              "route": "External",
              "instructions": "Start 60 mA, increase until capture; rate 60-80 bpm",
              "orderSentence": "Transcutaneous pacing 60-80 mA External"
            },
            "contraindications": "Pacemaker in place (relative); conscious patient (sedate first)",
            "monitoring": "Capture confirmation; BP; sedation level",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Trendelenburg position",
            "route": "Physical",
            "indication": "Immediate management of acute syncope",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Supine with legs elevated",
                  "orderSentence": "Trendelenburg position Supine with legs elevated Physical"
                }
              ],
              "route": "Physical",
              "instructions": "Elevate legs 30-45 degrees; maintain until fully recovered",
              "orderSentence": "Trendelenburg position Supine with legs elevated Physical"
            },
            "contraindications": "Respiratory distress; increased ICP",
            "monitoring": "Mental status; BP recovery",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Epinephrine",
            "route": "IV/IM",
            "indication": "Anaphylaxis causing syncope",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.3 mg IM",
                  "orderSentence": "Epinephrine 0.3 mg IM IM/IV"
                },
                {
                  "text": "0.5 mg IM",
                  "orderSentence": "Epinephrine 0.5 mg IM IM/IV"
                },
                {
                  "text": "0.1 mg IV",
                  "orderSentence": "Epinephrine 0.1 mg IV IM/IV"
                }
              ],
              "route": "IM/IV",
              "instructions": "0.3-0.5 mg IM (1:1000); 0.1 mg IV (1:10,000) for severe",
              "orderSentence": "Epinephrine 0.3 mg IM IM/IV"
            },
            "contraindications": "Uncontrolled hypertension (relative in anaphylaxis)",
            "monitoring": "HR, BP, symptoms",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Glucagon",
            "route": "IV/IM",
            "indication": "Beta-blocker or calcium channel blocker toxicity causing bradycardia/hypotension",
            "dosing": {
              "doseOptions": [
                {
                  "text": "3-5 mg IV",
                  "orderSentence": "Glucagon 3-5 mg IV IV"
                },
                {
                  "text": "10 mg IV",
                  "orderSentence": "Glucagon 10 mg IV IV"
                }
              ],
              "route": "IV",
              "instructions": "3-10 mg IV bolus; may follow with infusion 1-5 mg/hr",
              "orderSentence": "Glucagon 3-5 mg IV IV"
            },
            "contraindications": "Pheochromocytoma; insulinoma",
            "monitoring": "Glucose, BP, HR, nausea",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          }
        ],
        "Symptomatic Treatments": [
          {
            "item": "Compression stockings (30-40 mmHg)",
            "route": "Physical",
            "indication": "Orthostatic hypotension; vasovagal syncope prophylaxis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Waist-high preferred",
                  "orderSentence": "Compression stockings (30-40 mmHg) Waist-high preferred Physical"
                }
              ],
              "route": "Physical",
              "instructions": "30-40 mmHg compression; waist-high more effective than knee-high; wear during daytime",
              "orderSentence": "Compression stockings (30-40 mmHg) Waist-high preferred Physical"
            },
            "contraindications": "Peripheral vascular disease; skin ulcers",
            "monitoring": "Skin integrity; compliance; symptom frequency",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Increased salt intake",
            "route": "Dietary",
            "indication": "Orthostatic hypotension; recurrent vasovagal syncope (no contraindication)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "6-10 g Na/day",
                  "orderSentence": "Increased salt intake 6-10 g Na/day Dietary"
                }
              ],
              "route": "Dietary",
              "instructions": "Increase to 6-10 g sodium daily (salt tablets 1 g TID or dietary salt)",
              "orderSentence": "Increased salt intake 6-10 g Na/day Dietary"
            },
            "contraindications": "Heart failure; uncontrolled HTN; CKD",
            "monitoring": "BP; weight; edema; syncope frequency",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Increased fluid intake",
            "route": "Dietary",
            "indication": "Orthostatic hypotension; volume depletion",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2-3 L/day",
                  "orderSentence": "Increased fluid intake 2-3 L/day Dietary"
                }
              ],
              "route": "Dietary",
              "instructions": "2-3 L daily fluid intake; bolus 500 mL water prior to prolonged standing",
              "orderSentence": "Increased fluid intake 2-3 L/day Dietary"
            },
            "contraindications": "Heart failure; fluid restriction needed",
            "monitoring": "Volume status; electrolytes",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Physical counterpressure maneuvers",
            "route": "Physical",
            "indication": "Prodromal symptoms of vasovagal syncope",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Perform at onset of prodrome",
                  "orderSentence": "Physical counterpressure maneuvers Perform at onset of prodrome Physical"
                }
              ],
              "route": "Physical",
              "instructions": "Leg crossing with tensing; handgrip; arm tensing; squat; abort 30% of episodes",
              "orderSentence": "Physical counterpressure maneuvers Perform at onset of prodrome Physical"
            },
            "contraindications": "None",
            "monitoring": "Symptom diary; effectiveness",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Head-of-bed elevation",
            "route": "Physical",
            "indication": "Orthostatic hypotension; supine hypertension",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10-20 degree elevation",
                  "orderSentence": "Head-of-bed elevation 10-20 degree elevation Physical"
                }
              ],
              "route": "Physical",
              "instructions": "Elevate head of bed 10-20 degrees (4-6 inch blocks); reduces nocturnal natriuresis",
              "orderSentence": "Head-of-bed elevation 10-20 degree elevation Physical"
            },
            "contraindications": "None",
            "monitoring": "Morning BP; symptom frequency",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Second-line/Refractory": [
          {
            "item": "Midodrine",
            "route": "PO",
            "indication": "Orthostatic hypotension refractory to non-pharmacologic measures",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2.5 mg TID",
                  "orderSentence": "Midodrine 2.5 mg TID PO"
                },
                {
                  "text": "5 mg TID",
                  "orderSentence": "Midodrine 5 mg TID PO"
                },
                {
                  "text": "10 mg TID",
                  "orderSentence": "Midodrine 10 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 2.5-5 mg TID (q4h while upright); titrate to 10 mg TID; last dose 4 hrs before bed",
              "orderSentence": "Midodrine 2.5 mg TID PO"
            },
            "contraindications": "Supine HTN; urinary retention; severe heart disease; pheochromocytoma",
            "monitoring": "Supine BP (avoid >180/100); urinary symptoms",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Fludrocortisone",
            "route": "PO",
            "indication": "Orthostatic hypotension; volume expansion needed",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.1 mg daily",
                  "orderSentence": "Fludrocortisone 0.1 mg daily PO"
                },
                {
                  "text": "0.2 mg daily",
                  "orderSentence": "Fludrocortisone 0.2 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.1 mg daily; may increase to 0.2-0.3 mg daily; takes 1-2 weeks for effect",
              "orderSentence": "Fludrocortisone 0.1 mg daily PO"
            },
            "contraindications": "Heart failure; uncontrolled HTN; hypokalemia",
            "monitoring": "K+; supine BP; weight; edema",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Droxidopa (Northera)",
            "route": "PO",
            "indication": "Neurogenic orthostatic hypotension (autonomic failure, Parkinson's)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg TID",
                  "orderSentence": "Droxidopa (Northera) 100 mg TID PO"
                },
                {
                  "text": "200 mg TID",
                  "orderSentence": "Droxidopa (Northera) 200 mg TID PO"
                },
                {
                  "text": "300 mg TID",
                  "orderSentence": "Droxidopa (Northera) 300 mg TID PO"
                },
                {
                  "text": "600 mg TID",
                  "orderSentence": "Droxidopa (Northera) 600 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 100 mg TID; titrate by 100 mg TID q24-48h; max 600 mg TID",
              "orderSentence": "Droxidopa (Northera) 100 mg TID PO"
            },
            "contraindications": "Supine HTN; concomitant catecholamine drugs",
            "monitoring": "Supine BP; syncope frequency",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pyridostigmine",
            "route": "PO",
            "indication": "Orthostatic hypotension with intact post-ganglionic neurons",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mg TID",
                  "orderSentence": "Pyridostigmine 30 mg TID PO"
                },
                {
                  "text": "60 mg TID",
                  "orderSentence": "Pyridostigmine 60 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "30-60 mg PO TID; enhances ganglionic transmission",
              "orderSentence": "Pyridostigmine 30 mg TID PO"
            },
            "contraindications": "Bowel/bladder obstruction; bradycardia",
            "monitoring": "GI side effects; HR",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Atomoxetine",
            "route": "PO",
            "indication": "Neurogenic orthostatic hypotension (off-label)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg daily",
                  "orderSentence": "Atomoxetine 10 mg daily PO"
                },
                {
                  "text": "18 mg BID",
                  "orderSentence": "Atomoxetine 18 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "10-18 mg BID; norepinephrine reuptake inhibitor",
              "orderSentence": "Atomoxetine 10 mg daily PO"
            },
            "contraindications": "MAOIs; narrow-angle glaucoma; pheochromocytoma",
            "monitoring": "BP; HR; urinary retention",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Beta-blocker (low-dose)",
            "route": "PO",
            "indication": "Vasovagal syncope with prominent cardioinhibitory component (controversial)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Metoprolol 25 mg BID",
                  "orderSentence": "Beta-blocker (low-dose) Metoprolol 25 mg BID PO"
                },
                {
                  "text": "Atenolol 25 mg daily",
                  "orderSentence": "Beta-blocker (low-dose) Atenolol 25 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Low-dose beta-blocker (metoprolol 25 mg BID or atenolol 25 mg daily); limited evidence",
              "orderSentence": "Beta-blocker (low-dose) Metoprolol 25 mg BID PO"
            },
            "contraindications": "Bradycardia; hypotension; asthma; 2nd/3rd degree AVB",
            "monitoring": "HR; BP; syncope frequency",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "SSRI (paroxetine, sertraline)",
            "route": "PO",
            "indication": "Recurrent vasovagal syncope refractory to first-line measures",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Paroxetine 20 mg daily",
                  "orderSentence": "SSRI (paroxetine, sertraline) Paroxetine 20 mg daily PO"
                },
                {
                  "text": "Sertraline 50 mg daily",
                  "orderSentence": "SSRI (paroxetine, sertraline) Sertraline 50 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Paroxetine 20 mg daily or sertraline 50 mg daily; may modulate autonomic response",
              "orderSentence": "SSRI (paroxetine, sertraline) Paroxetine 20 mg daily PO"
            },
            "contraindications": "MAOIs; uncontrolled bipolar",
            "monitoring": "Mood; syncope frequency",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Disease-Modifying or Chronic Therapies": [
          {
            "item": "Permanent pacemaker",
            "route": "Implant",
            "indication": "Cardioinhibitory syncope with documented asystole >3 sec or symptomatic bradycardia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Dual-chamber preferred",
                  "orderSentence": "Permanent pacemaker Dual-chamber preferred Implant"
                }
              ],
              "route": "Implant",
              "instructions": "Dual-chamber pacemaker (DDD) for sinus node dysfunction; VVI/DDD for AV block",
              "orderSentence": "Permanent pacemaker Dual-chamber preferred Implant"
            },
            "pretreatment": "EPS, Holter showing bradyarrhythmia, tilt-positive cardioinhibitory",
            "contraindications": "Active infection; coagulopathy",
            "monitoring": "Device interrogation q6-12mo; wound healing",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Implantable cardioverter-defibrillator (ICD)",
            "route": "Implant",
            "indication": "Syncope with structural heart disease and high sudden death risk",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per device type",
                  "orderSentence": "Implantable cardioverter-defibrillator (ICD) Per device type Implant"
                }
              ],
              "route": "Implant",
              "instructions": "Single or dual chamber ICD based on indication",
              "orderSentence": "Implantable cardioverter-defibrillator (ICD) Per device type Implant"
            },
            "pretreatment": "EF assessment, risk stratification completed",
            "contraindications": "Active infection; terminal illness",
            "monitoring": "Device interrogation; driving restrictions",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Catheter ablation",
            "route": "Procedure",
            "indication": "Documented arrhythmia causing syncope (SVT, VT, WPW)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Ablation of arrhythmia focus",
                  "orderSentence": "Catheter ablation Ablation of arrhythmia focus Procedure"
                }
              ],
              "route": "Procedure",
              "instructions": "EP study with ablation of identified arrhythmia substrate",
              "orderSentence": "Catheter ablation Ablation of arrhythmia focus Procedure"
            },
            "pretreatment": "EP study identifying arrhythmia",
            "contraindications": "Active infection; coagulopathy",
            "monitoring": "Post-procedure rhythm monitoring",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Cardioneuroablation",
            "route": "Procedure",
            "indication": "Refractory cardioinhibitory syncope with documented asystole",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Ablation of vagal ganglia",
                  "orderSentence": "Cardioneuroablation Ablation of vagal ganglia Procedure"
                }
              ],
              "route": "Procedure",
              "instructions": "Catheter-based ablation of cardiac vagal ganglia; emerging therapy",
              "orderSentence": "Cardioneuroablation Ablation of vagal ganglia Procedure"
            },
            "pretreatment": "Failed conservative management",
            "contraindications": "Limited availability; investigational",
            "monitoring": "HR variability; syncope recurrence",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Cardiology consultation for arrhythmia evaluation, structural heart disease assessment, or device implantation consideration",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Electrophysiology referral for documented arrhythmias requiring ablation, pacemaker or ICD evaluation, or unexplained high-risk syncope",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Neurology consultation if seizure-syncope differentiation unclear, autonomic testing needed, or neurological symptoms present",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Autonomic disorders specialist for recurrent orthostatic hypotension, suspected pure autonomic failure, or multiple system atrophy",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Driving evaluation per state regulations for commercial drivers or recurrent unexplained syncope affecting driving ability",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Psychiatry referral if psychogenic pseudosyncope suspected based on atypical features and normal workup",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Fall prevention physical therapy for elderly patients with recurrent syncope to reduce injury risk",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Occupational health evaluation for patients in safety-sensitive occupations (pilots, heavy machinery operators, commercial drivers)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Return immediately if syncope recurs, especially with chest pain, palpitations, shortness of breath, or exercise (may indicate cardiac cause requiring urgent evaluation)",
            "ED": "STAT",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Return immediately if prolonged confusion, seizure activity, tongue biting, or urinary incontinence occurs with loss of consciousness (suggests seizure rather than syncope)",
            "ED": "STAT",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Do NOT drive until cleared by physician due to risk of syncope while operating a vehicle; specific restrictions depend on diagnosis and state law",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid prolonged standing, hot environments, and dehydration which are common triggers for vasovagal syncope",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Learn to recognize prodromal symptoms (lightheadedness, warmth, nausea, tunnel vision) and immediately sit or lie down to prevent injury",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Perform physical counterpressure maneuvers (leg crossing, squatting, handgrip) at first sign of prodrome to abort vasovagal episode",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Rise slowly from lying to sitting to standing (staged position changes) to prevent orthostatic syncope",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Maintain adequate hydration (2-3 L daily) and salt intake (unless contraindicated) to support blood volume",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Keep a symptom diary noting triggers, prodrome, circumstances, duration of LOC, and recovery to aid diagnosis",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Wear medical alert identification if recurrent syncope diagnosis confirmed",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Avoid known triggers including prolonged standing, crowded/hot environments, excessive alcohol, and large meals",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Increase oral fluid intake to 2-3 liters daily to maintain intravascular volume and reduce syncope frequency",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Increase dietary salt intake to 6-10 g/day if no contraindication (hypertension, heart failure, CKD) to expand plasma volume",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Wear waist-high compression stockings (30-40 mmHg) during daytime to reduce venous pooling",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid sudden postural changes; use staged position changes (lie-sit-stand with 1-2 min at each stage)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Review and minimize medications that contribute to hypotension (diuretics, antihypertensives, alpha-blockers, nitrates, psychiatric medications)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid excessive heat exposure including hot showers, saunas, and hot tubs which cause vasodilation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Sleep with head of bed elevated 10-20 degrees to reduce nocturnal natriuresis and improve morning orthostatic tolerance",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Moderate regular aerobic exercise to improve vascular tone and reduce vasovagal susceptibility; avoid deconditioning",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Alcohol moderation or avoidance as alcohol causes vasodilation and impairs autonomic reflexes",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Vasovagal (neurocardiogenic) syncope",
        "features": "Prodrome (warmth, nausea, diaphoresis, tunnel vision); identifiable trigger (prolonged standing, pain, emotional stress); rapid recovery",
        "tests": "History; tilt table testing reproduces symptoms"
      },
      {
        "diagnosis": "Orthostatic hypotension",
        "features": "Syncope immediately upon standing; BP drop >20/10 mmHg within 3 min of standing; associated with medications, volume depletion, or autonomic failure",
        "tests": "Orthostatic vital signs; autonomic function testing"
      },
      {
        "diagnosis": "Cardiac arrhythmia (tachy or brady)",
        "features": "Sudden onset without prodrome; palpitations; associated with exertion or supine position; abnormal ECG",
        "tests": "ECG; Holter; event recorder; EP study"
      },
      {
        "diagnosis": "Structural heart disease (AS, HCM, PE)",
        "features": "Exertional syncope; murmur; dyspnea; chest pain; signs of right heart failure (PE)",
        "tests": "Echo; CT chest (PE); cardiac MRI"
      },
      {
        "diagnosis": "Situational syncope",
        "features": "Occurs with specific triggers: micturition, defecation, cough, swallow",
        "tests": "History is diagnostic; occurs during or immediately after trigger activity"
      },
      {
        "diagnosis": "Carotid sinus hypersensitivity",
        "features": "Syncope with head turning, shaving, tight collars; age >40; male predominance",
        "tests": "Carotid sinus massage (after excluding stenosis)"
      },
      {
        "diagnosis": "Seizure (convulsive syncope mimic)",
        "features": "Tonic-clonic movements; lateral tongue bite; prolonged confusion (>5 min); urinary incontinence; no prodrome",
        "tests": "EEG; prolactin (within 20 min); witnessed description"
      },
      {
        "diagnosis": "Psychogenic pseudosyncope",
        "features": "Very frequent episodes; prolonged duration; eyes closed; no injury; normal exam during event",
        "tests": "Normal testing during observed episode; psychiatric evaluation"
      },
      {
        "diagnosis": "Hypoglycemia",
        "features": "Associated with diabetes or insulin use; diaphoresis; hunger; confusion; responds to glucose",
        "tests": "Fingerstick glucose; witnessed glucose administration"
      },
      {
        "diagnosis": "Vertebrobasilar insufficiency",
        "features": "Associated with head movement, vertigo, diplopia, dysarthria, drop attacks",
        "tests": "MRA head/neck; vertebral Doppler"
      },
      {
        "diagnosis": "Subclavian steal syndrome",
        "features": "Arm exercise triggers; BP difference >20 mmHg between arms; vertebrobasilar symptoms",
        "tests": "Bilateral arm BPs; subclavian Doppler; angiography"
      },
      {
        "diagnosis": "Pulmonary embolism",
        "features": "Dyspnea; pleuritic chest pain; unilateral leg swelling; tachycardia; hypoxia",
        "tests": "D-dimer; CTA chest; Wells score"
      },
      {
        "diagnosis": "Aortic dissection",
        "features": "Tearing chest/back pain; BP difference between arms; widened mediastinum",
        "tests": "CT angiography; TEE"
      },
      {
        "diagnosis": "Ruptured AAA",
        "features": "Abdominal or back pain; pulsatile mass; hypotension; older patient",
        "tests": "CT abdomen; bedside ultrasound"
      },
      {
        "diagnosis": "Subarachnoid hemorrhage",
        "features": "Thunderclap headache; neck stiffness; altered mental status; may have syncope at onset",
        "tests": "CT head; lumbar puncture if CT negative"
      }
    ],
    "evidence": [
      {
        "recommendation": "Canadian Syncope Risk Score for ED risk stratification",
        "evidenceLevel": "Class I, Level B",
        "source": "[Thiruganasambandamoorthy et al. CMAJ 2016](https://pubmed.ncbi.nlm.nih.gov/27378464/)"
      },
      {
        "recommendation": "San Francisco Syncope Rule validation",
        "evidenceLevel": "Class II, Level B",
        "source": "[Quinn et al. Ann Emerg Med 2004](https://pubmed.ncbi.nlm.nih.gov/14747812/)"
      },
      {
        "recommendation": "Tilt table testing for vasovagal syncope diagnosis",
        "evidenceLevel": "Class IIa, Level B",
        "source": "[Sheldon et al. Circulation 2015](https://pubmed.ncbi.nlm.nih.gov/26092700/)"
      },
      {
        "recommendation": "Physical counterpressure maneuvers reduce syncope recurrence",
        "evidenceLevel": "Class I, Level B",
        "source": "[van Dijk et al. Circulation 2006](https://pubmed.ncbi.nlm.nih.gov/16651474/)"
      },
      {
        "recommendation": "Midodrine for orthostatic hypotension",
        "evidenceLevel": "Class I, Level A",
        "source": "[Izcovich et al. Heart 2014](https://pubmed.ncbi.nlm.nih.gov/24914034/)"
      },
      {
        "recommendation": "Fludrocortisone for orthostatic hypotension",
        "evidenceLevel": "Class IIa, Level B",
        "source": "[Sheldon et al. Circulation 2015](https://pubmed.ncbi.nlm.nih.gov/26092700/)"
      },
      {
        "recommendation": "Droxidopa for neurogenic orthostatic hypotension",
        "evidenceLevel": "Class I, Level A",
        "source": "[Kaufmann et al. Neurology 2014](https://pubmed.ncbi.nlm.nih.gov/24951477/)"
      },
      {
        "recommendation": "Pacemaker for cardioinhibitory carotid sinus syndrome",
        "evidenceLevel": "Class I, Level B",
        "source": "[Brignole et al. Eur Heart J 2018](https://pubmed.ncbi.nlm.nih.gov/29562304/)"
      },
      {
        "recommendation": "ILR superior to conventional testing for unexplained syncope",
        "evidenceLevel": "Class I, Level A",
        "source": "[Krahn et al. Circulation 2001](https://pubmed.ncbi.nlm.nih.gov/11208669/)"
      },
      {
        "recommendation": "POST trial: beta-blockers ineffective for vasovagal syncope",
        "evidenceLevel": "Class I, Level A",
        "source": "[Sheldon et al. Circulation 2006](https://pubmed.ncbi.nlm.nih.gov/16717147/)"
      },
      {
        "recommendation": "ESC Guidelines on syncope diagnosis and management",
        "evidenceLevel": "Consensus",
        "source": "[Brignole et al. Eur Heart J 2018](https://pubmed.ncbi.nlm.nih.gov/29562304/)"
      },
      {
        "recommendation": "ACC/AHA/HRS Guidelines on bradycardia and pacing",
        "evidenceLevel": "Consensus",
        "source": "[Kusumoto et al. Circulation 2019](https://pubmed.ncbi.nlm.nih.gov/30586772/)"
      },
      {
        "recommendation": "Compression stockings reduce orthostatic intolerance",
        "evidenceLevel": "Class IIa, Level B",
        "source": "[Figueroa et al. Neurology 2015](https://pubmed.ncbi.nlm.nih.gov/26503616/)"
      },
      {
        "recommendation": "Autonomic testing in orthostatic hypotension",
        "evidenceLevel": "Class IIa, Level C",
        "source": "[Freeman et al. Neurology 2011](https://pubmed.ncbi.nlm.nih.gov/21300968/)"
      },
      {
        "recommendation": "Seizure vs syncope differentiation: prolactin levels",
        "evidenceLevel": "Class II, Level B",
        "source": "[Chen et al. Neurology 2005](https://pubmed.ncbi.nlm.nih.gov/15699375/)"
      },
      {
        "recommendation": "Driving restrictions after syncope",
        "evidenceLevel": "Consensus",
        "source": "[Epstein et al. J Am Coll Cardiol 2007](https://pubmed.ncbi.nlm.nih.gov/17692752/)"
      }
    ],
    "monitoring": [
      {
        "item": "Continuous cardiac telemetry",
        "frequency": "Continuous while admitted",
        "action": "Capture rhythm strips; cardiology consult for significant arrhythmia",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT"
      },
      {
        "item": "Orthostatic vital signs",
        "frequency": "Q8H in hospital; each clinic visit",
        "action": "Optimize volume; review medications; consider pharmacotherapy",
        "ED": "STAT",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Syncope recurrence",
        "frequency": "Each encounter",
        "action": "Reassess diagnosis; consider advanced testing (ILR)",
        "ED": "STAT",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "ECG intervals (QTc, PR, QRS)",
        "frequency": "Baseline; with QT-prolonging drugs",
        "action": "Discontinue offending drugs; cardiology evaluation",
        "ED": "STAT",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "STAT"
      },
      {
        "item": "Fall risk assessment",
        "frequency": "Each encounter",
        "action": "PT evaluation; home safety assessment; assistive devices",
        "ED": "URGENT",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Injury from falls",
        "frequency": "Each encounter",
        "action": "Head imaging if concern for intracranial injury",
        "ED": "STAT",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "STAT"
      },
      {
        "item": "Medication reconciliation",
        "frequency": "Each encounter",
        "action": "Reduce/discontinue hypotensive medications",
        "ED": "URGENT",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Driving status",
        "frequency": "Each visit",
        "action": "Document restrictions; report to DMV if required",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Response to treatment (midodrine, fludrocortisone)",
        "frequency": "2-4 weeks after initiation",
        "action": "Dose adjustment; alternative therapy",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      }
    ],
    "disposition": [
      {
        "disposition": "Discharge home",
        "criteria": "Low-risk features: isolated vasovagal syncope with clear trigger, normal ECG, normal cardiac exam, no significant injury, reliable follow-up; San Francisco Syncope Rule negative OR Canadian Syncope Risk Score very low/low risk"
      },
      {
        "disposition": "Observation (ED or short stay)",
        "criteria": "Intermediate risk: unexplained syncope with normal initial workup; awaiting troponin results; awaiting echocardiogram; single syncopal episode without high-risk features"
      },
      {
        "disposition": "Admit to floor",
        "criteria": "High-risk features: abnormal ECG, structural heart disease, heart failure, exertional syncope, syncope causing significant injury, recurrent syncope of unclear etiology, syncope with chest pain or dyspnea"
      },
      {
        "disposition": "Admit to ICU/monitored bed",
        "criteria": "Very high-risk: hemodynamic instability, documented malignant arrhythmia, syncope with ongoing ischemia, severe bradycardia requiring pacing, PE with hypotension"
      },
      {
        "disposition": "Outpatient follow-up",
        "criteria": "Low-risk syncope discharged from ED: cardiology/neurology follow-up within 1-2 weeks; recurrent vasovagal syncope: 2-4 weeks; post-device implantation: per device protocol"
      }
    ]
  },
  "Carpal Tunnel Syndrome": {
    "id": "carpal-tunnel-syndrome",
    "title": "Carpal Tunnel Syndrome",
    "version": "1.0",
    "icd10": [
      "** G56.00 (Carpal tunnel syndrome",
      "unspecified upper limb)",
      "G56.01 (Carpal tunnel syndrome",
      "right upper limb)",
      "G56.02 (Carpal tunnel syndrome",
      "left upper limb)",
      "G56.03 (Carpal tunnel syndrome",
      "bilateral upper limbs)"
    ],
    "scope": "** Evaluation and management of carpal tunnel syndrome from initial presentation through conservative treatment, injection therapy, and surgical referral. Covers clinical diagnosis, electrodiagnostic testing, severity grading, and treatment options. For acute median nerve injury or severe CTS with thenar atrophy, early surgical referral is indicated.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "Fasting glucose",
            "rationale": "Screen for diabetes (common CTS risk factor)",
            "target": "<100 mg/dL",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "HbA1c",
            "rationale": "Diabetes/prediabetes screening (diabetic neuropathy overlap)",
            "target": "<5.7%",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "TSH",
            "rationale": "Hypothyroidism causes CTS (myxedematous tissue infiltration)",
            "target": "0.4-4.0 mIU/L",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended Workup": [
          {
            "item": "Rheumatoid factor",
            "rationale": "RA-associated CTS (synovial hypertrophy)",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Anti-CCP antibody",
            "rationale": "More specific for RA if RF negative",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "ESR",
            "rationale": "Inflammatory arthritis screen",
            "target": "<20 mm/hr",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CRP",
            "rationale": "Inflammatory marker",
            "target": "<3.0 mg/L",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Uric acid",
            "rationale": "Gout/tophaceous deposits in carpal tunnel",
            "target": "Normal (3.5-7.2 mg/dL male; 2.5-6.2 mg/dL female)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "BUN/Creatinine",
            "rationale": "Renal disease (dialysis-associated CTS from amyloid deposition)",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CBC",
            "rationale": "Anemia workup, infection screen",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pregnancy test (women of childbearing age)",
            "rationale": "Pregnancy-associated CTS (common, often resolves postpartum)",
            "target": "Document status",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin B12",
            "rationale": "Concomitant peripheral neuropathy",
            "target": ">300 pg/mL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Serum protein electrophoresis (SPEP)",
            "rationale": "Amyloidosis, myeloma (bilateral CTS may be presenting sign of AL amyloid)",
            "target": "No M-spike",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Free light chains (kappa/lambda)",
            "rationale": "AL amyloidosis if bilateral CTS with cardiac/renal involvement",
            "target": "Normal ratio (0.26-1.65)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "TTR gene testing",
            "rationale": "Hereditary transthyretin amyloidosis if young onset bilateral CTS",
            "target": "No pathogenic variant",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Fat pad biopsy",
            "rationale": "Confirm amyloidosis if strongly suspected",
            "target": "No amyloid deposits",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Acromegaly workup (IGF-1, GH)",
            "rationale": "Bilateral CTS in patient with acromegalic features",
            "target": "Normal",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "Nerve conduction studies (NCS) and EMG",
            "timing": "Recommended for diagnosis confirmation and severity grading; optimal before surgery",
            "target": "Prolonged median sensory and/or motor distal latency; reduced SNAP amplitude; denervation in thenar muscles (severe)",
            "contraindications": "Anticoagulation for needle EMG (relative)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Wrist X-ray (PA and lateral)",
            "timing": "If fracture, arthritis, or bony abnormality suspected",
            "target": "Normal or degenerative changes; exclude fracture",
            "contraindications": "None",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended": [
          {
            "item": "Wrist/carpal tunnel ultrasound",
            "timing": "Alternative to MRI; can measure median nerve CSA; operator-dependent",
            "target": "Median nerve CSA >10-12 mm² at pisiform level; flattening at tunnel",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "MRI wrist without contrast",
            "timing": "Mass lesion, ganglion cyst, tenosynovitis, anatomic variant",
            "target": "No mass, normal median nerve signal",
            "contraindications": "Pacemaker; claustrophobia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "MRI cervical spine with and without contrast",
            "timing": "Rule out cervical radiculopathy if double crush suspected or atypical presentation",
            "target": "No foraminal stenosis at C6-C7",
            "contraindications": "GFR <30; pacemaker; gadolinium allergy",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "CT wrist",
            "timing": "Bony pathology not visible on X-ray; post-traumatic",
            "target": "No fracture or bony deformity",
            "contraindications": "Pregnancy (relative)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "MRI with contrast",
            "timing": "Suspected tumor or inflammatory mass in carpal tunnel",
            "target": "No enhancing mass",
            "contraindications": "GFR <30; pacemaker; gadolinium allergy",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Comparative NCS (ulnar and radial)",
            "timing": "Distinguish CTS from polyneuropathy or brachial plexopathy",
            "target": "Normal ulnar and radial studies",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "Wrist splinting (neutral position)",
            "route": "External",
            "indication": "First-line conservative therapy; nocturnal use prevents wrist flexion",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Neutral position splint",
                  "orderSentence": "Wrist splinting (neutral position) Neutral position splint External"
                }
              ],
              "route": "External",
              "instructions": "Wear nightly x 4-6 weeks; may use during day if symptomatic; neutral wrist position (0-5 degrees extension)",
              "orderSentence": "Wrist splinting (neutral position) Neutral position splint External"
            },
            "contraindications": "None",
            "monitoring": "Skin irritation; compliance",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "NSAID therapy (short-term)",
            "route": "PO",
            "indication": "Acute symptom relief; limited evidence for CTS-specific benefit",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Ibuprofen 400 mg TID",
                  "orderSentence": "NSAID therapy (short-term) Ibuprofen 400 mg TID PO"
                },
                {
                  "text": "Naproxen 500 mg BID",
                  "orderSentence": "NSAID therapy (short-term) Naproxen 500 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Short course (7-14 days); take with food; not for long-term use",
              "orderSentence": "NSAID therapy (short-term) Ibuprofen 400 mg TID PO"
            },
            "contraindications": "GI bleeding; renal impairment; cardiovascular disease; third trimester pregnancy",
            "monitoring": "GI symptoms; renal function",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Symptomatic Treatments": [
          {
            "item": "Gabapentin",
            "route": "PO",
            "indication": "Neuropathic pain/paresthesias (adjunctive)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg qHS",
                  "orderSentence": "Gabapentin 300 mg qHS PO"
                },
                {
                  "text": "300 mg TID",
                  "orderSentence": "Gabapentin 300 mg TID PO"
                },
                {
                  "text": "600 mg TID",
                  "orderSentence": "Gabapentin 600 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 300 mg qHS; increase by 300 mg q3-7d; max 1800 mg/day for CTS",
              "orderSentence": "Gabapentin 300 mg qHS PO"
            },
            "contraindications": "Renal impairment (dose adjust per CrCl)",
            "monitoring": "Sedation, dizziness, edema",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pregabalin",
            "route": "PO",
            "indication": "Neuropathic pain/paresthesias",
            "dosing": {
              "doseOptions": [
                {
                  "text": "75 mg BID",
                  "orderSentence": "Pregabalin 75 mg BID PO"
                },
                {
                  "text": "150 mg BID",
                  "orderSentence": "Pregabalin 150 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 75 mg BID; may increase to 150 mg BID after 1 week",
              "orderSentence": "Pregabalin 75 mg BID PO"
            },
            "contraindications": "Renal impairment; Class V controlled",
            "monitoring": "Sedation, weight gain, edema",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Duloxetine",
            "route": "PO",
            "indication": "Neuropathic pain with comorbid anxiety/depression",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mg daily",
                  "orderSentence": "Duloxetine 30 mg daily PO"
                },
                {
                  "text": "60 mg daily",
                  "orderSentence": "Duloxetine 60 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 30 mg daily; increase to 60 mg after 1 week",
              "orderSentence": "Duloxetine 30 mg daily PO"
            },
            "contraindications": "Hepatic impairment; CrCl <30; MAOIs; narrow-angle glaucoma",
            "monitoring": "Nausea, BP; taper to discontinue",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Amitriptyline",
            "route": "PO",
            "indication": "Nocturnal paresthesias (second-line)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg qHS",
                  "orderSentence": "Amitriptyline 10 mg qHS PO"
                },
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Amitriptyline 25 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10 mg qHS; increase by 10 mg weekly; max 50 mg qHS",
              "orderSentence": "Amitriptyline 10 mg qHS PO"
            },
            "contraindications": "Cardiac conduction abnormality; urinary retention; glaucoma; elderly",
            "monitoring": "ECG if >50 mg; anticholinergic effects",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Topical diclofenac",
            "route": "TOP",
            "indication": "Localized pain/inflammation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Apply gel",
                  "orderSentence": "Topical diclofenac Apply gel TOP"
                }
              ],
              "route": "TOP",
              "instructions": "Apply to wrist area TID-QID; max 4 weeks",
              "orderSentence": "Topical diclofenac Apply gel TOP"
            },
            "contraindications": "Aspirin-sensitive asthma; open wounds",
            "monitoring": "Local skin irritation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lidocaine 5% patch",
            "route": "TOP",
            "indication": "Localized pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 patch",
                  "orderSentence": "Lidocaine 5% patch 1 patch TOP"
                }
              ],
              "route": "TOP",
              "instructions": "Apply to wrist/forearm 12h on, 12h off",
              "orderSentence": "Lidocaine 5% patch 1 patch TOP"
            },
            "contraindications": "Broken skin; severe hepatic impairment",
            "monitoring": "Minimal systemic absorption",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Second-line/Refractory (Injection Therapy)": [
          {
            "item": "Methylprednisolone acetate injection",
            "route": "Local injection",
            "indication": "Moderate CTS failing conservative therapy; bridge to surgery; pregnancy-related CTS",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg",
                  "orderSentence": "Methylprednisolone acetate injection 40 mg Local injection"
                }
              ],
              "route": "Local injection",
              "instructions": "40 mg (1 mL) injected into carpal tunnel under ultrasound guidance preferred; may repeat x1 at 4-6 weeks",
              "orderSentence": "Methylprednisolone acetate injection 40 mg Local injection"
            },
            "contraindications": "Local infection; bleeding disorder; uncontrolled diabetes",
            "monitoring": "Blood glucose (diabetics) 24-48h post-injection; tendon rupture (rare)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Triamcinolone acetonide injection",
            "route": "Local injection",
            "indication": "Alternative corticosteroid for injection",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20-40 mg",
                  "orderSentence": "Triamcinolone acetonide injection 20-40 mg Local injection"
                }
              ],
              "route": "Local injection",
              "instructions": "20-40 mg injected into carpal tunnel; ultrasound guidance recommended",
              "orderSentence": "Triamcinolone acetonide injection 20-40 mg Local injection"
            },
            "contraindications": "Local infection; bleeding disorder; uncontrolled diabetes",
            "monitoring": "Blood glucose (diabetics); skin depigmentation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Dexamethasone injection",
            "route": "Local injection",
            "indication": "Alternative corticosteroid (shorter acting)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4 mg",
                  "orderSentence": "Dexamethasone injection 4 mg Local injection"
                }
              ],
              "route": "Local injection",
              "instructions": "4 mg injected into carpal tunnel; shorter duration than triamcinolone",
              "orderSentence": "Dexamethasone injection 4 mg Local injection"
            },
            "contraindications": "Local infection; bleeding disorder",
            "monitoring": "Blood glucose (diabetics)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Platelet-rich plasma (PRP) injection",
            "route": "Local injection",
            "indication": "Experimental; refractory cases; patient preference to avoid surgery",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2-3 mL PRP",
                  "orderSentence": "Platelet-rich plasma (PRP) injection 2-3 mL PRP Local injection"
                }
              ],
              "route": "Local injection",
              "instructions": "Single injection under ultrasound; emerging evidence",
              "orderSentence": "Platelet-rich plasma (PRP) injection 2-3 mL PRP Local injection"
            },
            "contraindications": "Infection; thrombocytopenia; malignancy",
            "monitoring": "Observe 15 min post-injection",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Definitive Surgical Treatment": [
          {
            "item": "Carpal tunnel release (CTR) - open",
            "route": "Surgical",
            "indication": "Moderate-severe CTS; thenar atrophy; failed conservative therapy x 3-6 months; constant numbness",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Surgical release",
                  "orderSentence": "Carpal tunnel release (CTR) - open Surgical release Outpatient surgery"
                }
              ],
              "route": "Outpatient surgery",
              "instructions": "Open technique; divide transverse carpal ligament; 15-30 min procedure",
              "orderSentence": "Carpal tunnel release (CTR) - open Surgical release Outpatient surgery"
            },
            "pretreatment": "NCS confirmation of diagnosis recommended; optimize diabetes; discuss expectations",
            "contraindications": "Active infection; unstable medical status; anticoagulation (relative)",
            "monitoring": "Post-op pain; wound healing; grip strength; pillar pain",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Carpal tunnel release (CTR) - endoscopic",
            "route": "Surgical",
            "indication": "Same indications as open CTR; faster return to work; surgeon preference",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Surgical release",
                  "orderSentence": "Carpal tunnel release (CTR) - endoscopic Surgical release Outpatient surgery"
                }
              ],
              "route": "Outpatient surgery",
              "instructions": "Endoscopic technique (1 or 2 portal); divide transverse carpal ligament",
              "orderSentence": "Carpal tunnel release (CTR) - endoscopic Surgical release Outpatient surgery"
            },
            "pretreatment": "NCS confirmation recommended; optimize diabetes",
            "contraindications": "Active infection; prior carpal tunnel surgery (relative); anatomic variants",
            "monitoring": "Post-op pain; transient nerve injury (1-2%); wound healing",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Hand surgery or orthopedic surgery referral for carpal tunnel release evaluation when conservative therapy fails or severe CTS present",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Electrodiagnostic medicine/neurology for NCS/EMG to confirm diagnosis and grade severity before surgical intervention",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Occupational medicine for workplace ergonomic assessment and work restrictions if occupational risk factors present",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Physical/occupational therapy for nerve gliding exercises, ergonomic training, and activity modification",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rheumatology referral if inflammatory arthritis suspected as underlying cause (RA, gout)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Endocrinology for diabetes optimization or hypothyroidism management if contributing to CTS",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Primary care for management of modifiable risk factors (diabetes, obesity, hypothyroidism)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pain management if refractory neuropathic symptoms despite treatment",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Wear wrist splint nightly in neutral position for minimum 4-6 weeks; may wear during day if symptoms persist with activities",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid prolonged wrist flexion or extension (typing, gripping tools, driving) as this increases carpal tunnel pressure",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Take frequent breaks during repetitive hand activities (every 30-60 minutes) to rest wrists",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Perform nerve gliding exercises as instructed by therapist to improve median nerve mobility",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Apply ice for 10-15 minutes if wrist swelling present; avoid direct ice contact with skin",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Report worsening numbness, weakness in thumb, or dropping objects (may indicate progression requiring surgery)",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid sleeping with wrists curled under pillow; maintain neutral wrist position during sleep",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "If pregnant, symptoms often improve after delivery; conservative management preferred during pregnancy",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "After corticosteroid injection, temporary increase in symptoms may occur first 24-48 hours before improvement",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Post-surgical: Keep incision clean and dry; elevate hand; start motion as directed; full grip strength recovery may take 3-6 months",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Optimize glycemic control (HbA1c <7%) as diabetes worsens nerve function and CTS outcomes",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Weight loss if overweight/obese as obesity is modifiable risk factor for CTS",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Ergonomic workstation setup: keyboard at elbow height, wrists neutral, avoid resting wrists on hard surfaces",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Use ergonomic keyboard, mouse, and tools if occupation involves repetitive hand use",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Smoking cessation to improve microvascular circulation and nerve healing",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid prolonged use of vibrating tools or take breaks every 15-30 minutes when using such equipment",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Reduce caffeine and alcohol intake as these may worsen paresthesias in some patients",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Treat underlying thyroid disease as hypothyroidism contributes to CTS through tissue edema",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Stretch and warm up hands before repetitive activities",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Vitamin B6 supplementation not recommended (evidence does not support benefit; high doses cause neuropathy)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Cervical radiculopathy (C6-C7)",
        "features": "Neck pain, dermatomal pattern (not strictly median), reflex changes (C6: brachioradialis; C7: triceps), negative Phalen/Tinel",
        "tests": "MRI cervical spine; NCS/EMG shows radicular pattern; neck range of motion limited"
      },
      {
        "diagnosis": "Pronator syndrome",
        "features": "Forearm pain/tenderness at pronator teres, symptoms with resisted pronation, no nocturnal worsening, palmar cutaneous branch affected",
        "tests": "NCS/EMG; tenderness at pronator teres on exam; provocative testing"
      },
      {
        "diagnosis": "Anterior interosseous syndrome",
        "features": "Weakness only (FPL, FDP to index, pronator quadratus); no sensory loss; pinch weakness",
        "tests": "NCS/EMG; cannot make \"OK\" sign (pinch between thumb and index)"
      },
      {
        "diagnosis": "Thoracic outlet syndrome",
        "features": "Shoulder/arm pain, positional symptoms, vascular symptoms (pallor, cyanosis), C8-T1 distribution",
        "tests": "Adson test; ROOS test; X-ray for cervical rib; MRA; NCS"
      },
      {
        "diagnosis": "Ulnar neuropathy at elbow (cubital tunnel)",
        "features": "Numbness in ring and small finger, hand weakness, elbow symptoms, positive Tinel at elbow",
        "tests": "NCS/EMG shows ulnar slowing at elbow; sensory exam (ulnar digits spared in CTS)"
      },
      {
        "diagnosis": "Peripheral polyneuropathy",
        "features": "Symmetric symptoms, length-dependent, feet often affected first, multiple nerve territories",
        "tests": "NCS shows generalized abnormalities; HbA1c; B12; metabolic panel"
      },
      {
        "diagnosis": "De Quervain tenosynovitis",
        "features": "Radial wrist pain, positive Finkelstein test, no numbness, tenderness over 1st dorsal compartment",
        "tests": "Finkelstein test positive; ultrasound shows tendon thickening; no NCS abnormalities"
      },
      {
        "diagnosis": "Raynaud phenomenon",
        "features": "Color changes (white-blue-red), cold-triggered, bilateral, no weakness",
        "tests": "No NCS abnormalities; may have positive ANA; capillaroscopy"
      },
      {
        "diagnosis": "Brachial plexopathy",
        "features": "Shoulder/arm weakness and sensory loss in plexus pattern, may have Horner syndrome",
        "tests": "NCS/EMG; MRI brachial plexus; distribution beyond median nerve"
      },
      {
        "diagnosis": "Trigger finger",
        "features": "Finger locking/clicking, palm nodule, no numbness in median distribution",
        "tests": "Palpable nodule at A1 pulley; no NCS abnormalities; triggering on exam"
      },
      {
        "diagnosis": "Ganglion cyst (volar wrist)",
        "features": "Palpable mass, may transilluminate, compresses median nerve",
        "tests": "Ultrasound or MRI shows cystic structure; NCS may be normal or show CTS"
      },
      {
        "diagnosis": "Multiple sclerosis",
        "features": "Central demyelination; other neurologic symptoms; sensory symptoms may mimic CTS",
        "tests": "MRI brain/spine; CSF oligoclonal bands; NCS normal"
      },
      {
        "diagnosis": "Syringomyelia",
        "features": "Dissociated sensory loss (pain/temp preserved, vibration lost), cape distribution, central cord lesion",
        "tests": "MRI cervical spine shows syrinx cavity"
      },
      {
        "diagnosis": "Amyloidosis",
        "features": "Bilateral CTS, cardiac involvement, macroglossia, renal disease, family history (hATTR)",
        "tests": "SPEP/UPEP; free light chains; TTR gene; tissue biopsy"
      }
    ],
    "evidence": [
      {
        "recommendation": "Nocturnal wrist splinting is effective first-line treatment for CTS",
        "evidenceLevel": "Class I, Level A",
        "source": "[Page MJ et al. Cochrane Database Syst Rev 2012](https://pubmed.ncbi.nlm.nih.gov/22786497/)"
      },
      {
        "recommendation": "NCS/EMG recommended for diagnostic confirmation before surgery",
        "evidenceLevel": "Class II, Level B",
        "source": "[Werner RA et al. Muscle Nerve 2011](https://pubmed.ncbi.nlm.nih.gov/21922474/)"
      },
      {
        "recommendation": "Corticosteroid injection provides short-term symptom relief",
        "evidenceLevel": "Class I, Level A",
        "source": "[Marshall S et al. Cochrane Database Syst Rev 2007](https://pubmed.ncbi.nlm.nih.gov/17253462/)"
      },
      {
        "recommendation": "Carpal tunnel release surgery is effective for moderate-severe CTS",
        "evidenceLevel": "Class I, Level A",
        "source": "[Verdugo RJ et al. Cochrane Database Syst Rev 2008](https://pubmed.ncbi.nlm.nih.gov/18843658/)"
      },
      {
        "recommendation": "Ultrasound-guided injection improves accuracy and outcomes",
        "evidenceLevel": "Class II, Level B",
        "source": "[Ustun N et al. Arch Phys Med Rehabil 2013](https://pubmed.ncbi.nlm.nih.gov/23267555/)"
      },
      {
        "recommendation": "Diabetes mellitus is significant risk factor for CTS",
        "evidenceLevel": "Class II, Level B",
        "source": "[Pourmemari MH et al. Diabet Med 2016](https://pubmed.ncbi.nlm.nih.gov/26108553/)"
      },
      {
        "recommendation": "Clinical examination (Phalen, Tinel) has moderate sensitivity/specificity",
        "evidenceLevel": "Class II, Level B",
        "source": "[Middleton SD et al. J Hand Surg Eur Vol 2014](https://pubmed.ncbi.nlm.nih.gov/23824222/)"
      },
      {
        "recommendation": "Severe CTS with thenar atrophy should be referred for surgery",
        "evidenceLevel": "Class II, Level B",
        "source": "[Graham B et al. J Am Acad Orthop Surg 2016](https://pubmed.ncbi.nlm.nih.gov/26803543/)"
      },
      {
        "recommendation": "Endoscopic and open CTR have equivalent long-term outcomes",
        "evidenceLevel": "Class I, Level A",
        "source": "[Scholten RJ et al. Cochrane Database Syst Rev 2007](https://pubmed.ncbi.nlm.nih.gov/17943857/)"
      },
      {
        "recommendation": "Pregnancy-related CTS often resolves postpartum",
        "evidenceLevel": "Class III, Level C",
        "source": "[Padua L et al. Muscle Nerve 2010](https://pubmed.ncbi.nlm.nih.gov/20082417/)"
      },
      {
        "recommendation": "Median nerve CSA >10-12 mm² on ultrasound supports CTS diagnosis",
        "evidenceLevel": "Class II, Level B",
        "source": "[Cartwright MS et al. Muscle Nerve 2012](https://pubmed.ncbi.nlm.nih.gov/22334176/)"
      },
      {
        "recommendation": "Nerve gliding exercises may provide modest benefit as adjunct therapy",
        "evidenceLevel": "Class II, Level C",
        "source": "[Ballestero-Perez R et al. J Orthop Sports Phys Ther 2017](https://pubmed.ncbi.nlm.nih.gov/28622488/)"
      },
      {
        "recommendation": "AAOS Clinical Practice Guideline for CTS",
        "evidenceLevel": "Guideline",
        "source": "[AAOS Guideline 2016](https://pubmed.ncbi.nlm.nih.gov/26803543/)"
      },
      {
        "recommendation": "AANEM practice parameter for electrodiagnosis of CTS",
        "evidenceLevel": "Guideline",
        "source": "[Jablecki CK et al. Muscle Nerve 2002](https://pubmed.ncbi.nlm.nih.gov/12210353/)"
      }
    ],
    "monitoring": [
      {
        "item": "Symptom severity (numbness, tingling, nocturnal symptoms)",
        "frequency": "Each visit",
        "action": "Consider escalation: injection if splinting fails; surgery if injection fails",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Grip strength",
        "frequency": "Baseline and q4-8 weeks if weakness",
        "action": "Expedite surgical referral if progressive weakness",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Thenar muscle bulk",
        "frequency": "Each visit",
        "action": "If atrophy developing, urgent surgical referral (indicates severe CTS)",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Two-point discrimination",
        "frequency": "Baseline and periodic",
        "action": "If abnormal/worsening, indicates sensory axonal loss; consider surgery",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Splint compliance",
        "frequency": "Each visit",
        "action": "Re-educate; consider injection if compliant but not improving",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "HbA1c (diabetic patients)",
        "frequency": "Every 3 months",
        "action": "Intensify diabetes management",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "TSH (if hypothyroid)",
        "frequency": "Every 6-12 months",
        "action": "Adjust thyroid replacement",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Post-injection response",
        "frequency": "2-4 weeks after injection",
        "action": "If no improvement, discuss surgical options",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Post-surgical wound healing",
        "frequency": "7-14 days post-op",
        "action": "If infection signs, antibiotics and wound care",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Post-surgical sensory/motor function",
        "frequency": "6 weeks, 3 months, 6 months post-op",
        "action": "If not improving, NCS/EMG; consider incomplete release or scarring",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Recurrence after surgery",
        "frequency": "Annual if risk factors present",
        "action": "NCS; consider revision surgery if confirmed recurrence",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      }
    ],
    "disposition": [
      {
        "disposition": "**Discharge home**",
        "criteria": "Mild-moderate CTS; can use splint; outpatient neurology/hand surgery follow-up arranged; no thenar atrophy; no progressive weakness"
      },
      {
        "disposition": "**Admit to floor**",
        "criteria": "Acute compartment syndrome of forearm/hand (rare); post-operative complication requiring observation; severe medical comorbidities requiring inpatient management"
      },
      {
        "disposition": "**Admit to ICU**",
        "criteria": "Not typical for CTS; only if concurrent critical illness"
      },
      {
        "disposition": "**Urgent surgical referral**",
        "criteria": "Thenar atrophy; progressive weakness; constant numbness with sensory loss; failed conservative therapy >6 months; severe CTS on NCS with denervation"
      },
      {
        "disposition": "**Routine surgical referral**",
        "criteria": "Moderate CTS with inadequate response to splinting and injection; patient preference; occupational impairment"
      },
      {
        "disposition": "**Outpatient follow-up**",
        "criteria": "Most patients; splinting trial with reassessment in 4-6 weeks; post-injection follow-up in 2-4 weeks"
      }
    ]
  },
  "Radiculopathy - Cervical and Lumbar": {
    "id": "radiculopathy",
    "title": "Radiculopathy - Cervical and Lumbar",
    "version": "1.0",
    "icd10": [
      "** M54.10 (Radiculopathy",
      "site unspecified)",
      "M54.11 (Radiculopathy",
      "occipito-atlanto-axial region)",
      "M54.12 (Radiculopathy",
      "cervical region)",
      "M54.13 (Radiculopathy",
      "cervicothoracic region)",
      "M54.14 (Radiculopathy",
      "thoracic region)",
      "M54.15 (Radiculopathy",
      "thoracolumbar region)",
      "M54.16 (Radiculopathy",
      "lumbar region)",
      "M54.17 (Radiculopathy",
      "lumbosacral region)",
      "M54.18 (Radiculopathy",
      "sacral and sacrococcygeal region)",
      "G55 (Nerve root and plexus compressions in diseases classified elsewhere)",
      "M50.10 (Cervical disc disorder with radiculopathy",
      "unspecified)",
      "M51.16 (Intervertebral disc disorders with radiculopathy",
      "lumbar region)"
    ],
    "scope": "** Evaluation and management of cervical (C5-T1) and lumbar (L2-S1) radiculopathy in adults. Covers red flag identification, diagnostic workup including imaging and electrodiagnostic testing, conservative management, interventional treatments, and surgical indications. Excludes spinal cord compression (myelopathy), cauda equina syndrome (requires emergent surgical evaluation), thoracic radiculopathy, and post-surgical radiculopathy.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC with differential",
            "rationale": "Infection screen if fever, malignancy screen",
            "target": "Normal WBC; no anemia",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "CMP (BMP + LFTs)",
            "rationale": "Baseline renal/hepatic function for medications; metabolic causes",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "ESR",
            "rationale": "Inflammatory marker for infection, malignancy, spondyloarthropathy",
            "target": "<20 mm/hr (age-adjusted)",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "CRP",
            "rationale": "Inflammatory marker for infection, malignancy",
            "target": "<0.5 mg/dL",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          }
        ],
        "Extended Workup": [
          {
            "item": "HbA1c",
            "rationale": "Diabetes increases neuropathy risk; affects surgical outcomes",
            "target": "<5.7%",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Fasting glucose",
            "rationale": "Diabetes screening",
            "target": "<100 mg/dL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin B12",
            "rationale": "Combined neuropathy may confuse presentation",
            "target": ">300 pg/mL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "TSH",
            "rationale": "Hypothyroidism can cause myopathy, neuropathy",
            "target": "Normal (0.4-4.0 mIU/L)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "HLA-B27",
            "rationale": "Ankylosing spondylitis, spondyloarthropathy if young patient with inflammatory back pain",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Urinalysis",
            "rationale": "UTI can mimic/exacerbate symptoms; pre-operative screen",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "PSA (males >50)",
            "rationale": "Prostate cancer metastases to spine",
            "target": "Age-appropriate normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Blood cultures (x2)",
            "rationale": "If fever or infection suspected",
            "target": "No growth",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "SPEP with immunofixation",
            "rationale": "Multiple myeloma with vertebral lesions",
            "target": "No M-spike",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Lyme serology",
            "rationale": "Endemic areas with radiculopathy, polyradiculopathy",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Paraneoplastic panel",
            "rationale": "Atypical presentation, weight loss, subacute course",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "ANA",
            "rationale": "Connective tissue disease",
            "target": "Negative or low titer",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "ACE level",
            "rationale": "Sarcoidosis with multifocal radiculopathy",
            "target": "Normal",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "MRI spine (cervical or lumbar) without contrast",
            "timing": "STAT if red flags; otherwise after 4-6 weeks conservative treatment fails",
            "target": "Disc herniation, foraminal stenosis, nerve root compression",
            "contraindications": "Pacemaker (MRI-incompatible), cochlear implant, metallic foreign body",
            "ED": "STAT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "MRI spine with and without contrast",
            "timing": "If infection, tumor, or inflammatory etiology suspected",
            "target": "Enhancement pattern (abscess rim, tumor, leptomeningeal)",
            "contraindications": "GFR <30 (for gadolinium); pacemaker; gadolinium allergy",
            "ED": "STAT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "X-ray spine (AP/lateral, flexion/extension)",
            "timing": "Initial screen for instability, spondylolisthesis, fracture, alignment",
            "target": "No fracture, normal alignment, no listhesis",
            "contraindications": "Pregnancy (shield abdomen)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          }
        ],
        "Extended": [
          {
            "item": "CT spine without contrast",
            "timing": "If MRI contraindicated; bony detail for fracture, foraminal stenosis",
            "target": "Foraminal narrowing, osteophytes, fracture",
            "contraindications": "Pregnancy (relative); contrast allergy (if contrast used)",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "CT myelogram",
            "timing": "MRI contraindicated and need for neural visualization",
            "target": "Filling defect at nerve root, cord compression",
            "contraindications": "Coagulopathy (for LP); intracranial mass",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "EMG/NCS (electrodiagnostic studies)",
            "timing": "3-4 weeks after symptom onset to confirm radiculopathy, exclude peripheral neuropathy, localize level",
            "target": "Fibrillations/positive sharp waves in myotomal distribution; reduced recruitment",
            "contraindications": "Pacemaker (relative for needle EMG); anticoagulation (relative)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Diagnostic selective nerve root block",
            "timing": "To confirm symptomatic level when imaging shows multilevel disease",
            "target": ">50% pain relief confirms level",
            "contraindications": "Coagulopathy; infection at injection site; allergy to contrast/anesthetic",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Bone scan (nuclear)",
            "timing": "Suspected occult fracture, metastatic disease, infection",
            "target": "No increased uptake",
            "contraindications": "Pregnancy",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "PET-CT",
            "timing": "Occult malignancy, extent of metastatic disease",
            "target": "No FDG-avid lesions",
            "contraindications": "Pregnancy; uncontrolled diabetes",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Discography",
            "timing": "Identify painful disc level before fusion (controversial)",
            "target": "Concordant pain reproduction",
            "contraindications": "Coagulopathy; local infection; allergy",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "Methylprednisolone",
            "route": "IV",
            "indication": "Severe acute radiculopathy with significant weakness",
            "dosing": {
              "doseOptions": [
                {
                  "text": "125 mg",
                  "orderSentence": "Methylprednisolone 125 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "125 mg IV once; may give for severe acute radicular symptoms",
              "orderSentence": "Methylprednisolone 125 mg IV"
            },
            "contraindications": "Active infection; uncontrolled diabetes; GI bleeding",
            "monitoring": "Glucose; BP; GI symptoms",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Dexamethasone",
            "route": "IV/PO",
            "indication": "Acute severe radiculopathy, disc herniation with inflammation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Dexamethasone 10 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "10 mg IV once, then 4 mg IV/PO q6h x 3-5 days; taper over 5-7 days",
              "orderSentence": "Dexamethasone 10 mg IV"
            },
            "contraindications": "Active infection; uncontrolled diabetes; GI bleeding",
            "monitoring": "Glucose; BP; psychiatric effects",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Prednisone",
            "route": "PO",
            "indication": "Acute radiculopathy with moderate-severe symptoms",
            "dosing": {
              "doseOptions": [
                {
                  "text": "60 mg",
                  "orderSentence": "Prednisone 60 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "60 mg daily x 5 days then taper; OR Medrol dose pack",
              "orderSentence": "Prednisone 60 mg PO"
            },
            "contraindications": "Active GI bleed; uncontrolled DM; active infection",
            "monitoring": "Glucose; BP; mood",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ketorolac",
            "route": "IV/IM",
            "indication": "Acute pain, anti-inflammatory",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mg",
                  "orderSentence": "Ketorolac 30 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "30 mg IV/IM q6h; max 5 days; reduce to 15 mg if elderly/renal impairment",
              "orderSentence": "Ketorolac 30 mg IV"
            },
            "contraindications": "CrCl <30; active GI bleed; aspirin allergy; post-CABG",
            "monitoring": "Renal function; GI bleeding",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Morphine",
            "route": "IV",
            "indication": "Severe acute radicular pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2-4 mg",
                  "orderSentence": "Morphine 2-4 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "2-4 mg IV q2-4h PRN severe pain; titrate to effect",
              "orderSentence": "Morphine 2-4 mg IV"
            },
            "contraindications": "Respiratory depression; severe asthma; paralytic ileus",
            "monitoring": "Respiratory status; sedation; pain scores",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Hydromorphone",
            "route": "IV",
            "indication": "Severe acute radicular pain (alternative to morphine)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5-1 mg",
                  "orderSentence": "Hydromorphone 0.5-1 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "0.5-1 mg IV q2-4h PRN; titrate to effect",
              "orderSentence": "Hydromorphone 0.5-1 mg IV"
            },
            "contraindications": "Respiratory depression; severe asthma; paralytic ileus",
            "monitoring": "Respiratory status; sedation; pain scores",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Diazepam",
            "route": "PO/IV",
            "indication": "Acute muscle spasm",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Diazepam 5 mg PO/IV"
                }
              ],
              "route": "PO/IV",
              "instructions": "5-10 mg PO/IV q6-8h PRN for muscle spasm; short course (1-2 weeks)",
              "orderSentence": "Diazepam 5 mg PO/IV"
            },
            "contraindications": "Severe respiratory insufficiency; myasthenia gravis; acute narrow-angle glaucoma",
            "monitoring": "Sedation; respiratory depression; dependence",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          }
        ],
        "Symptomatic Treatments - Pain Management": [
          {
            "item": "Ibuprofen",
            "route": "PO",
            "indication": "Radicular pain, inflammation (first-line OTC)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "400 mg TID",
                  "orderSentence": "Ibuprofen 400 mg TID PO"
                },
                {
                  "text": "600 mg TID",
                  "orderSentence": "Ibuprofen 600 mg TID PO"
                },
                {
                  "text": "800 mg TID",
                  "orderSentence": "Ibuprofen 800 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "400-800 mg TID with food; max 3200 mg/day; short-term use preferred",
              "orderSentence": "Ibuprofen 400 mg TID PO"
            },
            "contraindications": "CrCl <30; active GI bleed; aspirin allergy; third trimester pregnancy",
            "monitoring": "GI symptoms; renal function with prolonged use",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Naproxen",
            "route": "PO",
            "indication": "Radicular pain, inflammation (longer duration)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "250 mg BID",
                  "orderSentence": "Naproxen 250 mg BID PO"
                },
                {
                  "text": "500 mg BID",
                  "orderSentence": "Naproxen 500 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "250-500 mg BID with food; max 1500 mg/day",
              "orderSentence": "Naproxen 250 mg BID PO"
            },
            "contraindications": "CrCl <30; active GI bleed; aspirin allergy; third trimester pregnancy",
            "monitoring": "GI symptoms; renal function with prolonged use",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Meloxicam",
            "route": "PO",
            "indication": "Radicular pain (once daily dosing)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "7.5 mg daily",
                  "orderSentence": "Meloxicam 7.5 mg daily PO"
                },
                {
                  "text": "15 mg daily",
                  "orderSentence": "Meloxicam 15 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "7.5-15 mg daily; max 15 mg/day",
              "orderSentence": "Meloxicam 7.5 mg daily PO"
            },
            "contraindications": "CrCl <30; active GI bleed; aspirin allergy",
            "monitoring": "GI symptoms; renal function",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Celecoxib",
            "route": "PO",
            "indication": "Radicular pain (GI-sparing COX-2)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg BID",
                  "orderSentence": "Celecoxib 100 mg BID PO"
                },
                {
                  "text": "200 mg BID",
                  "orderSentence": "Celecoxib 200 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "100-200 mg BID; max 400 mg/day",
              "orderSentence": "Celecoxib 100 mg BID PO"
            },
            "contraindications": "Sulfonamide allergy; CAD/CVD (increased CV risk); CrCl <30",
            "monitoring": "CV events; GI symptoms; renal function",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Acetaminophen",
            "route": "PO",
            "indication": "Mild-moderate pain (adjunct, avoid hepatotoxicity)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "650 mg q6h",
                  "orderSentence": "Acetaminophen 650 mg q6h PO"
                },
                {
                  "text": "1000 mg q6h",
                  "orderSentence": "Acetaminophen 1000 mg q6h PO"
                }
              ],
              "route": "PO",
              "instructions": "650-1000 mg q6h; max 3000 mg/day (2000 mg/day if liver disease)",
              "orderSentence": "Acetaminophen 650 mg q6h PO"
            },
            "contraindications": "Severe hepatic impairment; chronic alcohol use",
            "monitoring": "LFTs with prolonged use",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Gabapentin",
            "route": "PO",
            "indication": "Neuropathic/radicular pain (first-line for radiculopathy)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg qHS",
                  "orderSentence": "Gabapentin 300 mg qHS PO"
                },
                {
                  "text": "300 mg TID",
                  "orderSentence": "Gabapentin 300 mg TID PO"
                },
                {
                  "text": "600 mg TID",
                  "orderSentence": "Gabapentin 600 mg TID PO"
                },
                {
                  "text": "900 mg TID",
                  "orderSentence": "Gabapentin 900 mg TID PO"
                },
                {
                  "text": "1200 mg TID",
                  "orderSentence": "Gabapentin 1200 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 300 mg qHS; increase by 300 mg q1-3d; target 900-1800 mg TID; max 3600 mg/day",
              "orderSentence": "Gabapentin 300 mg qHS PO"
            },
            "contraindications": "Renal impairment (adjust: CrCl 30-59 max 1400 mg/day; CrCl 15-29 max 600 mg/day; CrCl <15 max 300 mg/day)",
            "monitoring": "Sedation; dizziness; edema; taper to discontinue",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Pregabalin",
            "route": "PO",
            "indication": "Neuropathic/radicular pain (first-line alternative)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "75 mg BID",
                  "orderSentence": "Pregabalin 75 mg BID PO"
                },
                {
                  "text": "150 mg BID",
                  "orderSentence": "Pregabalin 150 mg BID PO"
                },
                {
                  "text": "225 mg BID",
                  "orderSentence": "Pregabalin 225 mg BID PO"
                },
                {
                  "text": "300 mg BID",
                  "orderSentence": "Pregabalin 300 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 75 mg BID; increase to 150 mg BID after 1 week; max 300 mg BID (600 mg/day)",
              "orderSentence": "Pregabalin 75 mg BID PO"
            },
            "contraindications": "Renal impairment (adjust per CrCl); Class V controlled",
            "monitoring": "Sedation; weight gain; edema; dizziness",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Duloxetine",
            "route": "PO",
            "indication": "Neuropathic/radicular pain with depression/anxiety",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mg daily",
                  "orderSentence": "Duloxetine 30 mg daily PO"
                },
                {
                  "text": "60 mg daily",
                  "orderSentence": "Duloxetine 60 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 30 mg daily x 1 week; increase to 60 mg daily; max 120 mg/day",
              "orderSentence": "Duloxetine 30 mg daily PO"
            },
            "contraindications": "Hepatic impairment; CrCl <30; MAOIs; narrow-angle glaucoma",
            "monitoring": "Nausea; BP; discontinuation syndrome (taper over 2+ weeks)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Cyclobenzaprine",
            "route": "PO",
            "indication": "Muscle spasm (short-term)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg TID",
                  "orderSentence": "Cyclobenzaprine 5 mg TID PO"
                },
                {
                  "text": "10 mg TID",
                  "orderSentence": "Cyclobenzaprine 10 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "5-10 mg TID; max 30 mg/day; limit to 2-3 weeks",
              "orderSentence": "Cyclobenzaprine 5 mg TID PO"
            },
            "contraindications": "Arrhythmia; heart failure; MAOIs within 14 days; hyperthyroidism",
            "monitoring": "Sedation; anticholinergic effects; dry mouth",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Tizanidine",
            "route": "PO",
            "indication": "Muscle spasm (alternative to cyclobenzaprine)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 mg TID",
                  "orderSentence": "Tizanidine 2 mg TID PO"
                },
                {
                  "text": "4 mg TID",
                  "orderSentence": "Tizanidine 4 mg TID PO"
                },
                {
                  "text": "8 mg TID",
                  "orderSentence": "Tizanidine 8 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 2 mg TID; increase by 2-4 mg q6-8h; max 36 mg/day in divided doses",
              "orderSentence": "Tizanidine 2 mg TID PO"
            },
            "contraindications": "Concurrent ciprofloxacin or fluvoxamine (CYP1A2 inhibitors); hepatic impairment",
            "monitoring": "LFTs at baseline, 1, 3, 6 months; sedation; hypotension",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Methocarbamol",
            "route": "PO",
            "indication": "Muscle spasm (less sedating)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "750 mg QID",
                  "orderSentence": "Methocarbamol 750 mg QID PO"
                },
                {
                  "text": "1500 mg QID",
                  "orderSentence": "Methocarbamol 1500 mg QID PO"
                }
              ],
              "route": "PO",
              "instructions": "1500 mg QID x 2-3 days, then 750 mg QID or 1500 mg TID",
              "orderSentence": "Methocarbamol 750 mg QID PO"
            },
            "contraindications": "Renal impairment (use caution); myasthenia gravis",
            "monitoring": "Sedation; dizziness (less than other relaxants)",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Baclofen",
            "route": "PO",
            "indication": "Muscle spasm (if other relaxants fail)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg TID",
                  "orderSentence": "Baclofen 5 mg TID PO"
                },
                {
                  "text": "10 mg TID",
                  "orderSentence": "Baclofen 10 mg TID PO"
                },
                {
                  "text": "20 mg TID",
                  "orderSentence": "Baclofen 20 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg TID; increase by 5 mg/dose q3d; max 80 mg/day",
              "orderSentence": "Baclofen 5 mg TID PO"
            },
            "contraindications": "Withdrawal risk if stopped abruptly; renal impairment",
            "monitoring": "Sedation; weakness; must taper to discontinue (seizure risk)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lidocaine patch 5%",
            "route": "TOP",
            "indication": "Localized radicular pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1-3 patches",
                  "orderSentence": "Lidocaine patch 5% 1-3 patches TOP"
                }
              ],
              "route": "TOP",
              "instructions": "Apply 1-3 patches to affected area for 12h on, 12h off",
              "orderSentence": "Lidocaine patch 5% 1-3 patches TOP"
            },
            "contraindications": "Severe hepatic impairment; broken skin",
            "monitoring": "Minimal systemic absorption; local skin irritation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Capsaicin cream 0.075%",
            "route": "TOP",
            "indication": "Localized radicular pain (adjunct)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Apply thin layer",
                  "orderSentence": "Capsaicin cream 0.075% Apply thin layer TOP"
                }
              ],
              "route": "TOP",
              "instructions": "Apply TID-QID to affected area; takes 2-4 weeks for effect",
              "orderSentence": "Capsaicin cream 0.075% Apply thin layer TOP"
            },
            "contraindications": "Open wounds; avoid eyes/mucous membranes",
            "monitoring": "Initial burning (decreases with use); wash hands after",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Amitriptyline",
            "route": "PO",
            "indication": "Neuropathic pain (second-line, helps sleep)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg qHS",
                  "orderSentence": "Amitriptyline 10 mg qHS PO"
                },
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Amitriptyline 25 mg qHS PO"
                },
                {
                  "text": "50 mg qHS",
                  "orderSentence": "Amitriptyline 50 mg qHS PO"
                },
                {
                  "text": "75 mg qHS",
                  "orderSentence": "Amitriptyline 75 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10-25 mg qHS; increase by 10-25 mg weekly; max 150 mg qHS",
              "orderSentence": "Amitriptyline 10 mg qHS PO"
            },
            "contraindications": "Cardiac conduction abnormality; recent MI; urinary retention; glaucoma; elderly",
            "monitoring": "ECG if dose >100 mg/day; anticholinergic effects",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Nortriptyline",
            "route": "PO",
            "indication": "Neuropathic pain (second-line, less sedating than amitriptyline)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg qHS",
                  "orderSentence": "Nortriptyline 10 mg qHS PO"
                },
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Nortriptyline 25 mg qHS PO"
                },
                {
                  "text": "50 mg qHS",
                  "orderSentence": "Nortriptyline 50 mg qHS PO"
                },
                {
                  "text": "75 mg qHS",
                  "orderSentence": "Nortriptyline 75 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10-25 mg qHS; increase by 10-25 mg weekly; max 150 mg qHS",
              "orderSentence": "Nortriptyline 10 mg qHS PO"
            },
            "contraindications": "Cardiac conduction abnormality; recent MI; urinary retention; glaucoma; elderly",
            "monitoring": "ECG if dose >100 mg/day; fewer anticholinergic effects than amitriptyline",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Second-line/Refractory": [
          {
            "item": "Tramadol",
            "route": "PO",
            "indication": "Moderate radicular pain not controlled by NSAIDs/gabapentinoids",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg q6h PRN",
                  "orderSentence": "Tramadol 50 mg q6h PRN PO"
                },
                {
                  "text": "100 mg ER daily",
                  "orderSentence": "Tramadol 100 mg ER daily PO"
                },
                {
                  "text": "200 mg ER daily",
                  "orderSentence": "Tramadol 200 mg ER daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 50 mg q6h PRN; may use ER 100 mg daily; max 400 mg/day",
              "orderSentence": "Tramadol 50 mg q6h PRN PO"
            },
            "contraindications": "Seizure disorder; MAOIs; SSRIs (serotonin syndrome); severe renal/hepatic impairment",
            "monitoring": "Serotonin syndrome; seizures; dependence (Schedule IV)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Oxycodone",
            "route": "PO",
            "indication": "Moderate-severe radicular pain (short-term)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg q4-6h PRN",
                  "orderSentence": "Oxycodone 5 mg q4-6h PRN PO"
                },
                {
                  "text": "10 mg q4-6h PRN",
                  "orderSentence": "Oxycodone 10 mg q4-6h PRN PO"
                }
              ],
              "route": "PO",
              "instructions": "5-10 mg PO q4-6h PRN; for short-term use only",
              "orderSentence": "Oxycodone 5 mg q4-6h PRN PO"
            },
            "contraindications": "Respiratory depression; paralytic ileus; MAOIs",
            "monitoring": "Sedation; constipation; respiratory status; dependence (Schedule II)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Oxycodone/Acetaminophen",
            "route": "PO",
            "indication": "Moderate-severe radicular pain (short-term)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5/325 mg q4-6h PRN",
                  "orderSentence": "Oxycodone/Acetaminophen 5/325 mg q4-6h PRN PO"
                },
                {
                  "text": "10/325 mg q4-6h PRN",
                  "orderSentence": "Oxycodone/Acetaminophen 10/325 mg q4-6h PRN PO"
                }
              ],
              "route": "PO",
              "instructions": "5-10/325 mg q4-6h PRN; max acetaminophen 3000 mg/day",
              "orderSentence": "Oxycodone/Acetaminophen 5/325 mg q4-6h PRN PO"
            },
            "contraindications": "Respiratory depression; hepatic impairment; paralytic ileus",
            "monitoring": "Sedation; respiratory status; LFTs; total acetaminophen intake",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Epidural steroid injection (ESI)",
            "route": "Fluoroscopic",
            "indication": "Radicular pain refractory to conservative treatment x 4-6 weeks",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per interventional protocol",
                  "orderSentence": "Epidural steroid injection (ESI) Per interventional protocol Fluoroscopic"
                }
              ],
              "route": "Fluoroscopic",
              "instructions": "Transforaminal or interlaminar approach; up to 3 injections per year",
              "orderSentence": "Epidural steroid injection (ESI) Per interventional protocol Fluoroscopic"
            },
            "contraindications": "Coagulopathy (INR >1.5, plt <100k); infection at site; allergy to contrast/steroids",
            "monitoring": "Post-procedure neuro exam; glucose (diabetics); headache",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Transforaminal epidural steroid injection (TFESI)",
            "route": "Fluoroscopic",
            "indication": "Unilateral radicular symptoms, foraminal stenosis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per interventional protocol",
                  "orderSentence": "Transforaminal epidural steroid injection (TFESI) Per interventional protocol Fluoroscopic"
                }
              ],
              "route": "Fluoroscopic",
              "instructions": "More selective nerve root coverage than interlaminar; up to 3 per year",
              "orderSentence": "Transforaminal epidural steroid injection (TFESI) Per interventional protocol Fluoroscopic"
            },
            "contraindications": "Coagulopathy; infection; severe foraminal stenosis",
            "monitoring": "Post-procedure neuro check; glucose monitoring",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Medial branch blocks",
            "route": "Fluoroscopic",
            "indication": "Facet-mediated pain component",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per interventional protocol",
                  "orderSentence": "Medial branch blocks Per interventional protocol Fluoroscopic"
                }
              ],
              "route": "Fluoroscopic",
              "instructions": "Diagnostic blocks before radiofrequency ablation consideration",
              "orderSentence": "Medial branch blocks Per interventional protocol Fluoroscopic"
            },
            "contraindications": "Coagulopathy; infection at site",
            "monitoring": "Pain response documentation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Radiofrequency ablation (RFA)",
            "route": "Fluoroscopic",
            "indication": "Facet-mediated pain with positive diagnostic blocks",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per interventional protocol",
                  "orderSentence": "Radiofrequency ablation (RFA) Per interventional protocol Fluoroscopic"
                }
              ],
              "route": "Fluoroscopic",
              "instructions": "If >50% relief from diagnostic medial branch blocks x 2",
              "orderSentence": "Radiofrequency ablation (RFA) Per interventional protocol Fluoroscopic"
            },
            "contraindications": "Coagulopathy; infection; pacemaker (relative)",
            "monitoring": "Neurologic exam post-procedure; pain scores",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Surgical Treatments (Specialist Decision)": [
          {
            "item": "Microdiscectomy",
            "route": "Surgical",
            "indication": "Herniated disc with refractory radiculopathy >6 weeks or progressive motor deficit",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Microdiscectomy N/A Surgical"
                }
              ],
              "route": "Surgical",
              "instructions": "Standard of care for single-level disc herniation with radiculopathy",
              "orderSentence": "Microdiscectomy N/A Surgical"
            },
            "pretreatment": "MRI confirmation; failed conservative therapy (unless emergent); medical clearance",
            "contraindications": "Active infection; uncorrectable coagulopathy",
            "monitoring": "Post-op neuro checks; wound monitoring; pain control",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Anterior cervical discectomy and fusion (ACDF)",
            "route": "Surgical",
            "indication": "Cervical disc herniation with radiculopathy, cervical spondylosis with radiculopathy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Anterior cervical discectomy and fusion (ACDF) N/A Surgical"
                }
              ],
              "route": "Surgical",
              "instructions": "Most common cervical spine procedure for radiculopathy",
              "orderSentence": "Anterior cervical discectomy and fusion (ACDF) N/A Surgical"
            },
            "pretreatment": "MRI confirmation; medical clearance; discussion of fusion alternatives",
            "contraindications": "Active infection; severe osteoporosis (relative); uncorrectable coagulopathy",
            "monitoring": "Swallowing assessment; airway monitoring; neuro checks",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Cervical disc arthroplasty",
            "route": "Surgical",
            "indication": "Single-level cervical disc herniation (alternative to ACDF)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Cervical disc arthroplasty N/A Surgical"
                }
              ],
              "route": "Surgical",
              "instructions": "Motion-preserving alternative to fusion at appropriate levels (C3-7)",
              "orderSentence": "Cervical disc arthroplasty N/A Surgical"
            },
            "pretreatment": "MRI confirmation; intact facet joints; no significant instability",
            "contraindications": "Instability; facet arthropathy; osteoporosis; infection",
            "monitoring": "Post-op neuro checks; wound monitoring",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Posterior cervical foraminotomy",
            "route": "Surgical",
            "indication": "Lateral/foraminal cervical disc herniation or foraminal stenosis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Posterior cervical foraminotomy N/A Surgical"
                }
              ],
              "route": "Surgical",
              "instructions": "Motion-preserving option for lateral pathology",
              "orderSentence": "Posterior cervical foraminotomy N/A Surgical"
            },
            "pretreatment": "MRI confirmation; lateral/foraminal pathology",
            "contraindications": "Central disc herniation; instability",
            "monitoring": "Post-op neuro checks; wound monitoring",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lumbar laminectomy/laminotomy",
            "route": "Surgical",
            "indication": "Lumbar stenosis with radiculopathy, large central disc",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Lumbar laminectomy/laminotomy N/A Surgical"
                }
              ],
              "route": "Surgical",
              "instructions": "Decompression for stenosis or central disc",
              "orderSentence": "Lumbar laminectomy/laminotomy N/A Surgical"
            },
            "pretreatment": "MRI confirmation; failed conservative therapy",
            "contraindications": "Active infection; uncorrectable coagulopathy",
            "monitoring": "Post-op neuro checks; wound; urinary retention",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lumbar fusion (TLIF, PLIF, ALIF)",
            "route": "Surgical",
            "indication": "Radiculopathy with instability, spondylolisthesis, recurrent disc herniation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Lumbar fusion (TLIF, PLIF, ALIF) N/A Surgical"
                }
              ],
              "route": "Surgical",
              "instructions": "Reserved for instability or recurrent pathology",
              "orderSentence": "Lumbar fusion (TLIF, PLIF, ALIF) N/A Surgical"
            },
            "pretreatment": "MRI/CT confirmation; bone density evaluation; medical clearance",
            "contraindications": "Active infection; severe osteoporosis (relative); uncorrectable coagulopathy",
            "monitoring": "Post-op neuro checks; hardware position; fusion assessment",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Emergent decompression",
            "route": "Surgical",
            "indication": "Cauda equina syndrome (within 48h), severe/progressive motor deficit",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Emergent decompression N/A Surgical"
                }
              ],
              "route": "Surgical",
              "instructions": "Within 24-48h of symptom onset for best outcomes",
              "orderSentence": "Emergent decompression N/A Surgical"
            },
            "pretreatment": "STAT MRI confirming compression",
            "contraindications": "None absolute if true CES",
            "monitoring": "Bladder function; motor recovery; wound",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Spine surgery (neurosurgery or orthopedic spine) consult STAT for cauda equina syndrome, progressive motor deficit, or myelopathic signs",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Spine surgery consult URGENT for significant weakness (<4/5) or radiculopathy refractory to 6+ weeks conservative treatment",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Physical therapy for core strengthening, McKenzie exercises, nerve gliding, and posture training",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pain management/Interventional spine for epidural steroid injections if conservative treatment fails after 4-6 weeks",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "PM&R (Physical Medicine & Rehabilitation) for comprehensive spine rehabilitation program",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "EMG/NCS referral to confirm radiculopathy level and exclude peripheral neuropathy or plexopathy (optimal timing 3-4 weeks after symptom onset)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Oncology consult for suspected spinal metastases or pathologic fracture",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Infectious disease consult for suspected epidural abscess, discitis, or vertebral osteomyelitis",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Rheumatology for suspected inflammatory spondyloarthropathy (ankylosing spondylitis, psoriatic arthritis)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Occupational therapy for ergonomic assessment, workplace modifications, and ADL training",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Psychology/Pain psychology for chronic pain management, CBT for pain, catastrophizing assessment",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Neurology for atypical presentation, polyradiculopathy, or suspected inflammatory/infectious etiology",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Social work for disability assistance, return-to-work planning, and insurance navigation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Return to ED IMMEDIATELY if bladder or bowel incontinence, inability to urinate, saddle area numbness, or bilateral leg weakness (may indicate cauda equina syndrome)",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Return to ED if fever develops with back/neck pain (may indicate infection)",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Return if weakness is progressing or you are unable to lift foot/hand (progressive motor deficit requires urgent evaluation)",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Most radiculopathy improves with conservative treatment over 4-6 weeks; surgery is rarely needed",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Stay active within pain limits; prolonged bed rest (>1-2 days) is not recommended and may delay recovery",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Apply ice for first 48-72 hours (20 min on/off), then switch to heat for muscle relaxation",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Avoid heavy lifting, twisting, and prolonged sitting; use proper body mechanics",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Sleep with pillow between knees (side) or under knees (back) to reduce spine stress",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "For cervical radiculopathy: avoid prolonged neck flexion (looking down at phone); use cervical pillow",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Do not stop gabapentin/pregabalin abruptly - taper under medical guidance to avoid withdrawal",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Neuropathic pain medications (gabapentin, pregabalin) take 2-4 weeks to reach full effect",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Physical therapy exercises should be continued daily at home for best outcomes",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Do not drive while taking opioids or sedating muscle relaxants",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Follow up with primary care or neurology in 2-4 weeks to assess treatment response",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Smoking cessation to improve disc nutrition and surgical outcomes (smoking accelerates disc degeneration)",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Weight loss if BMI >25 to reduce spinal load and improve symptoms",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Core strengthening exercises to support spine (plank, bird-dog, bridges)",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Proper lifting technique: bend at knees, keep load close, avoid twisting",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Ergonomic workstation setup: monitor at eye level, lumbar support, feet flat",
            "ED": "-",
            "HOSP": "-",
            "OPD": "✓"
          },
          {
            "item": "Take breaks every 30-60 minutes if seated for prolonged periods",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Maintain good posture: shoulders back, chin tucked, avoid forward head position",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Regular low-impact exercise (walking, swimming, stationary bike) to maintain fitness",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Avoid high-impact activities (running, jumping) during acute phase",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Yoga or Pilates (modified) for flexibility and core strength after acute phase resolves",
            "ED": "-",
            "HOSP": "-",
            "OPD": "✓"
          },
          {
            "item": "Use supportive mattress; avoid sleeping on stomach",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Manage stress as tension can worsen muscle spasm and pain perception",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Glycemic control if diabetic (HbA1c <7%) to reduce neuropathic component and improve surgical outcomes",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Peripheral neuropathy",
        "features": "Stocking-glove distribution, bilateral, length-dependent, not dermatomal",
        "tests": "NCS/EMG shows polyneuropathy; HbA1c; B12; no imaging abnormality"
      },
      {
        "diagnosis": "Lumbar spinal stenosis (neurogenic claudication)",
        "features": "Bilateral leg symptoms, worse with walking/standing, better with sitting/flexion, older patients",
        "tests": "MRI shows central stenosis; symptoms bilateral; walking tolerance limited"
      },
      {
        "diagnosis": "Piriformis syndrome",
        "features": "Buttock pain radiating to posterior thigh, negative straight leg raise, tenderness at piriformis",
        "tests": "MRI spine normal; tenderness at piriformis; FAIR test positive"
      },
      {
        "diagnosis": "Hip pathology (OA, AVN, labral tear)",
        "features": "Groin pain, limited hip ROM, pain with hip flexion/rotation, normal spine exam",
        "tests": "Hip X-ray/MRI; pain reproduced with hip exam, not spine"
      },
      {
        "diagnosis": "Sacroiliac joint dysfunction",
        "features": "Low back/buttock pain, positive SI joint provocative tests, pain at PSIS",
        "tests": "SI joint injection diagnostic; MRI may show SI joint changes"
      },
      {
        "diagnosis": "Greater trochanteric bursitis",
        "features": "Lateral hip pain, tender at greater trochanter, pain with side-lying",
        "tests": "Normal spine MRI; tenderness localized to trochanter"
      },
      {
        "diagnosis": "Diabetic amyotrophy (lumbosacral plexopathy)",
        "features": "Acute/subacute proximal thigh weakness and pain, weight loss, often bilateral sequential",
        "tests": "EMG shows plexopathy; MRI lumbosacral plexus may show enhancement"
      },
      {
        "diagnosis": "Meralgia paresthetica",
        "features": "Lateral thigh numbness/burning only (L2-L3 distribution), no weakness",
        "tests": "Normal EMG; may have abnormal lateral femoral cutaneous nerve conduction"
      },
      {
        "diagnosis": "Herpes zoster (shingles)",
        "features": "Dermatomal pain followed by vesicular rash, older/immunocompromised",
        "tests": "Clinical diagnosis; vesicular rash in dermatomal pattern"
      },
      {
        "diagnosis": "Vascular claudication",
        "features": "Calf pain with walking, relieved by rest (not position), diminished pulses",
        "tests": "ABI <0.9; Doppler shows arterial disease; spine MRI normal"
      },
      {
        "diagnosis": "Cauda equina syndrome",
        "features": "Saddle anesthesia, bladder/bowel dysfunction, bilateral leg weakness/numbness",
        "tests": "STAT MRI shows large central disc or mass compressing cauda equina"
      },
      {
        "diagnosis": "Spinal cord tumor (intra/extramedullary)",
        "features": "Progressive symptoms, night pain, myelopathic signs, weight loss",
        "tests": "MRI with contrast shows enhancing mass"
      },
      {
        "diagnosis": "Epidural abscess",
        "features": "Fever, severe localized back pain, rapid progression, risk factors (IVDU, diabetes)",
        "tests": "MRI with contrast shows rim-enhancing collection; elevated WBC, ESR, CRP"
      },
      {
        "diagnosis": "Vertebral metastases",
        "features": "History of cancer, night pain, weight loss, multiple levels",
        "tests": "MRI shows destructive lesions; bone scan; tumor markers; biopsy"
      },
      {
        "diagnosis": "Ankylosing spondylitis",
        "features": "Young male, morning stiffness >30 min, improves with activity, sacroiliitis",
        "tests": "HLA-B27; MRI shows sacroiliitis; ESR elevated"
      },
      {
        "diagnosis": "Spinal epidural hematoma",
        "features": "Post-procedure or anticoagulation, acute severe pain, rapid neuro decline",
        "tests": "STAT MRI shows epidural collection; coags abnormal"
      },
      {
        "diagnosis": "Arachnoiditis",
        "features": "Prior spine surgery or infection, diffuse radicular symptoms, clumped nerve roots",
        "tests": "MRI shows clumped/adherent nerve roots in thecal sac"
      },
      {
        "diagnosis": "Tarlov (perineural) cyst",
        "features": "Incidental finding on MRI, may cause radicular symptoms if large",
        "tests": "MRI shows sacral cyst; often asymptomatic"
      }
    ],
    "evidence": [
      {
        "recommendation": "MRI is imaging modality of choice for suspected radiculopathy",
        "evidenceLevel": "Class I, Level A",
        "source": "[Boden SD et al. J Bone Joint Surg Am 1990](https://pubmed.ncbi.nlm.nih.gov/2312537/)"
      },
      {
        "recommendation": "Most cervical and lumbar radiculopathy improves with conservative treatment",
        "evidenceLevel": "Class I, Level A",
        "source": "[Saal JA et al. Spine 1996](https://pubmed.ncbi.nlm.nih.gov/8961451/)"
      },
      {
        "recommendation": "NSAIDs effective for acute radiculopathy pain",
        "evidenceLevel": "Class I, Level A",
        "source": "[Roelofs PD et al. Cochrane 2008](https://pubmed.ncbi.nlm.nih.gov/18253976/)"
      },
      {
        "recommendation": "Gabapentin/pregabalin effective for radicular neuropathic pain",
        "evidenceLevel": "Class I, Level A",
        "source": "[Finnerup NB et al. Lancet Neurol 2015](https://pubmed.ncbi.nlm.nih.gov/25575710/)"
      },
      {
        "recommendation": "Oral steroids provide short-term benefit for lumbar radiculopathy",
        "evidenceLevel": "Class I, Level B",
        "source": "[Goldberg H et al. JAMA 2015](https://pubmed.ncbi.nlm.nih.gov/26151393/)"
      },
      {
        "recommendation": "Epidural steroid injections provide short-term pain relief for lumbar radiculopathy",
        "evidenceLevel": "Class I, Level B",
        "source": "[Manchikanti L et al. Pain Physician 2021](https://pubmed.ncbi.nlm.nih.gov/33400438/)"
      },
      {
        "recommendation": "EMG/NCS useful for confirming radiculopathy and excluding mimics after 3-4 weeks",
        "evidenceLevel": "Class II, Level B",
        "source": "[AANEM Practice Parameter 2010](https://pubmed.ncbi.nlm.nih.gov/20645032/)"
      },
      {
        "recommendation": "Surgery superior to conservative treatment for severe lumbar radiculopathy at 1 year",
        "evidenceLevel": "Class I, Level A",
        "source": "[SPORT Trial: Weinstein JN et al. JAMA 2006](https://pubmed.ncbi.nlm.nih.gov/17105757/)"
      },
      {
        "recommendation": "Cauda equina syndrome requires decompression within 48 hours for best outcomes",
        "evidenceLevel": "Class II, Level B",
        "source": "[Ahn UM et al. Spine 2000](https://pubmed.ncbi.nlm.nih.gov/10751293/)"
      },
      {
        "recommendation": "Physical therapy effective for cervical and lumbar radiculopathy",
        "evidenceLevel": "Class I, Level B",
        "source": "[Kuijper B et al. BMJ 2009](https://pubmed.ncbi.nlm.nih.gov/19818915/)"
      },
      {
        "recommendation": "Smoking cessation improves spine health and surgical outcomes",
        "evidenceLevel": "Class II, Level B",
        "source": "[Battie MC et al. Spine 1991](https://pubmed.ncbi.nlm.nih.gov/1836285/)"
      },
      {
        "recommendation": "Short-term muscle relaxants may help acute radiculopathy with spasm",
        "evidenceLevel": "Class II, Level B",
        "source": "[Chou R et al. Cochrane 2003](https://pubmed.ncbi.nlm.nih.gov/14973984/)"
      },
      {
        "recommendation": "ACDF effective for cervical radiculopathy refractory to conservative treatment",
        "evidenceLevel": "Class I, Level B",
        "source": "[Herkowitz HN et al. Spine 1990](https://pubmed.ncbi.nlm.nih.gov/2353855/)"
      },
      {
        "recommendation": "Microdiscectomy effective for lumbar disc herniation with radiculopathy",
        "evidenceLevel": "Class I, Level A",
        "source": "[Peul WC et al. NEJM 2007](https://pubmed.ncbi.nlm.nih.gov/17538085/)"
      },
      {
        "recommendation": "Duloxetine effective for chronic musculoskeletal pain including radiculopathy",
        "evidenceLevel": "Class I, Level A",
        "source": "[Skljarevski V et al. J Pain 2010](https://pubmed.ncbi.nlm.nih.gov/20338815/)"
      },
      {
        "recommendation": "Red flags warrant urgent imaging and evaluation for serious pathology",
        "evidenceLevel": "Class II, Level B",
        "source": "[Chou R et al. Ann Intern Med 2007](https://pubmed.ncbi.nlm.nih.gov/17909209/)"
      }
    ],
    "monitoring": [
      {
        "item": "Pain scores (0-10 NRS)",
        "frequency": "Each visit",
        "action": "Escalate therapy; consider interventional/surgical referral",
        "ED": "ROUTINE",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "ROUTINE"
      },
      {
        "item": "Motor strength (MRC grading)",
        "frequency": "Each visit; more frequent if weakness present",
        "action": "Progressive weakness: urgent spine surgery consult; imaging",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT"
      },
      {
        "item": "Sensory exam (dermatomal)",
        "frequency": "Each visit",
        "action": "Document progression; correlate with imaging",
        "ED": "ROUTINE",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "ROUTINE"
      },
      {
        "item": "Deep tendon reflexes",
        "frequency": "Each visit",
        "action": "Hyperreflexia suggests myelopathy: MRI cervical spine",
        "ED": "ROUTINE",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "ROUTINE"
      },
      {
        "item": "Bladder function",
        "frequency": "Each visit; more frequent if any symptoms",
        "action": "Retention or incontinence: STAT catheterization, STAT MRI, emergent surgery consult",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT"
      },
      {
        "item": "Straight leg raise (lumbar) / Spurling test (cervical)",
        "frequency": "Each visit",
        "action": "Positive with worsening: consider imaging if not done",
        "ED": "ROUTINE",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "ROUTINE"
      },
      {
        "item": "Gait assessment",
        "frequency": "Each visit",
        "action": "Foot drop: EMG, surgical consult; ataxia: cervical MRI for myelopathy",
        "ED": "ROUTINE",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "ROUTINE"
      },
      {
        "item": "Functional status (ODI, NDI)",
        "frequency": "Baseline, 6 weeks, 3 months, 6 months",
        "action": "Not improving: reassess treatment strategy; consider surgery",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Renal function (if on NSAIDs >2 weeks)",
        "frequency": "Baseline, then q3 months",
        "action": "Decline: discontinue NSAIDs; switch to acetaminophen/other",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Glucose (if on steroids)",
        "frequency": "Daily if inpatient; before/after ESI",
        "action": "Adjust diabetes medications; short steroid courses",
        "ED": "ROUTINE",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "ROUTINE"
      }
    ],
    "disposition": [
      {
        "disposition": "**Discharge home**",
        "criteria": "No red flags present; pain controlled with oral medications; able to ambulate; normal bladder function; motor strength ≥4/5 and stable; reliable follow-up arranged within 2-4 weeks"
      },
      {
        "disposition": "**Admit to floor**",
        "criteria": "Severe pain requiring IV analgesia; significant motor weakness (≤3/5) requiring close monitoring; need for IV antibiotics (suspected infection); inability to ambulate safely; need for urgent MRI not available as outpatient"
      },
      {
        "disposition": "**Admit to ICU**",
        "criteria": "Rapidly progressive motor deficit requiring emergent surgery; hemodynamic instability from sepsis (spinal infection); airway compromise (high cervical pathology); post-operative monitoring for complex spine surgery"
      },
      {
        "disposition": "**Emergent surgery consult**",
        "criteria": "Cauda equina syndrome (bladder dysfunction, saddle anesthesia, bilateral weakness); progressive motor deficit despite steroids; epidural abscess with neurologic deficit"
      },
      {
        "disposition": "**Transfer to higher level**",
        "criteria": "Spine surgery not available; MRI not available for emergent imaging; interventional spine services not available for ESI when indicated"
      }
    ]
  },
  "Small Fiber Neuropathy": {
    "id": "small-fiber-neuropathy",
    "title": "Small Fiber Neuropathy",
    "version": "1.0",
    "icd10": [
      "** G62.9 (Polyneuropathy",
      "unspecified)",
      "G62.89 (Other specified polyneuropathies)",
      "G90.09 (Other idiopathic peripheral autonomic neuropathy)"
    ],
    "scope": "** Diagnosis and management of small fiber neuropathy presenting with painful sensory and/or autonomic symptoms with normal or near-normal nerve conduction studies. Includes length-dependent and non-length-dependent (ganglionopathy) patterns. Covers etiologic workup for treatable causes, symptomatic pain management, and autonomic symptom treatment.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "HbA1c",
            "rationale": "Diabetes and prediabetes are most common causes of SFN",
            "target": "<5.7% normal; ≥5.7% prediabetes",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Fasting glucose",
            "rationale": "Current glycemic status; impaired fasting glucose",
            "target": "<100 mg/dL",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "2-hour oral glucose tolerance test (OGTT)",
            "rationale": "Impaired glucose tolerance causes SFN even with normal HbA1c",
            "target": "2-hr glucose <140 mg/dL normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "BMP (creatinine, eGFR, electrolytes)",
            "rationale": "Renal function; medication dosing; uremic neuropathy",
            "target": "eGFR >60; normal electrolytes",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CBC",
            "rationale": "Baseline; anemia evaluation",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin B12",
            "rationale": "B12 deficiency causes SFN; common and treatable",
            "target": ">300 pg/mL (>400 optimal)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "TSH",
            "rationale": "Hypothyroidism causes neuropathy",
            "target": "0.4-4.0 mIU/L",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "ESR, CRP",
            "rationale": "Inflammatory markers; vasculitis screen",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "ANA",
            "rationale": "Autoimmune etiology; Sjogren's screen",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Anti-SSA (Ro) and anti-SSB (La) antibodies",
            "rationale": "Sjogren syndrome is common cause of SFN (up to 40% of SFN)",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Hepatitis B and C serologies",
            "rationale": "HCV-associated neuropathy; cryoglobulinemia",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended Workup": [
          {
            "item": "Methylmalonic acid (MMA)",
            "rationale": "More sensitive for B12 deficiency if B12 borderline (200-400)",
            "target": "Normal (<0.4 μmol/L)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Tissue transglutaminase IgA (TTG-IgA)",
            "rationale": "Celiac disease causes SFN even without GI symptoms",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Total serum IgA",
            "rationale": "IgA deficiency causes false-negative TTG",
            "target": "Normal (not deficient)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "SPEP/UPEP with immunofixation",
            "rationale": "Paraproteinemia; monoclonal gammopathy",
            "target": "No monoclonal protein",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "HIV",
            "rationale": "HIV-associated sensory neuropathy",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lipid panel",
            "rationale": "Metabolic syndrome associated with SFN",
            "target": "Normal/controlled",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin D",
            "rationale": "Deficiency associated with neuropathic pain",
            "target": ">30 ng/mL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin B1 (thiamine)",
            "rationale": "Deficiency causes painful neuropathy",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin B6",
            "rationale": "Both deficiency and excess cause neuropathy",
            "target": "Normal (neither high nor low)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Copper",
            "rationale": "Copper deficiency neuropathy (especially post-bariatric surgery)",
            "target": "Normal (70-140 μg/dL)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Zinc",
            "rationale": "Excessive zinc causes copper deficiency",
            "target": "Normal (not elevated)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Salivary gland biopsy",
            "rationale": "Sjogren syndrome if clinical suspicion high and serology negative",
            "target": "Negative for lymphocytic infiltration",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Alpha-galactosidase A enzyme activity",
            "rationale": "Fabry disease screening (X-linked; consider in males and females)",
            "target": "Normal enzyme activity",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "GLA gene sequencing",
            "rationale": "Confirm Fabry disease if enzyme low or high clinical suspicion",
            "target": "No pathogenic variants",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "TTR gene sequencing",
            "rationale": "Hereditary transthyretin amyloidosis; early SFN with autonomic symptoms",
            "target": "No pathogenic variants",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Fat pad or skin biopsy (Congo red)",
            "rationale": "Amyloidosis if suspected (autonomic features, cardiomyopathy, CTS)",
            "target": "No amyloid deposits",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Serum free light chains",
            "rationale": "AL amyloidosis screen",
            "target": "Normal kappa:lambda ratio",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Anti-FGFR3 antibodies",
            "rationale": "Autoimmune SFN (especially ganglionopathy pattern)",
            "target": "Negative",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Anti-TS-HDS antibodies",
            "rationale": "Autoimmune SFN marker",
            "target": "Negative",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Sarcoidosis workup (ACE, chest imaging)",
            "rationale": "Sarcoid neuropathy",
            "target": "Normal ACE; no hilar adenopathy",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Paraneoplastic antibody panel",
            "rationale": "Paraneoplastic sensory ganglionopathy (anti-Hu) if rapid onset",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Cryoglobulins",
            "rationale": "Cryoglobulinemic neuropathy (especially with HCV)",
            "target": "Negative",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Schirmer test",
            "rationale": "Objective dry eye for Sjogren diagnosis",
            "target": "Normal (>5mm in 5 min)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "SCN9A, SCN10A, SCN11A gene testing",
            "rationale": "Sodium channelopathies causing inherited SFN (erythromelalgia)",
            "target": "No pathogenic variants",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "Nerve conduction studies (NCS)",
            "timing": "At initial evaluation",
            "target": "Normal or near-normal (SFN spares large fibers)",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Skin biopsy (3mm punch at distal leg and thigh)",
            "timing": "After NCS shows normal large fiber function",
            "target": "Reduced IENFD below normative threshold for age/sex/site",
            "contraindications": "Bleeding diathesis; anticoagulation (relative)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended": [
          {
            "item": "Quantitative sudomotor axon reflex test (QSART)",
            "timing": "Autonomic symptoms; suspected sudomotor dysfunction",
            "target": "Normal sweat volumes at all sites",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sudoscan",
            "timing": "Screening for sudomotor dysfunction; non-invasive",
            "target": "Normal electrochemical skin conductance hands and feet",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Autonomic reflex screen (ARS)",
            "timing": "Comprehensive autonomic evaluation; orthostatic symptoms",
            "target": "Normal cardiovagal, adrenergic, and sudomotor function",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Tilt table test",
            "timing": "Orthostatic intolerance; POTS evaluation",
            "target": "No excessive HR rise; no orthostatic hypotension",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Quantitative sensory testing (QST)",
            "timing": "Thermal threshold testing; research and specialized centers",
            "target": "Normal thermal detection thresholds",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Thermoregulatory sweat test (TST)",
            "timing": "Global sudomotor evaluation if QSART equivocal",
            "target": "Normal sweat distribution",
            "contraindications": "Cardiac instability",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Corneal confocal microscopy",
            "timing": "Non-invasive small fiber assessment; research tool",
            "target": "Normal corneal nerve fiber density and length",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "EMG",
            "timing": "If large fiber involvement suspected; atypical features",
            "target": "Normal (SFN spares motor and large sensory fibers)",
            "contraindications": "Anticoagulation (relative)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "MRI spine (cervical/thoracic)",
            "timing": "Ganglionopathy pattern; non-length-dependent SFN",
            "target": "Normal dorsal root ganglia; no dorsal column signal",
            "contraindications": "MRI contraindications",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "MRI neurography",
            "timing": "Research; visualize small nerves",
            "target": "No nerve enlargement or signal abnormality",
            "contraindications": "MRI contraindications",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "PET-CT",
            "timing": "Sarcoidosis or malignancy suspected; paraneoplastic evaluation",
            "target": "No abnormal uptake",
            "contraindications": "Pregnancy",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Echocardiogram",
            "timing": "Amyloidosis suspected (cardiomyopathy screening)",
            "target": "No infiltrative cardiomyopathy features",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Cardiac MRI",
            "timing": "Cardiac amyloidosis evaluation if echo abnormal",
            "target": "No amyloid infiltration",
            "contraindications": "MRI contraindications; devices",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "IV fluids",
            "route": "IV",
            "indication": "Acute orthostatic hypotension with symptoms",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Normal saline bolus",
                  "orderSentence": "IV fluids Normal saline bolus IV"
                }
              ],
              "route": "IV",
              "instructions": "500-1000 mL NS bolus for symptomatic orthostatic hypotension; avoid in heart failure",
              "orderSentence": "IV fluids Normal saline bolus IV"
            },
            "contraindications": "Heart failure; volume overload",
            "monitoring": "Volume status; BP response",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Pain crisis management",
            "route": "IV/PO",
            "indication": "Severe acute neuropathic pain flare not responding to outpatient regimen",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Multimodal",
                  "orderSentence": "Pain crisis management Multimodal IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "IV lidocaine infusion (1-3 mg/kg/hr) if refractory; avoid chronic opioids",
              "orderSentence": "Pain crisis management Multimodal IV/PO"
            },
            "contraindications": "Lidocaine: cardiac conduction abnormality",
            "monitoring": "Pain scores; cardiac monitoring for lidocaine",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT"
          },
          {
            "item": "Glucose management",
            "route": "Various",
            "indication": "Acute presentation with new diabetes diagnosis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per protocol",
                  "orderSentence": "Glucose management Per protocol Various"
                }
              ],
              "route": "Various",
              "instructions": "Initiate diabetes management; hypoglycemia causes SFN flare",
              "orderSentence": "Glucose management Per protocol Various"
            },
            "contraindications": "Per specific agent",
            "monitoring": "Glucose",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          }
        ],
        "Symptomatic Treatments (Neuropathic Pain - First-line)": [
          {
            "item": "Duloxetine",
            "route": "PO",
            "indication": "First-line for neuropathic pain; also treats depression/anxiety common in SFN",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mg daily",
                  "orderSentence": "Duloxetine 30 mg daily PO"
                },
                {
                  "text": "60 mg daily",
                  "orderSentence": "Duloxetine 60 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 30 mg daily x 1 week; increase to 60 mg daily; max 120 mg/day",
              "orderSentence": "Duloxetine 30 mg daily PO"
            },
            "contraindications": "MAOIs; uncontrolled narrow-angle glaucoma; severe renal impairment (CrCl <30)",
            "monitoring": "Hepatic function; BP; suicidal ideation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pregabalin",
            "route": "PO",
            "indication": "First-line for neuropathic pain; FDA-approved for postherpetic neuralgia and DPN",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg TID",
                  "orderSentence": "Pregabalin 50 mg TID PO"
                },
                {
                  "text": "75 mg BID",
                  "orderSentence": "Pregabalin 75 mg BID PO"
                },
                {
                  "text": "100 mg TID",
                  "orderSentence": "Pregabalin 100 mg TID PO"
                },
                {
                  "text": "150 mg BID",
                  "orderSentence": "Pregabalin 150 mg BID PO"
                },
                {
                  "text": "200 mg TID",
                  "orderSentence": "Pregabalin 200 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 50 mg TID or 75 mg BID; titrate q3-7d; max 300 mg/day; reduce if CrCl <60",
              "orderSentence": "Pregabalin 50 mg TID PO"
            },
            "contraindications": "Angioedema to pregabalin/gabapentin",
            "monitoring": "Dizziness, somnolence, weight gain, peripheral edema",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Gabapentin",
            "route": "PO",
            "indication": "First-line; less expensive alternative to pregabalin",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg qHS",
                  "orderSentence": "Gabapentin 300 mg qHS PO"
                },
                {
                  "text": "300 mg TID",
                  "orderSentence": "Gabapentin 300 mg TID PO"
                },
                {
                  "text": "600 mg TID",
                  "orderSentence": "Gabapentin 600 mg TID PO"
                },
                {
                  "text": "900 mg TID",
                  "orderSentence": "Gabapentin 900 mg TID PO"
                },
                {
                  "text": "1200 mg TID",
                  "orderSentence": "Gabapentin 1200 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 300 mg qHS; titrate by 300 mg q3-7d; target 1800-3600 mg/day divided TID; reduce if CrCl <60",
              "orderSentence": "Gabapentin 300 mg qHS PO"
            },
            "contraindications": "Severe renal impairment (dose adjust required)",
            "monitoring": "Sedation, dizziness, ataxia, edema",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Amitriptyline",
            "route": "PO",
            "indication": "TCA for neuropathic pain; helps insomnia; inexpensive",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg qHS",
                  "orderSentence": "Amitriptyline 10 mg qHS PO"
                },
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Amitriptyline 25 mg qHS PO"
                },
                {
                  "text": "50 mg qHS",
                  "orderSentence": "Amitriptyline 50 mg qHS PO"
                },
                {
                  "text": "75 mg qHS",
                  "orderSentence": "Amitriptyline 75 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10-25 mg qHS; titrate by 10-25 mg q1-2wk; typical 25-75 mg qHS; max 150 mg",
              "orderSentence": "Amitriptyline 10 mg qHS PO"
            },
            "contraindications": "Cardiac conduction disease; recent MI; urinary retention; narrow-angle glaucoma; elderly (high anticholinergic burden)",
            "monitoring": "ECG if age >40 or cardiac history; anticholinergic side effects",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Nortriptyline",
            "route": "PO",
            "indication": "TCA with less sedation and anticholinergic effects than amitriptyline",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg qHS",
                  "orderSentence": "Nortriptyline 10 mg qHS PO"
                },
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Nortriptyline 25 mg qHS PO"
                },
                {
                  "text": "50 mg qHS",
                  "orderSentence": "Nortriptyline 50 mg qHS PO"
                },
                {
                  "text": "75 mg qHS",
                  "orderSentence": "Nortriptyline 75 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10-25 mg qHS; titrate by 10-25 mg q1-2wk; typical 25-75 mg qHS",
              "orderSentence": "Nortriptyline 10 mg qHS PO"
            },
            "contraindications": "Cardiac conduction disease; recent MI; urinary retention; narrow-angle glaucoma",
            "monitoring": "ECG if dose >100 mg/day or cardiac risk factors",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Venlafaxine XR",
            "route": "PO",
            "indication": "SNRI alternative to duloxetine",
            "dosing": {
              "doseOptions": [
                {
                  "text": "37.5 mg daily",
                  "orderSentence": "Venlafaxine XR 37.5 mg daily PO"
                },
                {
                  "text": "75 mg daily",
                  "orderSentence": "Venlafaxine XR 75 mg daily PO"
                },
                {
                  "text": "150 mg daily",
                  "orderSentence": "Venlafaxine XR 150 mg daily PO"
                },
                {
                  "text": "225 mg daily",
                  "orderSentence": "Venlafaxine XR 225 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 37.5 mg daily; increase by 37.5-75 mg q1wk; target 150-225 mg daily",
              "orderSentence": "Venlafaxine XR 37.5 mg daily PO"
            },
            "contraindications": "MAOIs; uncontrolled hypertension",
            "monitoring": "BP at higher doses; discontinuation syndrome if stopped abruptly",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Second-line/Refractory (Neuropathic Pain)": [
          {
            "item": "Capsaicin 8% patch (Qutenza)",
            "route": "Topical",
            "indication": "Localized neuropathic pain; add-on therapy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Apply for 30-60 min",
                  "orderSentence": "Capsaicin 8% patch (Qutenza) Apply for 30-60 min Topical"
                }
              ],
              "route": "Topical",
              "instructions": "Applied by trained healthcare provider; pre-treat with topical anesthetic; may repeat q3mo",
              "orderSentence": "Capsaicin 8% patch (Qutenza) Apply for 30-60 min Topical"
            },
            "contraindications": "Application to face/mucous membranes; broken skin",
            "monitoring": "Pain/burning during application; transient BP increase",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lidocaine 5% patch",
            "route": "Topical",
            "indication": "Localized pain; adjunctive therapy; allodynia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1-3 patches daily",
                  "orderSentence": "Lidocaine 5% patch 1-3 patches daily Topical"
                }
              ],
              "route": "Topical",
              "instructions": "Apply to most painful area; up to 3 patches for 12h on/12h off",
              "orderSentence": "Lidocaine 5% patch 1-3 patches daily Topical"
            },
            "contraindications": "Allergy to local anesthetics; damaged skin",
            "monitoring": "Skin irritation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lamotrigine",
            "route": "PO",
            "indication": "Sodium channel blocker; some evidence in SFN",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg daily",
                  "orderSentence": "Lamotrigine 25 mg daily PO"
                },
                {
                  "text": "50 mg daily",
                  "orderSentence": "Lamotrigine 50 mg daily PO"
                },
                {
                  "text": "100 mg BID",
                  "orderSentence": "Lamotrigine 100 mg BID PO"
                },
                {
                  "text": "200 mg BID",
                  "orderSentence": "Lamotrigine 200 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg daily x 2wk; then 50 mg daily x 2wk; increase by 50 mg q2wk; max 400 mg/day",
              "orderSentence": "Lamotrigine 25 mg daily PO"
            },
            "contraindications": "SJS/TEN history; valproate use (reduce dose by 50%)",
            "monitoring": "RASH (especially first 8 weeks) - stop immediately if rash",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lacosamide",
            "route": "PO",
            "indication": "Sodium channel blocker; well-tolerated",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg BID",
                  "orderSentence": "Lacosamide 50 mg BID PO"
                },
                {
                  "text": "100 mg BID",
                  "orderSentence": "Lacosamide 100 mg BID PO"
                },
                {
                  "text": "150 mg BID",
                  "orderSentence": "Lacosamide 150 mg BID PO"
                },
                {
                  "text": "200 mg BID",
                  "orderSentence": "Lacosamide 200 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 50 mg BID; increase by 50 mg/day weekly; max 400 mg/day",
              "orderSentence": "Lacosamide 50 mg BID PO"
            },
            "contraindications": "Second or third degree AV block (without pacemaker)",
            "monitoring": "ECG for PR prolongation; dizziness",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Carbamazepine",
            "route": "PO",
            "indication": "Sodium channel blocker; limited evidence for SFN specifically",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg BID",
                  "orderSentence": "Carbamazepine 100 mg BID PO"
                },
                {
                  "text": "200 mg BID",
                  "orderSentence": "Carbamazepine 200 mg BID PO"
                },
                {
                  "text": "400 mg BID",
                  "orderSentence": "Carbamazepine 400 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 100 mg BID; titrate by 200 mg/wk; max 1200 mg/day",
              "orderSentence": "Carbamazepine 100 mg BID PO"
            },
            "contraindications": "AV block; bone marrow suppression; HLA-B*1502 in Asian patients (SJS risk)",
            "monitoring": "CBC, LFTs, sodium; drug interactions (CYP3A4 inducer)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Mexiletine",
            "route": "PO",
            "indication": "Sodium channel blocker; especially if SCN9A mutation suspected",
            "dosing": {
              "doseOptions": [
                {
                  "text": "150 mg TID",
                  "orderSentence": "Mexiletine 150 mg TID PO"
                },
                {
                  "text": "200 mg TID",
                  "orderSentence": "Mexiletine 200 mg TID PO"
                },
                {
                  "text": "300 mg TID",
                  "orderSentence": "Mexiletine 300 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 150 mg TID; titrate by 150 mg q3d; max 1200 mg/day; take with food",
              "orderSentence": "Mexiletine 150 mg TID PO"
            },
            "contraindications": "Cardiomyopathy; second/third degree AV block",
            "monitoring": "ECG; arrhythmia monitoring",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Desipramine",
            "route": "PO",
            "indication": "TCA with minimal anticholinergic effects",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Desipramine 25 mg qHS PO"
                },
                {
                  "text": "50 mg qHS",
                  "orderSentence": "Desipramine 50 mg qHS PO"
                },
                {
                  "text": "75 mg qHS",
                  "orderSentence": "Desipramine 75 mg qHS PO"
                },
                {
                  "text": "100 mg qHS",
                  "orderSentence": "Desipramine 100 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg qHS; titrate by 25 mg q1-2wk; target 50-100 mg",
              "orderSentence": "Desipramine 25 mg qHS PO"
            },
            "contraindications": "Same as other TCAs",
            "monitoring": "ECG; drug levels available if needed",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Tramadol",
            "route": "PO",
            "indication": "Moderate pain; opioid-like with serotonergic properties",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg q6h PRN",
                  "orderSentence": "Tramadol 50 mg q6h PRN PO"
                },
                {
                  "text": "100 mg ER BID",
                  "orderSentence": "Tramadol 100 mg ER BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 50 mg q6h PRN; max 400 mg/day; reduce if renal/hepatic impairment",
              "orderSentence": "Tramadol 50 mg q6h PRN PO"
            },
            "contraindications": "Seizure disorder; concurrent MAOIs/SSRIs (serotonin syndrome risk)",
            "monitoring": "Seizures, serotonin syndrome, constipation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Tapentadol ER",
            "route": "PO",
            "indication": "Refractory pain; mu-opioid agonist with norepinephrine reuptake inhibition",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg BID",
                  "orderSentence": "Tapentadol ER 50 mg BID PO"
                },
                {
                  "text": "100 mg BID",
                  "orderSentence": "Tapentadol ER 100 mg BID PO"
                },
                {
                  "text": "150 mg BID",
                  "orderSentence": "Tapentadol ER 150 mg BID PO"
                },
                {
                  "text": "200 mg BID",
                  "orderSentence": "Tapentadol ER 200 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 50 mg BID; titrate by 50 mg BID q3d; max 500 mg/day",
              "orderSentence": "Tapentadol ER 50 mg BID PO"
            },
            "contraindications": "Severe respiratory depression; MAOIs; paralytic ileus",
            "monitoring": "Respiratory status, constipation, sedation",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Combination therapy",
            "route": "Various",
            "indication": "Inadequate response to monotherapy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Combine agents from different classes",
                  "orderSentence": "Combination therapy Combine agents from different classes Various"
                }
              ],
              "route": "Various",
              "instructions": "Gabapentinoid + SNRI; TCA + gabapentinoid; use lower doses of each",
              "orderSentence": "Combination therapy Combine agents from different classes Various"
            },
            "contraindications": "Per individual agents",
            "monitoring": "Additive side effects; falls in elderly",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Low-dose naltrexone (LDN)",
            "route": "PO",
            "indication": "Emerging evidence for neuropathic pain; anti-inflammatory",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1.5 mg qHS",
                  "orderSentence": "Low-dose naltrexone (LDN) 1.5 mg qHS PO"
                },
                {
                  "text": "3 mg qHS",
                  "orderSentence": "Low-dose naltrexone (LDN) 3 mg qHS PO"
                },
                {
                  "text": "4.5 mg qHS",
                  "orderSentence": "Low-dose naltrexone (LDN) 4.5 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 1.5 mg qHS; increase by 1.5 mg q2wk; max 4.5 mg; compounded",
              "orderSentence": "Low-dose naltrexone (LDN) 1.5 mg qHS PO"
            },
            "contraindications": "Current opioid use; hepatic impairment",
            "monitoring": "Vivid dreams, insomnia (take in AM if occurs)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Spinal cord stimulation",
            "route": "Implant",
            "indication": "Refractory SFN pain; failed multiple medications",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per implant protocol",
                  "orderSentence": "Spinal cord stimulation Per implant protocol Implant"
                }
              ],
              "route": "Implant",
              "instructions": "Trial stimulation before permanent implant; high-frequency or burst stimulation preferred",
              "orderSentence": "Spinal cord stimulation Per implant protocol Implant"
            },
            "contraindications": "Infection; coagulopathy; psychiatric instability",
            "monitoring": "Device function; pain relief",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Autonomic Symptom Management": [
          {
            "item": "Fludrocortisone",
            "route": "PO",
            "indication": "Orthostatic hypotension; volume expansion",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.1 mg daily",
                  "orderSentence": "Fludrocortisone 0.1 mg daily PO"
                },
                {
                  "text": "0.2 mg daily",
                  "orderSentence": "Fludrocortisone 0.2 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.1 mg daily; may increase to 0.2 mg daily; max 0.3 mg",
              "orderSentence": "Fludrocortisone 0.1 mg daily PO"
            },
            "pretreatment": "Check potassium; assess volume status",
            "contraindications": "Heart failure; hypertension; hypokalemia",
            "monitoring": "Weight, BP supine and standing, potassium, edema",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Midodrine",
            "route": "PO",
            "indication": "Orthostatic hypotension; alpha-1 agonist vasoconstrictor",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2.5 mg TID",
                  "orderSentence": "Midodrine 2.5 mg TID PO"
                },
                {
                  "text": "5 mg TID",
                  "orderSentence": "Midodrine 5 mg TID PO"
                },
                {
                  "text": "10 mg TID",
                  "orderSentence": "Midodrine 10 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 2.5 mg TID (with meals); titrate to 5-10 mg TID; last dose 4h before bed",
              "orderSentence": "Midodrine 2.5 mg TID PO"
            },
            "pretreatment": "None specific",
            "contraindications": "Severe cardiac disease; urinary retention; supine hypertension",
            "monitoring": "Supine BP (check for supine hypertension); avoid at bedtime",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Droxidopa (Northera)",
            "route": "PO",
            "indication": "Neurogenic orthostatic hypotension; FDA-approved for autonomic failure",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg TID",
                  "orderSentence": "Droxidopa (Northera) 100 mg TID PO"
                },
                {
                  "text": "200 mg TID",
                  "orderSentence": "Droxidopa (Northera) 200 mg TID PO"
                },
                {
                  "text": "300 mg TID",
                  "orderSentence": "Droxidopa (Northera) 300 mg TID PO"
                },
                {
                  "text": "400 mg TID",
                  "orderSentence": "Droxidopa (Northera) 400 mg TID PO"
                },
                {
                  "text": "600 mg TID",
                  "orderSentence": "Droxidopa (Northera) 600 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 100 mg TID; titrate by 100 mg/day q24-48h; max 600 mg TID",
              "orderSentence": "Droxidopa (Northera) 100 mg TID PO"
            },
            "pretreatment": "None specific",
            "contraindications": "Supine hypertension (severe)",
            "monitoring": "Supine BP; avoid lying flat for 2h after dose",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pyridostigmine",
            "route": "PO",
            "indication": "Orthostatic hypotension; enhances ganglionic transmission",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mg TID",
                  "orderSentence": "Pyridostigmine 30 mg TID PO"
                },
                {
                  "text": "60 mg TID",
                  "orderSentence": "Pyridostigmine 60 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 30 mg TID; may increase to 60 mg TID; modest BP effect but no supine hypertension",
              "orderSentence": "Pyridostigmine 30 mg TID PO"
            },
            "pretreatment": "None specific",
            "contraindications": "Mechanical GI/GU obstruction; bradyarrhythmia",
            "monitoring": "Cholinergic effects (diarrhea, salivation)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Compression stockings",
            "route": "External",
            "indication": "Orthostatic hypotension; venous pooling",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Waist-high 30-40 mmHg",
                  "orderSentence": "Compression stockings Waist-high 30-40 mmHg External"
                }
              ],
              "route": "External",
              "instructions": "Waist-high preferred over knee-high; put on before rising; 30-40 mmHg compression",
              "orderSentence": "Compression stockings Waist-high 30-40 mmHg External"
            },
            "pretreatment": "Peripheral arterial disease (ABI <0.5)",
            "contraindications": "Skin breakdown; PAD",
            "monitoring": "Skin integrity; ABI if arterial disease suspected",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Oxybutynin",
            "route": "PO",
            "indication": "Bladder urgency/frequency",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg BID",
                  "orderSentence": "Oxybutynin 5 mg BID PO"
                },
                {
                  "text": "5 mg TID",
                  "orderSentence": "Oxybutynin 5 mg TID PO"
                },
                {
                  "text": "10 mg XL daily",
                  "orderSentence": "Oxybutynin 10 mg XL daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg BID or 10 mg XL daily; max 30 mg/day",
              "orderSentence": "Oxybutynin 5 mg BID PO"
            },
            "pretreatment": "Urinary retention; uncontrolled narrow-angle glaucoma; GI obstruction",
            "contraindications": "Cognitive effects in elderly; dry mouth",
            "monitoring": "Anticholinergic effects; cognition in elderly",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Solifenacin",
            "route": "PO",
            "indication": "Bladder urgency; better tolerated anticholinergic",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg daily",
                  "orderSentence": "Solifenacin 5 mg daily PO"
                },
                {
                  "text": "10 mg daily",
                  "orderSentence": "Solifenacin 10 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg daily; may increase to 10 mg daily",
              "orderSentence": "Solifenacin 5 mg daily PO"
            },
            "pretreatment": "Same as oxybutynin; severe hepatic impairment",
            "contraindications": "Same as oxybutynin but less cognitive",
            "monitoring": "Anticholinergic effects",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Mirabegron",
            "route": "PO",
            "indication": "Bladder urgency; beta-3 agonist (non-anticholinergic)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg daily",
                  "orderSentence": "Mirabegron 25 mg daily PO"
                },
                {
                  "text": "50 mg daily",
                  "orderSentence": "Mirabegron 50 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg daily; may increase to 50 mg daily",
              "orderSentence": "Mirabegron 25 mg daily PO"
            },
            "pretreatment": "Uncontrolled hypertension; severe hepatic impairment",
            "contraindications": "BP; urinary retention",
            "monitoring": "-",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "-"
          },
          {
            "item": "Metoclopramide",
            "route": "PO",
            "indication": "Gastroparesis; prokinetic",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg AC",
                  "orderSentence": "Metoclopramide 5 mg AC PO"
                },
                {
                  "text": "10 mg AC",
                  "orderSentence": "Metoclopramide 10 mg AC PO"
                }
              ],
              "route": "PO",
              "instructions": "5-10 mg 30 min before meals and at bedtime; limit to <12 weeks",
              "orderSentence": "Metoclopramide 5 mg AC PO"
            },
            "pretreatment": "Tardive dyskinesia (limit duration); GI obstruction; Parkinson disease",
            "contraindications": "Tardive dyskinesia; extrapyramidal symptoms",
            "monitoring": "-",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "-"
          },
          {
            "item": "Domperidone",
            "route": "PO",
            "indication": "Gastroparesis; prokinetic with less CNS effects",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg TID",
                  "orderSentence": "Domperidone 10 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "10 mg TID before meals; not FDA-approved (requires IND or international pharmacy)",
              "orderSentence": "Domperidone 10 mg TID PO"
            },
            "pretreatment": "QT prolongation; ventricular arrhythmia",
            "contraindications": "ECG for QT; arrhythmia",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "-"
          },
          {
            "item": "Erythromycin",
            "route": "PO",
            "indication": "Gastroparesis; motilin receptor agonist",
            "dosing": {
              "doseOptions": [
                {
                  "text": "250 mg TID",
                  "orderSentence": "Erythromycin 250 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "250 mg PO TID before meals; short-term use due to tachyphylaxis",
              "orderSentence": "Erythromycin 250 mg TID PO"
            },
            "pretreatment": "QT prolongation; drug interactions",
            "contraindications": "ECG; GI upset; tachyphylaxis limits long-term use",
            "monitoring": "-",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "-"
          },
          {
            "item": "Sildenafil",
            "route": "PO",
            "indication": "Erectile dysfunction in autonomic SFN",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg PRN",
                  "orderSentence": "Sildenafil 25 mg PRN PO"
                },
                {
                  "text": "50 mg PRN",
                  "orderSentence": "Sildenafil 50 mg PRN PO"
                },
                {
                  "text": "100 mg PRN",
                  "orderSentence": "Sildenafil 100 mg PRN PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25-50 mg 1h before activity; max 100 mg; avoid with nitrates",
              "orderSentence": "Sildenafil 25 mg PRN PO"
            },
            "pretreatment": "Nitrate use; severe cardiovascular disease",
            "contraindications": "Cardiovascular status; vision changes",
            "monitoring": "-",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-"
          }
        ],
        "Disease-Modifying / Etiology-Targeted Therapies": [
          {
            "item": "Glycemic control optimization",
            "route": "Various",
            "indication": "Diabetes/prediabetes-associated SFN",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per diabetes guidelines",
                  "orderSentence": "Glycemic control optimization Per diabetes guidelines Various"
                }
              ],
              "route": "Various",
              "instructions": "Lifestyle first for prediabetes; HbA1c <7% target; tighter control slows progression",
              "orderSentence": "Glycemic control optimization Per diabetes guidelines Various"
            },
            "pretreatment": "Diabetes education",
            "contraindications": "Hypoglycemia risk",
            "monitoring": "HbA1c q3-6mo; glucose monitoring",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "IVIG",
            "route": "IV",
            "indication": "Autoimmune SFN (Sjogren-associated; anti-FGFR3+; idiopathic with evidence of inflammation)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 g/kg divided over 2-5 days",
                  "orderSentence": "IVIG 2 g/kg divided over 2-5 days IV"
                }
              ],
              "route": "IV",
              "instructions": "2 g/kg divided over 2-5 days monthly; limited evidence; consider trial",
              "orderSentence": "IVIG 2 g/kg divided over 2-5 days IV"
            },
            "pretreatment": "Check IgA level (IgA-deficient patients need IgA-depleted product)",
            "contraindications": "IgA deficiency (use IgA-depleted); renal impairment; hypercoagulable state",
            "monitoring": "Renal function; thrombotic risk; headache",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Enzyme replacement therapy (Fabry disease)",
            "route": "IV",
            "indication": "Fabry disease-associated SFN",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Agalsidase beta (Fabrazyme) 1 mg/kg IV q2wk",
                  "orderSentence": "Enzyme replacement therapy (Fabry disease) Agalsidase beta (Fabrazyme) 1 mg/kg IV q2wk IV"
                }
              ],
              "route": "IV",
              "instructions": "Lifelong therapy; infusion reactions common early",
              "orderSentence": "Enzyme replacement therapy (Fabry disease) Agalsidase beta (Fabrazyme) 1 mg/kg IV q2wk IV"
            },
            "pretreatment": "None",
            "contraindications": "None absolute",
            "monitoring": "Infusion reactions; anti-drug antibodies",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Tafamidis (Vyndamax/Vyndaqel)",
            "route": "PO",
            "indication": "Hereditary and wild-type TTR amyloidosis with polyneuropathy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "80 mg daily",
                  "orderSentence": "Tafamidis (Vyndamax/Vyndaqel) 80 mg daily PO"
                },
                {
                  "text": "61 mg daily",
                  "orderSentence": "Tafamidis (Vyndamax/Vyndaqel) 61 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "80 mg (Vyndamax) or 61 mg (Vyndaqel) PO daily; TTR stabilizer",
              "orderSentence": "Tafamidis (Vyndamax/Vyndaqel) 80 mg daily PO"
            },
            "pretreatment": "Genetic confirmation of TTR amyloidosis",
            "contraindications": "None",
            "monitoring": "Cardiac function; neuropathy progression",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Inotersen/Patisiran",
            "route": "SC/IV",
            "indication": "Hereditary TTR amyloidosis with polyneuropathy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per prescribing protocol",
                  "orderSentence": "Inotersen/Patisiran Per prescribing protocol SC/IV"
                }
              ],
              "route": "SC/IV",
              "instructions": "Inotersen 284 mg SC weekly; Patisiran 0.3 mg/kg IV q3wk",
              "orderSentence": "Inotersen/Patisiran Per prescribing protocol SC/IV"
            },
            "pretreatment": "TTR gene mutation confirmed; specialist management",
            "contraindications": "Thrombocytopenia (inotersen); infusion reactions",
            "monitoring": "Platelets (inotersen); hepatic function",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Gluten-free diet",
            "route": "Diet",
            "indication": "Celiac disease-associated SFN",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Strict gluten-free",
                  "orderSentence": "Gluten-free diet Strict gluten-free Diet"
                }
              ],
              "route": "Diet",
              "instructions": "Lifelong strict gluten-free diet; dietitian referral; neuropathy may stabilize/improve",
              "orderSentence": "Gluten-free diet Strict gluten-free Diet"
            },
            "pretreatment": "Celiac confirmation",
            "contraindications": "None",
            "monitoring": "TTG-IgA levels; symptom response",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "B12 supplementation",
            "route": "PO/IM",
            "indication": "B12 deficiency-associated SFN",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mcg daily PO",
                  "orderSentence": "B12 supplementation 1000 mcg daily PO PO/IM"
                },
                {
                  "text": "1000 mcg IM monthly",
                  "orderSentence": "B12 supplementation 1000 mcg IM monthly PO/IM"
                }
              ],
              "route": "PO/IM",
              "instructions": "1000-2000 mcg PO daily; or 1000 mcg IM weekly x 4, then monthly if poor absorption",
              "orderSentence": "B12 supplementation 1000 mcg daily PO PO/IM"
            },
            "pretreatment": "None",
            "contraindications": "None",
            "monitoring": "B12 and MMA levels q3-6mo until stable",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Immunosuppression (Sjogren's)",
            "route": "Various",
            "indication": "Sjogren's-associated SFN with systemic disease activity",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per rheumatology",
                  "orderSentence": "Immunosuppression (Sjogren's) Per rheumatology Various"
                }
              ],
              "route": "Various",
              "instructions": "Hydroxychloroquine, methotrexate, rituximab; coordinate with rheumatology",
              "orderSentence": "Immunosuppression (Sjogren's) Per rheumatology Various"
            },
            "pretreatment": "Rheumatology co-management",
            "contraindications": "Per specific agent",
            "monitoring": "Per specific agent",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Alpha-lipoic acid",
            "route": "PO",
            "indication": "Antioxidant; some evidence in painful neuropathy; European guidelines",
            "dosing": {
              "doseOptions": [
                {
                  "text": "600 mg daily",
                  "orderSentence": "Alpha-lipoic acid 600 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "600 mg PO daily; may take 3-6 months for effect; limited evidence",
              "orderSentence": "Alpha-lipoic acid 600 mg daily PO"
            },
            "pretreatment": "None",
            "contraindications": "GI upset",
            "monitoring": "May enhance hypoglycemia in diabetics",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neuromuscular specialist for skin biopsy interpretation and complex SFN management",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rheumatology if Sjogren's, lupus, or other connective tissue disease suspected",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Endocrinology if diabetes/prediabetes for glycemic optimization and metabolic management",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Genetics counselor if hereditary etiology suspected (Fabry, TTR amyloidosis, SCN9A channelopathies)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Gastroenterology for celiac confirmation, gastroparesis management, or liver biopsy if amyloid suspected",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Cardiology if TTR amyloidosis suspected or autonomic symptoms with cardiac involvement",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pain management for refractory neuropathic pain and interventional options (spinal cord stimulation)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Physical therapy for balance training, strengthening, and fall prevention",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Autonomic disorders specialist if complex autonomic symptoms (POTS, orthostatic hypotension)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Psychiatry/psychology for chronic pain coping and comorbid depression/anxiety management",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Hematology/oncology if amyloidosis confirmed for staging and treatment",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Report any new weakness, gait difficulty, or falls as these may indicate progression to large fiber involvement",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Monitor for signs of infection in feet (redness, warmth, drainage) if sensation is impaired",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Keep a pain diary to track triggers, severity, and medication response",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Rise slowly from sitting or lying to prevent falls from orthostatic hypotension",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Increase salt and fluid intake (2-3L/day, 6-10g sodium) if orthostatic hypotension present (unless contraindicated)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Wear compression stockings before rising in the morning if orthostatic hypotension diagnosed",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Take all prescribed pain medications as directed; do not stop gabapentinoids or SNRIs abruptly",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid excessive heat exposure which can worsen symptoms; stay hydrated in warm weather",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Return if severe headache, vision changes, or syncope develop (may indicate medication side effects or disease progression)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Strict glycemic control (HbA1c <7% or <5.7% if prediabetes) to prevent progression; lifestyle modifications first",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Alcohol cessation as alcohol independently causes and worsens small fiber neuropathy",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Smoking cessation as smoking impairs nerve regeneration and worsens outcomes",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Regular low-impact exercise (swimming, stationary bike, walking) to improve pain and maintain function",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Healthy diet (Mediterranean or DASH) to optimize metabolic health and reduce inflammation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Weight management as metabolic syndrome is associated with SFN",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Sleep hygiene to improve sleep quality; chronic pain worsens with poor sleep",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Stress reduction techniques (mindfulness, meditation) as stress can amplify pain perception",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Fall prevention with home safety evaluation given proprioceptive deficits and orthostatic hypotension",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid B6 (pyridoxine) supplementation above RDA (1.3-2 mg/day) as excess causes neuropathy",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Diabetic polyneuropathy (large fiber)",
        "features": "NCS abnormal; mixed sensorimotor findings; more numbness than pain",
        "tests": "EMG/NCS shows axonal polyneuropathy"
      },
      {
        "diagnosis": "Fibromyalgia",
        "features": "Widespread pain; tender points; normal skin biopsy; chronic fatigue",
        "tests": "ACR criteria; normal IENFD on skin biopsy"
      },
      {
        "diagnosis": "Complex regional pain syndrome (CRPS)",
        "features": "Regional rather than length-dependent; swelling, color changes, dystrophy",
        "tests": "Budapest criteria; regional distribution"
      },
      {
        "diagnosis": "Erythromelalgia",
        "features": "Intermittent burning with redness and warmth; triggered by heat; may have SCN9A mutation",
        "tests": "Clinical pattern; genetic testing if suspected"
      },
      {
        "diagnosis": "Central sensitization syndromes",
        "features": "Normal peripheral testing; pain out of proportion to objective findings",
        "tests": "QST pattern; skin biopsy normal"
      },
      {
        "diagnosis": "Psychogenic/functional sensory symptoms",
        "features": "Non-anatomical distribution; inconsistent findings; psychiatric comorbidity",
        "tests": "Careful neurological exam; normal objective testing"
      },
      {
        "diagnosis": "Vitamin B12 deficiency",
        "features": "May have subacute combined degeneration; cognitive changes; macrocytic anemia",
        "tests": "B12, MMA levels; MRI spine"
      },
      {
        "diagnosis": "Lyme disease",
        "features": "Endemic area; prior tick bite; rash history; may have radiculopathy",
        "tests": "Lyme serology (ELISA + Western blot)"
      },
      {
        "diagnosis": "Hereditary sensory neuropathy (HSAN)",
        "features": "Family history; anhidrosis; painless injuries; mutilating features",
        "tests": "Genetic testing (HSAN genes)"
      },
      {
        "diagnosis": "Burning mouth syndrome",
        "features": "Isolated to oral mucosa; taste changes; dry mouth",
        "tests": "Location-specific; oral exam"
      },
      {
        "diagnosis": "Restless legs syndrome",
        "features": "Urge to move legs; worse at rest/night; relief with movement",
        "tests": "Clinical criteria; may coexist with SFN"
      },
      {
        "diagnosis": "Vasculitic neuropathy",
        "features": "Asymmetric; mononeuritis multiplex pattern; systemic symptoms; rapid onset",
        "tests": "Nerve biopsy; inflammatory markers; angiography"
      },
      {
        "diagnosis": "Paraneoplastic sensory ganglionopathy",
        "features": "Subacute onset; asymmetric; non-length-dependent; cancer history/risk",
        "tests": "Anti-Hu antibodies; CT chest/abdomen/pelvis"
      }
    ],
    "evidence": [
      {
        "recommendation": "Skin biopsy (IENFD) as diagnostic standard for SFN",
        "evidenceLevel": "Class II, Level B",
        "source": "[Lauria et al. European Journal of Neurology 2010](https://pubmed.ncbi.nlm.nih.gov/20298428/)"
      },
      {
        "recommendation": "QSART for sudomotor function assessment in SFN",
        "evidenceLevel": "Class II, Level B",
        "source": "[Low et al. Muscle & Nerve 1983](https://pubmed.ncbi.nlm.nih.gov/6308464/)"
      },
      {
        "recommendation": "Impaired glucose tolerance as cause of SFN",
        "evidenceLevel": "Class II, Level B",
        "source": "[Singleton et al. Neurology 2001](https://pubmed.ncbi.nlm.nih.gov/11723275/)"
      },
      {
        "recommendation": "Sjogren syndrome associated with SFN",
        "evidenceLevel": "Class II, Level B",
        "source": "[Chai et al. Annals of Neurology 2005](https://pubmed.ncbi.nlm.nih.gov/15984030/)"
      },
      {
        "recommendation": "Duloxetine for neuropathic pain",
        "evidenceLevel": "Class I, Level A",
        "source": "[Lunn et al. Cochrane 2014](https://pubmed.ncbi.nlm.nih.gov/24399144/)"
      },
      {
        "recommendation": "Gabapentin for neuropathic pain",
        "evidenceLevel": "Class I, Level A",
        "source": "[Wiffen et al. Cochrane 2017](https://pubmed.ncbi.nlm.nih.gov/28597471/)"
      },
      {
        "recommendation": "Pregabalin for neuropathic pain",
        "evidenceLevel": "Class I, Level A",
        "source": "[Derry et al. Cochrane 2019](https://pubmed.ncbi.nlm.nih.gov/30673120/)"
      },
      {
        "recommendation": "TCAs for neuropathic pain",
        "evidenceLevel": "Class II, Level B",
        "source": "[Moore et al. Cochrane 2015](https://pubmed.ncbi.nlm.nih.gov/25879104/)"
      },
      {
        "recommendation": "Fludrocortisone for orthostatic hypotension",
        "evidenceLevel": "Class II, Level C",
        "source": "[Freeman et al. Neurology 2018 Consensus Statement](https://pubmed.ncbi.nlm.nih.gov/29666232/)"
      },
      {
        "recommendation": "Midodrine for orthostatic hypotension",
        "evidenceLevel": "Class I, Level A",
        "source": "[Wright et al. Am Heart J 1998](https://pubmed.ncbi.nlm.nih.gov/9463419/)"
      },
      {
        "recommendation": "Droxidopa for neurogenic orthostatic hypotension",
        "evidenceLevel": "Class I, Level A",
        "source": "[Biaggioni et al. Neurology 2015](https://pubmed.ncbi.nlm.nih.gov/25646278/)"
      },
      {
        "recommendation": "IVIG for autoimmune SFN",
        "evidenceLevel": "Class III, Level C",
        "source": "[Liu et al. J Periph Nerv Syst 2014](https://pubmed.ncbi.nlm.nih.gov/24750390/)"
      },
      {
        "recommendation": "Fabry disease as cause of SFN",
        "evidenceLevel": "Class II, Level B",
        "source": "[Biegstraaten et al. Orphanet J Rare Dis 2012](https://pubmed.ncbi.nlm.nih.gov/22452838/)"
      },
      {
        "recommendation": "TTR amyloidosis neuropathy treatment",
        "evidenceLevel": "Class I, Level A",
        "source": "[Adams et al. NEJM 2018 (Patisiran trial)](https://pubmed.ncbi.nlm.nih.gov/29972757/)"
      },
      {
        "recommendation": "Sodium channelopathies (SCN9A) in SFN",
        "evidenceLevel": "Class II, Level B",
        "source": "[Faber et al. Ann Neurol 2012](https://pubmed.ncbi.nlm.nih.gov/22522478/)"
      }
    ],
    "monitoring": [
      {
        "item": "Pain scores (NRS, VAS, BPI)",
        "frequency": "Each visit",
        "action": "Adjust medications; consider combination or referral",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "HbA1c (if diabetes/prediabetes)",
        "frequency": "Every 3-6 months",
        "action": "Intensify glycemic management",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Orthostatic vitals (lying, sitting, standing)",
        "frequency": "Each visit if autonomic symptoms",
        "action": "Adjust autonomic medications; hydration; compression",
        "ED": "STAT",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Repeat skin biopsy (IENFD)",
        "frequency": "Every 1-2 years if monitoring disease course",
        "action": "Intensify etiology treatment if declining",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Autonomic symptoms inventory",
        "frequency": "Each visit",
        "action": "Adjust autonomic treatments; workup new symptoms",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "ECG",
        "frequency": "Baseline if on TCAs or sodium channel blockers; periodically",
        "action": "Dose reduction or discontinuation if prolonged intervals",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Renal function (eGFR)",
        "frequency": "Every 6-12 months",
        "action": "Adjust medication doses; nephrology referral",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Potassium (if on fludrocortisone)",
        "frequency": "Monthly initially, then every 3-6 months",
        "action": "Supplement potassium; reduce fludrocortisone dose",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Weight and edema",
        "frequency": "Each visit",
        "action": "Adjust pregabalin/gabapentin or autonomic meds",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Depression screen (PHQ-9)",
        "frequency": "Every 6-12 months",
        "action": "Mental health referral; consider duloxetine/venlafaxine",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Falls assessment",
        "frequency": "Each visit",
        "action": "PT referral; home safety; reduce sedating medications",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      }
    ],
    "disposition": [
      {
        "disposition": "Discharge home",
        "criteria": "Symptoms stable; pain controlled; autonomic symptoms not causing hemodynamic instability; follow-up arranged"
      },
      {
        "disposition": "Admit to floor",
        "criteria": "Severe uncontrolled pain requiring IV medications; syncope from orthostatic hypotension; new diagnosis requiring urgent workup (suspected amyloidosis with cardiac involvement)"
      },
      {
        "disposition": "Admit to ICU",
        "criteria": "Hemodynamically unstable from autonomic dysfunction; severe symptomatic bradycardia or hypotension"
      },
      {
        "disposition": "Outpatient follow-up",
        "criteria": "Every 3-6 months for medication optimization; annually for etiology reassessment if initially idiopathic"
      }
    ]
  },
  "Myasthenia Gravis - Outpatient Management": {
    "id": "myasthenia-gravis",
    "title": "Myasthenia Gravis - Outpatient Management",
    "version": "1.0",
    "icd10": [
      "** G70.00 (Myasthenia gravis without exacerbation)",
      "G70.01 (Myasthenia gravis with exacerbation)"
    ],
    "scope": "** Outpatient diagnosis, management, and monitoring of myasthenia gravis in adults. Covers antibody-positive (AChR, MuSK, LRP4) and seronegative MG, ocular and generalized subtypes, pyridostigmine optimization, immunotherapy initiation and monitoring, thymectomy evaluation, and crisis prevention. Excludes myasthenic crisis (see \"Myasthenia Gravis - Exacerbation/Crisis\"), Lambert-Eaton myasthenic syndrome (LEMS), congenital myasthenic syndromes, and drug-induced myasthenia.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "AChR binding antibody",
            "rationale": "Primary diagnostic test; positive in 85% generalized, 50% ocular MG",
            "target": "Positive confirms diagnosis",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "AChR modulating antibody",
            "rationale": "Increases sensitivity when combined with binding antibody",
            "target": "Positive supports diagnosis",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "AChR blocking antibody",
            "rationale": "Additional AChR antibody; may be positive when binding negative",
            "target": "Positive supports diagnosis",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "MuSK antibody",
            "rationale": "Order if AChR negative; positive in ~40% of AChR-negative patients",
            "target": "Positive confirms MuSK MG",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "LRP4 antibody",
            "rationale": "Order if AChR and MuSK negative; available at specialized labs",
            "target": "Positive confirms LRP4 MG",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Anti-striated muscle antibody",
            "rationale": "Thymoma association; if positive, high likelihood of thymoma",
            "target": "Positive warrants urgent CT chest",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "TSH",
            "rationale": "Autoimmune thyroid disease common comorbidity (10-15%)",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CBC with differential",
            "rationale": "Baseline before immunotherapy; infection assessment",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "CMP",
            "rationale": "Baseline renal/hepatic function; electrolytes",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          }
        ],
        "Extended Workup": [
          {
            "item": "TPMT activity or genotype",
            "rationale": "Required before azathioprine initiation; low activity increases toxicity risk",
            "target": "Normal or intermediate activity",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Hepatitis B surface antigen and core antibody",
            "rationale": "Before rituximab or other B-cell depleting therapy",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Hepatitis C antibody",
            "rationale": "Before immunosuppressive therapy",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Quantitative immunoglobulins (IgG, IgA, IgM)",
            "rationale": "Baseline before IVIg or rituximab; IgA deficiency is IVIg contraindication",
            "target": "Normal; IgA >7 mg/dL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "HIV antibody",
            "rationale": "Before immunosuppressive therapy",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Tuberculosis screen (QuantiFERON-Gold or PPD)",
            "rationale": "Before chronic immunosuppression",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Fasting glucose and HbA1c",
            "rationale": "Baseline before chronic steroid therapy",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin D, 25-hydroxy",
            "rationale": "Steroid-induced osteoporosis prevention",
            "target": ">30 ng/mL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Free T4",
            "rationale": "If TSH abnormal; autoimmune thyroid disease",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Clustered AChR antibody assay",
            "rationale": "Seronegative MG; may detect low-affinity antibodies not seen on standard assay",
            "target": "Positive supports diagnosis in seronegative cases",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Paraneoplastic panel",
            "rationale": "Occult malignancy concern; particularly if anti-striated muscle positive",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Cortisol (AM)",
            "rationale": "Adrenal insufficiency if on chronic steroids being tapered",
            "target": "Normal stress response",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "ACTH stimulation test",
            "rationale": "Suspected secondary adrenal insufficiency from steroid withdrawal",
            "target": "Normal cortisol response",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Bone densitometry markers (CTX, P1NP)",
            "rationale": "Osteoporosis risk on chronic steroids",
            "target": "Normal",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "CT chest with contrast",
            "timing": "At diagnosis; exclude thymoma",
            "target": "No thymoma or thymic hyperplasia (or if present, surgical planning)",
            "contraindications": "Contrast allergy, renal impairment (CrCl <30)",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "CT chest without contrast",
            "timing": "If contrast contraindicated",
            "target": "Thymic abnormality assessment",
            "contraindications": "None",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Repetitive nerve stimulation (RNS)",
            "timing": "Diagnostic confirmation; if antibodies negative or for monitoring",
            "target": "Decremental response >10% at 3 Hz (positive)",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pulmonary function tests (FVC, NIF)",
            "timing": "Baseline respiratory function; symptom correlation",
            "target": "FVC >80% predicted; NIF more negative than -60 cmH2O",
            "contraindications": "Facial weakness limiting seal",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          }
        ],
        "Extended": [
          {
            "item": "Single-fiber EMG (SFEMG)",
            "timing": "Most sensitive test; if RNS and antibodies negative",
            "target": "Increased jitter and blocking",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "MRI chest",
            "timing": "If CT indeterminate for thymoma; cystic thymic lesions",
            "target": "Characterize thymic mass",
            "contraindications": "Pacemaker, severe claustrophobia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "PET-CT",
            "timing": "Suspected thymoma malignancy or metastasis",
            "target": "No FDG-avid lesions",
            "contraindications": "Pregnancy; hemodynamic instability",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Ice pack test",
            "timing": "Bedside diagnostic for ptosis; cooling improves neuromuscular transmission",
            "target": "Improvement in ptosis after 2 minutes of ice application",
            "contraindications": "None",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Video swallow study",
            "timing": "Dysphagia symptoms; aspiration risk assessment",
            "target": "Safe swallow; define texture modifications",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "DEXA scan",
            "timing": "Chronic steroid exposure; osteoporosis screening",
            "target": "T-score >-2.5",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Edrophonium (Tensilon) test",
            "timing": "Rarely used now; if diagnostic uncertainty and other tests unavailable",
            "target": "Improvement in weakness within 30-60 seconds",
            "contraindications": "Cardiac arrhythmia, asthma (relative)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Sleep study (polysomnography)",
            "timing": "Sleep-disordered breathing; respiratory weakness; fatigue",
            "target": "AHI <5/hour; no nocturnal desaturation",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Cardiac MRI",
            "timing": "Suspected cardiac involvement (rare)",
            "target": "Normal",
            "contraindications": "Pacemaker",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Treatment": {
        "Cholinesterase Inhibitors (Symptomatic Treatment)": [
          {
            "item": "Pyridostigmine",
            "route": "PO",
            "indication": "First-line symptomatic treatment for all MG subtypes",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mg TID",
                  "orderSentence": "Pyridostigmine 30 mg TID PO"
                },
                {
                  "text": "60 mg TID",
                  "orderSentence": "Pyridostigmine 60 mg TID PO"
                },
                {
                  "text": "60 mg QID",
                  "orderSentence": "Pyridostigmine 60 mg QID PO"
                },
                {
                  "text": "90 mg QID",
                  "orderSentence": "Pyridostigmine 90 mg QID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 30 mg TID; increase by 30 mg/dose every 3-5 days as tolerated; usual maintenance 60 mg q4-6h (max 120 mg q4h); take 30-60 min before meals for swallowing",
              "orderSentence": "Pyridostigmine 30 mg TID PO"
            },
            "contraindications": "Mechanical bowel/bladder obstruction; known hypersensitivity",
            "monitoring": "Cholinergic symptoms (SLUDGE: salivation, lacrimation, urination, defecation, GI distress, emesis); bradycardia; if symptoms occur, reduce dose",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Pyridostigmine SR (Mestinon Timespan)",
            "route": "PO",
            "indication": "Nocturnal symptoms; morning weakness on awakening",
            "dosing": {
              "doseOptions": [
                {
                  "text": "180 mg qHS",
                  "orderSentence": "Pyridostigmine SR (Mestinon Timespan) 180 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "180 mg at bedtime for nocturnal weakness; do NOT crush; erratic absorption limits daytime use; max 1 tablet daily",
              "orderSentence": "Pyridostigmine SR (Mestinon Timespan) 180 mg qHS PO"
            },
            "contraindications": "Same as immediate-release",
            "monitoring": "Same as immediate-release",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Glycopyrrolate",
            "route": "PO",
            "indication": "Cholinergic side effects from pyridostigmine",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 mg BID",
                  "orderSentence": "Glycopyrrolate 1 mg BID PO"
                },
                {
                  "text": "1 mg TID",
                  "orderSentence": "Glycopyrrolate 1 mg TID PO"
                },
                {
                  "text": "2 mg TID",
                  "orderSentence": "Glycopyrrolate 2 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "1-2 mg PO BID-TID for secretions, diarrhea, or cramping from pyridostigmine; does not cross BBB",
              "orderSentence": "Glycopyrrolate 1 mg BID PO"
            },
            "contraindications": "Glaucoma; severe cardiac disease; GI obstruction",
            "monitoring": "Dry mouth; urinary retention; constipation; tachycardia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Corticosteroids": [
          {
            "item": "Prednisone (low-dose start)",
            "route": "PO",
            "indication": "Ocular or mild generalized MG; outpatient initiation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg daily",
                  "orderSentence": "Prednisone (low-dose start) 10 mg daily PO"
                },
                {
                  "text": "20 mg daily",
                  "orderSentence": "Prednisone (low-dose start) 20 mg daily PO"
                },
                {
                  "text": "30 mg daily",
                  "orderSentence": "Prednisone (low-dose start) 30 mg daily PO"
                },
                {
                  "text": "40 mg daily",
                  "orderSentence": "Prednisone (low-dose start) 40 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10-20 mg daily; increase by 10 mg every 5-7 days to target 1 mg/kg/day (max 60-80 mg); LOW-DOSE START prevents transient worsening in outpatient setting",
              "orderSentence": "Prednisone (low-dose start) 10 mg daily PO"
            },
            "contraindications": "Active untreated infection; psychosis (relative); poorly controlled diabetes",
            "monitoring": "Glucose weekly during titration; BP; weight; mood; bone density annually",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Prednisone (high-dose)",
            "route": "PO",
            "indication": "Hospital setting with crisis protection (post-IVIg/PLEX)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "60 mg daily",
                  "orderSentence": "Prednisone (high-dose) 60 mg daily PO"
                },
                {
                  "text": "1 mg/kg daily",
                  "orderSentence": "Prednisone (high-dose) 1 mg/kg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "60-80 mg or 1 mg/kg daily; only start high-dose after IVIg/PLEX coverage in hospital or if admitted for monitoring",
              "orderSentence": "Prednisone (high-dose) 60 mg daily PO"
            },
            "contraindications": "Active infection (relative); NOT FOR OUTPATIENT INITIATION",
            "monitoring": "Glucose q6h; BP; K+; monitor for transient worsening days 5-10",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Prednisone (maintenance/taper)",
            "route": "PO",
            "indication": "Chronic MG on stable steroids",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per taper schedule",
                  "orderSentence": "Prednisone (maintenance/taper) Per taper schedule PO"
                }
              ],
              "route": "PO",
              "instructions": "Once stable on target dose x 2-4 weeks, begin slow taper: reduce by 10 mg q2-4 weeks until 20 mg, then by 5 mg q2-4 weeks until 10 mg, then by 2.5 mg q month; may need minimum maintenance dose indefinitely",
              "orderSentence": "Prednisone (maintenance/taper) Per taper schedule PO"
            },
            "contraindications": "-",
            "monitoring": "Symptoms of adrenal insufficiency during taper; flare",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Steroid-Sparing Immunosuppressants (Disease-Modifying)": [
          {
            "item": "Azathioprine",
            "route": "PO",
            "indication": "Steroid-sparing; first-line maintenance immunosuppressant",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg daily",
                  "orderSentence": "Azathioprine 50 mg daily PO"
                },
                {
                  "text": "100 mg daily",
                  "orderSentence": "Azathioprine 100 mg daily PO"
                },
                {
                  "text": "150 mg daily",
                  "orderSentence": "Azathioprine 150 mg daily PO"
                },
                {
                  "text": "2-3 mg/kg daily",
                  "orderSentence": "Azathioprine 2-3 mg/kg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 50 mg daily x 1-2 weeks; increase by 50 mg every 2-4 weeks to target 2-3 mg/kg/day (usually 150-200 mg/day); takes 6-12 months for full effect",
              "orderSentence": "Azathioprine 50 mg daily PO"
            },
            "pretreatment": "TPMT genotype or enzyme activity; CBC; LFTs; hepatitis panel",
            "contraindications": "TPMT deficiency (intermediate requires 50% dose reduction); pregnancy; concurrent allopurinol (75% dose reduction required)",
            "monitoring": "CBC weekly x 4 weeks, then monthly x 3 months, then q3 months; LFTs monthly x 3 months, then q3 months; flu-like symptoms on initiation (hypersensitivity, discontinue)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Mycophenolate mofetil",
            "route": "PO",
            "indication": "Steroid-sparing; alternative to azathioprine",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mg BID",
                  "orderSentence": "Mycophenolate mofetil 500 mg BID PO"
                },
                {
                  "text": "1000 mg BID",
                  "orderSentence": "Mycophenolate mofetil 1000 mg BID PO"
                },
                {
                  "text": "1500 mg BID",
                  "orderSentence": "Mycophenolate mofetil 1500 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 500 mg BID; increase to 1000 mg BID after 2 weeks; may increase to 1500 mg BID if needed; takes 3-6 months for effect",
              "orderSentence": "Mycophenolate mofetil 500 mg BID PO"
            },
            "pretreatment": "CBC; LFTs; hepatitis panel; pregnancy test",
            "contraindications": "Pregnancy (teratogenic); breastfeeding; hypersensitivity",
            "monitoring": "CBC every 2 weeks x 2 months, then monthly x 4 months, then q3 months; LFTs q3 months; GI side effects common",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Mycophenolate sodium (Myfortic)",
            "route": "PO",
            "indication": "Alternative formulation with less GI side effects",
            "dosing": {
              "doseOptions": [
                {
                  "text": "360 mg BID",
                  "orderSentence": "Mycophenolate sodium (Myfortic) 360 mg BID PO"
                },
                {
                  "text": "720 mg BID",
                  "orderSentence": "Mycophenolate sodium (Myfortic) 720 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 360 mg BID; increase to 720 mg BID; 720 mg = 1000 mg mycophenolate mofetil",
              "orderSentence": "Mycophenolate sodium (Myfortic) 360 mg BID PO"
            },
            "pretreatment": "Same as mycophenolate mofetil",
            "contraindications": "Same as mycophenolate mofetil",
            "monitoring": "Same as mycophenolate mofetil",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Tacrolimus",
            "route": "PO",
            "indication": "Steroid-sparing; faster onset than azathioprine (3-6 months)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "3 mg daily",
                  "orderSentence": "Tacrolimus 3 mg daily PO"
                },
                {
                  "text": "3 mg BID",
                  "orderSentence": "Tacrolimus 3 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 3 mg daily; adjust to trough level 5-10 ng/mL; usual dose 3 mg BID; faster onset than azathioprine",
              "orderSentence": "Tacrolimus 3 mg daily PO"
            },
            "pretreatment": "Renal function; glucose; BP; drug interaction review",
            "contraindications": "Renal impairment; uncontrolled hypertension; concurrent potassium-sparing diuretics",
            "monitoring": "Tacrolimus trough level monthly; renal function monthly; glucose; BP; tremor; headache",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Cyclosporine",
            "route": "PO",
            "indication": "Alternative to tacrolimus; similar efficacy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "3-5 mg/kg/day divided BID",
                  "orderSentence": "Cyclosporine 3-5 mg/kg/day divided BID PO"
                }
              ],
              "route": "PO",
              "instructions": "3-5 mg/kg/day divided BID; adjust to trough 100-200 ng/mL",
              "orderSentence": "Cyclosporine 3-5 mg/kg/day divided BID PO"
            },
            "pretreatment": "Renal function; BP; lipids",
            "contraindications": "Renal impairment; uncontrolled hypertension; concurrent nephrotoxins",
            "monitoring": "Cyclosporine trough monthly; renal function monthly; BP; lipids; gingival hyperplasia; hirsutism",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Biologic and Targeted Immunotherapies": [
          {
            "item": "Rituximab",
            "route": "IV",
            "indication": "MuSK-positive MG (often first-line after steroids); refractory AChR+ MG",
            "dosing": {
              "doseOptions": [
                {
                  "text": "375 mg/m2 weekly x 4 weeks",
                  "orderSentence": "Rituximab 375 mg/m2 weekly x 4 weeks IV"
                },
                {
                  "text": "1000 mg q2 weeks x 2",
                  "orderSentence": "Rituximab 1000 mg q2 weeks x 2 IV"
                }
              ],
              "route": "IV",
              "instructions": "Either 375 mg/m2 IV weekly x 4 weeks OR 1000 mg IV x 2 doses (2 weeks apart); premedicate with methylprednisolone 100 mg, acetaminophen, diphenhydramine; repeat courses as needed",
              "orderSentence": "Rituximab 375 mg/m2 weekly x 4 weeks IV"
            },
            "pretreatment": "Hepatitis B screening (HBsAg, anti-HBc); quantitative immunoglobulins; TB screen",
            "contraindications": "Active hepatitis B; active severe infection; live vaccines within 4 weeks",
            "monitoring": "Infusion reactions; CD19/CD20 B-cell count q3-6 months; immunoglobulins annually; infection monitoring",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Eculizumab (Soliris)",
            "route": "IV",
            "indication": "AChR+ refractory generalized MG; FDA approved",
            "dosing": {
              "doseOptions": [
                {
                  "text": "900 mg weekly x 4 weeks, then 1200 mg q2 weeks",
                  "orderSentence": "Eculizumab (Soliris) 900 mg weekly x 4 weeks, then 1200 mg q2 weeks IV"
                }
              ],
              "route": "IV",
              "instructions": "900 mg IV weekly x 4 weeks (induction), then 1200 mg IV every 2 weeks (maintenance); infuse over 35 min",
              "orderSentence": "Eculizumab (Soliris) 900 mg weekly x 4 weeks, then 1200 mg q2 weeks IV"
            },
            "pretreatment": "Meningococcal vaccination (MenACWY and MenB) at least 2 weeks before; REMS enrollment",
            "contraindications": "Unresolved Neisseria meningitidis infection; not current with meningococcal vaccines",
            "monitoring": "Meningococcal infection risk (BLACK BOX); infusion reactions; headache; URI",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ravulizumab (Ultomiris)",
            "route": "IV",
            "indication": "AChR+ refractory generalized MG; longer dosing interval",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Weight-based loading then maintenance q8 weeks",
                  "orderSentence": "Ravulizumab (Ultomiris) Weight-based loading then maintenance q8 weeks IV"
                }
              ],
              "route": "IV",
              "instructions": "Load: 40-60 kg: 2400 mg; 60-100 kg: 2700 mg; >100 kg: 3000 mg; Maintenance q8 weeks: 40-60 kg: 3000 mg; 60-100 kg: 3300 mg; >100 kg: 3600 mg",
              "orderSentence": "Ravulizumab (Ultomiris) Weight-based loading then maintenance q8 weeks IV"
            },
            "pretreatment": "Meningococcal vaccination; REMS enrollment",
            "contraindications": "Same as eculizumab",
            "monitoring": "Same as eculizumab; less frequent infusions",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Efgartigimod (Vyvgart)",
            "route": "IV",
            "indication": "AChR+ generalized MG; FcRn inhibitor; lowers IgG",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg/kg weekly x 4 weeks",
                  "orderSentence": "Efgartigimod (Vyvgart) 10 mg/kg weekly x 4 weeks IV"
                }
              ],
              "route": "IV",
              "instructions": "10 mg/kg IV infusion over 1 hour weekly x 4 weeks per treatment cycle; repeat cycles as needed based on clinical response",
              "orderSentence": "Efgartigimod (Vyvgart) 10 mg/kg weekly x 4 weeks IV"
            },
            "pretreatment": "Baseline immunoglobulins; infection screening",
            "contraindications": "Active serious infection; IgG <2 g/L (relative)",
            "monitoring": "IgG levels; infection; infusion reactions; headache",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Efgartigimod-fvhp + hyaluronidase (Vyvgart Hytrulo)",
            "route": "SC",
            "indication": "AChR+ generalized MG; subcutaneous administration",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1008 mg SC weekly x 4 weeks",
                  "orderSentence": "Efgartigimod-fvhp + hyaluronidase (Vyvgart Hytrulo) 1008 mg SC weekly x 4 weeks SC"
                }
              ],
              "route": "SC",
              "instructions": "1008 mg SC injection weekly x 4 weeks per treatment cycle; self-administered at home after training",
              "orderSentence": "Efgartigimod-fvhp + hyaluronidase (Vyvgart Hytrulo) 1008 mg SC weekly x 4 weeks SC"
            },
            "pretreatment": "Same as IV efgartigimod",
            "contraindications": "Same as IV efgartigimod",
            "monitoring": "Same as IV efgartigimod; injection site reactions",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rozanolixizumab (Rystiggo)",
            "route": "SC",
            "indication": "AChR+ generalized MG; FcRn inhibitor",
            "dosing": {
              "doseOptions": [
                {
                  "text": "420 mg SC weekly x 6 weeks",
                  "orderSentence": "Rozanolixizumab (Rystiggo) 420 mg SC weekly x 6 weeks SC"
                }
              ],
              "route": "SC",
              "instructions": "420 mg SC injection weekly x 6 weeks per treatment cycle; repeat cycles as needed",
              "orderSentence": "Rozanolixizumab (Rystiggo) 420 mg SC weekly x 6 weeks SC"
            },
            "pretreatment": "Baseline immunoglobulins; infection screening",
            "contraindications": "Active serious infection",
            "monitoring": "IgG levels; infection; pyrexia; headache; diarrhea",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Zilucoplan (Zilbrysq)",
            "route": "SC",
            "indication": "AChR+ generalized MG; C5 complement inhibitor; daily SC",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.3 mg/kg daily",
                  "orderSentence": "Zilucoplan (Zilbrysq) 0.3 mg/kg daily SC"
                }
              ],
              "route": "SC",
              "instructions": "0.3 mg/kg SC daily; self-administered; meningococcal vaccination required",
              "orderSentence": "Zilucoplan (Zilbrysq) 0.3 mg/kg daily SC"
            },
            "pretreatment": "Meningococcal vaccination (MenACWY and MenB); REMS enrollment",
            "contraindications": "Unresolved Neisseria infection",
            "monitoring": "Meningococcal infection risk; injection site reactions; diarrhea; URI",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Supportive Care and Comorbidities": [
          {
            "item": "Calcium + Vitamin D",
            "route": "PO",
            "indication": "Bone protection on chronic steroids",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Calcium 1000-1200 mg daily + Vitamin D 1000-2000 IU daily",
                  "orderSentence": "Calcium + Vitamin D Calcium 1000-1200 mg daily + Vitamin D 1000-2000 IU daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Calcium 500-600 mg BID with meals; Vitamin D 1000-2000 IU daily; target 25-OH Vitamin D >30 ng/mL",
              "orderSentence": "Calcium + Vitamin D Calcium 1000-1200 mg daily + Vitamin D 1000-2000 IU daily PO"
            },
            "contraindications": "Hypercalcemia; kidney stones",
            "monitoring": "Vitamin D level annually; calcium as needed",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Bisphosphonate (Alendronate)",
            "route": "PO",
            "indication": "Osteoporosis prevention/treatment on chronic steroids",
            "dosing": {
              "doseOptions": [
                {
                  "text": "70 mg weekly",
                  "orderSentence": "Bisphosphonate (Alendronate) 70 mg weekly PO"
                }
              ],
              "route": "PO",
              "instructions": "70 mg PO weekly on empty stomach with full glass of water; remain upright 30 min; consider if steroids >3 months at prednisone >5 mg/day",
              "orderSentence": "Bisphosphonate (Alendronate) 70 mg weekly PO"
            },
            "contraindications": "GFR <30-35; esophageal disorders; inability to remain upright",
            "monitoring": "DEXA at baseline and q1-2 years; jaw osteonecrosis rare",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "PPI (Omeprazole)",
            "route": "PO",
            "indication": "GI protection during high-dose steroids",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg daily",
                  "orderSentence": "PPI (Omeprazole) 20 mg daily PO"
                },
                {
                  "text": "40 mg daily",
                  "orderSentence": "PPI (Omeprazole) 40 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "20-40 mg PO daily while on high-dose prednisone; consider tapering off when steroids reduced",
              "orderSentence": "PPI (Omeprazole) 20 mg daily PO"
            },
            "contraindications": "Long-term use increases C. diff risk",
            "monitoring": "Limit duration; consider H2 blocker alternative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Trimethoprim-sulfamethoxazole",
            "route": "PO",
            "indication": "PJP prophylaxis if on high-dose steroids + other immunosuppression",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 DS tablet 3x weekly",
                  "orderSentence": "Trimethoprim-sulfamethoxazole 1 DS tablet 3x weekly PO"
                }
              ],
              "route": "PO",
              "instructions": "1 DS tablet (160/800 mg) PO Monday/Wednesday/Friday; or 1 SS tablet daily",
              "orderSentence": "Trimethoprim-sulfamethoxazole 1 DS tablet 3x weekly PO"
            },
            "contraindications": "Sulfa allergy; G6PD deficiency",
            "monitoring": "CBC periodically; rash",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neuromuscular specialist/MG center for diagnosis confirmation, treatment optimization, and clinical trial consideration",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Thoracic surgery consult for thymectomy evaluation in AChR+ generalized MG age 18-65 years without thymoma, or any patient with thymoma",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pulmonology consult for baseline pulmonary function testing and ongoing respiratory monitoring in patients with respiratory symptoms",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Neuro-ophthalmology for diplopia management, prism prescription, or ptosis surgery evaluation in stable ocular MG",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Speech therapy for swallow evaluation given bulbar symptoms and aspiration risk assessment",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Physical therapy for generalized weakness to maintain function and prevent deconditioning",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Occupational therapy for ADL assessment and energy conservation strategies given fatigable weakness",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rheumatology if concurrent autoimmune disease suspected (thyroid, lupus, rheumatoid arthritis)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Infusion center for IVIg, rituximab, eculizumab, or other IV immunotherapy administration",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "High-risk OB for pregnancy planning in women with MG given medication adjustments and delivery planning",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Endocrinology for steroid-induced diabetes, osteoporosis, or adrenal insufficiency management",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Social work for disability planning, MG Foundation resources, and insurance navigation for expensive biologics",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Psychiatry for depression or anxiety related to chronic illness or steroid side effects",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Return immediately if worsening weakness, breathing difficulty, or difficulty swallowing develops (may indicate crisis requiring hospitalization)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Carry MG medical alert card or bracelet listing diagnosis and medications to avoid (aminoglycosides, fluoroquinolones, beta-blockers, magnesium)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Do not stop prednisone or immunosuppressants abruptly; sudden discontinuation may trigger exacerbation or adrenal crisis",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Take pyridostigmine 30-60 minutes before meals to improve swallowing and reduce choking risk during eating",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Report fever or signs of infection promptly as immunosuppression increases infection risk and infection can trigger MG exacerbation",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid extreme heat as high temperatures worsen neuromuscular transmission and increase weakness",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Do not drive if diplopia or ptosis impairs vision; symptoms may fluctuate throughout the day",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid overexertion; pace activities throughout the day with rest periods to manage fatigable weakness",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Report new medications (including over-the-counter) to neurologist before taking, as many common drugs worsen MG",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Women: Discuss pregnancy plans with MG specialist in advance as medication adjustments are needed before conception",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Contact Myasthenia Gravis Foundation of America (www.myasthenia.org) for patient support, educational resources, and community",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Report symptoms of cholinergic overdose: excessive secretions, diarrhea, cramping, muscle twitching, bradycardia (reduce pyridostigmine dose)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Medication reconciliation before any new prescription to avoid MG-exacerbating drugs; bring medication list to all appointments",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid live vaccines while on immunosuppression (azathioprine, mycophenolate, rituximab, high-dose steroids); inactivated vaccines are safe",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Annual influenza vaccine (inactivated) to prevent respiratory infections that can trigger exacerbation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Pneumococcal vaccination (PCV15 or PCV20 + PPSV23) before starting immunosuppression",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Aspiration precautions including upright positioning during and after meals, small bites, and avoiding mixed textures if bulbar symptoms present",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Energy conservation techniques including pacing activities, scheduled rest periods, and prioritizing important tasks for morning",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid smoking as respiratory infections worsen MG and smoking reduces treatment efficacy",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Limit alcohol intake as it can worsen weakness and interact with medications",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Stress management as psychological stress can trigger MG exacerbations",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Good sleep hygiene as fatigue and sleep deprivation worsen MG symptoms",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Wear medical alert identification listing MG diagnosis and medications to avoid in emergencies",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Weight management to reduce respiratory load and minimize steroid side effects",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Lambert-Eaton myasthenic syndrome (LEMS)",
        "features": "Proximal weakness improves with exercise; autonomic symptoms (dry mouth); SCLC association; areflexia",
        "tests": "VGCC antibody; EMG with incremental response; CT chest for malignancy"
      },
      {
        "diagnosis": "Botulism",
        "features": "Descending paralysis; fixed dilated pupils; GI symptoms; recent wound or food exposure",
        "tests": "Stool/serum toxin assay; EMG (incremental response); clinical history"
      },
      {
        "diagnosis": "Oculopharyngeal muscular dystrophy",
        "features": "Ptosis, dysphagia; slowly progressive; no fluctuation; onset >45 years; family history",
        "tests": "Genetic testing (GCN repeat in PABPN1); muscle biopsy"
      },
      {
        "diagnosis": "Thyroid eye disease",
        "features": "Proptosis; lid retraction (not ptosis); restrictive ophthalmopathy; thyroid dysfunction",
        "tests": "TSH, free T4; orbital CT/MRI (extraocular muscle enlargement)"
      },
      {
        "diagnosis": "Chronic progressive external ophthalmoplegia (CPEO)",
        "features": "Slowly progressive ptosis and ophthalmoparesis; no fluctuation; may have systemic features",
        "tests": "Muscle biopsy; mitochondrial DNA analysis; lactate"
      },
      {
        "diagnosis": "Miller Fisher syndrome",
        "features": "Ataxia, areflexia, ophthalmoplegia; post-infectious; acute onset",
        "tests": "Anti-GQ1b antibody; CSF (albuminocytologic dissociation)"
      },
      {
        "diagnosis": "Brainstem lesion (stroke, tumor, MS)",
        "features": "Cranial nerve palsies; other brainstem signs; no fatigability",
        "tests": "MRI brain with contrast"
      },
      {
        "diagnosis": "Guillain-Barre syndrome",
        "features": "Ascending weakness; areflexia; no fluctuation; sensory symptoms",
        "tests": "CSF (elevated protein); EMG/NCS (demyelinating pattern)"
      },
      {
        "diagnosis": "Amyotrophic lateral sclerosis (ALS)",
        "features": "Upper and lower motor neuron signs; fasciculations; no fatigability; progressive",
        "tests": "EMG (denervation); no antibodies; clinical criteria"
      },
      {
        "diagnosis": "Drug-induced myasthenia",
        "features": "Temporal relationship to D-penicillamine, checkpoint inhibitors, aminoglycosides",
        "tests": "Medication history; may have positive AChR antibodies"
      }
    ],
    "evidence": [
      {
        "recommendation": "Pyridostigmine for symptomatic treatment of MG",
        "evidenceLevel": "Class I, Level A",
        "source": "[Mehndiratta MM et al. Cochrane 2014](https://pubmed.ncbi.nlm.nih.gov/25304970/)"
      },
      {
        "recommendation": "Thymectomy improves outcomes in AChR+ generalized MG age 18-65",
        "evidenceLevel": "Class I, Level B",
        "source": "[Wolfe GI et al. NEJM 2016 (MGTX Trial)](https://pubmed.ncbi.nlm.nih.gov/27509100/)"
      },
      {
        "recommendation": "Corticosteroids effective for MG",
        "evidenceLevel": "Class II, Level B",
        "source": "[Schneider-Gold C et al. Cochrane 2005](https://pubmed.ncbi.nlm.nih.gov/16034852/)"
      },
      {
        "recommendation": "Azathioprine as steroid-sparing agent",
        "evidenceLevel": "Class I, Level B",
        "source": "[Palace J et al. NEJM 1998](https://pubmed.ncbi.nlm.nih.gov/9771070/)"
      },
      {
        "recommendation": "Mycophenolate mofetil in MG (mixed evidence)",
        "evidenceLevel": "Class II, Level B",
        "source": "[Sanders DB et al. Muscle Nerve 2016](https://pubmed.ncbi.nlm.nih.gov/27438060/)"
      },
      {
        "recommendation": "Rituximab effective in MuSK-positive MG",
        "evidenceLevel": "Class II, Level B",
        "source": "[Nowak RJ et al. Neurology 2022](https://pubmed.ncbi.nlm.nih.gov/34986310/)"
      },
      {
        "recommendation": "Rituximab in refractory AChR+ MG",
        "evidenceLevel": "Class II, Level C",
        "source": "[Tandan R et al. Muscle Nerve 2017](https://pubmed.ncbi.nlm.nih.gov/27463434/)"
      },
      {
        "recommendation": "Eculizumab for refractory generalized AChR+ MG",
        "evidenceLevel": "Class I, Level A",
        "source": "[Howard JF et al. Lancet Neurol 2017 (REGAIN)](https://pubmed.ncbi.nlm.nih.gov/28969986/)"
      },
      {
        "recommendation": "Efgartigimod for generalized AChR+ MG",
        "evidenceLevel": "Class I, Level A",
        "source": "[Howard JF et al. Lancet Neurol 2021 (ADAPT)](https://pubmed.ncbi.nlm.nih.gov/34146511/)"
      },
      {
        "recommendation": "Medications that exacerbate MG",
        "evidenceLevel": "Class III, Level C",
        "source": "[Juel VC. Semin Neurol 2004](https://pubmed.ncbi.nlm.nih.gov/15257515/)"
      },
      {
        "recommendation": "AAN/MGFA guidelines for MG management",
        "evidenceLevel": "Expert consensus",
        "source": "[Sanders DB et al. Neurology 2016](https://pubmed.ncbi.nlm.nih.gov/27386767/)"
      },
      {
        "recommendation": "Ocular MG: 50-80% generalize within 2 years",
        "evidenceLevel": "Class II, Level B",
        "source": "[Kupersmith MJ et al. Arch Neurol 2003](https://pubmed.ncbi.nlm.nih.gov/12975292/)"
      },
      {
        "recommendation": "Low-dose steroid initiation prevents worsening",
        "evidenceLevel": "Class II, Level B",
        "source": "[Pascuzzi RM. Semin Neurol 2003](https://pubmed.ncbi.nlm.nih.gov/12865163/)"
      },
      {
        "recommendation": "Anti-striated muscle antibody and thymoma association",
        "evidenceLevel": "Class II, Level B",
        "source": "[Romi F et al. Arch Neurol 2005](https://pubmed.ncbi.nlm.nih.gov/15956157/)"
      },
      {
        "recommendation": "Ravulizumab for generalized AChR+ MG",
        "evidenceLevel": "Class I, Level A",
        "source": "[Vu T et al. NEJM 2022 (CHAMPION-MG)](https://pubmed.ncbi.nlm.nih.gov/36129997/)"
      },
      {
        "recommendation": "Rozanolixizumab for generalized AChR+ MG",
        "evidenceLevel": "Class I, Level A",
        "source": "[Bril V et al. Lancet Neurol 2023](https://pubmed.ncbi.nlm.nih.gov/37385280/)"
      },
      {
        "recommendation": "Zilucoplan for generalized AChR+ MG",
        "evidenceLevel": "Class I, Level A",
        "source": "[Howard JF et al. Lancet Neurol 2023 (RAISE)](https://pubmed.ncbi.nlm.nih.gov/37863588/)"
      }
    ],
    "monitoring": [
      {
        "item": "**CLINICAL**"
      },
      {
        "item": "MG composite or QMG score",
        "frequency": "Every visit",
        "action": "Escalate therapy if worsening",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Forced vital capacity (FVC)",
        "frequency": "Baseline; q3-6 months if respiratory symptoms; urgent if symptoms worsen",
        "action": "If FVC declining: hospitalize, consider IVIg/PLEX",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT"
      },
      {
        "item": "Negative inspiratory force (NIF)",
        "frequency": "With FVC; if respiratory symptoms",
        "action": "If NIF >-20 cmH2O: crisis, intubate",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT"
      },
      {
        "item": "Swallow function",
        "frequency": "Each visit if bulbar symptoms",
        "action": "Modified diet; speech therapy; consider PEG if severe",
        "ED": "-",
        "HOSP": "URGENT",
        "OPD": "ROUTINE",
        "ICU": "URGENT"
      },
      {
        "item": "Weight",
        "frequency": "Each visit",
        "action": "Monitor steroid side effects; nutritional assessment if losing",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "**LABORATORY**"
      },
      {
        "item": "CBC with differential",
        "frequency": "Weekly x 4 then monthly x 3 then q3 months (azathioprine/MMF)",
        "action": "Hold immunosuppressant if low; may resume at lower dose",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "LFTs",
        "frequency": "Monthly x 3 then q3 months",
        "action": "Reduce dose or discontinue if >3x with symptoms",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Glucose",
        "frequency": "Weekly during steroid titration; q3 months on maintenance",
        "action": "Initiate diabetes treatment if elevated",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Blood pressure",
        "frequency": "Each visit",
        "action": "Antihypertensive if elevated",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "TPMT level/genotype",
        "frequency": "Once before azathioprine",
        "action": "Reduce dose 50% if intermediate; avoid if deficient",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Tacrolimus trough",
        "frequency": "Monthly if on tacrolimus",
        "action": "Dose adjustment",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Immunoglobulins (IgG, IgA, IgM)",
        "frequency": "Baseline; annually on rituximab or anti-CD20",
        "action": "Consider IVIG replacement if low and recurrent infections",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "B-cell count (CD19/CD20)",
        "frequency": "q3-6 months on rituximab",
        "action": "Guide re-dosing",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "**BONE HEALTH**"
      },
      {
        "item": "DEXA scan",
        "frequency": "Baseline; q1-2 years if on chronic steroids",
        "action": "Bisphosphonate if osteopenia/osteoporosis",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Vitamin D, 25-OH",
        "frequency": "Baseline; annually",
        "action": "Supplement if low",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      }
    ],
    "disposition": [
      {
        "disposition": "**Manage outpatient**",
        "criteria": "Stable ocular or mild generalized MG; FVC >60% and stable; able to swallow safely; no respiratory symptoms; reliable follow-up"
      },
      {
        "disposition": "**Admit to floor**",
        "criteria": "Moderate-severe worsening not requiring ICU; initiation of high-dose steroids with IVIg/PLEX coverage; significant bulbar symptoms with aspiration risk; FVC 30-60% and declining; new diagnosis with moderate severity"
      },
      {
        "disposition": "**Admit to ICU**",
        "criteria": "FVC <30% or rapidly declining; NIF weaker than -30 cmH2O; impending respiratory failure; severe bulbar dysfunction with aspiration; need for intubation or BiPAP"
      },
      {
        "disposition": "**Emergency evaluation**",
        "criteria": "Acute worsening of weakness; new respiratory symptoms (dyspnea, orthopnea); difficulty swallowing or speaking; recent infection or medication change with weakness; FVC declining on outpatient checks"
      },
      {
        "disposition": "**Transfer to MG center**",
        "criteria": "Refractory MG not responding to standard therapy; thymectomy evaluation; clinical trial consideration; complex immunotherapy decisions"
      }
    ]
  },
  "Amyotrophic Lateral Sclerosis (ALS) / Motor Neuron Disease": {
    "id": "als",
    "title": "Amyotrophic Lateral Sclerosis (ALS) / Motor Neuron Disease",
    "version": "1.0",
    "icd10": [
      "** G12.21 (Amyotrophic lateral sclerosis)"
    ],
    "scope": "** Comprehensive outpatient-focused management of ALS including diagnostic workup, El Escorial/Awaji criteria application, disease-modifying therapy (riluzole, edaravone, AMX0035), symptomatic management (sialorrhea, spasticity, pseudobulbar affect, pain, dyspnea), respiratory monitoring with BiPAP timing, nutritional support with PEG timing, multidisciplinary clinic model, and palliative care integration. Excludes primary lateral sclerosis (PLS), progressive muscular atrophy (PMA), and pediatric motor neuron disease.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC with differential",
            "rationale": "Baseline; exclude infection",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "CMP (BMP + LFTs)",
            "rationale": "Baseline; monitor for riluzole hepatotoxicity",
            "target": "Normal; ALT <3x ULN",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "TSH",
            "rationale": "Thyroid disease can mimic weakness",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Vitamin B12",
            "rationale": "B12 deficiency causes myelopathy",
            "target": ">300 pg/mL",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "CPK",
            "rationale": "Often mildly elevated in ALS; rule out myopathy",
            "target": "Mildly elevated OK; <5x ULN",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "ESR, CRP",
            "rationale": "Inflammatory markers",
            "target": "Normal or mildly elevated",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Hemoglobin A1c",
            "rationale": "Diabetic neuropathy in differential",
            "target": "<6.5%",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Fasting lipid panel",
            "rationale": "Cardiovascular risk assessment",
            "target": "LDL goal per guidelines",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Serum protein electrophoresis (SPEP)",
            "rationale": "Exclude monoclonal gammopathy",
            "target": "No monoclonal spike",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Urinalysis",
            "rationale": "Baseline; UTI assessment",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          }
        ],
        "Extended Workup": [
          {
            "item": "HIV",
            "rationale": "HIV-associated motor neuron disease",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Lyme serology (endemic areas)",
            "rationale": "Lyme disease causes neuropathy",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Copper and ceruloplasmin",
            "rationale": "Wilson disease in younger patients",
            "target": "Normal",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Parathyroid hormone (PTH)",
            "rationale": "Hyperparathyroidism causes weakness",
            "target": "Normal",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Anti-GM1 antibodies",
            "rationale": "Multifocal motor neuropathy (treatable mimic)",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Anti-MAG antibodies",
            "rationale": "Demyelinating neuropathy",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Lead level",
            "rationale": "Lead neuropathy mimics ALS",
            "target": "<10 mcg/dL",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "Hexosaminidase A",
            "rationale": "Adult Tay-Sachs (rare mimic)",
            "target": "Normal activity",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "Very long chain fatty acids",
            "rationale": "Adrenomyeloneuropathy (X-linked)",
            "target": "Normal",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "Serum immunofixation",
            "rationale": "Paraprotein-associated neuropathy",
            "target": "No monoclonal protein",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "SOD1 genetic testing",
            "rationale": "Familial ALS (10%); affects prognosis and therapy",
            "target": "Document mutation",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "C9orf72 repeat expansion",
            "rationale": "Most common familial ALS mutation; FTD link",
            "target": "<30 repeats normal",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "ALS gene panel (FUS, TARDBP, etc.)",
            "rationale": "Familial ALS with family history",
            "target": "Document variants",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "Muscle biopsy",
            "rationale": "Only if myopathy suspected",
            "target": "Neurogenic changes",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "CSF analysis",
            "rationale": "Atypical cases; exclude inflammatory",
            "target": "Protein mildly elevated OK",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "Anti-voltage-gated calcium channel Ab",
            "rationale": "Lambert-Eaton syndrome",
            "target": "Negative",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "Anti-acetylcholine receptor Ab",
            "rationale": "Myasthenia gravis",
            "target": "Negative",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "EMG with nerve conduction studies",
            "timing": "At diagnosis; within 2 weeks",
            "target": "Widespread denervation (3+ regions), fibrillations, fasciculations, chronic reinnervation; normal sensory studies",
            "contraindications": "Anticoagulation (relative)",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "MRI brain without contrast",
            "timing": "Exclude structural lesion",
            "target": "No mass, stroke, or demyelination",
            "contraindications": "Pacemaker",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "MRI cervical spine without contrast",
            "timing": "Exclude cervical myelopathy/radiculopathy",
            "target": "No cord compression; mild spondylosis OK",
            "contraindications": "Pacemaker",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Chest X-ray",
            "timing": "Baseline; aspiration screen",
            "target": "Clear or evidence of aspiration",
            "contraindications": "None",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Pulmonary function tests (FVC sitting and supine)",
            "timing": "Baseline respiratory status",
            "target": "FVC >80% predicted",
            "contraindications": "Severe bulbar dysfunction",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          }
        ],
        "Extended": [
          {
            "item": "MRI thoracic/lumbar spine",
            "timing": "If thoracic/lumbosacral symptoms predominant",
            "target": "Exclude cord compression",
            "contraindications": "Pacemaker",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Videofluoroscopic swallow study (VFSS)",
            "timing": "Bulbar symptoms; dysphagia",
            "target": "Quantify aspiration risk",
            "contraindications": "Severe aspiration (relative)",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Fiberoptic endoscopic evaluation of swallowing (FEES)",
            "timing": "Alternative to VFSS",
            "target": "Laryngeal function, aspiration",
            "contraindications": "Severe nasal obstruction",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Sleep study (polysomnography)",
            "timing": "Suspected nocturnal hypoventilation",
            "target": "Assess for REM hypoventilation, AHI",
            "contraindications": "None",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Sniff nasal inspiratory pressure (SNIP)",
            "timing": "More sensitive for bulbar patients",
            "target": ">40 cmH2O normal",
            "contraindications": "Nasal obstruction",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Arterial blood gas",
            "timing": "Acute respiratory failure",
            "target": "pH, pCO2, pO2",
            "contraindications": "Severe coagulopathy",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "EXT",
            "ICU": "STAT"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Transcranial magnetic stimulation (TMS)",
            "timing": "Research; UMN localization",
            "target": "Prolonged central motor conduction time",
            "contraindications": "Seizure history, pacemaker",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "PET-FDG brain",
            "timing": "Cognitive symptoms, FTD evaluation",
            "target": "Frontotemporal hypometabolism",
            "contraindications": "Unable to cooperate",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "Neuropsychological testing",
            "timing": "Cognitive concerns; FTD screening",
            "target": "Document cognitive profile",
            "contraindications": "Severe dysarthria (limited)",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Diaphragm ultrasound",
            "timing": "Assess diaphragm function",
            "target": "Reduced excursion",
            "contraindications": "None",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "EXT"
          },
          {
            "item": "Maximum inspiratory/expiratory pressure",
            "timing": "Additional respiratory metrics",
            "target": "MIP >60 cmH2O; MEP >40 cmH2O",
            "contraindications": "Poor mouth seal",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          }
        ]
      },
      "Treatment": {
        "Disease-Modifying Therapy": [
          {
            "item": "Riluzole (Rilutek)",
            "route": "PO",
            "indication": "Slows disease progression; extends survival 2-3 months",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg BID",
                  "orderSentence": "Riluzole (Rilutek) 50 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "50 mg PO BID; take 1 hour before or 2 hours after meals for best absorption",
              "orderSentence": "Riluzole (Rilutek) 50 mg BID PO"
            },
            "pretreatment": "Baseline LFTs",
            "contraindications": "ALT >5x ULN; hepatic impairment",
            "monitoring": "LFTs monthly x 3 months, then q3 months; CBC if neutropenia suspected",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Edaravone (Radicava) - IV formulation",
            "route": "IV",
            "indication": "Antioxidant; slows functional decline in selected patients",
            "dosing": {
              "doseOptions": [
                {
                  "text": "60 mg IV daily",
                  "orderSentence": "Edaravone (Radicava) - IV formulation 60 mg IV daily IV"
                }
              ],
              "route": "IV",
              "instructions": "Initial cycle: 60 mg IV daily x 14 days, then 14 days off; subsequent cycles: 60 mg IV daily x 10 of 14 days, then 14 days off",
              "orderSentence": "Edaravone (Radicava) - IV formulation 60 mg IV daily IV"
            },
            "pretreatment": "Baseline renal function, IV access established",
            "contraindications": "Hypersensitivity to edaravone or sodium bisulfite",
            "monitoring": "Infusion reactions; renal function; gait (sulfite sensitivity)",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Edaravone oral suspension (Radicava ORS)",
            "route": "PO",
            "indication": "Oral alternative to IV edaravone",
            "dosing": {
              "doseOptions": [
                {
                  "text": "105 mg daily",
                  "orderSentence": "Edaravone oral suspension (Radicava ORS) 105 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Initial cycle: 105 mg PO daily x 14 days, then 14 days off; subsequent cycles: 105 mg PO daily x 10 of 14 days, then 14 days off",
              "orderSentence": "Edaravone oral suspension (Radicava ORS) 105 mg daily PO"
            },
            "pretreatment": "Baseline renal function",
            "contraindications": "Hypersensitivity to edaravone or sodium bisulfite",
            "monitoring": "Same as IV formulation",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "AMX0035 / Relyvrio (sodium phenylbutyrate-taurursodiol)",
            "route": "PO",
            "indication": "Slows functional decline; extends survival",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 packet daily",
                  "orderSentence": "AMX0035 / Relyvrio (sodium phenylbutyrate-taurursodiol) 1 packet daily PO"
                },
                {
                  "text": "then 1 packet BID",
                  "orderSentence": "AMX0035 / Relyvrio (sodium phenylbutyrate-taurursodiol) then 1 packet BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Week 1: 1 packet (3g sodium phenylbutyrate + 1g taurursodiol) mixed in 8 oz room temp water daily; Week 2+: 1 packet BID",
              "orderSentence": "AMX0035 / Relyvrio (sodium phenylbutyrate-taurursodiol) 1 packet daily PO"
            },
            "pretreatment": "Baseline LFTs; assess swallowing",
            "contraindications": "Known hypersensitivity; disorders of urea cycle",
            "monitoring": "GI side effects (diarrhea, nausea); LFTs q3 months",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Tofersen (Qalsody) - for SOD1 mutations",
            "route": "IT",
            "indication": "SOD1-ALS only; reduces SOD1 protein",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg monthly after loading",
                  "orderSentence": "Tofersen (Qalsody) - for SOD1 mutations 100 mg monthly after loading IT"
                }
              ],
              "route": "IT",
              "instructions": "Loading: 100 mg IT on Days 1, 15, 29; Maintenance: 100 mg IT q28 days",
              "orderSentence": "Tofersen (Qalsody) - for SOD1 mutations 100 mg monthly after loading IT"
            },
            "pretreatment": "SOD1 gene mutation confirmed; lumbar access",
            "contraindications": "No SOD1 mutation; contraindication to IT injection",
            "monitoring": "Neurofilament levels; CSF analysis; myelopathy monitoring",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          }
        ],
        "Symptomatic Treatments": [
          {
            "item": "Glycopyrrolate",
            "route": "PO",
            "indication": "Sialorrhea (excess saliva)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 mg TID",
                  "orderSentence": "Glycopyrrolate 1 mg TID PO"
                },
                {
                  "text": "2 mg TID",
                  "orderSentence": "Glycopyrrolate 2 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 1 mg PO TID; may increase to 2 mg TID; max 8 mg/day",
              "orderSentence": "Glycopyrrolate 1 mg TID PO"
            },
            "contraindications": "Narrow-angle glaucoma; urinary retention; GI obstruction",
            "monitoring": "Dry mouth (paradoxical thick secretions), constipation, urinary retention",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Atropine 1% ophthalmic drops (sublingual)",
            "route": "SL",
            "indication": "Sialorrhea (rescue)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1-2 drops q4-6h PRN",
                  "orderSentence": "Atropine 1% ophthalmic drops (sublingual) 1-2 drops q4-6h PRN SL"
                }
              ],
              "route": "SL",
              "instructions": "1-2 drops sublingual q4-6h as needed; max 4 doses/day",
              "orderSentence": "Atropine 1% ophthalmic drops (sublingual) 1-2 drops q4-6h PRN SL"
            },
            "contraindications": "Narrow-angle glaucoma; cardiac arrhythmia",
            "monitoring": "HR, dry mouth, urinary retention",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Scopolamine transdermal patch",
            "route": "TOP",
            "indication": "Sialorrhea (continuous)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1.5 mg patch q72h",
                  "orderSentence": "Scopolamine transdermal patch 1.5 mg patch q72h TOP"
                }
              ],
              "route": "TOP",
              "instructions": "Apply 1.5 mg patch behind ear; replace every 72 hours",
              "orderSentence": "Scopolamine transdermal patch 1.5 mg patch q72h TOP"
            },
            "contraindications": "Narrow-angle glaucoma; urinary retention; GI obstruction",
            "monitoring": "Confusion (especially elderly), dry mouth, constipation",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Botulinum toxin A (salivary gland injection)",
            "route": "IM",
            "indication": "Refractory sialorrhea",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30-50 units per parotid",
                  "orderSentence": "Botulinum toxin A (salivary gland injection) 30-50 units per parotid IM"
                },
                {
                  "text": "10-20 units per submandibular",
                  "orderSentence": "Botulinum toxin A (salivary gland injection) 10-20 units per submandibular IM"
                }
              ],
              "route": "IM",
              "instructions": "30-50 units per parotid gland + 10-20 units per submandibular gland (total 80-140 units); effects last 3-4 months",
              "orderSentence": "Botulinum toxin A (salivary gland injection) 30-50 units per parotid IM"
            },
            "contraindications": "Hypersensitivity; neuromuscular disease (use cautiously)",
            "monitoring": "Dysphagia worsening (rare); dry mouth",
            "ED": "—",
            "HOSP": "—",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Dextromethorphan-quinidine (Nuedexta)",
            "route": "PO",
            "indication": "Pseudobulbar affect (PBA)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20/10 mg daily",
                  "orderSentence": "Dextromethorphan-quinidine (Nuedexta) 20/10 mg daily PO"
                },
                {
                  "text": "20/10 mg BID",
                  "orderSentence": "Dextromethorphan-quinidine (Nuedexta) 20/10 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 20/10 mg (DM/Q) daily x 7 days, then increase to 20/10 mg BID",
              "orderSentence": "Dextromethorphan-quinidine (Nuedexta) 20/10 mg daily PO"
            },
            "contraindications": "QT prolongation; concurrent quinidine or CYP2D6 substrates; hepatic impairment",
            "monitoring": "Baseline ECG; QTc monitoring; avoid with other QT-prolonging drugs",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Baclofen",
            "route": "PO",
            "indication": "Spasticity",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg TID",
                  "orderSentence": "Baclofen 5 mg TID PO"
                },
                {
                  "text": "10 mg TID",
                  "orderSentence": "Baclofen 10 mg TID PO"
                },
                {
                  "text": "20 mg TID",
                  "orderSentence": "Baclofen 20 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg PO TID; increase by 5 mg/dose q3 days; max 80 mg/day in divided doses",
              "orderSentence": "Baclofen 5 mg TID PO"
            },
            "contraindications": "Abrupt withdrawal (risk of seizures, hallucinations)",
            "monitoring": "Sedation, weakness (may unmask underlying weakness); taper to discontinue",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Tizanidine",
            "route": "PO",
            "indication": "Spasticity (alternative to baclofen)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 mg qHS",
                  "orderSentence": "Tizanidine 2 mg qHS PO"
                },
                {
                  "text": "4 mg TID",
                  "orderSentence": "Tizanidine 4 mg TID PO"
                },
                {
                  "text": "8 mg TID",
                  "orderSentence": "Tizanidine 8 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 2 mg qHS; may increase by 2-4 mg q6-8h; max 36 mg/day",
              "orderSentence": "Tizanidine 2 mg qHS PO"
            },
            "contraindications": "Concurrent CYP1A2 inhibitors (ciprofloxacin, fluvoxamine); hepatic impairment",
            "monitoring": "LFTs at baseline, 1 month, 3 months; sedation, hypotension, dry mouth",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Gabapentin",
            "route": "PO",
            "indication": "Muscle cramps; neuropathic pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg qHS",
                  "orderSentence": "Gabapentin 300 mg qHS PO"
                },
                {
                  "text": "300 mg TID",
                  "orderSentence": "Gabapentin 300 mg TID PO"
                },
                {
                  "text": "600 mg TID",
                  "orderSentence": "Gabapentin 600 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 300 mg qHS; titrate by 300 mg/day q1-3 days; max 3600 mg/day divided TID",
              "orderSentence": "Gabapentin 300 mg qHS PO"
            },
            "contraindications": "Severe renal impairment (adjust dose)",
            "monitoring": "Sedation, dizziness; reduce dose if CrCl <60",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Mexiletine",
            "route": "PO",
            "indication": "Muscle cramps (refractory)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "150 mg BID",
                  "orderSentence": "Mexiletine 150 mg BID PO"
                },
                {
                  "text": "300 mg BID",
                  "orderSentence": "Mexiletine 300 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 150 mg PO BID; may increase to 300 mg BID; max 1200 mg/day",
              "orderSentence": "Mexiletine 150 mg BID PO"
            },
            "contraindications": "Cardiogenic shock; 2nd/3rd degree AV block without pacemaker",
            "monitoring": "Baseline ECG; monitor for arrhythmia; GI upset",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Quinine sulfate",
            "route": "PO",
            "indication": "Muscle cramps (limited use)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "200-300 mg qHS",
                  "orderSentence": "Quinine sulfate 200-300 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "200-300 mg PO at bedtime; FDA warns against off-label use for cramps",
              "orderSentence": "Quinine sulfate 200-300 mg qHS PO"
            },
            "contraindications": "Thrombocytopenia; G6PD deficiency; prolonged QT; myasthenia",
            "monitoring": "CBC, cardiac rhythm; FDA black box warning for thrombocytopenia",
            "ED": "—",
            "HOSP": "—",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "Lorazepam",
            "route": "PO/SL",
            "indication": "Anxiety; dyspnea (end of life)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5 mg BID PRN",
                  "orderSentence": "Lorazepam 0.5 mg BID PRN PO/SL"
                },
                {
                  "text": "1 mg TID PRN",
                  "orderSentence": "Lorazepam 1 mg TID PRN PO/SL"
                }
              ],
              "route": "PO/SL",
              "instructions": "0.5-1 mg PO/SL q8h PRN for anxiety or dyspnea; use low doses due to respiratory depression risk",
              "orderSentence": "Lorazepam 0.5 mg BID PRN PO/SL"
            },
            "contraindications": "Severe respiratory insufficiency (relative); acute narrow-angle glaucoma",
            "monitoring": "Respiratory status, sedation; paradoxical agitation",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Morphine",
            "route": "PO/SL",
            "indication": "Dyspnea (palliative)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2.5 mg q4h PRN",
                  "orderSentence": "Morphine 2.5 mg q4h PRN PO/SL"
                },
                {
                  "text": "5 mg q4h PRN",
                  "orderSentence": "Morphine 5 mg q4h PRN PO/SL"
                }
              ],
              "route": "PO/SL",
              "instructions": "Start 2.5-5 mg PO/SL q4h PRN for dyspnea; titrate to comfort; may reduce respiratory distress without significantly worsening ventilation",
              "orderSentence": "Morphine 2.5 mg q4h PRN PO/SL"
            },
            "contraindications": "Active respiratory failure without comfort focus",
            "monitoring": "Respiratory rate, comfort, sedation",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Modafinil",
            "route": "PO",
            "indication": "Fatigue",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg qAM",
                  "orderSentence": "Modafinil 100 mg qAM PO"
                },
                {
                  "text": "200 mg qAM",
                  "orderSentence": "Modafinil 200 mg qAM PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 100 mg PO every morning; may increase to 200 mg; avoid afternoon dosing",
              "orderSentence": "Modafinil 100 mg qAM PO"
            },
            "contraindications": "Hypersensitivity; cardiac arrhythmia",
            "monitoring": "Headache, insomnia, cardiac monitoring if history",
            "ED": "—",
            "HOSP": "—",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Amitriptyline",
            "route": "PO",
            "indication": "Sialorrhea; insomnia; depression",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg qHS",
                  "orderSentence": "Amitriptyline 10 mg qHS PO"
                },
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Amitriptyline 25 mg qHS PO"
                },
                {
                  "text": "50 mg qHS",
                  "orderSentence": "Amitriptyline 50 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10 mg PO qHS; increase by 10 mg weekly; max 75-100 mg qHS",
              "orderSentence": "Amitriptyline 10 mg qHS PO"
            },
            "contraindications": "Cardiac conduction abnormality; recent MI; urinary retention",
            "monitoring": "ECG if dose >50 mg; anticholinergic effects; sedation",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Sertraline",
            "route": "PO",
            "indication": "Depression; anxiety",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg daily",
                  "orderSentence": "Sertraline 25 mg daily PO"
                },
                {
                  "text": "50 mg daily",
                  "orderSentence": "Sertraline 50 mg daily PO"
                },
                {
                  "text": "100 mg daily",
                  "orderSentence": "Sertraline 100 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg PO daily; increase by 25-50 mg q1-2 weeks; max 200 mg/day",
              "orderSentence": "Sertraline 25 mg daily PO"
            },
            "contraindications": "Concurrent MAOIs; caution with QT-prolonging drugs",
            "monitoring": "Suicidality (first weeks), GI upset, sexual dysfunction",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          }
        ],
        "Respiratory Support": [
          {
            "item": "BiPAP (noninvasive ventilation)",
            "route": "INH",
            "indication": "FVC <50% predicted OR symptoms of nocturnal hypoventilation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "IPAP 8-12 cmH2O",
                  "orderSentence": "BiPAP (noninvasive ventilation) IPAP 8-12 cmH2O INH"
                },
                {
                  "text": "EPAP 4-6 cmH2O",
                  "orderSentence": "BiPAP (noninvasive ventilation) EPAP 4-6 cmH2O INH"
                }
              ],
              "route": "INH",
              "instructions": "Start with nocturnal use; IPAP 8-12, EPAP 4-6; titrate for comfort; increase time as tolerated; extend to daytime as needed",
              "orderSentence": "BiPAP (noninvasive ventilation) IPAP 8-12 cmH2O INH"
            },
            "contraindications": "Severe bulbar dysfunction with aspiration (relative); inability to clear secretions",
            "monitoring": "Comfort, adherence, transcutaneous CO2 or ABG, mask fit",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Mechanical insufflation-exsufflation (Cough Assist)",
            "route": "—",
            "indication": "Weak cough; peak cough flow <270 L/min",
            "dosing": {
              "doseOptions": [
                {
                  "text": "+40/-40 cmH2O",
                  "orderSentence": "Mechanical insufflation-exsufflation (Cough Assist) +40/-40 cmH2O —"
                }
              ],
              "route": "—",
              "instructions": "Set insufflation +40 cmH2O, exsufflation -40 cmH2O; 2-4 cycles per session; 2-4 sessions daily; use before meals and PRN",
              "orderSentence": "Mechanical insufflation-exsufflation (Cough Assist) +40/-40 cmH2O —"
            },
            "contraindications": "Bullous emphysema; pneumothorax",
            "monitoring": "Secretion clearance, respiratory status",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Portable suction",
            "route": "—",
            "indication": "Secretion management",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Portable suction N/A —"
                }
              ],
              "route": "—",
              "instructions": "Oral or pharyngeal suction PRN for secretion management",
              "orderSentence": "Portable suction N/A —"
            },
            "contraindications": "None",
            "monitoring": "Secretion burden, mucosal trauma",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Oxygen supplementation",
            "route": "INH",
            "indication": "Hypoxemia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1-4 L/min NC PRN",
                  "orderSentence": "Oxygen supplementation 1-4 L/min NC PRN INH"
                }
              ],
              "route": "INH",
              "instructions": "Use cautiously; O2 may suppress respiratory drive; BiPAP preferred; use only for hypoxemia with BiPAP",
              "orderSentence": "Oxygen supplementation 1-4 L/min NC PRN INH"
            },
            "contraindications": "May suppress respiratory drive in hypercapnic patients",
            "monitoring": "SpO2, pCO2, respiratory rate",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Diaphragm pacing (NeuRx)",
            "route": "—",
            "indication": "Diaphragm weakness",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Surgical implantation",
                  "orderSentence": "Diaphragm pacing (NeuRx) Surgical implantation —"
                }
              ],
              "route": "—",
              "instructions": "Laparoscopic implantation of intramuscular diaphragm electrodes; controversial efficacy; FDA approved but limited evidence",
              "orderSentence": "Diaphragm pacing (NeuRx) Surgical implantation —"
            },
            "contraindications": "Severe diaphragm atrophy; unable to tolerate surgery",
            "monitoring": "Diaphragm function, surgical complications",
            "ED": "—",
            "HOSP": "—",
            "OPD": "EXT",
            "ICU": "—"
          }
        ],
        "Nutritional Support": [
          {
            "item": "Oral nutritional supplements",
            "route": "PO",
            "indication": "Weight loss; inadequate oral intake",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1-3 supplements daily",
                  "orderSentence": "Oral nutritional supplements 1-3 supplements daily PO"
                }
              ],
              "route": "PO",
              "instructions": "High-calorie, high-protein supplements (e.g., Ensure Plus, Boost Plus) 1-3 daily between meals",
              "orderSentence": "Oral nutritional supplements 1-3 supplements daily PO"
            },
            "contraindications": "Aspiration risk",
            "monitoring": "Weight, caloric intake, albumin",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Thickened liquids",
            "route": "PO",
            "indication": "Dysphagia with thin liquid aspiration",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Nectar to honey thick consistency",
                  "orderSentence": "Thickened liquids Nectar to honey thick consistency PO"
                }
              ],
              "route": "PO",
              "instructions": "Thicken all thin liquids per SLP recommendation; nectar, honey, or pudding thick consistency",
              "orderSentence": "Thickened liquids Nectar to honey thick consistency PO"
            },
            "contraindications": "None",
            "monitoring": "Hydration status, swallow function",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Percutaneous endoscopic gastrostomy (PEG)",
            "route": "—",
            "indication": "Dysphagia with weight loss >10% or FVC declining toward 50%",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Percutaneous endoscopic gastrostomy (PEG) N/A —"
                }
              ],
              "route": "—",
              "instructions": "Place electively when FVC >50% predicted; allows continued oral intake for pleasure; start tube feeds gradually",
              "orderSentence": "Percutaneous endoscopic gastrostomy (PEG) N/A —"
            },
            "contraindications": "FVC <50% (higher risk; consider RIG or PIG); severe coagulopathy",
            "monitoring": "Weight, tube site, aspiration",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Radiologically-inserted gastrostomy (RIG)",
            "route": "—",
            "indication": "PEG contraindicated; FVC <50%",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Radiologically-inserted gastrostomy (RIG) N/A —"
                }
              ],
              "route": "—",
              "instructions": "Alternative to PEG when FVC <50% or unable to tolerate endoscopy; fluoroscopic placement",
              "orderSentence": "Radiologically-inserted gastrostomy (RIG) N/A —"
            },
            "contraindications": "Severe ascites; peritoneal adhesions",
            "monitoring": "Weight, tube site",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Per-oral image-guided gastrostomy (PIG)",
            "route": "—",
            "indication": "Alternative to PEG/RIG",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Per-oral image-guided gastrostomy (PIG) N/A —"
                }
              ],
              "route": "—",
              "instructions": "Transoral placement under endoscopic and radiologic guidance; may tolerate lower FVC",
              "orderSentence": "Per-oral image-guided gastrostomy (PIG) N/A —"
            },
            "contraindications": "Same as RIG",
            "monitoring": "Weight, tube site",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "—"
          }
        ],
        "Acute/Emergent Care": [
          {
            "item": "Noninvasive ventilation (acute)",
            "route": "INH",
            "indication": "Acute respiratory failure",
            "dosing": {
              "doseOptions": [
                {
                  "text": "IPAP 12-20",
                  "orderSentence": "Noninvasive ventilation (acute) IPAP 12-20 INH"
                },
                {
                  "text": "EPAP 5-8",
                  "orderSentence": "Noninvasive ventilation (acute) EPAP 5-8 INH"
                }
              ],
              "route": "INH",
              "instructions": "IPAP 12-20 cmH2O, EPAP 5-8 cmH2O; FiO2 to maintain SpO2 >92%; close monitoring for escalation",
              "orderSentence": "Noninvasive ventilation (acute) IPAP 12-20 INH"
            },
            "contraindications": "Inability to protect airway; hemodynamic instability",
            "monitoring": "ABG, respiratory rate, work of breathing",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Intubation and mechanical ventilation",
            "route": "—",
            "indication": "Respiratory failure not responding to NIV",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Intubation and mechanical ventilation N/A —"
                }
              ],
              "route": "—",
              "instructions": "Discuss advance directives; many ALS patients decline invasive ventilation; if desired, standard intubation and ventilation",
              "orderSentence": "Intubation and mechanical ventilation N/A —"
            },
            "contraindications": "Patient declines; DNI documented",
            "monitoring": "Ventilator parameters, sedation",
            "ED": "STAT",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "IV fluids",
            "route": "IV",
            "indication": "Dehydration",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000-2000 mL NS or LR daily",
                  "orderSentence": "IV fluids 1000-2000 mL NS or LR daily IV"
                }
              ],
              "route": "IV",
              "instructions": "1-2 L IV daily; adjust for cardiac status",
              "orderSentence": "IV fluids 1000-2000 mL NS or LR daily IV"
            },
            "contraindications": "Fluid overload",
            "monitoring": "I/O, electrolytes, edema",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Empiric antibiotics (aspiration pneumonia)",
            "route": "IV",
            "indication": "Suspected aspiration pneumonia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Ampicillin-sulbactam 3g IV q6h",
                  "orderSentence": "Empiric antibiotics (aspiration pneumonia) Ampicillin-sulbactam 3g IV q6h IV"
                }
              ],
              "route": "IV",
              "instructions": "3g IV q6h; alternative: piperacillin-tazobactam 4.5g q6h; cover oral flora and anaerobes",
              "orderSentence": "Empiric antibiotics (aspiration pneumonia) Ampicillin-sulbactam 3g IV q6h IV"
            },
            "contraindications": "Allergies",
            "monitoring": "WBC, fever curve, respiratory status",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurology (ALS specialist/multidisciplinary clinic) for diagnosis confirmation, disease-modifying therapy, and comprehensive management coordination",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Pulmonology for respiratory function monitoring, BiPAP initiation, and ventilator management decisions",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Physical therapy for mobility assessment, strengthening (submaximal), range of motion, and assistive device prescription",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Occupational therapy for ADL assessment, adaptive equipment, energy conservation, and home modification",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Speech-language pathology for swallow evaluation, communication strategies, and AAC device assessment",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Respiratory therapy for BiPAP setup and titration, cough assist training, and secretion management",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Nutrition/dietitian for caloric needs assessment, weight optimization, and tube feeding management",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Palliative care for symptom management, goals of care discussions, and quality of life optimization",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Social work for financial resources (SSDI, Medicaid), caregiver support, and ALS Association resources",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Psychiatry/psychology for depression, anxiety, and adjustment disorder common in ALS",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Gastroenterology for PEG placement when FVC declining toward 50% or significant dysphagia",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Hospice care for end-of-life care when prognosis <6 months and/or patient declines aggressive interventions",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Genetic counseling for familial ALS, gene testing interpretation, and family planning implications",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Return immediately for increased shortness of breath, choking episodes, or inability to clear secretions (may indicate respiratory failure requiring urgent intervention)",
            "ED": "STAT",
            "HOSP": "—",
            "OPD": "STAT"
          },
          {
            "item": "Return for fever, worsening cough, or change in sputum color (may indicate aspiration pneumonia)",
            "ED": "STAT",
            "HOSP": "—",
            "OPD": "STAT"
          },
          {
            "item": "Do not drive if experiencing significant weakness or fatigue that could impair vehicle control",
            "ED": "URGENT",
            "HOSP": "—",
            "OPD": "ROUTINE"
          },
          {
            "item": "Continue eating foods that are safe to swallow; use thickened liquids if recommended by speech therapy",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Use BiPAP as prescribed, even if initially uncomfortable; adherence improves symptoms and survival",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Perform prescribed exercises but avoid exhaustion; rest before becoming overly fatigued",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Complete advance directives including healthcare proxy, living will, and decisions about mechanical ventilation and feeding tubes",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Contact ALS Association (www.als.org) for educational resources, support groups, and equipment loan programs",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Attend multidisciplinary ALS clinic visits every 2-3 months for comprehensive care coordination",
            "ED": "—",
            "HOSP": "—",
            "OPD": "ROUTINE"
          },
          {
            "item": "Consider joining ALS research registries and clinical trials (www.clinicaltrials.gov)",
            "ED": "—",
            "HOSP": "—",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Aspiration precautions including upright positioning during meals, small bites, and chin-tuck swallowing technique",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Energy conservation with scheduled rest periods and prioritization of activities to reduce fatigue",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Home safety evaluation to remove fall hazards, install grab bars, and ensure wheelchair accessibility",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Maintain optimal nutrition with high-calorie, high-protein diet; weight loss accelerates decline",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Sleep with head of bed elevated 30 degrees if using BiPAP or experiencing orthopnea",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Smoking cessation is essential to optimize respiratory function and reduce aspiration risk",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Limit alcohol as it may worsen weakness, sedation, and respiratory depression",
            "ED": "—",
            "HOSP": "—",
            "OPD": "ROUTINE"
          },
          {
            "item": "Frequent repositioning if immobile to prevent pressure ulcers",
            "ED": "—",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Emotional and spiritual support for patient and caregivers; caregiver burnout is common",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Consider assistive technology early (voice banking, eye-tracking devices) before speech becomes unintelligible",
            "ED": "—",
            "HOSP": "—",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Cervical spondylotic myelopathy",
        "features": "Sensory level, bladder dysfunction, neck pain; UMN signs only",
        "tests": "MRI cervical spine shows cord compression"
      },
      {
        "diagnosis": "Multifocal motor neuropathy (MMN)",
        "features": "Pure LMN; treatable with IVIg; no UMN signs; asymmetric",
        "tests": "Anti-GM1 antibodies; NCS shows conduction block"
      },
      {
        "diagnosis": "Kennedy disease (SBMA)",
        "features": "X-linked; gynecomastia; sensory involvement; slower progression",
        "tests": "Androgen receptor gene CAG repeat expansion"
      },
      {
        "diagnosis": "Primary lateral sclerosis (PLS)",
        "features": "Pure UMN for >4 years; no LMN signs; slower progression",
        "tests": "EMG normal; clinical course"
      },
      {
        "diagnosis": "Progressive muscular atrophy (PMA)",
        "features": "Pure LMN; no UMN signs; may evolve to ALS",
        "tests": "EMG; clinical follow-up"
      },
      {
        "diagnosis": "Myasthenia gravis",
        "features": "Fatigable weakness; ptosis, diplopia; reflexes preserved",
        "tests": "AChR antibodies; RNS decrement; edrophonium test"
      },
      {
        "diagnosis": "Lambert-Eaton myasthenic syndrome",
        "features": "Proximal weakness; autonomic symptoms; improves with exercise",
        "tests": "Anti-VGCC antibodies; RNS increment"
      },
      {
        "diagnosis": "Inclusion body myositis (IBM)",
        "features": "Finger flexor and quadriceps weakness; older males; inflammatory",
        "tests": "Muscle biopsy; CPK mildly elevated"
      },
      {
        "diagnosis": "Post-polio syndrome",
        "features": "History of polio; new weakness in previously affected limbs",
        "tests": "Clinical history; EMG"
      },
      {
        "diagnosis": "Hirayama disease",
        "features": "Young males; asymmetric hand weakness; self-limited",
        "tests": "Cervical MRI in flexion shows posterior dural detachment"
      },
      {
        "diagnosis": "Monomelic amyotrophy",
        "features": "Unilateral limb LMN findings; non-progressive after years",
        "tests": "EMG limited to one limb; clinical course"
      },
      {
        "diagnosis": "Hereditary spastic paraplegia",
        "features": "Pure UMN; family history; sensory neuropathy in some types",
        "tests": "Genetic testing"
      },
      {
        "diagnosis": "Adrenomyeloneuropathy",
        "features": "X-linked; adrenal insufficiency; sensory neuropathy",
        "tests": "Very long chain fatty acids elevated"
      },
      {
        "diagnosis": "Hexosaminidase A deficiency",
        "features": "Early onset; may have psychiatric symptoms; Jewish ancestry",
        "tests": "Hexosaminidase A enzyme level"
      },
      {
        "diagnosis": "Copper deficiency myelopathy",
        "features": "Sensory ataxia; prior gastric surgery; anemia",
        "tests": "Serum copper and ceruloplasmin low"
      }
    ],
    "evidence": [
      {
        "recommendation": "Riluzole extends survival by 2-3 months",
        "evidenceLevel": "Class I, Level A",
        "source": "[Bensimon et al. NEJM 1994](https://pubmed.ncbi.nlm.nih.gov/8302340/); [Miller et al. Cochrane 2012](https://pubmed.ncbi.nlm.nih.gov/22419278/)"
      },
      {
        "recommendation": "El Escorial diagnostic criteria",
        "evidenceLevel": "Consensus, Level U",
        "source": "[Brooks et al. ALS Other Motor Neuron Disord 2000](https://pubmed.ncbi.nlm.nih.gov/11464847/)"
      },
      {
        "recommendation": "Awaji-shima criteria enhance diagnostic sensitivity",
        "evidenceLevel": "Class III, Level C",
        "source": "[de Carvalho et al. Clin Neurophysiol 2008](https://pubmed.ncbi.nlm.nih.gov/18024169/)"
      },
      {
        "recommendation": "BiPAP improves survival and quality of life",
        "evidenceLevel": "Class I, Level A",
        "source": "[Bourke et al. Lancet Neurol 2006](https://pubmed.ncbi.nlm.nih.gov/16545749/)"
      },
      {
        "recommendation": "Early PEG placement (FVC >50%) safer than late",
        "evidenceLevel": "Class II, Level B",
        "source": "[ProGas Study Group. Lancet Neurol 2015](https://pubmed.ncbi.nlm.nih.gov/25476873/)"
      },
      {
        "recommendation": "Multidisciplinary clinics improve survival 7-10 months",
        "evidenceLevel": "Class II, Level B",
        "source": "[Van den Berg et al. Lancet Neurol 2005](https://pubmed.ncbi.nlm.nih.gov/16109360/)"
      },
      {
        "recommendation": "Dextromethorphan-quinidine for pseudobulbar affect",
        "evidenceLevel": "Class I, Level A",
        "source": "[Brooks et al. Neurology 2004](https://pubmed.ncbi.nlm.nih.gov/15365143/)"
      },
      {
        "recommendation": "Edaravone slows functional decline in selected patients",
        "evidenceLevel": "Class I, Level B",
        "source": "[Writing Group. Lancet Neurol 2017](https://pubmed.ncbi.nlm.nih.gov/28522181/)"
      },
      {
        "recommendation": "AMX0035 (Relyvrio) slows ALSFRS-R decline",
        "evidenceLevel": "Class II, Level B",
        "source": "[Paganoni et al. NEJM 2020](https://pubmed.ncbi.nlm.nih.gov/32897034/)"
      },
      {
        "recommendation": "Tofersen reduces SOD1 in SOD1-ALS",
        "evidenceLevel": "Class I, Level B",
        "source": "[Miller et al. NEJM 2022](https://pubmed.ncbi.nlm.nih.gov/35363263/)"
      },
      {
        "recommendation": "Glycopyrrolate effective for sialorrhea",
        "evidenceLevel": "Class II, Level B",
        "source": "[Arbouw et al. J Neurol 2010](https://pubmed.ncbi.nlm.nih.gov/19943165/)"
      },
      {
        "recommendation": "Botulinum toxin for refractory sialorrhea",
        "evidenceLevel": "Class II, Level B",
        "source": "[Jackson et al. ALS FTD 2009](https://pubmed.ncbi.nlm.nih.gov/19929742/)"
      },
      {
        "recommendation": "C9orf72 most common genetic cause",
        "evidenceLevel": "Class II, Level B",
        "source": "[DeJesus-Hernandez et al. Neuron 2011](https://pubmed.ncbi.nlm.nih.gov/21944778/)"
      },
      {
        "recommendation": "ALSFRS-R validated outcome measure",
        "evidenceLevel": "Class II, Level B",
        "source": "[Cedarbaum et al. J Neurol Sci 1999](https://pubmed.ncbi.nlm.nih.gov/10540002/)"
      },
      {
        "recommendation": "Early palliative care improves quality of life",
        "evidenceLevel": "Class I, Level A",
        "source": "[Temel et al. NEJM 2010](https://pubmed.ncbi.nlm.nih.gov/20818875/) (oncology; extrapolated)"
      },
      {
        "recommendation": "FVC and NIF for respiratory monitoring",
        "evidenceLevel": "Class II, Level B",
        "source": "[Lechtzin et al. ALS Other Motor Neuron Disord 2002](https://pubmed.ncbi.nlm.nih.gov/12430545/)"
      },
      {
        "recommendation": "Cough assist improves secretion clearance",
        "evidenceLevel": "Class III, Level C",
        "source": "[Sancho et al. ALS Other Motor Neuron Disord 2004](https://pubmed.ncbi.nlm.nih.gov/15512884/)"
      },
      {
        "recommendation": "AAN Practice Parameters for ALS",
        "evidenceLevel": "Guideline",
        "source": "[Miller et al. Neurology 2009](https://pubmed.ncbi.nlm.nih.gov/19770405/)"
      }
    ],
    "monitoring": [
      {
        "item": "Forced vital capacity (FVC) sitting and supine",
        "frequency": "Every clinic visit (q2-3 months); more often if declining",
        "action": "Initiate BiPAP when <50% or symptoms; discuss PEG when declining toward 50%",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT"
      },
      {
        "item": "ALSFRS-R score",
        "frequency": "Every clinic visit",
        "action": "Adjust care intensity; prognostic indicator",
        "ED": "—",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "—"
      },
      {
        "item": "Weight",
        "frequency": "Every clinic visit",
        "action": "Nutrition consult; consider PEG if >10% loss",
        "ED": "STAT",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "STAT"
      },
      {
        "item": "LFTs (ALT/AST)",
        "frequency": "Monthly x 3 months on riluzole, then q3 months",
        "action": "Hold riluzole if ALT >5x ULN; reduce dose if 3-5x ULN",
        "ED": "—",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "—"
      },
      {
        "item": "Respiratory symptoms (orthopnea, morning headache, daytime somnolence)",
        "frequency": "Every visit",
        "action": "Initiate or titrate BiPAP",
        "ED": "STAT",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "STAT"
      },
      {
        "item": "SpO2 and EtCO2 (if on BiPAP)",
        "frequency": "Each visit",
        "action": "Adjust BiPAP settings",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT"
      },
      {
        "item": "Swallowing function",
        "frequency": "Every visit",
        "action": "SLP evaluation; diet modification; consider PEG",
        "ED": "—",
        "HOSP": "URGENT",
        "OPD": "ROUTINE",
        "ICU": "—"
      },
      {
        "item": "Peak cough flow",
        "frequency": "Every visit",
        "action": "Initiate cough assist if <270 L/min",
        "ED": "—",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "—"
      },
      {
        "item": "Mood screening (PHQ-9)",
        "frequency": "Every visit",
        "action": "Antidepressant; psychology referral",
        "ED": "—",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "—"
      },
      {
        "item": "Caregiver stress",
        "frequency": "Every visit",
        "action": "Social work; respite care; support groups",
        "ED": "—",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "—"
      },
      {
        "item": "Advance directive status",
        "frequency": "At diagnosis and annually",
        "action": "Complete/update advance directives",
        "ED": "URGENT",
        "HOSP": "URGENT",
        "OPD": "ROUTINE",
        "ICU": "URGENT"
      },
      {
        "item": "BiPAP adherence",
        "frequency": "Every visit",
        "action": "Education; mask refitting; troubleshoot",
        "ED": "—",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "—"
      }
    ],
    "disposition": [
      {
        "disposition": "**ICU admission**",
        "criteria": "Acute respiratory failure (FVC <15 mL/kg, pCO2 >50, SpO2 <88% on supplemental O2); aspiration pneumonia with respiratory distress; need for invasive ventilation (if patient desires)"
      },
      {
        "disposition": "**Step-down/telemetry**",
        "criteria": "Respiratory compromise improving on BiPAP; autonomic instability; aspiration pneumonia responding to treatment"
      },
      {
        "disposition": "**General floor admission**",
        "criteria": "Aspiration pneumonia without respiratory distress; severe dehydration or malnutrition; new bulbar symptoms requiring evaluation; falls with injury"
      },
      {
        "disposition": "**Discharge home**",
        "criteria": "Stable respiratory status; adequate nutrition (oral or PEG); caregiver support in place; equipment needs met; follow-up arranged"
      },
      {
        "disposition": "**Discharge to skilled nursing facility**",
        "criteria": "Requires 24-hour care that cannot be provided at home; feeding tube with complex care needs; no available caregivers"
      },
      {
        "disposition": "**Discharge to hospice**",
        "criteria": "Prognosis <6 months; patient declines aggressive interventions; focus on comfort care; FVC <30% or continuous BiPAP dependence"
      },
      {
        "disposition": "**Multidisciplinary ALS clinic follow-up**",
        "criteria": "Every 2-3 months; sooner if rapid decline; coordinate all subspecialty care"
      }
    ]
  },
  "Dystonia": {
    "id": "dystonia",
    "title": "Dystonia",
    "version": "1.0",
    "icd10": [
      "** G24.9 (Dystonia",
      "unspecified)",
      "G24.1 (Genetic torsion dystonia)",
      "G24.2 (Idiopathic nonfamilial dystonia)",
      "G24.3 (Spasmodic torticollis)",
      "G24.5 (Blepharospasm)",
      "G24.8 (Other dystonia)"
    ],
    "scope": "** Diagnosis, classification, workup for secondary causes, and symptomatic management of dystonia. Covers focal (cervical, blepharospasm, writer's cramp), segmental, and generalized forms. Includes evaluation for Wilson's disease, dopa-responsive dystonia, and drug-induced dystonia.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC with differential",
            "rationale": "Baseline; exclude systemic illness",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "BMP",
            "rationale": "Electrolyte abnormalities can exacerbate movement disorders",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Hepatic panel (AST, ALT, Alk Phos, bilirubin, albumin)",
            "rationale": "Screen for hepatic dysfunction suggesting Wilson's disease",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ceruloplasmin",
            "rationale": "Wilson's disease screen; essential for age <50 with dystonia",
            "target": ">20 mg/dL (low suggests Wilson's)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "TSH",
            "rationale": "Hyperthyroidism can cause movement disorders",
            "target": "Normal (0.4-4.0 mIU/L)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended Workup": [
          {
            "item": "24-hour urine copper",
            "rationale": "Wilson's disease confirmation if ceruloplasmin low/borderline",
            "target": "<40 mcg/24hr (elevated in Wilson's)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Serum copper",
            "rationale": "Interpret with ceruloplasmin (low free copper ratio in Wilson's)",
            "target": "75-145 mcg/dL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin B12",
            "rationale": "Deficiency causes myelopathy and movement disorders",
            "target": ">300 pg/mL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ferritin, serum iron, TIBC",
            "rationale": "Neurodegeneration with brain iron accumulation (NBIA)",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Uric acid",
            "rationale": "Low in ataxia-telangiectasia, Lesch-Nyhan",
            "target": "Normal",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lactate, pyruvate",
            "rationale": "Mitochondrial disorders",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Calcium, magnesium",
            "rationale": "Hypocalcemia, hypomagnesemia can cause movement disorders",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "CK",
            "rationale": "Elevated in dystonia crises, NMS, prolonged dystonic posturing",
            "target": "Normal or mildly elevated",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "STAT"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "ATP7B gene sequencing",
            "rationale": "Definitive Wilson's disease diagnosis",
            "target": "No pathogenic variants",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "GCH1 gene sequencing",
            "rationale": "Dopa-responsive dystonia (DYT5a)",
            "target": "No pathogenic variants",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "TOR1A gene sequencing",
            "rationale": "DYT1 dystonia (early-onset generalized)",
            "target": "No GAG deletion",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "THAP1 gene sequencing",
            "rationale": "DYT6 dystonia",
            "target": "No pathogenic variants",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Dystonia gene panel (multi-gene NGS)",
            "rationale": "Atypical presentations; family history; early onset",
            "target": "No pathogenic variants",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "CSF neurotransmitter metabolites (HVA, 5-HIAA, pterins)",
            "rationale": "Dopa-responsive dystonia; neurotransmitter disorders",
            "target": "Normal ratios",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Acanthocyte smear",
            "rationale": "Chorea-acanthocytosis, McLeod syndrome",
            "target": "No acanthocytes",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Lysosomal enzyme panel",
            "rationale": "Lysosomal storage disorders (GM1, GM2 gangliosidosis)",
            "target": "Normal enzyme activity",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Anti-neuronal antibodies (NMDAR, LGI1, CASPR2)",
            "rationale": "Autoimmune dystonia (rare)",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Paraneoplastic antibody panel",
            "rationale": "Paraneoplastic dystonia",
            "target": "Negative",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "MRI Brain without and with contrast",
            "timing": "All new dystonia cases; rule out structural lesion",
            "target": "Normal; no basal ganglia lesions",
            "contraindications": "MRI-incompatible devices",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended": [
          {
            "item": "MRI Brain with SWI/iron sequences",
            "timing": "Suspected Wilson's disease or NBIA",
            "target": "No T2 hypointensity in basal ganglia",
            "contraindications": "MRI contraindications",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Slit lamp examination by ophthalmology",
            "timing": "Wilson's disease evaluation; Kayser-Fleischer rings",
            "target": "No KF rings",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "EMG with dystonia protocol",
            "timing": "Confirm diagnosis; characterize pattern; guide botulinum toxin",
            "target": "Co-contraction of agonist/antagonist; overflow",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "DaTscan (ioflupane I-123)",
            "timing": "Differentiate dystonic tremor from PD; combined dystonia-parkinsonism",
            "target": "Normal in primary dystonia; abnormal if parkinsonism",
            "contraindications": "Iodine allergy",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "MRI Spine (cervical/thoracic)",
            "timing": "Cervical dystonia with radiculopathy symptoms",
            "target": "Normal; no cord compression",
            "contraindications": "MRI contraindications",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "FDG-PET Brain",
            "timing": "Atypical parkinsonism with dystonia",
            "target": "Pattern interpretation varies",
            "contraindications": "None significant",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Liver MRI or ultrasound",
            "timing": "Wilson's disease staging if diagnosed",
            "target": "Assess hepatic involvement",
            "contraindications": "None significant",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "Diphenhydramine",
            "route": "IV/IM",
            "indication": "Acute dystonic reaction (drug-induced)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg IV",
                  "orderSentence": "Diphenhydramine 25 mg IV IV/IM"
                },
                {
                  "text": "50 mg IV",
                  "orderSentence": "Diphenhydramine 50 mg IV IV/IM"
                },
                {
                  "text": "50 mg IM",
                  "orderSentence": "Diphenhydramine 50 mg IM IV/IM"
                }
              ],
              "route": "IV/IM",
              "instructions": "25-50 mg IV/IM over 2-5 min; may repeat in 30 min if needed; max 100 mg",
              "orderSentence": "Diphenhydramine 25 mg IV IV/IM"
            },
            "contraindications": "Narrow-angle glaucoma; urinary retention",
            "monitoring": "Sedation, hypotension",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Benztropine",
            "route": "IV/IM",
            "indication": "Acute dystonic reaction (drug-induced)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 mg IV",
                  "orderSentence": "Benztropine 1 mg IV IV/IM"
                },
                {
                  "text": "2 mg IV",
                  "orderSentence": "Benztropine 2 mg IV IV/IM"
                },
                {
                  "text": "1 mg IM",
                  "orderSentence": "Benztropine 1 mg IM IV/IM"
                },
                {
                  "text": "2 mg IM",
                  "orderSentence": "Benztropine 2 mg IM IV/IM"
                }
              ],
              "route": "IV/IM",
              "instructions": "1-2 mg IV/IM; may repeat in 30 min; follow with oral 1-2 mg BID x 2-3 days to prevent recurrence",
              "orderSentence": "Benztropine 1 mg IV IV/IM"
            },
            "contraindications": "Narrow-angle glaucoma; GI obstruction; myasthenia gravis",
            "monitoring": "Anticholinergic effects, confusion (elderly)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Lorazepam",
            "route": "IV/PO",
            "indication": "Status dystonicus; severe dystonic storm",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 mg IV",
                  "orderSentence": "Lorazepam 1 mg IV IV/PO"
                },
                {
                  "text": "2 mg IV",
                  "orderSentence": "Lorazepam 2 mg IV IV/PO"
                },
                {
                  "text": "2 mg PO",
                  "orderSentence": "Lorazepam 2 mg PO IV/PO"
                },
                {
                  "text": "4 mg PO",
                  "orderSentence": "Lorazepam 4 mg PO IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "1-2 mg IV slow push or 2-4 mg PO; may repeat q4-6h PRN; monitor respiratory status",
              "orderSentence": "Lorazepam 1 mg IV IV/PO"
            },
            "contraindications": "Severe respiratory depression; acute narrow-angle glaucoma",
            "monitoring": "Respiratory depression, sedation",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Diazepam",
            "route": "IV/PO",
            "indication": "Status dystonicus; muscle spasm relief",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg IV",
                  "orderSentence": "Diazepam 5 mg IV IV/PO"
                },
                {
                  "text": "10 mg IV",
                  "orderSentence": "Diazepam 10 mg IV IV/PO"
                },
                {
                  "text": "5 mg PO",
                  "orderSentence": "Diazepam 5 mg PO IV/PO"
                },
                {
                  "text": "10 mg PO",
                  "orderSentence": "Diazepam 10 mg PO IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "5-10 mg IV slow push (2 mg/min) or PO; may repeat q4h PRN",
              "orderSentence": "Diazepam 5 mg IV IV/PO"
            },
            "contraindications": "Same as lorazepam",
            "monitoring": "Same as lorazepam",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          }
        ],
        "Symptomatic Treatments (First-line for Focal Dystonia)": [
          {
            "item": "OnabotulinumtoxinA (Botox) - Cervical dystonia",
            "route": "IM",
            "indication": "First-line for cervical dystonia/torticollis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 units total",
                  "orderSentence": "OnabotulinumtoxinA (Botox) - Cervical dystonia 100 units total IM"
                },
                {
                  "text": "200 units total",
                  "orderSentence": "OnabotulinumtoxinA (Botox) - Cervical dystonia 200 units total IM"
                },
                {
                  "text": "300 units total",
                  "orderSentence": "OnabotulinumtoxinA (Botox) - Cervical dystonia 300 units total IM"
                }
              ],
              "route": "IM",
              "instructions": "Start 100-200 units divided among affected muscles (SCM, splenius, trapezius, levator scapulae); adjust based on response; max 300 units/session; repeat q12wk",
              "orderSentence": "OnabotulinumtoxinA (Botox) - Cervical dystonia 100 units total IM"
            },
            "contraindications": "Infection at site; myasthenia gravis; ALS",
            "monitoring": "Dysphagia (especially bilateral SCM); neck weakness; antibody formation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "OnabotulinumtoxinA (Botox) - Blepharospasm",
            "route": "IM",
            "indication": "First-line for blepharospasm",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 units total",
                  "orderSentence": "OnabotulinumtoxinA (Botox) - Blepharospasm 25 units total IM"
                },
                {
                  "text": "50 units total",
                  "orderSentence": "OnabotulinumtoxinA (Botox) - Blepharospasm 50 units total IM"
                }
              ],
              "route": "IM",
              "instructions": "1.25-5 units per site; inject orbicularis oculi at multiple points; total 25-50 units per eye; repeat q12wk",
              "orderSentence": "OnabotulinumtoxinA (Botox) - Blepharospasm 25 units total IM"
            },
            "contraindications": "Same as above",
            "monitoring": "Ptosis, diplopia, dry eyes, lagophthalmos",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "OnabotulinumtoxinA (Botox) - Writer's cramp",
            "route": "IM",
            "indication": "Focal hand dystonia refractory to therapy modification",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 units total",
                  "orderSentence": "OnabotulinumtoxinA (Botox) - Writer's cramp 50 units total IM"
                },
                {
                  "text": "100 units total",
                  "orderSentence": "OnabotulinumtoxinA (Botox) - Writer's cramp 100 units total IM"
                }
              ],
              "route": "IM",
              "instructions": "10-50 units per muscle; EMG guidance required; target FCR, FCU, FDS as needed; repeat q12wk",
              "orderSentence": "OnabotulinumtoxinA (Botox) - Writer's cramp 50 units total IM"
            },
            "contraindications": "Same as above",
            "monitoring": "Finger weakness (may impair function)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "AbobotulinumtoxinA (Dysport) - Cervical dystonia",
            "route": "IM",
            "indication": "Alternative to onabotulinum; different potency",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 units total",
                  "orderSentence": "AbobotulinumtoxinA (Dysport) - Cervical dystonia 500 units total IM"
                },
                {
                  "text": "750 units total",
                  "orderSentence": "AbobotulinumtoxinA (Dysport) - Cervical dystonia 750 units total IM"
                },
                {
                  "text": "1000 units total",
                  "orderSentence": "AbobotulinumtoxinA (Dysport) - Cervical dystonia 1000 units total IM"
                }
              ],
              "route": "IM",
              "instructions": "Start 500 units divided among affected muscles; max 1000 units/session; repeat q12wk",
              "orderSentence": "AbobotulinumtoxinA (Dysport) - Cervical dystonia 500 units total IM"
            },
            "contraindications": "Same as onabotulinum",
            "monitoring": "Same as onabotulinum",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "IncobotulinumtoxinA (Xeomin) - Cervical dystonia",
            "route": "IM",
            "indication": "Alternative; no complexing proteins",
            "dosing": {
              "doseOptions": [
                {
                  "text": "120 units total",
                  "orderSentence": "IncobotulinumtoxinA (Xeomin) - Cervical dystonia 120 units total IM"
                },
                {
                  "text": "200 units total",
                  "orderSentence": "IncobotulinumtoxinA (Xeomin) - Cervical dystonia 200 units total IM"
                },
                {
                  "text": "300 units total",
                  "orderSentence": "IncobotulinumtoxinA (Xeomin) - Cervical dystonia 300 units total IM"
                }
              ],
              "route": "IM",
              "instructions": "Start 120-200 units divided; max 300 units/session; repeat q12wk; may have lower immunogenicity",
              "orderSentence": "IncobotulinumtoxinA (Xeomin) - Cervical dystonia 120 units total IM"
            },
            "contraindications": "Same as onabotulinum",
            "monitoring": "Same as onabotulinum",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "RimabotulinumtoxinB (Myobloc) - Cervical dystonia",
            "route": "IM",
            "indication": "Type A toxin non-responders; secondary non-response",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2500 units total",
                  "orderSentence": "RimabotulinumtoxinB (Myobloc) - Cervical dystonia 2500 units total IM"
                },
                {
                  "text": "5000 units total",
                  "orderSentence": "RimabotulinumtoxinB (Myobloc) - Cervical dystonia 5000 units total IM"
                },
                {
                  "text": "10000 units total",
                  "orderSentence": "RimabotulinumtoxinB (Myobloc) - Cervical dystonia 10000 units total IM"
                }
              ],
              "route": "IM",
              "instructions": "Start 2500-5000 units divided; max 10000 units; repeat q12wk; higher dry mouth rate",
              "orderSentence": "RimabotulinumtoxinB (Myobloc) - Cervical dystonia 2500 units total IM"
            },
            "contraindications": "Same; type B protein allergy",
            "monitoring": "Dry mouth more common; dysphagia",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Second-line/Oral Medications": [
          {
            "item": "Trihexyphenidyl",
            "route": "PO",
            "indication": "First-line oral for generalized dystonia; young patients tolerate best",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 mg daily",
                  "orderSentence": "Trihexyphenidyl 1 mg daily PO"
                },
                {
                  "text": "2 mg TID",
                  "orderSentence": "Trihexyphenidyl 2 mg TID PO"
                },
                {
                  "text": "5 mg TID",
                  "orderSentence": "Trihexyphenidyl 5 mg TID PO"
                },
                {
                  "text": "10 mg TID",
                  "orderSentence": "Trihexyphenidyl 10 mg TID PO"
                },
                {
                  "text": "15 mg TID",
                  "orderSentence": "Trihexyphenidyl 15 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 1 mg daily; increase by 1-2 mg q3-5d; typical target 6-30 mg/day divided TID; some patients require up to 60-80 mg/day",
              "orderSentence": "Trihexyphenidyl 1 mg daily PO"
            },
            "contraindications": "Narrow-angle glaucoma; GI obstruction; urinary retention; dementia",
            "monitoring": "Anticholinergic effects (dry mouth, constipation, urinary retention, confusion); cognitive effects in elderly",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Benztropine",
            "route": "PO",
            "indication": "Alternative anticholinergic; maintenance after acute dystonic reaction",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5 mg BID",
                  "orderSentence": "Benztropine 0.5 mg BID PO"
                },
                {
                  "text": "1 mg BID",
                  "orderSentence": "Benztropine 1 mg BID PO"
                },
                {
                  "text": "2 mg BID",
                  "orderSentence": "Benztropine 2 mg BID PO"
                },
                {
                  "text": "3 mg BID",
                  "orderSentence": "Benztropine 3 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.5 mg BID; increase by 0.5 mg q5-7d; typical 1-4 mg/day; max 6 mg/day",
              "orderSentence": "Benztropine 0.5 mg BID PO"
            },
            "contraindications": "Same as trihexyphenidyl",
            "monitoring": "Same as trihexyphenidyl",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Baclofen",
            "route": "PO",
            "indication": "Muscle relaxant; useful adjunct for dystonia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg TID",
                  "orderSentence": "Baclofen 5 mg TID PO"
                },
                {
                  "text": "10 mg TID",
                  "orderSentence": "Baclofen 10 mg TID PO"
                },
                {
                  "text": "20 mg TID",
                  "orderSentence": "Baclofen 20 mg TID PO"
                },
                {
                  "text": "30 mg TID",
                  "orderSentence": "Baclofen 30 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg TID; increase by 5 mg/dose q3d; typical 30-80 mg/day divided TID; max 80-120 mg/day",
              "orderSentence": "Baclofen 5 mg TID PO"
            },
            "contraindications": "Severe renal impairment (dose adjust); abrupt withdrawal risk",
            "monitoring": "Sedation, weakness; taper slowly if discontinuing",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Clonazepam",
            "route": "PO",
            "indication": "Adjunct for dystonia; myoclonus-dystonia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.25 mg BID",
                  "orderSentence": "Clonazepam 0.25 mg BID PO"
                },
                {
                  "text": "0.5 mg BID",
                  "orderSentence": "Clonazepam 0.5 mg BID PO"
                },
                {
                  "text": "1 mg BID",
                  "orderSentence": "Clonazepam 1 mg BID PO"
                },
                {
                  "text": "1 mg TID",
                  "orderSentence": "Clonazepam 1 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.25 mg BID; increase by 0.25-0.5 mg q3-7d; typical 1-4 mg/day; max 6 mg/day",
              "orderSentence": "Clonazepam 0.25 mg BID PO"
            },
            "contraindications": "Respiratory depression; severe hepatic impairment; substance abuse history",
            "monitoring": "Sedation, dependence, falls; taper if discontinuing",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Diazepam",
            "route": "PO",
            "indication": "Alternative benzodiazepine; muscle relaxant properties",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 mg TID",
                  "orderSentence": "Diazepam 2 mg TID PO"
                },
                {
                  "text": "5 mg TID",
                  "orderSentence": "Diazepam 5 mg TID PO"
                },
                {
                  "text": "10 mg TID",
                  "orderSentence": "Diazepam 10 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 2 mg TID; increase by 2-5 mg/day q3-7d; typical 10-40 mg/day divided",
              "orderSentence": "Diazepam 2 mg TID PO"
            },
            "contraindications": "Same as clonazepam",
            "monitoring": "Same as clonazepam",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Levodopa/Carbidopa",
            "route": "PO",
            "indication": "Dopa-responsive dystonia (DRD); diagnostic trial for young-onset",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25/100 mg TID",
                  "orderSentence": "Levodopa/Carbidopa 25/100 mg TID PO"
                },
                {
                  "text": "50/200 mg TID",
                  "orderSentence": "Levodopa/Carbidopa 50/200 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25/100 mg TID; if DRD, dramatic response at low dose; may titrate to 50/200 mg TID; response confirms diagnosis",
              "orderSentence": "Levodopa/Carbidopa 25/100 mg TID PO"
            },
            "contraindications": "None absolute; use caution in psychosis",
            "monitoring": "Nausea, orthostatic hypotension; dramatic improvement suggests DRD",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Tetrabenazine",
            "route": "PO",
            "indication": "Hyperkinetic movements including some dystonias",
            "dosing": {
              "doseOptions": [
                {
                  "text": "12.5 mg daily",
                  "orderSentence": "Tetrabenazine 12.5 mg daily PO"
                },
                {
                  "text": "12.5 mg BID",
                  "orderSentence": "Tetrabenazine 12.5 mg BID PO"
                },
                {
                  "text": "25 mg TID",
                  "orderSentence": "Tetrabenazine 25 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 12.5 mg daily; increase by 12.5 mg q1wk; max 200 mg/day; CYP2D6 testing recommended",
              "orderSentence": "Tetrabenazine 12.5 mg daily PO"
            },
            "contraindications": "Depression; suicidality; Parkinsonism",
            "monitoring": "Depression, sedation, parkinsonism, akathisia; Black Box: suicidality",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Deutetrabenazine (Austedo)",
            "route": "PO",
            "indication": "Longer half-life alternative to tetrabenazine",
            "dosing": {
              "doseOptions": [
                {
                  "text": "6 mg BID",
                  "orderSentence": "Deutetrabenazine (Austedo) 6 mg BID PO"
                },
                {
                  "text": "12 mg BID",
                  "orderSentence": "Deutetrabenazine (Austedo) 12 mg BID PO"
                },
                {
                  "text": "24 mg BID",
                  "orderSentence": "Deutetrabenazine (Austedo) 24 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 6 mg BID; increase by 6 mg/day weekly; max 48 mg/day",
              "orderSentence": "Deutetrabenazine (Austedo) 6 mg BID PO"
            },
            "contraindications": "Same as tetrabenazine",
            "monitoring": "Same but may be better tolerated",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Clonidine",
            "route": "PO",
            "indication": "Adjunct; may help in some patients",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.1 mg BID",
                  "orderSentence": "Clonidine 0.1 mg BID PO"
                },
                {
                  "text": "0.2 mg BID",
                  "orderSentence": "Clonidine 0.2 mg BID PO"
                },
                {
                  "text": "0.3 mg BID",
                  "orderSentence": "Clonidine 0.3 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.1 mg BID; increase by 0.1 mg q1wk; max 0.6 mg/day",
              "orderSentence": "Clonidine 0.1 mg BID PO"
            },
            "contraindications": "Severe bradycardia; renal impairment (adjust)",
            "monitoring": "Hypotension, bradycardia, sedation; rebound hypertension if stopped abruptly",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Carbamazepine",
            "route": "PO",
            "indication": "Paroxysmal kinesigenic dystonia/dyskinesia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg BID",
                  "orderSentence": "Carbamazepine 100 mg BID PO"
                },
                {
                  "text": "200 mg BID",
                  "orderSentence": "Carbamazepine 200 mg BID PO"
                },
                {
                  "text": "400 mg BID",
                  "orderSentence": "Carbamazepine 400 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 100 mg BID; increase by 100-200 mg q1wk; target 400-800 mg/day; check HLA-B*1502 in at-risk populations",
              "orderSentence": "Carbamazepine 100 mg BID PO"
            },
            "contraindications": "Bone marrow suppression; AV block; SJS risk (HLA-B*1502)",
            "monitoring": "CBC, LFTs, sodium; drug levels (4-12 mcg/mL)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Disease-Modifying/Specialized Therapies": [
          {
            "item": "Deep brain stimulation (GPi-DBS)",
            "route": "Surgical",
            "indication": "Medication-refractory generalized or segmental dystonia; DYT1 positive",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Bilateral GPi stimulation",
                  "orderSentence": "Deep brain stimulation (GPi-DBS) Bilateral GPi stimulation Surgical"
                }
              ],
              "route": "Surgical",
              "instructions": "Bilateral GPi electrode placement; programming over weeks-months; full effect may take 6-12 months",
              "orderSentence": "Deep brain stimulation (GPi-DBS) Bilateral GPi stimulation Surgical"
            },
            "pretreatment": "MRI; neuropsych testing; multidisciplinary evaluation; genetic testing if indicated",
            "contraindications": "Cognitive impairment; coagulopathy; infection; unrealistic expectations",
            "monitoring": "Programming optimization; battery replacement q3-5yr; speech/swallowing",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Deep brain stimulation (GPi-DBS)",
            "route": "Surgical",
            "indication": "Cervical dystonia refractory to botulinum toxin",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Bilateral GPi stimulation",
                  "orderSentence": "Deep brain stimulation (GPi-DBS) Bilateral GPi stimulation Surgical"
                }
              ],
              "route": "Surgical",
              "instructions": "Same as above",
              "orderSentence": "Deep brain stimulation (GPi-DBS) Bilateral GPi stimulation Surgical"
            },
            "pretreatment": "Same as above",
            "contraindications": "Same as above",
            "monitoring": "Same as above",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Intrathecal baclofen pump",
            "route": "Surgical",
            "indication": "Severe generalized dystonia with spasticity component; CP-related",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Continuous IT infusion",
                  "orderSentence": "Intrathecal baclofen pump Continuous IT infusion IT"
                }
              ],
              "route": "IT",
              "instructions": "Test dose 25-100 mcg; maintenance typically 100-1000 mcg/day; titrate over months",
              "orderSentence": "Intrathecal baclofen pump Continuous IT infusion IT"
            },
            "pretreatment": "IT baclofen trial with >50% improvement",
            "contraindications": "Infection; CSF obstruction; baclofen hypersensitivity",
            "monitoring": "Pump refills q1-3mo; withdrawal syndrome if interruption; MRI conditional pumps",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "D-penicillamine",
            "route": "PO",
            "indication": "Wilson's disease with neurological symptoms",
            "dosing": {
              "doseOptions": [
                {
                  "text": "250 mg daily",
                  "orderSentence": "D-penicillamine 250 mg daily PO"
                },
                {
                  "text": "500 mg BID",
                  "orderSentence": "D-penicillamine 500 mg BID PO"
                },
                {
                  "text": "750 mg BID",
                  "orderSentence": "D-penicillamine 750 mg BID PO"
                },
                {
                  "text": "1000 mg BID",
                  "orderSentence": "D-penicillamine 1000 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 250 mg daily; increase by 250 mg q4-7d; target 1000-1500 mg/day divided BID (take 1hr before meals); lifelong treatment",
              "orderSentence": "D-penicillamine 250 mg daily PO"
            },
            "pretreatment": "24h urine copper, LFTs, CBC, urinalysis",
            "contraindications": "Penicillin allergy (not absolute but caution); nephrotoxicity",
            "monitoring": "CBC weekly x1mo then monthly x6mo then q3mo; urinalysis monthly; LFTs monthly; neurologic worsening first 6 months possible",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Trientine (Syprine)",
            "route": "PO",
            "indication": "Wilson's disease; D-penicillamine intolerant",
            "dosing": {
              "doseOptions": [
                {
                  "text": "250 mg TID",
                  "orderSentence": "Trientine (Syprine) 250 mg TID PO"
                },
                {
                  "text": "500 mg TID",
                  "orderSentence": "Trientine (Syprine) 500 mg TID PO"
                },
                {
                  "text": "750 mg BID",
                  "orderSentence": "Trientine (Syprine) 750 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 250 mg TID; target 750-1250 mg/day divided TID; take 1hr before or 2hr after meals",
              "orderSentence": "Trientine (Syprine) 250 mg TID PO"
            },
            "pretreatment": "Same as D-penicillamine",
            "contraindications": "Caution with iron supplements (separate by 2hr)",
            "monitoring": "Same monitoring as D-penicillamine; fewer side effects",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Zinc acetate (Galzin)",
            "route": "PO",
            "indication": "Wilson's disease maintenance; presymptomatic; adjunct",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg TID",
                  "orderSentence": "Zinc acetate (Galzin) 50 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "50 mg TID (elemental zinc); take between meals; blocks intestinal copper absorption",
              "orderSentence": "Zinc acetate (Galzin) 50 mg TID PO"
            },
            "pretreatment": "Take separately from copper chelators",
            "contraindications": "GI upset",
            "monitoring": "24h urine copper; serum zinc; 24h urine zinc",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Movement disorders neurology for diagnosis confirmation, classification, and treatment planning",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ophthalmology for slit lamp examination to evaluate for Kayser-Fleischer rings (Wilson's disease workup)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Hepatology if Wilson's disease diagnosed for hepatic management and transplant evaluation if severe",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Genetic counseling if genetic dystonia confirmed or suspected (DYT1, DYT6, GCH1)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Neurosurgery consultation for DBS evaluation if medication-refractory",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Physical therapy for posture correction, stretching, and range of motion exercises",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Occupational therapy for adaptive techniques and assistive devices for ADLs",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Speech therapy if oromandibular dystonia, laryngeal dystonia, or cervical dystonia affecting swallowing",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pain management if chronic pain from dystonic posturing not controlled with primary treatment",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Psychology/psychiatry for coping strategies, depression/anxiety management related to chronic dystonia",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "After botulinum toxin injection: avoid rubbing injection sites; effects develop over 3-14 days and last 10-12 weeks",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Report any swallowing difficulty or breathing problems after botulinum toxin injection (may indicate spread)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Use sensory tricks (geste antagoniste) such as touching chin or face which may temporarily reduce cervical dystonia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Return to ED if severe muscle spasms with fever, confusion, or dark urine (possible dystonic storm or rhabdomyolysis)",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Continue physical therapy exercises at home to maintain range of motion and prevent contractures",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid medications that worsen dystonia: metoclopramide, prochlorperazine, haloperidol, and other dopamine blockers",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "For Wilson's disease: strict adherence to copper chelation is lifelong; follow dietary copper restrictions",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Keep a symptom diary noting triggers, sensory tricks that help, and response to medications",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Stress management with relaxation techniques as stress can exacerbate dystonia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Adequate sleep as fatigue worsens dystonia symptoms",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Limit caffeine and stimulants which may worsen tremor/dystonia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Regular gentle exercise (swimming, yoga) to maintain flexibility without overexertion",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Ergonomic workstation modifications for task-specific dystonia (writer's cramp, musician's dystonia)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "For Wilson's disease: avoid high-copper foods (liver, shellfish, chocolate, nuts, mushrooms) especially during initial treatment",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid alcohol especially if on benzodiazepines or with hepatic involvement (Wilson's)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Heat application to affected muscles may provide temporary relief",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Support groups for dystonia provide coping strategies and community connection",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Drug-induced dystonia",
        "features": "Temporal relationship with dopamine blockers (antipsychotics, antiemetics); acute or tardive",
        "tests": "Medication history; resolves with withdrawal (acute) or persists (tardive)"
      },
      {
        "diagnosis": "Wilson's disease",
        "features": "Age <50; hepatic dysfunction; psychiatric symptoms; Kayser-Fleischer rings",
        "tests": "Ceruloplasmin (low), 24h urine copper (high), slit lamp exam, ATP7B testing"
      },
      {
        "diagnosis": "Dopa-responsive dystonia (DYT5/Segawa)",
        "features": "Childhood onset; diurnal fluctuation (worse evening); dramatic levodopa response",
        "tests": "Levodopa trial (dramatic improvement); GCH1 gene testing"
      },
      {
        "diagnosis": "Parkinson's disease with dystonia",
        "features": "Rest tremor; bradykinesia; rigidity; asymmetric; sustained postures",
        "tests": "DaTscan (abnormal); clinical exam; levodopa response"
      },
      {
        "diagnosis": "Psychogenic/functional dystonia",
        "features": "Inconsistent; distractible; fixed posture from onset; associated somatization",
        "tests": "Clinical features; psychiatric evaluation; resolution with distraction"
      },
      {
        "diagnosis": "Stiff-person syndrome",
        "features": "Axial rigidity; episodic spasms triggered by startle; anti-GAD antibodies",
        "tests": "Anti-GAD65 antibodies; EMG (continuous motor unit activity)"
      },
      {
        "diagnosis": "Tardive dystonia",
        "features": "Prolonged dopamine blocker exposure (months-years); may persist after withdrawal",
        "tests": "History of antipsychotic/antiemetic use; AIMS assessment"
      },
      {
        "diagnosis": "Cervical spondylotic myelopathy",
        "features": "Neck pain; sensory symptoms; hyperreflexia; Hoffmann sign",
        "tests": "MRI C-spine (cord compression, myelopathy signal)"
      },
      {
        "diagnosis": "Torticollis from posterior fossa tumor",
        "features": "Constant head tilt; headache; papilledema; cranial nerve signs",
        "tests": "MRI Brain with contrast (tumor, hydrocephalus)"
      },
      {
        "diagnosis": "Neuroacanthocytosis/chorea-acanthocytosis",
        "features": "Chorea; orofacial dystonia; lip/tongue biting; elevated CK",
        "tests": "Acanthocyte smear; CK; VPS13A gene testing"
      },
      {
        "diagnosis": "NBIA (neurodegeneration with brain iron accumulation)",
        "features": "Progressive; childhood/young adult onset; parkinsonism; retinopathy",
        "tests": "MRI (eye-of-the-tiger sign); genetic panels (PANK2, etc.)"
      },
      {
        "diagnosis": "Meige syndrome",
        "features": "Combined blepharospasm + oromandibular dystonia",
        "tests": "Clinical diagnosis; rule out secondary causes"
      },
      {
        "diagnosis": "Myoclonus-dystonia (DYT11)",
        "features": "Myoclonic jerks + dystonia; alcohol responsive; SGCE gene",
        "tests": "SGCE gene testing; alcohol response"
      },
      {
        "diagnosis": "Paroxysmal kinesigenic dyskinesia",
        "features": "Brief attacks (<1 min); triggered by sudden movement; responds to carbamazepine",
        "tests": "Clinical history; PRRT2 gene testing"
      }
    ],
    "evidence": [
      {
        "recommendation": "Botulinum toxin first-line for cervical dystonia",
        "evidenceLevel": "Class I, Level A",
        "source": "[Simpson DM et al. Neurology 2008 (AAN Guideline)](https://pubmed.ncbi.nlm.nih.gov/18458229/)"
      },
      {
        "recommendation": "Botulinum toxin for blepharospasm",
        "evidenceLevel": "Class I, Level A",
        "source": "[Simpson DM et al. Neurology 2008](https://pubmed.ncbi.nlm.nih.gov/18458229/)"
      },
      {
        "recommendation": "GPi-DBS effective for generalized dystonia",
        "evidenceLevel": "Class I, Level A",
        "source": "[Vidailhet M et al. NEJM 2005](https://pubmed.ncbi.nlm.nih.gov/15689584/)"
      },
      {
        "recommendation": "DBS superior effect in DYT1-positive patients",
        "evidenceLevel": "Class II, Level B",
        "source": "[Coubes P et al. J Neurosurg 2004](https://pubmed.ncbi.nlm.nih.gov/15540920/)"
      },
      {
        "recommendation": "Trihexyphenidyl for generalized dystonia",
        "evidenceLevel": "Class II, Level C",
        "source": "[Burke RE et al. Neurology 1986](https://pubmed.ncbi.nlm.nih.gov/3703234/)"
      },
      {
        "recommendation": "Levodopa trial for suspected dopa-responsive dystonia",
        "evidenceLevel": "Class II, Level B",
        "source": "[Nygaard TG et al. Neurology 1991](https://pubmed.ncbi.nlm.nih.gov/1891117/)"
      },
      {
        "recommendation": "Dystonia classification consensus",
        "evidenceLevel": "Expert consensus",
        "source": "[Albanese A et al. Mov Disord 2013](https://pubmed.ncbi.nlm.nih.gov/23649720/)"
      },
      {
        "recommendation": "Wilson's disease diagnosis and treatment",
        "evidenceLevel": "Class I, Level A",
        "source": "[Roberts EA, Schilsky ML. Hepatology 2008 (AASLD Guideline)](https://pubmed.ncbi.nlm.nih.gov/18506894/)"
      },
      {
        "recommendation": "D-penicillamine for Wilson's disease",
        "evidenceLevel": "Class I, Level A",
        "source": "[Roberts EA, Schilsky ML. Hepatology 2008](https://pubmed.ncbi.nlm.nih.gov/18506894/)"
      },
      {
        "recommendation": "Intrathecal baclofen for severe dystonia",
        "evidenceLevel": "Class II, Level B",
        "source": "[Albright AL et al. J Neurosurg 2001](https://pubmed.ncbi.nlm.nih.gov/11453401/)"
      },
      {
        "recommendation": "Benztropine/diphenhydramine for acute dystonic reaction",
        "evidenceLevel": "Class III, Level C",
        "source": "[van Harten PN et al. J Clin Psychiatry 1999](https://pubmed.ncbi.nlm.nih.gov/10401919/)"
      },
      {
        "recommendation": "Carbamazepine for paroxysmal kinesigenic dyskinesia",
        "evidenceLevel": "Class II, Level B",
        "source": "[Bruno MK et al. Brain 2004](https://pubmed.ncbi.nlm.nih.gov/14607786/)"
      },
      {
        "recommendation": "EFNS guidelines on dystonia diagnosis and treatment",
        "evidenceLevel": "Expert consensus",
        "source": "[Albanese A et al. Eur J Neurol 2011](https://pubmed.ncbi.nlm.nih.gov/20649898/)"
      },
      {
        "recommendation": "Tetrabenazine for hyperkinetic movement disorders",
        "evidenceLevel": "Class II, Level B",
        "source": "[Jankovic J, Beach J. Neurology 1997](https://pubmed.ncbi.nlm.nih.gov/9109891/)"
      }
    ],
    "monitoring": [
      {
        "item": "Dystonia severity (Burke-Fahn-Marsden scale, TWSTRS for cervical)",
        "frequency": "Each visit",
        "action": "Adjust botulinum toxin dose/muscles; add oral agent; consider DBS",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Functional status and disability",
        "frequency": "Each visit",
        "action": "OT/PT referral; adaptive devices; treatment escalation",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Anticholinergic side effects (dry mouth, constipation, urinary retention, cognition)",
        "frequency": "Each visit on anticholinergics",
        "action": "Reduce dose; switch agents; add symptomatic treatment",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Dysphagia screening (after cervical botulinum toxin)",
        "frequency": "2 weeks post-injection",
        "action": "Dietary modification; speech therapy; reduce dose next session",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "CK level (if severe dystonia or dystonic storm)",
        "frequency": "PRN",
        "action": "IV fluids; monitor renal function; treat underlying cause",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT"
      },
      {
        "item": "24-hour urine copper (Wilson's on chelation)",
        "frequency": "Every 3-6 months",
        "action": "Adjust chelator dose; assess compliance",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "CBC, urinalysis (on D-penicillamine)",
        "frequency": "Monthly initially then q3mo",
        "action": "Hold drug if cytopenias or proteinuria; switch to trientine",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "LFTs (Wilson's disease)",
        "frequency": "Monthly initially then q3mo",
        "action": "Hepatology consultation if worsening",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Depression screening (on tetrabenazine)",
        "frequency": "Each visit",
        "action": "Discontinue tetrabenazine; psychiatric referral",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "DBS parameters and battery",
        "frequency": "Every 6-12 months",
        "action": "Reprogram; schedule battery replacement if needed",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      }
    ],
    "disposition": [
      {
        "disposition": "Discharge home",
        "criteria": "New diagnosis with workup initiated; mild symptoms; treatment plan in place; follow-up scheduled"
      },
      {
        "disposition": "Admit to floor",
        "criteria": "Acute dystonic reaction requiring observation; new generalized dystonia requiring workup; Wilson's disease with hepatic decompensation"
      },
      {
        "disposition": "Admit to ICU",
        "criteria": "Status dystonicus (dystonic storm); respiratory compromise; rhabdomyolysis; severe drug-induced dystonia with airway concern"
      },
      {
        "disposition": "Transfer to higher level",
        "criteria": "DBS programming issues requiring movement disorders center; refractory status dystonicus requiring specialized center"
      },
      {
        "disposition": "Outpatient follow-up",
        "criteria": "2-4 weeks after new medication started; 12 weeks for botulinum toxin reassessment; 6-12 months when stable"
      }
    ]
  },
  "Huntington's Disease": {
    "id": "huntingtons-disease",
    "title": "Huntington's Disease",
    "version": "1.0",
    "icd10": [
      "** G10 (Huntington disease)"
    ],
    "scope": "** Diagnosis confirmation via genetic testing, chorea management, psychiatric symptom treatment, cognitive decline management, dysphagia assessment, genetic counseling, and end-of-life planning. Focuses primarily on outpatient management. Excludes Huntington disease-like syndromes (HDL1-4) and other chorea etiologies.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "Huntington gene test (HTT CAG repeat)",
            "rationale": "Definitive diagnosis; CAG repeat expansion",
            "target": "≥36 CAG repeats diagnostic (40+ fully penetrant)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CBC",
            "rationale": "Baseline; anemia contributes to fatigue; infection screen",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "BMP",
            "rationale": "Electrolytes; renal function for medication dosing",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Hepatic panel (LFTs)",
            "rationale": "Baseline before tetrabenazine/deutetrabenazine; valproate if used",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "TSH",
            "rationale": "Hypothyroidism can mimic apathy and cognitive slowing",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin B12",
            "rationale": "Deficiency can worsen cognitive and psychiatric symptoms",
            "target": ">300 pg/mL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin D, 25-hydroxy",
            "rationale": "Deficiency common; contributes to falls and bone health",
            "target": ">30 ng/mL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended Workup": [
          {
            "item": "Iron studies, ferritin",
            "rationale": "Neurodegeneration with brain iron accumulation if HD-negative",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ceruloplasmin, serum copper",
            "rationale": "Wilson's disease if younger onset, HD gene-negative",
            "target": "Normal",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "ACTN3 gene test",
            "rationale": "Research; may modify age of onset",
            "target": "Research use",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Acanthocyte screen (peripheral smear)",
            "rationale": "Chorea-acanthocytosis if HD gene-negative",
            "target": "No acanthocytes",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Lipid panel",
            "rationale": "Cardiovascular risk; weight loss monitoring",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Prealbumin/albumin",
            "rationale": "Nutritional status assessment in advanced disease",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Genetic testing for HDL syndromes (PRNP, JPH3, TBP, ATN1)",
            "rationale": "HD-like phenotype with negative HTT test",
            "target": "Identifies HD-like syndrome",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "CSF biomarkers (neurofilament light chain)",
            "rationale": "Disease progression monitoring; research",
            "target": "Elevated in active disease",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Kynurenine pathway metabolites",
            "rationale": "Research; therapeutic target assessment",
            "target": "Research use",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "MRI Brain without contrast",
            "timing": "At diagnosis",
            "target": "Caudate atrophy; lateral ventricle enlargement (\"boxcar\" ventricles)",
            "contraindications": "MRI-incompatible devices",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended": [
          {
            "item": "MRI Brain volumetric",
            "timing": "Baseline and annually for progression",
            "target": "Quantify caudate and striatal volume loss",
            "contraindications": "MRI contraindications",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Swallowing evaluation (VFSS or FEES)",
            "timing": "At diagnosis and with dysphagia symptoms",
            "target": "Identify aspiration risk; guide diet modification",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "ECG",
            "timing": "Baseline before tetrabenazine/deutetrabenazine",
            "target": "QTc <450 ms",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Polysomnography",
            "timing": "Sleep disturbance evaluation",
            "target": "Rule out sleep apnea; assess sleep architecture",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "PET imaging (FDG or specific tracers)",
            "timing": "Research; atypical presentation",
            "target": "Striatal hypometabolism",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Neuropsychological testing battery",
            "timing": "At diagnosis and annually",
            "target": "Baseline cognitive profile; monitor decline",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Genetic modifier testing (research)",
            "timing": "Prognosis; clinical trials",
            "target": "Identifies modifiers of age of onset",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "Lorazepam",
            "route": "IV/PO",
            "indication": "Severe chorea causing injury or exhaustion",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5 mg IV",
                  "orderSentence": "Lorazepam 0.5 mg IV IV/PO"
                },
                {
                  "text": "1 mg IV",
                  "orderSentence": "Lorazepam 1 mg IV IV/PO"
                },
                {
                  "text": "2 mg PO",
                  "orderSentence": "Lorazepam 2 mg PO IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "0.5-2 mg IV/PO q4-6h PRN; short-term use only",
              "orderSentence": "Lorazepam 0.5 mg IV IV/PO"
            },
            "contraindications": "Respiratory depression; acute narrow-angle glaucoma",
            "monitoring": "Respiratory status, sedation",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Haloperidol",
            "route": "IV/IM",
            "indication": "Severe psychosis with agitation; acute behavioral emergency",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 mg IM",
                  "orderSentence": "Haloperidol 2 mg IM IM"
                },
                {
                  "text": "5 mg IM",
                  "orderSentence": "Haloperidol 5 mg IM IM"
                }
              ],
              "route": "IM",
              "instructions": "2-5 mg IM; may repeat q4-6h; max 20 mg/day; transition to oral",
              "orderSentence": "Haloperidol 2 mg IM IM"
            },
            "contraindications": "QTc prolongation; history of NMS; worsens dystonia",
            "monitoring": "ECG, EPS, sedation",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Olanzapine",
            "route": "IM/PO",
            "indication": "Acute agitation with psychosis; alternative to haloperidol",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg IM",
                  "orderSentence": "Olanzapine 5 mg IM IM"
                },
                {
                  "text": "10 mg IM",
                  "orderSentence": "Olanzapine 10 mg IM IM"
                }
              ],
              "route": "IM",
              "instructions": "5-10 mg IM; may repeat in 2 hours; max 30 mg/day",
              "orderSentence": "Olanzapine 5 mg IM IM"
            },
            "contraindications": "Concurrent benzodiazepines (caution); diabetes",
            "monitoring": "Glucose, sedation, EPS",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "IV fluids",
            "route": "IV",
            "indication": "Dehydration from dysphagia or decreased oral intake",
            "dosing": {
              "doseOptions": [
                {
                  "text": "NS at 75-125 mL/hr",
                  "orderSentence": "IV fluids NS at 75-125 mL/hr IV"
                }
              ],
              "route": "IV",
              "instructions": "Correct dehydration; transition to oral when safe",
              "orderSentence": "IV fluids NS at 75-125 mL/hr IV"
            },
            "contraindications": "Fluid overload",
            "monitoring": "I/O, electrolytes",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Thiamine",
            "route": "IV",
            "indication": "Nutritional deficiency; altered mental status",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg IV",
                  "orderSentence": "Thiamine 100 mg IV IV"
                }
              ],
              "route": "IV",
              "instructions": "100 mg IV daily x 3-5 days; then oral",
              "orderSentence": "Thiamine 100 mg IV IV"
            },
            "contraindications": "None",
            "monitoring": "None",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          }
        ],
        "Symptomatic Treatments - Chorea": [
          {
            "item": "Tetrabenazine (Xenazine)",
            "route": "PO",
            "indication": "FDA-approved for HD chorea; first-line",
            "dosing": {
              "doseOptions": [
                {
                  "text": "12.5 mg daily",
                  "orderSentence": "Tetrabenazine (Xenazine) 12.5 mg daily PO"
                },
                {
                  "text": "12.5 mg BID",
                  "orderSentence": "Tetrabenazine (Xenazine) 12.5 mg BID PO"
                },
                {
                  "text": "12.5 mg TID",
                  "orderSentence": "Tetrabenazine (Xenazine) 12.5 mg TID PO"
                },
                {
                  "text": "25 mg TID",
                  "orderSentence": "Tetrabenazine (Xenazine) 25 mg TID PO"
                },
                {
                  "text": "37.5 mg TID",
                  "orderSentence": "Tetrabenazine (Xenazine) 37.5 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 12.5 mg daily; increase by 12.5 mg q1wk; max 100 mg/day (25 mg per dose); CYP2D6 testing recommended",
              "orderSentence": "Tetrabenazine (Xenazine) 12.5 mg daily PO"
            },
            "contraindications": "Active suicidality; untreated depression; concurrent MAOIs; hepatic impairment",
            "monitoring": "Depression (PHQ-9 monthly), akathisia, parkinsonism, QTc",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Deutetrabenazine (Austedo)",
            "route": "PO",
            "indication": "FDA-approved for HD chorea; better tolerability than tetrabenazine",
            "dosing": {
              "doseOptions": [
                {
                  "text": "6 mg daily",
                  "orderSentence": "Deutetrabenazine (Austedo) 6 mg daily PO"
                },
                {
                  "text": "6 mg BID",
                  "orderSentence": "Deutetrabenazine (Austedo) 6 mg BID PO"
                },
                {
                  "text": "9 mg BID",
                  "orderSentence": "Deutetrabenazine (Austedo) 9 mg BID PO"
                },
                {
                  "text": "12 mg BID",
                  "orderSentence": "Deutetrabenazine (Austedo) 12 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 6 mg daily; increase by 6 mg/wk; max 48 mg/day (24 mg per dose)",
              "orderSentence": "Deutetrabenazine (Austedo) 6 mg daily PO"
            },
            "contraindications": "Same as tetrabenazine",
            "monitoring": "Depression, akathisia, parkinsonism, QTc",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Valbenazine (Ingrezza)",
            "route": "PO",
            "indication": "Off-label for HD chorea; once daily dosing",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg daily",
                  "orderSentence": "Valbenazine (Ingrezza) 40 mg daily PO"
                },
                {
                  "text": "80 mg daily",
                  "orderSentence": "Valbenazine (Ingrezza) 80 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 40 mg daily; may increase to 80 mg after 1 week",
              "orderSentence": "Valbenazine (Ingrezza) 40 mg daily PO"
            },
            "contraindications": "Severe hepatic impairment; concurrent MAOIs; congenital long QT",
            "monitoring": "Depression, akathisia, QTc prolongation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Risperidone",
            "route": "PO",
            "indication": "Chorea with psychosis; antipsychotic with motor benefit",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5 mg daily",
                  "orderSentence": "Risperidone 0.5 mg daily PO"
                },
                {
                  "text": "0.5 mg BID",
                  "orderSentence": "Risperidone 0.5 mg BID PO"
                },
                {
                  "text": "1 mg BID",
                  "orderSentence": "Risperidone 1 mg BID PO"
                },
                {
                  "text": "2 mg BID",
                  "orderSentence": "Risperidone 2 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.5 mg daily; titrate by 0.5 mg q1wk; max 6 mg/day",
              "orderSentence": "Risperidone 0.5 mg daily PO"
            },
            "contraindications": "QTc prolongation; history of NMS",
            "monitoring": "EPS, metabolic panel, prolactin",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Olanzapine",
            "route": "PO",
            "indication": "Chorea with weight loss; promotes weight gain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2.5 mg daily",
                  "orderSentence": "Olanzapine 2.5 mg daily PO"
                },
                {
                  "text": "5 mg daily",
                  "orderSentence": "Olanzapine 5 mg daily PO"
                },
                {
                  "text": "10 mg daily",
                  "orderSentence": "Olanzapine 10 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 2.5-5 mg qHS; titrate to effect; typical 5-15 mg/day",
              "orderSentence": "Olanzapine 2.5 mg daily PO"
            },
            "contraindications": "Diabetes; significant metabolic risk",
            "monitoring": "Weight, glucose, lipids",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Clonazepam",
            "route": "PO",
            "indication": "Adjunct for chorea; also helps myoclonus and anxiety",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.25 mg BID",
                  "orderSentence": "Clonazepam 0.25 mg BID PO"
                },
                {
                  "text": "0.5 mg BID",
                  "orderSentence": "Clonazepam 0.5 mg BID PO"
                },
                {
                  "text": "0.5 mg TID",
                  "orderSentence": "Clonazepam 0.5 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.25 mg BID; titrate slowly; max 4 mg/day",
              "orderSentence": "Clonazepam 0.25 mg BID PO"
            },
            "contraindications": "Severe respiratory disease; falls risk",
            "monitoring": "Sedation, falls, cognitive effects",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Amantadine",
            "route": "PO",
            "indication": "Mild chorea; may help fatigue",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg BID",
                  "orderSentence": "Amantadine 100 mg BID PO"
                },
                {
                  "text": "100 mg TID",
                  "orderSentence": "Amantadine 100 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 100 mg daily; titrate to 100 mg TID; max 400 mg/day",
              "orderSentence": "Amantadine 100 mg BID PO"
            },
            "contraindications": "End-stage renal disease; seizure history",
            "monitoring": "Livedo reticularis, hallucinations, edema",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Symptomatic Treatments - Psychiatric": [
          {
            "item": "Sertraline",
            "route": "PO",
            "indication": "Depression; anxiety; irritability",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg daily",
                  "orderSentence": "Sertraline 25 mg daily PO"
                },
                {
                  "text": "50 mg daily",
                  "orderSentence": "Sertraline 50 mg daily PO"
                },
                {
                  "text": "100 mg daily",
                  "orderSentence": "Sertraline 100 mg daily PO"
                },
                {
                  "text": "150 mg daily",
                  "orderSentence": "Sertraline 150 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg daily; titrate by 25-50 mg q1-2wk; max 200 mg/day",
              "orderSentence": "Sertraline 25 mg daily PO"
            },
            "contraindications": "MAOIs within 14 days",
            "monitoring": "Suicidality, serotonin syndrome",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Citalopram",
            "route": "PO",
            "indication": "Depression; anxiety; good tolerability",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg daily",
                  "orderSentence": "Citalopram 10 mg daily PO"
                },
                {
                  "text": "20 mg daily",
                  "orderSentence": "Citalopram 20 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10 mg daily; max 20 mg/day due to QTc risk",
              "orderSentence": "Citalopram 10 mg daily PO"
            },
            "contraindications": "QTc >500 ms; concurrent QT-prolonging drugs",
            "monitoring": "QTc if risk factors",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Escitalopram",
            "route": "PO",
            "indication": "Depression; anxiety; similar to citalopram",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg daily",
                  "orderSentence": "Escitalopram 5 mg daily PO"
                },
                {
                  "text": "10 mg daily",
                  "orderSentence": "Escitalopram 10 mg daily PO"
                },
                {
                  "text": "20 mg daily",
                  "orderSentence": "Escitalopram 20 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5-10 mg daily; max 20 mg/day",
              "orderSentence": "Escitalopram 5 mg daily PO"
            },
            "contraindications": "Same as citalopram",
            "monitoring": "Same as citalopram",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Venlafaxine XR",
            "route": "PO",
            "indication": "Depression with fatigue; dual mechanism",
            "dosing": {
              "doseOptions": [
                {
                  "text": "37.5 mg daily",
                  "orderSentence": "Venlafaxine XR 37.5 mg daily PO"
                },
                {
                  "text": "75 mg daily",
                  "orderSentence": "Venlafaxine XR 75 mg daily PO"
                },
                {
                  "text": "150 mg daily",
                  "orderSentence": "Venlafaxine XR 150 mg daily PO"
                },
                {
                  "text": "225 mg daily",
                  "orderSentence": "Venlafaxine XR 225 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 37.5 mg daily; titrate q1wk; max 225 mg/day",
              "orderSentence": "Venlafaxine XR 37.5 mg daily PO"
            },
            "contraindications": "Uncontrolled hypertension",
            "monitoring": "BP at higher doses",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Mirtazapine",
            "route": "PO",
            "indication": "Depression with insomnia and weight loss; promotes appetite",
            "dosing": {
              "doseOptions": [
                {
                  "text": "7.5 mg qHS",
                  "orderSentence": "Mirtazapine 7.5 mg qHS PO"
                },
                {
                  "text": "15 mg qHS",
                  "orderSentence": "Mirtazapine 15 mg qHS PO"
                },
                {
                  "text": "30 mg qHS",
                  "orderSentence": "Mirtazapine 30 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 7.5-15 mg qHS; titrate q1-2wk; max 45 mg",
              "orderSentence": "Mirtazapine 7.5 mg qHS PO"
            },
            "contraindications": "None significant",
            "monitoring": "Weight, sedation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Quetiapine",
            "route": "PO",
            "indication": "Psychosis; irritability; insomnia; less EPS than other antipsychotics",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Quetiapine 25 mg qHS PO"
                },
                {
                  "text": "50 mg BID",
                  "orderSentence": "Quetiapine 50 mg BID PO"
                },
                {
                  "text": "100 mg BID",
                  "orderSentence": "Quetiapine 100 mg BID PO"
                },
                {
                  "text": "200 mg BID",
                  "orderSentence": "Quetiapine 200 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg qHS; titrate by 25-50 mg q3d; typical 150-400 mg/day",
              "orderSentence": "Quetiapine 25 mg qHS PO"
            },
            "contraindications": "Uncontrolled diabetes",
            "monitoring": "Glucose, lipids, QTc",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Aripiprazole",
            "route": "PO",
            "indication": "Psychosis; irritability; weight-neutral",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 mg daily",
                  "orderSentence": "Aripiprazole 2 mg daily PO"
                },
                {
                  "text": "5 mg daily",
                  "orderSentence": "Aripiprazole 5 mg daily PO"
                },
                {
                  "text": "10 mg daily",
                  "orderSentence": "Aripiprazole 10 mg daily PO"
                },
                {
                  "text": "15 mg daily",
                  "orderSentence": "Aripiprazole 15 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 2-5 mg daily; titrate by 5 mg q1wk; max 30 mg/day",
              "orderSentence": "Aripiprazole 2 mg daily PO"
            },
            "contraindications": "None significant",
            "monitoring": "Akathisia, EPS",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lamotrigine",
            "route": "PO",
            "indication": "Mood stabilization; irritability",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg daily",
                  "orderSentence": "Lamotrigine 25 mg daily PO"
                },
                {
                  "text": "50 mg daily",
                  "orderSentence": "Lamotrigine 50 mg daily PO"
                },
                {
                  "text": "100 mg daily",
                  "orderSentence": "Lamotrigine 100 mg daily PO"
                },
                {
                  "text": "200 mg daily",
                  "orderSentence": "Lamotrigine 200 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg daily x 2wk; then 50 mg daily x 2wk; titrate by 50 mg q2wk; max 400 mg/day",
              "orderSentence": "Lamotrigine 25 mg daily PO"
            },
            "contraindications": "History of severe rash with lamotrigine",
            "monitoring": "Rash (SJS risk); slow titration mandatory",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Valproic acid",
            "route": "PO",
            "indication": "Irritability; aggression; mood stabilization",
            "dosing": {
              "doseOptions": [
                {
                  "text": "250 mg BID",
                  "orderSentence": "Valproic acid 250 mg BID PO"
                },
                {
                  "text": "500 mg BID",
                  "orderSentence": "Valproic acid 500 mg BID PO"
                },
                {
                  "text": "750 mg BID",
                  "orderSentence": "Valproic acid 750 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 250 mg BID; titrate to level 50-100 mcg/mL",
              "orderSentence": "Valproic acid 250 mg BID PO"
            },
            "contraindications": "Hepatic disease; pregnancy (teratogenic); mitochondrial disease",
            "monitoring": "LFTs, ammonia, level, weight",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Carbamazepine",
            "route": "PO",
            "indication": "Irritability; aggression; alternative mood stabilizer",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg BID",
                  "orderSentence": "Carbamazepine 100 mg BID PO"
                },
                {
                  "text": "200 mg BID",
                  "orderSentence": "Carbamazepine 200 mg BID PO"
                },
                {
                  "text": "400 mg BID",
                  "orderSentence": "Carbamazepine 400 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 100 mg BID; titrate by 200 mg/wk; target level 4-12 mcg/mL",
              "orderSentence": "Carbamazepine 100 mg BID PO"
            },
            "contraindications": "AV block; blood dyscrasias; concurrent MAOIs",
            "monitoring": "CBC, LFTs, level, HLA-B*1502 in Asians",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Buspirone",
            "route": "PO",
            "indication": "Anxiety without sedation; adjunct for irritability",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg TID",
                  "orderSentence": "Buspirone 5 mg TID PO"
                },
                {
                  "text": "10 mg TID",
                  "orderSentence": "Buspirone 10 mg TID PO"
                },
                {
                  "text": "15 mg TID",
                  "orderSentence": "Buspirone 15 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg TID; titrate by 5 mg q2-3d; max 60 mg/day",
              "orderSentence": "Buspirone 5 mg TID PO"
            },
            "contraindications": "Concurrent MAOIs",
            "monitoring": "None significant",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Symptomatic Treatments - Cognitive and Other": [
          {
            "item": "Donepezil",
            "route": "PO",
            "indication": "Cognitive impairment; limited evidence in HD",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg qHS",
                  "orderSentence": "Donepezil 5 mg qHS PO"
                },
                {
                  "text": "10 mg qHS",
                  "orderSentence": "Donepezil 10 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg qHS; may increase to 10 mg after 4-6 weeks",
              "orderSentence": "Donepezil 5 mg qHS PO"
            },
            "contraindications": "GI bleeding; sick sinus syndrome",
            "monitoring": "Nausea, bradycardia, diarrhea",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rivastigmine",
            "route": "PO/Patch",
            "indication": "Cognitive impairment; alternative to donepezil",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1.5 mg BID",
                  "orderSentence": "Rivastigmine 1.5 mg BID PO/Patch"
                },
                {
                  "text": "3 mg BID",
                  "orderSentence": "Rivastigmine 3 mg BID PO/Patch"
                },
                {
                  "text": "4.5 mg BID",
                  "orderSentence": "Rivastigmine 4.5 mg BID PO/Patch"
                },
                {
                  "text": "9.5 mg/24hr patch",
                  "orderSentence": "Rivastigmine 9.5 mg/24hr patch PO/Patch"
                },
                {
                  "text": "13.3 mg/24hr patch",
                  "orderSentence": "Rivastigmine 13.3 mg/24hr patch PO/Patch"
                }
              ],
              "route": "PO/Patch",
              "instructions": "Start 1.5 mg BID or 4.6 mg patch; titrate monthly",
              "orderSentence": "Rivastigmine 1.5 mg BID PO/Patch"
            },
            "contraindications": "Severe hepatic impairment",
            "monitoring": "Nausea, weight loss",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Memantine",
            "route": "PO",
            "indication": "Moderate-severe cognitive impairment; neuroprotective theory",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg daily",
                  "orderSentence": "Memantine 5 mg daily PO"
                },
                {
                  "text": "10 mg BID",
                  "orderSentence": "Memantine 10 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg daily; titrate by 5 mg/wk; target 10 mg BID",
              "orderSentence": "Memantine 5 mg daily PO"
            },
            "contraindications": "Severe renal impairment (dose adjust)",
            "monitoring": "Confusion, constipation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Modafinil",
            "route": "PO",
            "indication": "Apathy; excessive daytime sleepiness",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg AM",
                  "orderSentence": "Modafinil 100 mg AM PO"
                },
                {
                  "text": "200 mg AM",
                  "orderSentence": "Modafinil 200 mg AM PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 100 mg each morning; may increase to 200 mg; avoid afternoon dosing",
              "orderSentence": "Modafinil 100 mg AM PO"
            },
            "contraindications": "Arrhythmias; severe anxiety",
            "monitoring": "Insomnia, anxiety, BP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Methylphenidate",
            "route": "PO",
            "indication": "Apathy; bradyphrenia; fatigue",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg BID",
                  "orderSentence": "Methylphenidate 5 mg BID PO"
                },
                {
                  "text": "10 mg BID",
                  "orderSentence": "Methylphenidate 10 mg BID PO"
                },
                {
                  "text": "20 mg BID",
                  "orderSentence": "Methylphenidate 20 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg at breakfast and lunch; titrate by 5-10 mg q1wk; max 60 mg/day",
              "orderSentence": "Methylphenidate 5 mg BID PO"
            },
            "contraindications": "Severe anxiety; psychosis; cardiac arrhythmia",
            "monitoring": "HR, BP, appetite, insomnia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Trazodone",
            "route": "PO",
            "indication": "Insomnia; irritability; mild sedation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Trazodone 25 mg qHS PO"
                },
                {
                  "text": "50 mg qHS",
                  "orderSentence": "Trazodone 50 mg qHS PO"
                },
                {
                  "text": "100 mg qHS",
                  "orderSentence": "Trazodone 100 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25-50 mg qHS; titrate by 25-50 mg; max 200 mg for sleep",
              "orderSentence": "Trazodone 25 mg qHS PO"
            },
            "contraindications": "Concurrent MAOIs; priapism history",
            "monitoring": "Orthostatic hypotension, priapism",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Melatonin",
            "route": "PO",
            "indication": "Insomnia; circadian rhythm disturbance",
            "dosing": {
              "doseOptions": [
                {
                  "text": "3 mg qHS",
                  "orderSentence": "Melatonin 3 mg qHS PO"
                },
                {
                  "text": "6 mg qHS",
                  "orderSentence": "Melatonin 6 mg qHS PO"
                },
                {
                  "text": "9 mg qHS",
                  "orderSentence": "Melatonin 9 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 3 mg 30 min before bed; may increase to 9 mg",
              "orderSentence": "Melatonin 3 mg qHS PO"
            },
            "contraindications": "None",
            "monitoring": "Generally well-tolerated",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Botulinum toxin (onabotulinumtoxinA)",
            "route": "IM",
            "indication": "Focal dystonia; bruxism; sialorrhea",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Variable per muscle",
                  "orderSentence": "Botulinum toxin (onabotulinumtoxinA) Variable per muscle IM"
                }
              ],
              "route": "IM",
              "instructions": "Dose depends on target muscles; repeat q12 weeks",
              "orderSentence": "Botulinum toxin (onabotulinumtoxinA) Variable per muscle IM"
            },
            "contraindications": "Infection at site; myasthenia gravis",
            "monitoring": "Weakness, dysphagia",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Glycopyrrolate",
            "route": "PO",
            "indication": "Sialorrhea (drooling)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 mg BID",
                  "orderSentence": "Glycopyrrolate 1 mg BID PO"
                },
                {
                  "text": "1 mg TID",
                  "orderSentence": "Glycopyrrolate 1 mg TID PO"
                },
                {
                  "text": "2 mg TID",
                  "orderSentence": "Glycopyrrolate 2 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 1 mg BID; titrate to effect; max 2 mg TID",
              "orderSentence": "Glycopyrrolate 1 mg BID PO"
            },
            "contraindications": "Glaucoma; urinary retention; GI obstruction",
            "monitoring": "Dry mouth, constipation, urinary retention",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Polyethylene glycol (MiraLAX)",
            "route": "PO",
            "indication": "Constipation (common with reduced mobility and anticholinergics)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "17 g daily",
                  "orderSentence": "Polyethylene glycol (MiraLAX) 17 g daily PO"
                },
                {
                  "text": "17 g BID",
                  "orderSentence": "Polyethylene glycol (MiraLAX) 17 g BID PO"
                }
              ],
              "route": "PO",
              "instructions": "17 g in 8 oz liquid daily; may increase to BID",
              "orderSentence": "Polyethylene glycol (MiraLAX) 17 g daily PO"
            },
            "contraindications": "Bowel obstruction",
            "monitoring": "Diarrhea if excessive",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "High-calorie nutritional supplements",
            "route": "PO",
            "indication": "Weight loss; increased metabolic demands",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1-3 cans daily",
                  "orderSentence": "High-calorie nutritional supplements 1-3 cans daily PO"
                }
              ],
              "route": "PO",
              "instructions": "1-3 cans (Ensure Plus, Boost Plus) daily between meals",
              "orderSentence": "High-calorie nutritional supplements 1-3 cans daily PO"
            },
            "contraindications": "None",
            "monitoring": "Weight, nutritional markers",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Huntington Disease Society of America (HDSA) Center of Excellence for comprehensive multidisciplinary care",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Genetic counselor for pre-test counseling, results disclosure, and family testing discussion",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Psychiatry for depression, suicidality assessment, irritability, and psychosis management",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Neuropsychology for baseline and serial cognitive assessment to guide care planning",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Speech-language pathology for swallowing evaluation and communication strategies",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Physical therapy for gait training, fall prevention, and adaptive exercise program",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Occupational therapy for ADL adaptation, home safety evaluation, and energy conservation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Dietitian/nutritionist for weight maintenance strategies and caloric supplementation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Social work for caregiver support, disability planning, and community resources",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Palliative care for symptom management, advance care planning, and goals of care discussions",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pulmonology for respiratory assessment in advanced disease and ventilation decisions",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Gastroenterology for PEG tube placement consideration in advanced dysphagia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "CRITICAL: Report suicidal thoughts immediately as depression is common and treatable in HD",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Do not drive if experiencing significant chorea, cognitive impairment, or sedating medication effects",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Maintain high caloric intake (3000-4000 kcal/day may be needed) due to hypermetabolic state",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Eat slowly, take small bites, and remain upright 30 minutes after meals to reduce aspiration risk",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Complete advance directive and healthcare power of attorney while capacity is preserved",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Inform all healthcare providers about HD as many common medications can worsen symptoms",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "First-degree relatives have 50% risk; genetic counseling available but genetic testing is a personal choice",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid alcohol which worsens balance, cognition, and interacts with medications",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Regular aerobic exercise (walking, swimming, stationary bike) improves motor function and mood",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Fall prevention: remove home hazards, adequate lighting, grab bars, non-slip surfaces",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Maintain social engagement and meaningful activities to reduce depression and apathy",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Cognitive engagement through puzzles, reading, and structured activities may help maintain function",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Structure daily routine with consistent timing for medications, meals, and activities",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Caregiver respite and support groups essential to prevent caregiver burnout",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Smoking cessation to reduce aspiration pneumonia risk and cardiovascular disease",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Limit caffeine if insomnia or anxiety are problematic",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Huntington disease-like 1 (HDL1)",
        "features": "Prion protein gene mutation; similar phenotype",
        "tests": "PRNP gene testing"
      },
      {
        "diagnosis": "Huntington disease-like 2 (HDL2)",
        "features": "African ancestry; JPH3 gene mutation",
        "tests": "JPH3 gene testing"
      },
      {
        "diagnosis": "Spinocerebellar ataxia 17 (HDL4)",
        "features": "Prominent ataxia; TBP gene expansion",
        "tests": "TBP gene testing"
      },
      {
        "diagnosis": "Chorea-acanthocytosis",
        "features": "Orolingual dystonia; self-mutilation; acanthocytes",
        "tests": "Peripheral smear; VPS13A gene testing"
      },
      {
        "diagnosis": "McLeod syndrome",
        "features": "X-linked; cardiomyopathy; elevated CK",
        "tests": "Kell antigen typing; XK gene testing"
      },
      {
        "diagnosis": "Sydenham chorea",
        "features": "Post-streptococcal; younger patients; self-limited",
        "tests": "ASO titer; anti-DNAse B"
      },
      {
        "diagnosis": "Benign hereditary chorea",
        "features": "Childhood onset; non-progressive; NKX2-1 mutation",
        "tests": "NKX2-1 gene testing; family history"
      },
      {
        "diagnosis": "Wilson's disease",
        "features": "Younger onset; Kayser-Fleischer rings; hepatic disease",
        "tests": "Ceruloplasmin; 24-hr urine copper; slit lamp"
      },
      {
        "diagnosis": "Neuroacanthocytosis",
        "features": "Peripheral neuropathy; seizures; elevated CK",
        "tests": "Peripheral smear; genetic testing"
      },
      {
        "diagnosis": "Tardive dyskinesia",
        "features": "Antipsychotic exposure; orobuccal predominant",
        "tests": "Medication history; AIMS scale"
      },
      {
        "diagnosis": "Anti-NMDA receptor encephalitis",
        "features": "Psychiatric symptoms; seizures; dyskinesias",
        "tests": "NMDA receptor antibodies; CSF analysis"
      }
    ],
    "evidence": [
      {
        "recommendation": "Tetrabenazine reduces chorea in HD",
        "evidenceLevel": "Class I, Level A",
        "source": "[Huntington Study Group. Neurology 2006](https://pubmed.ncbi.nlm.nih.gov/16894067/)"
      },
      {
        "recommendation": "Deutetrabenazine reduces chorea with improved tolerability",
        "evidenceLevel": "Class I, Level A",
        "source": "[Huntington Study Group. JAMA 2016](https://pubmed.ncbi.nlm.nih.gov/27532915/)"
      },
      {
        "recommendation": "CAG repeat length inversely correlates with age of onset",
        "evidenceLevel": "Class II, Level B",
        "source": "[Andrew et al. Nat Genet 1993](https://pubmed.ncbi.nlm.nih.gov/8401577/)"
      },
      {
        "recommendation": "AAN practice parameter for HD treatment",
        "evidenceLevel": "Guideline",
        "source": "[Armstrong & Miyasaki. Neurology 2012](https://pubmed.ncbi.nlm.nih.gov/22815562/)"
      },
      {
        "recommendation": "High suicide rate in HD requires screening",
        "evidenceLevel": "Class II, Level B",
        "source": "[Paulsen et al. J Neuropsychiatry Clin Neurosci 2005](https://pubmed.ncbi.nlm.nih.gov/16179652/)"
      },
      {
        "recommendation": "UHDRS reliable for tracking disease progression",
        "evidenceLevel": "Class II, Level A",
        "source": "[Huntington Study Group. Mov Disord 1996](https://pubmed.ncbi.nlm.nih.gov/8684382/)"
      },
      {
        "recommendation": "CYP2D6 genotype affects tetrabenazine metabolism",
        "evidenceLevel": "Class II, Level B",
        "source": "[Xenazine FDA prescribing information 2008](https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021894lbl.pdf)"
      },
      {
        "recommendation": "Genetic counseling improves outcomes in at-risk individuals",
        "evidenceLevel": "Class II, Level B",
        "source": "[Tibben. Handb Clin Neurol 2007](https://pubmed.ncbi.nlm.nih.gov/18808860/)"
      },
      {
        "recommendation": "Dysphagia common and associated with aspiration risk",
        "evidenceLevel": "Class II, Level C",
        "source": "[Heemskerk & Roos. Dysphagia 2011](https://pubmed.ncbi.nlm.nih.gov/20803049/)"
      },
      {
        "recommendation": "Multidisciplinary care improves outcomes",
        "evidenceLevel": "Class III, Level C",
        "source": "[Veenhuizen & Bherer. J Huntingtons Dis 2017](https://pubmed.ncbi.nlm.nih.gov/28339403/)"
      },
      {
        "recommendation": "Exercise benefits motor and cognitive function",
        "evidenceLevel": "Class II, Level B",
        "source": "[Quinn et al. Cochrane Database Syst Rev 2022](https://pubmed.ncbi.nlm.nih.gov/35416314/)"
      },
      {
        "recommendation": "Valbenazine effective for hyperkinetic movements",
        "evidenceLevel": "Class I, Level A",
        "source": "[Hauser et al. JAMA Neurol 2017](https://pubmed.ncbi.nlm.nih.gov/28241163/)"
      }
    ],
    "monitoring": [
      {
        "item": "UHDRS (Unified Huntington's Disease Rating Scale)",
        "frequency": "Every 6-12 months",
        "action": "Adjust medications; update care plan",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Depression screening (PHQ-9)",
        "frequency": "Every visit; monthly if on VMAT2 inhibitor",
        "action": "Intensify antidepressant; psychiatry referral if PHQ-9 >15",
        "ED": "URGENT",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Suicidality assessment",
        "frequency": "Every visit",
        "action": "Immediate psychiatric evaluation; safety planning",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Cognitive assessment (MoCA or MMSE)",
        "frequency": "Every 6-12 months",
        "action": "Update care planning; capacity assessment",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Weight",
        "frequency": "Every visit",
        "action": "Increase caloric intake; dietitian referral",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Swallowing function",
        "frequency": "Annually or if symptoms",
        "action": "Modify diet texture; speech therapy; PEG consideration",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "ECG (if on VMAT2 inhibitor)",
        "frequency": "Baseline and with dose changes",
        "action": "Hold medication if QTc >500 ms; reduce dose",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Functional independence (TFC)",
        "frequency": "Every 6-12 months",
        "action": "Adjust level of care; advance care planning",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Caregiver burden assessment",
        "frequency": "Annually",
        "action": "Respite care; support resources",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Falls frequency",
        "frequency": "Each visit",
        "action": "PT referral; home safety; medication review",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      }
    ],
    "disposition": [
      {
        "disposition": "Discharge home",
        "criteria": "Stable psychiatric status; adequate oral intake; safe swallowing; caregiver available; outpatient follow-up arranged"
      },
      {
        "disposition": "Admit to floor",
        "criteria": "Severe psychiatric symptoms requiring stabilization; aspiration pneumonia; significant weight loss requiring evaluation; severe chorea causing exhaustion or injury"
      },
      {
        "disposition": "Admit to ICU",
        "criteria": "Aspiration with respiratory failure; severe rhabdomyolysis from chorea; neuroleptic malignant syndrome; suicidal attempt requiring medical stabilization"
      },
      {
        "disposition": "Skilled nursing facility",
        "criteria": "Advanced disease; 24-hour care needs; dysphagia requiring supervision; frequent falls; caregiver unable to provide required care"
      },
      {
        "disposition": "Hospice referral",
        "criteria": "End-stage disease (TFC stage 5); recurrent aspiration; patient/family goals favor comfort care"
      }
    ]
  },
  "Tardive Dyskinesia": {
    "id": "tardive-dyskinesia",
    "title": "Tardive Dyskinesia",
    "version": "1.0",
    "icd10": [
      "** G24.01 (Drug-induced tardive dyskinesia)",
      "G24.02 (Drug-induced acute dystonia)",
      "G24.09 (Drug-induced dystonia",
      "unspecified)"
    ],
    "scope": "** Diagnosis confirmation, severity assessment using AIMS, identification of causative agents, risk factor evaluation, FDA-approved VMAT2 inhibitor therapy, antipsychotic management strategies, prevention, and psychiatric coordination. Covers classic orofacial-lingual TD, tardive dystonia, tardive akathisia, and tardive stereotypy.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CMP (comprehensive metabolic panel)",
            "rationale": "Baseline renal/hepatic function before VMAT2 inhibitor therapy; electrolyte abnormalities can worsen movements",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "CBC with differential",
            "rationale": "Baseline for medication monitoring; rule out infection if acute change",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "TSH",
            "rationale": "Thyroid dysfunction can cause or exacerbate movement disorders",
            "target": "Normal (0.4-4.0 mIU/L)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Medication and dose history review",
            "rationale": "Identify causative agent(s): antipsychotics, metoclopramide, prochlorperazine, other dopamine blockers",
            "target": "Document agent, duration, cumulative dose",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended Workup": [
          {
            "item": "Ceruloplasmin, serum copper",
            "rationale": "Rule out Wilson's disease if age <50 or atypical presentation",
            "target": "Normal",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "24-hour urine copper",
            "rationale": "Wilson's disease confirmation if ceruloplasmin low or borderline",
            "target": "<100 μg/24hr",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Vitamin B12, folate",
            "rationale": "Deficiency can cause movement disorders",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Iron studies (ferritin, serum iron, TIBC)",
            "rationale": "Rule out brain iron accumulation disorders",
            "target": "Normal",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CK (creatine kinase)",
            "rationale": "If concern for neuroleptic malignant syndrome or severe dystonia",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Antipsychotic drug level",
            "rationale": "Assess compliance and toxicity if indicated",
            "target": "Therapeutic range",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Huntington disease genetic testing (HTT CAG repeats)",
            "rationale": "Chorea with psychiatric history; family history",
            "target": "<36 CAG repeats (normal)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Acanthocyte smear",
            "rationale": "Neuroacanthocytosis if orofacial dyskinesia with chorea",
            "target": "Negative",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Paraneoplastic antibody panel",
            "rationale": "Atypical movement disorder; occult malignancy; autoimmune chorea",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Anti-NMDA receptor antibodies",
            "rationale": "Young patient; psychiatric symptoms; orofacial dyskinesia",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "SLC6A3 genetic testing (DAT-1)",
            "rationale": "Research; consider if dopamine transporter dysfunction suspected",
            "target": "Normal",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "AIMS (Abnormal Involuntary Movement Scale)",
            "timing": "At evaluation; before treatment; q3-6 months on antipsychotics",
            "target": "Document baseline severity (0-4 scale per item; total score)",
            "contraindications": "None",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Clinical examination (orofacial, trunk, limbs)",
            "timing": "At evaluation",
            "target": "Characterize movement type, distribution, severity",
            "contraindications": "None",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Video documentation",
            "timing": "At baseline and follow-up",
            "target": "Record for comparison; share with psychiatry",
            "contraindications": "Patient consent",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended": [
          {
            "item": "MRI Brain",
            "timing": "Atypical presentation; focal findings; rule out structural lesion",
            "target": "Normal or chronic dopaminergic medication changes",
            "contraindications": "MRI-incompatible devices",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "DaTscan (ioflupane I-123)",
            "timing": "Differentiate from Parkinson's disease or Huntington's if uncertain",
            "target": "Normal or mild reduction (dopamine blockers can affect)",
            "contraindications": "Iodine hypersensitivity",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "MRI Brain with SWI sequence",
            "timing": "Suspected brain iron accumulation (NBIA)",
            "target": "No abnormal iron deposition",
            "contraindications": "MRI contraindications",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "PET scan (FDG or dopamine receptor imaging)",
            "timing": "Research; atypical cases",
            "target": "Variable",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Slit lamp examination",
            "timing": "Wilson's disease evaluation",
            "target": "No Kayser-Fleischer rings",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "EMG",
            "timing": "Characterize tremor vs dystonic movements",
            "target": "Define movement characteristics",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "Discontinue or reduce causative agent",
            "route": "N/A",
            "indication": "First step if psychiatrically safe; requires psychiatry coordination",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Discontinue or reduce causative agent N/A N/A"
                }
              ],
              "route": "N/A",
              "instructions": "Collaborate with psychiatry; gradual taper preferred if stopping; dose reduction may help",
              "orderSentence": "Discontinue or reduce causative agent N/A N/A"
            },
            "contraindications": "Cannot discontinue if psychosis relapse risk too high",
            "monitoring": "Monitor for psychiatric decompensation",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Switch to clozapine",
            "route": "PO",
            "indication": "Lowest TD risk; for patients requiring continued antipsychotic",
            "dosing": {
              "doseOptions": [
                {
                  "text": "12.5 mg qHS",
                  "orderSentence": "Switch to clozapine 12.5 mg qHS PO"
                },
                {
                  "text": "25 mg BID",
                  "orderSentence": "Switch to clozapine 25 mg BID PO"
                },
                {
                  "text": "50 mg BID",
                  "orderSentence": "Switch to clozapine 50 mg BID PO"
                },
                {
                  "text": "100 mg BID",
                  "orderSentence": "Switch to clozapine 100 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 12.5-25 mg/day; titrate by 25-50 mg q3-7d; target 200-450 mg/day; requires REMS",
              "orderSentence": "Switch to clozapine 12.5 mg qHS PO"
            },
            "contraindications": "Agranulocytosis history; severe neutropenia; seizure disorder (relative)",
            "monitoring": "ANC weekly x 6mo, q2wk x 6mo, then monthly; seizures; myocarditis",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Switch to quetiapine",
            "route": "PO",
            "indication": "Lower TD risk; for patients requiring continued antipsychotic",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg BID",
                  "orderSentence": "Switch to quetiapine 25 mg BID PO"
                },
                {
                  "text": "50 mg BID",
                  "orderSentence": "Switch to quetiapine 50 mg BID PO"
                },
                {
                  "text": "100 mg BID",
                  "orderSentence": "Switch to quetiapine 100 mg BID PO"
                },
                {
                  "text": "200 mg BID",
                  "orderSentence": "Switch to quetiapine 200 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25-50 mg BID; titrate by 50-100 mg/day q2-3d; target 300-800 mg/day",
              "orderSentence": "Switch to quetiapine 25 mg BID PO"
            },
            "contraindications": "QT prolongation; severe hepatic impairment",
            "monitoring": "QTc, sedation, metabolic parameters",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Benzodiazepine (severe distress)",
            "route": "PO/IV",
            "indication": "Severe anxiety/distress from TD movements; temporary relief",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5 mg TID",
                  "orderSentence": "Benzodiazepine (severe distress) 0.5 mg TID PO"
                },
                {
                  "text": "1 mg TID",
                  "orderSentence": "Benzodiazepine (severe distress) 1 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Lorazepam 0.5-1 mg TID PRN for acute distress; short-term only",
              "orderSentence": "Benzodiazepine (severe distress) 0.5 mg TID PO"
            },
            "contraindications": "Respiratory depression; substance use disorder",
            "monitoring": "Sedation, respiratory status",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT"
          }
        ],
        "Symptomatic Treatments (FDA-Approved for TD)": [
          {
            "item": "Valbenazine (Ingrezza)",
            "route": "PO",
            "indication": "FDA-approved first-line for TD; VMAT2 inhibitor",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg daily",
                  "orderSentence": "Valbenazine (Ingrezza) 40 mg daily PO"
                },
                {
                  "text": "80 mg daily",
                  "orderSentence": "Valbenazine (Ingrezza) 80 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 40 mg once daily; increase to 80 mg daily after 1 week if tolerated; take with or without food",
              "orderSentence": "Valbenazine (Ingrezza) 40 mg daily PO"
            },
            "contraindications": "Congenital long QT; strong CYP2D6 inhibitors at higher dose; severe hepatic impairment",
            "monitoring": "QTc (baseline, after dose increase); somnolence; depression",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Deutetrabenazine (Austedo)",
            "route": "PO",
            "indication": "FDA-approved first-line for TD; VMAT2 inhibitor",
            "dosing": {
              "doseOptions": [
                {
                  "text": "6 mg BID",
                  "orderSentence": "Deutetrabenazine (Austedo) 6 mg BID PO"
                },
                {
                  "text": "9 mg BID",
                  "orderSentence": "Deutetrabenazine (Austedo) 9 mg BID PO"
                },
                {
                  "text": "12 mg BID",
                  "orderSentence": "Deutetrabenazine (Austedo) 12 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 6 mg BID (12 mg/day); increase by 6 mg/day weekly; max 48 mg/day; take with food",
              "orderSentence": "Deutetrabenazine (Austedo) 6 mg BID PO"
            },
            "contraindications": "Depression/suicidality; MAO-I use; hepatic impairment; reserpine use within 20 days",
            "monitoring": "Depression (PHQ-9); parkinsonism; QTc; akathisia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Tetrabenazine (Xenazine)",
            "route": "PO",
            "indication": "VMAT2 inhibitor; older agent with more side effects",
            "dosing": {
              "doseOptions": [
                {
                  "text": "12.5 mg daily",
                  "orderSentence": "Tetrabenazine (Xenazine) 12.5 mg daily PO"
                },
                {
                  "text": "12.5 mg BID",
                  "orderSentence": "Tetrabenazine (Xenazine) 12.5 mg BID PO"
                },
                {
                  "text": "12.5 mg TID",
                  "orderSentence": "Tetrabenazine (Xenazine) 12.5 mg TID PO"
                },
                {
                  "text": "25 mg TID",
                  "orderSentence": "Tetrabenazine (Xenazine) 25 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 12.5 mg daily; increase by 12.5 mg q1wk; max 50 mg/day (100 mg if CYP2D6 extensive metabolizer); require CYP2D6 genotyping >50 mg",
              "orderSentence": "Tetrabenazine (Xenazine) 12.5 mg daily PO"
            },
            "contraindications": "Depression/suicidality; untreated or inadequately treated depression",
            "monitoring": "Depression (PHQ-9); parkinsonism; akathisia; sedation; requires CYP2D6 genotyping",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Second-line/Refractory": [
          {
            "item": "Clonazepam",
            "route": "PO",
            "indication": "Adjunct for TD; limited evidence; reduces choreiform movements",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.25 mg BID",
                  "orderSentence": "Clonazepam 0.25 mg BID PO"
                },
                {
                  "text": "0.5 mg BID",
                  "orderSentence": "Clonazepam 0.5 mg BID PO"
                },
                {
                  "text": "1 mg BID",
                  "orderSentence": "Clonazepam 1 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.25 mg BID; titrate slowly; typical 0.5-4 mg/day divided",
              "orderSentence": "Clonazepam 0.25 mg BID PO"
            },
            "contraindications": "Respiratory depression; substance use disorder",
            "monitoring": "Sedation, dependence, falls",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Amantadine",
            "route": "PO",
            "indication": "Limited evidence; may reduce TD severity; antiglutamatergic",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg BID",
                  "orderSentence": "Amantadine 100 mg BID PO"
                },
                {
                  "text": "100 mg TID",
                  "orderSentence": "Amantadine 100 mg TID PO"
                },
                {
                  "text": "200 mg BID",
                  "orderSentence": "Amantadine 200 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 100 mg BID; may increase to 300-400 mg/day divided; adjust for renal function",
              "orderSentence": "Amantadine 100 mg BID PO"
            },
            "contraindications": "Severe renal impairment; seizure history (relative)",
            "monitoring": "Livedo reticularis; edema; hallucinations; confusion (elderly)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ginkgo biloba",
            "route": "PO",
            "indication": "Limited evidence; antioxidant mechanism; modest benefit in trials",
            "dosing": {
              "doseOptions": [
                {
                  "text": "120 mg BID",
                  "orderSentence": "Ginkgo biloba 120 mg BID PO"
                },
                {
                  "text": "240 mg daily",
                  "orderSentence": "Ginkgo biloba 240 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "240 mg/day divided; EGb 761 extract standardized",
              "orderSentence": "Ginkgo biloba 120 mg BID PO"
            },
            "contraindications": "Bleeding disorders; anticoagulant use",
            "monitoring": "Bleeding risk",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin E",
            "route": "PO",
            "indication": "Limited evidence; may prevent progression; minimal therapeutic effect",
            "dosing": {
              "doseOptions": [
                {
                  "text": "400 IU daily",
                  "orderSentence": "Vitamin E 400 IU daily PO"
                },
                {
                  "text": "800 IU daily",
                  "orderSentence": "Vitamin E 800 IU daily PO"
                }
              ],
              "route": "PO",
              "instructions": "400-1600 IU daily; better evidence for prevention than treatment",
              "orderSentence": "Vitamin E 400 IU daily PO"
            },
            "contraindications": "Coagulopathy; vitamin K deficiency",
            "monitoring": "Bleeding risk at high doses",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin B6 (pyridoxine)",
            "route": "PO",
            "indication": "Limited evidence; some trials show benefit",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg daily",
                  "orderSentence": "Vitamin B6 (pyridoxine) 100 mg daily PO"
                },
                {
                  "text": "200 mg daily",
                  "orderSentence": "Vitamin B6 (pyridoxine) 200 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "100-400 mg daily; monitor for neuropathy at high doses",
              "orderSentence": "Vitamin B6 (pyridoxine) 100 mg daily PO"
            },
            "contraindications": "Peripheral neuropathy",
            "monitoring": "Neuropathy with chronic high dose (>200 mg)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Levetiracetam",
            "route": "PO",
            "indication": "Limited evidence; case reports of benefit",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mg BID",
                  "orderSentence": "Levetiracetam 500 mg BID PO"
                },
                {
                  "text": "750 mg BID",
                  "orderSentence": "Levetiracetam 750 mg BID PO"
                },
                {
                  "text": "1000 mg BID",
                  "orderSentence": "Levetiracetam 1000 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 500 mg BID; titrate to 1500-3000 mg/day; adjust for renal function",
              "orderSentence": "Levetiracetam 500 mg BID PO"
            },
            "contraindications": "Severe renal impairment without adjustment",
            "monitoring": "Mood changes; sedation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Propranolol",
            "route": "PO",
            "indication": "For tardive akathisia component",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg TID",
                  "orderSentence": "Propranolol 10 mg TID PO"
                },
                {
                  "text": "20 mg TID",
                  "orderSentence": "Propranolol 20 mg TID PO"
                },
                {
                  "text": "40 mg TID",
                  "orderSentence": "Propranolol 40 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10 mg TID; titrate to 30-120 mg/day divided",
              "orderSentence": "Propranolol 10 mg TID PO"
            },
            "contraindications": "Asthma; bradycardia; heart block",
            "monitoring": "HR, BP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Interventional/Advanced Therapies": [
          {
            "item": "Botulinum toxin (focal TD)",
            "route": "IM",
            "indication": "Focal tardive dystonia (e.g., cervical, blepharospasm)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Dose varies by target",
                  "orderSentence": "Botulinum toxin (focal TD) Dose varies by target IM"
                }
              ],
              "route": "IM",
              "instructions": "Cervical: 100-300 units; blepharospasm: 25-50 units per eye; repeat q3mo",
              "orderSentence": "Botulinum toxin (focal TD) Dose varies by target IM"
            },
            "pretreatment": "EMG guidance recommended for some targets",
            "contraindications": "Active infection at site; myasthenia gravis",
            "monitoring": "Dysphagia (cervical); ptosis (periocular); local weakness",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Deep brain stimulation (DBS)",
            "route": "Surgical",
            "indication": "Severe, disabling, medication-refractory TD",
            "dosing": {
              "doseOptions": [
                {
                  "text": "GPi (globus pallidus internus) target",
                  "orderSentence": "Deep brain stimulation (DBS) GPi (globus pallidus internus) target Surgical"
                }
              ],
              "route": "Surgical",
              "instructions": "Bilateral GPi most common; programming optimization over months",
              "orderSentence": "Deep brain stimulation (DBS) GPi (globus pallidus internus) target Surgical"
            },
            "pretreatment": "MRI; neuropsychological testing; multidisciplinary evaluation; psychiatry clearance",
            "contraindications": "Untreated psychiatric instability; cognitive impairment; coagulopathy",
            "monitoring": "Programming; psychiatric monitoring; speech/swallowing",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Pallidal lesioning",
            "route": "Surgical",
            "indication": "Alternative to DBS if not candidate; irreversible",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Unilateral pallidotomy",
                  "orderSentence": "Pallidal lesioning Unilateral pallidotomy Surgical"
                }
              ],
              "route": "Surgical",
              "instructions": "Stereotactic lesion of GPi; reserved for DBS failures or contraindications",
              "orderSentence": "Pallidal lesioning Unilateral pallidotomy Surgical"
            },
            "pretreatment": "Same as DBS",
            "contraindications": "Same as DBS",
            "monitoring": "Permanent side effect risk higher than DBS",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Psychiatry consultation for antipsychotic management, dose reduction, or switch to lower-risk agent (ESSENTIAL - requires collaborative decision-making)",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Movement disorders neurology for diagnosis confirmation, AIMS scoring, and VMAT2 inhibitor initiation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Neurosurgery consultation for DBS evaluation if medication-refractory disabling TD",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Speech therapy for dysphagia evaluation if oropharyngeal involvement",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Occupational therapy for adaptive strategies if hand involvement affects function",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Social work for disability evaluation and resources if TD causes functional impairment",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Dentistry for oral health evaluation with orofacial TD (tooth damage, denture issues)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Report any worsening movements, difficulty swallowing, or breathing problems immediately (may indicate progression)",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Do not stop antipsychotic medications without psychiatry guidance as this can worsen psychosis or cause withdrawal dyskinesia",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Report any new or worsening depression, suicidal thoughts, or mood changes on VMAT2 inhibitors (boxed warning)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Movements may temporarily worsen after stopping causative drug before improving (withdrawal dyskinesia)",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "VMAT2 inhibitors may take 2-6 weeks to show maximum benefit; continue as prescribed",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid caffeine and stimulants which may worsen involuntary movements",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Maintain regular dental visits for oral health if orofacial TD present (prevents tooth damage, ulceration)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Consider support groups and counseling for coping with visible movement disorder",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Use lowest effective antipsychotic dose for shortest duration needed (primary prevention)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Perform AIMS examination at baseline, 3 months, 6 months, then q6-12 months on dopamine-blocking agents",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Prefer second-generation antipsychotics over first-generation when clinically appropriate (lower TD risk)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid metoclopramide for >12 weeks; use domperidone or other alternatives when possible (not available in US)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Document informed consent regarding TD risk when starting dopamine-blocking agents",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Identify and monitor high-risk patients more frequently: elderly, female, mood disorders, diabetes, longer exposure, higher cumulative dose",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Consider early intervention with VMAT2 inhibitors before TD becomes severe and irreversible",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Stress management and adequate sleep may help reduce movement severity",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Huntington disease",
        "features": "Family history; cognitive decline; chorea; CAG expansion",
        "tests": "Genetic testing for HTT CAG repeats"
      },
      {
        "diagnosis": "Sydenham chorea",
        "features": "History of rheumatic fever; anti-streptolysin O; younger patients",
        "tests": "ASO titer; echocardiogram"
      },
      {
        "diagnosis": "Withdrawal dyskinesia",
        "features": "Occurs immediately after stopping dopamine blocker; self-limited (<3 months)",
        "tests": "History; timeline (TD persists >3 months)"
      },
      {
        "diagnosis": "Spontaneous orofacial dyskinesia (elderly)",
        "features": "Elderly without antipsychotic exposure; edentulous",
        "tests": "Careful medication history; dental exam"
      },
      {
        "diagnosis": "Wilson disease",
        "features": "Age <50; Kayser-Fleischer rings; liver disease; psychiatric symptoms",
        "tests": "Ceruloplasmin; 24h urine copper; slit lamp"
      },
      {
        "diagnosis": "Neuroacanthocytosis",
        "features": "Orofacial dyskinesia; chorea; self-mutilation; elevated CK; acanthocytes",
        "tests": "Acanthocyte smear; CK; genetic testing"
      },
      {
        "diagnosis": "Autoimmune chorea (anti-NMDA, anti-LGI1)",
        "features": "Subacute onset; psychiatric symptoms; seizures; encephalopathy",
        "tests": "Autoimmune antibody panels; CSF"
      },
      {
        "diagnosis": "Meige syndrome (primary cranial dystonia)",
        "features": "Blepharospasm and oromandibular dystonia without antipsychotic exposure",
        "tests": "Clinical history; no dopamine blocker use"
      },
      {
        "diagnosis": "Tourette syndrome",
        "features": "Childhood onset; tics (brief, suppressible); premonitory urge",
        "tests": "Clinical criteria; onset <18 years"
      },
      {
        "diagnosis": "Drug-induced acute dystonia",
        "features": "Occurs within days of drug exposure; not persistent",
        "tests": "Timeline (acute dystonia is immediate, TD delayed)"
      },
      {
        "diagnosis": "Parkinson disease dyskinesia",
        "features": "History of Parkinson's; peak-dose or diphasic dyskinesia on levodopa",
        "tests": "Clear PD diagnosis; levodopa relationship"
      },
      {
        "diagnosis": "Hyperthyroidism",
        "features": "Tremor predominant; tachycardia; weight loss; heat intolerance",
        "tests": "TSH, free T4"
      }
    ],
    "evidence": [
      {
        "recommendation": "Valbenazine FDA-approved for TD (KINECT 3)",
        "evidenceLevel": "Class I, Level A",
        "source": "[Hauser et al. Am J Psychiatry 2017](https://pubmed.ncbi.nlm.nih.gov/28320224/)"
      },
      {
        "recommendation": "Valbenazine efficacy and safety (KINECT 4)",
        "evidenceLevel": "Class I, Level A",
        "source": "[Factor et al. J Clin Psychiatry 2017](https://pubmed.ncbi.nlm.nih.gov/29141123/)"
      },
      {
        "recommendation": "Deutetrabenazine FDA-approved for TD (ARM-TD/AIM-TD)",
        "evidenceLevel": "Class I, Level A",
        "source": "[Anderson et al. JAMA Neurol 2017](https://pubmed.ncbi.nlm.nih.gov/28586827/)"
      },
      {
        "recommendation": "Tetrabenazine efficacy for TD",
        "evidenceLevel": "Class II, Level B",
        "source": "[Kenney et al. Expert Rev Neurother 2006](https://pubmed.ncbi.nlm.nih.gov/17052096/)"
      },
      {
        "recommendation": "AIMS as standard TD assessment",
        "evidenceLevel": "Class II, Level B",
        "source": "[Guy W. ECDEU Assessment Manual 1976](https://pubmed.ncbi.nlm.nih.gov/28685532/)"
      },
      {
        "recommendation": "Clozapine lowest TD risk",
        "evidenceLevel": "Class II, Level B",
        "source": "[Correll et al. J Clin Psychiatry 2004](https://pubmed.ncbi.nlm.nih.gov/15291684/)"
      },
      {
        "recommendation": "Second-generation antipsychotics lower TD risk than first-generation",
        "evidenceLevel": "Class I, Level A",
        "source": "[Carbon et al. World Psychiatry 2017](https://pubmed.ncbi.nlm.nih.gov/28941101/)"
      },
      {
        "recommendation": "Risk factors for TD (age, duration, dose, diabetes)",
        "evidenceLevel": "Class II, Level B",
        "source": "[Woerner et al. J Clin Psychopharmacol 1998](https://pubmed.ncbi.nlm.nih.gov/9555598/)"
      },
      {
        "recommendation": "AAN evidence-based guideline for TD treatment",
        "evidenceLevel": "Class I-IV, Level A-U",
        "source": "[Bhidayasiri et al. Mov Disord 2018](https://pubmed.ncbi.nlm.nih.gov/29352501/)"
      },
      {
        "recommendation": "DBS for medication-refractory TD",
        "evidenceLevel": "Class IV, Level C",
        "source": "[Macerollo et al. J Neurol 2020](https://pubmed.ncbi.nlm.nih.gov/32367207/)"
      },
      {
        "recommendation": "Ginkgo biloba modest benefit in TD",
        "evidenceLevel": "Class II, Level B",
        "source": "[Zhang et al. J Clin Psychiatry 2011](https://pubmed.ncbi.nlm.nih.gov/22075213/)"
      },
      {
        "recommendation": "Vitamin E for TD prevention (not treatment)",
        "evidenceLevel": "Class II, Level U",
        "source": "[Soares-Weiser et al. Cochrane 2018](https://pubmed.ncbi.nlm.nih.gov/29552749/)"
      },
      {
        "recommendation": "Clonazepam for TD",
        "evidenceLevel": "Class IV, Level U",
        "source": "[Thaker et al. Acta Psychiatr Scand 1990](https://pubmed.ncbi.nlm.nih.gov/1978471/)"
      },
      {
        "recommendation": "Metoclopramide black box warning (>12 weeks increases TD risk)",
        "evidenceLevel": "Regulatory guidance",
        "source": "[FDA Drug Safety Communication 2009](https://www.fda.gov/drugs/drug-safety-and-availability/fda-requires-boxed-warning-and-risk-mitigation-strategy-metoclopramide-containing-drugs)"
      }
    ],
    "monitoring": [
      {
        "item": "AIMS score",
        "frequency": "Baseline, 3mo, 6mo, then q6-12mo on antipsychotics",
        "action": "Adjust treatment; consider VMAT2 inhibitor",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "AIMS score on VMAT2 inhibitor",
        "frequency": "q4-8 weeks until stable, then q3-6mo",
        "action": "Optimize dose; consider second agent",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Depression screen (PHQ-9)",
        "frequency": "Baseline, 2wk, 4wk, then q3mo on VMAT2 inhibitors",
        "action": "Hold VMAT2 inhibitor; psychiatry consultation; consider switch",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Suicidality assessment",
        "frequency": "Each visit on VMAT2 inhibitors",
        "action": "Immediate psychiatry referral; hold medication",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "QTc interval",
        "frequency": "Baseline, after dose increase (valbenazine/deutetrabenazine)",
        "action": "Reduce dose; evaluate medications; electrolytes",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "ANC (if on clozapine)",
        "frequency": "Weekly x 6mo, q2wk x 6mo, then monthly",
        "action": "Follow REMS protocol for neutropenia",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Parkinsonism symptoms",
        "frequency": "Each visit on VMAT2 inhibitors",
        "action": "Reduce VMAT2 dose",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Akathisia",
        "frequency": "Each visit on VMAT2 inhibitors",
        "action": "Reduce dose; consider propranolol",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Swallowing function",
        "frequency": "Each visit with orofacial TD",
        "action": "Speech therapy referral; modify diet",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Functional status",
        "frequency": "Each visit",
        "action": "OT referral; treatment intensification",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Weight and metabolic parameters",
        "frequency": "q3-6mo on antipsychotics",
        "action": "Lifestyle modification; consider antipsychotic switch",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      }
    ],
    "disposition": [
      {
        "disposition": "Discharge home",
        "criteria": "Mild-moderate TD; able to manage oral medications; follow-up with neurology and psychiatry arranged; no psychiatric instability"
      },
      {
        "disposition": "Admit to floor",
        "criteria": "New severe TD with swallowing/respiratory involvement; psychiatric decompensation from medication change; severe dystonic component causing pain/disability; need for expedited workup (suspect alternative diagnosis)"
      },
      {
        "disposition": "Admit to ICU",
        "criteria": "Respiratory compromise from severe oropharyngeal/laryngeal TD; neuroleptic malignant syndrome; severe tardive dystonia with rhabdomyolysis"
      },
      {
        "disposition": "Outpatient follow-up",
        "criteria": "Initial: 4-6 weeks for medication titration; Stable: q3-6 months for AIMS monitoring; More frequent if depression risk on VMAT2 inhibitors"
      }
    ]
  },
  "Alzheimer's Disease": {
    "id": "alzheimers-disease",
    "title": "Alzheimer's Disease",
    "version": "1.0",
    "icd10": [
      "** G30.9 (Alzheimer's disease",
      "unspecified)",
      "G30.0 (Early-onset AD)",
      "G30.1 (Late-onset AD)",
      "F02.80 (Dementia in AD without behavioral disturbance)",
      "F02.81 (Dementia in AD with behavioral disturbance)"
    ],
    "scope": "** Diagnosis confirmation using NIA-AA criteria, biomarker assessment, pharmacologic treatment with cholinesterase inhibitors and memantine, anti-amyloid disease-modifying therapies, BPSD management, safety planning, and caregiver support. Primarily outpatient-focused with coverage for ED and hospital presentations.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC with differential",
            "rationale": "Rule out infection, anemia, malignancy contributing to cognitive impairment",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "BMP (Na, K, BUN, Cr, glucose)",
            "rationale": "Metabolic causes of confusion (hyponatremia, uremia, hypoglycemia)",
            "target": "Normal electrolytes, renal function",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "TSH",
            "rationale": "Hypothyroidism is reversible cause of cognitive impairment",
            "target": "0.4-4.0 mIU/L",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin B12",
            "rationale": "B12 deficiency causes reversible cognitive decline",
            "target": ">300 pg/mL (>400 optimal)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Folate",
            "rationale": "Deficiency contributes to cognitive impairment",
            "target": ">3 ng/mL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Hepatic panel (AST, ALT, albumin)",
            "rationale": "Hepatic encephalopathy; nutritional status",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Calcium",
            "rationale": "Hypercalcemia causes confusion",
            "target": "8.5-10.5 mg/dL",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Urinalysis",
            "rationale": "UTI common cause of acute confusion in elderly",
            "target": "Negative for infection",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended Workup": [
          {
            "item": "Hemoglobin A1c",
            "rationale": "Diabetes affects cognition and vascular risk",
            "target": "<7.0%",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lipid panel",
            "rationale": "Vascular risk factor modification",
            "target": "LDL <100 mg/dL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Homocysteine",
            "rationale": "Elevated levels associated with AD and vascular disease",
            "target": "<15 μmol/L",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin D, 25-hydroxy",
            "rationale": "Deficiency associated with cognitive decline",
            "target": ">30 ng/mL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "RPR or VDRL",
            "rationale": "Neurosyphilis is treatable cause",
            "target": "Nonreactive",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "HIV testing",
            "rationale": "HIV-associated neurocognitive disorder if risk factors",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "ESR, CRP",
            "rationale": "Inflammatory or autoimmune causes",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "APOE genotyping",
            "rationale": "Risk stratification; ARIA risk assessment for anti-amyloid therapy",
            "target": "APOE ε4 status",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Genetic panel (PSEN1, PSEN2, APP)",
            "rationale": "Early-onset AD (<65) with family history",
            "target": "No pathogenic mutation (AD diagnosis still valid)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Heavy metal panel (lead, mercury)",
            "rationale": "History of occupational exposure",
            "target": "Normal",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Copper, ceruloplasmin",
            "rationale": "Wilson disease if age <50 with movement disorder",
            "target": "Normal",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Paraneoplastic antibody panel",
            "rationale": "Rapid progression; cancer history",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Anti-neuronal antibodies (NMDA-R, LGI1, CASPR2)",
            "rationale": "Atypical presentation; rapid progression",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "Cell count, protein, glucose",
            "rationale": "Rule out infection, inflammation",
            "target": "WBC <5, protein <45 mg/dL, glucose >60% serum",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CSF Aβ42 (amyloid beta 1-42)",
            "rationale": "Reduced in AD due to brain amyloid deposition",
            "target": "<600 pg/mL suggests AD pathology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CSF Aβ42/Aβ40 ratio",
            "rationale": "More accurate than Aβ42 alone",
            "target": "<0.05-0.08 suggests AD (assay-dependent)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CSF total tau (t-tau)",
            "rationale": "Elevated in neurodegeneration",
            "target": ">400 pg/mL suggests neuronal injury",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CSF phosphorylated tau (p-tau181 or p-tau217)",
            "rationale": "Specific for AD pathology; best discriminator",
            "target": "Elevated p-tau181 >60 pg/mL or p-tau217 >20 pg/mL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CSF NfL (neurofilament light)",
            "rationale": "Non-specific marker of neuronal damage",
            "target": "Elevated suggests active neurodegeneration",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "14-3-3 protein",
            "rationale": "Rapid progression; suspected CJD",
            "target": "Negative (positive suggests CJD)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "RT-QuIC",
            "rationale": "Prion disease confirmation if suspected",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Autoimmune encephalitis panel",
            "rationale": "Atypical presentation; subacute onset",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "MRI Brain without contrast",
            "timing": "At initial evaluation",
            "target": "Hippocampal and medial temporal atrophy; rule out structural causes (tumor, SDH, NPH, stroke)",
            "contraindications": "MRI-incompatible devices, severe claustrophobia",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CT Head non-contrast",
            "timing": "If MRI unavailable or contraindicated",
            "target": "Rule out mass, hemorrhage, hydrocephalus",
            "contraindications": "None",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended": [
          {
            "item": "Amyloid PET (florbetapir, florbetaben, flutemetamol)",
            "timing": "Diagnostic uncertainty; anti-amyloid therapy eligibility",
            "target": "Positive amyloid deposition confirms AD pathology",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "FDG-PET Brain",
            "timing": "Differentiate AD from FTD; atypical presentations",
            "target": "AD: bilateral temporoparietal hypometabolism",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Tau PET (flortaucipir)",
            "timing": "Staging AD; donanemab eligibility",
            "target": "Elevated tau correlates with disease stage",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "MRI Brain volumetrics",
            "timing": "Baseline for anti-amyloid monitoring; track progression",
            "target": "Quantify hippocampal and whole brain atrophy",
            "contraindications": "MRI contraindications",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "MRI with SWI/GRE sequences",
            "timing": "Pre-treatment for anti-amyloid (microbleed assessment)",
            "target": "Count microbleeds (<4 eligible for therapy)",
            "contraindications": "MRI contraindications",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "EEG",
            "timing": "Seizures, encephalopathy, or rapid decline",
            "target": "Diffuse slowing typical in AD; rule out CJD",
            "contraindications": "None",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sleep study (polysomnography)",
            "timing": "Sleep apnea contributing to cognition; RBD evaluation",
            "target": "Assess AHI; REM without atonia suggests DLB",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "DaTscan (ioflupane I-123)",
            "timing": "Differentiate DLB/PDD from AD",
            "target": "Reduced uptake: DLB; Normal: AD",
            "contraindications": "Iodine hypersensitivity",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "SPECT (perfusion)",
            "timing": "Alternative to PET if unavailable",
            "target": "Regional hypoperfusion patterns",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Whole body PET-CT",
            "timing": "Paraneoplastic workup if suspected",
            "target": "Rule out occult malignancy",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "Treat reversible causes",
            "route": "Various",
            "indication": "Identified metabolic or infectious etiology",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per specific cause",
                  "orderSentence": "Treat reversible causes Per specific cause Various"
                }
              ],
              "route": "Various",
              "instructions": "Correct hyponatremia slowly, treat UTI, replace B12, treat hypothyroidism",
              "orderSentence": "Treat reversible causes Per specific cause Various"
            },
            "contraindications": "Depends on intervention",
            "monitoring": "Cognitive reassessment after treatment",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Thiamine",
            "route": "IV/PO",
            "indication": "Suspected Wernicke's; alcoholism; malnutrition",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mg IV TID x 3 days",
                  "orderSentence": "Thiamine 500 mg IV TID x 3 days IV/PO"
                },
                {
                  "text": "100 mg PO daily",
                  "orderSentence": "Thiamine 100 mg PO daily IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "500 mg IV TID x 3 days if Wernicke suspected; then 100 mg PO daily maintenance",
              "orderSentence": "Thiamine 500 mg IV TID x 3 days IV/PO"
            },
            "contraindications": "None",
            "monitoring": "Clinical improvement in confusion",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin B12",
            "route": "IM/PO",
            "indication": "B12 deficiency (<300 pg/mL)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mcg IM daily x 7d",
                  "orderSentence": "Vitamin B12 1000 mcg IM daily x 7d IM/PO"
                },
                {
                  "text": "1000 mcg IM weekly x 4wk",
                  "orderSentence": "Vitamin B12 1000 mcg IM weekly x 4wk IM/PO"
                },
                {
                  "text": "1000 mcg IM monthly",
                  "orderSentence": "Vitamin B12 1000 mcg IM monthly IM/PO"
                }
              ],
              "route": "IM/PO",
              "instructions": "1000 mcg IM daily x 7d, then weekly x 4wk, then monthly; or high-dose oral 1000-2000 mcg daily",
              "orderSentence": "Vitamin B12 1000 mcg IM daily x 7d IM/PO"
            },
            "contraindications": "None",
            "monitoring": "B12 level at 2 months; cognitive improvement over months",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Cholinesterase Inhibitors (Cognitive Enhancement)": [
          {
            "item": "Donepezil (Aricept)",
            "route": "PO",
            "indication": "Mild, moderate, or severe AD (first-line)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg qHS",
                  "orderSentence": "Donepezil (Aricept) 5 mg qHS PO"
                },
                {
                  "text": "10 mg qHS",
                  "orderSentence": "Donepezil (Aricept) 10 mg qHS PO"
                },
                {
                  "text": "23 mg daily",
                  "orderSentence": "Donepezil (Aricept) 23 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg qHS x 4-6 weeks; if tolerated, increase to 10 mg qHS; 23 mg available for moderate-severe AD after stable on 10 mg",
              "orderSentence": "Donepezil (Aricept) 5 mg qHS PO"
            },
            "contraindications": "Sick sinus syndrome; second/third degree heart block without pacemaker; active GI bleeding; severe COPD",
            "monitoring": "Heart rate; GI symptoms (nausea, diarrhea); vivid dreams; muscle cramps",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rivastigmine oral (Exelon)",
            "route": "PO",
            "indication": "Mild-moderate AD; may be better for attention/executive symptoms",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1.5 mg BID",
                  "orderSentence": "Rivastigmine oral (Exelon) 1.5 mg BID PO"
                },
                {
                  "text": "3 mg BID",
                  "orderSentence": "Rivastigmine oral (Exelon) 3 mg BID PO"
                },
                {
                  "text": "4.5 mg BID",
                  "orderSentence": "Rivastigmine oral (Exelon) 4.5 mg BID PO"
                },
                {
                  "text": "6 mg BID",
                  "orderSentence": "Rivastigmine oral (Exelon) 6 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 1.5 mg BID with meals; increase by 1.5 mg BID every 2 weeks; target 6 mg BID",
              "orderSentence": "Rivastigmine oral (Exelon) 1.5 mg BID PO"
            },
            "contraindications": "Same as donepezil; severe hepatic impairment",
            "monitoring": "GI symptoms (most common); weight loss; bradycardia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rivastigmine patch (Exelon Patch)",
            "route": "TD",
            "indication": "Mild-moderate AD; better GI tolerability than oral",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4.6 mg/24hr",
                  "orderSentence": "Rivastigmine patch (Exelon Patch) 4.6 mg/24hr TD"
                },
                {
                  "text": "9.5 mg/24hr",
                  "orderSentence": "Rivastigmine patch (Exelon Patch) 9.5 mg/24hr TD"
                },
                {
                  "text": "13.3 mg/24hr",
                  "orderSentence": "Rivastigmine patch (Exelon Patch) 13.3 mg/24hr TD"
                }
              ],
              "route": "TD",
              "instructions": "Start 4.6 mg/24hr patch; increase every 4 weeks; target 9.5-13.3 mg/24hr; apply to clean, hairless skin",
              "orderSentence": "Rivastigmine patch (Exelon Patch) 4.6 mg/24hr TD"
            },
            "contraindications": "Same as oral",
            "monitoring": "Skin irritation (rotate sites); GI symptoms less than oral",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Galantamine (Razadyne)",
            "route": "PO",
            "indication": "Mild-moderate AD; dual mechanism (AChE inhibitor + nicotinic modulator)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4 mg BID",
                  "orderSentence": "Galantamine (Razadyne) 4 mg BID PO"
                },
                {
                  "text": "8 mg BID",
                  "orderSentence": "Galantamine (Razadyne) 8 mg BID PO"
                },
                {
                  "text": "12 mg BID",
                  "orderSentence": "Galantamine (Razadyne) 12 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 4 mg BID with meals x 4 weeks; increase to 8 mg BID x 4 weeks; target 8-12 mg BID",
              "orderSentence": "Galantamine (Razadyne) 4 mg BID PO"
            },
            "contraindications": "Same as donepezil; severe renal impairment (CrCl <9); severe hepatic impairment",
            "monitoring": "GI symptoms; bradycardia; weight loss",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Galantamine ER (Razadyne ER)",
            "route": "PO",
            "indication": "Once-daily alternative for adherence",
            "dosing": {
              "doseOptions": [
                {
                  "text": "8 mg daily",
                  "orderSentence": "Galantamine ER (Razadyne ER) 8 mg daily PO"
                },
                {
                  "text": "16 mg daily",
                  "orderSentence": "Galantamine ER (Razadyne ER) 16 mg daily PO"
                },
                {
                  "text": "24 mg daily",
                  "orderSentence": "Galantamine ER (Razadyne ER) 24 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 8 mg daily with breakfast x 4 weeks; increase by 8 mg every 4 weeks; target 16-24 mg daily",
              "orderSentence": "Galantamine ER (Razadyne ER) 8 mg daily PO"
            },
            "contraindications": "Same as immediate release",
            "monitoring": "Same as immediate release",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "NMDA Receptor Antagonist": [
          {
            "item": "Memantine (Namenda)",
            "route": "PO",
            "indication": "Moderate-severe AD; add to cholinesterase inhibitor",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg daily",
                  "orderSentence": "Memantine (Namenda) 5 mg daily PO"
                },
                {
                  "text": "5 mg BID",
                  "orderSentence": "Memantine (Namenda) 5 mg BID PO"
                },
                {
                  "text": "10 mg BID",
                  "orderSentence": "Memantine (Namenda) 10 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg daily x 1 week; increase by 5 mg/week: 5 mg BID, then 5 mg/10 mg, then 10 mg BID",
              "orderSentence": "Memantine (Namenda) 5 mg daily PO"
            },
            "contraindications": "Severe renal impairment (reduce dose if CrCl 5-29: max 5 mg BID)",
            "monitoring": "Confusion, dizziness, constipation, headache",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Memantine XR (Namenda XR)",
            "route": "PO",
            "indication": "Once-daily option for adherence",
            "dosing": {
              "doseOptions": [
                {
                  "text": "7 mg daily",
                  "orderSentence": "Memantine XR (Namenda XR) 7 mg daily PO"
                },
                {
                  "text": "14 mg daily",
                  "orderSentence": "Memantine XR (Namenda XR) 14 mg daily PO"
                },
                {
                  "text": "21 mg daily",
                  "orderSentence": "Memantine XR (Namenda XR) 21 mg daily PO"
                },
                {
                  "text": "28 mg daily",
                  "orderSentence": "Memantine XR (Namenda XR) 28 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 7 mg daily; increase by 7 mg/week; target 28 mg daily",
              "orderSentence": "Memantine XR (Namenda XR) 7 mg daily PO"
            },
            "contraindications": "Same as immediate release",
            "monitoring": "Same as immediate release",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Memantine/Donepezil (Namzaric)",
            "route": "PO",
            "indication": "Combination for moderate-severe AD already on both",
            "dosing": {
              "doseOptions": [
                {
                  "text": "28/10 mg daily",
                  "orderSentence": "Memantine/Donepezil (Namzaric) 28/10 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "One capsule (28 mg memantine XR + 10 mg donepezil) once daily at bedtime; must be stable on both drugs first",
              "orderSentence": "Memantine/Donepezil (Namzaric) 28/10 mg daily PO"
            },
            "contraindications": "Same as individual drugs",
            "monitoring": "Same as individual drugs",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Disease-Modifying Therapies (Anti-Amyloid)": [
          {
            "item": "Lecanemab (Leqembi)",
            "route": "IV",
            "indication": "Early AD (MCI or mild dementia) with confirmed amyloid pathology",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg/kg IV q2wk",
                  "orderSentence": "Lecanemab (Leqembi) 10 mg/kg IV q2wk IV"
                }
              ],
              "route": "IV",
              "instructions": "10 mg/kg IV every 2 weeks; infuse over approximately 1 hour",
              "orderSentence": "Lecanemab (Leqembi) 10 mg/kg IV q2wk IV"
            },
            "pretreatment": "Amyloid PET positive OR CSF biomarkers confirming amyloid; MRI within 1 year (assess microbleeds); APOE genotyping strongly recommended; informed consent for ARIA risk",
            "contraindications": ">4 cerebral microbleeds; superficial siderosis; recent macrohemorrhage; concurrent anticoagulation (relative); APOE ε4/ε4 (higher ARIA risk - not absolute CI)",
            "monitoring": "MRI: baseline, weeks 7, 14, 52, 78 (ARIA monitoring); clinical assessment for ARIA symptoms (headache, confusion, visual changes)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Donanemab (Kisunla)",
            "route": "IV",
            "indication": "Early AD (MCI or mild dementia) with confirmed amyloid AND intermediate/high tau pathology",
            "dosing": {
              "doseOptions": [
                {
                  "text": "700 mg IV q4wk x 3",
                  "orderSentence": "Donanemab (Kisunla) 700 mg IV q4wk x 3 IV"
                },
                {
                  "text": "then 1400 mg IV q4wk",
                  "orderSentence": "Donanemab (Kisunla) then 1400 mg IV q4wk IV"
                }
              ],
              "route": "IV",
              "instructions": "700 mg IV every 4 weeks x 3 doses, then 1400 mg IV every 4 weeks until amyloid clearance (by PET); discontinue when PET negative",
              "orderSentence": "Donanemab (Kisunla) 700 mg IV q4wk x 3 IV"
            },
            "pretreatment": "Amyloid PET positive; Tau PET showing intermediate or high tau levels; MRI baseline; APOE genotyping (higher ARIA in ε4/ε4)",
            "contraindications": "Same as lecanemab; higher ARIA risk in APOE ε4 homozygotes",
            "monitoring": "MRI: baseline, weeks 12, 24, 52, 76 (ARIA monitoring); repeat amyloid PET to assess clearance",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Aducanumab (Aduhelm)",
            "route": "IV",
            "indication": "Early AD with confirmed amyloid (limited adoption)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 mg/kg",
                  "orderSentence": "Aducanumab (Aduhelm) 1 mg/kg IV"
                },
                {
                  "text": "3 mg/kg",
                  "orderSentence": "Aducanumab (Aduhelm) 3 mg/kg IV"
                },
                {
                  "text": "6 mg/kg",
                  "orderSentence": "Aducanumab (Aduhelm) 6 mg/kg IV"
                },
                {
                  "text": "10 mg/kg IV q4wk",
                  "orderSentence": "Aducanumab (Aduhelm) 10 mg/kg IV q4wk IV"
                }
              ],
              "route": "IV",
              "instructions": "Titration: 1 mg/kg q4wk x 2, then 3 mg/kg x 2, then 6 mg/kg x 2, then 10 mg/kg maintenance; slow titration over 6 months",
              "orderSentence": "Aducanumab (Aduhelm) 1 mg/kg IV"
            },
            "pretreatment": "Same as lecanemab",
            "contraindications": "Same as lecanemab",
            "monitoring": "MRI for ARIA at baseline and during titration",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Behavioral and Psychological Symptoms of Dementia (BPSD)": [
          {
            "item": "Citalopram",
            "route": "PO",
            "indication": "Depression; mild-moderate agitation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg daily",
                  "orderSentence": "Citalopram 10 mg daily PO"
                },
                {
                  "text": "20 mg daily",
                  "orderSentence": "Citalopram 20 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10 mg daily; max 20 mg in elderly due to QT prolongation risk",
              "orderSentence": "Citalopram 10 mg daily PO"
            },
            "contraindications": "QT prolongation; concurrent QT-prolonging drugs; severe hepatic impairment",
            "monitoring": "ECG at baseline if cardiac risk; QTc monitoring if >20 mg",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sertraline (Zoloft)",
            "route": "PO",
            "indication": "Depression; anxiety",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg daily",
                  "orderSentence": "Sertraline (Zoloft) 25 mg daily PO"
                },
                {
                  "text": "50 mg daily",
                  "orderSentence": "Sertraline (Zoloft) 50 mg daily PO"
                },
                {
                  "text": "100 mg daily",
                  "orderSentence": "Sertraline (Zoloft) 100 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg daily; increase by 25 mg every 1-2 weeks; typical dose 50-100 mg daily",
              "orderSentence": "Sertraline (Zoloft) 25 mg daily PO"
            },
            "contraindications": "MAOIs; uncontrolled seizures (lowers threshold slightly)",
            "monitoring": "GI symptoms initially; bleeding risk with anticoagulants",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Mirtazapine (Remeron)",
            "route": "PO",
            "indication": "Depression with poor appetite, insomnia, and weight loss",
            "dosing": {
              "doseOptions": [
                {
                  "text": "7.5 mg qHS",
                  "orderSentence": "Mirtazapine (Remeron) 7.5 mg qHS PO"
                },
                {
                  "text": "15 mg qHS",
                  "orderSentence": "Mirtazapine (Remeron) 15 mg qHS PO"
                },
                {
                  "text": "30 mg qHS",
                  "orderSentence": "Mirtazapine (Remeron) 30 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 7.5-15 mg qHS; may increase to 30-45 mg qHS; lower doses more sedating",
              "orderSentence": "Mirtazapine (Remeron) 7.5 mg qHS PO"
            },
            "contraindications": "MAOIs; angle-closure glaucoma",
            "monitoring": "Weight gain (often desired); sedation; hyperlipidemia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Trazodone",
            "route": "PO",
            "indication": "Insomnia; sundowning; mild agitation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Trazodone 25 mg qHS PO"
                },
                {
                  "text": "50 mg qHS",
                  "orderSentence": "Trazodone 50 mg qHS PO"
                },
                {
                  "text": "100 mg qHS",
                  "orderSentence": "Trazodone 100 mg qHS PO"
                },
                {
                  "text": "150 mg qHS",
                  "orderSentence": "Trazodone 150 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25-50 mg qHS; titrate by 25-50 mg every 3-5 days; typical 50-150 mg qHS for sleep",
              "orderSentence": "Trazodone 25 mg qHS PO"
            },
            "contraindications": "Concurrent MAOIs; significant QT prolongation",
            "monitoring": "Orthostatic hypotension (fall risk); priapism (rare); QTc",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Melatonin",
            "route": "PO",
            "indication": "Sleep disturbance; circadian rhythm dysfunction",
            "dosing": {
              "doseOptions": [
                {
                  "text": "3 mg qHS",
                  "orderSentence": "Melatonin 3 mg qHS PO"
                },
                {
                  "text": "6 mg qHS",
                  "orderSentence": "Melatonin 6 mg qHS PO"
                },
                {
                  "text": "9 mg qHS",
                  "orderSentence": "Melatonin 9 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 3 mg qHS, 30 min before bed; may increase to 6-9 mg if needed",
              "orderSentence": "Melatonin 3 mg qHS PO"
            },
            "contraindications": "None significant",
            "monitoring": "Daytime drowsiness; minimal side effects",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Brexpiprazole (Rexulti)",
            "route": "PO",
            "indication": "Agitation in AD (FDA approved 2023)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5 mg daily",
                  "orderSentence": "Brexpiprazole (Rexulti) 0.5 mg daily PO"
                },
                {
                  "text": "1 mg daily",
                  "orderSentence": "Brexpiprazole (Rexulti) 1 mg daily PO"
                },
                {
                  "text": "2 mg daily",
                  "orderSentence": "Brexpiprazole (Rexulti) 2 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.5 mg daily x 1 week; increase to 1 mg daily x 1 week; target 2-3 mg daily",
              "orderSentence": "Brexpiprazole (Rexulti) 0.5 mg daily PO"
            },
            "contraindications": "Black box: increased mortality in dementia (but FDA approved for this use)",
            "monitoring": "Weight, metabolic parameters, EPS, falls",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Quetiapine (Seroquel)",
            "route": "PO",
            "indication": "Severe agitation/psychosis when non-pharmacologic fails",
            "dosing": {
              "doseOptions": [
                {
                  "text": "12.5 mg qHS",
                  "orderSentence": "Quetiapine (Seroquel) 12.5 mg qHS PO"
                },
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Quetiapine (Seroquel) 25 mg qHS PO"
                },
                {
                  "text": "25 mg BID",
                  "orderSentence": "Quetiapine (Seroquel) 25 mg BID PO"
                },
                {
                  "text": "50 mg BID",
                  "orderSentence": "Quetiapine (Seroquel) 50 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 12.5-25 mg qHS; titrate slowly (25 mg increments); keep dose as low as possible",
              "orderSentence": "Quetiapine (Seroquel) 12.5 mg qHS PO"
            },
            "contraindications": "Black box: increased mortality in dementia; Parkinson's (less risk than other antipsychotics)",
            "monitoring": "Metabolic effects; sedation; falls; QTc",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Risperidone (Risperdal)",
            "route": "PO",
            "indication": "Severe aggression/psychosis (short-term only)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.25 mg BID",
                  "orderSentence": "Risperidone (Risperdal) 0.25 mg BID PO"
                },
                {
                  "text": "0.5 mg BID",
                  "orderSentence": "Risperidone (Risperdal) 0.5 mg BID PO"
                },
                {
                  "text": "1 mg BID",
                  "orderSentence": "Risperidone (Risperdal) 1 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.25 mg BID; increase by 0.25 mg BID weekly; max 1 mg BID; limit to 6-12 weeks",
              "orderSentence": "Risperidone (Risperdal) 0.25 mg BID PO"
            },
            "contraindications": "Black box: increased mortality and CVA in dementia",
            "monitoring": "EPS, metabolic effects, stroke risk, prolactin",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Haloperidol",
            "route": "IM/IV/PO",
            "indication": "Acute severe agitation in delirium-crisis only (not chronic use)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5 mg IM",
                  "orderSentence": "Haloperidol 0.5 mg IM IM/IV/PO"
                },
                {
                  "text": "1 mg IM",
                  "orderSentence": "Haloperidol 1 mg IM IM/IV/PO"
                },
                {
                  "text": "2 mg IM",
                  "orderSentence": "Haloperidol 2 mg IM IM/IV/PO"
                }
              ],
              "route": "IM/IV/PO",
              "instructions": "0.5-2 mg IM/IV q4-6h PRN; short-term acute use only; avoid chronic use",
              "orderSentence": "Haloperidol 0.5 mg IM IM/IV/PO"
            },
            "contraindications": "QT prolongation; Parkinson's disease; DLB (avoid)",
            "monitoring": "QTc; EPS; akathisia",
            "ED": "STAT",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurology/Cognitive neurology for diagnosis confirmation, biomarker interpretation, and treatment planning",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Neuropsychology for formal cognitive testing (MoCA insufficient) to establish baseline and track progression",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Geriatric psychiatry for BPSD management and capacity evaluation when decision-making ability questioned",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Occupational therapy for ADL assessment, cognitive strategies, and home safety evaluation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Speech therapy for communication strategies and swallowing evaluation if dysphagia develops",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Social work for caregiver support resources, community services, and long-term care planning",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Palliative care for advanced AD symptom management and goals of care discussions",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Elder law attorney for advance directives, healthcare proxy, and financial planning while capacity exists",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Genetics counseling for early-onset AD (<65) families or those considering predictive testing",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Driving rehabilitation specialist for formal on-road driving evaluation when ability is questioned",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Infusion center coordination for anti-amyloid therapy administration and ARIA monitoring",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Return immediately if sudden worsening of confusion which may indicate stroke, infection, or medication toxicity",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "If on anti-amyloid therapy (lecanemab, donanemab): return immediately for new headache, visual changes, confusion, or unsteadiness (possible ARIA)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Complete advance directives (living will, healthcare proxy, POLST) while patient has capacity to document preferences for future care",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Designate financial power of attorney and consider trust arrangements early while patient can participate",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Do not drive until cleared by physician or formal driving evaluation; report diagnosis to DMV per state requirements",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Use pill organizers, alarms, or caregiver supervision to ensure medication adherence",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Wear medical alert bracelet with diagnosis and emergency contact in case of wandering",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Keep environment safe: remove throw rugs, install grab bars, secure stove knobs, lock away dangerous items",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Maintain consistent daily routines which help with orientation and reduce anxiety",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Regular aerobic exercise (150 min/week moderate intensity) may slow cognitive decline and improve mood",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Mediterranean or MIND diet emphasizing vegetables, berries, fish, whole grains, nuts, and olive oil",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Cognitive stimulation through reading, puzzles, music, social activities to support cognitive reserve",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Adequate sleep (7-8 hours); treat sleep apnea aggressively as it worsens cognition",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Social engagement and meaningful activities to reduce isolation and support emotional well-being",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Cardiovascular risk factor control: BP <130/80, A1c <7%, LDL <100 to reduce vascular contribution",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Hearing aids for hearing loss which is a modifiable dementia risk factor (Lancet Commission)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Limit alcohol to ≤1 drink daily; excess alcohol accelerates cognitive decline",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Smoking cessation to reduce vascular damage and improve overall brain health",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Caregiver respite services to prevent burnout; Alzheimer's Association support groups",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Mild Cognitive Impairment (MCI)",
        "features": "Cognitive decline without functional impairment; may progress to AD",
        "tests": "Serial cognitive testing; preserved ADLs"
      },
      {
        "diagnosis": "Vascular dementia",
        "features": "Stepwise decline; focal neurologic findings; executive dysfunction prominent; vascular risk factors",
        "tests": "MRI shows significant WM disease, strategic infarcts"
      },
      {
        "diagnosis": "Dementia with Lewy bodies (DLB)",
        "features": "Visual hallucinations; parkinsonism; REM sleep behavior disorder; fluctuating cognition",
        "tests": "DaTscan reduced; clinical criteria"
      },
      {
        "diagnosis": "Frontotemporal dementia (behavioral variant)",
        "features": "Personality/behavior changes; disinhibition; apathy; hyperorality; often <65 years",
        "tests": "FDG-PET frontal hypometabolism; genetics"
      },
      {
        "diagnosis": "Primary progressive aphasia",
        "features": "Language dysfunction predominates (word-finding, comprehension, grammar)",
        "tests": "Neuropsych pattern; FDG-PET language regions"
      },
      {
        "diagnosis": "Parkinson's disease dementia",
        "features": "Parkinsonism precedes dementia by >1 year; different from DLB timing",
        "tests": "Clinical history; DaTscan"
      },
      {
        "diagnosis": "Normal pressure hydrocephalus (NPH)",
        "features": "Triad: gait disturbance, urinary incontinence, dementia; gait earliest",
        "tests": "MRI ventriculomegaly; large-volume LP with gait improvement"
      },
      {
        "diagnosis": "Depression (pseudodementia)",
        "features": "Prominent mood symptoms; often aware of deficits; improves with treatment",
        "tests": "GDS, PHQ-9; antidepressant trial"
      },
      {
        "diagnosis": "Creutzfeldt-Jakob disease (CJD)",
        "features": "Rapid progression (weeks-months); myoclonus; ataxia; pyramidal signs",
        "tests": "EEG (periodic sharp waves); MRI DWI ribboning; CSF RT-QuIC"
      },
      {
        "diagnosis": "Autoimmune encephalitis",
        "features": "Subacute onset; psychiatric features; seizures; often younger",
        "tests": "Autoantibody panel; MRI limbic changes"
      },
      {
        "diagnosis": "Medication-induced cognitive impairment",
        "features": "Anticholinergics, benzodiazepines, opioids",
        "tests": "Medication reconciliation; improvement with discontinuation"
      }
    ],
    "evidence": [
      {
        "recommendation": "NIA-AA diagnostic criteria for AD",
        "evidenceLevel": "Class I, Level A",
        "source": "[Jack et al. Alzheimers Dement 2018](https://pubmed.ncbi.nlm.nih.gov/29653606/)"
      },
      {
        "recommendation": "CSF biomarkers (Aβ42, t-tau, p-tau) accurate for AD",
        "evidenceLevel": "Class I, Level A",
        "source": "[Hansson et al. Lancet Neurol 2018](https://pubmed.ncbi.nlm.nih.gov/30244989/)"
      },
      {
        "recommendation": "Donepezil efficacy in mild-moderate AD",
        "evidenceLevel": "Class I, Level A",
        "source": "[Birks & Harvey. Cochrane 2018](https://pubmed.ncbi.nlm.nih.gov/29923184/)"
      },
      {
        "recommendation": "Rivastigmine efficacy in AD",
        "evidenceLevel": "Class I, Level A",
        "source": "[Birks et al. Cochrane 2015](https://pubmed.ncbi.nlm.nih.gov/25858345/)"
      },
      {
        "recommendation": "Galantamine efficacy in AD",
        "evidenceLevel": "Class I, Level A",
        "source": "[Loy & Schneider. Cochrane 2006](https://pubmed.ncbi.nlm.nih.gov/16437501/)"
      },
      {
        "recommendation": "Memantine efficacy in moderate-severe AD",
        "evidenceLevel": "Class I, Level A",
        "source": "[Reisberg et al. NEJM 2003](https://pubmed.ncbi.nlm.nih.gov/12672860/)"
      },
      {
        "recommendation": "Combination therapy (ChEI + memantine)",
        "evidenceLevel": "Class I, Level A",
        "source": "[Tariot et al. JAMA 2004](https://pubmed.ncbi.nlm.nih.gov/14970063/)"
      },
      {
        "recommendation": "Lecanemab slows cognitive decline in early AD",
        "evidenceLevel": "Class I, Level A",
        "source": "[van Dyck et al. NEJM 2023 (Clarity AD)](https://pubmed.ncbi.nlm.nih.gov/36449413/)"
      },
      {
        "recommendation": "Donanemab slows cognitive decline",
        "evidenceLevel": "Class I, Level A",
        "source": "[Sims et al. JAMA 2023 (TRAILBLAZER-ALZ 2)](https://pubmed.ncbi.nlm.nih.gov/37459141/)"
      },
      {
        "recommendation": "Brexpiprazole for agitation in AD",
        "evidenceLevel": "Class I, Level A",
        "source": "[Grossberg et al. NEJM 2024](https://pubmed.ncbi.nlm.nih.gov/37888914/)"
      },
      {
        "recommendation": "Antipsychotic mortality risk in dementia",
        "evidenceLevel": "Class I, Level A",
        "source": "[Schneider et al. JAMA 2005](https://pubmed.ncbi.nlm.nih.gov/16219884/)"
      },
      {
        "recommendation": "Mediterranean diet reduces dementia risk",
        "evidenceLevel": "Class II, Level B",
        "source": "[Scarmeas et al. Ann Neurol 2006](https://pubmed.ncbi.nlm.nih.gov/16832238/)"
      },
      {
        "recommendation": "Physical exercise may slow cognitive decline",
        "evidenceLevel": "Class II, Level B",
        "source": "[Livingston et al. Lancet 2020](https://pubmed.ncbi.nlm.nih.gov/32738937/)"
      },
      {
        "recommendation": "APOE genotyping for ARIA risk stratification",
        "evidenceLevel": "Class II, Level B",
        "source": "[Sperling et al. JAMA Neurol 2024](https://pubmed.ncbi.nlm.nih.gov/38587851/)"
      },
      {
        "recommendation": "Citalopram for agitation in AD (CitAD)",
        "evidenceLevel": "Class II, Level B",
        "source": "[Porsteinsson et al. JAMA 2014](https://pubmed.ncbi.nlm.nih.gov/24549548/)"
      },
      {
        "recommendation": "Hearing aid use reduces dementia risk",
        "evidenceLevel": "Class II, Level B",
        "source": "[Lin et al. JAMA Intern Med 2023](https://pubmed.ncbi.nlm.nih.gov/36592413/)"
      },
      {
        "recommendation": "Driving assessment in dementia",
        "evidenceLevel": "Class III, Level C",
        "source": "[Iverson et al. Neurology 2010](https://pubmed.ncbi.nlm.nih.gov/20439849/)"
      }
    ],
    "monitoring": [
      {
        "item": "Cognitive testing (MoCA or MMSE)",
        "frequency": "Every 6-12 months",
        "action": "Adjust staging; modify treatment; increase support",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Functional status (ADL/IADL, FAQ)",
        "frequency": "Every 6-12 months",
        "action": "Increase caregiver support; consider placement",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Neuropsychiatric Inventory (NPI)",
        "frequency": "Each visit",
        "action": "Non-pharmacologic interventions; consider medications",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Weight",
        "frequency": "Each visit",
        "action": "Nutritional consult; assess swallowing",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "MRI Brain (ARIA monitoring)",
        "frequency": "Per protocol if on anti-amyloid",
        "action": "Hold infusion; follow protocol for resumption",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Caregiver burden (Zarit Burden Interview)",
        "frequency": "Every 6-12 months",
        "action": "Support resources; respite care; social work",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Driving status",
        "frequency": "Each visit",
        "action": "Formal driving evaluation; report to DMV if unsafe",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "ECG (if on donepezil or citalopram)",
        "frequency": "Baseline; with dose changes",
        "action": "Reduce dose or switch medication",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Amyloid PET (if on donanemab)",
        "frequency": "Annually until clearance",
        "action": "Discontinue donanemab when cleared",
        "ED": "-",
        "HOSP": "-",
        "OPD": "EXT",
        "ICU": "-"
      },
      {
        "item": "Fall risk assessment",
        "frequency": "Each visit",
        "action": "PT referral; home safety; assistive devices",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      }
    ],
    "disposition": [
      {
        "disposition": "Discharge home",
        "criteria": "Stable cognition; safe environment; adequate caregiver support; outpatient follow-up arranged; reversible causes treated"
      },
      {
        "disposition": "Admit to floor",
        "criteria": "Acute delirium requiring workup; behavioral crisis unsafe for home; aspiration pneumonia; falls with injury"
      },
      {
        "disposition": "Admit to psychiatry",
        "criteria": "Severe behavioral disturbance requiring specialized psychiatric management; danger to self or others"
      },
      {
        "disposition": "Long-term care/Memory care",
        "criteria": "Progressive decline; caregiver unable to manage safely; wandering; 24-hour supervision needed"
      },
      {
        "disposition": "Hospice",
        "criteria": "End-stage AD; limited responsiveness; recurrent aspiration; weight loss; goals focused on comfort"
      },
      {
        "disposition": "Outpatient follow-up",
        "criteria": "Neurology every 3-6 months early disease; every 6-12 months stable; more frequent if on anti-amyloid therapy"
      }
    ]
  },
  "Lewy Body Dementia": {
    "id": "lewy-body-dementia",
    "title": "Lewy Body Dementia",
    "version": "1.0",
    "icd10": [
      "** G31.83 (Dementia with Lewy bodies)"
    ],
    "scope": "** Diagnosis based on McKeith criteria (2017), biomarker-supported diagnosis (DaTscan, MIBG), symptomatic management of cognitive, motor, behavioral, and autonomic symptoms. Emphasizes neuroleptic sensitivity and safe treatment approaches. Covers both pure DLB and Parkinson's disease dementia (PDD) overlap.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC with differential",
            "rationale": "Infection screen; anemia contributing to cognitive changes",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "BMP",
            "rationale": "Hyponatremia, uremia, hypercalcemia as causes of confusion",
            "target": "Normal electrolytes, BUN, Cr",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "TSH",
            "rationale": "Hypothyroidism is reversible cause of cognitive impairment",
            "target": "0.4-4.0 mIU/L",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin B12",
            "rationale": "Deficiency can cause cognitive impairment and parkinsonism",
            "target": ">300 pg/mL (>400 optimal)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Folate",
            "rationale": "Deficiency contributes to cognitive impairment",
            "target": ">3 ng/mL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Glucose (fasting)",
            "rationale": "Diabetes affects cognition and autonomic function",
            "target": "70-100 mg/dL",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Hepatic panel (LFTs)",
            "rationale": "Baseline before medications; hepatic encephalopathy",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Urinalysis",
            "rationale": "UTI common cause of acute confusion in elderly",
            "target": "Negative for infection",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended Workup": [
          {
            "item": "Vitamin D, 25-hydroxy",
            "rationale": "Deficiency associated with falls and cognitive decline",
            "target": ">30 ng/mL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Hemoglobin A1c",
            "rationale": "Chronic glucose control affects cognition",
            "target": "<7%",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lipid panel",
            "rationale": "Vascular risk factors",
            "target": "LDL <100 mg/dL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "RPR or VDRL",
            "rationale": "Neurosyphilis (rare but treatable)",
            "target": "Nonreactive",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "HIV testing",
            "rationale": "HIV-associated neurocognitive disorder",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "ESR, CRP",
            "rationale": "Inflammatory/autoimmune causes",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Cortisol (AM)",
            "rationale": "Adrenal insufficiency causing orthostatic hypotension",
            "target": "10-20 μg/dL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "CSF alpha-synuclein seed amplification assay (SAA)",
            "rationale": "Confirms synucleinopathy; research/atypical cases",
            "target": "Positive aggregation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Skin biopsy for phosphorylated alpha-synuclein",
            "rationale": "Peripheral synuclein deposition confirms synucleinopathy",
            "target": "Positive deposits in cutaneous nerves",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Genetic testing (GBA, SNCA)",
            "rationale": "Family history or early-onset; GBA mutations increase DLB risk",
            "target": "Identifies genetic risk",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Paraneoplastic antibody panel",
            "rationale": "Autoimmune dementia; rapid progression",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Anti-neuronal antibodies (NMDA-R, LGI1, CASPR2)",
            "rationale": "Autoimmune encephalitis if rapid onset",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "MRI Brain without contrast",
            "timing": "At initial evaluation",
            "target": "Relative preservation of medial temporal lobes (vs AD); rule out structural causes",
            "contraindications": "MRI-incompatible devices",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CT Head non-contrast",
            "timing": "If MRI unavailable",
            "target": "Rule out mass, hemorrhage, hydrocephalus",
            "contraindications": "None",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended": [
          {
            "item": "DaTscan (ioflupane I-123 SPECT)",
            "timing": "Diagnostic uncertainty; differentiating DLB from AD",
            "target": "Reduced dopamine transporter uptake in putamen (indicative biomarker)",
            "contraindications": "Hypersensitivity to iodine",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Cardiac MIBG scintigraphy",
            "timing": "Differentiate DLB from AD; supports diagnosis",
            "target": "Reduced cardiac uptake (indicative biomarker)",
            "contraindications": "Recent MI; drugs affecting uptake (labetalol, reserpine)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "FDG-PET Brain",
            "timing": "Differentiate from AD; atypical presentations",
            "target": "Posterior occipital hypometabolism with cingulate island sign (supportive biomarker)",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Polysomnography",
            "timing": "REM sleep behavior disorder confirmation",
            "target": "REM sleep without atonia (indicative biomarker)",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "EEG",
            "timing": "Encephalopathy; fluctuating cognition",
            "target": "Posterior slow-wave activity with periodic fluctuations (supportive)",
            "contraindications": "None",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Autonomic function testing",
            "timing": "Dysautonomia assessment",
            "target": "Orthostatic hypotension, abnormal HR variability",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Amyloid PET",
            "timing": "Atypical cases; AD co-pathology assessment",
            "target": "May be positive (AD-DLB overlap common)",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Tau PET",
            "timing": "Research; differentiate from AD tauopathy",
            "target": "Less tau deposition than AD for similar dementia severity",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "SPECT perfusion",
            "timing": "Alternative to FDG-PET",
            "target": "Posterior hypoperfusion pattern",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "MRI with SWI",
            "timing": "Microbleeds; cerebral amyloid angiopathy",
            "target": "Lobar microbleed pattern",
            "contraindications": "MRI contraindications",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "AVOID TYPICAL ANTIPSYCHOTICS",
            "route": "-",
            "indication": "CRITICAL SAFETY WARNING",
            "dosing": {
              "doseOptions": [
                {
                  "text": "DO NOT USE",
                  "orderSentence": "AVOID TYPICAL ANTIPSYCHOTICS DO NOT USE -"
                }
              ],
              "route": "-",
              "instructions": "Haloperidol, chlorpromazine, fluphenazine absolutely contraindicated; risk of severe parkinsonism, NMS, and death",
              "orderSentence": "AVOID TYPICAL ANTIPSYCHOTICS DO NOT USE -"
            },
            "contraindications": "DLB is absolute contraindication",
            "monitoring": "N/A",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "AVOID MOST ATYPICAL ANTIPSYCHOTICS",
            "route": "-",
            "indication": "CRITICAL SAFETY WARNING",
            "dosing": {
              "doseOptions": [
                {
                  "text": "DO NOT USE",
                  "orderSentence": "AVOID MOST ATYPICAL ANTIPSYCHOTICS DO NOT USE -"
                }
              ],
              "route": "-",
              "instructions": "Risperidone, olanzapine, aripiprazole, ziprasidone contraindicated; 2-3x mortality risk",
              "orderSentence": "AVOID MOST ATYPICAL ANTIPSYCHOTICS DO NOT USE -"
            },
            "contraindications": "DLB is relative contraindication",
            "monitoring": "N/A",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Quetiapine (if antipsychotic absolutely needed)",
            "route": "PO",
            "indication": "Severe psychosis/agitation when non-pharmacologic fails",
            "dosing": {
              "doseOptions": [
                {
                  "text": "12.5 mg qHS",
                  "orderSentence": "Quetiapine (if antipsychotic absolutely needed) 12.5 mg qHS PO"
                },
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Quetiapine (if antipsychotic absolutely needed) 25 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 12.5 mg qHS; increase slowly by 12.5 mg q3-7d; max 50-100 mg; lowest effective dose for shortest time",
              "orderSentence": "Quetiapine (if antipsychotic absolutely needed) 12.5 mg qHS PO"
            },
            "contraindications": "QT prolongation",
            "monitoring": "Monitor for worsening parkinsonism, sedation",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Treat delirium triggers",
            "route": "Various",
            "indication": "Infection, metabolic, medication-induced delirium",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per cause",
                  "orderSentence": "Treat delirium triggers Per cause Various"
                }
              ],
              "route": "Various",
              "instructions": "Treat UTI, correct electrolytes, remove offending drugs (especially anticholinergics)",
              "orderSentence": "Treat delirium triggers Per cause Various"
            },
            "contraindications": "Depends on intervention",
            "monitoring": "Mental status",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Symptomatic Treatments": [
          {
            "item": "Rivastigmine oral",
            "route": "PO",
            "indication": "Cognitive impairment and visual hallucinations (FDA approved for PDD)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1.5 mg BID",
                  "orderSentence": "Rivastigmine oral 1.5 mg BID PO"
                },
                {
                  "text": "3 mg BID",
                  "orderSentence": "Rivastigmine oral 3 mg BID PO"
                },
                {
                  "text": "4.5 mg BID",
                  "orderSentence": "Rivastigmine oral 4.5 mg BID PO"
                },
                {
                  "text": "6 mg BID",
                  "orderSentence": "Rivastigmine oral 6 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 1.5 mg BID with meals; increase by 1.5 mg BID q2-4wk; target 6 mg BID; may improve hallucinations",
              "orderSentence": "Rivastigmine oral 1.5 mg BID PO"
            },
            "contraindications": "Sick sinus syndrome; GI bleeding; severe hepatic impairment",
            "monitoring": "Nausea, weight loss, tremor worsening, bradycardia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rivastigmine patch",
            "route": "TD",
            "indication": "Cognitive impairment; better GI tolerability",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4.6 mg/24hr",
                  "orderSentence": "Rivastigmine patch 4.6 mg/24hr TD"
                },
                {
                  "text": "9.5 mg/24hr",
                  "orderSentence": "Rivastigmine patch 9.5 mg/24hr TD"
                },
                {
                  "text": "13.3 mg/24hr",
                  "orderSentence": "Rivastigmine patch 13.3 mg/24hr TD"
                }
              ],
              "route": "TD",
              "instructions": "Start 4.6 mg/24hr patch; increase q4wk; target 9.5-13.3 mg/24hr",
              "orderSentence": "Rivastigmine patch 4.6 mg/24hr TD"
            },
            "contraindications": "Same as oral",
            "monitoring": "Skin irritation, nausea",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Donepezil",
            "route": "PO",
            "indication": "Cognitive impairment; alternative to rivastigmine",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg qHS",
                  "orderSentence": "Donepezil 5 mg qHS PO"
                },
                {
                  "text": "10 mg qHS",
                  "orderSentence": "Donepezil 10 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg qHS x 4-6 weeks; may increase to 10 mg qHS",
              "orderSentence": "Donepezil 5 mg qHS PO"
            },
            "contraindications": "Sick sinus syndrome; GI bleeding; COPD exacerbation",
            "monitoring": "Bradycardia, vivid dreams (may worsen RBD), GI",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Galantamine",
            "route": "PO",
            "indication": "Cognitive impairment; alternative cholinesterase inhibitor",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4 mg BID",
                  "orderSentence": "Galantamine 4 mg BID PO"
                },
                {
                  "text": "8 mg BID",
                  "orderSentence": "Galantamine 8 mg BID PO"
                },
                {
                  "text": "12 mg BID",
                  "orderSentence": "Galantamine 12 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 4 mg BID x 4wk; increase to 8 mg BID; target 8-12 mg BID",
              "orderSentence": "Galantamine 4 mg BID PO"
            },
            "contraindications": "Same as donepezil; severe renal/hepatic",
            "monitoring": "GI symptoms, bradycardia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Memantine",
            "route": "PO",
            "indication": "Moderate-severe dementia; add to cholinesterase inhibitor",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg daily",
                  "orderSentence": "Memantine 5 mg daily PO"
                },
                {
                  "text": "5 mg BID",
                  "orderSentence": "Memantine 5 mg BID PO"
                },
                {
                  "text": "10 mg BID",
                  "orderSentence": "Memantine 10 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg daily; increase by 5 mg/wk; target 10 mg BID",
              "orderSentence": "Memantine 5 mg daily PO"
            },
            "contraindications": "Severe renal impairment (dose adjust CrCl <30)",
            "monitoring": "Confusion, dizziness, constipation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Carbidopa-Levodopa",
            "route": "PO",
            "indication": "Motor parkinsonism symptoms",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25/100 TID",
                  "orderSentence": "Carbidopa-Levodopa 25/100 TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25/100 mg TID; titrate slowly; use lowest effective dose; may worsen hallucinations",
              "orderSentence": "Carbidopa-Levodopa 25/100 TID PO"
            },
            "contraindications": "Active psychosis",
            "monitoring": "Dyskinesias, confusion, hallucination worsening",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Melatonin",
            "route": "PO",
            "indication": "REM sleep behavior disorder (first-line)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "3 mg qHS",
                  "orderSentence": "Melatonin 3 mg qHS PO"
                },
                {
                  "text": "6 mg qHS",
                  "orderSentence": "Melatonin 6 mg qHS PO"
                },
                {
                  "text": "9 mg qHS",
                  "orderSentence": "Melatonin 9 mg qHS PO"
                },
                {
                  "text": "12 mg qHS",
                  "orderSentence": "Melatonin 12 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 3-6 mg 30 min before bed; may increase to 12 mg; first-line for RBD",
              "orderSentence": "Melatonin 3 mg qHS PO"
            },
            "contraindications": "None",
            "monitoring": "Generally well-tolerated",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Clonazepam",
            "route": "PO",
            "indication": "REM sleep behavior disorder (second-line)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.25 mg qHS",
                  "orderSentence": "Clonazepam 0.25 mg qHS PO"
                },
                {
                  "text": "0.5 mg qHS",
                  "orderSentence": "Clonazepam 0.5 mg qHS PO"
                },
                {
                  "text": "1 mg qHS",
                  "orderSentence": "Clonazepam 1 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.25-0.5 mg qHS; typical 0.5-1 mg; use with caution due to sedation and fall risk",
              "orderSentence": "Clonazepam 0.25 mg qHS PO"
            },
            "contraindications": "Severe sleep apnea; respiratory compromise; dementia (relative)",
            "monitoring": "Sedation, falls, cognitive worsening",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pimavanserin (Nuplazid)",
            "route": "PO",
            "indication": "Visual hallucinations and psychosis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "34 mg daily",
                  "orderSentence": "Pimavanserin (Nuplazid) 34 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "34 mg once daily; takes 4-6 weeks for effect; no titration; selective 5-HT2A inverse agonist",
              "orderSentence": "Pimavanserin (Nuplazid) 34 mg daily PO"
            },
            "contraindications": "Severe hepatic impairment; QT prolongation",
            "monitoring": "QTc at baseline; efficacy assessment 6 weeks",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Trazodone",
            "route": "PO",
            "indication": "Insomnia; sundowning",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Trazodone 25 mg qHS PO"
                },
                {
                  "text": "50 mg qHS",
                  "orderSentence": "Trazodone 50 mg qHS PO"
                },
                {
                  "text": "100 mg qHS",
                  "orderSentence": "Trazodone 100 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25-50 mg qHS; titrate by 25 mg; typical 50-100 mg qHS",
              "orderSentence": "Trazodone 25 mg qHS PO"
            },
            "contraindications": "MAOIs; QT prolongation",
            "monitoring": "Orthostatic hypotension",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Autonomic Dysfunction Treatments": [
          {
            "item": "Midodrine",
            "route": "PO",
            "indication": "Orthostatic hypotension",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2.5 mg TID",
                  "orderSentence": "Midodrine 2.5 mg TID PO"
                },
                {
                  "text": "5 mg TID",
                  "orderSentence": "Midodrine 5 mg TID PO"
                },
                {
                  "text": "10 mg TID",
                  "orderSentence": "Midodrine 10 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 2.5 mg TID (before arising, lunch, mid-afternoon); titrate by 2.5 mg/dose; max 10 mg TID; last dose by 6 PM",
              "orderSentence": "Midodrine 2.5 mg TID PO"
            },
            "contraindications": "Supine hypertension; urinary retention; severe cardiac disease",
            "monitoring": "Supine BP; avoid lying flat 4 hours after dose",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Droxidopa (Northera)",
            "route": "PO",
            "indication": "Neurogenic orthostatic hypotension",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg TID",
                  "orderSentence": "Droxidopa (Northera) 100 mg TID PO"
                },
                {
                  "text": "200 mg TID",
                  "orderSentence": "Droxidopa (Northera) 200 mg TID PO"
                },
                {
                  "text": "300 mg TID",
                  "orderSentence": "Droxidopa (Northera) 300 mg TID PO"
                },
                {
                  "text": "600 mg TID",
                  "orderSentence": "Droxidopa (Northera) 600 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 100 mg TID; titrate by 100 mg/dose q24-48h; max 600 mg TID",
              "orderSentence": "Droxidopa (Northera) 100 mg TID PO"
            },
            "contraindications": "Supine hypertension",
            "monitoring": "Supine BP, headache",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Fludrocortisone",
            "route": "PO",
            "indication": "Orthostatic hypotension adjunct",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.1 mg daily",
                  "orderSentence": "Fludrocortisone 0.1 mg daily PO"
                },
                {
                  "text": "0.2 mg daily",
                  "orderSentence": "Fludrocortisone 0.2 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.1 mg daily; may increase to 0.2 mg daily",
              "orderSentence": "Fludrocortisone 0.1 mg daily PO"
            },
            "contraindications": "CHF; severe hypertension",
            "monitoring": "K+, edema, supine BP, weight",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Polyethylene glycol (MiraLAX)",
            "route": "PO",
            "indication": "Constipation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "17 g daily",
                  "orderSentence": "Polyethylene glycol (MiraLAX) 17 g daily PO"
                },
                {
                  "text": "17 g BID",
                  "orderSentence": "Polyethylene glycol (MiraLAX) 17 g BID PO"
                }
              ],
              "route": "PO",
              "instructions": "17 g (1 capful) in 8 oz liquid daily; may increase to BID",
              "orderSentence": "Polyethylene glycol (MiraLAX) 17 g daily PO"
            },
            "contraindications": "Bowel obstruction",
            "monitoring": "Diarrhea if excessive",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Senna + docusate",
            "route": "PO",
            "indication": "Constipation stimulant",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 tablets qHS",
                  "orderSentence": "Senna + docusate 2 tablets qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "2 tablets qHS; may increase to 4 tablets",
              "orderSentence": "Senna + docusate 2 tablets qHS PO"
            },
            "contraindications": "Bowel obstruction; undiagnosed abdominal pain",
            "monitoring": "Electrolytes with chronic use",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Tamsulosin",
            "route": "PO",
            "indication": "Urinary retention",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.4 mg daily",
                  "orderSentence": "Tamsulosin 0.4 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "0.4 mg once daily 30 min after meal",
              "orderSentence": "Tamsulosin 0.4 mg daily PO"
            },
            "contraindications": "Known hypersensitivity; concurrent silodosin",
            "monitoring": "Orthostatic hypotension (caution with existing OH)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Oxybutynin",
            "route": "PO",
            "indication": "Urinary urgency (use with extreme caution)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2.5 mg BID",
                  "orderSentence": "Oxybutynin 2.5 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "2.5 mg BID only; avoid higher doses; anticholinergic burden worsens cognition",
              "orderSentence": "Oxybutynin 2.5 mg BID PO"
            },
            "contraindications": "Narrow-angle glaucoma; urinary retention; dementia (relative)",
            "monitoring": "Cognitive worsening; dry mouth",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Depression and Anxiety Treatments": [
          {
            "item": "Sertraline",
            "route": "PO",
            "indication": "Depression; anxiety",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg daily",
                  "orderSentence": "Sertraline 25 mg daily PO"
                },
                {
                  "text": "50 mg daily",
                  "orderSentence": "Sertraline 50 mg daily PO"
                },
                {
                  "text": "100 mg daily",
                  "orderSentence": "Sertraline 100 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg daily; titrate by 25 mg q1-2wk; typical 50-100 mg",
              "orderSentence": "Sertraline 25 mg daily PO"
            },
            "contraindications": "MAOIs",
            "monitoring": "GI upset; may worsen OH",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Escitalopram",
            "route": "PO",
            "indication": "Depression; anxiety",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg daily",
                  "orderSentence": "Escitalopram 5 mg daily PO"
                },
                {
                  "text": "10 mg daily",
                  "orderSentence": "Escitalopram 10 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg daily; may increase to 10 mg; max 10 mg in elderly (QT)",
              "orderSentence": "Escitalopram 5 mg daily PO"
            },
            "contraindications": "MAOIs; QT prolongation",
            "monitoring": "QTc; GI upset",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Venlafaxine XR",
            "route": "PO",
            "indication": "Depression; anxiety",
            "dosing": {
              "doseOptions": [
                {
                  "text": "37.5 mg daily",
                  "orderSentence": "Venlafaxine XR 37.5 mg daily PO"
                },
                {
                  "text": "75 mg daily",
                  "orderSentence": "Venlafaxine XR 75 mg daily PO"
                },
                {
                  "text": "150 mg daily",
                  "orderSentence": "Venlafaxine XR 150 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 37.5 mg daily; titrate q1-2wk; typical 75-150 mg",
              "orderSentence": "Venlafaxine XR 37.5 mg daily PO"
            },
            "contraindications": "Same as SSRIs",
            "monitoring": "BP at higher doses",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Mirtazapine",
            "route": "PO",
            "indication": "Depression with poor appetite and insomnia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "7.5 mg qHS",
                  "orderSentence": "Mirtazapine 7.5 mg qHS PO"
                },
                {
                  "text": "15 mg qHS",
                  "orderSentence": "Mirtazapine 15 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 7.5-15 mg qHS; may increase to 30 mg",
              "orderSentence": "Mirtazapine 7.5 mg qHS PO"
            },
            "contraindications": "MAOIs",
            "monitoring": "Weight gain, sedation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Cognitive/behavioral neurology for diagnosis confirmation using McKeith criteria and treatment planning",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Movement disorders specialist if motor symptoms prominent or considering dopaminergic therapy",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Neuropsychology for comprehensive cognitive testing to establish baseline and differentiate from AD",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Geriatric psychiatry for behavioral symptoms, medication management, and capacity evaluation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sleep medicine for polysomnography to confirm REM sleep behavior disorder (indicative biomarker)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Occupational therapy for ADL assessment, cognitive strategies, and home safety evaluation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Physical therapy for gait training, balance exercises, and fall prevention",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Speech therapy for communication strategies and swallowing evaluation if dysphagia present",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Social work for caregiver support, community resources, and long-term care planning",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Palliative care for advanced dementia symptom management and goals of care discussions",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Cardiology if orthostatic hypotension refractory to first-line treatment",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "CRITICAL: Avoid all typical antipsychotics and most atypical antipsychotics - severe sensitivity can cause parkinsonism, rigidity, and death",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Carry a medication alert card listing \"Lewy Body Dementia - Neuroleptic Sensitivity\" for all healthcare encounters",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Report visual hallucinations immediately as these may indicate disease progression or medication effect",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Rise slowly from sitting or lying to prevent falls from orthostatic hypotension",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Implement safety measures for REM sleep behavior disorder: padded bed rails, mattress on floor, remove sharp objects from bedside",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Complete advance directives while patient has capacity to document wishes for future care",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Do not drive due to fluctuating attention, visual-spatial deficits, and hallucinations",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Return immediately if sudden worsening of confusion, falls, or inability to walk (may indicate medication effect or infection)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Fall prevention: remove home hazards, adequate lighting, grab bars, non-slip surfaces due to high fall risk",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "AVOID medications that worsen symptoms: anticholinergics, antihistamines (diphenhydramine), sleep aids (Benadryl, Tylenol PM)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "AVOID antiemetics: metoclopramide, prochlorperazine, promethazine (D2 blocking worsens parkinsonism)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Regular physical exercise as tolerated to maintain mobility and reduce fall risk",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Structured daily routine with consistent sleep-wake times helps with fluctuating cognition",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Adequate lighting and avoid overstimulation which may trigger hallucinations",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Simplify environment and reduce visual clutter to minimize misperceptions",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Caregiver education about fluctuating cognition, which is characteristic and not willful",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Treat sleep apnea if present as it worsens cognition and autonomic dysfunction",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Alzheimer's disease",
        "features": "Memory impairment predominates; no parkinsonism; no visual hallucinations early",
        "tests": "DaTscan normal in AD; MRI hippocampal atrophy; amyloid/tau biomarkers"
      },
      {
        "diagnosis": "Parkinson's disease dementia (PDD)",
        "features": "Motor symptoms precede dementia by >1 year (vs DLB dementia within 1 year of motor)",
        "tests": "Clinical timeline; considered same disease spectrum as DLB"
      },
      {
        "diagnosis": "Vascular dementia",
        "features": "Stepwise decline; focal findings; executive dysfunction; vascular risk factors",
        "tests": "MRI with significant white matter disease, strategic infarcts"
      },
      {
        "diagnosis": "Frontotemporal dementia",
        "features": "Personality change; disinhibition; apathy; hyperorality; younger onset",
        "tests": "FDG-PET frontal hypometabolism; preserved posterior metabolism"
      },
      {
        "diagnosis": "Progressive supranuclear palsy (PSP)",
        "features": "Vertical gaze palsy; axial rigidity > limb; early falls backward; poor levodopa response",
        "tests": "MRI \"hummingbird sign\"; clinical criteria"
      },
      {
        "diagnosis": "Corticobasal syndrome",
        "features": "Asymmetric rigidity; apraxia; alien limb; cortical sensory loss",
        "tests": "MRI asymmetric cortical atrophy; clinical criteria"
      },
      {
        "diagnosis": "Multiple system atrophy (MSA)",
        "features": "Severe early dysautonomia; cerebellar signs; stridor; poor levodopa response",
        "tests": "MRI \"hot cross bun\" sign; cardiac MIBG preserved (vs reduced in DLB)"
      },
      {
        "diagnosis": "Creutzfeldt-Jakob disease",
        "features": "Rapid progression (weeks-months); myoclonus; periodic sharp waves on EEG",
        "tests": "EEG PSWCs; MRI DWI cortical ribboning; CSF RT-QuIC positive"
      },
      {
        "diagnosis": "Drug-induced parkinsonism",
        "features": "Medication exposure (antipsychotics, metoclopramide); symmetric; no hallucinations",
        "tests": "DaTscan normal; medication history; resolves with drug removal"
      },
      {
        "diagnosis": "Delirium",
        "features": "Acute onset; fluctuating attention; identifiable cause",
        "tests": "Treat cause; reassess cognition when clear"
      },
      {
        "diagnosis": "Charles Bonnet syndrome",
        "features": "Visual hallucinations with insight; occurs with visual impairment; no dementia",
        "tests": "Ophthalmologic evaluation; cognitive testing normal"
      }
    ],
    "evidence": [
      {
        "recommendation": "McKeith diagnostic criteria for DLB",
        "evidenceLevel": "Consensus Guidelines",
        "source": "[McKeith et al. Neurology 2017](https://pubmed.ncbi.nlm.nih.gov/28592453/)"
      },
      {
        "recommendation": "DaTscan indicative biomarker for DLB",
        "evidenceLevel": "Class II, Level B",
        "source": "[McKeith et al. Lancet Neurol 2007](https://pubmed.ncbi.nlm.nih.gov/17509489/)"
      },
      {
        "recommendation": "Cardiac MIBG indicative biomarker",
        "evidenceLevel": "Class II, Level B",
        "source": "[Yoshita et al. Neurology 2015](https://pubmed.ncbi.nlm.nih.gov/26519540/)"
      },
      {
        "recommendation": "Rivastigmine for PDD/DLB cognition",
        "evidenceLevel": "Class I, Level A",
        "source": "[Emre et al. NEJM 2004](https://pubmed.ncbi.nlm.nih.gov/15590953/)"
      },
      {
        "recommendation": "Donepezil for DLB",
        "evidenceLevel": "Class I, Level A",
        "source": "[Mori et al. Ann Neurol 2012](https://pubmed.ncbi.nlm.nih.gov/22926857/)"
      },
      {
        "recommendation": "Cholinesterase inhibitors reduce visual hallucinations",
        "evidenceLevel": "Class II, Level B",
        "source": "[Stinton et al. Int J Geriatr Psychiatry 2015](https://pubmed.ncbi.nlm.nih.gov/25676160/)"
      },
      {
        "recommendation": "Neuroleptic sensitivity in DLB",
        "evidenceLevel": "Class II, Level B",
        "source": "[McKeith et al. BMJ 1992](https://pubmed.ncbi.nlm.nih.gov/1392706/)"
      },
      {
        "recommendation": "Antipsychotic mortality risk in dementia",
        "evidenceLevel": "Class I, Level A",
        "source": "[Schneider et al. JAMA 2005](https://pubmed.ncbi.nlm.nih.gov/16219884/)"
      },
      {
        "recommendation": "Pimavanserin for PD psychosis",
        "evidenceLevel": "Class I, Level A",
        "source": "[Cummings et al. Lancet 2014](https://pubmed.ncbi.nlm.nih.gov/24315521/)"
      },
      {
        "recommendation": "Melatonin for REM sleep behavior disorder",
        "evidenceLevel": "Class II, Level B",
        "source": "[Kunz et al. Sleep Med 2010](https://pubmed.ncbi.nlm.nih.gov/20817595/)"
      },
      {
        "recommendation": "Clonazepam for REM sleep behavior disorder",
        "evidenceLevel": "Class II, Level B",
        "source": "[Aurora et al. Sleep 2010](https://pubmed.ncbi.nlm.nih.gov/21135521/)"
      },
      {
        "recommendation": "CSF alpha-synuclein SAA for synucleinopathies",
        "evidenceLevel": "Class II, Level B",
        "source": "[Siderowf et al. Lancet Neurol 2023](https://pubmed.ncbi.nlm.nih.gov/37068508/)"
      }
    ],
    "monitoring": [
      {
        "item": "Cognitive function (MoCA or MMSE)",
        "frequency": "Every 6 months",
        "action": "Adjust treatment; reassess diagnosis",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Motor function (UPDRS-III)",
        "frequency": "Every 6 months",
        "action": "Adjust levodopa if motor symptoms dominant",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Visual hallucinations frequency/severity",
        "frequency": "Each visit",
        "action": "Adjust cholinesterase inhibitor; add pimavanserin if distressing",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Orthostatic blood pressure",
        "frequency": "Each visit",
        "action": "Add midodrine or droxidopa",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Falls frequency",
        "frequency": "Each visit",
        "action": "PT referral; medication review; home safety",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "RBD symptoms",
        "frequency": "Each visit",
        "action": "Adjust melatonin or clonazepam; safety measures",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Mood (GDS, PHQ-9)",
        "frequency": "Every 6 months",
        "action": "Add antidepressant; psychiatry referral",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "ADL/IADL function",
        "frequency": "Every 6 months",
        "action": "Increase support services; OT referral",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Caregiver burden (Zarit scale)",
        "frequency": "Every 6-12 months",
        "action": "Support resources; respite care; social work",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Weight",
        "frequency": "Each visit",
        "action": "Nutritional assessment; speech for swallowing",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "ECG (if on pimavanserin, citalopram)",
        "frequency": "Baseline; if dose increased",
        "action": "Reduce dose or switch agent",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      }
    ],
    "disposition": [
      {
        "disposition": "Discharge home",
        "criteria": "Reversible causes treated; safe environment; caregiver support; no acute behavioral crisis; follow-up arranged"
      },
      {
        "disposition": "Admit to floor",
        "criteria": "Acute delirium requiring workup; severe behavioral crisis unsafe for home; falls with injury; medication toxicity"
      },
      {
        "disposition": "Admit to psychiatry",
        "criteria": "Severe behavioral disturbance requiring specialized psychiatric management; suicidal ideation"
      },
      {
        "disposition": "Outpatient follow-up",
        "criteria": "Neurology/geriatrics 1-2 months after diagnosis; then every 3-6 months"
      },
      {
        "disposition": "Long-term care",
        "criteria": "Progressive decline; caregiver unable to manage safely; nocturnal behavioral disturbance; 24-hour supervision needed"
      }
    ]
  },
  "Vascular Dementia": {
    "id": "vascular-dementia",
    "title": "Vascular Dementia",
    "version": "1.0",
    "icd10": [
      "** F01.50 (Vascular dementia without behavioral disturbance)",
      "F01.51 (Vascular dementia with behavioral disturbance)",
      "I67.3 (Progressive vascular leukoencephalopathy - Binswanger disease)",
      "I67.89 (Other cerebrovascular disease)"
    ],
    "scope": "** Diagnosis using NINDS-AIREN and DSM-5 criteria, neuroimaging evaluation for strategic infarcts and white matter disease, vascular risk factor modification, secondary stroke prevention, cholinesterase inhibitors for cognitive symptoms, and management of post-stroke depression, apathy, and behavioral symptoms. Primarily outpatient-focused with coverage for ED and hospital presentations.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC with differential",
            "rationale": "Polycythemia, anemia, infection affecting cognition",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "BMP (Na, K, BUN, Cr, glucose)",
            "rationale": "Metabolic causes of confusion; renal function for medication dosing",
            "target": "Normal electrolytes, renal function",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "TSH",
            "rationale": "Hypothyroidism is reversible cause of cognitive impairment",
            "target": "0.4-4.0 mIU/L",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin B12",
            "rationale": "Deficiency causes reversible cognitive decline and may worsen vascular dementia",
            "target": ">300 pg/mL (>400 optimal)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Folate",
            "rationale": "Deficiency contributes to hyperhomocysteinemia and cognitive impairment",
            "target": ">3 ng/mL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Hemoglobin A1c",
            "rationale": "Diabetes is major vascular risk factor; assess chronic glucose control",
            "target": "<7.0% (individualized 7-8% in frail elderly)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Fasting lipid panel",
            "rationale": "Assess LDL for secondary stroke prevention; target <70 mg/dL",
            "target": "LDL <70 mg/dL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Urinalysis",
            "rationale": "UTI common cause of acute confusion in elderly",
            "target": "Negative for infection",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "PT/INR, PTT",
            "rationale": "Baseline coagulation; assess if on anticoagulation",
            "target": "Normal or therapeutic",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended Workup": [
          {
            "item": "Homocysteine",
            "rationale": "Elevated levels increase stroke risk and contribute to vascular dementia",
            "target": "<15 μmol/L",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lipoprotein(a)",
            "rationale": "Independent cardiovascular risk marker; elevated increases stroke risk",
            "target": "<50 nmol/L (or <30 mg/dL)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "hsCRP",
            "rationale": "Inflammatory marker; elevated predicts vascular events",
            "target": "<2 mg/L",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin D, 25-hydroxy",
            "rationale": "Deficiency associated with cognitive decline and vascular disease",
            "target": ">30 ng/mL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "RPR or VDRL",
            "rationale": "Neurosyphilis is treatable cause of dementia",
            "target": "Nonreactive",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "HIV testing",
            "rationale": "HIV-associated neurocognitive disorder if risk factors",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Hepatic panel (AST, ALT, albumin)",
            "rationale": "Hepatic encephalopathy; nutritional status; statin safety",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "BNP/NT-proBNP",
            "rationale": "Heart failure; atrial fibrillation risk assessment",
            "target": "Age-adjusted normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Uric acid",
            "rationale": "Elevated associated with increased stroke and dementia risk",
            "target": "<6 mg/dL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "APOE genotyping",
            "rationale": "Risk stratification; mixed AD/VaD assessment",
            "target": "APOE status for prognosis",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Hypercoagulability panel",
            "rationale": "Age <50, cryptogenic strokes, recurrent events",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Antiphospholipid antibodies",
            "rationale": "Lupus anticoagulant, anticardiolipin; young-onset vascular disease",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "ESR, ANA",
            "rationale": "Suspected CNS vasculitis causing multi-infarct state",
            "target": "Normal/Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "ANCA panel",
            "rationale": "Vasculitis workup if suspected",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Fabry disease testing (alpha-galactosidase A)",
            "rationale": "Young-onset stroke; angiokeratomas; neuropathy",
            "target": "Normal enzyme activity",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "NOTCH3 genetic testing",
            "rationale": "Suspected CADASIL (family history, migraine, early WM disease)",
            "target": "No pathogenic mutation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Mitochondrial DNA analysis",
            "rationale": "Suspected MELAS or mitochondrial disease",
            "target": "No pathogenic mutation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "Cell count, protein, glucose",
            "rationale": "Rule out infection, inflammation, vasculitis",
            "target": "WBC <5, protein <45 mg/dL, glucose >60% serum",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CSF Aβ42 and Aβ42/Aβ40 ratio",
            "rationale": "Differentiate from Alzheimer's disease",
            "target": "Normal Aβ42 in pure VaD; low suggests mixed AD/VaD",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CSF total tau and p-tau181",
            "rationale": "Elevated in AD; can help distinguish VaD from AD",
            "target": "Normal or mildly elevated in pure VaD; high p-tau suggests AD",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CSF NfL (neurofilament light)",
            "rationale": "Non-specific marker of neuronal damage; elevated in vascular injury",
            "target": "Elevated suggests ongoing neurodegeneration",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Oligoclonal bands, IgG index",
            "rationale": "Rule out inflammatory/demyelinating disease",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "VDRL",
            "rationale": "Neurosyphilis",
            "target": "Nonreactive",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Autoimmune encephalitis panel",
            "rationale": "Atypical presentation; subacute onset",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "MRI Brain without contrast",
            "timing": "At initial evaluation",
            "target": "Strategic infarcts (thalamus, basal ganglia, angular gyrus); confluent white matter hyperintensities (Fazekas ≥2); lacunar infarcts",
            "contraindications": "MRI-incompatible devices, severe claustrophobia",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CT Head non-contrast",
            "timing": "If MRI unavailable or contraindicated",
            "target": "Rule out hemorrhage, mass, hydrocephalus; may show old infarcts, leukoaraiosis",
            "contraindications": "None",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "MRA Head and Neck",
            "timing": "With initial MRI",
            "target": "Intracranial and extracranial atherosclerosis; assess for stenosis >50%",
            "contraindications": "MRI contraindications",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CTA Head and Neck",
            "timing": "Alternative to MRA",
            "target": "Vascular stenosis; atherosclerotic burden",
            "contraindications": "Contrast allergy, CKD (relative)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Carotid duplex ultrasound",
            "timing": "Within 1 week of diagnosis",
            "target": "Assess carotid stenosis; plaque characterization",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "ECG (12-lead)",
            "timing": "At diagnosis",
            "target": "Assess for atrial fibrillation, LVH, prior MI",
            "contraindications": "None",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Transthoracic echocardiogram",
            "timing": "Within 2 weeks",
            "target": "LV function; valvular disease; intracardiac thrombus",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended": [
          {
            "item": "MRI Brain with SWI/GRE sequences",
            "timing": "With initial MRI",
            "target": "Microbleeds (cerebral amyloid angiopathy pattern vs hypertensive); hemosiderin",
            "contraindications": "MRI contraindications",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "MRI volumetrics",
            "timing": "Baseline for progression",
            "target": "Quantify white matter lesion volume; global and regional atrophy",
            "contraindications": "MRI contraindications",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "FDG-PET Brain",
            "timing": "Differentiate VaD from AD; atypical cases",
            "target": "Scattered hypometabolism (vs temporoparietal in AD)",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Amyloid PET",
            "timing": "Distinguish pure VaD from mixed AD/VaD",
            "target": "Negative suggests pure VaD; positive suggests mixed pathology",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Cardiac telemetry/Holter monitor",
            "timing": "Screen for paroxysmal AF",
            "target": "Sinus rhythm; detect occult AF",
            "contraindications": "None",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Extended cardiac monitoring (14-30 day)",
            "timing": "Cryptogenic strokes; suspected occult AF",
            "target": "Sinus rhythm; detect paroxysmal AF",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "EEG",
            "timing": "Encephalopathy; seizures; rapid decline",
            "target": "Non-specific slowing (not CJD pattern)",
            "contraindications": "None",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sleep study (polysomnography)",
            "timing": "Sleep apnea is vascular risk factor; assess for OSA",
            "target": "AHI <5 (or treat if elevated)",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Vessel wall MRI",
            "timing": "Suspected CNS vasculitis or reversible vasoconstriction",
            "target": "No vessel wall enhancement or thickening",
            "contraindications": "MRI contraindications",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "DSA (cerebral angiogram)",
            "timing": "Vasculitis confirmation; moyamoya; intracranial stenosis",
            "target": "Define vascular anatomy",
            "contraindications": "Contrast allergy, bleeding risk",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "SPECT (perfusion)",
            "timing": "Alternative to PET if unavailable",
            "target": "Regional hypoperfusion patterns",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Transesophageal echocardiogram",
            "timing": "Cryptogenic strokes; suspected aortic arch atheroma or PFO",
            "target": "No embolic source",
            "contraindications": "Esophageal pathology",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "Treat reversible causes",
            "route": "Various",
            "indication": "Identified metabolic or infectious etiology",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per specific cause",
                  "orderSentence": "Treat reversible causes Per specific cause Various"
                }
              ],
              "route": "Various",
              "instructions": "Correct hyponatremia slowly, treat UTI, replace B12, treat hypothyroidism",
              "orderSentence": "Treat reversible causes Per specific cause Various"
            },
            "contraindications": "Depends on intervention",
            "monitoring": "Cognitive reassessment after treatment",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Thiamine",
            "route": "IV/PO",
            "indication": "Suspected Wernicke's; alcoholism; malnutrition",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mg IV TID x 3 days",
                  "orderSentence": "Thiamine 500 mg IV TID x 3 days IV/PO"
                },
                {
                  "text": "100 mg PO daily",
                  "orderSentence": "Thiamine 100 mg PO daily IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "500 mg IV TID x 3 days if Wernicke suspected; then 100 mg PO daily maintenance",
              "orderSentence": "Thiamine 500 mg IV TID x 3 days IV/PO"
            },
            "contraindications": "None",
            "monitoring": "Clinical improvement in confusion",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Aspirin",
            "route": "PO",
            "indication": "Immediate antiplatelet therapy for secondary stroke prevention",
            "dosing": {
              "doseOptions": [
                {
                  "text": "325 mg PO x1 load",
                  "orderSentence": "Aspirin 325 mg PO x1 load PO"
                },
                {
                  "text": "81 mg PO daily",
                  "orderSentence": "Aspirin 81 mg PO daily PO"
                }
              ],
              "route": "PO",
              "instructions": "325 mg loading dose if no recent stroke, then 81 mg daily ongoing",
              "orderSentence": "Aspirin 325 mg PO x1 load PO"
            },
            "contraindications": "Active GI bleed; aspirin allergy",
            "monitoring": "GI symptoms, bleeding",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Blood pressure management (acute)",
            "route": "Various",
            "indication": "Acute delirium or new stroke",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Target <180/110 acutely",
                  "orderSentence": "Blood pressure management (acute) Target <180/110 acutely Various"
                }
              ],
              "route": "Various",
              "instructions": "Do NOT lower BP aggressively unless >220/120 or end-organ damage; permissive hypertension first 24-48h of stroke",
              "orderSentence": "Blood pressure management (acute) Target <180/110 acutely Various"
            },
            "contraindications": "Symptomatic hypotension",
            "monitoring": "BP q1h initially",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          }
        ],
        "Vascular Risk Factor Modification (Secondary Stroke Prevention)": [
          {
            "item": "Atorvastatin",
            "route": "PO",
            "indication": "High-intensity statin for secondary stroke prevention; LDL target <70",
            "dosing": {
              "doseOptions": [
                {
                  "text": "40 mg daily",
                  "orderSentence": "Atorvastatin 40 mg daily PO"
                },
                {
                  "text": "80 mg daily",
                  "orderSentence": "Atorvastatin 80 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 40-80 mg daily; target LDL <70 mg/dL; 80 mg preferred for established vascular disease",
              "orderSentence": "Atorvastatin 40 mg daily PO"
            },
            "contraindications": "Active liver disease; pregnancy",
            "monitoring": "LFTs at baseline, 6-12 weeks, then annually; myalgias",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rosuvastatin",
            "route": "PO",
            "indication": "Alternative high-intensity statin; may be better tolerated",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg daily",
                  "orderSentence": "Rosuvastatin 20 mg daily PO"
                },
                {
                  "text": "40 mg daily",
                  "orderSentence": "Rosuvastatin 40 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 20 mg daily; max 40 mg; potent LDL lowering",
              "orderSentence": "Rosuvastatin 20 mg daily PO"
            },
            "contraindications": "Active liver disease; pregnancy; Asian dose adjustment (10 mg start)",
            "monitoring": "LFTs; myalgias; CK if symptomatic",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Aspirin (long-term)",
            "route": "PO",
            "indication": "Lifelong antiplatelet for secondary stroke prevention",
            "dosing": {
              "doseOptions": [
                {
                  "text": "81 mg daily",
                  "orderSentence": "Aspirin (long-term) 81 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "81 mg daily indefinitely for non-cardioembolic vascular dementia",
              "orderSentence": "Aspirin (long-term) 81 mg daily PO"
            },
            "contraindications": "Active GI bleeding; aspirin allergy",
            "monitoring": "GI symptoms; annual CBC",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Clopidogrel",
            "route": "PO",
            "indication": "Alternative to aspirin if aspirin-intolerant; or after DAPT period",
            "dosing": {
              "doseOptions": [
                {
                  "text": "75 mg daily",
                  "orderSentence": "Clopidogrel 75 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "75 mg daily; may use instead of aspirin if intolerant",
              "orderSentence": "Clopidogrel 75 mg daily PO"
            },
            "contraindications": "Active bleeding",
            "monitoring": "Bleeding signs",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lisinopril",
            "route": "PO",
            "indication": "Blood pressure control; target <130/80 for secondary prevention",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg daily",
                  "orderSentence": "Lisinopril 5 mg daily PO"
                },
                {
                  "text": "10 mg daily",
                  "orderSentence": "Lisinopril 10 mg daily PO"
                },
                {
                  "text": "20 mg daily",
                  "orderSentence": "Lisinopril 20 mg daily PO"
                },
                {
                  "text": "40 mg daily",
                  "orderSentence": "Lisinopril 40 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5-10 mg daily; titrate to goal BP <130/80; max 40 mg daily",
              "orderSentence": "Lisinopril 5 mg daily PO"
            },
            "contraindications": "Angioedema history; pregnancy; bilateral RAS; hyperkalemia",
            "monitoring": "K+, Cr at 1-2 weeks; BP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Amlodipine",
            "route": "PO",
            "indication": "BP control; add-on or alternative antihypertensive",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg daily",
                  "orderSentence": "Amlodipine 5 mg daily PO"
                },
                {
                  "text": "10 mg daily",
                  "orderSentence": "Amlodipine 10 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg daily; may increase to 10 mg daily",
              "orderSentence": "Amlodipine 5 mg daily PO"
            },
            "contraindications": "Severe aortic stenosis (relative)",
            "monitoring": "Peripheral edema; BP",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Chlorthalidone",
            "route": "PO",
            "indication": "Thiazide-like diuretic for BP control; effective for stroke prevention",
            "dosing": {
              "doseOptions": [
                {
                  "text": "12.5 mg daily",
                  "orderSentence": "Chlorthalidone 12.5 mg daily PO"
                },
                {
                  "text": "25 mg daily",
                  "orderSentence": "Chlorthalidone 25 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 12.5 mg daily; may increase to 25 mg daily",
              "orderSentence": "Chlorthalidone 12.5 mg daily PO"
            },
            "contraindications": "Severe hypokalemia; hyponatremia",
            "monitoring": "K+, Na+, uric acid, glucose",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Metformin",
            "route": "PO",
            "indication": "First-line for type 2 diabetes if eGFR >30",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mg daily",
                  "orderSentence": "Metformin 500 mg daily PO"
                },
                {
                  "text": "500 mg BID",
                  "orderSentence": "Metformin 500 mg BID PO"
                },
                {
                  "text": "1000 mg BID",
                  "orderSentence": "Metformin 1000 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 500 mg daily with meal; titrate by 500 mg weekly; max 2000-2550 mg/day in divided doses",
              "orderSentence": "Metformin 500 mg daily PO"
            },
            "contraindications": "eGFR <30; acute illness; contrast within 48h",
            "monitoring": "eGFR; B12 annually; lactic acidosis symptoms",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Empagliflozin",
            "route": "PO",
            "indication": "SGLT2 inhibitor for diabetes with cardiovascular benefit",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg daily",
                  "orderSentence": "Empagliflozin 10 mg daily PO"
                },
                {
                  "text": "25 mg daily",
                  "orderSentence": "Empagliflozin 25 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10 mg daily; may increase to 25 mg; cardiovascular mortality benefit",
              "orderSentence": "Empagliflozin 10 mg daily PO"
            },
            "contraindications": "eGFR <20; Type 1 DM; DKA history",
            "monitoring": "eGFR; volume status; genital infections",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ezetimibe",
            "route": "PO",
            "indication": "Add-on for LDL not at goal on statin",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg daily",
                  "orderSentence": "Ezetimibe 10 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "10 mg daily with or without food",
              "orderSentence": "Ezetimibe 10 mg daily PO"
            },
            "contraindications": "Severe hepatic impairment",
            "monitoring": "LDL; LFTs",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Apixaban",
            "route": "PO",
            "indication": "Atrial fibrillation-related vascular dementia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg BID",
                  "orderSentence": "Apixaban 5 mg BID PO"
                },
                {
                  "text": "2.5 mg BID",
                  "orderSentence": "Apixaban 2.5 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "5 mg BID (2.5 mg BID if ≥2 of: age ≥80, weight ≤60 kg, Cr ≥1.5)",
              "orderSentence": "Apixaban 5 mg BID PO"
            },
            "contraindications": "Active major bleeding; mechanical valve",
            "monitoring": "CrCl; bleeding signs",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rivaroxaban",
            "route": "PO",
            "indication": "AF-related vascular dementia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg daily",
                  "orderSentence": "Rivaroxaban 20 mg daily PO"
                },
                {
                  "text": "15 mg daily",
                  "orderSentence": "Rivaroxaban 15 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "20 mg daily with dinner (15 mg if CrCl 15-50)",
              "orderSentence": "Rivaroxaban 20 mg daily PO"
            },
            "contraindications": "Active bleeding; mechanical valve",
            "monitoring": "CrCl; bleeding",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Warfarin",
            "route": "PO",
            "indication": "Mechanical valve; select hypercoagulable states; AF if DOACs contraindicated",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2-10 mg daily adjusted",
                  "orderSentence": "Warfarin 2-10 mg daily adjusted PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg daily; adjust to INR 2-3",
              "orderSentence": "Warfarin 2-10 mg daily adjusted PO"
            },
            "contraindications": "Active bleeding; frequent falls; poor adherence",
            "monitoring": "INR weekly then monthly",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Cholinesterase Inhibitors (Cognitive Enhancement - Modest Benefit)": [
          {
            "item": "Donepezil (Aricept)",
            "route": "PO",
            "indication": "Vascular dementia cognitive symptoms; modest but measurable benefit",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg qHS",
                  "orderSentence": "Donepezil (Aricept) 5 mg qHS PO"
                },
                {
                  "text": "10 mg qHS",
                  "orderSentence": "Donepezil (Aricept) 10 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg qHS x 4-6 weeks; if tolerated, increase to 10 mg qHS; benefit smaller than in AD",
              "orderSentence": "Donepezil (Aricept) 5 mg qHS PO"
            },
            "contraindications": "Sick sinus syndrome; second/third degree heart block without pacemaker; active GI bleeding",
            "monitoring": "Heart rate; GI symptoms (nausea, diarrhea); vivid dreams",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rivastigmine oral (Exelon)",
            "route": "PO",
            "indication": "Vascular dementia; executive dysfunction; may help mixed AD/VaD",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1.5 mg BID",
                  "orderSentence": "Rivastigmine oral (Exelon) 1.5 mg BID PO"
                },
                {
                  "text": "3 mg BID",
                  "orderSentence": "Rivastigmine oral (Exelon) 3 mg BID PO"
                },
                {
                  "text": "4.5 mg BID",
                  "orderSentence": "Rivastigmine oral (Exelon) 4.5 mg BID PO"
                },
                {
                  "text": "6 mg BID",
                  "orderSentence": "Rivastigmine oral (Exelon) 6 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 1.5 mg BID with meals; increase by 1.5 mg BID every 2 weeks; target 6 mg BID",
              "orderSentence": "Rivastigmine oral (Exelon) 1.5 mg BID PO"
            },
            "contraindications": "Sick sinus; severe hepatic impairment",
            "monitoring": "GI symptoms; weight loss; bradycardia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rivastigmine patch (Exelon Patch)",
            "route": "TD",
            "indication": "Vascular dementia; better GI tolerability than oral",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4.6 mg/24hr",
                  "orderSentence": "Rivastigmine patch (Exelon Patch) 4.6 mg/24hr TD"
                },
                {
                  "text": "9.5 mg/24hr",
                  "orderSentence": "Rivastigmine patch (Exelon Patch) 9.5 mg/24hr TD"
                },
                {
                  "text": "13.3 mg/24hr",
                  "orderSentence": "Rivastigmine patch (Exelon Patch) 13.3 mg/24hr TD"
                }
              ],
              "route": "TD",
              "instructions": "Start 4.6 mg/24hr patch; increase every 4 weeks; target 9.5-13.3 mg/24hr",
              "orderSentence": "Rivastigmine patch (Exelon Patch) 4.6 mg/24hr TD"
            },
            "contraindications": "Same as oral",
            "monitoring": "Skin irritation; rotate sites",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Galantamine (Razadyne)",
            "route": "PO",
            "indication": "Vascular dementia; dual mechanism may benefit executive function",
            "dosing": {
              "doseOptions": [
                {
                  "text": "4 mg BID",
                  "orderSentence": "Galantamine (Razadyne) 4 mg BID PO"
                },
                {
                  "text": "8 mg BID",
                  "orderSentence": "Galantamine (Razadyne) 8 mg BID PO"
                },
                {
                  "text": "12 mg BID",
                  "orderSentence": "Galantamine (Razadyne) 12 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 4 mg BID with meals x 4 weeks; increase to 8 mg BID x 4 weeks; target 8-12 mg BID",
              "orderSentence": "Galantamine (Razadyne) 4 mg BID PO"
            },
            "contraindications": "Sick sinus; severe renal impairment (CrCl <9); severe hepatic impairment",
            "monitoring": "GI symptoms; bradycardia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Memantine (Namenda)",
            "route": "PO",
            "indication": "Moderate-severe vascular dementia; add to cholinesterase inhibitor",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg daily",
                  "orderSentence": "Memantine (Namenda) 5 mg daily PO"
                },
                {
                  "text": "5 mg BID",
                  "orderSentence": "Memantine (Namenda) 5 mg BID PO"
                },
                {
                  "text": "10 mg BID",
                  "orderSentence": "Memantine (Namenda) 10 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg daily x 1 week; increase by 5 mg/week: 5 mg BID, then 5/10 mg, then 10 mg BID",
              "orderSentence": "Memantine (Namenda) 5 mg daily PO"
            },
            "contraindications": "Severe renal impairment (reduce dose if CrCl 5-29: max 5 mg BID)",
            "monitoring": "Confusion, dizziness, constipation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Post-Stroke Depression and Apathy": [
          {
            "item": "Sertraline (Zoloft)",
            "route": "PO",
            "indication": "Post-stroke depression (evidence-based; FLAME trial); first-line",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg daily",
                  "orderSentence": "Sertraline (Zoloft) 25 mg daily PO"
                },
                {
                  "text": "50 mg daily",
                  "orderSentence": "Sertraline (Zoloft) 50 mg daily PO"
                },
                {
                  "text": "100 mg daily",
                  "orderSentence": "Sertraline (Zoloft) 100 mg daily PO"
                },
                {
                  "text": "150 mg daily",
                  "orderSentence": "Sertraline (Zoloft) 150 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg daily; increase by 25 mg every 1-2 weeks; typical 50-100 mg daily; max 200 mg",
              "orderSentence": "Sertraline (Zoloft) 25 mg daily PO"
            },
            "contraindications": "MAOIs; concurrent QT-prolonging drugs (high doses)",
            "monitoring": "GI upset initially; bleeding risk with anticoagulants; sexual dysfunction",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Escitalopram (Lexapro)",
            "route": "PO",
            "indication": "Post-stroke depression; well-tolerated in elderly",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg daily",
                  "orderSentence": "Escitalopram (Lexapro) 5 mg daily PO"
                },
                {
                  "text": "10 mg daily",
                  "orderSentence": "Escitalopram (Lexapro) 10 mg daily PO"
                },
                {
                  "text": "20 mg daily",
                  "orderSentence": "Escitalopram (Lexapro) 20 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg daily in elderly; increase to 10 mg after 1 week; max 20 mg (10 mg if >65y)",
              "orderSentence": "Escitalopram (Lexapro) 5 mg daily PO"
            },
            "contraindications": "MAOIs; QT prolongation",
            "monitoring": "QTc if cardiac risk; GI symptoms",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Citalopram (Celexa)",
            "route": "PO",
            "indication": "Depression; agitation in dementia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg daily",
                  "orderSentence": "Citalopram (Celexa) 10 mg daily PO"
                },
                {
                  "text": "20 mg daily",
                  "orderSentence": "Citalopram (Celexa) 20 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10 mg daily; max 20 mg in elderly due to QT prolongation risk",
              "orderSentence": "Citalopram (Celexa) 10 mg daily PO"
            },
            "contraindications": "QT prolongation; concurrent QT-prolonging drugs",
            "monitoring": "ECG at baseline if cardiac risk; QTc monitoring",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Mirtazapine (Remeron)",
            "route": "PO",
            "indication": "Depression with poor appetite, weight loss, and insomnia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "7.5 mg qHS",
                  "orderSentence": "Mirtazapine (Remeron) 7.5 mg qHS PO"
                },
                {
                  "text": "15 mg qHS",
                  "orderSentence": "Mirtazapine (Remeron) 15 mg qHS PO"
                },
                {
                  "text": "30 mg qHS",
                  "orderSentence": "Mirtazapine (Remeron) 30 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 7.5-15 mg qHS; may increase to 30-45 mg qHS; lower doses more sedating",
              "orderSentence": "Mirtazapine (Remeron) 7.5 mg qHS PO"
            },
            "contraindications": "MAOIs; angle-closure glaucoma",
            "monitoring": "Weight gain (often desired); sedation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Bupropion SR/XL",
            "route": "PO",
            "indication": "Depression with fatigue and apathy; no sexual side effects; avoid if seizure risk",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg SR daily",
                  "orderSentence": "Bupropion SR/XL 100 mg SR daily PO"
                },
                {
                  "text": "150 mg SR BID",
                  "orderSentence": "Bupropion SR/XL 150 mg SR BID PO"
                },
                {
                  "text": "150 mg XL daily",
                  "orderSentence": "Bupropion SR/XL 150 mg XL daily PO"
                },
                {
                  "text": "300 mg XL daily",
                  "orderSentence": "Bupropion SR/XL 300 mg XL daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 100 mg SR daily or 150 mg XL daily; may increase after 3 days; max 400 mg/day",
              "orderSentence": "Bupropion SR/XL 100 mg SR daily PO"
            },
            "contraindications": "Seizure disorder; anorexia/bulimia; abrupt alcohol/benzo withdrawal",
            "monitoring": "Seizure risk; insomnia; anxiety",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Methylphenidate",
            "route": "PO",
            "indication": "Apathy refractory to antidepressants; psychomotor retardation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2.5 mg BID",
                  "orderSentence": "Methylphenidate 2.5 mg BID PO"
                },
                {
                  "text": "5 mg BID",
                  "orderSentence": "Methylphenidate 5 mg BID PO"
                },
                {
                  "text": "10 mg BID",
                  "orderSentence": "Methylphenidate 10 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 2.5-5 mg BID (morning and noon); titrate by 2.5-5 mg every 3-5 days; max 30 mg/day",
              "orderSentence": "Methylphenidate 2.5 mg BID PO"
            },
            "contraindications": "Severe hypertension; cardiac arrhythmias; hyperthyroidism; glaucoma",
            "monitoring": "BP, HR; appetite; sleep",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Modafinil",
            "route": "PO",
            "indication": "Apathy; fatigue; excessive daytime sleepiness",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg daily",
                  "orderSentence": "Modafinil 100 mg daily PO"
                },
                {
                  "text": "200 mg daily",
                  "orderSentence": "Modafinil 200 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 100 mg each morning; may increase to 200 mg daily",
              "orderSentence": "Modafinil 100 mg daily PO"
            },
            "contraindications": "Severe hepatic impairment; cardiac arrhythmias",
            "monitoring": "BP, HR; sleep disturbance",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Behavioral and Psychological Symptoms of Dementia (BPSD)": [
          {
            "item": "Trazodone",
            "route": "PO",
            "indication": "Insomnia; sundowning; mild agitation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Trazodone 25 mg qHS PO"
                },
                {
                  "text": "50 mg qHS",
                  "orderSentence": "Trazodone 50 mg qHS PO"
                },
                {
                  "text": "100 mg qHS",
                  "orderSentence": "Trazodone 100 mg qHS PO"
                },
                {
                  "text": "150 mg qHS",
                  "orderSentence": "Trazodone 150 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25-50 mg qHS; titrate by 25-50 mg every 3-5 days; typical 50-150 mg qHS",
              "orderSentence": "Trazodone 25 mg qHS PO"
            },
            "contraindications": "MAOIs; significant QT prolongation",
            "monitoring": "Orthostatic hypotension (fall risk); priapism (rare)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Melatonin",
            "route": "PO",
            "indication": "Sleep disturbance; circadian rhythm dysfunction; sundowning",
            "dosing": {
              "doseOptions": [
                {
                  "text": "3 mg qHS",
                  "orderSentence": "Melatonin 3 mg qHS PO"
                },
                {
                  "text": "6 mg qHS",
                  "orderSentence": "Melatonin 6 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 3 mg qHS, 30 min before bed; may increase to 6 mg if needed",
              "orderSentence": "Melatonin 3 mg qHS PO"
            },
            "contraindications": "None significant",
            "monitoring": "Daytime drowsiness",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Quetiapine (Seroquel)",
            "route": "PO",
            "indication": "Severe agitation/psychosis when non-pharmacologic interventions fail",
            "dosing": {
              "doseOptions": [
                {
                  "text": "12.5 mg qHS",
                  "orderSentence": "Quetiapine (Seroquel) 12.5 mg qHS PO"
                },
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Quetiapine (Seroquel) 25 mg qHS PO"
                },
                {
                  "text": "25 mg BID",
                  "orderSentence": "Quetiapine (Seroquel) 25 mg BID PO"
                },
                {
                  "text": "50 mg BID",
                  "orderSentence": "Quetiapine (Seroquel) 50 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 12.5-25 mg qHS; titrate slowly; keep dose as low as possible",
              "orderSentence": "Quetiapine (Seroquel) 12.5 mg qHS PO"
            },
            "contraindications": "Black box: increased mortality and stroke in dementia; Parkinson's (less risk than others)",
            "monitoring": "Metabolic effects; sedation; falls; QTc",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Risperidone (Risperdal)",
            "route": "PO",
            "indication": "Severe aggression/psychosis (short-term use only)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.25 mg BID",
                  "orderSentence": "Risperidone (Risperdal) 0.25 mg BID PO"
                },
                {
                  "text": "0.5 mg BID",
                  "orderSentence": "Risperidone (Risperdal) 0.5 mg BID PO"
                },
                {
                  "text": "1 mg BID",
                  "orderSentence": "Risperidone (Risperdal) 1 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.25 mg BID; increase by 0.25 mg BID weekly; max 1 mg BID; limit to 6-12 weeks",
              "orderSentence": "Risperidone (Risperdal) 0.25 mg BID PO"
            },
            "contraindications": "Black box: increased mortality and CVA in dementia",
            "monitoring": "EPS, metabolic effects, stroke risk, prolactin",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Haloperidol",
            "route": "IM/IV/PO",
            "indication": "Acute severe agitation in delirium-crisis only (avoid chronic use)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5 mg IM",
                  "orderSentence": "Haloperidol 0.5 mg IM IM/IV/PO"
                },
                {
                  "text": "1 mg IM",
                  "orderSentence": "Haloperidol 1 mg IM IM/IV/PO"
                },
                {
                  "text": "2 mg IM",
                  "orderSentence": "Haloperidol 2 mg IM IM/IV/PO"
                }
              ],
              "route": "IM/IV/PO",
              "instructions": "0.5-2 mg IM/IV q4-6h PRN; short-term acute use only; avoid chronic use in dementia",
              "orderSentence": "Haloperidol 0.5 mg IM IM/IV/PO"
            },
            "contraindications": "QT prolongation; Parkinson's disease",
            "monitoring": "QTc; EPS; akathisia",
            "ED": "STAT",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Carbamazepine",
            "route": "PO",
            "indication": "Agitation/aggression refractory to other treatments",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg BID",
                  "orderSentence": "Carbamazepine 100 mg BID PO"
                },
                {
                  "text": "200 mg BID",
                  "orderSentence": "Carbamazepine 200 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 100 mg BID; titrate to 200-400 mg BID based on response; monitor levels",
              "orderSentence": "Carbamazepine 100 mg BID PO"
            },
            "contraindications": "Bone marrow suppression; AV block",
            "monitoring": "CBC; LFTs; Na; drug levels",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Dextromethorphan-quinidine (Nuedexta)",
            "route": "PO",
            "indication": "Pseudobulbar affect (emotional lability) post-stroke",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20/10 mg daily",
                  "orderSentence": "Dextromethorphan-quinidine (Nuedexta) 20/10 mg daily PO"
                },
                {
                  "text": "20/10 mg BID",
                  "orderSentence": "Dextromethorphan-quinidine (Nuedexta) 20/10 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 20/10 mg daily x 7 days, then increase to 20/10 mg BID",
              "orderSentence": "Dextromethorphan-quinidine (Nuedexta) 20/10 mg daily PO"
            },
            "contraindications": "MAOIs; concurrent quinidine; prolonged QT; complete heart block",
            "monitoring": "QTc; drug interactions (quinidine inhibits CYP2D6)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurology/Cognitive neurology for diagnosis confirmation, differentiation from AD, and treatment planning",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Neuropsychology for formal cognitive testing to characterize executive dysfunction and memory profile",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Cardiology for atrial fibrillation management, anticoagulation decisions, and heart failure optimization",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vascular surgery consultation for symptomatic carotid stenosis ≥50% to evaluate for endarterectomy",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Physical therapy for gait training, balance assessment, and fall prevention given motor involvement",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Occupational therapy for ADL assessment, cognitive strategies, and home safety evaluation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Speech therapy for communication strategies, cognitive-linguistic exercises, and swallowing evaluation if dysphagia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Social work for caregiver support resources, community services, and long-term care planning",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Geriatric psychiatry for behavioral symptoms, depression management, and capacity evaluation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Registered dietitian for Mediterranean/DASH diet counseling and sodium restriction education",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Smoking cessation program with pharmacotherapy for current smokers",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sleep medicine for obstructive sleep apnea evaluation and CPAP initiation if indicated",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Palliative care for advanced vascular dementia symptom management and goals of care discussions",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Call 911 immediately if new stroke symptoms develop (sudden weakness, speech difficulty, vision changes)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Return immediately if sudden worsening of confusion which may indicate new stroke, infection, or delirium",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Take all medications as prescribed especially antiplatelet/anticoagulant and statin which prevent further strokes",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Complete advance directives (living will, healthcare proxy, POLST) while patient has capacity",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Do not drive if cognitive impairment affects judgment or reaction time; formal driving evaluation may be needed",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Use pill organizers, alarms, or caregiver supervision to ensure medication adherence",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Check blood pressure at home regularly; notify provider if consistently >140/90 or <90/60",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Wear medical alert bracelet with diagnosis and emergency contact in case of wandering or emergency",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Keep environment safe: remove throw rugs, install grab bars, ensure adequate lighting, secure stove knobs",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Blood pressure target <130/80 mmHg to reduce progression and prevent further strokes (SPRINT-MIND data)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "LDL target <70 mg/dL with high-intensity statin for secondary vascular prevention",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Smoking cessation immediately; reduces stroke risk by 50% within 1 year of quitting",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Mediterranean or MIND diet emphasizing vegetables, berries, fish, whole grains, nuts, and olive oil",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Limit sodium to <2300 mg/day (ideally <1500 mg if hypertensive) to improve blood pressure control",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Limit alcohol to ≤1 drink daily as excess alcohol increases stroke risk and worsens cognition",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Regular aerobic exercise (150 min/week moderate intensity) to improve cardiovascular health and cognition",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Treat obstructive sleep apnea with CPAP as OSA worsens vascular risk and cognitive function",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Strict glycemic control (HbA1c <7% or individualized 7-8% in frail elderly) to reduce microvascular damage",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Social engagement and cognitive stimulation to support cognitive reserve",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Weight management with target BMI 18.5-27 kg/m² (less stringent in elderly)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Fall prevention with home safety modifications and assistive devices as needed",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "CPAP compliance for sleep apnea patients to reduce nocturnal hypoxia and vascular events",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Alzheimer's disease",
        "features": "Insidious onset; gradual decline; memory predominant; no focal signs; no stepwise progression",
        "tests": "MRI: hippocampal atrophy without significant WM disease; CSF Aβ42 low, p-tau elevated; amyloid PET positive"
      },
      {
        "diagnosis": "Mixed dementia (AD + VaD)",
        "features": "Features of both; memory impairment with vascular burden",
        "tests": "Amyloid PET positive with significant WM disease; CSF biomarkers show AD pattern"
      },
      {
        "diagnosis": "Dementia with Lewy bodies",
        "features": "Visual hallucinations; parkinsonism; REM sleep behavior disorder; fluctuating cognition",
        "tests": "DaTscan reduced; clinical criteria; may have less WM disease"
      },
      {
        "diagnosis": "Frontotemporal dementia (behavioral)",
        "features": "Personality/behavior changes; disinhibition; apathy; hyperorality; often age <65",
        "tests": "FDG-PET frontal hypometabolism; less vascular disease on MRI"
      },
      {
        "diagnosis": "Normal pressure hydrocephalus",
        "features": "Triad: gait disturbance (prominent), urinary incontinence, dementia; ventriculomegaly disproportionate to atrophy",
        "tests": "MRI: ventriculomegaly with effaced sulci; high-volume LP with gait improvement"
      },
      {
        "diagnosis": "Chronic traumatic encephalopathy (CTE)",
        "features": "History of repetitive head trauma; mood and behavioral changes; no diagnostic test in life",
        "tests": "History; clinical pattern; cavum septum pellucidum on MRI (suggestive)"
      },
      {
        "diagnosis": "CADASIL",
        "features": "Migraine with aura; early WM disease; family history; temporal pole and external capsule involvement",
        "tests": "NOTCH3 genetic testing; skin biopsy showing GOM deposits"
      },
      {
        "diagnosis": "CNS vasculitis",
        "features": "Younger age; headache; encephalopathy; multifocal strokes; elevated inflammatory markers",
        "tests": "Vessel wall MRI; DSA; brain/leptomeningeal biopsy"
      },
      {
        "diagnosis": "Creutzfeldt-Jakob disease",
        "features": "Rapid progression (weeks-months); myoclonus; periodic sharp waves on EEG; MRI DWI ribboning",
        "tests": "CSF RT-QuIC; 14-3-3; EEG"
      },
      {
        "diagnosis": "Delirium superimposed on dementia",
        "features": "Acute change; fluctuating attention; identifiable precipitant (infection, medication, metabolic)",
        "tests": "Treat cause; reassess cognition when clear"
      }
    ],
    "evidence": [
      {
        "recommendation": "NINDS-AIREN criteria for vascular dementia diagnosis",
        "evidenceLevel": "Class II, Level B",
        "source": "[Roman et al. Neurology 1993](https://pubmed.ncbi.nlm.nih.gov/8426677/)"
      },
      {
        "recommendation": "Cholinesterase inhibitors for vascular dementia (modest benefit)",
        "evidenceLevel": "Class I, Level A",
        "source": "[Kavirajan & Schneider. Lancet Neurol 2007](https://pubmed.ncbi.nlm.nih.gov/17509485/)"
      },
      {
        "recommendation": "Donepezil efficacy in vascular dementia",
        "evidenceLevel": "Class I, Level A",
        "source": "[Erkinjuntti et al. Lancet 2002](https://pubmed.ncbi.nlm.nih.gov/11809203/)"
      },
      {
        "recommendation": "Galantamine for mixed AD/VaD",
        "evidenceLevel": "Class I, Level A",
        "source": "[Erkinjuntti et al. Lancet Neurol 2002](https://pubmed.ncbi.nlm.nih.gov/12849397/)"
      },
      {
        "recommendation": "Memantine for vascular dementia",
        "evidenceLevel": "Class II, Level B",
        "source": "[Orgogozo et al. Stroke 2002](https://pubmed.ncbi.nlm.nih.gov/11935051/)"
      },
      {
        "recommendation": "Intensive BP lowering reduces dementia risk (SPRINT-MIND)",
        "evidenceLevel": "Class I, Level A",
        "source": "[SPRINT MIND Investigators. JAMA 2019](https://pubmed.ncbi.nlm.nih.gov/30688979/)"
      },
      {
        "recommendation": "High-intensity statin for secondary stroke prevention",
        "evidenceLevel": "Class I, Level A",
        "source": "[Amarenco et al. NEJM 2006 (SPARCL)](https://pubmed.ncbi.nlm.nih.gov/16899775/)"
      },
      {
        "recommendation": "Antiplatelet therapy for secondary stroke prevention",
        "evidenceLevel": "Class I, Level A",
        "source": "[Antithrombotic Trialists. BMJ 2002](https://pubmed.ncbi.nlm.nih.gov/11786451/)"
      },
      {
        "recommendation": "DOACs preferred over warfarin for AF-related stroke",
        "evidenceLevel": "Class I, Level A",
        "source": "[Ruff et al. Lancet 2014](https://pubmed.ncbi.nlm.nih.gov/24315724/)"
      },
      {
        "recommendation": "Sertraline for post-stroke depression",
        "evidenceLevel": "Class II, Level B",
        "source": "[Chollet et al. Lancet Neurol 2011 (FLAME)](https://pubmed.ncbi.nlm.nih.gov/21195350/)"
      },
      {
        "recommendation": "Mediterranean diet reduces dementia risk",
        "evidenceLevel": "Class II, Level B",
        "source": "[Scarmeas et al. Ann Neurol 2006](https://pubmed.ncbi.nlm.nih.gov/16832238/)"
      },
      {
        "recommendation": "Physical exercise may slow cognitive decline",
        "evidenceLevel": "Class II, Level B",
        "source": "[Livingston et al. Lancet 2020 (Lancet Commission)](https://pubmed.ncbi.nlm.nih.gov/32738937/)"
      },
      {
        "recommendation": "Avoid antipsychotics long-term in dementia (mortality risk)",
        "evidenceLevel": "Class I, Level A",
        "source": "[Schneider et al. JAMA 2005](https://pubmed.ncbi.nlm.nih.gov/16219884/)"
      },
      {
        "recommendation": "CEA for symptomatic carotid stenosis 70-99%",
        "evidenceLevel": "Class I, Level A",
        "source": "[NASCET Collaborators. NEJM 1991](https://pubmed.ncbi.nlm.nih.gov/1852179/)"
      },
      {
        "recommendation": "CPAP treatment improves cognition in OSA patients",
        "evidenceLevel": "Class II, Level B",
        "source": "[Osorio et al. Neurology 2015](https://pubmed.ncbi.nlm.nih.gov/25878183/)"
      },
      {
        "recommendation": "CSF biomarkers help differentiate VaD from AD",
        "evidenceLevel": "Class II, Level B",
        "source": "[Skillback et al. Dement Geriatr Cogn Disord 2015](https://pubmed.ncbi.nlm.nih.gov/26448651/)"
      }
    ],
    "monitoring": [
      {
        "item": "Cognitive testing (MoCA)",
        "frequency": "Every 6-12 months",
        "action": "Adjust support; consider treatment changes",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Blood pressure",
        "frequency": "Each visit; daily at home",
        "action": "Titrate antihypertensives; reduce if symptomatic hypotension",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "LDL cholesterol",
        "frequency": "Baseline, 6 weeks, then annually",
        "action": "Intensify statin; add ezetimibe or PCSK9 inhibitor",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "HbA1c",
        "frequency": "Baseline, then q3mo if diabetic",
        "action": "Optimize diabetes regimen",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Functional status (ADL/IADL, FAQ)",
        "frequency": "Every 6-12 months",
        "action": "Increase support services; OT referral",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Weight",
        "frequency": "Each visit",
        "action": "Nutritional consult; assess swallowing",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Neuropsychiatric symptoms (NPI)",
        "frequency": "Each visit",
        "action": "Non-pharmacologic first; consider medications",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "MRI Brain",
        "frequency": "Every 1-2 years or if new symptoms",
        "action": "Optimize vascular risk factors; investigate new events",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "ECG/Cardiac rhythm",
        "frequency": "Annually or if symptomatic",
        "action": "Anticoagulation if AF detected",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Caregiver burden (Zarit scale)",
        "frequency": "Every 6-12 months",
        "action": "Support resources; respite care",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Fall risk assessment",
        "frequency": "Each visit",
        "action": "PT referral; home safety evaluation; assistive devices",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Driving status",
        "frequency": "Each visit",
        "action": "Formal driving evaluation; DMV report if unsafe",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Creatinine/eGFR",
        "frequency": "Annually; with medication changes",
        "action": "Adjust ACE-I, metformin, anticoagulants",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      }
    ],
    "disposition": [
      {
        "disposition": "Discharge home",
        "criteria": "Stable cognition; no acute stroke; safe environment; adequate caregiver support; outpatient follow-up arranged; reversible causes treated"
      },
      {
        "disposition": "Admit to floor",
        "criteria": "Acute delirium requiring workup; new stroke symptoms; behavioral crisis unsafe for home; aspiration pneumonia; falls with injury"
      },
      {
        "disposition": "Admit to stroke unit",
        "criteria": "New stroke with progression; recurrent TIAs; symptomatic carotid stenosis requiring urgent intervention"
      },
      {
        "disposition": "Admit to psychiatry",
        "criteria": "Severe behavioral disturbance requiring specialized psychiatric management; danger to self or others"
      },
      {
        "disposition": "Long-term care/Memory care",
        "criteria": "Progressive decline; caregiver unable to manage safely; wandering; 24-hour supervision needed"
      },
      {
        "disposition": "Hospice",
        "criteria": "End-stage vascular dementia; recurrent aspiration; weight loss; goals focused on comfort"
      },
      {
        "disposition": "Outpatient follow-up",
        "criteria": "Neurology every 3-6 months initially; every 6-12 months when stable; PCP for vascular risk factor management"
      }
    ]
  },
  "Frontotemporal Dementia": {
    "id": "frontotemporal-dementia",
    "title": "Frontotemporal Dementia",
    "version": "1.0",
    "icd10": [
      "** G31.09 (Frontotemporal dementia",
      "unspecified)",
      "G31.0 (Frontotemporal dementia)",
      "F02.80 (Dementia in FTD without behavioral disturbance)",
      "F02.81 (Dementia in FTD with behavioral disturbance)",
      "G31.01 (Pick's disease)"
    ],
    "scope": "** Diagnosis and management of frontotemporal lobar degeneration syndromes including behavioral variant FTD (bvFTD), semantic variant primary progressive aphasia (svPPA), nonfluent/agrammatic variant PPA (nfvPPA), FTD with motor neuron disease (FTD-ALS), and genetic forms (C9orf72, MAPT, GRN). Covers diagnostic evaluation, symptomatic treatment, behavioral management, genetic counseling, safety planning, and caregiver support. Primarily outpatient-focused with coverage for ED and hospital presentations of behavioral crises.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC with differential",
            "rationale": "Rule out infection, anemia, malignancy contributing to behavioral changes",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "BMP (Na, K, BUN, Cr, glucose)",
            "rationale": "Metabolic causes of behavioral disturbance (hyponatremia, uremia, hypoglycemia)",
            "target": "Normal electrolytes, renal function",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "TSH",
            "rationale": "Hypothyroidism can cause apathy; hyperthyroidism can cause behavioral changes",
            "target": "0.4-4.0 mIU/L",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin B12",
            "rationale": "B12 deficiency causes neuropsychiatric symptoms and cognitive decline",
            "target": ">300 pg/mL (>400 optimal)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Folate",
            "rationale": "Deficiency contributes to cognitive impairment",
            "target": ">3 ng/mL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Hepatic panel (AST, ALT, albumin, ammonia)",
            "rationale": "Hepatic encephalopathy; nutritional status; liver function for medications",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Calcium",
            "rationale": "Hypercalcemia causes neuropsychiatric symptoms",
            "target": "8.5-10.5 mg/dL",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Urinalysis",
            "rationale": "UTI common cause of acute behavioral changes in elderly",
            "target": "Negative for infection",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended Workup": [
          {
            "item": "RPR or VDRL",
            "rationale": "Neurosyphilis is treatable cause of behavioral and cognitive changes",
            "target": "Nonreactive",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "HIV testing",
            "rationale": "HIV-associated neurocognitive disorder if risk factors",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "ESR, CRP",
            "rationale": "Inflammatory or autoimmune causes; baseline before immunotherapy",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "ANA, RF",
            "rationale": "Screen for systemic autoimmune disease",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Creatine kinase",
            "rationale": "Elevated in FTD-ALS; baseline for motor neuron involvement",
            "target": "Normal (elevated suggests MND)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "EMG/NCS referral",
            "rationale": "If motor symptoms present; evaluate for ALS overlap",
            "target": "Normal or denervation pattern",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Serum progranulin level",
            "rationale": "Low levels suggest GRN mutation (screening test)",
            "target": "Normal (low <100 ng/mL suggests GRN mutation)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "C9orf72 hexanucleotide repeat expansion",
            "rationale": "Most common genetic cause of FTD; also causes ALS",
            "target": "<30 repeats (pathogenic >30)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "MAPT (tau) gene sequencing",
            "rationale": "Familial FTD with parkinsonism; tau-positive pathology",
            "target": "No pathogenic mutation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "GRN (progranulin) gene sequencing",
            "rationale": "Familial FTD; asymmetric atrophy; TDP-43 pathology",
            "target": "No pathogenic mutation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "FTD genetic panel (TARDBP, VCP, CHMP2B, FUS)",
            "rationale": "Extended genetic evaluation if first-line negative",
            "target": "No pathogenic mutation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Paraneoplastic antibody panel",
            "rationale": "Rapid behavioral change; history of cancer; atypical features",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Anti-neuronal antibodies (NMDA-R, LGI1, CASPR2, GAD65)",
            "rationale": "Autoimmune encephalitis mimicking FTD",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Heavy metal panel (lead, mercury, arsenic)",
            "rationale": "Occupational exposure history; atypical presentation",
            "target": "Normal",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "Cell count, protein, glucose",
            "rationale": "Rule out infection, inflammation",
            "target": "WBC <5, protein <45 mg/dL, glucose >60% serum",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CSF Aβ42/Aβ40 ratio",
            "rationale": "Distinguish from AD (normal in FTD)",
            "target": "Normal ratio >0.08 supports non-AD etiology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CSF total tau (t-tau)",
            "rationale": "Non-specific neurodegeneration marker",
            "target": "May be elevated but less than AD",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CSF phosphorylated tau (p-tau181)",
            "rationale": "AD-specific; should be normal in FTD",
            "target": "Normal p-tau supports FTD over AD",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CSF NfL (neurofilament light)",
            "rationale": "Neurodegeneration marker; prognostic; very high in ALS-FTD",
            "target": "Elevated (higher = faster progression)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "14-3-3 protein",
            "rationale": "Rapid progression; rule out CJD",
            "target": "Negative (positive suggests CJD)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "RT-QuIC",
            "rationale": "Prion disease confirmation if suspected",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Autoimmune encephalitis panel (CSF)",
            "rationale": "Subacute behavioral change; seizures",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "MRI Brain without contrast",
            "timing": "At initial evaluation",
            "target": "Frontal and/or anterior temporal atrophy; asymmetric patterns; rule out structural causes",
            "contraindications": "MRI-incompatible devices, severe claustrophobia",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CT Head non-contrast",
            "timing": "If MRI unavailable or contraindicated",
            "target": "Rule out mass, hemorrhage, hydrocephalus; frontal atrophy visible",
            "contraindications": "None",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended": [
          {
            "item": "FDG-PET Brain",
            "timing": "Diagnostic confirmation; differentiate from AD",
            "target": "Frontal and/or anterior temporal hypometabolism; sparing of posterior parietal (unlike AD)",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "MRI Brain volumetrics",
            "timing": "Quantify regional atrophy; track progression",
            "target": "Frontal/temporal volume loss; hemispheric asymmetry",
            "contraindications": "MRI contraindications",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Amyloid PET",
            "timing": "Exclude AD pathology if clinical uncertainty",
            "target": "Negative amyloid supports FTD diagnosis",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "EEG",
            "timing": "Seizures; behavioral episodes; differentiate from CJD",
            "target": "Usually normal or mild slowing; no periodic discharges (CJD has)",
            "contraindications": "None",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sleep study (polysomnography)",
            "timing": "RBD suggests DLB rather than FTD; sleep disturbance common",
            "target": "REM without atonia absent (if RBD, reconsider DLB)",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "DaTscan (ioflupane I-123)",
            "timing": "Parkinsonism present; differentiate PSP/CBD from PD/DLB",
            "target": "Reduced uptake in PSP/CBD; may be normal early in bvFTD",
            "contraindications": "Iodine hypersensitivity",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Tau PET (flortaucipir)",
            "timing": "Research; distinguish tau-positive from TDP-43 FTD",
            "target": "Tau-positive FTD shows frontal/temporal uptake",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Whole body PET-CT",
            "timing": "Paraneoplastic workup if suspected",
            "target": "Rule out occult malignancy",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent (Behavioral Crisis Management)": [
          {
            "item": "Lorazepam",
            "route": "PO/IM/IV",
            "indication": "Acute severe agitation when de-escalation fails",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5 mg PO",
                  "orderSentence": "Lorazepam 0.5 mg PO PO/IM/IV"
                },
                {
                  "text": "1 mg PO",
                  "orderSentence": "Lorazepam 1 mg PO PO/IM/IV"
                },
                {
                  "text": "0.5 mg IM",
                  "orderSentence": "Lorazepam 0.5 mg IM PO/IM/IV"
                },
                {
                  "text": "1 mg IM",
                  "orderSentence": "Lorazepam 1 mg IM PO/IM/IV"
                }
              ],
              "route": "PO/IM/IV",
              "instructions": "0.5-1 mg PO or IM; may repeat q30min PRN; max 4 mg; short-term use only",
              "orderSentence": "Lorazepam 0.5 mg PO PO/IM/IV"
            },
            "contraindications": "Respiratory depression; severe hepatic impairment; paradoxical agitation risk in elderly",
            "monitoring": "Respiratory status; sedation; paradoxical reactions",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Haloperidol",
            "route": "IM/IV",
            "indication": "Severe aggression/psychosis when benzodiazepines insufficient",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.5 mg IM",
                  "orderSentence": "Haloperidol 0.5 mg IM IM/IV"
                },
                {
                  "text": "1 mg IM",
                  "orderSentence": "Haloperidol 1 mg IM IM/IV"
                },
                {
                  "text": "2 mg IM",
                  "orderSentence": "Haloperidol 2 mg IM IM/IV"
                }
              ],
              "route": "IM/IV",
              "instructions": "0.5-2 mg IM q4-6h PRN; lowest effective dose; short-term crisis only",
              "orderSentence": "Haloperidol 0.5 mg IM IM/IV"
            },
            "contraindications": "QT prolongation; Parkinson's disease; FTD-parkinsonism overlap (avoid if possible)",
            "monitoring": "QTc; EPS; akathisia; sedation",
            "ED": "STAT",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Environmental de-escalation",
            "route": "N/A",
            "indication": "First-line for all behavioral disturbance",
            "dosing": {
              "doseOptions": [
                {
                  "text": "N/A",
                  "orderSentence": "Environmental de-escalation N/A N/A"
                }
              ],
              "route": "N/A",
              "instructions": "Reduce stimulation; dim lights; calm voice; remove triggers; one-to-one observation; familiar caregiver presence",
              "orderSentence": "Environmental de-escalation N/A N/A"
            },
            "contraindications": "None",
            "monitoring": "Response to intervention",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Symptomatic Treatments (Behavioral and Neuropsychiatric)": [
          {
            "item": "Trazodone",
            "route": "PO",
            "indication": "Agitation; irritability; disinhibition; insomnia; compulsive behaviors",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg BID",
                  "orderSentence": "Trazodone 25 mg BID PO"
                },
                {
                  "text": "50 mg BID",
                  "orderSentence": "Trazodone 50 mg BID PO"
                },
                {
                  "text": "50 mg TID",
                  "orderSentence": "Trazodone 50 mg TID PO"
                },
                {
                  "text": "100 mg TID",
                  "orderSentence": "Trazodone 100 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25-50 mg BID; titrate by 25-50 mg q3-5d; typical 150-300 mg/day divided; max 400 mg/day",
              "orderSentence": "Trazodone 25 mg BID PO"
            },
            "contraindications": "Concurrent MAOIs; significant QT prolongation",
            "monitoring": "Orthostatic hypotension (fall risk); priapism (rare); QTc; sedation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sertraline (Zoloft)",
            "route": "PO",
            "indication": "Depression; apathy; anxiety; compulsive behaviors; disinhibition",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg daily",
                  "orderSentence": "Sertraline (Zoloft) 25 mg daily PO"
                },
                {
                  "text": "50 mg daily",
                  "orderSentence": "Sertraline (Zoloft) 50 mg daily PO"
                },
                {
                  "text": "100 mg daily",
                  "orderSentence": "Sertraline (Zoloft) 100 mg daily PO"
                },
                {
                  "text": "150 mg daily",
                  "orderSentence": "Sertraline (Zoloft) 150 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg daily; increase by 25-50 mg every 1-2 weeks; typical 100-200 mg daily; max 200 mg",
              "orderSentence": "Sertraline (Zoloft) 25 mg daily PO"
            },
            "contraindications": "MAOIs; uncontrolled seizures (lowers threshold slightly)",
            "monitoring": "GI symptoms; bleeding risk; apathy (rarely worsens)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Citalopram",
            "route": "PO",
            "indication": "Depression; anxiety; compulsive behaviors",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg daily",
                  "orderSentence": "Citalopram 10 mg daily PO"
                },
                {
                  "text": "20 mg daily",
                  "orderSentence": "Citalopram 20 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10 mg daily; max 20 mg in elderly due to QT prolongation risk",
              "orderSentence": "Citalopram 10 mg daily PO"
            },
            "contraindications": "QT prolongation; concurrent QT-prolonging drugs; severe hepatic impairment",
            "monitoring": "ECG at baseline if cardiac risk; QTc monitoring",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Escitalopram (Lexapro)",
            "route": "PO",
            "indication": "Depression; anxiety; better tolerated than citalopram",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg daily",
                  "orderSentence": "Escitalopram (Lexapro) 5 mg daily PO"
                },
                {
                  "text": "10 mg daily",
                  "orderSentence": "Escitalopram (Lexapro) 10 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg daily; increase to 10 mg after 1 week; max 10 mg in elderly",
              "orderSentence": "Escitalopram (Lexapro) 5 mg daily PO"
            },
            "contraindications": "QT prolongation; concurrent MAOIs",
            "monitoring": "QTc if cardiac risk factors",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Fluvoxamine",
            "route": "PO",
            "indication": "Compulsive behaviors; repetitive behaviors; may have specific benefit in FTD",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Fluvoxamine 25 mg qHS PO"
                },
                {
                  "text": "50 mg qHS",
                  "orderSentence": "Fluvoxamine 50 mg qHS PO"
                },
                {
                  "text": "100 mg qHS",
                  "orderSentence": "Fluvoxamine 100 mg qHS PO"
                },
                {
                  "text": "100 mg BID",
                  "orderSentence": "Fluvoxamine 100 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg qHS; titrate by 25-50 mg weekly; typical 100-200 mg/day; max 300 mg/day",
              "orderSentence": "Fluvoxamine 25 mg qHS PO"
            },
            "contraindications": "MAOIs; alosetron, tizanidine (drug interactions)",
            "monitoring": "Multiple drug interactions (CYP1A2, 2C19, 3A4 inhibitor); GI symptoms",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Mirtazapine (Remeron)",
            "route": "PO",
            "indication": "Depression with poor appetite, weight loss, and insomnia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "7.5 mg qHS",
                  "orderSentence": "Mirtazapine (Remeron) 7.5 mg qHS PO"
                },
                {
                  "text": "15 mg qHS",
                  "orderSentence": "Mirtazapine (Remeron) 15 mg qHS PO"
                },
                {
                  "text": "30 mg qHS",
                  "orderSentence": "Mirtazapine (Remeron) 30 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 7.5-15 mg qHS; may increase to 30-45 mg qHS; lower doses more sedating",
              "orderSentence": "Mirtazapine (Remeron) 7.5 mg qHS PO"
            },
            "contraindications": "MAOIs; angle-closure glaucoma",
            "monitoring": "Weight gain (often desired in FTD); sedation; hyperlipidemia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Bupropion (Wellbutrin)",
            "route": "PO",
            "indication": "Apathy-predominant FTD; depression; may help with motivation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg BID",
                  "orderSentence": "Bupropion (Wellbutrin) 100 mg BID PO"
                },
                {
                  "text": "150 mg SR daily",
                  "orderSentence": "Bupropion (Wellbutrin) 150 mg SR daily PO"
                },
                {
                  "text": "150 mg SR BID",
                  "orderSentence": "Bupropion (Wellbutrin) 150 mg SR BID PO"
                },
                {
                  "text": "300 mg XL daily",
                  "orderSentence": "Bupropion (Wellbutrin) 300 mg XL daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 100 mg BID or 150 mg SR daily; titrate to 150 mg SR BID or 300 mg XL daily",
              "orderSentence": "Bupropion (Wellbutrin) 100 mg BID PO"
            },
            "contraindications": "Seizure disorder; bulimia/anorexia; concurrent MAOIs; abrupt alcohol withdrawal",
            "monitoring": "Seizure risk (dose-related); insomnia; agitation (may worsen some patients)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Melatonin",
            "route": "PO",
            "indication": "Sleep disturbance; circadian rhythm dysfunction; sundowning",
            "dosing": {
              "doseOptions": [
                {
                  "text": "3 mg qHS",
                  "orderSentence": "Melatonin 3 mg qHS PO"
                },
                {
                  "text": "6 mg qHS",
                  "orderSentence": "Melatonin 6 mg qHS PO"
                },
                {
                  "text": "9 mg qHS",
                  "orderSentence": "Melatonin 9 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 3 mg qHS, 30 min before bed; may increase to 6-9 mg if needed",
              "orderSentence": "Melatonin 3 mg qHS PO"
            },
            "contraindications": "None significant",
            "monitoring": "Daytime drowsiness; minimal side effects",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Second-line/Refractory (Behavioral Management)": [
          {
            "item": "Quetiapine (Seroquel)",
            "route": "PO",
            "indication": "Severe agitation/psychosis when non-pharmacologic and first-line fail",
            "dosing": {
              "doseOptions": [
                {
                  "text": "12.5 mg qHS",
                  "orderSentence": "Quetiapine (Seroquel) 12.5 mg qHS PO"
                },
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Quetiapine (Seroquel) 25 mg qHS PO"
                },
                {
                  "text": "25 mg BID",
                  "orderSentence": "Quetiapine (Seroquel) 25 mg BID PO"
                },
                {
                  "text": "50 mg BID",
                  "orderSentence": "Quetiapine (Seroquel) 50 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 12.5-25 mg qHS; titrate slowly (25 mg increments); keep dose as low as possible; max 200 mg/day",
              "orderSentence": "Quetiapine (Seroquel) 12.5 mg qHS PO"
            },
            "contraindications": "Black box: increased mortality in dementia; avoid in FTD-parkinsonism",
            "monitoring": "Metabolic effects; sedation; falls; QTc; EPS",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Olanzapine",
            "route": "PO/IM",
            "indication": "Severe agitation when other options fail; IM for acute crisis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2.5 mg daily",
                  "orderSentence": "Olanzapine 2.5 mg daily PO/IM"
                },
                {
                  "text": "5 mg daily",
                  "orderSentence": "Olanzapine 5 mg daily PO/IM"
                },
                {
                  "text": "2.5 mg IM",
                  "orderSentence": "Olanzapine 2.5 mg IM PO/IM"
                },
                {
                  "text": "5 mg IM",
                  "orderSentence": "Olanzapine 5 mg IM PO/IM"
                }
              ],
              "route": "PO/IM",
              "instructions": "PO: Start 2.5 mg daily; increase slowly; max 10 mg; IM: 2.5-5 mg for acute crisis",
              "orderSentence": "Olanzapine 2.5 mg daily PO/IM"
            },
            "contraindications": "Black box: increased mortality in dementia; diabetes; QT prolongation",
            "monitoring": "Weight gain; metabolic syndrome; sedation; EPS",
            "ED": "EXT",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Dextromethorphan/quinidine (Nuedexta)",
            "route": "PO",
            "indication": "Pseudobulbar affect; emotional lability; pathological laughing/crying",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20/10 mg daily",
                  "orderSentence": "Dextromethorphan/quinidine (Nuedexta) 20/10 mg daily PO"
                },
                {
                  "text": "20/10 mg BID",
                  "orderSentence": "Dextromethorphan/quinidine (Nuedexta) 20/10 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 20/10 mg daily x 7 days; then 20/10 mg BID",
              "orderSentence": "Dextromethorphan/quinidine (Nuedexta) 20/10 mg daily PO"
            },
            "contraindications": "QT prolongation; concurrent MAOIs; quinidine hypersensitivity; complete AV block",
            "monitoring": "QTc; avoid in hepatic/renal impairment",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Valproic acid",
            "route": "PO",
            "indication": "Impulsivity; aggression; mood instability (off-label)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "125 mg BID",
                  "orderSentence": "Valproic acid 125 mg BID PO"
                },
                {
                  "text": "250 mg BID",
                  "orderSentence": "Valproic acid 250 mg BID PO"
                },
                {
                  "text": "500 mg BID",
                  "orderSentence": "Valproic acid 500 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 125-250 mg BID; titrate to 500-1000 mg/day; monitor levels",
              "orderSentence": "Valproic acid 125 mg BID PO"
            },
            "contraindications": "Hepatic disease; urea cycle disorders; mitochondrial disorders",
            "monitoring": "Valproate level, LFTs, CBC, ammonia; weight gain; tremor; thrombocytopenia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Memantine (Namenda)",
            "route": "PO",
            "indication": "May help some behavioral symptoms; limited evidence",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg daily",
                  "orderSentence": "Memantine (Namenda) 5 mg daily PO"
                },
                {
                  "text": "5 mg BID",
                  "orderSentence": "Memantine (Namenda) 5 mg BID PO"
                },
                {
                  "text": "10 mg BID",
                  "orderSentence": "Memantine (Namenda) 10 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg daily; increase by 5 mg/week to 10 mg BID; evidence weak in FTD",
              "orderSentence": "Memantine (Namenda) 5 mg daily PO"
            },
            "contraindications": "Severe renal impairment (reduce dose)",
            "monitoring": "Confusion, dizziness; generally well tolerated",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Methylphenidate",
            "route": "PO",
            "indication": "Severe apathy unresponsive to other treatments",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2.5 mg BID",
                  "orderSentence": "Methylphenidate 2.5 mg BID PO"
                },
                {
                  "text": "5 mg BID",
                  "orderSentence": "Methylphenidate 5 mg BID PO"
                },
                {
                  "text": "10 mg BID",
                  "orderSentence": "Methylphenidate 10 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 2.5-5 mg BID (morning and noon); titrate slowly; max 20 mg/day",
              "orderSentence": "Methylphenidate 2.5 mg BID PO"
            },
            "contraindications": "Severe anxiety; cardiac arrhythmias; glaucoma; concurrent MAOIs",
            "monitoring": "BP, HR; appetite; insomnia; agitation; abuse potential",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Treatments to AVOID in FTD": [
          {
            "item": "Donepezil (Aricept)",
            "route": "PO",
            "indication": "AVOID - May worsen behavioral symptoms in FTD",
            "dosing": {
              "doseOptions": [
                {
                  "text": "AVOID",
                  "orderSentence": "Donepezil (Aricept) AVOID PO"
                }
              ],
              "route": "PO",
              "instructions": "Do NOT use; cholinesterase inhibitors can worsen disinhibition, agitation, and behavioral symptoms in FTD",
              "orderSentence": "Donepezil (Aricept) AVOID PO"
            },
            "contraindications": "FTD diagnosis",
            "monitoring": "Worsening behavior if inadvertently started",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Rivastigmine (Exelon)",
            "route": "PO/TD",
            "indication": "AVOID - May worsen behavioral symptoms in FTD",
            "dosing": {
              "doseOptions": [
                {
                  "text": "AVOID",
                  "orderSentence": "Rivastigmine (Exelon) AVOID PO/TD"
                }
              ],
              "route": "PO/TD",
              "instructions": "Do NOT use; cholinesterase inhibitors not recommended in FTD; may cause paradoxical worsening",
              "orderSentence": "Rivastigmine (Exelon) AVOID PO/TD"
            },
            "contraindications": "FTD diagnosis",
            "monitoring": "Worsening behavior if inadvertently started",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Galantamine (Razadyne)",
            "route": "PO",
            "indication": "AVOID - May worsen behavioral symptoms in FTD",
            "dosing": {
              "doseOptions": [
                {
                  "text": "AVOID",
                  "orderSentence": "Galantamine (Razadyne) AVOID PO"
                }
              ],
              "route": "PO",
              "instructions": "Do NOT use; cholinesterase inhibitors contraindicated in FTD",
              "orderSentence": "Galantamine (Razadyne) AVOID PO"
            },
            "contraindications": "FTD diagnosis",
            "monitoring": "Worsening behavior if inadvertently started",
            "ED": "-",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-"
          }
        ],
        "FTD-ALS/Motor Neuron Disease Overlap": [
          {
            "item": "Riluzole",
            "route": "PO",
            "indication": "FTD with ALS overlap; may modestly slow MND progression",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg BID",
                  "orderSentence": "Riluzole 50 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "50 mg PO BID; take 1 hour before or 2 hours after meals",
              "orderSentence": "Riluzole 50 mg BID PO"
            },
            "contraindications": "Hepatic impairment; pregnancy",
            "monitoring": "LFTs monthly x 3 months, then q3mo; neutropenia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Edaravone (Radicava)",
            "route": "IV/PO",
            "indication": "FTD-ALS if early in disease course",
            "dosing": {
              "doseOptions": [
                {
                  "text": "60 mg IV daily x 14d",
                  "orderSentence": "Edaravone (Radicava) 60 mg IV daily x 14d IV/PO"
                },
                {
                  "text": "10-day cycles",
                  "orderSentence": "Edaravone (Radicava) 10-day cycles IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "Initial: 60 mg IV daily x 14 days; maintenance: 60 mg IV daily x 10 days of 14-day cycles; oral formulation available",
              "orderSentence": "Edaravone (Radicava) 60 mg IV daily x 14d IV/PO"
            },
            "contraindications": "Hypersensitivity; sulfite allergy",
            "monitoring": "Infusion reactions; hypersensitivity",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sodium phenylbutyrate/taurursodiol (Relyvrio)",
            "route": "PO",
            "indication": "FTD-ALS overlap; neuroprotective",
            "dosing": {
              "doseOptions": [
                {
                  "text": "3g/1g sachet BID",
                  "orderSentence": "Sodium phenylbutyrate/taurursodiol (Relyvrio) 3g/1g sachet BID PO"
                }
              ],
              "route": "PO",
              "instructions": "One sachet dissolved in water BID; titrate over 3 weeks to full dose",
              "orderSentence": "Sodium phenylbutyrate/taurursodiol (Relyvrio) 3g/1g sachet BID PO"
            },
            "contraindications": "Hepatic impairment",
            "monitoring": "GI symptoms (diarrhea, nausea); gallbladder disorders",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Behavioral/cognitive neurology for diagnosis confirmation, FTD subtype classification, and treatment guidance",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Neuropsychology for comprehensive cognitive testing to establish baseline, characterize deficits, and track progression",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Genetic counseling for all patients with suspected FTD given high heritability (30-50% familial); discuss testing implications",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Speech-language pathology for language variant PPA evaluation, communication strategies, and swallowing assessment",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Geriatric psychiatry for complex behavioral management and psychotropic medication optimization",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Social work for caregiver support resources, community services, respite care, and long-term care planning",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Occupational therapy for ADL assessment, cognitive strategies, home safety evaluation, and activity structuring",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Physical therapy for fall prevention, mobility assessment, and exercise program particularly if motor features present",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Palliative care for symptom management and goals of care discussions, especially with advanced disease or ALS overlap",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Neuromuscular specialist if motor neuron disease features (weakness, fasciculations, bulbar symptoms) present",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Elder law attorney for advance directives, healthcare proxy, conservatorship, and financial planning while capacity exists",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Return immediately if sudden worsening of behavior, new weakness, difficulty breathing, or inability to swallow safely",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Complete advance directives (living will, healthcare proxy, POLST) while patient retains capacity; FTD can progress rapidly",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Designate durable power of attorney for healthcare AND finances early as judgment may be impaired before memory",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Do not drive; FTD impairs judgment, impulse control, and decision-making even if memory appears intact",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Remove access to weapons, power tools, and dangerous equipment due to impaired judgment and safety awareness",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Supervise financial decisions; patients with FTD are vulnerable to fraud, impulsive spending, and poor judgment",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Secure medications to prevent accidental or intentional overdose; use locked medication storage",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Monitor for wandering; consider GPS tracking devices and door alarms as disease progresses",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Report diagnosis to DMV per state requirements; most states require physician reporting for unsafe drivers",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Genetic testing results have implications for family members; discuss with genetic counselor before testing",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Structured daily routine with consistent schedule reduces anxiety and behavioral symptoms",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Regular physical activity (walking, supervised exercise) improves mood and maintains function",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Simplified communication using short sentences, yes/no questions, and visual cues for PPA variants",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid overstimulation; reduce noise, crowds, and complex environments that trigger agitation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Caregiver education through AFTD (Association for Frontotemporal Degeneration) resources and support groups",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Respite care for caregivers to prevent burnout; FTD caregiving is particularly demanding due to behavioral symptoms",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Address hyperorality and dietary changes with portion control, healthy snack availability, and locked food storage if needed",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Safe environment modifications: remove fall hazards, lock cabinets with dangerous items, install stove knob covers",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "One-to-one supervision may be needed for safety; consider adult day programs or in-home care",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Smoking cessation and alcohol avoidance to prevent additional brain injury and drug interactions",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Alzheimer's disease",
        "features": "Memory impairment prominent early; episodic memory loss; posterior cortical atrophy pattern",
        "tests": "CSF Aβ42 low, p-tau elevated; amyloid PET positive; temporal-parietal atrophy on MRI"
      },
      {
        "diagnosis": "Dementia with Lewy bodies",
        "features": "Visual hallucinations; parkinsonism; REM sleep behavior disorder; fluctuating cognition",
        "tests": "DaTscan reduced; RBD on sleep study; better response to cholinesterase inhibitors"
      },
      {
        "diagnosis": "Primary psychiatric disorder",
        "features": "Onset often younger; personal/family psychiatric history; may have insight; responds to treatment",
        "tests": "Normal MRI; normal FDG-PET; improvement with psychiatric treatment"
      },
      {
        "diagnosis": "Huntington's disease",
        "features": "Chorea; family history (autosomal dominant); psychiatric symptoms precede motor",
        "tests": "CAG repeat expansion; caudate atrophy on MRI"
      },
      {
        "diagnosis": "Progressive supranuclear palsy (PSP)",
        "features": "Vertical gaze palsy; axial rigidity; early falls; frontal features",
        "tests": "\"Hummingbird sign\" on MRI; poor levodopa response"
      },
      {
        "diagnosis": "Corticobasal syndrome (CBS)",
        "features": "Asymmetric apraxia; alien limb; cortical sensory loss; dystonia",
        "tests": "Asymmetric atrophy; may have FTD overlap"
      },
      {
        "diagnosis": "Creutzfeldt-Jakob disease",
        "features": "Rapid progression (weeks-months); myoclonus; ataxia; startle",
        "tests": "MRI DWI ribboning; EEG periodic discharges; CSF RT-QuIC positive"
      },
      {
        "diagnosis": "Autoimmune encephalitis",
        "features": "Subacute onset; seizures; psychiatric features; often younger",
        "tests": "Autoantibody panel positive; MRI limbic changes; CSF inflammation"
      },
      {
        "diagnosis": "Normal pressure hydrocephalus",
        "features": "Gait disturbance predominant; urinary incontinence; magnetic gait",
        "tests": "MRI ventriculomegaly out of proportion to atrophy; large-volume LP improvement"
      },
      {
        "diagnosis": "Vascular dementia",
        "features": "Stepwise decline; vascular risk factors; focal deficits",
        "tests": "Extensive white matter disease and strategic infarcts on MRI"
      },
      {
        "diagnosis": "Medication/substance-induced",
        "features": "Temporal relationship to drug exposure; anticholinergics, sedatives common culprits",
        "tests": "Medication reconciliation; improvement with discontinuation"
      },
      {
        "diagnosis": "Late-onset bipolar disorder",
        "features": "Episodic mood symptoms; family history; intact cognition between episodes",
        "tests": "Normal neuroimaging; psychiatric evaluation; treatment response"
      }
    ],
    "evidence": [
      {
        "recommendation": "Diagnostic criteria for bvFTD (International Consensus)",
        "evidenceLevel": "Class I, Level A",
        "source": "[Rascovsky et al. Brain 2011](https://pubmed.ncbi.nlm.nih.gov/21824939/)"
      },
      {
        "recommendation": "Diagnostic criteria for PPA variants",
        "evidenceLevel": "Class I, Level A",
        "source": "[Gorno-Tempini et al. Neurology 2011](https://pubmed.ncbi.nlm.nih.gov/21325651/)"
      },
      {
        "recommendation": "SSRIs for behavioral symptoms in FTD",
        "evidenceLevel": "Class II, Level B",
        "source": "[Herrmann et al. J Clin Psychiatry 2012](https://pubmed.ncbi.nlm.nih.gov/22687702/)"
      },
      {
        "recommendation": "Trazodone for FTD behavioral symptoms",
        "evidenceLevel": "Class II, Level B",
        "source": "[Lebert et al. Dement Geriatr Cogn Disord 2004](https://pubmed.ncbi.nlm.nih.gov/15178936/)"
      },
      {
        "recommendation": "Cholinesterase inhibitors not recommended in FTD",
        "evidenceLevel": "Class II, Level B",
        "source": "[Mendez et al. Am J Alzheimers Dis Other Demen 2007](https://pubmed.ncbi.nlm.nih.gov/17804830/)"
      },
      {
        "recommendation": "Antipsychotic mortality risk in dementia",
        "evidenceLevel": "Class I, Level A",
        "source": "[Schneider et al. JAMA 2005](https://pubmed.ncbi.nlm.nih.gov/16219884/)"
      },
      {
        "recommendation": "C9orf72 as most common genetic cause of FTD/ALS",
        "evidenceLevel": "Class I, Level A",
        "source": "[DeJesus-Hernandez et al. Neuron 2011](https://pubmed.ncbi.nlm.nih.gov/21944778/); [Renton et al. Neuron 2011](https://pubmed.ncbi.nlm.nih.gov/21944779/)"
      },
      {
        "recommendation": "MAPT and GRN mutations in familial FTD",
        "evidenceLevel": "Class I, Level A",
        "source": "[Rohrer et al. Lancet Neurol 2009](https://pubmed.ncbi.nlm.nih.gov/19345567/)"
      },
      {
        "recommendation": "FDG-PET in FTD diagnosis",
        "evidenceLevel": "Class II, Level B",
        "source": "[Foster et al. Ann Neurol 2007](https://pubmed.ncbi.nlm.nih.gov/17315189/)"
      },
      {
        "recommendation": "CSF NfL as prognostic biomarker in FTD",
        "evidenceLevel": "Class II, Level B",
        "source": "[Rohrer et al. Neurology 2016](https://pubmed.ncbi.nlm.nih.gov/27164711/)"
      },
      {
        "recommendation": "Memantine limited efficacy in FTD",
        "evidenceLevel": "Class II, Level C",
        "source": "[Boxer et al. Lancet Neurol 2013](https://pubmed.ncbi.nlm.nih.gov/23684085/)"
      },
      {
        "recommendation": "FTD-ALS continuum",
        "evidenceLevel": "Class I, Level A",
        "source": "[Burrell et al. Lancet Neurol 2016](https://pubmed.ncbi.nlm.nih.gov/27083437/)"
      },
      {
        "recommendation": "Serum progranulin as GRN mutation screen",
        "evidenceLevel": "Class II, Level B",
        "source": "[Finch et al. J Mol Diagn 2009](https://pubmed.ncbi.nlm.nih.gov/19359499/)"
      },
      {
        "recommendation": "Practice guidelines for FTD management",
        "evidenceLevel": "Class III, Level C",
        "source": "[Tsai et al. Neurology 2021](https://pubmed.ncbi.nlm.nih.gov/34341099/)"
      },
      {
        "recommendation": "Riluzole in ALS",
        "evidenceLevel": "Class I, Level A",
        "source": "[Miller et al. Cochrane 2012](https://pubmed.ncbi.nlm.nih.gov/22419334/)"
      }
    ],
    "monitoring": [
      {
        "item": "Cognitive testing (MoCA, MMSE, or FTLD-specific battery)",
        "frequency": "Every 6-12 months",
        "action": "Adjust care level; medication review; genetics if rapid",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Frontal assessment battery (FAB)",
        "frequency": "Every 6-12 months",
        "action": "Increase supervision; safety planning",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Functional status (ADL/IADL, FBI, CBI)",
        "frequency": "Every 6 months",
        "action": "Increase caregiver support; consider placement",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Behavioral assessment (NPI-Q, FBI)",
        "frequency": "Each visit",
        "action": "Adjust medications; non-pharmacologic strategies",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Motor function (if FTD-ALS)",
        "frequency": "Every 3-6 months",
        "action": "Respiratory support; PT/OT; feeding tube discussion",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Weight",
        "frequency": "Each visit",
        "action": "Nutritional consult; address hyperphagia or dysphagia",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Swallowing function",
        "frequency": "Every 6-12 months or if symptoms",
        "action": "Speech therapy; diet modification; feeding tube if needed",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Caregiver burden (Zarit Burden Interview)",
        "frequency": "Every 6-12 months",
        "action": "Respite care; support groups; social work",
        "ED": "-",
        "HOSP": "-",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Safety assessment",
        "frequency": "Each visit",
        "action": "Increase supervision; remove hazards; consider placement",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "ECG (if on QT-prolonging medications)",
        "frequency": "Baseline; with dose changes",
        "action": "Reduce dose or switch medication",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "LFTs (if on valproic acid or riluzole)",
        "frequency": "Monthly x 3, then q3mo",
        "action": "Reduce or discontinue if >3x ULN",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      }
    ],
    "disposition": [
      {
        "disposition": "Discharge home",
        "criteria": "Behavioral crisis resolved; safe environment; adequate caregiver supervision; outpatient follow-up arranged; medications optimized"
      },
      {
        "disposition": "Admit to floor",
        "criteria": "Severe behavioral disturbance unsafe for home; medical workup needed; medication adjustment requiring monitoring; caregiver unable to manage"
      },
      {
        "disposition": "Admit to psychiatry",
        "criteria": "Danger to self or others; severe aggression; psychotic features; requires locked unit for safety"
      },
      {
        "disposition": "Memory care/Long-term care",
        "criteria": "Progressive decline; wandering risk; 24-hour supervision needed; caregiver unable to provide safe care"
      },
      {
        "disposition": "Hospice",
        "criteria": "End-stage FTD; minimal responsiveness; recurrent aspiration; weight loss; goals focused on comfort; FVC <50% in FTD-ALS"
      },
      {
        "disposition": "Outpatient follow-up",
        "criteria": "Neurology/cognitive neurology every 3-6 months; more frequent if on psychotropics or rapid progression; genetics follow-up after testing"
      }
    ]
  },
  "Normal Pressure Hydrocephalus": {
    "id": "normal-pressure-hydrocephalus",
    "title": "Normal Pressure Hydrocephalus",
    "version": "1.0",
    "icd10": [
      "** G91.2 (Normal pressure hydrocephalus)",
      "G91.0 (Communicating hydrocephalus)",
      "R41.0 (Disorientation",
      "unspecified)",
      "R26.0 (Ataxic gait)",
      "R32 (Unspecified urinary incontinence)"
    ],
    "scope": "** Comprehensive evaluation of suspected NPH, diagnostic workup including high-volume lumbar puncture (tap test), prediction of shunt responsiveness, neurosurgical referral, and post-shunt monitoring. Covers idiopathic NPH (most common) and secondary NPH. Does not cover acute obstructive hydrocephalus or pediatric hydrocephalus.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC with differential",
            "rationale": "Pre-surgical screening; rule out infection",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "BMP",
            "rationale": "Electrolyte assessment; pre-surgical renal function",
            "target": "Normal electrolytes, BUN, Cr",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Coagulation panel (PT/INR, PTT)",
            "rationale": "Pre-procedural assessment for LP and surgery",
            "target": "INR <1.5, PTT <40",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "TSH",
            "rationale": "Hypothyroidism can cause cognitive impairment",
            "target": "0.4-4.0 mIU/L",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin B12",
            "rationale": "B12 deficiency causes reversible dementia and gait ataxia",
            "target": ">300 pg/mL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Urinalysis with culture",
            "rationale": "Rule out UTI as cause of incontinence or confusion",
            "target": "Negative for infection",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Hemoglobin A1c",
            "rationale": "Diabetes contributes to small vessel disease and neuropathy",
            "target": "<7%",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended Workup": [
          {
            "item": "Folate",
            "rationale": "Deficiency contributes to cognitive impairment",
            "target": ">3 ng/mL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "RPR or VDRL",
            "rationale": "Neurosyphilis can cause dementia and gait abnormalities",
            "target": "Nonreactive",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "HIV antibody",
            "rationale": "HIV-associated neurocognitive disorder in at-risk patients",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "ESR, CRP",
            "rationale": "Inflammatory or infectious causes of meningitis/encephalitis",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Hepatic panel",
            "rationale": "Hepatic encephalopathy in patients with liver disease",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "PSA (males)",
            "rationale": "Prostate disease contributing to urinary symptoms",
            "target": "Normal for age",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Paraneoplastic antibody panel",
            "rationale": "Autoimmune etiology if subacute presentation",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Anti-neuronal antibodies (NMDA-R, LGI1, CASPR2)",
            "rationale": "Autoimmune encephalitis causing cognitive/behavioral changes",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Genetic testing for APP, PSEN1, PSEN2",
            "rationale": "Early-onset dementia with family history",
            "target": "No pathogenic variants",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "Opening pressure",
            "rationale": "Confirm normal or mildly elevated pressure in NPH",
            "target": "5-18 cm H2O (typically normal or low-normal in NPH)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Cell count (tubes 1 and 4)",
            "rationale": "Rule out infection or inflammation",
            "target": "WBC <5, RBC 0",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Protein",
            "rationale": "Rule out infectious/inflammatory causes",
            "target": "Normal 15-45 mg/dL",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Glucose with serum glucose",
            "rationale": "Rule out infectious meningitis",
            "target": ">60% of serum glucose",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CSF Abeta-42, total tau, p-tau",
            "rationale": "Differentiate from Alzheimer's disease (optional)",
            "target": "Normal in NPH; low Abeta-42 with high tau in AD",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "MRI Brain without contrast",
            "timing": "Initial evaluation",
            "target": "Ventriculomegaly with Evans index >0.3; callosal angle <90 degrees; DESH pattern; periventricular edema (transependymal flow); absence of cortical atrophy proportionate to ventricular size",
            "contraindications": "MRI-incompatible devices; claustrophobia",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CT Head non-contrast",
            "timing": "If MRI unavailable or emergent presentation",
            "target": "Ventriculomegaly out of proportion to sulcal enlargement; Evans index >0.3",
            "contraindications": "Pregnancy (relative)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended": [
          {
            "item": "MRI Brain with volumetric analysis",
            "timing": "Detailed assessment",
            "target": "Quantify ventricular volume; hippocampal volume preservation (unlike AD); tight high-convexity sulci",
            "contraindications": "MRI contraindications",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "MRI with CSF flow study (phase-contrast)",
            "timing": "Assess aqueductal CSF flow",
            "target": "Hyperdynamic aqueductal flow; increased stroke volume (>42 microL)",
            "contraindications": "MRI contraindications",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "MR spectroscopy",
            "timing": "Atypical cases to differentiate from AD",
            "target": "Normal NAA/Cr ratio (reduced in AD); no significant metabolic abnormality",
            "contraindications": "MRI contraindications",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "FDG-PET Brain",
            "timing": "Differentiate NPH from AD or FTD",
            "target": "Preserved metabolism (unlike AD temporoparietal hypometabolism)",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Intracranial pressure monitoring (continuous)",
            "timing": "Diagnostic uncertainty after tap test",
            "target": "B-waves present (indicates impaired CSF dynamics)",
            "contraindications": "Coagulopathy; skin infection",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Infusion testing (CSF outflow resistance)",
            "timing": "Research settings; predict shunt response",
            "target": "Elevated Rout >12-18 mmHg/mL/min suggests shunt responsiveness",
            "contraindications": "Coagulopathy",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Radionuclide cisternography",
            "timing": "Rarely used; assesses CSF flow patterns",
            "target": "Delayed clearance over convexities; ventricular reflux",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "Acetazolamide",
            "route": "PO",
            "indication": "Temporizing measure while awaiting surgery; reduces CSF production",
            "dosing": {
              "doseOptions": [
                {
                  "text": "250 mg BID",
                  "orderSentence": "Acetazolamide 250 mg BID PO"
                },
                {
                  "text": "250 mg TID",
                  "orderSentence": "Acetazolamide 250 mg TID PO"
                },
                {
                  "text": "500 mg BID",
                  "orderSentence": "Acetazolamide 500 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 250 mg BID; titrate to 250 mg TID or 500 mg BID; max 2 g/day",
              "orderSentence": "Acetazolamide 250 mg BID PO"
            },
            "contraindications": "Sulfa allergy; severe hepatic/renal disease; hypokalemia; metabolic acidosis",
            "monitoring": "BMP for potassium, bicarbonate; paresthesias",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Serial therapeutic LP",
            "route": "LP",
            "indication": "Temporizing measure; confirm continued benefit; bridge to surgery",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30-50 mL removed",
                  "orderSentence": "Serial therapeutic LP 30-50 mL removed LP"
                }
              ],
              "route": "LP",
              "instructions": "Remove 30-50 mL every 1-4 weeks based on symptom recurrence",
              "orderSentence": "Serial therapeutic LP 30-50 mL removed LP"
            },
            "contraindications": "Coagulopathy; anticoagulation; skin infection",
            "monitoring": "Post-LP symptoms; duration of benefit",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Symptomatic Treatments": [
          {
            "item": "Memantine",
            "route": "PO",
            "indication": "Cognitive symptoms; may provide modest benefit pending surgery",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg daily",
                  "orderSentence": "Memantine 5 mg daily PO"
                },
                {
                  "text": "5 mg BID",
                  "orderSentence": "Memantine 5 mg BID PO"
                },
                {
                  "text": "10 mg BID",
                  "orderSentence": "Memantine 10 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg daily; increase by 5 mg/week; target 10 mg BID",
              "orderSentence": "Memantine 5 mg daily PO"
            },
            "contraindications": "Severe renal impairment (adjust dose if CrCl <30)",
            "monitoring": "Confusion, dizziness",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Donepezil",
            "route": "PO",
            "indication": "Cognitive symptoms if AD component suspected",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg qHS",
                  "orderSentence": "Donepezil 5 mg qHS PO"
                },
                {
                  "text": "10 mg qHS",
                  "orderSentence": "Donepezil 10 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg qHS x 4-6 weeks; increase to 10 mg qHS",
              "orderSentence": "Donepezil 5 mg qHS PO"
            },
            "contraindications": "Sick sinus syndrome; GI bleeding; COPD",
            "monitoring": "Bradycardia, GI symptoms",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Oxybutynin",
            "route": "PO",
            "indication": "Urinary urgency/incontinence",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg BID",
                  "orderSentence": "Oxybutynin 5 mg BID PO"
                },
                {
                  "text": "5 mg TID",
                  "orderSentence": "Oxybutynin 5 mg TID PO"
                },
                {
                  "text": "10 mg ER daily",
                  "orderSentence": "Oxybutynin 10 mg ER daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg BID; may increase to 5 mg TID; or use ER 10-30 mg daily",
              "orderSentence": "Oxybutynin 5 mg BID PO"
            },
            "contraindications": "Uncontrolled narrow-angle glaucoma; urinary retention; GI obstruction",
            "monitoring": "Anticholinergic effects; cognitive worsening",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Mirabegron",
            "route": "PO",
            "indication": "Urinary urgency if anticholinergics contraindicated or cause cognitive worsening",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg daily",
                  "orderSentence": "Mirabegron 25 mg daily PO"
                },
                {
                  "text": "50 mg daily",
                  "orderSentence": "Mirabegron 50 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg daily; may increase to 50 mg daily",
              "orderSentence": "Mirabegron 25 mg daily PO"
            },
            "contraindications": "Severe uncontrolled hypertension",
            "monitoring": "Blood pressure",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Tamsulosin",
            "route": "PO",
            "indication": "Urinary retention (males with BPH component)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.4 mg daily",
                  "orderSentence": "Tamsulosin 0.4 mg daily PO"
                },
                {
                  "text": "0.8 mg daily",
                  "orderSentence": "Tamsulosin 0.8 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.4 mg daily; may increase to 0.8 mg daily",
              "orderSentence": "Tamsulosin 0.4 mg daily PO"
            },
            "contraindications": "Orthostatic hypotension; planned cataract surgery (IFIS)",
            "monitoring": "Orthostatic hypotension",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Trazodone",
            "route": "PO",
            "indication": "Sleep disturbance; sundowning",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Trazodone 25 mg qHS PO"
                },
                {
                  "text": "50 mg qHS",
                  "orderSentence": "Trazodone 50 mg qHS PO"
                },
                {
                  "text": "100 mg qHS",
                  "orderSentence": "Trazodone 100 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25-50 mg qHS; titrate to 50-150 mg qHS",
              "orderSentence": "Trazodone 25 mg qHS PO"
            },
            "contraindications": "Concurrent MAOIs; QT prolongation",
            "monitoring": "Orthostatic hypotension",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Physical therapy",
            "route": "-",
            "indication": "Gait training and fall prevention",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per PT evaluation",
                  "orderSentence": "Physical therapy Per PT evaluation -"
                }
              ],
              "route": "-",
              "instructions": "Initial evaluation plus ongoing therapy for gait training, balance, strength",
              "orderSentence": "Physical therapy Per PT evaluation -"
            },
            "contraindications": "None",
            "monitoring": "Fall risk assessment",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Definitive Treatment (Shunt Surgery)": [
          {
            "item": "Ventriculoperitoneal (VP) shunt",
            "route": "Surgical",
            "indication": "Definitive treatment for NPH; positive tap test or extended drain trial",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Programmable valve preferred",
                  "orderSentence": "Ventriculoperitoneal (VP) shunt Programmable valve preferred Surgical"
                }
              ],
              "route": "Surgical",
              "instructions": "Valve pressure setting adjusted based on symptoms; typical starting setting 120-180 mmH2O",
              "orderSentence": "Ventriculoperitoneal (VP) shunt Programmable valve preferred Surgical"
            },
            "contraindications": "Active peritoneal infection; peritoneal adhesions; recent abdominal surgery; ascites",
            "monitoring": "Post-op neuro checks; shunt series imaging; valve setting verification",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ventriculoatrial (VA) shunt",
            "route": "Surgical",
            "indication": "Alternative if peritoneum unsuitable (adhesions, peritonitis history)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Programmable valve preferred",
                  "orderSentence": "Ventriculoatrial (VA) shunt Programmable valve preferred Surgical"
                }
              ],
              "route": "Surgical",
              "instructions": "Catheter tip in right atrium; valve adjusted as VP shunt",
              "orderSentence": "Ventriculoatrial (VA) shunt Programmable valve preferred Surgical"
            },
            "contraindications": "Active bacteremia; severe cardiac disease; pulmonary hypertension",
            "monitoring": "Same as VP; plus cardiac monitoring; watch for shunt nephritis",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Lumboperitoneal (LP) shunt",
            "route": "Surgical",
            "indication": "Alternative approach; avoids cranial surgery",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Programmable valve preferred",
                  "orderSentence": "Lumboperitoneal (LP) shunt Programmable valve preferred Surgical"
                }
              ],
              "route": "Surgical",
              "instructions": "Catheter from lumbar subarachnoid space to peritoneum",
              "orderSentence": "Lumboperitoneal (LP) shunt Programmable valve preferred Surgical"
            },
            "contraindications": "Spinal stenosis; arachnoiditis; Chiari malformation",
            "monitoring": "Similar to VP; watch for overdrainage with positional changes",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Endoscopic third ventriculostomy (ETV)",
            "route": "Surgical",
            "indication": "Secondary NPH with aqueductal stenosis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "NA",
                  "orderSentence": "Endoscopic third ventriculostomy (ETV) NA Surgical"
                }
              ],
              "route": "Surgical",
              "instructions": "Create opening between third ventricle and interpeduncular cistern",
              "orderSentence": "Endoscopic third ventriculostomy (ETV) NA Surgical"
            },
            "contraindications": "Communicating hydrocephalus (most iNPH); scarred prepontine cistern",
            "monitoring": "Post-op neuro checks; repeat imaging",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "-"
          }
        ],
        "Post-Shunt Complication Management": [
          {
            "item": "Valve pressure adjustment",
            "route": "External",
            "indication": "Overdrainage symptoms (headache, subdural hematoma)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Increase valve setting",
                  "orderSentence": "Valve pressure adjustment Increase valve setting External programming"
                }
              ],
              "route": "External programming",
              "instructions": "Increase opening pressure by 20-30 mmH2O increments; recheck in 1-2 weeks",
              "orderSentence": "Valve pressure adjustment Increase valve setting External programming"
            },
            "contraindications": "None",
            "monitoring": "Symptom response; repeat imaging",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Valve pressure adjustment",
            "route": "External",
            "indication": "Underdrainage (persistent or worsening NPH symptoms)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Decrease valve setting",
                  "orderSentence": "Valve pressure adjustment Decrease valve setting External programming"
                }
              ],
              "route": "External programming",
              "instructions": "Decrease opening pressure by 20-30 mmH2O increments; recheck in 1-2 weeks",
              "orderSentence": "Valve pressure adjustment Decrease valve setting External programming"
            },
            "contraindications": "None",
            "monitoring": "Symptom response; repeat imaging",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vancomycin",
            "route": "IV",
            "indication": "Shunt infection (empiric)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "15-20 mg/kg IV q8-12h",
                  "orderSentence": "Vancomycin 15-20 mg/kg IV q8-12h IV"
                }
              ],
              "route": "IV",
              "instructions": "15-20 mg/kg IV q8-12h; adjust for renal function; target trough 15-20 mcg/mL",
              "orderSentence": "Vancomycin 15-20 mg/kg IV q8-12h IV"
            },
            "contraindications": "Vancomycin allergy",
            "monitoring": "Vancomycin trough; renal function",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Cefepime",
            "route": "IV",
            "indication": "Shunt infection (empiric gram-negative coverage)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 g IV q8h",
                  "orderSentence": "Cefepime 2 g IV q8h IV"
                }
              ],
              "route": "IV",
              "instructions": "2 g IV q8h; adjust for renal function",
              "orderSentence": "Cefepime 2 g IV q8h IV"
            },
            "contraindications": "Cephalosporin allergy",
            "monitoring": "Renal function",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Shunt revision surgery",
            "route": "Surgical",
            "indication": "Shunt malfunction, obstruction, or infection",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per neurosurgery",
                  "orderSentence": "Shunt revision surgery Per neurosurgery Surgical"
                }
              ],
              "route": "Surgical",
              "instructions": "Shunt externalization if infected; revision for mechanical failure",
              "orderSentence": "Shunt revision surgery Per neurosurgery Surgical"
            },
            "contraindications": "Active systemic infection",
            "monitoring": "Post-op monitoring; infection clearance",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurology for comprehensive evaluation, differential diagnosis, and coordination of diagnostic workup",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Neurosurgery for shunt candidacy evaluation after positive tap test or extended drain trial",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Neuropsychology for baseline cognitive assessment and differentiation from other dementias (AD, vascular)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Physical therapy for gait assessment, fall prevention, and baseline measurement for tap test comparison",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Occupational therapy for ADL assessment, home safety evaluation, and cognitive strategies",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Urology for evaluation if urinary symptoms prominent or atypical for NPH",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Social work for caregiver support, community resources, and care planning",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Geriatrics or geriatric psychiatry for complex older patients with multiple comorbidities",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Return immediately if sudden severe headache, new weakness, or altered consciousness develops (may indicate shunt malfunction or complication)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Report fever, incision redness, or drainage after shunt surgery (may indicate shunt infection)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE"
          },
          {
            "item": "Keep scheduled follow-up appointments for shunt valve pressure adjustments and monitoring",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Use assistive devices (walker, cane) as recommended by physical therapy to prevent falls",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Do not drive until cleared by physician due to cognitive impairment and fall risk",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Avoid MRI without confirming shunt valve is MRI-conditional and checking valve setting afterward",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Carry shunt information card with valve type and current pressure setting",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Fall precautions including removal of throw rugs, adequate lighting, grab bars in bathroom due to gait instability",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Regular physical activity within safe limits to maintain strength and mobility",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Cognitive stimulation through reading, puzzles, and social engagement to support cognitive reserve",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE"
          },
          {
            "item": "Blood pressure optimization (target <130/80) to reduce vascular contribution to cognitive impairment",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Adequate hydration to maintain optimal CSF dynamics; avoid dehydration",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          },
          {
            "item": "Bladder training program in conjunction with physical therapy for urinary symptoms",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Alzheimer's disease",
        "features": "Memory impairment predominant; insidious progression; no significant gait disturbance early; no improvement with LP",
        "tests": "MRI shows hippocampal atrophy >ventricular enlargement; CSF low Abeta-42, high tau; no tap test response"
      },
      {
        "diagnosis": "Vascular dementia",
        "features": "Stepwise decline; focal neurological signs; executive dysfunction; vascular risk factors",
        "tests": "MRI shows extensive white matter disease, strategic infarcts; ventriculomegaly less prominent"
      },
      {
        "diagnosis": "Parkinson's disease",
        "features": "Rest tremor; rigidity; bradykinesia; shuffling gait differs from NPH magnetic gait; no incontinence early",
        "tests": "DaTscan abnormal; no tap test response; no ventriculomegaly disproportionate to atrophy"
      },
      {
        "diagnosis": "Dementia with Lewy bodies",
        "features": "Visual hallucinations; fluctuating cognition; parkinsonism; REM sleep behavior disorder",
        "tests": "DaTscan abnormal; no ventricular enlargement out of proportion to atrophy"
      },
      {
        "diagnosis": "Progressive supranuclear palsy",
        "features": "Vertical gaze palsy; postural instability with falls backward; axial rigidity",
        "tests": "MRI midbrain atrophy (\"hummingbird sign\"); no tap test response"
      },
      {
        "diagnosis": "Cervical spondylotic myelopathy",
        "features": "Upper motor neuron signs in legs; hyperreflexia; Babinski; sensory level",
        "tests": "Cervical MRI shows cord compression; EMG findings"
      },
      {
        "diagnosis": "Peripheral neuropathy",
        "features": "Sensory loss distally; reduced reflexes; no cognitive or urinary symptoms",
        "tests": "EMG/NCS confirms peripheral nerve involvement"
      },
      {
        "diagnosis": "Obstructive hydrocephalus",
        "features": "Acute onset; headache; papilledema; elevated opening pressure on LP",
        "tests": "MRI shows obstructive lesion; elevated ICP; requires emergent intervention"
      },
      {
        "diagnosis": "Spinal stenosis",
        "features": "Neurogenic claudication; leg pain with walking relieved by rest/leaning forward",
        "tests": "Lumbar MRI shows stenosis; normal brain imaging"
      },
      {
        "diagnosis": "Frontotemporal dementia",
        "features": "Behavioral changes prominent; personality changes; language impairment",
        "tests": "MRI frontal/temporal atrophy; FDG-PET frontal hypometabolism"
      }
    ],
    "evidence": [
      {
        "recommendation": "Evans index >0.3 diagnostic for ventriculomegaly",
        "evidenceLevel": "Class II, Level B",
        "source": "[Relkin et al. Neurosurgery 2005 (iNPH Guidelines)](https://pubmed.ncbi.nlm.nih.gov/16234657/)"
      },
      {
        "recommendation": "Callosal angle <90 degrees supports iNPH diagnosis",
        "evidenceLevel": "Class III, Level C",
        "source": "[Virhammar et al. J Neurosurg 2014](https://pubmed.ncbi.nlm.nih.gov/24506247/)"
      },
      {
        "recommendation": "DESH (disproportionately enlarged subarachnoid-space hydrocephalus) pattern",
        "evidenceLevel": "Class II, Level B",
        "source": "[Hashimoto et al. AJNR 2010](https://pubmed.ncbi.nlm.nih.gov/20150305/)"
      },
      {
        "recommendation": "High-volume LP (tap test) predicts shunt response",
        "evidenceLevel": "Class II, Level B",
        "source": "[Marmarou et al. J Neurosurg 2005](https://pubmed.ncbi.nlm.nih.gov/16234659/)"
      },
      {
        "recommendation": "Extended lumbar drainage more sensitive than single tap test",
        "evidenceLevel": "Class II, Level B",
        "source": "[Walchenbach et al. J Neurol Neurosurg Psychiatry 2002](https://pubmed.ncbi.nlm.nih.gov/12122181/)"
      },
      {
        "recommendation": "VP shunt improves symptoms in selected iNPH patients",
        "evidenceLevel": "Class II, Level B",
        "source": "[Hebb et al. Can J Neurol Sci 2001](https://pubmed.ncbi.nlm.nih.gov/11513352/)"
      },
      {
        "recommendation": "Programmable valves reduce revision surgery rates",
        "evidenceLevel": "Class II, Level B",
        "source": "[Zemack et al. Eur J Neurol 2003](https://pubmed.ncbi.nlm.nih.gov/14641516/)"
      },
      {
        "recommendation": "Gait improvement most responsive to shunting",
        "evidenceLevel": "Class II, Level B",
        "source": "[Ishikawa et al. Neurology 2012](https://pubmed.ncbi.nlm.nih.gov/22442434/)"
      },
      {
        "recommendation": "Short symptom duration predicts better shunt outcome",
        "evidenceLevel": "Class II, Level B",
        "source": "[Relkin et al. Neurosurgery 2005](https://pubmed.ncbi.nlm.nih.gov/16234657/)"
      },
      {
        "recommendation": "CSF biomarkers help differentiate NPH from AD",
        "evidenceLevel": "Class III, Level C",
        "source": "[Tarnaris et al. Neurology 2011](https://pubmed.ncbi.nlm.nih.gov/21282586/)"
      },
      {
        "recommendation": "Shunt infection rate 5-10%; requires shunt removal for treatment",
        "evidenceLevel": "Class III, Level C",
        "source": "[McGirt et al. J Neurosurg 2003](https://pubmed.ncbi.nlm.nih.gov/12959439/)"
      },
      {
        "recommendation": "Japanese iNPH Guidelines diagnostic criteria",
        "evidenceLevel": "Class II, Level B",
        "source": "[Mori et al. Neurol Med Chir 2012](https://pubmed.ncbi.nlm.nih.gov/23037929/)"
      }
    ],
    "monitoring": [
      {
        "item": "Gait assessment (timed 10m walk, Tinetti)",
        "frequency": "Pre-LP, post-LP, each follow-up",
        "action": "Positive change supports diagnosis; no change may indicate poor shunt candidacy",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "MoCA or MMSE",
        "frequency": "Baseline, post-LP, every 6 months",
        "action": "Improvement suggests NPH; decline suggests alternative diagnosis or shunt failure",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Post-shunt imaging (CT or MRI)",
        "frequency": "1-2 days post-op, 3 months, then PRN",
        "action": "Repeat imaging if symptoms change; adjust valve",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Shunt valve setting verification",
        "frequency": "After any MRI; at each clinic visit",
        "action": "Reprogram if reset; ensure appropriate setting",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Neurological exam",
        "frequency": "Each clinic visit",
        "action": "Decline triggers workup for shunt malfunction or alternative diagnosis",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Subdural hematoma surveillance",
        "frequency": "Post-shunt, especially if headache",
        "action": "Adjust valve pressure higher; surgical evacuation if large/symptomatic",
        "ED": "STAT",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Signs of shunt infection",
        "frequency": "Post-operatively and ongoing",
        "action": "Blood/CSF cultures; shunt tap; IV antibiotics; possible shunt removal",
        "ED": "STAT",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Urinary symptom diary",
        "frequency": "Baseline and follow-up",
        "action": "Adjust bladder medications; confirm NPH response",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "ADL/IADL function",
        "frequency": "Every 6 months",
        "action": "Increase support services; OT reassessment",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      }
    ],
    "disposition": [
      {
        "disposition": "Discharge home",
        "criteria": "Stable symptoms; workup complete; awaiting outpatient tap test; caregiver support available"
      },
      {
        "disposition": "Admit to floor",
        "criteria": "Extended lumbar drain trial; post-shunt observation; shunt complication evaluation"
      },
      {
        "disposition": "Admit to ICU",
        "criteria": "Acute shunt malfunction with altered mental status; symptomatic overdrainage with large subdural; shunt infection with sepsis"
      },
      {
        "disposition": "Outpatient follow-up",
        "criteria": "Neurology 2-4 weeks after tap test to review results; Neurosurgery evaluation if positive tap test; post-shunt follow-up at 1-3 months, 6 months, then annually"
      },
      {
        "disposition": "Urgent neurosurgery referral",
        "criteria": "Positive tap test; positive extended drain trial; progressive symptoms with classic imaging findings"
      }
    ]
  },
  "Optic Neuritis": {
    "id": "optic-neuritis",
    "title": "Optic Neuritis",
    "version": "1.0",
    "icd10": [
      "** H46.9 (Optic neuritis",
      "unspecified)",
      "H46.00 (Optic papillitis",
      "unspecified eye)",
      "H46.10 (Retrobulbar neuritis",
      "unspecified eye)",
      "G36.0 (Neuromyelitis optica - if NMOSD confirmed)"
    ],
    "scope": "** Acute evaluation and management of optic neuritis in adults. Covers typical demyelinating optic neuritis, atypical features requiring expanded workup, MS risk stratification, ONTT-based treatment, and NMO/MOG antibody evaluation. For established MS with optic neuritis as a relapse, can also use \"MS - Exacerbation\" template.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC with differential",
            "rationale": "Infection screen, baseline before steroids",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CMP",
            "rationale": "Metabolic screen, renal function for contrast",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "ESR",
            "rationale": "Inflammatory/vasculitis screen; elevated in GCA",
            "target": "Normal (<20 mm/hr); elevated in GCA",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CRP",
            "rationale": "Inflammatory marker",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Blood glucose",
            "rationale": "Pre-steroid baseline",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Urinalysis",
            "rationale": "UTI screen before steroids",
            "target": "Negative",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended Workup": [
          {
            "item": "**Mayo CDS1 Panel** (AQP4-IgG + MOG-IgG by FACS)",
            "rationale": "Combined NMO/MOGAD screen; critical for atypical cases",
            "target": "Both negative",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "ANA",
            "rationale": "Lupus/connective tissue disease",
            "target": "Negative or low titer",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "TSH",
            "rationale": "Thyroid eye disease (Graves ophthalmopathy)",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin B12",
            "rationale": "Nutritional optic neuropathy",
            "target": "Normal (>300 pg/mL)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Folate",
            "rationale": "Nutritional optic neuropathy",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "RPR/VDRL",
            "rationale": "Neurosyphilis",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "HIV",
            "rationale": "HIV-associated optic neuropathy",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "ACE level",
            "rationale": "Neurosarcoidosis",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lyme serology",
            "rationale": "Endemic areas; Lyme optic neuropathy",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "HbA1c",
            "rationale": "Glycemic status before steroids",
            "target": "<5.7%",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Anti-dsDNA",
            "rationale": "If ANA positive; SLE screen",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Anti-SSA/SSB (Ro/La)",
            "rationale": "Sjogren syndrome",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "ANCA panel",
            "rationale": "CNS/orbital vasculitis",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Serum protein electrophoresis",
            "rationale": "Paraproteinemic optic neuropathy",
            "target": "No M-spike",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Mitochondrial DNA testing",
            "rationale": "Leber hereditary optic neuropathy (LHON)",
            "target": "Normal",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Copper, ceruloplasmin",
            "rationale": "Wilson disease",
            "target": "Normal",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Paraneoplastic panel (anti-CRMP5/CV2)",
            "rationale": "Paraneoplastic optic neuropathy",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "Opening pressure",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Rule out elevated ICP (papilledema mimics)",
            "target": "10-20 cm H2O"
          },
          {
            "item": "Cell count (tubes 1 and 4)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Inflammation, rule out infection",
            "target": "WBC <50 (mild pleocytosis acceptable); RBC 0"
          },
          {
            "item": "Protein",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Elevated in inflammation",
            "target": "Normal to mildly elevated (<100 mg/dL)"
          },
          {
            "item": "Glucose with serum glucose",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Low in infection",
            "target": "Normal (>60% serum)"
          },
          {
            "item": "Gram stain and culture",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Rule out infection",
            "target": "No organisms"
          },
          {
            "item": "Oligoclonal bands (CSF AND serum)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Intrathecal IgG synthesis (supports MS)",
            "target": "≥2 CSF-specific bands (not in serum)"
          },
          {
            "item": "IgG index",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Intrathecal antibody synthesis",
            "target": ">0.7 = elevated"
          },
          {
            "item": "Cytology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Rule out malignancy",
            "target": "Negative"
          },
          {
            "item": "VDRL (CSF)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Neurosyphilis",
            "target": "Negative"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "MRI orbits with contrast (fat-suppressed T1, STIR)",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Within 24-48h",
            "target": "Optic nerve enhancement, swelling; enhancement >50% nerve length suggests atypical/NMOSD",
            "contraindications": "GFR <30, gadolinium allergy"
          },
          {
            "item": "MRI brain with and without contrast (MS protocol)",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "With orbit MRI",
            "target": "Demyelinating lesions (periventricular, juxtacortical, infratentorial); determines MS risk",
            "contraindications": "Same as above"
          },
          {
            "item": "MRI C-spine with and without contrast",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Within 1 week if MS suspected",
            "target": "Cord lesions supporting MS diagnosis",
            "contraindications": "Same as above"
          }
        ],
        "Extended": [
          {
            "item": "Visual evoked potentials (VEP)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "During workup",
            "target": "Prolonged P100 latency (confirms optic nerve dysfunction)",
            "contraindications": "None significant"
          },
          {
            "item": "OCT (Optical coherence tomography)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Baseline and at 3-6 months",
            "target": "RNFL thickening acutely; thinning at follow-up indicates axonal loss",
            "contraindications": "None significant"
          },
          {
            "item": "Formal visual field testing (Humphrey 30-2 or 24-2)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "At presentation and follow-up",
            "target": "Central/cecocentral scotoma typical; document baseline",
            "contraindications": "Patient cooperation required"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "CT chest",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "If sarcoidosis suspected",
            "target": "Hilar lymphadenopathy",
            "contraindications": "Contrast allergy"
          },
          {
            "item": "PET-CT",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "If malignancy/paraneoplastic suspected",
            "target": "FDG-avid lesions",
            "contraindications": "Pregnancy, uncontrolled diabetes"
          },
          {
            "item": "CT orbits",
            "ED": "STAT",
            "HOSP": "-",
            "OPD": "-",
            "ICU": "-",
            "timing": "Only if MRI unavailable/contraindicated",
            "target": "Optic nerve enlargement, orbital mass",
            "contraindications": "Contrast allergy"
          },
          {
            "item": "Fluorescein angiography",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "If retinal/vascular pathology suspected",
            "target": "Disc leakage, vascular abnormality",
            "contraindications": "Dye allergy"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "Methylprednisolone",
            "route": "IV",
            "indication": "Acute optic neuritis - accelerates visual recovery per ONTT",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mg daily x 3 days",
                  "orderSentence": "Methylprednisolone 1000 mg daily x 3 days IV"
                }
              ],
              "route": "IV",
              "instructions": "1000 mg IV daily for 3 days; infuse over 1-2 hours; followed by oral prednisone taper",
              "orderSentence": "Methylprednisolone 1000 mg daily x 3 days IV"
            },
            "contraindications": "Active untreated infection; uncontrolled diabetes; active psychosis; severe hypertension",
            "monitoring": "Glucose q6h (target <180); BP; mood; sleep; I/O",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Prednisone oral taper",
            "route": "PO",
            "indication": "Following IV methylprednisolone per ONTT protocol",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 mg/kg/day x 11 days",
                  "orderSentence": "Prednisone oral taper 1 mg/kg/day x 11 days PO"
                }
              ],
              "route": "PO",
              "instructions": "1 mg/kg/day (max 80 mg) x 11 days following 3 days IV steroids; then discontinue or rapid taper",
              "orderSentence": "Prednisone oral taper 1 mg/kg/day x 11 days PO"
            },
            "contraindications": "Same as IV steroids",
            "monitoring": "Glucose; BP; mood; GI prophylaxis",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Omeprazole",
            "route": "PO",
            "indication": "GI prophylaxis during steroids",
            "dosing": {
              "doseOptions": [
                {
                  "text": "20 mg daily",
                  "orderSentence": "Omeprazole 20 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "20-40 mg daily during steroid course",
              "orderSentence": "Omeprazole 20 mg daily PO"
            },
            "contraindications": "PPI allergy; osteoporosis (long-term)",
            "monitoring": "None routine",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Insulin sliding scale",
            "route": "SC",
            "indication": "Steroid-induced hyperglycemia",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per protocol",
                  "orderSentence": "Insulin sliding scale Per protocol SC"
                }
              ],
              "route": "SC",
              "instructions": "Per institutional protocol if glucose >180 mg/dL",
              "orderSentence": "Insulin sliding scale Per protocol SC"
            },
            "contraindications": "Hypoglycemia risk",
            "monitoring": "Glucose q6h",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "-"
          }
        ],
        "Symptomatic Treatments": [
          {
            "item": "Acetaminophen",
            "route": "PO",
            "indication": "Pain with eye movement",
            "dosing": {
              "doseOptions": [
                {
                  "text": "650-1000 mg q6h PRN",
                  "orderSentence": "Acetaminophen 650-1000 mg q6h PRN PO"
                }
              ],
              "route": "PO",
              "instructions": "650-1000 mg PO q6h as needed for pain; max 3000 mg/day (2000 mg if liver disease)",
              "orderSentence": "Acetaminophen 650-1000 mg q6h PRN PO"
            },
            "contraindications": "Hepatic impairment; chronic alcohol use",
            "monitoring": "LFTs if prolonged use",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ibuprofen",
            "route": "PO",
            "indication": "Pain with eye movement",
            "dosing": {
              "doseOptions": [
                {
                  "text": "400-800 mg q8h PRN",
                  "orderSentence": "Ibuprofen 400-800 mg q8h PRN PO"
                }
              ],
              "route": "PO",
              "instructions": "400-800 mg PO q8h as needed for pain; max 2400 mg/day; take with food",
              "orderSentence": "Ibuprofen 400-800 mg q8h PRN PO"
            },
            "contraindications": "Renal impairment; GI bleeding; concurrent anticoagulation",
            "monitoring": "Renal function if prolonged",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Gabapentin",
            "route": "PO",
            "indication": "Persistent periorbital pain/neuropathic symptoms",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg qHS",
                  "orderSentence": "Gabapentin 300 mg qHS PO"
                },
                {
                  "text": "300 mg TID",
                  "orderSentence": "Gabapentin 300 mg TID PO"
                },
                {
                  "text": "600 mg TID",
                  "orderSentence": "Gabapentin 600 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 300 mg qHS; increase by 300 mg every 1-3 days; target 900-1800 mg/day divided TID",
              "orderSentence": "Gabapentin 300 mg qHS PO"
            },
            "contraindications": "Renal impairment (adjust dose)",
            "monitoring": "Sedation; dizziness",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Artificial tears",
            "route": "TOP",
            "indication": "Dry eye secondary to reduced blink or lagophthalmos",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1-2 drops q2-4h PRN",
                  "orderSentence": "Artificial tears 1-2 drops q2-4h PRN TOP"
                }
              ],
              "route": "TOP",
              "instructions": "Preservative-free artificial tears 1-2 drops q2-4h as needed",
              "orderSentence": "Artificial tears 1-2 drops q2-4h PRN TOP"
            },
            "contraindications": "None",
            "monitoring": "None",
            "ED": "ROUTINE",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Second-line/Refractory": [
          {
            "item": "Plasmapheresis (PLEX)",
            "route": "-",
            "indication": "Steroid-refractory or severe vision loss",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5-7 exchanges over 10-14 days",
                  "orderSentence": "Plasmapheresis (PLEX) 5-7 exchanges over 10-14 days PLEX"
                }
              ],
              "route": "PLEX",
              "instructions": "5-7 exchanges every other day; typical volume 1-1.5 plasma volumes",
              "orderSentence": "Plasmapheresis (PLEX) 5-7 exchanges over 10-14 days PLEX"
            },
            "contraindications": "Hemodynamic instability; sepsis; line contraindication",
            "monitoring": "BP; electrolytes; coags; fibrinogen; line infection",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "IVIG",
            "route": "IV",
            "indication": "Steroid-refractory (alternative to PLEX)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.4 g/kg/day x 5 days",
                  "orderSentence": "IVIG 0.4 g/kg/day x 5 days IV"
                }
              ],
              "route": "IV",
              "instructions": "0.4 g/kg/day for 5 days (total 2 g/kg); infuse slowly day 1",
              "orderSentence": "IVIG 0.4 g/kg/day x 5 days IV"
            },
            "contraindications": "IgA deficiency; renal failure; thrombosis risk",
            "monitoring": "Renal function; headache; thrombosis",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "-"
          },
          {
            "item": "Extended IV steroids",
            "route": "IV",
            "indication": "Incomplete response to 3-day course",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mg daily additional 2-5 days",
                  "orderSentence": "Extended IV steroids 1000 mg daily additional 2-5 days IV"
                }
              ],
              "route": "IV",
              "instructions": "Extend to 5-7 total days if inadequate response",
              "orderSentence": "Extended IV steroids 1000 mg daily additional 2-5 days IV"
            },
            "contraindications": "Same as initial course",
            "monitoring": "Same as initial course",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "-"
          }
        ],
        "Disease-Modifying Therapies (If MS/NMOSD/MOGAD Confirmed)": [
          {
            "item": "MS DMT (various)",
            "route": "Variable",
            "indication": "If MS diagnosed based on MRI + clinical criteria",
            "dosing": {
              "instructions": "See MS - New Diagnosis template",
              "orderSentence": "MS DMT (various) - Variable - see dosing"
            },
            "pretreatment": "Per specific DMT",
            "contraindications": "Per specific DMT",
            "monitoring": "Per specific DMT",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rituximab",
            "route": "IV",
            "indication": "NMOSD (AQP4-IgG positive)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mg IV x 2 doses 2 weeks apart",
                  "orderSentence": "Rituximab 1000 mg IV x 2 doses 2 weeks apart IV"
                }
              ],
              "route": "IV",
              "instructions": "1000 mg IV days 1 and 15; maintenance 1000 mg q6 months",
              "orderSentence": "Rituximab 1000 mg IV x 2 doses 2 weeks apart IV"
            },
            "pretreatment": "Hepatitis B serology; TB test; immunoglobulins",
            "contraindications": "Active Hep B; active infection",
            "monitoring": "CD19/20; immunoglobulins annually",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Eculizumab (Soliris)",
            "route": "IV",
            "indication": "NMOSD (AQP4-IgG positive) - FDA approved",
            "dosing": {
              "doseOptions": [
                {
                  "text": "900 mg IV weekly x 4 then 1200 mg q2wk",
                  "orderSentence": "Eculizumab (Soliris) 900 mg IV weekly x 4 then 1200 mg q2wk IV"
                }
              ],
              "route": "IV",
              "instructions": "900 mg weekly x 4; then 1200 mg at week 5; then 1200 mg q2 weeks",
              "orderSentence": "Eculizumab (Soliris) 900 mg IV weekly x 4 then 1200 mg q2wk IV"
            },
            "pretreatment": "Meningococcal vaccination (2 weeks prior)",
            "contraindications": "Unresolved Neisseria infection",
            "monitoring": "CBC; LFTs; signs of meningococcal infection",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Immunosuppression (MOGAD)",
            "route": "Variable",
            "indication": "MOGAD (MOG-IgG positive) with relapsing course",
            "dosing": {
              "instructions": "Rituximab, azathioprine, or mycophenolate",
              "orderSentence": "Immunosuppression (MOGAD) - Variable - see dosing"
            },
            "pretreatment": "Per specific agent",
            "contraindications": "Per specific agent",
            "monitoring": "Per specific agent",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neuro-ophthalmology referral for comprehensive evaluation and follow-up",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Neurology/MS specialist referral if brain MRI shows demyelinating lesions",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Ophthalmology referral if neuro-ophthalmology unavailable or alternate diagnosis suspected",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "MS specialist/Neuroimmunology for DMT discussion if MS criteria met",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Low vision rehabilitation if significant persistent visual impairment",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Occupational therapy for ADL adaptation if functional visual impairment",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Social work for disability resources if visual impairment affects employment",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Vision typically improves over 2-4 weeks; 90%+ recover to 20/40 or better within 1 year",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Return immediately if vision worsening after initial improvement (may indicate new attack or alternate diagnosis)",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Return if new symptoms: weakness, numbness, imbalance, bladder problems (may indicate MS)",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Do not drive if vision in affected eye prevents safe driving; check with state DMV regarding vision requirements",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Heat may temporarily worsen symptoms (Uhthoff phenomenon) - this is not a new attack or permanent worsening",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Expect temporary steroid side effects: insomnia, mood changes, increased appetite, metallic taste during IV infusion",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "-"
          },
          {
            "item": "Do not stop oral prednisone abruptly if on taper (adrenal suppression risk)",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Monitor blood sugars if diabetic - steroids elevate glucose",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Avoid sick contacts while on high-dose steroids (immunosuppression)",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "-"
          },
          {
            "item": "Keep follow-up appointments - important to monitor for MS development",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Contact physician if fever, new headache, or worsening vision on steroids",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Smoking cessation - smoking increases MS conversion risk and worsens outcomes",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Vitamin D supplementation 2000-5000 IU daily (target serum 25-OH vitamin D >40 ng/mL) - low levels associated with MS risk",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Avoid prolonged heat exposure (hot tubs, saunas, exercising in heat) which can temporarily worsen vision (Uhthoff)",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Use sunglasses if photophobia present",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Regular aerobic exercise as tolerated once acute symptoms resolve",
            "ED": "-",
            "HOSP": "-",
            "OPD": "✓"
          },
          {
            "item": "Adequate sleep (7-8 hours nightly) and stress management",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Eye protection during activities if monocular vision (loss of depth perception)",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "NMOSD-associated optic neuritis",
        "features": "Severe vision loss (often <20/200); bilateral simultaneous or sequential; poor recovery; longitudinally extensive optic nerve enhancement (>50% nerve length)",
        "tests": "AQP4-IgG positive (Mayo CDS1 or NMOFS); MRI pattern"
      },
      {
        "diagnosis": "MOGAD-associated optic neuritis",
        "features": "Often bilateral; anterior optic nerve involvement; perineural enhancement (\"optic nerve sheath sign\"); disc edema more prominent; better steroid response; tends to relapse",
        "tests": "MOG-IgG positive (Mayo CDS1 or MOGFS)"
      },
      {
        "diagnosis": "Anterior ischemic optic neuropathy (AION)",
        "features": "Sudden painless vision loss; altitudinal field defect; disc edema with hemorrhages; age >50; vascular risk factors (hypertension, diabetes)",
        "tests": "ESR/CRP for GCA; fluorescein angiography; cardiovascular risk assessment"
      },
      {
        "diagnosis": "Giant cell arteritis (GCA)",
        "features": "Age >50; headache; jaw claudication; scalp tenderness; elevated ESR/CRP; bilateral risk",
        "tests": "ESR, CRP, temporal artery biopsy; prompt treatment to prevent fellow eye"
      },
      {
        "diagnosis": "Papilledema",
        "features": "Bilateral disc edema; transient visual obscurations; headache worse lying down; no RAPD unless asymmetric",
        "tests": "LP with elevated opening pressure; MRI/MRV for venous sinus thrombosis"
      },
      {
        "diagnosis": "Compressive optic neuropathy",
        "features": "Progressive vision loss; proptosis; may have disc pallor or edema; optic canal mass",
        "tests": "MRI orbits showing mass lesion; CT for bony detail"
      },
      {
        "diagnosis": "Leber hereditary optic neuropathy (LHON)",
        "features": "Painless; young males; sequential bilateral (weeks to months); central scotoma; no enhancement on MRI",
        "tests": "Mitochondrial DNA testing (mutations: 11778, 3460, 14484)"
      },
      {
        "diagnosis": "Toxic/nutritional optic neuropathy",
        "features": "Bilateral symmetric; ethambutol, methanol, B12/folate deficiency; cecocentral scotoma",
        "tests": "B12, folate, medication history, alcohol use"
      },
      {
        "diagnosis": "Neurosyphilis",
        "features": "May mimic optic neuritis; other neurologic signs; risk factors",
        "tests": "RPR/VDRL, FTA-ABS, CSF VDRL"
      },
      {
        "diagnosis": "Sarcoidosis",
        "features": "Granulomatous optic neuropathy; uveitis; other systemic involvement",
        "tests": "ACE, chest CT, tissue biopsy"
      },
      {
        "diagnosis": "Idiopathic intracranial hypertension (IIH)",
        "features": "Bilateral disc edema; obese young female; headache; transient visual obscurations",
        "tests": "LP with elevated opening pressure; normal MRI/MRV"
      }
    ],
    "evidence": [
      {
        "recommendation": "IV methylprednisolone accelerates visual recovery but does not change final outcome",
        "evidenceLevel": "Class I, Level A",
        "source": "[Beck RW et al. NEJM 1992 (ONTT)](https://pubmed.ncbi.nlm.nih.gov/1594973/)"
      },
      {
        "recommendation": "Oral prednisone alone (1 mg/kg) increases recurrence rate - avoid as monotherapy",
        "evidenceLevel": "Class I, Level A",
        "source": "[Beck RW et al. NEJM 1992 (ONTT)](https://pubmed.ncbi.nlm.nih.gov/1594973/)"
      },
      {
        "recommendation": "Visual prognosis excellent: 90%+ recover to 20/40 or better by 1 year",
        "evidenceLevel": "Class I",
        "source": "[Beck RW et al. Arch Ophthalmol 1993](https://pubmed.ncbi.nlm.nih.gov/8517838/)"
      },
      {
        "recommendation": "Brain MRI lesions predict MS: 50% at 15 years with ≥1 lesion vs 25% with normal MRI",
        "evidenceLevel": "Class I",
        "source": "[Beck RW et al. NEJM 2003 (ONTT 10-year)](https://pubmed.ncbi.nlm.nih.gov/12660385/); [Optic Neuritis Study Group 2008 (15-year)](https://pubmed.ncbi.nlm.nih.gov/18332318/)"
      },
      {
        "recommendation": "Cell-based assay (FACS) preferred for AQP4/MOG antibody testing",
        "evidenceLevel": "Class II, Level B",
        "source": "[Pittock SJ et al. Neurology 2019](https://pubmed.ncbi.nlm.nih.gov/31434689/); [Waters P et al. J Neurol Neurosurg Psychiatry 2014](https://pubmed.ncbi.nlm.nih.gov/24009151/)"
      },
      {
        "recommendation": "MOG-IgG associated with better visual recovery and relapsing course",
        "evidenceLevel": "Class II",
        "source": "[Jarius S et al. J Neuroinflammation 2018](https://pubmed.ncbi.nlm.nih.gov/30153836/)"
      },
      {
        "recommendation": "PLEX beneficial for steroid-refractory demyelinating optic neuritis",
        "evidenceLevel": "Class II, Level B",
        "source": "[Roesner S et al. J Neurol 2012](https://pubmed.ncbi.nlm.nih.gov/21822932/)"
      },
      {
        "recommendation": "VEP shows prolonged P100 latency in optic neuritis",
        "evidenceLevel": "Class I",
        "source": "[Halliday AM et al. Lancet 1972](https://pubmed.ncbi.nlm.nih.gov/4113644/)"
      },
      {
        "recommendation": "OCT RNFL thinning correlates with visual outcomes",
        "evidenceLevel": "Class II",
        "source": "[Trip SA et al. Brain 2005](https://pubmed.ncbi.nlm.nih.gov/16006539/)"
      },
      {
        "recommendation": "Vitamin D deficiency associated with increased MS risk after optic neuritis",
        "evidenceLevel": "Class II",
        "source": "[Munger KL et al. JAMA 2006](https://pubmed.ncbi.nlm.nih.gov/17179460/)"
      },
      {
        "recommendation": "Smoking increases MS conversion risk after CIS",
        "evidenceLevel": "Class II, Level B",
        "source": "[Hedstrom AK et al. Brain 2013](https://pubmed.ncbi.nlm.nih.gov/23365092/)"
      }
    ],
    "monitoring": [
      {
        "item": "Visual acuity",
        "ED": "✓",
        "HOSP": "✓",
        "OPD": "✓",
        "ICU": "-",
        "frequency": "Daily inpatient; each visit OPD",
        "action": "If no improvement by 2 weeks, reconsider diagnosis or escalate treatment"
      },
      {
        "item": "Color vision (Ishihara or HRR plates)",
        "ED": "-",
        "HOSP": "✓",
        "OPD": "✓",
        "ICU": "-",
        "frequency": "Baseline and follow-up",
        "action": "Persistent dyschromatopsia suggests residual dysfunction"
      },
      {
        "item": "Pupillary exam (RAPD)",
        "ED": "✓",
        "HOSP": "✓",
        "OPD": "✓",
        "ICU": "-",
        "frequency": "Daily inpatient; each visit OPD",
        "action": "Persistent or worsening RAPD concerning"
      },
      {
        "item": "Blood glucose",
        "ED": "✓",
        "HOSP": "✓",
        "OPD": "-",
        "ICU": "-",
        "frequency": "Q6h during IV steroids",
        "action": "Insulin sliding scale; endocrine consult if persistent >250"
      },
      {
        "item": "Blood pressure",
        "ED": "✓",
        "HOSP": "✓",
        "OPD": "-",
        "ICU": "-",
        "frequency": "Q shift during steroids",
        "action": "Antihypertensives PRN"
      },
      {
        "item": "Mood and sleep",
        "ED": "-",
        "HOSP": "✓",
        "OPD": "-",
        "ICU": "-",
        "frequency": "Daily during steroids",
        "action": "Psychiatry consult; consider dose reduction"
      },
      {
        "item": "Visual field (formal)",
        "ED": "-",
        "HOSP": "-",
        "OPD": "✓",
        "ICU": "-",
        "frequency": "Baseline, 1 month, 3 months, 6 months",
        "action": "Worsening field concerning for progression"
      },
      {
        "item": "OCT (RNFL thickness)",
        "ED": "-",
        "HOSP": "-",
        "OPD": "✓",
        "ICU": "-",
        "frequency": "Baseline, 3 months, 6 months",
        "action": ">20 micron loss associated with poorer outcome"
      },
      {
        "item": "MRI brain (follow-up)",
        "ED": "-",
        "HOSP": "-",
        "OPD": "✓",
        "ICU": "-",
        "frequency": "3-6 months after initial; annually if MS risk",
        "action": "If new lesions: MS diagnosed, start DMT"
      },
      {
        "item": "NMO/MOG antibodies (recheck)",
        "ED": "-",
        "HOSP": "-",
        "OPD": "✓",
        "ICU": "-",
        "frequency": "Repeat at 3-6 months if initially negative but atypical features",
        "action": "If seroconversion: diagnosis changes, different treatment"
      }
    ],
    "disposition": [
      {
        "disposition": "**Discharge home**",
        "criteria": "Mild-moderate vision loss with stable exam; able to perform ADLs safely; IV steroids completed or not indicated; reliable follow-up within 1-2 weeks with neuro-ophthalmology or neurology; understands return precautions"
      },
      {
        "disposition": "**Admit to floor**",
        "criteria": "Severe vision loss (20/200 or worse); bilateral involvement; diagnostic uncertainty requiring expedited workup; unable to care for self safely at home due to vision loss; IV steroids indicated and outpatient infusion not available"
      },
      {
        "disposition": "**Admit to ICU**",
        "criteria": "Not typically required for isolated optic neuritis; consider if concurrent severe neurologic involvement (e.g., NMOSD with myelitis and respiratory compromise)"
      },
      {
        "disposition": "**Transfer to higher level**",
        "criteria": "Neuro-ophthalmology or MS specialist not available; PLEX needed but unavailable; MRI unavailable for urgent imaging"
      }
    ]
  }
}